PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sridharan, D; Levitin, DJ; Chafe, CH; Berger, J; Menon, V				Sridharan, Devarajan; Levitin, Daniel J.; Chafe, Chris H.; Berger, Jonathan; Menon, Vinod			Neural dynamics of event segmentation in music: Converging evidence for dissociable ventral and dorsal networks	NEURON			English	Article								The real world presents our sensory systems with a continuous stream of undifferentiated information. Segmentation of this stream at event boundaries is necessary for object identification and feature extraction. Here, we investigate the neural dynamics of event segmentation in entire musical symphonies under natural listening conditions. We isolated time-dependent sequences of brain responses in a 10 s window surrounding transitions between movements of symphonic works. A strikingly right-lateralized network of brain regions showed peak response during the movement transitions when, paradoxically, there was no physical stimulus. Model-dependent and model-free analysis techniques provided converging evidence for activity in two distinct functional networks at the movement transition: a ventral fronto-temporal network associated with detecting salient events, followed in time by a dorsal fronto-parietal network associated with maintaining attention and updating working memory. Our study provides direct experimental evidence for dissociable and causally linked ventral and dorsal networks during event segmentation of ecologically valid auditory stimuli.	Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Neurosci Inst Stanford, Sch Med, Stanford, CA 94305 USA; McGill Univ, Sch Comp Sci, Dept Psychol & Mus Theory, Montreal, PQ, Canada; McGill Univ, Program Behav Neurosci, Montreal, PQ, Canada; Stanford Univ, Dept Mus, Stanford, CA 94305 USA; Ctr Comp Res Mus & Acoust, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; McGill University; McGill University; Stanford University	Sridharan, D (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA.	dsridhar@stanford.edu; menon@stanford.edu	Menon, Vinod/J-6402-2013	Menon, Vinod/0000-0003-1622-9857; Devarajan, Sridharan/0000-0003-1998-9018	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047520] Funding Source: NIH RePORTER; NICHD NIH HHS [HD047520] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Apel, 1950, HARVARD DICT MUSIC; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Astafiev SV, 2006, EUR J NEUROSCI, V23, P591, DOI 10.1111/j.1460-9568.2005.04573.x; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Burgund ED, 2005, NEUROIMAGE, V25, P511, DOI 10.1016/j.neuroimage.2004.12.039; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Cooper G., 1960, RHYTHMIC STRUCTURE M; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Formisano E, 2003, CURR OPIN NEUROBIOL, V13, P174, DOI 10.1016/S0959-4388(03)00044-8; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; HASSON RN, 2004, NEUROIMAGE, V5664, P1634; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Knosche TR, 2005, HUM BRAIN MAPP, V24, P259, DOI 10.1002/hbm.20088; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LEHRDAHL F, 1983, GENERATIVE THEORY TO; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Lungarella M, 2007, INT J BIFURCAT CHAOS, V17, P903, DOI 10.1142/S0218127407017628; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Menon RS, 1998, P NATL ACAD SCI USA, V95, P10902, DOI 10.1073/pnas.95.18.10902; Menon V, 2005, INT REV NEUROBIOL, V66, P291, DOI 10.1016/S0074-7742(05)66010-2; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Popescu M, 2004, NEUROIMAGE, V21, P1622, DOI 10.1016/j.neuroimage.2003.11.002; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; SETH AK, 2005, NETWORK, V1, P35; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Sterzer P, 2007, P NATL ACAD SCI USA, V104, P323, DOI 10.1073/pnas.0609006104; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; ZACKS JM, 2001, PSYCHOL BULL, V6, P651; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; ZATORRE RJ, 1993, J ACOUST SOC AM, V93, P2364	48	116	116	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					521	532		10.1016/j.neuron.2007.07.003	http://dx.doi.org/10.1016/j.neuron.2007.07.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678862	Green Submitted, Bronze			2022-12-24	WOS:000248711000017
J	Pizzorusso, T; Berardi, N; Maffei, L				Pizzorusso, Tommaso; Berardi, Nicoletta; Maffei, Lamberto			A richness that cures	NEURON			English	Editorial Material							ENVIRONMENTAL ENRICHMENT; MEMORY; PLASTICITY; EXPERIENCE; CORTEX; SYSTEM; MICE	A study in Nature by Fischer et al. shows that environmental enrichment or increasing histone acetylation rescue the ability to form new memories and re-establish access to remote memories even in the presence of brain degeneration. Chromatin remodeling may be the final gate environmental enrichment opens to enhance plasticity and represents a promising target for therapeutical intervention in neurodegenerative diseases.	Scuola Normale Super Pisa, Pisa, Italy; Univ Florence, Dipartimento Psicol, CNR, Ist Neurosci, Florence, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); University of Florence	Maffei, L (corresponding author), Scuola Normale Super Pisa, Pisa, Italy.	lamberto.maffei@in.cnr.it	Pizzorusso, Tommaso/D-1399-2013	Pizzorusso, Tommaso/0000-0001-5614-0668				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; BERARDI N, 2007, IN PRESS J ALZHEIMER; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; SALE A, 2007, IN PRESS NAT NEUROSC	15	13	14	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 24	2007	54	4					508	510		10.1016/j.neuron.2007.05.003	http://dx.doi.org/10.1016/j.neuron.2007.05.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521565	Bronze			2022-12-24	WOS:000246970800007
J	Matsumoto, M; Matsumoto, K; Abe, H; Tanaka, K				Matsumoto, Madoka; Matsumoto, Kenji; Abe, Hiroshi; Tanaka, Keiji			Medial prefrontal cell activity signaling prediction errors of action values	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; DOPAMINE NEURONS; REWARD PREDICTION; FRONTAL-CORTEX; MACAQUE MONKEY; NEURAL SYSTEM; BRAIN; REINFORCEMENT; PERFORMANCE; NEGATIVITY	To adapt behavior to a changing environment, one must monitor outcomes of executed actions and adjust subsequent actions accordingly. Involvement of the medial frontal cortex in performance monitoring has been suggested, but little is known about neural processes that link performance monitoring to performance adjustment. Here, we recorded from neurons in the medial prefrontal cortex of monkeys learning arbitrary action- outcome contingencies. Some cells preferentially responded to positive visual feedback stimuli and others to negative feedback stimuli. The magnitude of responses to positive feedback stimuli decreased over the course of behavioral adaptation, in correlation with decreases in the amount of prediction error of action values. Therefore, these responses in medial prefrontal cells may signal the direction and amount of error in prediction of values of executed actions to specify the adjustment in subsequent action selections.	RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan; Kyoto Univ, Inst Primate Res, Dept Behav & Brain Sci, Inuyama, Aichi 4848506, Japan; Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528552, Japan; Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan	RIKEN; Kyoto University; Tokyo Institute of Technology; Saitama University	Matsumoto, K (corresponding author), RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsumot@riken.jp	Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427; Matsumoto, Kenji/0000-0003-0883-4280				Allport G. W., 1961, PATTERN GROWTH PERSO; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Blatter K, 2006, EXP BRAIN RES, V168, P541, DOI 10.1007/s00221-005-0114-y; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FANTINO E, 1969, J EXP ANAL BEHAV, V12, P723, DOI 10.1901/jeab.1969.12-723; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LEWIS DA, 1988, BRAIN RES, V449, P225, DOI 10.1016/0006-8993(88)91040-2; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Maslow A.H., 1954, MOTIVATION PERSONALI; Matsumoto K, 2004, CURR OPIN NEUROBIOL, V14, P178, DOI 10.1016/j.conb.2004.03.005; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; Skinner B. F., 1953, SCI HUMAN BEHAV; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Walker AE, 1940, J COMP NEUROL, V73, P59, DOI 10.1002/cne.900730106; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; WILLIAMS BA, 1994, BEHAV ANALYST, V17, P261, DOI 10.1007/BF03392675; WOODWORTH RS, 1958, DYNAMICS BEHAV; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	50	317	320	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					647	656		10.1038/nn1890	http://dx.doi.org/10.1038/nn1890			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	160NB	17450137				2022-12-24	WOS:000245948000022
J	Vijayraghavan, S; Wang, M; Birnbaum, SG; Williams, GV; Arnsten, AFT				Vijayraghavan, Susheel; Wang, Min; Birnbaum, Shari G.; Williams, Graham V.; Arnsten, Amy F. T.			Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL NEURONS; MODULATION; GENOTYPE; CORTEX; MECHANISMS; INTERNEURONS; PERFORMANCE; ACTIVATION; INHIBITION; EXCITABILITY	Dopamine (DA) D1 receptor (D1R) stimulation in prefrontal cortex (PFC) produces an 'inverted-U' dose-response, whereby either too little or too much D1R stimulation impairs spatial working memory. This response has been observed across species, including genetic linkages with human cognitive abilities, PFC activation states and DA synthesis. The cellular basis for the inverted U has long been sought, with in vitro intracellular recordings supporting a variety of potential mechanisms. The current study demonstrates that the D1R agonist inverted-U response can be observed in PFC neurons of behaving monkeys: low levels of D1R stimulation enhance spatial tuning by suppressing responses to nonpreferred directions, whereas high levels reduce delay-related firing for all directions, eroding tuning. These sculpting actions of D1R stimulation are mediated in monkeys and rats by cyclic AMP intracellular signaling. The evidence for an inverted U at the cellular level in behaving animals promises to bridge in vitro molecular analyses with human cognitive experience.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA	Yale University; Yale University	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06520 USA.	amy.arnsten@yale.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789] Funding Source: NIH RePORTER; NIMH NIH HHS [P50MH068789] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Chudasama Y, 2004, NEUROPSYCHOPHARMACOL, V29, P1628, DOI 10.1038/sj.npp.1300490; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Floresco SB, 2001, BEHAV NEUROSCI, V115, P934, DOI 10.1037/0735-7044.115.4.934; FRANKE P, 1994, PSYCHIAT RES, V54, P259, DOI 10.1016/0165-1781(94)90020-5; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; Gibbs SEB, 2005, PSYCHOPHARMACOLOGY, V180, P644, DOI 10.1007/s00213-005-0077-5; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Gorelova NA, 2000, J NEUROPHYSIOL, V84, P75, DOI 10.1152/jn.2000.84.1.75; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Lidow MS, 2003, SYNAPSE, V47, P101, DOI 10.1002/syn.10143; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Mehta MA, 2000, J NEUROSCI, V20; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Minzenberg MJ, 2006, PSYCHIAT GENET, V16, P117, DOI 10.1097/01.ypg.0000199448.00163.e6; NUECHTERLEIN KH, 1992, SCHIZOPHRENIA BULL, V18, P387, DOI 10.1093/schbul/18.3.387; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; ROBBINS TW, 1979, NEUROPHARMACOLOGY, V18, P931, DOI 10.1016/0028-3908(79)90157-6; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHWARTZ ML, 1988, J NEUROSCI, V8, P1962; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Urban NN, 2002, J PHYSIOL-LONDON, V539, P707, DOI 10.1113/jphysiol.2001.015024; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Yan Z, 1997, NEURON, V19, P1115, DOI 10.1016/S0896-6273(00)80402-X; Yang CR, 1996, J NEUROSCI, V16, P1922; Yang CR, 1996, J NEUROSCI, V16, P1904; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016; Zhou FM, 1999, J NEUROPHYSIOL, V81, P967, DOI 10.1152/jn.1999.81.3.967	47	708	720	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					376	384		10.1038/nn1846	http://dx.doi.org/10.1038/nn1846			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17277774				2022-12-24	WOS:000244480300021
J	Sobczyk, A; Svoboda, K				Sobczyk, Aleksander; Svoboda, Karel			Activity-dependent plasticity of the NMDA-receptor fractional Ca2+ current	NEURON			English	Article							LONG-TERM POTENTIATION; SINGLE DENDRITIC SPINES; SYNAPTIC PLASTICITY; SUBUNIT COMPOSITION; CALCIUM-CHANNELS; VISUAL-CORTEX; CA1; HIPPOCAMPUS; EXPRESSION; AMPA	Ca2+, influx through NMDA receptors (NIVIDARs) triggers synaptic plasticity, gene transcription, and cytotoxicity, but little is known about the regulation of NMDA-Rs themselves. We used two-photon glutamate uncaging to activate NMDA-Rs on individual dendritic spines in rat CA1 neurons while we measured NMDAR currents at the soma and [Ca 2,] changes in spines. Low-frequency uncaging trains induced Ca 2, -dependent long-term depression of NMDA-R-mediated synaptic currents. Additionally, uncaging trains caused a reduction in the Ca2+ accumulation per unit of NMDA-R current in spines due to a reduction in the fraction of the NMDA-R current carried by Ca2+. Induction of depression of NMDA-R-mediated Ca2+ influx required activation of NR2B-containing receptors. Receptors in single spines depressed rapidly in an all-or-none manner. These adaptive changes in NMDA-R function likely play a critical role in metaplasticity and in stabilizing activity levels in neuronal networks with Hebbian synapses.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, POB 100, Cold Spring Harbor, NY 11724 USA.	svobodak@janelia.hhmi.org						Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kullmann DM, 2003, PHILOS T R SOC B, V358, P727, DOI 10.1098/rstb.2002.1229; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Montgomery JM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-48; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; MORISHITA W, 2006, IN PRESS NEUROPHARMA; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Racca C, 2000, J NEUROSCI, V20, P2512; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YASUDA R, 2004, SCI STKE, pPL5; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	55	77	85	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					17	24		10.1016/j.neuron.2006.11.016	http://dx.doi.org/10.1016/j.neuron.2006.11.016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196527	Green Accepted, Bronze			2022-12-24	WOS:000245126500005
J	Biron, D; Shibuya, M; Gabel, C; Wasserman, SM; Clark, DA; Brown, A; Sengupta, P; Samuel, ADT				Biron, David; Shibuya, Mayumi; Gabel, Christopher; Wasserman, Sara M.; Clark, Damon A.; Brown, Adam; Sengupta, Piali; Samuel, Aravinthan D. T.			A diacylglycerol kinase modulates long-term thermotactic behavioral plasticity in C. elegans	NATURE NEUROSCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; GILL-WITHDRAWAL REFLEX; NUCLEOTIDE-GATED CHANNEL; EF-HAND MOTIFS; SYNAPTIC-TRANSMISSION; MORPHOLOGICAL BASIS; SENSORY NEURONS; NERVOUS-SYSTEM; AFD NEURON; HABITUATION	A memory of prior thermal experience governs Caenorhabditis elegans thermotactic behavior. On a spatial thermal gradient, C. elegans tracks isotherms near a remembered temperature we call the thermotactic set-point (T-S). The T-S corresponds to the previous cultivation temperature and can be reset by sustained exposure to a new temperature. The mechanisms underlying this behavioral plasticity are unknown, partly because sensory and experience-dependent components of thermotactic behavior have been difficult to separate. Using newly developed quantitative behavioral analyses, we demonstrate that the TS represents a weighted average of a worm's temperature history. We identify the DGK-3 diacylglycerol kinase as a thermal memory molecule that regulates the rate of TS resetting by modulating the temperature range of synaptic output, but not temperature sensitivity, of the AFD thermosensory neurons. These results provide the first mechanistic insight into the basis of experience-dependent plasticity in this complex behavior.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Brandeis University; Brandeis University; Harvard University	Sengupta, P (corresponding author), Brandeis Univ, Dept Biol, 415 S St, Waltham, MA 02454 USA.	sengupta@brandeis.edu; samuel@physics.harvard.edu		Wasserman, Sara/0000-0002-8720-1117; Clark, Damon/0000-0001-8487-700X; Gabel, Christopher/0000-0002-2763-3938	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007122] Funding Source: Medline; NIMH NIH HHS [T32 MH019929] Funding Source: Medline; NINDS NIH HHS [NS44232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1988, J NEUROSCI, V8, P2452; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CASTELLUCCI VF, 1978, SCIENCE, V202, P1306, DOI 10.1126/science.214854; CASTELLUCCI VF, 1974, P NATL ACAD SCI USA, V71, P5004, DOI 10.1073/pnas.71.12.5004; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; COSSINS AR, 1994, PORTL PR P, P63; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HUTCHISON VH, 1979, AM ZOOL, V19, P367; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Maruyama H, 2001, NEUROSCIENCE, V104, P287, DOI 10.1016/S0306-4522(01)00097-5; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Ryu WS, 2002, J NEUROSCI, V22, P5727; SAKANE F, 1991, J BIOL CHEM, V266, P7096; SAKANE F, 1991, BIOCHEM BIOPH RES CO, V181, P1015, DOI 10.1016/0006-291X(91)92038-L; Sakane F, 1996, BIOCHEM J, V318, P583, DOI 10.1042/bj3180583; Samuel ADT, 2003, J NEUROSCI, V23, P373, DOI 10.1523/JNEUROSCI.23-02-00373.2003; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yamada K, 1997, BIOCHEM J, V321, P59, DOI 10.1042/bj3210059; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	50	68	72	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1499	1505		10.1038/nn1796	http://dx.doi.org/10.1038/nn1796			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17086178				2022-12-24	WOS:000242404000013
J	Santamaria, F; Wils, S; De Schutter, E; Augustine, GJ				Santamaria, Fidel; Wils, Stefan; De Schutter, Erik; Augustine, George J.			Anomalous diffusion in Purkinje cell dendrites caused by spines	NEURON			English	Article							CALCIUM DYNAMICS; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; NMDA RECEPTORS; CHANNELS; MECHANISMS; PLASTICITY; KINETICS; SYNAPSE; AXON	We combined local photolysis of caged compounds with fluorescence imaging to visualize molecular diffusion within dendrites of cerebellar Purkinje cells. Diffusion of a volume marker, fluorescein dextran, within spiny dendrites was remarkably slow in comparison to its diffusion in smooth dendrites. Computer simulations indicate that this retardation is due to a transient trapping of molecules within dendritic spines, yielding anomalous diffusion. We considered the influence of spine trapping on the diffusion of calcium ions (Ca2+) and inositol-1, 4,5-triphospate (IP3) two synaptic second messengers. Diffusion Of IP3 was strongly influenced by the presence of dendritic spines, while Ca2+ was removed so rapidly that it could not diffuse far enough to be trapped. We conclude that an important function of dendritic spines may be to trap chemical signals and thereby create slowed anomalous diffusion within dendrites.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Antwerp, Lab Theoret Neurobiol, B-2610 Antwerp, Belgium	Duke University; University of Antwerp	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, POB 3209, Durham, NC 27710 USA.	georgea@neuro.duke-edu	Santamaria, Fidel/I-2544-2012; De Schutter, Erik/G-8460-2011; Santamaria, Fidel/H-4721-2019; Augustine, George James/J-9228-2013	Santamaria, Fidel/0000-0001-8750-2932; De Schutter, Erik/0000-0001-8618-5138; Santamaria, Fidel/0000-0001-8750-2932; 	NIGMS NIH HHS [GM65473, R24 GM065473] Funding Source: Medline; NINDS NIH HHS [NS-34045, R01 NS034045] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM065473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034045] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; ben-Avraham D., 2005, DIFFUSION REACTIONS; Bird GS, 2004, CURR MOL MED, V4, P291, DOI 10.2174/1566524043360681; Bormann Guy, 2001, P189; Bower J. M., 1995, BOOK GENESIS; Crank J., 1975, MATH DIFFUSION; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Ellis-Davies GCR, 1998, TETRAHEDRON LETT, V39, P953, DOI 10.1016/S0040-4039(97)10668-2; Fiala J.C., 1999, DENDRITES, P1, DOI DOI 10.1093/ACPROF:OSO/9780198566564.003.0001; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; FRITZSCH B, 1993, J NEUROSCI METH, V50, P95, DOI 10.1016/0165-0270(93)90060-5; Fukano T, 2004, J STRUCT BIOL, V147, P12, DOI 10.1016/j.jsb.2003.11.002; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Hartmann J, 2005, CELL CALCIUM, V37, P459, DOI 10.1016/j.ceca.2005.01.014; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; Khodakhah K, 1997, BIOPHYS J, V73, P3349, DOI 10.1016/S0006-3495(97)78359-0; Klafter J, 2005, PHYS WORLD, V18, P29; Korkotian E, 2006, CELL CALCIUM, V40, P441, DOI 10.1016/j.ceca.2006.08.008; LAFARGA M, 1991, J NEUROCYTOL, V20, P533, DOI 10.1007/BF01215262; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; MARTONE ME, 1993, J NEUROSCI, V13, P4636; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Michailova A, 2002, BIOPHYS J, V83, P3134, DOI 10.1016/S0006-3495(02)75317-4; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; PALAY SL, 1974, CEREBELLAX CORTEX; Pattni K, 2004, CELL SIGNAL, V16, P643, DOI 10.1016/j.cellsig.2003.10.009; POO MM, 1990, J NEUROBIOL, V21, P157, DOI 10.1002/neu.480210111; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Schmidt H, 2005, P NATL ACAD SCI USA, V102, P5850, DOI 10.1073/pnas.0407855102; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; Schutter E. D. E., 1998, METHODS NEURONAL MOD, P211; Sepulveda MR, 2004, EUR J NEUROSCI, V19, P542, DOI 10.1111/j.0953-816X.2003.03156.x; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Stiles JR, 2001, METH NE FRO NEUROSCI, P87; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; WALKER JW, 1989, BIOCHEMISTRY-US, V28, P3272, DOI 10.1021/bi00434a023; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; Yuste R, 1999, J NEUROSCI, V19, P1976; ZADOR A, 1994, J NEUROSCI, V14, P4705; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	67	206	209	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					635	648		10.1016/j.neuron.2006.10.025	http://dx.doi.org/10.1016/j.neuron.2006.10.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114048	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000242413100011
J	Stetson, C; Xu, C; Montague, PR; Eagleman, DM				Stetson, Chess; Xu Cui; Montague, P. Read; Eagleman, David M.			Motor-sensory recalibration leads to an illusory reversal of action and sensation	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; TIME PERCEPTION; CONFLICT; FMRI; PERFORMANCE; ADAPTATION; INTENTION; ATTENTION; AWARENESS; SELECTION	To judge causality, organisms must determine the temporal order of their actions and sensations. However, this judgment may be confounded by changing delays in sensory pathways, suggesting the need for dynamic temporal recalibration. To test for such a mechanism, we artificially injected a fixed delay between participants' actions (keypresses) and subsequent sensations (flashes). After participants adapted to this delay, flashes at unexpectedly short delays after the keypress were often perceived as occurring before the keypress, demonstrating a recalibration of motor-sensory temporal order judgments. When participants experienced illusory reversals, fMRI BOLD signals increased in anterior cingulate cortex/medial frontal cortex (ACC/MFC), a brain region previously implicated in conflict monitoring. This illusion-specific activation suggests that the brain maintains not only a recalibrated representation of timing, but also a less-plastic representation against which to compare it.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA; Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Texas, Dept Biomed Engn, Austin, TX 77003 USA; Univ Texas, Dept Psychol, Austin, TX 77003 USA; Rice Univ, Dept Psychol, Houston, TX 77005 USA	University of Texas System; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Rice University	Eagleman, DM (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, 6431 Fannin St,Suite 7046, Houston, TX 77030 USA.	david@eaglemanlab.net			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA 11723] Funding Source: Medline; NINDS NIH HHS [NS 045790] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; CAMPBELL WW, 1981, MUSCLE NERVE, V4, P520, DOI 10.1002/mus.880040609; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cosmelli D, 2004, NEUROIMAGE, V23, P128, DOI 10.1016/j.neuroimage.2004.05.008; COULT JT, 2004, SCIENCE, P1506; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.d01-17; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Eagleman DM, 2004, SCIENCE, V303, P1144, DOI 10.1126/science.1095331; Eagleman DM, 2002, TRENDS COGN SCI, V6, P323, DOI 10.1016/S1364-6613(02)01945-9; EAGLEMAN DM, 2000, SCIENCE, V289, P1107; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jech R, 2005, NEUROREPORT, V16, P1467, DOI 10.1097/01.wnr.0000175616.00936.1c; Kao YC, 2005, NAT NEUROSCI, V8, P1776, DOI 10.1038/nn1595; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Namba J, 2004, PERCEPTION, V33, P621, DOI 10.1068/p5212; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nobre AC, 2004, TRENDS COGN SCI, V8, P387, DOI 10.1016/j.tics.2004.07.005; PAILLARD J, 1948, CR SOC BIOL, V142, P935; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339	45	226	233	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					651	659		10.1016/j.neuron.2006.08.006	http://dx.doi.org/10.1016/j.neuron.2006.08.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	085RZ	16950162	Bronze			2022-12-24	WOS:000240623400013
J	Kozorovitskiy, Y; Hughes, M; Lee, K; Gould, E				Kozorovitskiy, Yevgenia; Hughes, Maria; Lee, Kim; Gould, Elizabeth			Fatherhood affects dendritic spines and vasopressin V1a receptors in the primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							ACTIVATION; FOREBRAIN; PICTURES	Like human fathers, male marmosets help raise their young, yet the ways in which fatherhood influences the brain remain largely unknown. We show that first-time and experienced marmoset fathers have enhanced density of dendritic spines on pyramidal neurons in prefrontal cortex as compared to non-fathers. In parallel, the abundance of vasopressin V1a receptors and the proportion of V1a receptor - labeled dendritic spines increase.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Green Hall,Washington Rd, Princeton, NJ 08544 USA.	goulde@princeton.edu	Kozorovitskiy, Yevgenia/GOP-1185-2022; Rahmandar, Maria/I-7024-2015	Rahmandar, Maria/0000-0002-3226-9587; Kozorovitskiy, Yevgenia/0000-0002-3710-1484; Lee, Kim/0000-0002-5675-1896				Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; PEDEN JK, 1947, J COMP NEUROL, V86, P37, DOI 10.1002/cne.900860103; Radley JJ, 2005, EXP NEUROL, V196, P199, DOI 10.1016/j.expneurol.2005.07.008; Roky R, 1996, NEUROENDOCRINOLOGY, V63, P422, DOI 10.1159/000127067; Rylands AB, 1993, MARMOSETS TAMARINS S; Smeltzer MD, 2006, NEUROSCI LETT, V394, P146, DOI 10.1016/j.neulet.2005.10.019; Son MC, 2001, NEUROBIOL LEARN MEM, V76, P388, DOI 10.1006/nlme.2001.4020; Wang ZX, 1997, BRAIN RES, V768, P147, DOI 10.1016/S0006-8993(97)00636-7; Wynne-Edwards KE, 2001, HORM BEHAV, V40, P139, DOI 10.1006/hbeh.2001.1699	13	104	106	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1094	1095		10.1038/nn1753	http://dx.doi.org/10.1038/nn1753			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921371				2022-12-24	WOS:000240080800008
J	Ofen, N; Kao, YC; Sokol-Hessner, P; Kim, H; Whitfield-Gabrieli, S; Gabrieli, JDE				Ofen, Noa; Kao, Yun-Ching; Sokol-Hessner, Peter; Kim, Heesoo; Whitfield-Gabrieli, Susan; Gabrieli, John D. E.			Development of the declarative memory system in the human brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL FUNCTIONAL-ORGANIZATION; COMMON STEREOTACTIC SPACE; TEMPORAL-LOBE; CORTICAL DEVELOPMENT; STRUCTURAL MRI; FRONTAL-CORTEX; BOLD FMRI; CHILDREN; CHILDHOOD; ADULTS	Brain regions that are involved in memory formation, particularly medial temporal lobe ( MTL) structures and lateral prefrontal cortex ( PFC), have been identified in adults, but not in children. We investigated the development of brain regions involved in memory formation in 49 children and adults ( ages 8-24), who studied scenes during functional magnetic resonance imaging. Recognition memory for vividly recollected scenes improved with age. There was greater activation for subsequently remembered scenes than there was for forgotten scenes in MTL and PFC regions. These activations increased with age in specific PFC, but not in MTL, regions. PFC, but not MTL, activations correlated with developmental gains in memory for details of experiences. Voxel-based morphometry indicated that gray matter volume in PFC, but not in MTL, regions reduced with age. These results suggest that PFC regions that are important for the formation of detailed memories for experiences have a prolonged maturational trajectory.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; NYU, Dept Psychol, New York, NY 10003 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Stanford University; Harvard University; New York University; University of California System; University of California Berkeley	Ofen, N (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall,Bldg 420, Stanford, CA 94305 USA.	noa@mit.edu	Gabrieli, John/AAJ-2869-2020	Ofen, Noa/0000-0003-3927-8408				Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Billingsley RL, 2002, J EXP CHILD PSYCHOL, V82, P251, DOI 10.1016/S0022-0965(02)00007-3; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Chiu CYP, 2006, DEV NEUROPSYCHOL, V29, P321, DOI 10.1207/s15326942dn2902_3; Cycowicz YM, 2003, J COGNITIVE NEUROSCI, V15, P759, DOI 10.1162/jocn.2003.15.5.759; Cycowicz YM, 2001, NEUROPSYCHOLOGIA, V39, P255, DOI 10.1016/S0028-3932(00)00108-1; Czernochowski D, 2005, COGN AFFECT BEHAV NE, V5, P417, DOI 10.3758/CABN.5.4.417; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DIRKS J, 1977, J EXP CHILD PSYCHOL, V23, P315, DOI 10.1016/0022-0965(77)90108-4; Drummey AB, 2002, DEVELOPMENTAL SCI, V5, P502, DOI 10.1111/1467-7687.00243; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goswami U, 2006, NAT REV NEUROSCI, V7, P406, DOI 10.1038/nrn1907; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Kang HC, 2003, NEUROIMAGE, V19, P16, DOI 10.1016/S1053-8119(03)00038-7; KNOWLTON BJ, 1995, J EXP PSYCHOL LEARN, V21, P699, DOI 10.1037/0278-7393.21.3.699; MANDLER JM, 1978, J EXP CHILD PSYCHOL, V26, P122, DOI 10.1016/0022-0965(78)90114-5; Menon V, 2005, COGNITIVE BRAIN RES, V25, P379, DOI 10.1016/j.cogbrainres.2005.07.007; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sowell ER, 1998, DEV NEUROPSYCHOL, V14, P599, DOI 10.1080/87565649809540731; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wig GS, 2004, J COGNITIVE NEUROSCI, V16, P139, DOI 10.1162/089892904322755629; Wilke M, 2003, MAGN RESON MED, V50, P749, DOI 10.1002/mrm.10606; YONELINAS AP, 1995, PSYCHOL RES-PSYCH FO, V57, P156, DOI 10.1007/BF00431277	49	225	228	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1198	1205		10.1038/nn1950	http://dx.doi.org/10.1038/nn1950			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676059				2022-12-24	WOS:000249144000023
J	Petryniak, MA; Potter, GB; Rowitch, DH; Rubenstein, JLR				Petryniak, Magdalena A.; Potter, Gregory B.; Rowitch, David H.; Rubenstein, John L. R.			Dlx1 and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain	NEURON			English	Article							SONIC HEDGEHOG; TRANSCRIPTION FACTOR; SUBVENTRICULAR ZONE; GABAERGIC NEURONS; BASAL FOREBRAIN; CEREBRAL-CORTEX; SPINAL-CORD; NEOCORTICAL PROJECTION; PRECURSOR CELLS; HOMEOBOX GENES	Progenitors within the ventral telencephalon can generate GABAergic neurons and oligodendrocytes, but regulation of the neuron-glial switch is poorly understood. We investigated the combinatorial expression and function of Dlx1&2, Olig2, and Mash1 transcription factors in the ventral telencephalon. We show that Dlx homeobox transcription factors, required for GABAergic interneuron production, repress oligodendrocyte precursor cell (OPC) formation by acting on a common progenitor to determine neuronal versus oligodendroglial cell fate acquisition. We demonstrate that Dlx1&2 negatively regulate Olig2-dependant OPC formation and that Mash1 promotes OPC formation by restricting the number of Dlx+ progenitors. Progenitors transplanted from Dlx1&2 mutant ventral telencephalon into newborn wild-type mice do not produce neurons but differentiate into myelinating oligodendrocytes that survive into adulthood. Our results identify another role for Dlx genes as modulators of neuron versus oligodendrocyte development in the ventral embryonic forebrain.	Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pediat, Div Neonatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, Inst Regenerat Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Potter, GB (corresponding author), Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA.	gregory.potter@ucsf.edu; john.rubenstein@ucsf.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Rowitch, David/0000-0002-0079-0060; Potter, Gregory/0000-0002-0585-6575	NICHD NIH HHS [T32 HD007162-28, T32 HD007162, HD-07162H] Funding Source: Medline; NIMH NIH HHS [R01 MH49428-01, F32 MH070211, R01 MH049428, K05 MH065670, R01 MH049428-15, R37 MH049428, F32 MH070211-02, K05 MH065670-05] Funding Source: Medline; NINDS NIH HHS [R01 NS040511, R01 NS40511, L40 NS056772, L40 NS056772-01, R01 NS040511-08] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, F32MH070211, K05MH065670, R01MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040511] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agius E, 2004, DEV BIOL, V270, P308, DOI 10.1016/j.ydbio.2004.02.015; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Battiste J, 2007, DEVELOPMENT, V134, P285, DOI 10.1242/dev.02727; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; Furusho M, 2006, DEV BIOL, V293, P348, DOI 10.1016/j.ydbio.2006.01.031; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; Ivanova A, 2003, J NEUROSCI RES, V73, P581, DOI 10.1002/jnr.10717; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Le Bras B, 2005, INT J DEV BIOL, V49, P209, DOI 10.1387/ijdb.041963bl; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Marin O, 2000, J NEUROSCI, V20, P6063; Marshall CAG, 2002, J NEUROSCI, V22, P9821; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Nery S, 2001, DEVELOPMENT, V128, P527; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Oh S, 2005, DEV DYNAM, V234, P489, DOI 10.1002/dvdy.20422; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Poitras L, 2007, DEVELOPMENT, V134, P1755, DOI 10.1242/dev.02845; Qi YC, 2001, DEVELOPMENT, V128, P2723; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Sun T, 2003, J NEUROSCI, V23, P9547; Sussman CR, 2002, GLIA, V40, P55, DOI 10.1002/glia.10114; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yun K, 2002, DEVELOPMENT, V129, P5029; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	63	252	256	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					417	433		10.1016/j.neuron.2007.06.036	http://dx.doi.org/10.1016/j.neuron.2007.06.036			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678855	Green Accepted, Bronze			2022-12-24	WOS:000248711000010
J	Choi, JT; Bastian, AJ				Choi, Julia T.; Bastian, Amy J.			Adaptation reveals independent control networks for human walking	NATURE NEUROSCIENCE			English	Article							CENTRAL PATTERN GENERATOR; LOW SPINAL CAT; INTERLIMB COORDINATION; SPINOCEREBELLAR TRACT; LOCOMOTOR ADAPTATIONS; FICTIVE LOCOMOTION; CORD; CEREBELLUM; NEURONS; DELETIONS	Human walking is remarkably adaptable on short and long timescales. We can immediately transition between directions and gait patterns, and we can adaptively learn accurate calibrations for different walking contexts. Here we studied the degree to which different motor patterns can adapt independently. We used a split-belt treadmill to adapt the right and left legs to different speeds and in different directions (forward versus backward). To our surprise, adults could easily walk with their legs moving in opposite directions. Analysis of aftereffects showed that walking adaptations are stored independently for each leg and do not transfer across directions. Thus, there are separate functional networks controlling forward and backward walking in humans, and the circuits controlling the right and left legs can be trained individually. Such training could provide a new therapeutic approach for correcting various walking asymmetries.	Kennedy Krieger Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosurg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA	Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bastian, AJ (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.	julia.choi@jhu.edu; bastian@kennedykrieger.org	Hoogkamer, Wouter/G-4498-2010	Choi, Julia/0000-0003-4963-9094	NCRR NIH HHS [C06RR15488] Funding Source: Medline; NICHD NIH HHS [R01HD048740] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015488] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARSHAVSKY YI, 1978, BRAIN RES, V151, P493, DOI 10.1016/0006-8993(78)91082-X; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Batschelet E, 1981, CIRCULAR STAT BIOL; BERKOWITZ A, 1994, J NEUROSCI, V14, P5105; Bosco G, 2006, EXP BRAIN RES, V175, P83, DOI 10.1007/s00221-006-0530-7; Bosco G, 2005, EXP BRAIN RES, V167, P394, DOI 10.1007/s00221-005-0033-y; Bosco G, 2000, J NEUROPHYSIOL, V83, P2931, DOI 10.1152/jn.2000.83.5.2931; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; DIETZ V, 1994, EXP BRAIN RES, V101, P513; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; Grasso R, 1998, J NEUROPHYSIOL, V80, P1868, DOI 10.1152/jn.1998.80.4.1868; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Hammar I, 2004, EUR J NEUROSCI, V19, P1305, DOI 10.1111/j.1460-9568.2004.03239.x; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lafreniere-Roula M, 2005, J NEUROPHYSIOL, V94, P1120, DOI 10.1152/jn.00216.2005; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; MORTIN LI, 1989, J NEUROSCI, V9, P2285; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; ORLOVSKY GN, 1972, BRAIN RES, V46, P85, DOI 10.1016/0006-8993(72)90007-8; ORLOVSKY GN, 1972, BRAIN RES, V40, P359, DOI 10.1016/0006-8993(72)90139-4; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Poppele RE, 2003, EXP BRAIN RES, V149, P361, DOI 10.1007/s00221-003-1378-8; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; REISMAN DS, 2007, BRAIN           0402, DOI DOI 10.1093/BRAIN/AWM035; Reynolds RF, 2004, J NEUROPHYSIOL, V91, P92, DOI 10.1152/jn.00495.2003; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Yanagihara D, 1996, P NATL ACAD SCI USA, V93, P13292, DOI 10.1073/pnas.93.23.13292; Yang JF, 2005, J NEUROSCI, V25, P6869, DOI 10.1523/JNEUROSCI.1765-05.2005; Yang JF, 2004, CAN J PHYSIOL PHARM, V82, P662, DOI 10.1139/Y04-070; Zar JH, 1999, BIOSTATISTICAL ANAL	38	236	243	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1055	1062		10.1038/nn1930	http://dx.doi.org/10.1038/nn1930			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603479				2022-12-24	WOS:000248357500020
J	Beierlein, M; Fioravante, D; Regehr, WG				Beierlein, Michael; Fioravante, Diasynou; Regehr, Wade G.			Differential expression of posttetanic potentiation and retrograde signaling mediate target-dependent short-term synaptic plasticity	NEURON			English	Article							PROTEIN-KINASE-C; CEREBELLAR GRANULE CELLS; METABOTROPIC GLUTAMATE; PURKINJE-CELLS; GOLGI CELLS; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; RAT CEREBELLUM; ENDOGENOUS CANNABINOIDS; MULTIVESICULAR RELEASE	Short-term synaptic plasticity influences how presynaptic spike patterns control the firing of postsynaptic targets. Here we investigated whether specific mechanisms of short-term plasticity are regulated in a target-dependent manner by comparing synapses made by cerebellar granule cell parallel fibers onto Golgi cells (PF -> GC synapse) and Purkinje cells (PF -> PC synapse). Both synapses exhibited similar facilitation, suggesting that any differential short-term plasticity does not reflect differences in the initial release probability. PF -> PC synapses were highly sensitive to stimulus bursts, which could result in either depression of subsequent responses, mediated by endocannabinoid-dependent retrograde signaling, or enhancement of responses through posttetanic potentiation (PTP). In contrast, stimulus bursts had remarkably little effect on the strength of PF -> GC synapses. Unlike PCs, GCs were unable to regulate their PF synapses by releasing endocannabinoids. Moreover, PTP was reduced at the PF -> GC synapse compared to the PF -> PC synapse. Thus, the target-dependence of PF synapses arises from the differential expression of both retrograde signaling and PTP.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu		Beierlein, Michael/0000-0003-2210-3118	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032405, R01NS032405, R01NS044396] Funding Source: NIH RePORTER; NINDS NIH HHS [R37NS032405, R37 NS032405, R37 NS032405-17, R01NS044396, R01 NS032405, R01 NS044396] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Atluri PP, 1996, J NEUROSCI, V16, P5661; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Brager DH, 2003, NAT NEUROSCI, V6, P551, DOI 10.1038/nn1067; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; Brenowitz SD, 2006, J NEUROSCI, V26, P6841, DOI 10.1523/JNEUROSCI.1280-06.2006; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DELANEY KR, 1994, J NEUROSCI, V14, P5885; DIEUDONNE S, 1995, P NATL ACAD SCI USA, V92, P1441, DOI 10.1073/pnas.92.5.1441; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; ECCLES J, 1964, NATURE, V204, P1265, DOI 10.1038/2041265a0; ECCLES JC, 1966, EXP BRAIN RES, V1, P82; Foster KA, 2005, J NEUROSCI, V25, P11655, DOI 10.1523/JNEUROSCI.4029-05.2005; Gao WJ, 2003, P NATL ACAD SCI USA, V100, P2836, DOI 10.1073/pnas.262796399; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Khakh BS, 2003, J NEUROSCI, V23, P7426; Knoflach F, 2001, NEUROPHARMACOLOGY, V40, P163, DOI 10.1016/S0028-3908(00)00152-0; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Magleby K L, 1979, Prog Brain Res, V49, P175; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martin LA, 2001, J PHYSIOL-LONDON, V532, P685, DOI 10.1111/j.1469-7793.2001.0685e.x; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Palay S.L., 1974, CEREBELLAR CORTEX; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; REGEHR WG, 2000, MONITORING PRESYNAPT; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Tempia F, 1996, EUR J NEUROSCI, V8, P2690, DOI 10.1111/j.1460-9568.1996.tb01564.x; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trettel J, 2004, J PHYSIOL-LONDON, V556, P95, DOI 10.1113/jphysiol.2003.058198; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang J, 2001, J PHYSIOL-LONDON, V533, P757, DOI 10.1111/j.1469-7793.2001.t01-1-00757.x; Watanabe D, 2003, NEURON, V39, P821, DOI 10.1016/S0896-6273(03)00530-0; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	74	54	54	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 21	2007	54	6					949	959		10.1016/j.neuron.2007.06.002	http://dx.doi.org/10.1016/j.neuron.2007.06.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582334	Green Accepted, Bronze			2022-12-24	WOS:000247645600013
J	Piazza, M; Pinel, P; Le Bihan, D; Dehaene, S				Piazza, Manuela; Pinel, Philippe; Le Bihan, Denis; Dehaene, Stanislas			A magnitude code common to numerosities and number symbols in human intraparietal cortex	NEURON			English	Article							HEMISPHERIC-SPECIALIZATION; NUMERICAL MAGNITUDE; HUMAN BRAIN; REPRESENTATION; SYSTEMS; DISSOCIATION; KNOWLEDGE; FMRI; SPECIFICITY; LATERALITY	Activation of the horizontal segment of the intraparietal sulcus (hIPS) has been observed in various number-processing tasks, whether numbers were conveyed by symbolic numerals (digits, number words) or by nonsymbolic displays (dot patterns). This suggests an abstract coding of numerical magnitude. Here, we critically tested this hypothesis using fMRI adaptation to demonstrate notation-independent coding of numerical quantity in the hIPS. Once subjects were adapted either to dot patterns or to Arabic digits, activation in the hIPS and in frontal regions recovered in a distance-dependent fashion whenever a new number was presented, irrespective of notation changes. This remained unchanged when analyzing the hIPS peaks from an independent localizer scan of mental calculation. These results suggest an abstract coding of approximate number common to dots, digits, and number words. They support the idea that symbols acquire meaning by linking neural populations coding symbol shapes to those holding nonsymbolic representations of quantities.	Univ Trent, Ctr Mind Brain Sci, Funct NeuroImaging Lab, I-38068 Rovereto, TN, Italy; Serv Hosp Frederic Joliot, DSV, DRM, CEA, F-91406 Orsay, France; Coll France, F-75005 Paris, France; Serv Hosp Frederic Joliot, Cognit Neuroimaging Unit, INSERM, F-91401 Orsay, France	University of Trento; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Piazza, M (corresponding author), Univ Trent, Ctr Mind Brain Sci, Funct NeuroImaging Lab, Via Tartarotti 7, I-38068 Rovereto, TN, Italy.	manuela.piazza@unitn.it	Piazza, Manuela/D-2028-2010; pinel, philippe/AAJ-3768-2020	Piazza, Manuela/0000-0003-2557-9701; pinel, philippe/0000-0001-6945-1369				Andres M, 2005, COGNITIVE BRAIN RES, V25, P283, DOI 10.1016/j.cogbrainres.2005.06.002; Ansari D, 2006, BRAIN RES, V1067, P181, DOI 10.1016/j.brainres.2005.10.083; Brannon EM, 2006, CURR OPIN NEUROBIOL, V16, P222, DOI 10.1016/j.conb.2006.03.002; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Butterworth B, 2001, NAT NEUROSCI, V4, P784, DOI 10.1038/90484; Butterworth B., 1999, MATH BRAIN; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Cohen L, 1996, NEUROCASE, V2, P155, DOI 10.1093/neucas/2.3.155; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; DEHAENE S, 1991, NEUROPSYCHOLOGIA, V29, P1045, DOI 10.1016/0028-3932(91)90076-K; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 1997, NUMBER SENSE; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Halpern CH, 2004, NEUROLOGY, V62, P1163, DOI 10.1212/01.WNL.0000118209.95423.96; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; KIMURA D, 1966, NEUROPSYCHOLOGIA, V4, P275, DOI 10.1016/0028-3932(66)90033-9; Koechlin E, 1999, J EXP PSYCHOL HUMAN, V25, P1882, DOI 10.1037/0096-1523.25.6.1882; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; MCGLONE J, 1973, NEUROPSYCHOLOGIA, V11, P105, DOI 10.1016/0028-3932(73)90070-5; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Pasini M, 2001, PSYCHOL RES-PSYCH FO, V65, P57, DOI 10.1007/s004260000036; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P865; Piazza M, 2006, BRAIN RES, V1106, P177, DOI 10.1016/j.brainres.2006.05.104; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Reynvoet B, 2002, Q J EXP PSYCHOL-A, V55, P1127, DOI 10.1080/02724980244000116; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; SHEPARD RN, 1975, COGNITIVE PSYCHOL, V7, P82, DOI 10.1016/0010-0285(75)90006-7; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Thioux M, 1998, NEUROCASE, V4, P371, DOI 10.1080/13554799808410633; Thioux M, 2001, NEUROIMAGE, V13, pS617; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; WARRINGTON EK, 1967, J NEUROL NEUROSUR PS, V30, P468, DOI 10.1136/jnnp.30.5.468; YOUNG AW, 1979, NEUROPSYCHOLOGIA, V17, P99, DOI 10.1016/0028-3932(79)90028-9; Zamarian L, 2006, NEUROPSYCHOLOGIA, V44, P1708, DOI 10.1016/j.neuropsychologia.2006.03.032	53	565	570	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					293	305		10.1016/j.neuron.2006.11.022	http://dx.doi.org/10.1016/j.neuron.2006.11.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224409	Bronze			2022-12-24	WOS:000245126600013
J	Jakubs, K; Nanobashvili, A; Bonde, S; Ekdahl, CT; Kokaia, Z; Kokaia, M; Lindvall, O				Jakubs, Katherine; Nanobashvili, Avtandil; Bonde, Sara; Ekdahl, Christine T.; Kokaia, Zaal; Kokaia, Merab; Lindvall, Olle			Environment matters: Synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability	NEURON			English	Article							TEMPORAL-LOBE EPILEPSY; GENERATED GRANULE CELLS; LONG-TERM POTENTIATION; PRESYNAPTIC GABA(B) AUTORECEPTORS; PAIRED-PULSE DEPRESSION; RAT DENTATE GYRUS; PERFORANT PATH; FUNCTIONAL IMPLICATIONS; TRANSMITTER RELEASE; HIPPOCAMPAL SYNAPSE	Neural progenitors in the adult dentate gyrus continuously produce new functional granule cells. Here we used whole-cell patch-clamp recordings to explore whether a pathological environment influences synaptic properties of new granule cells labeled with a GFP-retroviral vector. Rats were exposed to a physiological stimulus, i.e., running, or a brain insult, i.e., status epilepticus, which gave rise to neuronal death, inflammation, and chronic seizures. Granule cells formed after these stimuli exhibited similar intrinsic membrane properties. However, the new neurons born into the pathological environment differed with respect to synaptic drive and short-term plasticity of both excitatory and inhibitory afferents. The new granule cells formed in the epileptic brain exhibited functional connectivity consistent with reduced excitability. We demonstrate a high degree of plasticity in synaptic inputs to adult-born new neurons, which could act to mitigate pathological brain function.	Univ Lund Hosp, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden; Univ Lund Hosp, Expt Epilepsy Grp, Sect Restorat Neurol, Wallenberg Neurosci Ctr, SE-22184 Lund, Sweden; Univ Lund Hosp, Lab Neural Stem Cell Biol, Sect Restorat Neurol, Stem Cell Inst, SE-22184 Lund, Sweden; Lund Strat Res Ctr Stem Cell Biol & Cell Therapy, Biomed Ctr, SE-22184 Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Lindvall, O (corresponding author), Univ Lund Hosp, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden.	olle.lindvall@med.lu.se	Kokaia, Zaal/AAL-6009-2020; Kokaia, Merab/A-2133-2010	Kokaia, Zaal/0000-0003-2296-2449; 				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Behr J, 1998, J NEUROPHYSIOL, V79, P1726, DOI 10.1152/jn.1998.79.4.1726; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Berninger B, 1999, LEARN MEMORY, V6, P232; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Cohen AS, 2003, EUR J NEUROSCI, V17, P1607, DOI 10.1046/j.1460-9568.2003.02597.x; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Crespel A, 2005, NEUROBIOL DIS, V19, P436, DOI 10.1016/j.nbd.2005.01.020; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; Gloveli T, 2003, NEUROBIOL DIS, V13, P203, DOI 10.1016/S0969-9961(03)00039-1; HANSE E, 1992, EUR J NEUROSCI, V4, P1191, DOI 10.1111/j.1460-9568.1992.tb00144.x; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Henneberger C, 2005, NEUROSCIENCE, V135, P749, DOI 10.1016/j.neuroscience.2005.06.044; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Ivanova SY, 2004, SYNAPSE, V53, P122, DOI 10.1002/syn.20040; Klapstein GJ, 1999, NEUROPHARMACOLOGY, V38, P927, DOI 10.1016/S0028-3908(99)00016-7; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kokaia M, 1998, J NEUROSCI, V18, P8730; Leinekugel X, 1999, Adv Neurol, V79, P189; LOTHMAN EW, 1989, EPILEPSY RES, V3, P107, DOI 10.1016/0920-1211(89)90038-7; Markakis EA, 1999, J COMP NEUROL, V406, P449; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Scharfman H, 2005, GROWTH FACTORS AND EPILEPSY, P1; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman HE, 2002, NEUROSCIENCE, V111, P71, DOI 10.1016/S0306-4522(01)00599-1; SCHARFMAN HE, 1992, EPILEPSY RES, P93; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Scimemi A, 2006, J NEUROPHYSIOL, V95, P1213, DOI 10.1152/jn.00680.2005; Shao LR, 2005, J NEUROPHYSIOL, V94, P952, DOI 10.1152/jn.01342.2004; Simmons ML, 1997, J NEUROPHYSIOL, V78, P1860, DOI 10.1152/jn.1997.78.4.1860; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; SUTULA T, 1986, BRAIN RES, V385, P291, DOI 10.1016/0006-8993(86)91075-9; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VANBOHLEN, 2005, IN PRESS BIOL PSYCHI; Wierenga CJ, 1999, J NEUROPHYSIOL, V82, P1352, DOI 10.1152/jn.1999.82.3.1352; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Wong M, 2005, EPILEPSY BEHAV, V7, P569, DOI 10.1016/j.yebeh.2005.08.007; Wu CP, 1997, J NEUROSCI, V17, P9261; Wuarin JP, 2001, J NEUROPHYSIOL, V85, P1067, DOI 10.1152/jn.2001.85.3.1067; Zha XM, 2005, MOL CELL NEUROSCI, V29, P494, DOI 10.1016/j.mcn.2005.04.007; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZUCKER RS, 1983, J NEUROSCI, V3, P1263	73	196	206	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1047	1059		10.1016/j.neuron.2006.11.004	http://dx.doi.org/10.1016/j.neuron.2006.11.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178407	Bronze			2022-12-24	WOS:000243115100012
J	Li, W; Luxenberg, E; Parrish, T; Gottfried, JA				Li, Wen; Luxenberg, Erin; Parrish, Todd; Gottfried, Jay A.			Learning to smell the roses: Experience-dependent neural plasticity in human piriform and orbitofrontal cortices	NEURON			English	Article							RAT OLFACTORY-BULB; PERCEIVED ODOR INTENSITY; ENHANCED SENSITIVITY; PREFRONTAL CORTEX; CROSS-ADAPTATION; DISCRIMINATION; PERCEPTION; RECOGNITION; ACTIVATION; MEMORY	It is widely presumed that odor quality is a direct outcome of odorant structure, but human studies indicate that molecular knowledge of an odorant is not always sufficient to predict odor quality. Indeed, the same olfactory input may generate different odor percepts depending on prior learning and experience. Combining functional magnetic resonance imaging with an olfactory paradigm of perceptual learning, we examined how sensory experience modifies odor perception and odor quality coding in the human brain. Prolonged exposure to a target odorant enhanced perceptual differentiation for odorants related in odor quality or functional group, an effect that was paralleled by learning-induced response increases in piriform cortex and orbitofrontal cortex (OFC). Critically, the magnitude of OFC activation predicted subsequent improvement in behavioral differentiation. Our findings suggest that neural representations of odor quality can be rapidly updated through mere perceptual experience, a mechanism that may underlie the development of odor perception.	Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Li, W (corresponding author), Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA.	wenli@northwestern.edu		Parrish, Todd/0000-0002-1184-1572	NIDCD NIH HHS [1 K08 DC007653-01A1, K08 DC007653] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC007653] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AMOORE JE, 1969, OLFACTION TASTE, V2; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Arctander S, 1994, PERFUME FLAVOR CHEM; BEDFORD FL, 1995, COGNITION, V54, P253, DOI 10.1016/0010-0277(94)00637-Z; BERGLUND B, 1978, SENS PROCESS, V2, P191; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CAIN WS, 1974, PERCEPT PSYCHOPHYS, V5, P271; Case TI, 2004, PERCEPTION, V33, P113, DOI 10.1068/p5044; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; EKMAN G, 1967, SCAND J PSYCHOL, V8, P177, DOI 10.1111/j.1467-9450.1967.tb01392.x; ESTES WK, 1986, COGNITIVE PSYCHOL, V18, P500, DOI 10.1016/0010-0285(86)90008-3; Fahle M, 2002, PERCEPTUAL LEARNING; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gibson E. J., 1991, ODYSSEY LEARNING PER; GIBSON EJ, 1956, J COMP PHYSIOL PSYCH, V49, P239, DOI 10.1037/h0048274; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Haberly L. B., 1998, OLFACTORY CORTEX; Hahn U, 2005, MEM COGNITION, V33, P289, DOI 10.3758/BF03195318; Hall G., 1991, PERCEPTUAL ASS LEARN; Hawkey DJC, 2004, NAT NEUROSCI, V7, P1055, DOI 10.1038/nn1315; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Herz RS, 2001, PERCEPTION, V30, P381, DOI 10.1068/p3179; JEHL C, 1995, PERCEPT PSYCHOPHYS, V57, P1002, DOI 10.3758/BF03205459; Johnson BA, 2002, J COMP NEUROL, V449, P180, DOI 10.1002/cne.10284; JONES PD, 1975, J EXP PSYCHOL HUMAN, V1, P323, DOI 10.1037/0096-1523.1.4.323; KOSSUT M, 1988, ACTA NEUROBIOL EXP, V48, P83; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; Livingston KR, 1998, J EXP PSYCHOL LEARN, V24, P732, DOI 10.1037/0278-7393.24.3.732; Mai J.K., 1997, ATLAS HUMAN BRAIN; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Meister M, 2001, J NEUROSCI, V21, P1351; NOSOFSKY RM, 1988, J EXP PSYCHOL LEARN, V14, P700, DOI 10.1037/0278-7393.14.4.700; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; OWEN DH, 1979, PERCEPTION, V8, P199, DOI 10.1068/p080199; PERON RM, 1988, J GEN PSYCHOL, V115, P403, DOI 10.1080/00221309.1988.9710577; Pierce JD, 1996, CHEM SENSES, V21, P223, DOI 10.1093/chemse/21.2.223; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Pothos EM, 2005, Q J EXP PSYCHOL-A, V58, P733, DOI 10.1080/02724980443000322; RABIN MD, 1988, PERCEPT PSYCHOPHYS, V44, P532, DOI 10.3758/BF03207487; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Schyns PG, 1998, BEHAV BRAIN SCI, V21, P1, DOI 10.1017/S0140525X98000107; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; STEVENS DA, 1995, CHEM SENSES, V20, P413, DOI 10.1093/chemse/20.4.413; Stevenson RJ, 2001, Q J EXP PSYCHOL-A, V54, P561, DOI 10.1080/02724980042000246; WADE NJ, 1994, PERCEPTION, V23, P1111, DOI 10.1068/p231111; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; WILSON DA, 2003, SENSORY PHYSL CTR OL; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; ZATORRE RJ, 1991, BRAIN, V114, P71; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368; ZELLNER DA, 1990, J EXP PSYCHOL HUMAN, V16, P391, DOI 10.1037/0096-1523.16.2.391	76	123	125	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					1097	1108		10.1016/j.neuron.2006.10.026	http://dx.doi.org/10.1016/j.neuron.2006.10.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	120VS	17178411	Green Accepted, Bronze			2022-12-24	WOS:000243115100016
J	Dai, Y; Taru, H; Deken, SL; Grill, B; Ackley, B; Nonet, ML; Jin, YS				Dai, Ya; Taru, Hidenori; Deken, Scott L.; Grill, Brock; Ackley, Brian; Nonet, Michael L.; Jin, Yishi			SYD-2 Liprin-alpha organizes presynaptic active zone formation through ELKS	NATURE NEUROSCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; RIM-BINDING PROTEINS; CAENORHABDITIS-ELEGANS; C-ELEGANS; SYNAPSE FORMATION; RECEPTOR; FAMILY; FORMS; LOCALIZATION; CYTOMATRIX	A central event in synapse development is formation of the presynaptic active zone in response to positional cues. Three active zone proteins, RIM, ELKS (also known as ERC or CAST) and Liprin-alpha, bind each other and are implicated in linking active zone formation to synaptic vesicle release. Loss of function in Caenorhabditis elegans syd-2 Liprin-alpha alters the size of presynaptic specializations and disrupts synaptic vesicle accumulation. Here we report that a missense mutation in the coiled-coil domain of SYD-2 causes a gain of function. In HSN synapses, the syd-2(gf) mutation promotes synapse formation in the absence of syd-1, which is essential for HSN synapse formation. syd-2(gf) also partially suppresses the synaptogenesis defects in syg-1 and syg-2 mutants. The activity of syd-2(gf) requires elks-1, an ELKS homolog; but not unc-10, a RIM homolog. The mutant SYD-2 shows increased association with ELKS. These results establish a functional dependency for assembly of the presynaptic active zone in which SYD-2 plays a key role.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Sinsheimer Labs, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Washington University (WUSTL)	Jin, YS (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Sinsheimer Labs, 1156 High St, Santa Cruz, CA 95064 USA.	jin@biology.ucsc.edu	Taru, Hidenori/B-7059-2009	Jin, Yishi/0000-0002-9371-9860; Grill, Brock/0000-0002-0379-3267; Ackley, Brian/0000-0002-1257-2407				Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BLOOM FE, 1972, STRUCTURE FUNCTION S, P101; BRENNER S, 1974, GENETICS, V77, P71; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; JIN Y, 2005, WORMBOOK; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Olsen O, 2006, CURR OPIN CELL BIOL, V18, P223, DOI 10.1016/j.ceb.2006.02.010; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	42	149	151	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1479	1487		10.1038/nn1808	http://dx.doi.org/10.1038/nn1808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115037				2022-12-24	WOS:000242404000011
J	Elias, GM; Funke, L; Stein, V; Grant, SG; Bredt, DS; Nicoll, RA				Elias, Guillermo M.; Funke, Lars; Stein, Valentin; Grant, Seth G.; Bredt, David S.; Nicoll, Roger A.			Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins	NEURON			English	Article							LONG-TERM POTENTIATION; PSD-95; PLASTICITY; NEUROLIGINS; TRANSMISSION; MEMBRANE; NEURONS; MICE	Trafficking of AMPA receptors (AMPA-Rs) to and from synapses controls the strength of excitatory synaptic transmission. However, proteins that cluster AMPA-Rs at synapses remain poorly understood. Here we show that PSD-95-like membrane-associated guanylate kinases (PSD-MAGUKs) mediate this synaptic targeting, and we uncover a remarkable functional redundancy within this protein family. By manipulating endogenous neuronal PSD-MAGUK levels, we find that both PSD-95 and PSD-93 independently mediate AMPA-R targeting at mature synapses. We also reveal unanticipated synapse heterogeneity as loss of either PSD-95 or PSD-93 silences largely nonoverlapping populations of excitatory synapses. In adult PSD-95 and PSD-93 double knockout animals, SAP-102 is upregulated and compensates for the loss of synaptic AMPA-Rs. At immature synapses, PSD-95 and PSD-93 play little role in synaptic AMPA-R clustering; instead, SAP-102 dominates. These studies establish a PSD-MAGUK-specific regulation of AMPA-R synaptic expression that establishes and maintains glutamatergic synaptic transmission in the mammalian central nervous system.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Free Univ Berlin, D-14195 Berlin, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wellcome Trust Sanger Institute; Free University of Berlin	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Stein, Valentin/A-8025-2008	Stein, Valentin/0000-0003-1222-4928; Grant, Seth/0000-0001-8732-8735				AEL DE, 2002, CELL, V108, P849; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Rao A, 1998, J NEUROSCI, V18, P1217; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Stein V, 2003, J NEUROSCI, V23, P5503; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	31	297	310	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					307	320		10.1016/j.neuron.2006.09.012	http://dx.doi.org/10.1016/j.neuron.2006.09.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046693	Bronze			2022-12-24	WOS:000241799900011
J	Gil-Da-Costa, R; Martin, A; Lopes, MA; Munoz, M; Fritz, JB; Braun, AR				Gil-da-Costa, Ricardo; Martin, Alex; Lopes, Marco A.; Munoz, Monica; Fritz, Jonathan B.; Braun, Allen R.			Species-specific calls activate homologs of Broca's and Wernicke's areas in the macaque	NATURE NEUROSCIENCE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; AUDITORY-CORTEX; RHESUS-MONKEY; FUNCTIONAL NEUROANATOMY; ASSOCIATION CORTEX; COMPLEX SOUNDS; MOTOR SYSTEM; LANGUAGE; REPRESENTATION; PARIETAL	The origin of brain mechanisms that support human language - whether these originated de novo in humans or evolved from a neural substrate that existed in a common ancestor -remains a controversial issue. Although the answer is not provided by the fossil record, it is possible to make inferences by studying living species of nonhuman primates. Here we identified neural systems associated with perceiving species-specific vocalizations in rhesus macaques using H(2)(15)O positron emission tomography (PET). These vocalizations evoke distinct patterns of brain activity in homologs of the human perisylvian language areas. Rather than resulting from differences in elementary acoustic properties, this activity seems to reflect higher order auditory processing. Although parallel evolution within independent primate species is feasible, this finding suggests the possibility that the last common ancestor of macaques and humans, which lived 25-30 million years ago, possessed key neural mechanisms that were plausible candidates for exaptation during the evolution of language.	Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA; NIMH, NIH, Bethesda, MD 20892 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Gulbenkian Inst Sci, Program Biol & Med, P-2781 Oeiras, Portugal; UCL, Inst Child Hlth, London WC1N 3JH, England; Univ Maryland, Syst Res Inst, Ctr Auditory & Acoust Res, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; University of London; University College London; University System of Maryland; University of Maryland College Park	Braun, AR (corresponding author), Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA.	brauna@nidcd.nih.gov	Munoz-Lopez, Monica/F-3154-2016; Munoz, Monica/C-9189-2009; Fritz, Jonathan/AAK-4863-2020; martin, alex/B-6176-2009	Munoz-Lopez, Monica/0000-0002-5530-2394; Fritz, Jonathan/0000-0002-0625-172X	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barsalou LW, 2005, TRENDS COGN SCI, V9, P309, DOI 10.1016/j.tics.2005.05.003; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Caplan D., 1987, NEUROLINGUISTICS LIN; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Damasio AR, 1984, ANNU REV NEUROSCI, V7, P127, DOI 10.1146/annurev.ne.07.030184.001015; Deacon T.W., 1989, Human Evolution, V4, P367, DOI 10.1007/BF02436435; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gannon PJ, 1998, SCIENCE, V279, P220, DOI 10.1126/science.279.5348.220; GEMBA H, 1995, BRAIN RES, V697, P143, DOI 10.1016/0006-8993(95)00797-T; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Geyer S, 2000, ANAT EMBRYOL, V202, P443, DOI 10.1007/s004290000127; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; Gifford GW, 2005, J COGNITIVE NEUROSCI, V17, P1471, DOI 10.1162/0898929054985464; Gil-Da-Costa R, 2004, P NATL ACAD SCI USA, V101, P17516, DOI 10.1073/pnas.0408077101; Gouzoules H, 2000, ANIM BEHAV, V59, P501, DOI 10.1006/anbe.1999.1318; HAST MH, 1974, BRAIN RES, V73, P229, DOI 10.1016/0006-8993(74)91046-4; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; PANDYA DN, 1973, Z ANAT ENTWICKLUNGS, V139, P127, DOI 10.1007/BF00523634; Papathanassiou D, 2000, NEUROIMAGE, V11, P347, DOI 10.1006/nimg.2000.0546; Passingham RE, 1998, COMP NEUROPSYCHOLOGY, P271; Paxinos G., 2000, RHESUS MONKEY BRAIN; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Poeppel D, 2004, NEUROPSYCHOLOGIA, V42, P183, DOI 10.1016/j.neuropsychologia.2003.07.010; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; PREUSS TM, 1991, J COMP NEUROL, V310, P475, DOI 10.1002/cne.903100403; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; SERENO MI, 1991, PROGRAM OF THE THIRTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P79; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Warren JD, 2003, J NEUROSCI, V23, P5799; WISE SP, IN PRESS EVOLUTION P, V4, pCH11	49	106	108	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1064	1070		10.1038/nn1741	http://dx.doi.org/10.1038/nn1741			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16862150				2022-12-24	WOS:000240080300020
J	Rapedius, M; Fowler, PW; Shang, LJ; Sansom, MSP; Tucker, SJ; Baukrowitz, T				Rapedius, Markus; Fowler, Philip W.; Shang, Lijun; Sansom, Mark S. P.; Tucker, Stephen J.; Baukrowitz, Thomas			H bonding at the helix-bundle crossing controls gating in Kir potassium channels	NEURON			English	Article							K-ATP CHANNELS; CHAIN COA ESTERS; MOLECULAR-DYNAMICS; INTRACELLULAR PH; K(IR)1.1 CHANNELS; EXTRACELLULAR K+; BARTTER-SYNDROME; ROMK1 CHANNEL; ION CHANNELS; ACTIVATION	Specific stimuli such as intracellular H+ and phosphoinositides (e.g., PIP2) gate inwardly rectifying potassium (Kir) channels by controlling the reversible transition between the closed and open states. This gating mechanism underlies many aspects of Kir channel physiology and pathophysiology; however, its structural basis is not well understood. Here, we demonstrate that H+ and PIP2 use a conserved gating mechanism defined by similar structural changes in the transmembrane (TM) helices and the selectivity filter. Our data support a model in which the gating motion of the TM helices is controlled by an intrasubunit hydrogen bond between TM1 and TM2 at the helix-bundle crossing, and we show that this defines a common gating motif in the Kir channel superfamily. Furthermore , we show that this proposed H-bonding interaction determines Kir channel pH sensitivity, pH and PIP2 gating kinetics, as well as a K+-dependent inactivation process at the selectivity filter and therefore many of the key regulatory mechanisms of Kir channel physiology.	Univ Oxford, Dept Phsiol Anat & Genet, Oxford Ctr Gene Funct, Oxford OX1 3PT, England; Univ Jena, Inst Physiol 2, D-07743 Jena, Germany; Univ Oxford, Dept Biochem, Struct Bioinformat & Computat Biochem Unit, Oxford OX1 3QU, England	University of Oxford; Friedrich Schiller University of Jena; University of Oxford	Tucker, SJ (corresponding author), Univ Oxford, Dept Phsiol Anat & Genet, Oxford Ctr Gene Funct, S Parks Rd, Oxford OX1 3PT, England.	stephen.tucker@physiol.ox.ac.uk; thomas.baukrowitz@mti.uni-jena.de	Tucker, Stephen J./ABE-7468-2020; Tucker, Stephen J./ABE-6741-2020; Sansom, Mark S.P./C-5157-2009; Fowler, Philip/AAD-2392-2020; Fowler, Philip/C-5116-2009; Shang, Lijun/AAT-8172-2020	Tucker, Stephen J./0000-0001-8996-2000; Tucker, Stephen J./0000-0001-8996-2000; Sansom, Mark S.P./0000-0001-6360-7959; Fowler, Philip/0000-0003-0912-4483; Fowler, Philip/0000-0003-0912-4483; Shang, Lijun/0000-0001-5925-5903; Baukrowitz, Thomas/0000-0003-4562-0505	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Baukrowitz T, 2000, BIOCHEM PHARMACOL, V60, P735, DOI 10.1016/S0006-2952(00)00267-7; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Dahlmann A, 2004, J GEN PHYSIOL, V123, P441, DOI 10.1085/jgp.200308989; Domene C, 2005, BIOPHYS J, V89, pL1, DOI 10.1529/biophysj.105.060855; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; Fakler B, 1996, EMBO J, V15, P4093, DOI 10.1002/j.1460-2075.1996.tb00784.x; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Leng Q, 2006, P NATL ACAD SCI USA, V103, P1982, DOI 10.1073/pnas.0510610103; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Nilius B, 2007, BIOCHEM SOC T, V35, P105, DOI 10.1042/BST0350105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Rapedius M, 2005, J BIOL CHEM, V280, P30760, DOI 10.1074/jbc.M503503200; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Sackin H, 2005, BIOPHYS J, V88, P2597, DOI 10.1529/biophysj.104.051474; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Scholle A, 2004, BIOPHYS J, V87, P873, DOI 10.1529/biophysj.104.040550; Schulte U, 2001, J PHYSIOL-LONDON, V534, P49, DOI 10.1111/j.1469-7793.2001.t01-1-00049.x; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; Shumilina E, 2006, J PHYSIOL-LONDON, V575, P433, DOI 10.1113/jphysiol.2006.111161; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; SU J, 2006, J PHYSL, V578, P831; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Wu J, 2004, J MEMBRANE BIOL, V197, P179, DOI 10.1007/s00232-004-0652-4; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zeng WZ, 2003, J BIOL CHEM, V278, P16852, DOI 10.1074/jbc.M300619200; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	55	54	56	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2007	55	4					602	614		10.1016/j.neuron.2007.07.026	http://dx.doi.org/10.1016/j.neuron.2007.07.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698013	Green Published, hybrid			2022-12-24	WOS:000249159200009
J	Bingel, U; Rose, M; Glascher, J; Buchel, C				Bingel, Ulrike; Rose, Michael; Glascher, Jan; Buchel, Christian			fMRI reveals how pain modulates visual object processing in the ventral visual stream	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; WORKING-MEMORY; VISUOSPATIAL ATTENTION; RESPONSE SELECTION; FUNCTIONAL-ANATOMY; IMPENDING PAIN; TASK; ANTICIPATION; STIMULATION; ACTIVATION	It is well known that pain attracts attention and interferes with cognition. Given that the mechanisms behind this phenomenon are largely unknown, we used functional magnetic resonance imaging and presented visual objects with or without concomitant pain stimuli. To test for the specificity of pain, we compared this modulatory effect with a previously established modulatory effect of working memory on visual object processing. Our data showed a comparable behavioral effect of both types of modulation and identified the lateral occipital complex (LOC) as the site of modulation in the ventral visual stream, for both pain and working memory. However, the sources of these modulatory effects differed for the two processes. Whereas the source of modulation for working memory could be attributed to the parietal cortex, the modulatory effect of pain was observed in the rostral anterior cingulate cortex (rACC), an area ideally suited to link pain perception and attentional control.	Univ Hamburg, Med Ctr Eppendorf, Dept Neurol, NeuroImage Nord, Hamburg, Germany; Univ Hamburg, Med Ctr Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany	University of Hamburg; University of Hamburg	Bingel, U (corresponding author), Univ Hamburg, Med Ctr Eppendorf, Dept Neurol, NeuroImage Nord, Hamburg, Germany.	bingel@uke.uni-hamburg.de	Gläscher, Jan/H-2930-2019	Gläscher, Jan/0000-0002-1020-7115				Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Benedict RHB, 2002, J COGNITIVE NEUROSCI, V14, P637, DOI 10.1162/08989290260045765; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Buchel C, 2002, J NEUROSCI, V22, P970, DOI 10.1523/JNEUROSCI.22-03-00970.2002; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Carter RM, 2003, P NATL ACAD SCI USA, V100, P1399, DOI 10.1073/pnas.0334049100; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Crombez G, 1998, BEHAV RES THER, V36, P195, DOI 10.1016/S0005-7967(97)10008-0; Crombez G, 1997, PAIN, V70, P149, DOI 10.1016/S0304-3959(96)03304-0; CROMBEZ G, 1994, BEHAV RES THER, V32, P611, DOI 10.1016/0005-7967(94)90015-9; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; ECCLESTON C, 1994, BRIT J CLIN PSYCHOL, V33, P535, DOI 10.1111/j.2044-8260.1994.tb01150.x; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; EVANS AC, 1993, P IEEE NUCL SCI S ME, V1, P1813; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Gimenez-Amaya JM, 2000, REV NEUROLOGIA, V30, P656, DOI 10.33588/rn.3007.99529; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Isomura Y, 2003, J NEUROSCI, V23, P8002; Jonides J, 1998, J NEUROSCI, V18, P5026; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kuhajda MC, 2002, PAIN, V97, P213, DOI 10.1016/S0304-3959(01)00488-2; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MORTON J, 1969, BRIT J PSYCHOL, V60, P329, DOI 10.1111/j.2044-8295.1969.tb01204.x; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2000, PAIN, V85, P19, DOI 10.1016/S0304-3959(99)00232-8; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Porro CA, 2003, NEUROIMAGE, V19, P1738, DOI 10.1016/S1053-8119(03)00184-8; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P937, DOI 10.1016/S0028-3932(01)00016-1; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Reinders AATS, 2005, EUR J NEUROSCI, V22, P524, DOI 10.1111/j.1460-9568.2005.04212.x; Rose M, 2005, CEREB CORTEX, V15, P1290, DOI 10.1093/cercor/bhi012; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224; Van Damme S, 2004, EUR J PAIN, V8, P227, DOI 10.1016/j.ejpain.2003.08.005; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048	55	100	103	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					157	167		10.1016/j.neuron.2007.05.032	http://dx.doi.org/10.1016/j.neuron.2007.05.032			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	189TF	17610824	Bronze			2022-12-24	WOS:000248010700015
J	Tai, CY; Mysore, SP; Chiu, C; Schuman, EM				Tai, Chin-Yin; Mysore, Shreesh P.; Chiu, Cindy; Schuman, Erin M.			Activity-regulated N-cadherin endocytosis	NEURON			English	Article							AMPA RECEPTOR ENDOCYTOSIS; CELL-ADHESION MOLECULES; DENDRITIC SPINES; BETA-CATENIN; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; COMPLEX-FORMATION; ASSOCIATION; INTERNALIZATION; TRAFFICKING	Enduring forms of synaptic plasticity are thought to require ongoing regulation of adhesion molecules, such as N-cadherin, at synaptic junctions. Little is known about the activity-regulated trafficking of adhesion molecules. Here we demonstrate that surface N-cadherin undergoes a surprisingly high basal rate of internalization. Upon activation of NMDA receptors (NMDAR), the rate of N-cadherin endocytosis is significantly reduced, resulting in an accumulation of N-cadherin in the plasma membrane. beta-catenin, an N-cadherin binding partner, is a primary regulator of N-cadherin endocytosis. Following NMDAR stimulation, beta-catenin accumulates in spines and exhibits increased binding to N-cadherin. Overexpression of a mutant form of beta-catenin, Y654F, prevents the NMDAR-dependent regulation of N-cadherin internalization, resulting in stabilization of surface N-cadherin molecules. Furthermore, the stabilization of surface N-cadherin blocks NMDAR-dependent synaptic plasticity. These results indicate that NMDAR activity regulates N-cadherin endocytosis, providing a mechanistic link between structural plasticity and persistent changes in synaptic efficacy.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Stanford University	Schuman, EM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011	Mysore, Shreesh/0000-0002-7781-8252				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BEESLEY PW, 1995, J NEUROCHEM, V64, P2288; Benson DL, 1998, J NEUROSCI, V18, P6892; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Dore S, 1997, NEUROSCIENCE, V78, P373, DOI 10.1016/S0306-4522(96)00594-5; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; Spacek J, 1998, J COMP NEUROL, V393, P58, DOI 10.1002/(SICI)1096-9861(19980330)393:1<58::AID-CNE6>3.0.CO;2-P; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132	50	122	126	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 7	2007	54	5					771	785		10.1016/j.neuron.2007.05.013	http://dx.doi.org/10.1016/j.neuron.2007.05.013			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553425	Bronze			2022-12-24	WOS:000247329900010
J	Hughes, ME; Bortnick, R; Tsubouchi, A; Baumer, P; Kondo, M; Uemura, T; Schmucker, D				Hughes, Michael E.; Bortnick, Rachel; Tsubouchi, Asako; Baumer, Philipp; Kondo, Masahiro; Uemura, Tadashi; Schmucker, Dietmar			Homophilic Dscam interactions control complex dendrite morphogenesis	NEURON			English	Article							DROSOPHILA SENSORY NEURONS; AXON GUIDANCE; MOLECULAR DIVERSITY; RECEPTOR; REPULSION; BRANCHES; DOCK; PAK; CNS	Alternative splicing of the Drosophila gene Dscam results in up to 38,016 different receptor isoforms proposed to interact by isoform-specific homophilic binding. We report that Dscam controls cell-intrinsic aspects of dendrite guidance in all four classes of dendrite arborization (da) neurons. Loss of Dscam in single neurons causes a strong increase in self-crossing. Restriction of dendritic fields of neighboring class III neurons appeared intact in mutant neurons, suggesting that dendritic self-avoidance, but not heteroneuronal tiling, may depend on Dscam. Overexpression of the same Dscam isoforms in two da neurons with overlapping dendritic fields forced a spatial segregation of the two fields, supporting the model that dendritic branches of da neurons use isoform-specific homophilic interactions to ensure minimal overlap. Homophilic binding of the highly diverse extracellular domains of Dscam may therefore limit the use of the same "core" repulsion mechanism to cell-intrinsic interactions without interfering with heteroneuronal interactions.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Kyoto University	Schmucker, D (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	dietmar_schmucker@dfci.harvard.edu		UEMURA, Tadashi/0000-0001-7204-3606; Tsubouchi, Asako/0000-0002-6284-8221	NINDS NIH HHS [R01 NS046747-03, R01 NS046747-02, R01 NS046747-01, R01 NS046747, R01-NS46747, R01 NS046747-04] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046747] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2005, CURR BIOL, V15, pR730, DOI 10.1016/j.cub.2005.08.023; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shepherd D, 1996, DEVELOPMENT, V122, P2375; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Sugimura K, 2003, J NEUROSCI, V23, P3752; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	27	193	195	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 3	2007	54	3					417	427		10.1016/j.neuron.2007.04.013	http://dx.doi.org/10.1016/j.neuron.2007.04.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481395	Green Accepted, Bronze			2022-12-24	WOS:000246855700012
J	Soba, P; Zhu, S; Emoto, K; Younger, S; Yang, SJ; Yu, HH; Lee, T; Jan, LY; Jan, YN				Soba, Peter; Zhu, Sijun; Emoto, Kazuo; Younger, Susan; Yang, Shun-Jen; Yu, Hung-Hsiang; Lee, Tzumin; Jan, Lily Yeh; Jan, Yuh-Nung			Drosophila sensory neurons require Dscam for dendritic self-avoidance and proper dendritic field organization	NEURON			English	Article							PRE-MESSENGER-RNA; MOLECULAR DIVERSITY; KINASE; MORPHOGENESIS; COMPETITION; ROLES; CELLS	A neuron's dendrites typically do not cross one another. This intrinsic self-avoidance mechanism ensures unambiguous processing of sensory or synaptic inputs. Moreover, some neurons respect the territory of others of the same type, a phenomenon known as tiling. Different types of neurons, however, often have overlapping dendritic fields. We found that Down's syndrome Cell Adhesion Molecule (Dscam) is required for dendritic self-avoidance of all four classes of Drosophila dendritic arborization (da) neurons. However, neighboring mutant class IV da neurons still exhibited tiling, suggesting that self-avoidance and tiling differ in their recognition and repulsion mechanisms. Introducing 1 of the 38,016 Dscam isoforms to da neurons in Dscam mutants was sufficient to significantly restore self-avoidance. Remarkably, expression of a common Dscam isoform in da neurons of different classes prevented their dendrites from sharing the same territory, suggesting that coexistence of dendritic fields of different neuronal classes requires divergent expression of Dscam isoforms.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biophys, San Francisco, CA 94143 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	Yang, Shun-Jen/G-2968-2015; Yu, Hung-Hsiang/AGP-0497-2022; Soba, Peter/AAC-8143-2020; EMOTO, KAZUO/G-4992-2014; Soba, Peter/AAK-1134-2021	Yu, Hung-Hsiang/0000-0002-2430-9251; Soba, Peter/0000-0002-6163-4686; Soba, Peter/0000-0002-6163-4686; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	NIMH NIH HHS [R01 MH084234] Funding Source: Medline; NINDS NIH HHS [R37 NS040929, R01 NS040929, R01 NS040929-07, R01 NS40929] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929, R37NS040929] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Celotto AM, 2001, GENETICS, V159, P599; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Geng W, 2000, GENETICS, V156, P1817; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SHELLENBARGER DL, 1975, GENETICS, V81, P143; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Stuart G., 1999, DENDRITES; Sugimura K, 2003, J NEUROSCI, V23, P3752; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	35	192	194	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 3	2007	54	3					403	416		10.1016/j.neuron.2007.03.029	http://dx.doi.org/10.1016/j.neuron.2007.03.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481394	Green Accepted, Bronze			2022-12-24	WOS:000246855700011
J	Hoeffer, CA; Klann, E				Hoeffer, Charles A.; Klann, Eric			Switching gears: Translational mastery of transcription during memory formation	NEURON			English	Editorial Material							TERM SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; CREB; CONSOLIDATION; STRESS; CELLS; MICE	A critical molecular requirement underlying many forms of long-lasting synaptic plasticity and memory is the de novo synthesis of mRNAs and proteins. In a recent paper in Cell, Costa-Mattioli et al. present data from a pharmacogenetic study that places a key regulatory event in the "neural decision" to undergo these persistent neuronal changes under translational control mediated by eIF2 alpha.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eklann@cns.nyu.edu						Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; Wagatsuma A, 2006, J NEUROSCI RES, V84, P954, DOI 10.1002/jnr.21012	15	2	3	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					186	189		10.1016/j.neuron.2007.04.003	http://dx.doi.org/10.1016/j.neuron.2007.04.003			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442240	Bronze			2022-12-24	WOS:000246190600004
J	Shimizu, H; Watanabe, E; Hiyama, TY; Nagakura, A; Fujikawa, A; Okado, H; Yanagawa, Y; Obata, K; Noda, M				Shimizu, Hidetada; Watanabe, Eiji; Hiyama, Takeshi Y.; Nagakura, Ayano; Fujikawa, Akihiro; Okado, Haruo; Yanagawa, Yuchio; Obata, Kunihiko; Noda, Masaharu			Glial Na-x channels control lactate signaling to neurons for brain [Na+] sensing	NEURON			English	Article							SENSORY CIRCUMVENTRICULAR ORGANS; NA+,K+-ATPASE ALPHA-SUBUNIT; SENSITIVE SODIUM-CHANNEL; SUBFORNICAL ORGAN; FIRING PATTERNS; GLUCOSE-UPTAKE; NA,K-ATPASE; METABOLISM; TRANSPORT; SINGLE	Sodium (Na) homeostasis is crucial for life, and Na levels in body fluids are constantly monitored in the brain. The subfornical organ (SFO) is the center of the sensing responsible for the control of salt-intake behavior, where Na-x channels are expressed in specific glial cells as the Na-level sensor. Here, we show direct interaction between Na-x channels and alpha subunits of Na+/K+-ATPase, which brings about Na-dependent activation of the metabolic state of the glial cells. The metabolic enhancement leading to extensive lactate production was observed in the SFO of wild-type mice, but not of the Na-x-knockout mice. Furthermore, lactate, as well as Na, stimulated the activity of GABAergic neurons in the SFO. These results suggest that the information on a physiological increase of the Na level in body fluids sensed by Na-x in glial cells is transmitted to neurons by lactate as a mediator to regulate neural activities of the SFO.	Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; Natl Inst Basic Biol, Lab Neurophysiol, Okazaki, Aichi 4448787, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan; Tokyo Metropolitan Inst Neurosci, Dept Mol Physiol, Fuchu, Tokyo 1838526, Japan; Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gunma 3718511, Japan; RIKEN, Neuronal Circuit Mechanisms Res Grp, Brain Sci Inst, Wako, Saitama 3510198, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Gunma University; RIKEN	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Fujikawa, Akihiro/K-9805-2015; Hiyama, Takeshi/X-4134-2018; Noda, Masaharu/D-7146-2016	Fujikawa, Akihiro/0000-0002-3950-0550; Hiyama, Takeshi/0000-0001-8612-8707; Noda, Masaharu/0000-0002-3796-524X; Watanabe, Eiji/0000-0001-9089-8122				ANDERSSON B, 1978, PHYSIOL REV, V58, P582, DOI 10.1152/physrev.1978.58.3.582; Chih CP, 2001, TRENDS NEUROSCI, V24, P573, DOI 10.1016/S0166-2236(00)01920-2; COX PS, 1987, AM J PHYSIOL, V252, pR1, DOI 10.1152/ajpregu.1987.252.1.R1; Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; GAUTRON S, 1992, P NATL ACAD SCI USA, V89, P7272, DOI 10.1073/pnas.89.15.7272; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; JOHNSON AK, 1993, FASEB J, V7, P678, DOI 10.1096/fasebj.7.8.8500693; Jung JH, 2002, J BIOL CHEM, V277, P48931, DOI 10.1074/jbc.M208806200; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kondo S, 1998, J PHYSIOL-LONDON, V509, P233, DOI 10.1111/j.1469-7793.1998.233bo.x; Krivoi II, 2006, PFLUG ARCH EUR J PHY, V452, P756, DOI 10.1007/s00424-006-0081-6; Magistretti PJ, 2000, BRAIN RES, V886, P108, DOI 10.1016/S0006-8993(00)02945-0; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Noda M, 2006, NEUROSCIENTIST, V12, P80, DOI 10.1177/1073858405279683; Noda M, 2005, CHEM SENSES, V30, pI44, DOI 10.1093/chemse/bjh105; NOSE H, 1992, J APPL PHYSIOL, V73, P1419, DOI 10.1152/jappl.1992.73.4.1419; PARK R, 1989, BRAIN RES, V493, P123, DOI 10.1016/0006-8993(89)91006-8; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; ROSENTHAL M, 1992, CAN J PHYSIOL PHARM, V70, pS165, DOI 10.1139/y92-258; SERPERSU EH, 1984, J BIOL CHEM, V259, P7155; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8; Wang XQ, 2005, J NEUROCHEM, V93, P1515, DOI 10.1111/j.1471-4159.2005.03147.x; Waniewski RA, 2004, NEUROCHEM RES, V29, P209, DOI 10.1023/B:NERE.0000010450.21586.a6; Washburn DLS, 2000, J PHYSIOL-LONDON, V529, P359, DOI 10.1111/j.1469-7793.2000.00359.x; Watanabe E, 2006, AM J PHYSIOL-REG I, V290, pR568, DOI 10.1152/ajpregu.00618.2005; Watanabe E, 2000, J NEUROSCI, V20, P7743; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425; WEISINGER RS, 1979, NATURE, V280, P490, DOI 10.1038/280490a0; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Zouzoulas A, 2006, J BIOL CHEM, V281, P8539, DOI 10.1074/jbc.M512700200	45	148	152	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					59	72		10.1016/j.neuron.2007.03.014	http://dx.doi.org/10.1016/j.neuron.2007.03.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408578	Bronze, Green Submitted			2022-12-24	WOS:000245848400010
J	Thierry, G; Martin, CD; Downing, P; Pegna, AJ				Thierry, Guillaume; Martin, Clara D.; Downing, Paul; Pegna, Alan J.			Controlling for interstimulus perceptual variance abolishes N170 face selectivity	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; EVENT-RELATED POTENTIALS; OBJECT; RECOGNITION; EXPERTISE; DYNAMICS; SPECIFICITY; ATTENTION; COMPONENT; STIMULI	Establishing when and how the human brain differentiates between object categories is key to understanding visual cognition. Event-related potential (ERP) investigations have led to the consensus that faces selectively elicit a negative wave peaking 170 ms after presentation, the 'N170'. In such experiments, however, faces are nearly always presented from a full front view, whereas other stimuli are more perceptually variable, leading to uncontrolled interstimulus perceptual variance (ISPV). Here, we compared ERPs elicited by faces, cars and butterflies while-for the first time-controlling ISPV (low or high). Surprisingly, the N170 was sensitive, not to object category, but to ISPV. In addition, we found category effects independent of ISPV 70 ms earlier than has been generally reported. These results demonstrate early ERP category effects in the visual domain, call into question the face selectivity of the N170 and establish ISPV as a critical factor to control in experiments relying on multitrial averaging.	Univ Wales, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales; Univ Lyon, CNRS, Inst Sci Cognit, Lab Langage Cerveau & Cognit, F-69675 Bron, France; Univ Hosp Geneva, Neurol Clin, Neuropsychol Unit, Lab Expt Neuropsychol, CH-1211 Geneva, Switzerland	Bangor University; Centre National de la Recherche Scientifique (CNRS); University of Geneva	Thierry, G (corresponding author), Univ Wales, Sch Psychol, Brigantia Bldg,Penrallt Rd, Bangor LL57 2AS, Gwynedd, Wales.	g.thierry@bangor.ac.uk	Pegna, A J/D-1297-2017; Martin, Clara/B-4563-2012; Thierry, Guillaume/C-2688-2008	Pegna, A J/0000-0001-9920-9290; Martin, Clara/0000-0003-2701-5045; Thierry, Guillaume/0000-0003-1325-2656; Downing, Paul/0000-0002-5046-2858				ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; BENNETT TL, 1992, NEUROPSYCHOLOGY EPIL, P73; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Boehm SG, 2006, NEUROIMAGE, V30, P1021, DOI 10.1016/j.neuroimage.2005.10.028; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; Cauquil AS, 2000, NEUROREPORT, V11, P2167, DOI 10.1097/00001756-200007140-00021; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Herrmann MJ, 2005, BRAIN TOPOGR, V18, P77, DOI 10.1007/s10548-005-0277-7; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; HILLYARD SA, 1989, HDB PHYSL 1, P519; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Lueschow A, 2004, PSYCHOPHYSIOLOGY, V41, P350, DOI 10.1111/j.1469-8986.2004.00159.x; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 1999, NEWS PHYSIOL SCI, V14, P206; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Pegna AJ, 1997, HUM BRAIN MAPP, V5, P410, DOI 10.1002/(SICI)1097-0193(1997)5:6<410::AID-HBM2>3.0.CO;2-6; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rossion B, 2002, COGNITION, V85, P189, DOI 10.1016/S0010-0277(02)00101-4; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Seeck M, 2001, EPILEPSY BEHAV, V2, P545, DOI 10.1006/ebeh.2001.0266; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; *U LJUBJ FAC COMP, CVL FAC DAT; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Xu YD, 2005, NEUROPSYCHOLOGIA, V43, P588, DOI 10.1016/j.neuropsychologia.2004.07.016	43	166	168	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					505	511		10.1038/nn1864	http://dx.doi.org/10.1038/nn1864			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17334361				2022-12-24	WOS:000245228600022
J	Katagiri, H; Fagiolini, M; Hensch, TK				Katagiri, Hiroyuki; Fagiolini, Michela; Hensch, Takao K.			Optimization of somatic inhibition at critical period onset in mouse visual cortex	NEURON			English	Article							SYNAPTIC GABA(A) RECEPTORS; GAMMA-AMINOBUTYRIC-ACID; HIPPOCAMPAL PYRAMIDAL CELLS; POSTNATAL-DEVELOPMENT; BENZODIAZEPINE-RECEPTOR; GABAERGIC INNERVATION; PLASTICITY; NUMBER; SYNAPSES; CIRCUITS	Local GABAergic circuits trigger visual cortical plasticity in early postnatal life. How these diverse connections contribute to critical period onset was investigated by nonstationary fluctuation analysis following laser photo-uncaging of GABA onto discrete sites upon individual pyramidal cells in slices of mouse visual cortex. The GABA(A) receptor number decreased on the soma-proximal dendrite (SPD), but not at the axon initial segment, with age and sensory deprivation. Benzodiazepine sensitivity was also higher on the immature SPD. Too many or too few SPID receptors in immature or dark-reared mice, respectively, were adjusted to critical period levels by benzodiazepine treatment in vivo, which engages ocular dominance plasticity in these animal models. Combining GAD65 deletion with dark rearing from birth confirmed that an intermediate number of SPD receptors enable plasticity. Site-specific optimization of perisomatic GABA response may thus trigger experience-dependent development in visual cortex.	RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Osaka 5600082, Japan	RIKEN; Japan Science & Technology Agency (JST)	Hensch, TK (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	hensch@mcb.harvard.edu	Hensch, Takao/L-4182-2019	fagiolini, michela/0000-0003-2807-803X				Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; BENEVENTO LA, 1992, BRAIN RES, V572, P198, DOI 10.1016/0006-8993(92)90470-T; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; CHATTOPADHYAYA B, 2006, CSHL GABA WORKSH, P7; Chen L, 2001, MOL BRAIN RES, V88, P135, DOI 10.1016/S0169-328X(01)00042-0; Cherubini E, 2001, TRENDS NEUROSCI, V24, P155, DOI 10.1016/S0166-2236(00)01724-0; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DAW N, 1995, VISUAL DEV; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Heinen K, 2004, NEUROSCIENCE, V124, P161, DOI 10.1016/j.neuroscience.2003.11.004; Henneberger C, 2005, NEUROSCIENCE, V135, P749, DOI 10.1016/j.neuroscience.2005.06.044; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; Iwai Y, 2003, J NEUROSCI, V23, P6695; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; KOMATSU Y, 1991, BRAIN RES, V540, P14, DOI 10.1016/0006-8993(91)90487-G; Kunig G, 2000, ANN NEUROL, V47, P644; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Morales B, 2002, J NEUROSCI, V22, P8084; Morrow AL, 2001, BRAIN RES REV, V37, P98, DOI 10.1016/S0165-0173(01)00127-8; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; MOWER GD, 1988, J COMP NEUROL, V272, P293, DOI 10.1002/cne.902720211; NICOLL RA, 1994, NATURE, V368, P808, DOI 10.1038/368808a0; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nutt DJ, 2001, BRIT J PSYCHIAT, V179, P390, DOI 10.1192/bjp.179.5.390; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; TANAKA K, 1987, EXP BRAIN RES, V65, P673; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327	54	99	103	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 15	2007	53	6					805	812		10.1016/j.neuron.2007.02.026	http://dx.doi.org/10.1016/j.neuron.2007.02.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359916	Bronze			2022-12-24	WOS:000245292800006
J	Papaleo, F; Kitchener, P; Contarino, A				Papaleo, Francesco; Kitchener, Pierre; Contarino, Angelo			Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal	NEURON			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ANXIETY-LIKE BEHAVIOR; NEUROPEPTIDE MESSENGER-RNA; GENE-EXPRESSION; PRECIPITATED WITHDRAWAL; REDUCED ANXIETY; BRAIN-REGIONS; MICE LACKING; DELTA-FOSB; ANTAGONIST	Escape from the extremely stressful opiate withdrawal syndrome may motivate opiate seeking and taking. The corticotropin-releasing factor receptor-1 (CRF1) pathway mediates behavioral and endocrine responses to stress. Here, we report that genetic inactivation (CRF1-/-) as well as pharmacological antagonism of the CRF/ CRF1 receptor pathway increased and prolonged the somatic expression of opiate withdrawal. Opiate-withdrawn CRF1-/- mice also showed aberrant CRF and dynorphin expression in the paraventricular nucleus of the hypothalamus (PVN) and the striatum, indicating profound impairments in stress-responsive brain circuitry. Intake of nonstressful amounts of corticosterone effectively reduced the exaggerated somatic reactions of CRF1-/- mice to opiate withdrawal. Exogenous corticosterone also restored "wild-type-like" patterns of CRF and dynorphin gene expression in the PVN and the striatum of opiate-withdrawn CRF1-/- mice, respectively. The present findings unravel a key role for the hypothalamus-pituitary-adrenal (HPA) system and brainextra- hypothalamic CRF/CRF1 receptor circuitry in somatic, molecular, and endocrine alterations induced by opiate withdrawal.	Univ Victor Segalen Bordeaux 2, EA 3666, Lab Homeostasie Allostasie Pathol, F-33076 Bordeaux, France; INSERM Unite 588, F-33076 Bordeaux, France; Dipartimento Farmacol & Anestesiol, I-35131 Padua, Italy	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Contarino, A (corresponding author), Univ Victor Segalen Bordeaux 2, EA 3666, Lab Homeostasie Allostasie Pathol, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	angelo.contarino@nppda.u-bordeaux2.fr	Contarino, Angelo/C-9429-2014; Papaleo, Francesco/AAD-1844-2019	Papaleo, Francesco/0000-0002-6326-0657; Contarino, Angelo/0000-0002-7286-6941				ALMEIDA OF, 1909, BRAIN RES, V571, P189; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Carrera MRA, 1999, PSYCHOPHARMACOLOGY, V144, P111, DOI 10.1007/s002130050983; Contarino A, 2005, P NATL ACAD SCI USA, V102, P18649, DOI 10.1073/pnas.0506999102; Contarino A, 2002, NEUROPEPTIDES, V36, P103, DOI 10.1054/npep.2002.0899; Contarino A, 1999, BRAIN RES, V835, P1, DOI 10.1016/S0006-8993(98)01158-5; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deak T, 1999, ENDOCRINOLOGY, V140, P79, DOI 10.1210/en.140.1.79; FACCHINETTI F, 1985, DRUG ALCOHOL DEPEN, V15, P361, DOI 10.1016/0376-8716(85)90014-6; FALLON JH, 1990, HDB CHEM NEUROANATOM, P1; Fukunaga Y, 2000, JPN J PHARMACOL, V82, P175, DOI 10.1254/jjp.82.175; Georges F, 1999, EUR J NEUROSCI, V11, P481, DOI 10.1046/j.1460-9568.1999.00462.x; Hauger RL, 2003, PHARMACOL REV, V55, P21, DOI 10.1124/pr.55.1.3; HEINRICHS SC, 1994, NEUROPSYCHOPHARMACOL, V11, P179, DOI 10.1038/sj.npp.1380104; HEINRICHS SC, 1995, BEHAV PHARMACOL, V6, P74; Houshyar H, 2004, J NEUROSCI, V24, P9414, DOI 10.1523/JNEUROSCI.1641-04.2004; Iredale PA, 2000, J NEUROCHEM, V74, P199, DOI 10.1046/j.1471-4159.2000.0740199.x; JABER M, 1995, NEUROSCIENCE, V65, P1041, DOI 10.1016/0306-4522(94)00537-F; Jutkiewicz EM, 2005, PSYCHOPHARMACOLOGY, V180, P215, DOI 10.1007/s00213-005-2164-z; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1999, BRAIN RES, V848, P141, DOI 10.1016/S0006-8993(99)01991-5; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; LIGHTMAN SL, 1998, J PHYSL, V403, P511; Limbird, 1996, GOODMAN GILMANS PHAR, P557; LINSEMAN MA, 1977, PSYCHOPHARMACOLOGY, V54, P159, DOI 10.1007/BF00426773; Lu L, 2005, PSYCHOPHARMACOLOGY, V181, P90, DOI 10.1007/s00213-005-2207-5; Lu L, 2000, EUR J NEUROSCI, V12, P4398; Lucas LR, 1998, J NEUROCHEM, V71, P833; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; MUCHA RF, 1987, BRAIN RES, V418, P214, DOI 10.1016/0006-8993(87)90088-6; Muller DL, 2005, J PHARMACOL EXP THER, V314, P148, DOI 10.1124/jpet.105.083410; NABESHIMA T, 1992, LIFE SCI, V51, P211, DOI 10.1016/0024-3205(92)90077-3; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; *NIDA, 2005, MON FUT NAT RES AD D; Papaleo F, 2006, BEHAV BRAIN RES, V170, P110, DOI 10.1016/j.bbr.2006.02.009; Paxinos G., 2001, MOUSE BRAIN STEREOTA; RATTAN AK, 1992, BRAIN RES, V584, P207, DOI 10.1016/0006-8993(92)90896-H; Reyes BAS, 2005, EUR J NEUROSCI, V22, P93, DOI 10.1111/j.1460-9568.2005.04197.x; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; SARNYAI Z, 1995, BRAIN RES, V675, P89, DOI 10.1016/0006-8993(95)00043-P; SAWCHENKO PE, 1993, CIBA F SYMP, V172, P5; SAWCHENKO PE, 1987, J NEUROSCI, V7, P1093; Schulteis G, 1996, NEUROCHEM RES, V21, P1437, DOI 10.1007/BF02532385; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shirayama Y, 2004, J NEUROCHEM, V90, P1258, DOI 10.1111/j.1471-4159.2004.02589.x; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Stinus L, 2005, NEUROPSYCHOPHARMACOL, V30, P90, DOI 10.1038/sj.npp.1300487; STORNETTA RL, 1993, BRAIN RES, V624, P19, DOI 10.1016/0006-8993(93)90055-R; Tanimura SM, 1998, ENDOCRINOLOGY, V139, P3830, DOI 10.1210/en.139.9.3830; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Tjon GHK, 1997, NEUROSCIENCE, V76, P167; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Wong ML, 1999, LIFE SCI, V65, pPL53, DOI 10.1016/S0024-3205(99)00268-4; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zorrilla EP, 2002, BRAIN RES, V952, P188, DOI 10.1016/S0006-8993(02)03189-X	59	42	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					577	589		10.1016/j.neuron.2007.01.022	http://dx.doi.org/10.1016/j.neuron.2007.01.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296558	Bronze			2022-12-24	WOS:000245126900015
J	Isomura, Y; Sirota, A; Ozen, S; Montgomery, S; Mizuseki, K; Henze, DA; Buzsaki, G				Isomura, Yoshikazu; Sirota, Anton; Ozen, Simal; Montgomery, Sean; Mizuseki, Kenji; Henze, Darrell A.; Buzsaki, Gyoergy			Integration and segregation of activity in entorhinal-hippocampal subregions by neocortical slow oscillations	NEURON			English	Article							LESS-THAN-1 HZ OSCILLATION; LOCAL-FIELD POTENTIALS; THALAMOCORTICAL NEURONS; NETWORK MECHANISMS; CEREBRAL-CORTEX; GUINEA-PIG; SLEEP; FREQUENCY; CELLS; BRAIN	Brain systems communicate by means of neuronal oscillations at multiple temporal and spatial scales. In anesthetized rats, we find that neocortical "slow" oscillation engages neurons in prefrontal, somatosensory, entorhinal, and subicular cortices into synchronous transitions between UP and DOWN states, with a corresponding bimodal distribution of their membrane potential. The membrane potential of hippocampal granule cells and CA3 and CA1 pyramidal cells lacked bimodality, yet it was influenced by the slow oscillation in a region-specific manner. Furthermore, in both anesthetized and naturally sleeping rats, the cortical UP states resulted in increased activity of dentate and most CA1 neurons, as well as the highest probability of ripple events. Yet, the CA3-CA1 network could self-organize into gamma bursts and occasional ripples during the DOWN state. Thus, neo/paleocortical and hippocampal networks periodically reset, self-organize, and temporally coordinate their cell assemblies via the slow oscillation.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; RIKEN Brain Sci Inst, Neural Circuit Theory, Wako, Saitama 3510198, Japan; Tokyo Metropolitan Inst Neurosci, Fuchu, Tokyo 1838526, Japan; Merck Res Labs, Neurosci Drug Discovery, West Point, PA 19486 USA	Rutgers State University Newark; Rutgers State University New Brunswick; RIKEN; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Merck & Company	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Mizuseki, Kenji/A-9214-2011; Sirota, Anton/G-1395-2011	Mizuseki, Kenji/0000-0002-1456-2149; , sukru/0000-0002-5538-6786; Montgomery, Sean/0000-0001-7370-0938; Buzsaki, Gyorgy/0000-0002-3100-4800	NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS034994, NS043157] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043157, R01NS034994] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AMZICA F, 1995, J NEUROSCI, V15, P4658; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Biesold, 1990, BRAIN CHOLINERGIC SY, P3; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; CHARPAK S, 1995, EUR J NEUROSCI, V7, P1548, DOI 10.1111/j.1460-9568.1995.tb01150.x; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Detari L, 1997, BRAIN RES, V759, P112, DOI 10.1016/S0006-8993(97)00252-7; Dickson CT, 2003, J NEUROPHYSIOL, V90, P39, DOI 10.1152/jn.01063.2002; Duque A, 2000, J NEUROPHYSIOL, V84, P1627, DOI 10.1152/jn.2000.84.3.1627; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisher NI, 1995, STAT ANAL CIRCULAR D; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; KLOOSTERMAN F, 2003, THESIS U AMSTERDAM; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Lestienne R, 1997, J PHYSIOLOGY-PARIS, V91, P273, DOI 10.1016/S0928-4257(97)82407-2; LUCZAK A, 2006, IN PRESS P NATL ACAD; MacLean P, 1990, TRIUNE BRAIN EVOLUTI; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; MUKOVSKI M, 2006, IN PRESS CEREB CORTE; Pelletier JG, 2004, J NEUROPHYSIOL, V91, P2079, DOI 10.1152/jn.01197.2003; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; TIRNOFEEV I, 2000, J PHYSIOL-PARIS, V94, P343; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Wilson CJ, 1996, J NEUROSCI, V16, P2397; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	66	323	328	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					871	882		10.1016/j.neuron.2006.10.023	http://dx.doi.org/10.1016/j.neuron.2006.10.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145507	Bronze			2022-12-24	WOS:000242856400014
J	Ohshiro, T; Weliky, M				Ohshiro, Tomokazu; Weliky, Michael			Simple fall-off pattern of correlated neural activity in the developing lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							FERRET VISUAL-CORTEX; RETINAL GANGLION-CELLS; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY; NEURONAL-ACTIVITY; BINOCULAR INTERACTION; CONTRAST SENSITIVITY; SYNAPTIC PLASTICITY; RESPONSE PROPERTIES; SELF-ORGANIZATION	Activity-dependent models for cortical simple-cell receptive field development predict specific patterns of correlated neural activity within the visual pathway, such as a Mexican hat-shaped pattern of correlated activity in the lateral geniculate nucleus (LGN). However, such activity patterns have yet to be experimentally demonstrated. We performed multielectrode recordings in the LGN of immature awake ferrets and found simple fall-off-shaped, rather than Mexican hat-shaped, patterns of correlated activity. A weak surround in the LGN neuron's receptive field and the statistics of the input contributed to this pattern of correlated activity. Computer simulation of cortical receptive field development incorporating the experimentally observed activity patterns demonstrated that a simple-cell receptive field emerges when a newly devised 'split' constraint on synaptic growth is combined with Hebbian synaptic modification rules. Thus, given certain developmental constraints on synaptic plasticity, patterns of correlated activity within the LGN are compatible with Hebbian models of simple-cell receptive field development.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Ohshiro, T (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Meliora Hall, Rochester, NY 14627 USA.	toshiro@bcs.rochester.edu						Akerman CJ, 2004, J NEUROSCI, V24, P170, DOI 10.1523/JNEUROSCI.1002-03.2004; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Chapman B, 1996, J NEUROSCI, V16, P6443; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; DUBIN MW, 1977, J NEUROPHYSIOL, V40, P410, DOI 10.1152/jn.1977.40.2.410; Elliott T, 2002, NEURAL COMPUT, V14, P1311, DOI 10.1162/089976602753712954; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hebb Donald O., 1949, ORG BEHAV; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Lee AB, 2000, P NATL ACAD SCI USA, V97, P12875, DOI 10.1073/pnas.97.23.12875; LINSENMEIER RA, 1982, VISION RES, V22, P1173, DOI 10.1016/0042-6989(82)90082-7; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MILLER KD, 1994, J NEUROSCI, V14, P409; PRICE DJ, 1987, EXP BRAIN RES, V68, P28; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SO YT, 1981, J NEUROPHYSIOL, V45, P1107; TANAKA S, 1990, NEURAL NETWORKS, V3, P625, DOI 10.1016/0893-6080(90)90053-N; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; TOOTLE JS, 1986, J NEUROPHYSIOL, V56, P523, DOI 10.1152/jn.1986.56.2.523; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; von der Malsburg C, 1973, Kybernetik, V14, P85; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Weliky M, 2000, NEURON, V27, P427, DOI 10.1016/S0896-6273(00)00053-2; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087	44	25	25	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1541	1548		10.1038/nn1799	http://dx.doi.org/10.1038/nn1799			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115045				2022-12-24	WOS:000242404000019
J	Hirzel, K; Muller, U; Latal, AT; Huelsmann, S; Grudzinska, J; Seeliger, MW; Betz, H; Laube, B				Hirzel, Klaus; Mueller, Ulrike; Latal, A. Tobias; Huelsmann, Swen; Grudzinska, Joanna; Seeliger, Mathias W.; Betz, Heinrich; Laube, Bodo			Hyperekplexia phenotype of glycine receptor alpha 1 subunit mutant mice identifies Zn2+ as an essential endogenous modulator of glycinergic neurotransmission	NEURON			English	Article							ZINC-ENRICHED TERMINALS; SPINAL-CORD; SYNAPTIC ZINC; ZEN TERMINALS; RECEPTOR; POTENTIATION; RAT; BRAIN; IONS; IMMUNOHISTOCHEMISTRY	Zn2+ is thought to modulate neurotransmission by affecting currents mediated by ligand-gated ion channels and transmitter reuptake by Na+-dependent transporter systems. Here, we examined the in vivo relevance of Zn2+ neuromodulation by producing knockin mice carrying the mutation D80A in the glycine receptor (GlyR) alpha 1 subunit gene (Glra1). This substitution selectively eliminates the potentiating effect of Zn2+ on GlyR currents. Mice homozygous for Glra1(D80A) develop a severe neuromotor phenotype postnatally that resembles forms of human hyperekplexia (startle disease) caused by mutations in GlyR genes. In spinal neurons and brainstem slices from Glra1(D80A) mice, GlyR expression, synaptic localization, and basal glycinergic transmission were normal; however, potentiation of spontaneous glycinergic currents by Zn2+ was significantly impaired. Thus, the hyperekplexia phenotype of Glra1(D80A) mice is due to the loss of Zn2+ potentiation of alpha 1 subunit containing GlyRs, indicating that synaptic Zn2+ is essential for proper in vivo functioning of glycinergic neurotransmission.	Max Planck Inst Hirnforsch, Neurochem Abt, D-60528 Frankfurt, Germany; Zentrum Physiol, Abt Neurosinnesphysiol, D-37073 Gottingen, Germany; Zentrum Physiol, DFG Forschungszentrum Mol Physiol Gehirns, D-37073 Gottingen, Germany; Univ Tubingen, Retinal Electrodiagnost Res Grp, Dept Pathophysiol Vis & Neuroophthamol, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Betz, H (corresponding author), Max Planck Inst Hirnforsch, Neurochem Abt, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de	Hülsmann, Swen/F-7169-2010	Hülsmann, Swen/0000-0001-5042-8724				ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Becker L, 2002, J NEUROSCI, V22, P2505, DOI 10.1523/JNEUROSCI.22-07-02505.2002; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Chandra T, 2005, NEUROSCIENCE, V134, P145, DOI 10.1016/j.neuroscience.2005.02.049; Chen CJ, 2003, NEUROCHEM INT, V42, P471, DOI 10.1016/S0197-0186(02)00154-7; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; Danscher G, 2001, NEUROSCIENCE, V105, P941, DOI 10.1016/S0306-4522(01)00243-3; Doraiswamy PM, 2004, LANCET NEUROL, V3, P431, DOI 10.1016/S1474-4422(04)00809-9; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Graham BA, 2006, J NEUROSCI, V26, P4880, DOI 10.1523/JNEUROSCI.3991-05.2006; Harvey RJ, 1999, J PHYSIOL-LONDON, V520, P53, DOI 10.1111/j.1469-7793.1999.00053.x; Haverkamp S, 2004, J COMP NEUROL, V477, P399, DOI 10.1002/cne.20267; Jo SM, 2000, BRAIN RES, V870, P163, DOI 10.1016/S0006-8993(00)02418-5; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kay AR, 2006, TRENDS NEUROSCI, V29, P200, DOI 10.1016/j.tins.2006.02.004; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Laube B, 2002, EUR J NEUROSCI, V16, P1025, DOI 10.1046/j.1460-9568.2002.02170.x; Laube B, 2000, J PHYSIOL-LONDON, V522, P215, DOI 10.1111/j.1469-7793.2000.t01-1-00215.x; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Lee JY, 2000, J NEUROSCI, V20; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Li Y.V., 2003, SCI STKE, V182, P19; Liguz-Lecznar M, 2005, BRAIN RES BULL, V66, P106, DOI 10.1016/j.brainresbull.2005.03.019; Lu YM, 2000, SYNAPSE, V38, P187, DOI 10.1002/1098-2396(200011)38:2<187::AID-SYN10>3.0.CO;2-R; Luo DG, 2002, BRAIN RES BULL, V58, P461, DOI 10.1016/S0361-9230(02)00818-3; Lynch JW, 1998, J NEUROCHEM, V71, P2159; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Paoletti P, 1997, J NEUROSCI, V17, P5711; Plappert CF, 2001, BEHAV BRAIN RES, V125, P183, DOI 10.1016/S0166-4328(01)00299-6; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Schofield PR, 2002, ADV NEUROL, V89, P263; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Suwa H, 2001, J NEUROPHYSIOL, V85, P912, DOI 10.1152/jn.2001.85.2.912; Ugarte M, 2001, PROG NEUROBIOL, V64, P219, DOI 10.1016/S0301-0082(00)00057-5; Velazquez RA, 1999, J NEUROSCI, V19, P2288; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wang ZY, 2002, NEUROSCI LETT, V321, P37, DOI 10.1016/S0304-3940(01)02560-5; Wang ZY, 2001, BRAIN RES, V921, P165, DOI 10.1016/S0006-8993(01)03114-6	47	104	108	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					679	690		10.1016/j.neuron.2006.09.035	http://dx.doi.org/10.1016/j.neuron.2006.09.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114051	hybrid			2022-12-24	WOS:000242413100014
J	Fonseca, R; Vabulas, RM; Hartl, FU; Bonhoeffer, T; Nagerl, UV				Fonseca, Rosalina; Vabulas, Ramunas M.; Hartl, F. Ulrich; Bonhoeffer, Tobias; Naegerl, U. Valentin			A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP	NEURON			English	Article							LONG-TERM POTENTIATION; UBIQUITIN SYSTEM; LATE-PHASE; MEMORY; FACILITATION; PROTEOLYSIS; ACTIVATION; MECHANISMS; INHIBITORS; TURNOVER	Long-lasting changes in synaptic strength are thought to play a pivotal role in activity-dependent plasticity and memory. There is ample evidence indicating that in hippocampal long-term potentiation (LTP) the synthesis of new proteins is crucial for enduring changes. However, whether protein degradation also plays a role in this process has only recently begun to receive attention. Here, we examine the effects of blocking protein degradation on LTP. We show that pharmacological inhibition of proteasome-dependent protein degradation, just like inhibition of protein synthesis, disrupts expression of late (L-)LTP. However, when protein degradation and protein synthesis are inhibited at the same time, LTP is restored to control levels, calling into question the commonly held hypothesis that synthesis of new proteins is indispensable for L-LTP. Instead, these findings point to a more facetted model, in which L-LTP is determined by the combined action of synthesis and degradation of plasticity proteins.	Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany; Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Munich, Germany	Max Planck Society; Max Planck Society	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, Klopferspitz 18, D-82152 Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de; naegerl@neuro.mpg.de	Nägerl, Valentin/AAD-2575-2022; Vabulas, R. Martin/D-3506-2011; Bonhoeffer, Tobias/B-9481-2009; Fonseca, Rosalina/I-1715-2012; Hartl, F. Ulrich/Y-8206-2019; Fonseca, Rosalina/AAS-1117-2020	Nägerl, Valentin/0000-0001-6831-9008; Bonhoeffer, Tobias/0000-0001-7897-6634; Fonseca, Rosalina/0000-0003-0884-6441				Ageta H, 2001, J BIOL CHEM, V276, P15893, DOI 10.1074/jbc.M011097200; Ageta H, 2001, MOL BRAIN RES, V97, P186, DOI 10.1016/S0169-328X(01)00303-5; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bradshaw KD, 2003, EUR J NEUROSCI, V18, P3150, DOI 10.1111/j.1460-9568.2003.03054.x; Calixto E, 2003, J NEUROSCI, V23, P4842; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CHAIN DG, 1995, J NEUROSCI, V15, P7592; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; STANTON PK, 1984, J NEUROSCI, V4, P3080; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	35	225	227	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					239	245		10.1016/j.neuron.2006.08.015	http://dx.doi.org/10.1016/j.neuron.2006.08.015			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046687	Bronze			2022-12-24	WOS:000241799900005
J	Miwa, JM; Stevens, TR; King, SL; Caldarone, BJ; Ibanez-Tallon, I; Cheng, X; Fitzsimonds, RM; Pavildes, C; Lester, HA; Picciotto, MR; Heintz, N				Miwa, Julie M.; Stevens, Tanya R.; King, Sarah L.; Caldarone, Barbara J.; Ibanez-Tallon, Ines; Cheng Xiao; Fitzsimonds, Reiko Maki; Pavildes, Constantine; Lester, Henry A.; Picciotto, Marina R.; Heintz, Nathaniel			The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo	NEURON			English	Article							MIDBRAIN DOPAMINE AREAS; FRONTAL-LOBE EPILEPSY; BRAIN REWARD AREAS; INDUCED SEIZURES; INCREASED SENSITIVITY; CA2+ PERMEABILITY; MICE; CALCIUM; DESENSITIZATION; DISEASE	Nicotinic acetylcholine receptors (nAChRs) affect a wide array of biological processes, including learning and memory, attention, and addiction. lynx1, the founding member of a family of mammalian prototoxins, modulates nAChR function in vitro by altering agonist sensitivity and desensitization kinetics. Here we demonstrate, through the generation of lynx1 null mutant mice, that lynx1 modulates nAChR signaling in vivo. Its loss decreases the EC50 for nicotine by similar to 10-fold, decreases receptor desensitization, elevates intracellular calcium levels in response to nicotine, and enhances synaptic efficacy. lynx1 null mutant mice exhibit enhanced performance in specific tests of learning and memory. Consistent with reports that mutations resulting in hyperactivation of nAChRs can lead to neurodegeneration, aging lynx1 null mutant mice exhibit a vacuolating degeneration that is exacerbated by nicotine and ameliorated by null mutations in nAChRs. We conclude that lynx1 functions as an allosteric modulator of nAChR function in vivo, balancing neuronal activity and survival in the CNS.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Rockefeller Univ, Dept Neuroendocrinol, New York, NY 10021 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Howard Hughes Medical Institute; Rockefeller University; Yale University; Yale University; Rockefeller University; California Institute of Technology	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA.	heintz@mail.rockefeller.edu	Xiao, Cheng/O-5696-2015; Picciotto, Marina/F-8747-2012	Xiao, Cheng/0000-0001-9649-7450; Picciotto, Marina/0000-0002-4404-1280; Miwa, Julie/0000-0002-4418-3756; Fitzsimonds, Reiko/0000-0002-0576-9885; King, Sarah/0000-0002-7412-9558	NCI NIH HHS [CA 09673] Funding Source: Medline; NIAAA NIH HHS [AA 15632] Funding Source: Medline; NIDA NIH HHS [DA 15241, DA 00436, DA 17279] Funding Source: Medline; NINDS NIH HHS [R21 NS 047751] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS047751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA015632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abrous DN, 2002, J NEUROSCI, V22, P3656; Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; Bertrand S, 1998, BRIT J PHARMACOL, V125, P751, DOI 10.1038/sj.bjp.0702154; Broide RS, 2002, MOL PHARMACOL, V61, P695, DOI 10.1124/mol.61.3.695; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Chorvat R J, 1998, Expert Opin Investig Drugs, V7, P499, DOI 10.1517/13543784.7.4.499; Chou JH, 2001, GENETICS, V157, P211; Clarke G, 2005, BRAIN RES BULL, V65, P59, DOI 10.1016/j.brainresbull.2004.11.009; CLARKE PBS, 1983, BRIT J PHARMACOL, V78, P329, DOI 10.1111/j.1476-5381.1983.tb09398.x; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Dajas-Bailador FA, 2000, NEUROPHARMACOLOGY, V39, P2799, DOI 10.1016/S0028-3908(00)00127-1; Damaj MI, 1999, J PHARMACOL EXP THER, V291, P1284; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; Dani JA, 2001, BIOL PSYCHIAT, V49, P166, DOI 10.1016/S0006-3223(00)01011-8; Dittman JS, 2000, J NEUROSCI, V20, P1374; Fonck C, 2005, J NEUROSCI, V25, P11396, DOI 10.1523/JNEUROSCI.3597-05.2005; Fonck C, 2003, J NEUROSCI, V23, P2582; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gould TJ, 1999, BEHAV BRAIN RES, V102, P31, DOI 10.1016/S0166-4328(98)00157-0; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Kaneko WM, 1998, DEV BRAIN RES, V105, P141, DOI 10.1016/S0165-3806(97)00160-0; Kelton MC, 2000, BRAIN COGNITION, V43, P274; King SL, 2004, NEUROPHARMACOLOGY, V47, P132, DOI 10.1016/j.neuropharm.2004.06.024; Klein RC, 2005, J PHYSIOL-LONDON, V568, P881, DOI 10.1113/jphysiol.2005.096081; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Maelicke A, 2000, BEHAV BRAIN RES, V113, P199, DOI 10.1016/S0166-4328(00)00214-X; Maggi L, 2004, J PHYSIOL-LONDON, V559, P863, DOI 10.1113/jphysiol.2004.067041; Mann EO, 2003, J PHYSIOL-LONDON, V551, P539, DOI 10.1113/jphysiol.2003.045492; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; MARKS MJ, 1992, J NEUROSCI, V12, P2765; MARKS MJ, 1994, J NEUROCHEM, V63, P2125, DOI 10.1046/j.1471-4159.1994.63062125.x; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; McLeod JR, 1998, J NEUROPHYSIOL, V80, P2688, DOI 10.1152/jn.1998.80.5.2688; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Orb S, 2004, PHYSIOL GENOMICS, V18, P299, DOI 10.1152/physiolgenomics.00012.2004; Orr-Urtreger A, 2000, J NEUROCHEM, V74, P2154, DOI 10.1046/j.1471-4159.2000.0742154.x; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; Picciotto MR, 2002, J NEUROBIOL, V53, P641, DOI 10.1002/neu.10102; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; RATHOUZ MM, 1994, J NEUROSCI, V14, P6935; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Sekhon HS, 2005, CELL TISSUE RES, V320, P287, DOI 10.1007/s00441-005-1077-9; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Sheffield EB, 2000, NEUROPHARMACOLOGY, V39, P2591, DOI 10.1016/S0028-3908(00)00138-6; Shinnick-Gallagher P, 2003, ANN NY ACAD SCI, V985, P135; Stevens TR, 2003, J NEUROSCI, V23, P10093; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Trinh NH, 2003, JAMA-J AM MED ASSOC, V289, P210, DOI 10.1001/jama.289.2.210; Truong A, 2001, MOL BRAIN RES, V96, P68, DOI 10.1016/S0169-328X(01)00268-6; Tsuneki H, 2000, EUR J NEUROSCI, V12, P2475, DOI 10.1046/j.1460-9568.2000.00138.x; *US DEP HHS, 1988, HLTH CONS SMOK NIC A; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Whiteaker P, 1998, MOL PHARMACOL, V53, P950; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235	65	127	133	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					587	600		10.1016/j.neuron.2006.07.025	http://dx.doi.org/10.1016/j.neuron.2006.07.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950157	Bronze			2022-12-24	WOS:000240623400008
J	Jack, AI; Shulman, GL; Snyder, AZ; McAvoy, M; Corbetta, M				Jack, Anthony I.; Shulman, Gordon L.; Snyder, Abraham Z.; McAvoy, Mark; Corbetta, Maurizio			Separate modulations of human V1 associated with spatial attention and task structure	NEURON			English	Article							STRIATE CORTEX; FRONTAL-CORTEX; VISUAL-CORTEX; PERFORMANCE; INTEGRATION; RESPONSES; SOFTWARE; SYSTEM; AREAS	Functional magnetic resonance imaging (fMRI) was used while normal human volunteers engaged in simple detection and discrimination tasks, revealing separable modulations of early visual cortex associated with spatial attention and task structure. Both modulations occur even when there is no change in sensory stimulation. The modulation due to spatial attention is present throughout the early visual areas V1, V2, V3, and VP, and varies with the attended location. The task structure activations are strongest in V1 and are greater in regions that represent more peripheral parts of the visual field. Control experiments demonstrate that the task structure activations cannot be attributed to visual, auditory, or somatosensory processing, the motor response for the detection/discrimination judgment, or oculomotor responses such as blinks or saccades. These findings demonstrate that early visual areas are modulated by at least two types of endogenous signals, each with distinct cortical distributions.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Jack, Anthony Ian/AAJ-7153-2021; Jack, Anthony/A-8929-2008	Jack, Anthony Ian/0000-0001-9613-3964; Jack, Anthony/0000-0001-9613-3964; CORBETTA, MAURIZIO/0000-0001-8295-3304	NATIONAL EYE INSTITUTE [T32EY013360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048013] Funding Source: NIH RePORTER; NEI NIH HHS [5-T32-EY13360-04] Funding Source: Medline; NIMH NIH HHS [R01 MH71920-06] Funding Source: Medline; NINDS NIH HHS [R01 NS48013] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; DOTY RW, 1983, J COMP NEUROL, V218, P159, DOI 10.1002/cne.902180204; Falchier A, 2002, J NEUROSCI, V22, P5749; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GRAHAM J, 1982, EXP BRAIN RES, V47, P1; Grossberg S, 1999, CONSCIOUS COGN, V8, P1, DOI 10.1006/ccog.1998.0372; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Neisser U., 1967, COGNITIVE PSYCHOL; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETERS A, 1994, CEREB CORTEX, V4, P215, DOI 10.1093/cercor/4.3.215; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	37	89	89	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					135	147		10.1016/j.neuron.2006.06.003	http://dx.doi.org/10.1016/j.neuron.2006.06.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815338	Bronze			2022-12-24	WOS:000239037700016
J	Han, YK; Kover, H; Insanally, MN; Semerdjian, JH; Bao, SW				Han, Yoon K.; Koever, Hania; Insanally, Michele N.; Semerdjian, John H.; Bao, Shaowen			Early experience impairs perceptual discrimination	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; CORTICAL MAP REORGANIZATION; SOMATOSENSORY CORTEX; TEMPORAL PLASTICITY; PHONETIC PERCEPTION; MUSICAL INTERVALS; INFANTS SHOW; INFORMATION; SPEECH; REPRESENTATION	Sensory experience can reorganize cortical sensory representations in an epoch of early development. During this period, cortical sensory neurons may shift their response selectivity and become tuned to more frequently occurring stimuli. Although this enlarged cortical representation is believed to underlie improved sensory processing of the experienced stimuli, its precise perceptual consequences are still unknown. We show that rearing rats in a single-frequency tonal environment results in enlarged cortical representations of the frequencies near that of the experienced tone, but the animals are impaired in perceptual discrimination of the over-represented frequencies. By contrast, discrimination of the neighboring under-represented frequencies is substantially improved. Computational analysis indicated that the altered perceptual ability could be fully accounted for by the sound exposure-induced reorganization of cortical primary auditory representations. These results indicate that early experience shapes sensory perception. The same plasticity processes may be important in optimizing phonemic representations in humans.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bao, SW (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 210X Barker Hall, Berkeley, CA 94720 USA.	sbao@berkeley.edu		Insanally, Michele/0000-0002-1049-1697				Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; BURNS EM, 1978, J ACOUST SOC AM, V63, P456, DOI 10.1121/1.381737; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chowdhury SA, 2000, J NEUROPHYSIOL, V83, P1856, DOI 10.1152/jn.2000.83.4.1856; Dayan P., 2001, THEORETICAL NEUROSCI; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P82, DOI 10.1037/0735-7044.107.1.82; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Godde B, 2000, J NEUROSCI, V20, P1597; Guenther FH, 1996, J ACOUST SOC AM, V100, P1111, DOI 10.1121/1.416296; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 2001, J NEUROPHYSIOL, V86, P326, DOI 10.1152/jn.2001.86.1.326; KNUDSEN EI, 1983, SCIENCE, V222, P939, DOI 10.1126/science.6635667; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; KUHL PK, 1991, PERCEPT PSYCHOPHYS, V50, P93, DOI 10.3758/BF03212211; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Ma XF, 2003, J NEUROPHYSIOL, V89, P90, DOI 10.1152/jn.00968.2001; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; Ohl FW, 1996, EUR J NEUROSCI, V8, P1001, DOI 10.1111/j.1460-9568.1996.tb01587.x; OHL FW, 1996, J NEUROSCI, V8, P1001; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; POWELL MJD, 1977, NUMERICAL ANAL; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1037; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Tegenthoff M, 2005, PLOS BIOL, V3, P2031, DOI 10.1371/journal.pbio.0030362; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; ZATORRE RJ, 1979, PERCEPT PSYCHOPHYS, V26, P384, DOI 10.3758/BF03204164; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398	50	98	99	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1191	1197		10.1038/nn1941	http://dx.doi.org/10.1038/nn1941			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660815				2022-12-24	WOS:000249144000022
J	He, Y; Dupree, J; Wang, J; Sandoval, J; Li, JD; Liu, HF; Shi, Y; Nave, KA; Casaccia-Bonnefil, P				He, Ye; Dupree, Jeff; Wang, Ju; Sandoval, Juan; Li, Jiadong; Liu, Huifei; Shi, Yang; Nave, Klaus Armin; Casaccia-Bonnefil, Patrizia			The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation	NEURON			English	Article							CELL-CYCLE EXIT; FACTOR YY1; RETINOIC ACID; BETA-CATENIN; GENE; MYELIN; EXPRESSION; PDGF; PROTEIN; ACTIVATION	The progression of progenitors to oligodendrocytes requires proliferative arrest and the activation of a transcriptional program of differentiation. While regulation of cell cycle exit has been extensively characterized, the molecular mechanisms responsible for the initiation of differentiation remain ill-defined. Here, we identify the transcription factor Yin Yang 1 (YY1) as a critical regulator of oligodendrocyte progenitor differentiation. Conditional ablation of yyl in the oligodendrocyte lineage in vivo induces a phenotype characterized by defective myelination, ataxia, and tremor. At the cellular level, lack of yyl arrests differentiation of oligodendrocyte progenitors after they exit from the cell cycle. At the molecular level, YY1 acts as a lineage-specific repressor of transcriptional inhibitors of myelin gene expression (Tcf4 and ld4), by recruiting histone deacetylase-1 to their promoters during oligodendrocyte, differentiation. Thus, we identify YY1 as an essential component of the transcriptional network regulating the transition of oligodendrocyte progenitors from cell cycle exit to differentiation.	R Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany	Virginia Commonwealth University; Harvard University; Harvard Medical School; Max Planck Society	Casaccia-Bonnefil, P (corresponding author), R Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	casaccpa@umdnj.edu	Nave, Klaus-Armin/C-8883-2011; Messier, Claude/A-2322-2008; He, Ye/G-7500-2011; sandoval, juan/M-4593-2015	Messier, Claude/0000-0002-4791-1763; sandoval, juan/0000-0002-5100-973X; He, Ye/0000-0002-3936-4958	NIGMS NIH HHS [GM53874] Funding Source: Medline; NINDS NIH HHS [R37 NS042925, R01 NS042925-05A1, R01 NS042925, NS42925] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS042925, R01NS042925] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Berndt JA, 2001, J NEUROCHEM, V77, P935, DOI 10.1046/j.1471-4159.2001.00307.x; BJELKE B, 1989, INT J DEV NEUROSCI, V7, P145, DOI 10.1016/0736-5748(89)90065-8; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; Casaccia-Bonnefil P, 2003, J NEUROSCI RES, V72, P1, DOI 10.1002/jnr.10565; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho EA, 1998, MECH DEVELOP, V77, P9; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dupree JL, 1998, J NEUROCYTOL, V27, P649, DOI 10.1023/A:1006908013972; Durand B, 1998, CURR BIOL, V8, P431, DOI 10.1016/S0960-9822(98)70177-0; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ghiani CA, 2001, J NEUROSCI, V21, P1274; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Griffiths IR, 1996, BIOESSAYS, V18, P789, DOI 10.1002/bies.950181005; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Hall A, 1996, DEVELOPMENT, V122, P4085; Hamano K, 1998, DEV BRAIN RES, V108, P287, DOI 10.1016/S0165-3806(98)00063-7; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Latinkic BV, 2004, DEVELOPMENT, V131, P669, DOI 10.1242/dev.00953; LEE YM, 1994, DNA CELL BIOL, V13, P1029, DOI 10.1089/dna.1994.13.1029; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Liu AX, 2006, EMBO J, V25, P4833, DOI 10.1038/sj.emboj.7601352; Liu HF, 2005, MOL B INT U, P182; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385; Miller RH, 2005, NEURON, V45, P1, DOI 10.1016/j.neuron.2004.12.032; Nakatsuji Y, 2001, DEV NEUROSCI-BASEL, V23, P356, DOI 10.1159/000048719; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; NOLL E, 1993, DEVELOPMENT, V118, P563; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shimizu T, 2005, DEV BIOL, V282, P397, DOI 10.1016/j.ydbio.2005.03.020; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Siegenthaler JA, 2005, J NEUROSCI, V25, P8627, DOI 10.1523/JNEUROSCI.1876-05.2005; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tang XM, 2000, J CELL BIOCHEM, V76, P270, DOI 10.1002/(SICI)1097-4644(20000201)76:2<270::AID-JCB10>3.0.CO;2-6; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tikoo R, 1998, J NEUROBIOL, V36, P431, DOI 10.1002/(SICI)1097-4695(19980905)36:3<431::AID-NEU10>3.3.CO;2-N; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Wang TW, 2005, DEVELOPMENT, V132, P2721, DOI 10.1242/dev.01867; Wegner M, 2000, GLIA, V31, P1, DOI 10.1002/(SICI)1098-1136(200007)31:1<1::AID-GLIA10>3.0.CO;2-V; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Xu XZ, 2004, J INVEST DERMATOL, V123, P1120, DOI 10.1111/j.0022-202X.2004.23492.x; YAMAGUCHI M, 2005, DEVELOPMENT, V132, P3207; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001	73	199	204	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2007	55	2					217	230		10.1016/j.neuron.2007.06.029	http://dx.doi.org/10.1016/j.neuron.2007.06.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NW	17640524	Green Accepted, Bronze			2022-12-24	WOS:000248635800007
J	Micheva, KD; Smith, SJ				Micheva, Kristina D.; Smith, Stephen J.			Array tomography: A new tool for Imaging the molecular architecture and ultrastructure of neural circuits	NEURON			English	Article							FLUORESCENCE MICROSCOPY; SEMITHIN SECTIONS; ELECTRON-MICROSCOPY; ADULT-RAT; LR-WHITE; IMMUNOFLUORESCENCE; PROTEIN; SYNAPSES; ANTIGENS; NEURONS	Many biological functions depend critically upon fine details of tissue molecular architecture that have resisted exploration by existing imaging techniques. This is particularly true for nervous system tissues, where information processing function depends on intricate circuit and synaptic architectures. Here, we describe a new imaging method, called array tomography, which combines and extends superlative features of modern optical fluorescence and electron microscopy methods. Based on methods for constructing and repeatedly staining and imaging ordered arrays of ultrathin (50-200 nm), resin-embedded serial sections on glass microscope slides, array tomography allows for quantitative, high-resolution, large-field volumetric imaging of large numbers of antigens, fluorescent proteins, and ultrastructure in individual tissue specimens. Compared to confocal microscopy, array tomography offers the advantage of better spatial resolution, in particular along the z axis, as well as depth-independent immunofluorescent staining. The application of array tomography can reveal important but previously unseen features of brain molecular architecture.	Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Micheva, KD (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kmicheva@stanford.edu; sjsmith@stanford.edu	Micheva, Kristina/ABH-6913-2020	Micheva, Kristina/0000-0003-1138-3732; Smith, Stephen/0000-0002-2290-8701	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054252] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054252-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRECHT U, 1990, BRAIN RES, V535, P49, DOI 10.1016/0006-8993(90)91823-Y; Blumer MJF, 2002, J NEUROSCI METH, V120, P11, DOI 10.1016/S0165-0270(02)00166-8; BRORSON SH, 1994, MICRON, V25, P453, DOI 10.1016/0968-4328(94)00035-2; Burette A, 2001, J NEUROSCI, V21, P495, DOI 10.1523/JNEUROSCI.21-02-00495.2001; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Frassoni C, 2005, NEUROSCIENCE, V131, P813, DOI 10.1016/j.neuroscience.2004.11.042; Geinisman Y, 1996, J NEUROCYTOL, V25, P805, DOI 10.1007/BF02284843; Haraguchi CM, 2002, HISTOCHEM CELL BIOL, V117, P81, DOI 10.1007/s00418-001-0363-1; HERKEN R, 1988, HISTOCHEM J, V20, P427, DOI 10.1007/BF01002428; KOLODZIEJCZYK E, 1986, J HISTOCHEM CYTOCHEM, V34, P1725, DOI 10.1177/34.12.3023476; Kurth T, 1996, CELL TISSUE RES, V286, P1, DOI 10.1007/s004410050669; Lee LY, 2004, APPL ENVIRON MICROB, V70, P5732, DOI 10.1128/AEM.70.10.5732-5736.2004; Luby-Phelps K, 2003, J HISTOCHEM CYTOCHEM, V51, P271, DOI 10.1177/002215540305100301; Matsunaga W, 2002, NEUROSCIENCE, V111, P151, DOI 10.1016/S0306-4522(01)00607-8; MATUS AI, 1975, J NEUROCYTOL, V4, P733, DOI 10.1007/BF01181633; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Mori M, 2006, J ELECTRON MICROSC, V55, P107, DOI 10.1093/jmicro/dfl011; Newman GR, 1999, HISTOCHEM J, V31, P495, DOI 10.1023/A:1003850921869; NEWMAN GR, 1987, J HISTOCHEM CYTOCHEM, V35, P971, DOI 10.1177/35.9.3302021; NEWMAN GR, 1983, HISTOCHEM J, V15, P543, DOI 10.1007/BF01954145; OJEDA JL, 1989, STAIN TECHNOL, V64, P243, DOI 10.3109/10520298909107009; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; PAWLEY JB, 1995, HDB BIOL CONFOCAL MI; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; SONG LL, 1995, BIOPHYS J, V68, P2588, DOI 10.1016/S0006-3495(95)80442-X; Sukhanova A, 2002, LAB INVEST, V82, P1259, DOI 10.1097/01.LAB.0000027837.13582.E8; Tafoya LCR, 2006, J NEUROSCI, V26, P7826, DOI 10.1523/JNEUROSCI.1866-06.2006; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; TRAMU G, 1978, J HISTOCHEM CYTOCHEM, V26, P322, DOI 10.1177/26.4.207771; Wahlby C, 2002, CYTOMETRY, V47, P32, DOI 10.1002/cyto.10026; Zondervan R, 2004, J PHYS CHEM A, V108, P1657, DOI 10.1021/jp037222e	36	529	549	3	46	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					25	36		10.1016/j.neuron.2007.06.014	http://dx.doi.org/10.1016/j.neuron.2007.06.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610815	Green Accepted, Bronze			2022-12-24	WOS:000248010700006
J	Iftinca, M; Hamid, J; Chen, L; Varela, D; Tadayonnejad, R; Altier, C; Turner, RW; Zamponi, GW				Iftinca, Mircea; Hamid, Jawed; Chen, Lina; Varela, Diego; Tadayonnejad, Reza; Altier, Christophe; Turner, Ray W.; Zamponi, Gerald W.			Regulation of T-type calcium channels by Rho-associated kinase	NATURE NEUROSCIENCE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTOR; CELL-GROWTH; SERINE/THREONINE KINASE; LATERAL HABENULA; SENSORY NEURONS; BINDING; EXPRESSION; ISOFORMS; SUBUNITS; TARGET	We investigated the regulation of T-type channels by Rho-associated kinase ( ROCK). Activation of ROCK via the endogenous ligand lysophosphatidic acid (LPA) reversibly inhibited the peak current amplitudes of rat Cav3.1 and Cav3.3 channels without affecting the voltage dependence of activation or inactivation, whereas Cav3.2 currents showed depolarizing shifts in these parameters. LPA-induced inhibition of Cav3.1 was dependent on intracellular GTP, and was antagonized by treatment with ROCK and RhoA inhibitors, LPA receptor antagonists or GDP beta S. Site-directed mutagenesis of the Ca(v)3.1 alpha(1) subunit revealed that the ROCK-mediated effects involve two distinct phosphorylation consensus sites in the domain II-III linker. ROCK activation by LPA reduced native T-type currents in Y79 retinoblastoma and in lateral habenular neurons, and upregulated native Cav3.2 current in dorsal root ganglion neurons. Our data suggest that ROCK is an important regulator of T-type calcium channels, with potentially far-reaching implications for multiple cell functions modulated by LPA.	Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Anat & Cell Biol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Anat, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca	Varela, Diego/AAG-7489-2019	Varela, Diego/0000-0002-9352-414X; Zamponi, Gerald W./0000-0002-0644-9066				Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P509, DOI 10.1016/j.mcn.2004.11.002; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Bertolesi GE, 2002, MOL PHARMACOL, V62, P210, DOI 10.1124/mol.62.2.210; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Cheng N, 2002, MOL CANCER RES, V1, P2; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dergham P, 2002, J NEUROSCI, V22, P6570; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Gu Y, 1999, PFLUG ARCH EUR J PHY, V438, P553, DOI 10.1007/s004240051075; Hirdes W, 2004, J PHYSIOL-LONDON, V559, P67, DOI 10.1113/jphysiol.2004.066944; Hirooka K, 2002, J NEUROPHYSIOL, V88, P196, DOI 10.1152/jn.2002.88.1.196; HUGUENARD JR, 1993, J NEUROPHYSIOL, V70, P158, DOI 10.1152/jn.1993.70.1.158; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Latour I, 2004, GLIA, V48, P112, DOI 10.1002/glia.20063; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; Panner A, 2005, CELL CALCIUM, V37, P105, DOI 10.1016/j.ceca.2004.07.002; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Shimizu T, 2003, J BIOL CHEM, V278, P46046, DOI 10.1074/jbc.M306458200; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Todorovic SM, 2001, MOL PHARMACOL, V60, P603; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; WILCOX KS, 1988, J NEUROPHYSIOL, V59, P212, DOI 10.1152/jn.1988.59.1.212; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48	50	58	58	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					854	860		10.1038/nn1921	http://dx.doi.org/10.1038/nn1921			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558400				2022-12-24	WOS:000247560200015
J	Spiegel, I; Adamsky, K; Eshed, Y; Milo, R; Sabanay, H; Sarig-Nadir, O; Horresh, I; Scherer, SS; Rasband, MN; Peles, E				Spiegel, Ivo; Adamsky, Konstantin; Eshed, Yael; Milo, Ron; Sabanay, Helena; Sarig-Nadir, Offra; Horresh, Ido; Scherer, Steven S.; Rasband, Matthew N.; Peles, Elior			A central role for Necl4 ( SynCAM4) in Schwann cell- axon interaction and myelination	NATURE NEUROSCIENCE			English	Article							ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; N-CADHERIN; PROTEIN; NECTIN; GLYCOPROTEIN; EXPRESSION; CHANNELS; DOMAIN; NODES	Myelination in the peripheral nervous system requires close contact between Schwann cells and the axon, but the underlying molecular basis remains largely unknown. Here we show that cell adhesion molecules (CAMs) of the nectin-like (Necl, also known as SynCAM or Cadm) family mediate Schwann cell-axon interaction during myelination. Necl4 is the main Necl expressed by myelinating Schwann cells and is located along the internodes in direct apposition to Necl1, which is localized on axons. Necl4 serves as the glial binding partner for axonal Necl1, and the interaction between these two CAMs mediates Schwann cell adhesion. The disruption of the interaction between Necl1 and Necl4 by their soluble extracellular domains, or the expression of a dominant-negative Necl4 in Schwann cells, inhibits myelination. These results suggest that Necl proteins are important for mediating axon-glia contact during myelination in peripheral nerves.	Weizmann Inst Sci, Dept Mol & Cell Biol, IL-76100 Rehovot, Israel; Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Connecticut, Hlth Sci Ctr, Dept Neurosci, Farmington, CT 06032 USA	Weizmann Institute of Science; University of Pennsylvania; University of Connecticut	Peles, E (corresponding author), Weizmann Inst Sci, Dept Mol & Cell Biol, POB 26, IL-76100 Rehovot, Israel.	peles@weizmann.ac.il	Scherer, Steven S/F-7979-2011; Spiegel, Ivo/O-4025-2014	Peles, Elior/0000-0002-3325-0597; Milo, Ron/0000-0003-1641-2299; Rasband, Matthew/0000-0001-8184-2477; Spiegel, Ivo/0000-0003-0979-1358	NINDS NIH HHS [R01 NS044916, NS044916, R01 NS050220, R01 NS050220-03, NS50220, R37 NS044916] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044916, R01NS050220, R37NS044916] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bartsch U, 2003, FRONT BIOSCI-LANDMRK, V8, pD477, DOI 10.2741/1028; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Fujita E, 2005, DEV BRAIN RES, V154, P199, DOI 10.1016/j.devbrainres.2004.10.015; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Gunn-Moore FJ, 2006, MOL CELL NEUROSCI, V33, P441, DOI 10.1016/j.mcn.2006.09.003; HALL SM, 1971, J CELL SCI, V9, P769; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; Irie K, 2004, SEMIN CELL DEV BIOL, V15, P643, DOI 10.1016/j.semcdb.2004.09.002; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Ohno N, 2006, J NEUROSCI RES, V84, P568, DOI 10.1002/jnr.20949; Ohta Y, 2005, DEV BRAIN RES, V156, P23, DOI 10.1016/j.devbrainres.2005.01.001; OWENS GC, 1990, J CELL BIOL, V111, P1171, DOI 10.1083/jcb.111.3.1171; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Spiegel I, 2002, MOL MEMBR BIOL, V19, P95, DOI 10.1080/09687680210130009; Spiegel I, 2006, NEURON GLIA BIOL, V2, P27, DOI 10.1017/S1740925X0600007X; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; THOMAS PK, 1984, PERIPHERAL NEUROPATH, V1, P97; Traka M, 2002, J NEUROSCI, V22, P3016, DOI 10.1523/JNEUROSCI.22-08-03016.2002; TRAPP BD, 1989, J NEUROCYTOL, V18, P47, DOI 10.1007/BF01188423; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Wanner IB, 2006, GLIA, V54, P439, DOI 10.1002/glia.20390; Williams YN, 2006, ONCOGENE, V25, P1446, DOI 10.1038/sj.onc.1209192; Yageta M, 2002, CANCER RES, V62, P5129; Zhou Y, 2005, BBA-BIOMEMBRANES, V1669, P142, DOI 10.1016/j.bbamem.2005.01.013	48	144	153	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					861	869		10.1038/nn1915	http://dx.doi.org/10.1038/nn1915			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558405	Green Accepted			2022-12-24	WOS:000247560200016
J	Kording, KP; Tenenbaum, JB; Shadmehr, R				Kording, Konrad P.; Tenenbaum, Joshua B.; Shadmehr, Reza			The dynamics of memory as a consequence of optimal adaptation to a changing body	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; CEREBELLAR CORTEX; SHORT-TERM; MONKEY; CONSOLIDATION; PLASTICITY; LESIONS; SHIFTS; TASK; SIZE	There are many causes for variation in the responses of the motor apparatus to neural commands. Fast-timescale disturbances occur when muscles fatigue. Slow-timescale disturbances occur when muscles are damaged or when limb dynamics change as a result of development. To maintain performance, motor commands need to adapt. Computing the best adaptation in response to any performance error results in a credit assignment problem: which timescale is responsible for this disturbance? Here we show that a Bayesian solution to this problem accounts for numerous behaviors of animals during both short- and long-term training. Our analysis focused on characteristics of the oculomotor system during learning, including the effects of time passage. However, we suggest that learning and memory in other paradigms, such as reach adaptation, adaptation of visual neurons and retrieval of declarative memories, largely follow similar rules.	Rehabil Inst Chicago, Chicago, IL 60611 USA; MIT, Cambridge, MA 02139 USA; Johns Hopkins Sch Med, Baltimore, MD 21205 USA	Shirley Ryan AbilityLab; Massachusetts Institute of Technology (MIT); Johns Hopkins University; Johns Hopkins Medicine	Kording, KP (corresponding author), Rehabil Inst Chicago, 446 E Ontario St,Rm 922, Chicago, IL 60611 USA.	kk@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	NIGMS NIH HHS [T32 GM007057] Funding Source: Medline; NINDS NIH HHS [R01 NS057814, R01 NS057814-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057814] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson J. R., 1990, ADAPTIVE CHARACTER T; Bahcall DO, 1999, NATURE, V400, P864, DOI 10.1038/23693; BAHRICK HP, 1993, PSYCHOL SCI, V4, P316, DOI 10.1111/j.1467-9280.1993.tb00571.x; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BARTON JJS, 1995, NEUROLOGY, V45, P2065, DOI 10.1212/WNL.45.11.2065; Becker W., 1989, NEUROBIOLOGY SACCADI, P13; Catz N, 2005, CURR BIOL, V15, P2179, DOI 10.1016/j.cub.2005.11.037; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; Dempster Frank N., 1996, MEMORY, P317, DOI DOI 10.1016/B978-012102570-0/50011-2; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; EBBINGHAUS H, 1885, UBER GEDACHTNIS INTE; ERKELENS CJ, 1993, EXP BRAIN RES, V93, P157; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fitzgibbon E. J., 1986, ADAPTIVE PROCESSES V, P329; Fuchs AF, 1996, J NEUROPHYSIOL, V76, P2522, DOI 10.1152/jn.1996.76.4.2522; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gancarz G, 1999, VISION RES, V39, P3123, DOI 10.1016/S0042-6989(99)00049-8; GLENBERG AM, 1977, J EXP PSYCHOL-HUM L, V3, P282, DOI 10.1037/0278-7393.3.3.282; HAYKIN S, 2001, KALMAN FILTERIN NEUR; Hinton G.E., 1987, P 9 ANN C COGNITIVE, P177; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Jost A., 1897, Z PSYCHOL PHYSIOL SI, V16, P436; Kalman R.E., 1960, T ASME J BASIC ENG, V82, P35, DOI [DOI 10.1115/1.3662552, 10.1115/1.3662552]; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; LEWIS RF, 1993, REV NEUROL, V149, P665; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; Rescorla RA, 2004, LEARN BEHAV, V32, P401; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Scudder CA, 1998, J NEUROPHYSIOL, V79, P704, DOI 10.1152/jn.1998.79.2.704; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; WHITTEN WB, 1977, J VERB LEARN VERB BE, V16, P465, DOI 10.1016/S0022-5371(77)80040-6; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	42	259	261	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					779	786		10.1038/nn1901	http://dx.doi.org/10.1038/nn1901			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17496891	Green Accepted			2022-12-24	WOS:000246799800021
J	Samanez-Larkin, GR; Gibbs, SEB; Khanna, K; Nielsen, L; Carstensen, LL; Knutson, B				Samanez-Larkin, Gregory R.; Gibbs, Sasha E. B.; Khanna, Kabir; Nielsen, Lisbeth; Carstensen, Laura L.; Knutson, Brian			Anticipation of monetary gain but not loss in healthy older adults	NATURE NEUROSCIENCE			English	Article							DECISION-MAKING; AGE; VISUALIZATION; COGNITION; OUTCOMES; FMRI	Although global declines in structure have been documented in the aging human brain, little is known about the functional integrity of the striatum and prefrontal cortex in older adults during incentive processing. We used event-related functional magnetic resonance imaging to determine whether younger and older adults differed in both self-reported and neural responsiveness to anticipated monetary gains and losses. The present study provides evidence for intact striatal and insular activation during gain anticipation with age, but shows a relative reduction in activation during loss anticipation. These findings suggest that there is an asymmetry in the processing of gains and losses in older adults that may have implications for decision-making.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; NIA, Bethesda, MD 20892 USA; NIH, Bethesda, MD 20892 USA; Stanford Ctr Longev, Stanford, CA 94305 USA; Stanford Univ, Inst Neurosci, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; Stanford University	Samanez-Larkin, GR (corresponding author), Stanford Univ, Dept Psychol, Bldg 420,Jordan Hall, Stanford, CA 94305 USA.	glarkin@stanford.edu	Samanez-Larkin, Gregory/A-1139-2007	Samanez-Larkin, Gregory/0000-0001-7846-3804; carstensen, laura/0000-0002-5011-3789; Knutson, Brian/0000-0002-7669-426X	NIA NIH HHS [P30 AG017253-09, R37 AG008816-17, AG017253, R01 AG008816, AG008816, AG024957, P30 AG017253, R37 AG008816, P30 AG024957-04, P30 AG024957] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG008816, P30AG024957, P30AG017253, R01AG008816] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Backman L, 2000, AM J PSYCHIAT, V157, P635; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Cabeza R., 2005, COGNITIVE NEUROSCIEN; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; CARSTENSEN LL, 2005, HDB PSYCHOL AGING, P343; Cohen J, 2003, ANIM COGN, V6, P93, DOI 10.1007/s10071-003-0168-9; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Denburg NL, 2006, INT J PSYCHOPHYSIOL, V61, P19, DOI 10.1016/j.ijpsycho.2005.10.021; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Garavan H, 2006, BRAIN RES, V1105, P130, DOI 10.1016/j.brainres.2006.03.029; Gazzaley A, 2005, COGNITIVE NEUROSCIEN, P107; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Kennedy KM, 2005, J COGNITIVE NEUROSCI, P140; KISLEY MA, IN PRESS PSYCHOL SCI; Knight M., 2006, BIOL BASES PERSONALI, P159; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Marschner A, 2005, BRAIN RES BULL, V67, P382, DOI 10.1016/j.brainresbull.2005.06.010; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2004, PSYCHOL SCI, V15, P259, DOI 10.1111/j.0956-7976.2004.00662.x; Neter J., 1996, APPL LINEAR STAT MOD; Park D.C., 2000, COGNITIVE AGING PRIM, V1st; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Wood S, 2006, PSYCHOL AGING, V21, P815, DOI 10.1037/0882-7974.21.4.815	30	279	284	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					787	791		10.1038/nn1894	http://dx.doi.org/10.1038/nn1894			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	172JI	17468751	Green Accepted			2022-12-24	WOS:000246799800022
J	Cheer, JF; Aragona, BJ; Heien, MLAV; Seipel, AT; Carelli, RM; Wightman, RM				Cheer, Joseph F.; Aragona, Brandon J.; Heien, Michael L. A. V.; Seipel, Andrew T.; Carelli, Regina M.; Wightman, R. Mark			Coordinated accumbal dopamine release and neural activity drive goal-directed behavior	NEURON			English	Article							MEDIAL FOREBRAIN-BUNDLE; INTRACRANIAL SELF-STIMULATION; COCAINE-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; NEOSTRIATAL NEURONS; PREFRONTAL CORTEX; DRUG-ADDICTION; D1 RECEPTORS; REWARD; RAT	Intracranial self-stimulation (ICSS) activates the neural pathways that mediate reward, including dopaminergic terminal areas such as the nucleus accumbens (NAc). However, a direct role of dopamine in ICSS-mediated reward has been questioned. Here, simultaneous voltammetric and electrophysiological recordings from the same electrode reveal that, at certain sites, the onset of anticipatory dopamine surges and changes in neuronal firing patterns during ICSS are coincident, whereas sites lacking dopamine changes also lack patterned firing. Intrashell microinfusion of a D1, but not a D2 receptor antagonist, blocks ICSS. An iontophoresis approach was implemented to explore the effect of dopamine antagonists on firing patterns without altering behavior. Similar to the microinfusion experiments, ICSS-related firing is selectively attenuated following D1 receptor blockade. This work establishes a temporal link between anticipatory rises of dopamine and firing patterns in the NAc shell during ICSS and suggests that they may play a similar role with natural rewards and during drug self-ad ministration.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wightman, RM (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	rmw@unc.edu	Heien, Michael/A-4731-2009; Cheer, Joseph F/J-6102-2014	Heien, Michael/0000-0001-5164-9596; Cheer, Joseph F/0000-0001-5086-7559	NIDA NIH HHS [DA 10900, DA 017318] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017318, R01DA010900] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arbuthnott GW, 2007, TRENDS NEUROSCI, V30, P62, DOI 10.1016/j.tins.2006.12.003; ARMSTRONGJAMES M, 1980, NATURE, V288, P181, DOI 10.1038/288181a0; Bassareo V, 2007, PSYCHOPHARMACOLOGY, V191, P689, DOI 10.1007/s00213-006-0560-7; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BIELAJEW C, 1986, J NEUROSCI, V6, P919; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; Carelli RM, 2000, J NEUROSCI, V20, P4255; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; Hernandez G, 2006, BEHAV NEUROSCI, V120, P888, DOI 10.1037/0735-7044.120.4.888; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Ito R, 2000, J NEUROSCI, V20, P7489; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; MOGENSON GJ, 1987, BRAIN RES, V404, P221, DOI 10.1016/0006-8993(87)91373-4; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; MURRAY B, 1994, BEHAV BRAIN RES, V63, P47, DOI 10.1016/0166-4328(94)90050-7; Nicola SM, 2005, NEUROSCIENCE, V135, P1025, DOI 10.1016/j.neuroscience.2005.06.088; PachecoCano MT, 1996, EXP BRAIN RES, V110, P205; Pecina S, 2006, NEUROSCIENTIST, V12, P500, DOI 10.1177/1073858406293154; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; SESACK SR, 1990, BRAIN RES, V527, P266, DOI 10.1016/0006-8993(90)91146-8; Singh J, 1997, BEHAV BRAIN RES, V86, P171, DOI 10.1016/S0166-4328(96)02263-2; STELLAR JR, 1989, BRAIN RES, V477, P126, DOI 10.1016/0006-8993(89)91400-5; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tran AH, 2005, P NATL ACAD SCI USA, V102, P2117, DOI 10.1073/pnas.0409726102; Tran AH, 2002, P NATL ACAD SCI USA, V99, P8986, DOI 10.1073/pnas.132284599; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Wightman RM, 2006, SCIENCE, V311, P1570, DOI 10.1126/science.1120027; WILLIAMS GV, 1990, NEUROSCIENCE, V39, P1, DOI 10.1016/0306-4522(90)90217-R; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2	49	150	151	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					237	244		10.1016/j.neuron.2007.03.021	http://dx.doi.org/10.1016/j.neuron.2007.03.021			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442245	Bronze, Green Submitted			2022-12-24	WOS:000246190600009
J	Cruikshank, SJ; Lewis, TJ; Connors, BW				Cruikshank, Scott J.; Lewis, Timothy J.; Connors, Barry W.			Synaptic basis for intense thalamocortical activation of feedforward inhibitory cells in neocortex	NATURE NEUROSCIENCE			English	Article							INTERNEURON DIVERSITY SERIES; SOMATOSENSORY BARREL CORTEX; CORTICAL RECEPTIVE-FIELDS; SPINY STELLATE NEURONS; PRIMARY VISUAL-CORTEX; LAYER-IV; RESPONSES; SYNAPSES; NETWORKS; GABA	The thalamus provides fundamental input to the neocortex. This input activates inhibitory interneurons more strongly than excitatory neurons, triggering powerful feedforward inhibition. We studied the mechanisms of this selective neuronal activation using a mouse somatosensory thalamocortical preparation. Notably, the greater responsiveness of inhibitory interneurons was not caused by their distinctive intrinsic properties but was instead produced by synaptic mechanisms. Axons from the thalamus made stronger and more frequent excitatory connections onto inhibitory interneurons than onto excitatory cells. Furthermore, circuit dynamics allowed feedforward inhibition to suppress responses in excitatory cells more effectively than in interneurons. Thalamocortical excitatory currents rose quickly in interneurons, allowing them to fire action potentials before significant feedforward inhibition emerged. In contrast, thalamocortical excitatory currents rose slowly in excitatory cells, overlapping with feedforward inhibitory currents that suppress action potentials. These results demonstrate the importance of selective synaptic targeting and precise timing in the initial stages of neocortical processing.	Brown Univ, Dept Neurosci, Div Biol & Med, Providence, RI 02912 USA; Univ Calif Davis, Dept Math, Davis, CA 95616 USA	Brown University; University of California System; University of California Davis	Connors, BW (corresponding author), Brown Univ, Dept Neurosci, Div Biol & Med, Box G-LN, Providence, RI 02912 USA.	barry_connors@brown.edu	Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157				AGMON A, 1992, J NEUROSCI, V12, P319; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Ahmed B, 1997, J COMP NEUROL, V380, P230; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2002, J NEUROSCI, V22, P10966; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1996, J NEUROSCI, V16, P6567; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Inoue T, 2006, J NEUROPHYSIOL, V96, P1746, DOI 10.1152/jn.00301.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; KELLER A, 1987, J COMP NEUROL, V262, P1, DOI 10.1002/cne.902620102; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; MCNAUGHTON BL, 1981, J NEUROPHYSIOL, V46, P952, DOI 10.1152/jn.1981.46.5.952; MILLER W, 1988, CABIOS, V4, P11; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; MOUNTCASTLE VM, 1989, PERPETUAL NEUROSCIEN; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Walker HC, 2002, NEURON, V35, P161, DOI 10.1016/S0896-6273(02)00734-1; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Zhou FM, 1998, BRAIN RES, V780, P166, DOI 10.1016/S0006-8993(97)01311-5	41	391	397	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					462	468		10.1038/nn1861	http://dx.doi.org/10.1038/nn1861			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17334362	Green Published			2022-12-24	WOS:000245228600017
J	Fusi, S; Abbott, LF				Fusi, Stefano; Abbott, L. F.			Limits on the memory storage capacity of bounded synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BIDIRECTIONAL SYNAPTIC PLASTICITY; TIMING-DEPENDENT PLASTICITY; FREQUENCY STIMULATION; INFORMATION-STORAGE; CORTICAL PLASTICITY; NEURAL NETWORKS; MODEL; HIPPOCAMPUS; LTP	Memories maintained in patterns of synaptic connectivity are rapidly overwritten and destroyed by ongoing plasticity related to the storage of new memories. Short memory lifetimes arise from the bounds that must be imposed on synaptic efficacy in any realistic model. We explored whether memory performance can be improved by allowing synapses to traverse a large number of states before reaching their bounds, or by changing the way these bounds are imposed. In the case of hard bounds, memory lifetimes grow proportional to the square of the number of synaptic states, but only if potentiation and depression are precisely balanced. Improved performance can be obtained without fine tuning by imposing soft bounds, but this improvement is only linear with respect to the number of synaptic states. We explored several other possibilities and conclude that improving memory performance requires a more radical modification of the standard model of memory storage.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kolb Res Annex, New York, NY 10032 USA	Columbia University	Abbott, LF (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kolb Res Annex, 1051 Riverside Dr, New York, NY 10032 USA.	lfa2103@columbia.edu	Fusi, Stefano/E-9109-2011	Fusi, Stefano/0000-0002-3035-6652	NIH HHS [5-DPI-OD114-02] Funding Source: Medline; PHS HHS [58754] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abraham WC, 2002, J NEUROSCI, V22, P9626; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; AMIT DJ, 1992, NETWORK-COMP NEURAL, V3, P443, DOI 10.1088/0954-898X/3/4/008; AMIT DJ, 1994, NEURAL COMPUT, V6, P957, DOI 10.1162/neco.1994.6.5.957; Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLOCK HD, 1962, REV MOD PHYS, V34, P123, DOI 10.1103/RevModPhys.34.123; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Brunel N, 1998, NETWORK-COMP NEURAL, V9, P123, DOI 10.1088/0954-898X/9/1/007; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; FESTA R, 1978, PHYSICA A, V90, P229, DOI 10.1016/0378-4371(78)90111-5; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; Fusi S, 2006, CHAOS, V16, DOI 10.1063/1.2213587; GROSSBERG S, 1982, PSYCHOL REV, V89, P529, DOI 10.1037/0033-295X.89.5.529; Gutig R, 2003, J NEUROSCI, V23, P3697; Hertz JA, 2018, INTRO THEORY NEURAL; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; KAHN PE, 1995, NETWORK-COMP NEURAL, V6, P415, DOI 10.1088/0954-898X/6/3/007; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Minsky M., 1988, PERCEPTRONS; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; O'Dell T J, 1994, Learn Mem, V1, P129; PARISI G, 1986, J PHYS A-MATH GEN, V19, pL617, DOI 10.1088/0305-4470/19/10/011; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rubin JE, 2001, NETWORK-COMP NEURAL, V12, P131, DOI 10.1088/0954-898X/12/2/303; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P713, DOI 10.1142/S0217984990000891; TSODYKS MV, 1988, EUROPHYS LETT, V6, P101, DOI 10.1209/0295-5075/6/2/002; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; Xiao MY, 1996, EUR J NEUROSCI, V8, P1916, DOI 10.1111/j.1460-9568.1996.tb01335.x; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	48	130	133	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					485	493		10.1038/nn1859	http://dx.doi.org/10.1038/nn1859			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17351638				2022-12-24	WOS:000245228600020
J	Nicol, X; Voyatzis, S; Muzerelle, A; Narboux-Neme, N; Sudhof, TC; Miles, R; Gaspar, P				Nicol, Xavier; Voyatzis, Sylvie; Muzerelle, Aude; Narboux-Neme, Nicolas; Sudhof, Thomas C.; Miles, Richard; Gaspar, Patricia			cAMP oscillations and retinal activity are permissive for ephrin signaling during the establishment of the retinotopic map	NATURE NEUROSCIENCE			English	Article							GROWTH-CONE; ELECTRICAL-ACTIVITY; CALCIUM TRANSIENTS; CYCLIC-AMP; IN-VIVO; RETINOCOLLICULAR AXONS; NEURITE OUTGROWTH; ADENYLYL-CYCLASE; RHO-GTPASES; CELL	Spontaneous activity generated in the retina is necessary to establish a precise retinotopic map, but the underlying mechanisms are poorly understood. We demonstrate here that neural activity controls ephrin-A-mediated responses. In the mouse retinotectal system, we show that spontaneous activity of the retinal ganglion cells (RGCs) is needed, independently of synaptic transmission, for the ordering of the retinotopic map and the elimination of exuberant retinal axons. Activity blockade suppressed the repellent action of ephrin-A on RGC growth cones by cyclic AMP (cAMP)-dependent pathways. Unexpectedly, the ephrin-A5-induced retraction required cAMP oscillations rather than sustained increases in intracellular cAMP concentrations. Periodic photoinduced release of caged cAMP in growth cones rescued the response to ephrin-A5 when activity was blocked. These results provide a direct molecular link between spontaneous neural activity and axon guidance mechanisms during the refinement of neural maps.	Hop La Pitie Salpetriere, INSERM, U616, F-75013 Paris, France; Univ Paris 06, Paris, France; Inst Fer Moulin, F-75005 Paris, France; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Neurosci, Dallas, TX 75390 USA; Univ Paris 06, Hop Salpetriere, U739, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gaspar, P (corresponding author), Hop La Pitie Salpetriere, INSERM, U616, 47 Blvd Hop, F-75013 Paris, France.	gaspar@chups.jussieu.fr	Nicol, Xavier/D-6087-2012; Gaspar, Patricia/G-8892-2011	Nicol, Xavier/0000-0002-0310-8047; Gaspar, Patricia/0000-0003-4217-5717; Narboux-Neme, Nicolas/0000-0002-3791-7459				Bansal A, 2000, J NEUROSCI, V20, P7672; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Cline H, 2003, TRENDS NEUROSCI, V26, P655, DOI 10.1016/j.tins.2003.10.005; Colonnese MT, 2001, J NEUROSCI, V21, P1557, DOI 10.1523/JNEUROSCI.21-05-01557.2001; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Fagan KA, 2000, J BIOL CHEM, V275, P40187, DOI 10.1074/jbc.M006606200; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; FIELDS RD, 1994, PROG BRAIN RES, V103, P127; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kolls BJ, 2002, J NEUROSCI, V22, P2626, DOI 10.1523/JNEUROSCI.22-07-02626.2002; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2006, EUR J NEUROSCI, V24, P3401, DOI 10.1111/j.1460-9568.2006.05227.x; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Ravary A, 2003, J NEUROSCI, V23, P2228; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spitzer NC, 2000, BIOESSAYS, V22, P811; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Uesaka N, 2005, J NEUROSCI, V25, P1, DOI 10.1523/JNEUROSCI.3855-04.2005; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	50	131	133	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					340	347		10.1038/nn1842	http://dx.doi.org/10.1038/nn1842			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259982				2022-12-24	WOS:000244480300016
J	Ligon, KL; Huillard, E; Mehta, S; Kesari, S; Liu, HY; Alberta, JA; Bachoo, RM; Kane, M; Louis, DN; DePinho, RA; Anderson, DJ; Stiles, CD; Rowitch, DH				Ligon, Keith L.; Huillard, Emmanuelle; Mehta, Shwetal; Kesari, Santosh; Liu, Hongye; Alberta, John A.; Bachoo, Robert M.; Kane, Michael; Louis, David N.; DePinho, Ronald A.; Anderson, David J.; Stiles, Charles D.; Rowitch, David H.			Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma	NEURON			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; FACTOR-BINDING SITES; HUMAN BRAIN-TUMORS; PROGENITOR CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GLIOBLASTOMA-MULTIFORME; SUBVENTRICULAR ZONE	Recent studies have identified stem cells in brain cancer. However, their relationship to normal CNS progenitors, including dependence on common lineage-restricted pathways, is unclear. We observe expression of the CNS-restricted transcription factor, OLIG2, in human glioma stem and progenitor cells reminiscent of type C transit-amplifying cells in germinal zones of the adult brain. Olig2 function is required for proliferation of neural progenitors and for glioma formation in a genetically relevant murine model. Moreover, we show p21(WAF1/CIP1), a tumor suppressor and inhibitor of stem cell proliferation, is directly repressed by OLIG2 in neural progenitors and gliomas. Our findings identify an Olig2-regulated lineage-restricted pathway critical for proliferation of normal and tumorigenic CNS stem cells.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Childrens Hosp, Informat Program, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02129 USA; Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02129 USA; CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; Childrens Hosp, Div Neonatol, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; California Institute of Technology; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stiles, CD (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 4 Binney St, Boston, MA 02115 USA.	charles_stiles@dfci.harvard.edu; rowitchd@peds.ucsf.edu	Kesari, Santosh/E-8461-2013	Rowitch, David/0000-0002-0079-0060; DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047213, P01NS047572, F32NS055631, R01NS040511] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA095616, P01 CA95616] Funding Source: Medline; NINDS NIH HHS [K08NS047213, NS05563, F32 NS055631, R01NS40511, P01NS047572, R01 NS040511, P01 NS047572, K08 NS047213] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams PD, 1998, CURR OPIN CELL BIOL, V10, P791, DOI 10.1016/S0955-0674(98)80123-3; Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Anderson RC, 2002, CLIN IMMUNOL, V102, P84, DOI 10.1006/clim.2001.5152; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Azzarelli B, 2004, J NEUROPATH EXP NEUR, V63, P170, DOI 10.1093/jnen/63.2.170; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; Barker FG, 1997, J NEURO-ONCOL, V31, P17, DOI 10.1023/A:1005768910871; Besson A, 2001, J NEURO-ONCOL, V51, P245, DOI 10.1023/A:1010657030494; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Bouvier C, 2003, J NEUROSURG, V99, P344, DOI 10.3171/jns.2003.99.2.0344; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Furusho M, 2006, DEV BIOL, V293, P348, DOI 10.1016/j.ydbio.2006.01.031; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kamiya M, 2002, J NEURO-ONCOL, V59, P143, DOI 10.1023/A:1019633910603; Kesari S, 2006, NEURON, V51, P151, DOI 10.1016/j.neuron.2006.07.001; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Korshunov A, 2002, J NEURO-ONCOL, V58, P237, DOI 10.1023/A:1016270101321; Kraus JA, 2001, J NEURO-ONCOL, V52, P263, DOI 10.1023/A:1010684203704; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Laywell Eric D, 2002, Methods Mol Biol, V198, P15; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; Louis DN, 2002, CANCER CELL, V1, P125, DOI 10.1016/S1535-6108(02)00040-5; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Miettinen HE, 2001, J NEURO-ONCOL, V55, P29, DOI 10.1023/A:1012961918848; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohnishi A, 2003, J NEUROPATH EXP NEUR, V62, P1052, DOI 10.1093/jnen/62.10.1052; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rasheed B K, 1999, Curr Opin Oncol, V11, P162; Rasheed BKA, 1997, CANCER RES, V57, P4187; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Setoguchi T, 2004, J CELL BIOL, V166, P963, DOI 10.1083/jcb.200404104; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STECK PA, 1988, CANCER RES, V48, P5433; Sun T, 2003, J NEUROSCI, V23, P9547; Tabu K, 2006, J CELL SCI, V119, P1433, DOI 10.1242/jcs.02854; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang JJ, 2000, P NATL ACAD SCI USA, V97, P3497, DOI 10.1073/pnas.97.7.3497; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	83	372	383	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					503	517		10.1016/j.neuron.2007.01.009	http://dx.doi.org/10.1016/j.neuron.2007.01.009			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296553	Green Accepted, Bronze			2022-12-24	WOS:000245126900010
J	Sindreu, CB; Scheiner, ZS; Storm, DR				Sindreu, Carlos Balet; Scheiner, Zachary S.; Storm, Daniel R.			Ca2+-Stimulated adenylyl cyclases regulate ERK-dependent activation of MSK1 during fear conditioning	NEURON			English	Article							LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; PROTEIN-KINASE-A; SYNAPTIC PLASTICITY; MUTANT MICE; MAP KINASE; NEURONAL PLASTICITY; DORSAL HIPPOCAMPUS; BINDING PROTEIN; SPATIAL MEMORY	The cAMP and ERK/MAP kinase (MAPK) signal transduction pathways are critical for hippocampus-dependent memory, a process that depends on CREB-mediated transcription. However, the extent of crosstalk between these pathways and the downstream CREB kinase activated during memory formation has not been elucidated. Here we report that PKA, MAPK, and MSK1, a CREB kinase, are coactivated in a subset of hippocampal CA1 pyramidal neurons following contextual fear conditioning. Activation of PKA, MAPK, MSK1, and CREB is absolutely dependent on Ca2+ -stimulated adenylyl cyclase activity. We conclude that adenylyl cyclase activity supports the activation of MAPK, and that MSK1 is the major CREB kinase activated during training for contextual memory.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu	sindreu, carlos/D-3901-2014	sindreu, carlos/0000-0001-6730-8278	NIGMS NIH HHS [T32 GM007108, T32 GM07108] Funding Source: Medline; NIMH NIH HHS [MH 073601, R01 MH073601] Funding Source: Medline; NINDS NIH HHS [NS 20498, R01 NS020498] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Vanhoose AM, 2006, J NEUROSCI, V26, P1138, DOI 10.1523/JNEUROSCI.3572-05.2006; Villacres EC, 1998, J NEUROSCI, V18, P3186; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	36	159	159	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					79	89		10.1016/j.neuron.2006.11.024	http://dx.doi.org/10.1016/j.neuron.2006.11.024			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196532	Bronze, Green Accepted			2022-12-24	WOS:000245126500010
J	Takahashi, H; Shin, Y; Cho, SJ; Zago, WM; Nakamura, T; Gu, ZZ; Ma, YL; Furukawa, H; Liddington, R; Zhang, DX; Tong, G; Chen, HSV; Lipton, SA				Takahashi, Hiroto; Shin, Yeonsook; Cho, Seung-Je; Zago, Wagner M.; Nakamura, Tomohiro; Gu, Zezong; Ma, Yuliang; Furukawa, Hiroyasu; Liddington, Robert; Zhang, Dongxian; Tong, Gary; Chen, Huei-Sheng Vincent; Lipton, Stuart A.			Hypoxia enhances S-nitrosylation-mediated NMDA receptor inhibition via a thiol oxygen sensor motif	NEURON			English	Article							D-ASPARTATE RECEPTOR; REDOX MODULATORY SITE; CALCIUM-RELEASE CHANNEL; ZINC-SULFUR CLUSTERS; NEURONS IN-VITRO; NITRIC-OXIDE; PYRROLOQUINOLINE QUINONE; PHOSPHORYLATION SITE; OXIDIZED GLUTATHIONE; CRYSTAL-STRUCTURES	Under ambient air conditions, NO inhibits NMDAR activity by reacting with the NR2A subunit C399 along with two additional cysteine pairs if their disulfide bonds are reduced to free thiol groups [NR1(C744,C798); NR2(C87, C320)]. Here we demonstrate that relative hypoxia enhances S-nitrosylation of NMDARs by a unique mechanism involving an "NO-reactive oxygen sensor motif" whose determinants include C744 and C798 of the NR1 subunit. Redox reactions involving these two thiol groups sensitize other NMDAR sites to S-nitrosylation and consequent receptor inhibition, while their own nitrosylation has little effect on NIVIDAR activity. The crystal structure of the ligand-binding domain of NR1 reveals a flexible disulfide bond (C744-C798), which may account for its susceptibility to reduction and subsequent reaction with NO that is observed with biochemical techniques. These thiols may be nitrosylated preferentially during increasing hypoxia or stroke conditions, thus preventing excessive activity associated with cytotoxicity while avoiding blockade of physiologically active NMDARs.	Burnham Inst Med Res, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Burnham Inst Med Res, Proteom Facil, La Jolla, CA 92037 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Cardiol, La Jolla, CA 92037 USA; Kanazawa Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Kanazawa, Ishikawa 9208640, Japan	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Columbia University; University of California System; University of California San Diego; University of California System; University of California San Diego; Kanazawa University	Lipton, SA (corresponding author), Burnham Inst Med Res, Ctr Neurosci & Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org	Tong, Gary/AAC-9426-2022	Lipton, Stuart/0000-0002-3490-1259	NEI NIH HHS [R01 EY009024, R01 EY05477, R01 EY005477, R01 EY09024] Funding Source: Medline; NICHD NIH HHS [P01 HD29587, P01 HD029587] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009024, R01EY005477] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AIZENMAN E, 1995, NEUROSCI LETT, V189, P57, DOI 10.1016/0304-3940(95)11442-Y; AIZENMAN E, 1992, J NEUROSCI, V12, P2362; AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Aravindakumar CT, 1999, BIOCHEM J, V344, P253, DOI 10.1042/0264-6021:3440253; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Choi YB, 2001, J NEUROSCI, V21, P392, DOI 10.1523/JNEUROSCI.21-02-00392.2001; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; GILBERT KR, 1991, NEUROSCI LETT, V133, P11, DOI 10.1016/0304-3940(91)90045-U; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kim WK, 1999, NEURON, V24, P461, DOI 10.1016/S0896-6273(00)80859-4; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kroncke KD, 2000, FASEB J, V14, P166; KRONCKE KD, 1994, BIOCHEM BIOPH RES CO, V200, P1105, DOI 10.1006/bbrc.1994.1564; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Lipton SA, 2004, NATURE, V428, P473, DOI 10.1038/428473a; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 2004, CELL DEATH DIFFER, V11, P18, DOI 10.1038/sj.cdd.4401344; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lipton SA, 1996, TRENDS PHARMACOL SCI, V17, P186, DOI 10.1016/0165-6147(96)20028-8; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; Misra RR, 1996, CHEM RES TOXICOL, V9, P326, DOI 10.1021/tx950109y; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce LL, 2000, P NATL ACAD SCI USA, V97, P477, DOI 10.1073/pnas.97.1.477; Scanlon JM, 1997, EUR J PHARMACOL, V326, P67, DOI 10.1016/S0014-2999(97)00137-4; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; TANG LH, 1993, MOL PHARMACOL, V44, P473; TANG LH, 1993, NEURON, V11, P857, DOI 10.1016/0896-6273(93)90115-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101	55	88	91	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					53	64		10.1016/j.neuron.2006.11.023	http://dx.doi.org/10.1016/j.neuron.2006.11.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196530	Green Accepted, Bronze			2022-12-24	WOS:000245126500008
J	Barbee, SA; Estes, PS; Cziko, AM; Hillebrand, J; Luedeman, RA; Coller, JM; Johnson, N; Howlett, IC; Geng, CY; Ueda, R; Brand, AH; Newbury, SF; Wilhelm, JE; Levine, RB; Nakamura, A; Parker, R; Ramaswamil, M				Barbee, Scott A.; Estes, Patricia S.; Cziko, Anne-Marie; Hillebrand, Jens; Luedeman, Rene A.; Coller, Jeff M.; Johnson, Nick; Howlett, Iris C.; Geng, Cuiyun; Ueda, Ryu; Brand, Andrea H.; Newbury, Sarah F.; Wilhelm, James E.; Levine, Richard B.; Nakamura, Akira; Parker, Roy; Ramaswami, Mani			Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies	NEURON			English	Article							OSKAR MESSENGER-RNA; CONTAINING RIBONUCLEOPROTEIN-PARTICLES; PHYSIOLOGICAL GERMLINE APOPTOSIS; BINDING-PROTEIN; TRANSLATIONAL REPRESSION; PROCESSING BODIES; LOCALIZATION; GRANULES; MICRORNA; COMPLEX	Local control of mRNA translation modulates neuronal development, synaptic plasticity, and memory formation. A poorly understood aspect of this control is the role and composition of ribonucleoprotein (RNP) particles that mediate transport and translation of neuronal RNAs. Here, we show that staufen- and FMRP-containing RNPs in Drosophila neurons contain proteins also present in somatic "P bodies," including the RNA-degradative enzymes Dcp1p and Xrn1p/Pacman and crucial components of miRNA (argonaute), NMD (Upf1p), and general translational repression (Dhh1p/Me31B) pathways. Drosophila Me31B is shown to participate (1) with an FMRP-associated, P body protein (Scd6p/trailer hitch) in FMRP-driven, argonaute-dependent translational repression in developing eye imaginal discs; (2) in dendritic elaboration of larval sensory neurons; and (3) in bantam miRNA-mediated translational repression in wing imaginal discs. These results argue for a conserved mechanism of translational control critical to neuronal function and open up new experimental avenues for understanding the regulation of mRNA function within neurons.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, ARL Div Neurobiol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA; Univ Dublin Trinity Coll, Smurfit Inst Genet & TCIN, Dublin 2, Ireland; Univ Texas, Inst Mol & Cellular Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; RIKEN, Ctr Dev Biol, Lab Germline Dev, Chuo Ku, Kobe, Hyogo 6500047, Japan; Natl Inst Genet, Invertebrate Genet Lab, Genet Strains Res Ctr, Mishima, Shizuoka 4118540, Japan	University of Arizona; University of Arizona; Howard Hughes Medical Institute; University of Arizona; Trinity College Dublin; University of Texas System; University of Texas Austin; University of Cambridge; University of Cambridge; Newcastle University - UK; University of California System; University of California San Diego; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu; mani@u.arizona.edu	Brand, Andrea H/F-8220-2014; Nakamura, Akira/V-6869-2019	Brand, Andrea H/0000-0002-2089-6954; Nakamura, Akira/0000-0001-6506-9146; Coller, Jeff/0000-0001-5662-8110; Ramaswami, Mani/0000-0001-7631-0468	Biotechnology and Biological Sciences Research Council [BB/C005163/1] Funding Source: Medline; Medical Research Council [G0300072] Funding Source: Medline; NIDA NIH HHS [DA15495, K02 DA017749, DA17749, R01 DA015495] Funding Source: Medline; NIGMS NIH HHS [R37 GM045443, R01 GM054409, GM54409] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054409, R37GM045443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015495, K02DA017749] Funding Source: NIH RePORTER; MRC [G0300072] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Forbes A, 1998, DEVELOPMENT, V125, P679; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Kraft R, 1998, J NEUROSCI, V18, P8886; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Lall S, 2005, MOL BIOL CELL, V16, P5880, DOI 10.1091/mbc.E05-07-0622; Lasko P, 2005, BIOCHEM SOC T, V33, P1544, DOI 10.1042/BST0331544; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Macchi P, 2003, J NEUROSCI, V23, P5778; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Mansfield JH, 2002, DEVELOPMENT, V129, P197; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Sanyal S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-20; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	73	275	277	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					997	1009		10.1016/j.neuron.2006.10.028	http://dx.doi.org/10.1016/j.neuron.2006.10.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178403	Bronze, Green Accepted			2022-12-24	WOS:000243115100008
J	Frank, CA; Kennedy, MJ; Goold, CP; Marek, KW; Davis, GW				Frank, C. Andrew; Kennedy, Matthew J.; Goold, Carleton P.; Marek, Kurt W.; Davis, Graeme W.			Mechanisms underlying the rapid induction and sustained expression of synaptic homeostasis	NEURON			English	Article							SENSITIVE PARALYTIC MUTANT; CHANNEL ALPHA-1 SUBUNIT; CALCIUM-CHANNEL; RETROGRADE SIGNAL; GENETIC-ANALYSIS; QUANTAL CONTENT; END-PLATES; CA2+ ENTRY; DROSOPHILA; RELEASE	Homeostatic signaling systems are thought to interface with the mechanisms of neural plasticity to achieve stable yet flexible neural circuitry. However, the time course, molecular design, and implementation of homeostatic signaling remain poorly defined. Here we demonstrate that a homeostatic increase in presynaptic neurotransmitter release can be induced within minutes following postsynaptic glutamate receptor blockade. The rapid induction of synaptic homeostasis is independent of new protein synthesis and does not require evoked neurotransmission, indicating that a change in the efficacy of spontaneous quantal release events is sufficient to trigger the induction of synaptic homeostasis. Finally, both the rapid induction and the sustained expression of synaptic homeostasis are blocked by mutations that disrupt the pore-forming subunit of the presynaptic Ca(v)2.1 calcium channel encoded by cacophony. These data confirm the presynaptic expression of synaptic homeostasis and implicate presynaptic Ca(v)2.1 in a homeostatic retrograde signaling system.	Univ Calif San Francisco, Dept Biochem & Biophys, Neurosci Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Neurosci Program, 1550 4th St,Rock Hall 4th Floor N, San Francisco, CA 94158 USA.	gdavis@biochem.ucsf.edu		Frank, C. Andrew/0000-0001-9599-421X	NINDS NIH HHS [F32 NS049694-02, NS39313, F32 NS049694, R01 NS039313-07, NS049694, F32 NS049694-03, R01 NS039313, F32 NS049694-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS049694, R01NS039313] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Barrett CF, 2005, J BIOL CHEM, V280, P24064, DOI 10.1074/jbc.M502223200; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Brooks IM, 2003, GENETICS, V164, P163; Cao YQ, 2005, P NATL ACAD SCI USA, V102, P2590, DOI 10.1073/pnas.0409896102; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Dellinger B, 2000, GENETICS, V155, P203; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DiAntonio A, 1999, J NEUROSCI, V19, P3023; ELDEFRAWI AT, 1988, P NATL ACAD SCI USA, V85, P4910, DOI 10.1073/pnas.85.13.4910; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; KARST H, 1991, COMP BIOCHEM PHYS C, V98, P479, DOI 10.1016/0742-8413(91)90237-N; Kawasaki F, 2002, J NEUROSCI, V22, P5856; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Macleod GT, 2006, EUR J NEUROSCI, V23, P3230, DOI 10.1111/j.1460-9568.2006.04873.x; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marrus SB, 2005, J NEUROBIOL, V63, P62, DOI 10.1002/neu.20120; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Plomp J J, 2001, Curr Opin Investig Drugs, V2, P1250; PLOMP JJ, 1994, J PHYSIOL-LONDON, V478, P125, DOI 10.1113/jphysiol.1994.sp020236; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Smith LA, 1998, GENETICS, V149, P1407; Smith LA, 1996, J NEUROSCI, V16, P7868; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Xing B, 2005, SYNAPSE, V57, P132, DOI 10.1002/syn.20165	52	259	260	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					663	677		10.1016/j.neuron.2006.09.029	http://dx.doi.org/10.1016/j.neuron.2006.09.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114050	Green Accepted, Bronze			2022-12-24	WOS:000242413100013
J	Costa, RM; Lin, SC; Sotnikova, TD; Cyr, M; Gainetdinov, RR; Caron, MG; Nicolelis, MAL				Costa, Rui M.; Lin, Shih-Chieh; Sotnikova, Tatyana D.; Cyr, Michel; Gainetdinov, Raul R.; Caron, Marc G.; Nicolelis, Miguel A. L.			Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction	NEURON			English	Article							LOCAL-FIELD POTENTIALS; PARKINSONS-DISEASE; GLOBUS-PALLIDUS; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; IN-VIVO; CORTEX STIMULATION; PROJECTION NEURONS; GABA INTERNEURONS; SUBSTANTIA-NIGRA	Dopaminergic dysregulation can cause motor dysfunction, but the mechanisms underlying dopamine-related motor disorders remain under debate. We used an inducible and reversible pharmacogenetic approach in dopamine transporter knockout mice to investigate the simultaneous activity of neuronal ensembles in the dorsolateral striatum and primary motor cortex during hyperdopaminergia (similar to 500% of controls) with hyperkinesia, and after rapid and profound dopamine depletion (< 0.2%) with akinesia in the same animal. Surprisingly, although most cortical and striatal neurons (similar to 70%) changed firing rate during the transition between dopamine-related hyperkinesia and akinesia, the overall cortical firing rate remained unchanged. Conversely, neuronal oscillations and ensemble activity coordination within and between cortex and striatum did change rapidly between these periods. During hyperkinesia, corticostriatal activity became largely asynchronous, while during dopamine-depletion the synchronicity increased. Thus, dopamine-related disorders like Parkinson's disease may not stem from changes in the overall levels of cortical activity, but from dysfunctional activity coordination in corticostriatal circuits.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychol & Brain Sci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Neuroengn, Durham, NC 27710 USA; NIAAA, Sect Vivo Neural Funct, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA	Duke University; Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Costa, RM (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	costarui@mail.nih.gov	Sotnikova, Tatyana D/T-9992-2017; Gainetdinov, Raul R/G-5875-2011	Gainetdinov, Raul R/0000-0003-2951-6038; Lin, Shih-Chieh/0000-0003-3693-5476; Costa, Rui M./0000-0003-0495-8374	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000416, ZIAAA000416] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Bar-Gad I, 2004, J NEUROSCI, V24, P7410, DOI 10.1523/JNEUROSCI.1691-04.2004; Bar-Gad I, 2003, J NEUROSCI, V23, P4012; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; CORDINGLEY GE, 1986, BRIT J PHARMACOL, V88, P847, DOI 10.1111/j.1476-5381.1986.tb16258.x; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DEUTCH AY, 1991, SCHIZOPHR RES, V4, P121, DOI 10.1016/0920-9964(91)90030-U; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; FILION M, 1991, BRAIN RES, V547, P142; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; GERFEN CR, 1992, J NEURAL TRANSM-GEN, P43; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; Goldberg JA, 2003, J NEUROSCI, V23, P10058; Gray JA, 1998, SCHIZOPHRENIA BULL, V24, P249, DOI 10.1093/oxfordjournals.schbul.a033324; Hof PR., 2000, COMP CYTOARCHITECTON; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kaneda K, 2005, EUR J NEUROSCI, V22, P3241, DOI 10.1111/j.1460-9568.2005.04488.x; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kuhn AA, 2005, EXP NEUROL, V194, P212, DOI 10.1016/j.expneurol.2005.02.010; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Levesque M, 2003, J CHEM NEUROANAT, V26, P271, DOI 10.1016/j.jchemneu.2003.07.001; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Liu XG, 2002, MOVEMENT DISORD, V17, P346, DOI 10.1002/mds.10038; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; Magill PJ, 2004, J NEUROPHYSIOL, V92, P700, DOI 10.1152/jn.00134.2004; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Masimore B, 2005, NEUROREPORT, V16, P2021, DOI 10.1097/00001756-200512190-00010; Masimore B, 2004, J NEUROSCI METH, V138, P97, DOI 10.1016/j.jneumeth.2004.03.014; MISGELD U, 1979, EXP BRAIN RES, V34, P575; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Parr-Brownlie LC, 2005, J NEUROSCI, V25, P5700, DOI 10.1523/JNEUROSCI.0523-05.2005; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Raz A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0006.2001; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; RYAN LJ, 1986, BRAIN RES BULL, V17, P751, DOI 10.1016/0361-9230(86)90086-9; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Silberstein P, 2003, BRAIN, V126, P2597, DOI 10.1093/brain/awg267; Smith Y, 1998, NEUROSCIENCE, V86, P353; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103	60	218	223	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					359	369		10.1016/j.neuron.2006.07.030	http://dx.doi.org/10.1016/j.neuron.2006.07.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046697	Bronze			2022-12-24	WOS:000241799900015
J	Foldy, C; Lee, SY; Szabadics, J; Neu, A; Soltesz, I				Foeldy, Csaba; Lee, Soo Yeun; Szabadics, Janos; Neu, Axel; Soltesz, Ivan			Cell type - specific gating of perisomatic inhibition by cholecystokinin	NATURE NEUROSCIENCE			English	Review							GABA RELEASE; MODULATION; RATS	Parvalbumin- and cholecystokinin ( CCK)-expressing basket cells provide two parallel, functionally distinct sources of perisomatic inhibition to postsynaptic cells. We show that exogenously applied CCK enhances the output from rat parvalbumin-expressing basket cells, while concurrently suppressing GABA release from CCK-expressing neurons through retrograde endocannabinoid action. These results indicate that CCK may act as a molecular switch that determines the source of perisomatic inhibition for hippocampal principal cells.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Foldy, C (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	cfoldy@uci.edu		Szabadics, Janos/0000-0002-4968-2562; Neu, Axel/0000-0001-7045-7194; Foldy, Csaba/0000-0001-8709-8490	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038580] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38580] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Deng PY, 2006, J PHYSIOL-LONDON, V572, P425, DOI 10.1113/jphysiol.2005.104463; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Gallopin T, 2006, CEREB CORTEX, V16, P1440, DOI 10.1093/cercor/bhj081; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Miller KK, 1997, J NEUROSCI, V17, P4994; Neu A, 2007, J PHYSIOL-LONDON, V578, P233, DOI 10.1113/jphysiol.2006.115691; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; RAVARD S, 1990, TRENDS PHARMACOL SCI, V11, P271, DOI 10.1016/0165-6147(90)90004-R; VALLEBUONA F, 1993, J NEUROCHEM, V61, P490; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; [No title captured]	15	98	98	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1128	1130		10.1038/nn1952	http://dx.doi.org/10.1038/nn1952			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676058				2022-12-24	WOS:000249144000012
J	Suh, J; Jackson, FR				Suh, Joowon; Jackson, F. Rob			Drosophila Ebony activity is required in glia for the circadian regulation of locomotor activity	NEURON			English	Article							NERVOUS-SYSTEM; GENE-EXPRESSION; PERIOD PROTEIN; VISUAL-SYSTEM; CLOCK GENE; WILD-TYPE; MELANOGASTER; RHYTHMS; METABOLISM; DOPAMINE	Previous studies suggest that glia may be required for normal circadian behavior, but glial factors required for rhythmicity have not been identified in any system. We show here that a circadian rhythm in Drosophila Ebony (N-beta-alanylbiogenic amine synthetase) abundance can be visualized in adult glia and that glial expression of Ebony rescues the altered circadian behavior of ebony mutants. We demonstrate that molecular oscillator function and clock neuron output are normal in ebony mutants, verifying a role for Ebony downstream of the clock. Surprisingly, the ebony oscillation persists in flies lacking PDF neuropeptide, indicating it is regulated by an autonomous glial oscillator or another neuronal factor. The proximity of Ebony-containing glia. to aminergic neurons and genetic interaction results suggest a function in dopaminergic signaling. We thus suggest a model for ebony function wherein Ebony glia participate in the clock control of dopaminergic function and the orchestration of circadian activity rhythms.	Tufts Univ, Sch Med, Dept Neurosci, Tufts Ctr Neurosci Res, Boston, MA 02111 USA; Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Jackson, FR (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Tufts Ctr Neurosci Res, 136 Harrison Ave, Boston, MA 02111 USA.	rob.jackson@tufts.edu			NHLBI NIH HHS [R01 HL59873, R01 HL059873-07, R01 HL059873-08, R01 HL059873-04, R01 HL059873-05, R01 HL059873, R01 HL059873-06, R01 HL059873-03, R01 HL059873-09A2] Funding Source: Medline; NINDS NIH HHS [P30 NS047243-03, P30 NS047243-019001, P30 NS047243-01, P30 NS047243-04, P30 NS047243, P30 NS047243-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Borycz J, 2002, J NEUROSCI, V22, P10549; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAMPOSORTEGA JA, 1974, Z ZELLFORSCH MIK ANA, V147, P415, DOI 10.1007/BF00307474; Cantera R, 1996, DEV GENES EVOL, V206, P277, DOI 10.1007/s004270050052; CARLSON SD, 1990, ANNU REV ENTOMOL, V35, P597, DOI 10.1146/annurev.en.35.010190.003121; Ceriani MF, 2003, CELL MOL NEUROBIOL, V23, P223; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Drapeau MD, 2003, BIOCHEM BIOPH RES CO, V311, P1, DOI 10.1016/j.bbrc.2003.09.106; Drapeau MD, 2003, J NEUROBIOL, V55, P53, DOI 10.1002/neu.10196; Dunlap JC, 2005, METHOD ENZYMOL, V393, P3, DOI 10.1016/S0076-6879(05)93001-2; EWER J, 1992, J NEUROSCI, V12, P3321; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Fricker-Gates RA, 2006, NEUROREPORT, V17, P1081, DOI 10.1097/01.wnr.0000230505.32726.65; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hartill M, 1998, PROF ENG, V11, P32; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; HODGETTS RB, 1973, J INSECT PHYSIOL, V19, P1211, DOI 10.1016/0022-1910(73)90205-9; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Hovemann BT, 1998, GENE, V221, P1, DOI 10.1016/S0378-1119(98)00440-5; Jackson FR, 2005, METHOD ENZYMOL, V393, P663, DOI 10.1016/S0076-6879(05)93035-8; Jones BW, 2005, DEV BIOL, V278, P265, DOI 10.1016/j.ydbio.2004.11.022; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; KYRIACOU CP, 1978, ANIM BEHAV, V26, P1195, DOI 10.1016/0003-3472(78)90109-4; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Miskiewicz K, 2004, NEUROSCI LETT, V363, P73, DOI 10.1016/j.neulet.2004.03.051; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; NEWBY LM, 1993, GENETICS, V135, P1077; NEWBY LM, 1991, J NEUROGENET, V7, P85, DOI 10.3109/01677069109066213; Perez M, 2004, NEUROSCI LETT, V368, P186, DOI 10.1016/j.neulet.2004.07.015; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; RAMADAN H, 1993, CELL BIOL INT, V17, P765, DOI 10.1006/cbir.1993.1138; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richardt A, 2003, J BIOL CHEM, V278, P41160, DOI 10.1074/jbc.M304303200; Richardt A, 2002, J COMP NEUROL, V452, P93, DOI 10.1002/cne.10360; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; XIONG WC, 1995, NEURON, V14, P581, DOI 10.1016/0896-6273(95)90314-3; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; ZERR DM, 1990, J NEUROSCI, V10, P2749	62	154	154	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					435	447		10.1016/j.neuron.2007.06.038	http://dx.doi.org/10.1016/j.neuron.2007.06.038			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678856	Green Accepted, Bronze			2022-12-24	WOS:000248711000011
J	Toni, N; Teng, EM; Bushong, EA; Aimone, JB; Zhao, CM; Consiglio, A; van Praag, H; Martone, ME; Ellisman, MH; Gage, FH				Toni, Nicolas; Teng, E. Matthew; Bushong, Eric A.; Aimone, James B.; Zhao, Chunmei; Consiglio, Antonella; van Praag, Henriette; Martone, Maryann E.; Ellisman, Mark H.; Gage, Fred H.			Synapse formation on neurons born in the adult hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; DENTATE GYRUS; IN-VIVO; 3-DIMENSIONAL STRUCTURE; STRUCTURAL PLASTICITY; GRANULE CELLS; NEUROGENESIS; FILOPODIA	Although new and functional neurons are produced in the adult brain, little is known about how they integrate into mature networks. Here we explored the mechanisms of synaptogenesis on neurons born in the adult mouse hippocampus using confocal microscopy, electron microscopy and live imaging. We report that new neurons, similar to mature granule neurons, were contacted by axosomatic, axodendritic and axospinous synapses. Consistent with their putative role in synaptogenesis, dendritic filopodia were more abundant during the early stages of maturation and, when analyzed in three dimensions, the tips of all filopodia were found within 200 nm of preexisting boutons that already synapsed on other neurons. Furthermore, dendritic spines primarily synapsed on multiple-synapse boutons, suggesting that initial contacts were preferentially made with preexisting boutons already involved in a synapse. The connectivity of new neurons continued to change until at least 2 months, long after the formation of the first dendritic protrusions.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	van Praag, Henriette/F-3939-2015; Aimone, James B/C-7821-2011; consiglio, antonella/AAA-5864-2019; consiglio, antonella/G-1815-2016; Toni, Nicolas/M-2057-2014; Aimone, James Bradley/H-4694-2016	van Praag, Henriette/0000-0002-5727-434X; consiglio, antonella/0000-0002-3988-6254; consiglio, antonella/0000-0002-3988-6254; Toni, Nicolas/0000-0001-5585-268X; Aimone, James Bradley/0000-0002-7361-253X; Martone, Maryann/0000-0002-8406-3871	NINDS NIH HHS [NS050217-02] Funding Source: Medline; PHS HHS [RRP41-04050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000328, Z01AG000328] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1995, TRENDS NEUROSCI, V18, P365, DOI 10.1016/0166-2236(95)93930-V; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HARRIS MI, 1997, INT TXB DIABETES MEL, V1, P9; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shepherd GMG, 2002, P NATL ACAD SCI USA, V99, P6340, DOI 10.1073/pnas.052151299; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	418	440	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					727	734		10.1038/nn1908	http://dx.doi.org/10.1038/nn1908			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486101				2022-12-24	WOS:000246799800015
J	Gleeson, P; Steuber, V; Silver, RA				Gleeson, Padraig; Steuber, Volker; Silver, R. Angus			neuroConstruct: A tool for modeling networks of neurons in 3D space	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; DENDRITIC MORPHOLOGY; HIPPOCAMPAL-NEURONS; SPIKE INITIATION; SYSTEMS BIOLOGY; NITRIC-OXIDE; IN-VIVO; CELL; SIMULATION; CORTEX	Conductance-based neuronal network models can help us understand how synaptic and cellular mechanisms underlie brain function. However, these complex models are difficult to develop and are inaccessible to most neuroscientists. Moreover, even the most biologically realistic network models disregard many 3D anatomical features of the brain. Here, we describe a new software application, neuroConstruct, that facilitates the creation, visualization, and analysis of networks of multicompartmental neurons in 3D space. A graphical user interface allows model generation and modification without programming. Models within neuroConstruct are based on new simulator-in dependent NeuroML standards, allowing automatic generation of code for NEURON or GENESIS simulators. neuroConstruct was tested by reproducing published models and its simulator independence verified by comparing the same model on two simulators. We show how more anatomically realistic network models can be created and their properties compared with experimental measurements by extending a published 1D cerebellar granule cell layer model to 3D.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk	Gleeson, Padraig/A-7549-2012	Gleeson, Padraig/0000-0001-5963-8576; Steuber, Volker/0000-0003-0186-3580; Silver, Robin/0000-0002-5480-6638	MRC [G0400598, G90/100] Funding Source: UKRI; Medical Research Council [G90/100, G0400598] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Ascoli GA, 2001, PHILOS T R SOC B, V356, P1131, DOI 10.1098/rstb.2001.0905; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bednar JA, 2004, NEUROCOMPUTING, V58, P1129, DOI 10.1016/j.neucom.2004.01.177; Berends M, 2004, NEUROCOMPUTING, V58, P587, DOI 10.1016/j.neucom.2004.01.099; BLOMFIELD S, 1974, BRAIN RES, V69, P115, DOI 10.1016/0006-8993(74)90375-8; Bower J, 1997, BOOK GENESIS EXPLORI; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Bush PC, 1999, J NEUROPHYSIOL, V82, P1748, DOI 10.1152/jn.1999.82.4.1748; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; CANNON RC, 2007, IN PRESS NEUROINFORM; Cornelis H, 2003, NEUROCOMPUTING, V52-4, P227, DOI [10.1016/S0925-2312(02)00750-6, 10.1016/SO925-2312(02)00750-6]; CROOK S, 2007, IN PRESS NEUROINFORM; Davison AP, 2003, J NEUROPHYSIOL, V90, P1921, DOI 10.1152/jn.00623.2002; De Schutter E, 2005, TRENDS NEUROSCI, V28, P562, DOI 10.1016/j.tins.2005.08.002; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Diesmann M., 2002, NEST ENV NEURAL SYST, V58, P43; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Eberhard JP, 2006, NEUROCOMPUTING, V70, P327, DOI 10.1016/j.neucom.2006.01.028; Eccles JC, 1967, CEREBELLUM NEURONAL; Finkelstein A, 2004, COMPUTER, V37, P26, DOI 10.1109/MC.2004.1297236; Goddard NH, 2001, PHILOS T ROY SOC B, V356, P1209, DOI 10.1098/rstb.2001.0910; Hanson JE, 2004, J NEUROSCI, V24, P329, DOI 10.1523/JNEUROSCI.3937-03.2004; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Howell FW, 2000, NEUROCOMPUTING, V32, P1041, DOI 10.1016/S0925-2312(00)00277-0; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ito M, 1984, CEREBELLUM NEURAL CO; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kunec S, 2005, J NEUROPHYSIOL, V94, P70, DOI 10.1152/jn.00731.2004; Lloyd CM, 2004, PROG BIOPHYS MOL BIO, V85, P433, DOI 10.1016/j.pbiomolbio.2004.01.004; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Migliore M, 2006, J COMPUT NEUROSCI, V21, P119, DOI 10.1007/s10827-006-7949-5; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nicolelis MAL, 2002, CURR OPIN NEUROBIOL, V12, P602, DOI 10.1016/S0959-4388(02)00374-4; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Schweighofer N, 2000, P NATL ACAD SCI USA, V97, P10661, DOI 10.1073/pnas.97.19.10661; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sultan F, 1998, J COMP NEUROL, V393, P353; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; van Ooyen A, 2002, NETWORK-COMP NEURAL, V13, P311, DOI 10.1088/0954-898X/13/3/304; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Vos BP, 1999, J NEUROSCI, V19; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	72	124	124	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					219	235		10.1016/j.neuron.2007.03.025	http://dx.doi.org/10.1016/j.neuron.2007.03.025			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442244	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000246190600008
J	Finn, IM; Priebe, NJ; Ferster, D				Finn, Ian M.; Priebe, Nicholas J.; Ferster, David			The emergence of contrast-invariant orientation tuning in simple cells of cat visual cortex	NEURON			English	Article							CORTICAL SIMPLE CELLS; STRIATE CORTEX; RECEPTIVE-FIELDS; DIRECTION SELECTIVITY; SPATIOTEMPORAL ORGANIZATION; RESPONSE VARIABILITY; SYNAPTIC POTENTIALS; SPATIAL SUMMATION; SPIKE THRESHOLD; THALAMIC INPUT	Simple cells in primary visual cortex exhibit contrast-invariant orientation tuning, in seeming contradiction to feed-forward models that rely on lateral geniculate nucleus (LGN) input alone. Contrast invariance has therefore been thought to depend on the presence of intracortical lateral inhibition. In vivo intracellular recordings instead suggest that contrast invariance can be explained by three properties of the excitatory pathway. (1) Depolarizations evoked by orthogonal stimuli are determined by the amount of excitation a cell receives from the LGN, relative to the excitation it receives from other cortical cells. (2) Depolarizations evoked by preferred stimuli saturate at lower contrasts than the spike output of LGN relay cells. (3) Visual stimuli evoke contrast-dependent changes in trial-to-trial variability, which lead to contrast-dependent changes in the relationship between membrane potential and spike rate. Thus, high-contrast, orthogonally oriented stimuli that evoke significant depolarizations evoke few spikes. Together these mechanisms, without lateral inhibition, can account for contrast-invariant stimulus selectivity.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2205 Tech Dr, Evanston, IL 60208 USA.	ferster@northwestern.edu			NEI NIH HHS [R01 EY04726, R01 EY004726, R01 EY004726-23] Funding Source: Medline; NIMH NIH HHS [P20 MH066239-01A10003, P20 MH066239] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH066239] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Bannister NJ, 2002, PHILOS T R SOC B, V357, P1793, DOI 10.1098/rstb.2002.1160; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carandini M, 2002, J NEUROSCI, V22, P10053; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HARTLINE HK, 1949, FED PROC, V8, P69; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Li BW, 2006, J NEUROPHYSIOL, V96, P1755, DOI 10.1152/jn.00425.2006; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; McLaughlin D, 2003, J PHYSIOL-PARIS, V97, P237, DOI 10.1016/j.jphysparis.2003.09.019; MILLER KD, 1994, J NEUROSCI, V14, P409; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SOMPOLINSKY H, 1990, P NATL ACAD SCI USA, V87, P7200, DOI 10.1073/pnas.87.18.7200; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x	60	172	173	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					137	152		10.1016/j.neuron.2007.02.029	http://dx.doi.org/10.1016/j.neuron.2007.02.029			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408583	Bronze, Green Accepted			2022-12-24	WOS:000245848400015
J	Burr, D; Tozzi, A; Morrone, MC				Burr, David; Tozzi, Arianna; Morrone, M. Concetta			Neural mechanisms for timing visual events are spatially selective in real-world coordinates	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; PARIETAL CORTEX; TIME; NEURONS; REPRESENTATION; ADAPTATION; MACAQUE; SPACE	It is generally assumed that perceptual events are timed by a centralized supramodal clock. This study challenges this notion in humans by providing clear evidence that visual events of subsecond duration are timed by visual neural mechanisms with spatially circumscribed receptive fields, localized in real-world, rather than retinal, coordinates.	Univ Florence, Dept Psychol, Florence, Italy; Univ Western Australia, Nedlands, WA 6009, Australia; CNR, Ist Neurosci, I-56100 Pisa, Italy; Univ Vita & Salute San Rafaele, Fac Psicol, Milan, Italy	University of Florence; University of Western Australia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Vita-Salute San Raffaele University	Burr, D (corresponding author), Univ Florence, Dept Psychol, Via S Nicolo 89, Florence, Italy.	dave@in.cnr.it	Morrone, Maria Concetta/C-6756-2014	Morrone, Maria Concetta/0000-0002-1025-0316; Burr, David/0000-0003-1541-8832				BUETI D, 2006, J COGN NEUROSCI F, V58, P335; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; MORGAN MJ, 2006, J VIS, V6, P1012; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; THOMPSON P, 1981, VISION RES, V21, P337, DOI 10.1016/0042-6989(81)90161-9	15	177	180	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					423	425		10.1038/nn1874	http://dx.doi.org/10.1038/nn1874			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369824				2022-12-24	WOS:000245228600012
J	Christensen, MS; Lundbye-Jensen, J; Geertsen, SS; Petersen, TH; Paulson, OB; Nielsen, JB				Christensen, Mark Schram; Lundbye-Jensen, Jesper; Geertsen, Svend Sparre; Petersen, Tue Hvass; Paulson, Olaf B.; Nielsen, Jens Bo			Premotor cortex modulates somatosensory cortex during voluntary movements without proprioceptive feedback	NATURE NEUROSCIENCE			English	Article							PATHWAYS; SENSE	Movement perception relies on sensory feedback, but the involvement of efference copies remains unclear. We investigated movements without proprioceptive feedback using ischemic nerve block during fMRI in healthy humans, and found preserved activation of the primary somatosensory cortex. This activation was associated with increased interaction with premotor cortex during voluntary movements, which demonstrates that perception of movements relies in part on predictions of sensory consequences of voluntary movements that are mediated by the premotor cortex.	Univ Copenhagen, Panum Inst, Dept Exercise & Sport Sci, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Neurobiol Res Unit,Dept Neurol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Christensen, MS (corresponding author), Univ Copenhagen, Panum Inst, Dept Exercise & Sport Sci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	markc@drcmr.dk	Geertsen, Svend/L-8526-2014; Geertsen, Svend/ABG-6254-2020; Nielsen, Jens Bo/C-7632-2015; Paulson, Olaf B./N-6924-2016; Lundbye-Jensen, Jesper/ABH-4025-2020	Geertsen, Svend/0000-0003-4497-3616; Geertsen, Svend/0000-0003-4497-3616; Nielsen, Jens Bo/0000-0001-5568-2916; Paulson, Olaf B./0000-0001-7712-8596; Lundbye-Jensen, Jesper/0000-0003-3144-861X				Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blankenburg F, 2006, PLOS BIOL, V4, P459, DOI 10.1371/journal.pbio.0040069; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; COLE JD, 1991, ELECTROEN CLIN NEURO, V80, P103, DOI 10.1016/0168-5597(91)90147-P; Ellaway PH, 2004, J PHYSIOL-LONDON, V556, P651, DOI 10.1113/jphysiol.2003.060483; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; FORGET R, 1987, HUM NEUROBIOL, V6, P27; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; LASZLO JI, 1966, Q J EXP PSYCHOL, V18, P1, DOI 10.1080/14640746608400001; SINCLAIR DC, 1948, J NEUROPHYSIOL, V11, P75, DOI 10.1152/jn.1948.11.2.75; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; TAUB E, 1966, SCIENCE, V151, P593, DOI 10.1126/science.151.3710.593; VANHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464	14	134	137	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					417	419		10.1038/nn1873	http://dx.doi.org/10.1038/nn1873			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369825				2022-12-24	WOS:000245228600010
J	Daw, MI; Ashby, MC; Isaac, JTR				Daw, Michael I.; Ashby, Michael C.; Isaac, John T. R.			Coordinated developmental recruitment of latent fast spiking interneurons in layer IV barrel cortex	NATURE NEUROSCIENCE			English	Article							RAT SOMATOSENSORY CORTEX; THALAMOCORTICAL FEEDFORWARD INHIBITION; CRITICAL PERIOD; SYNAPTIC PLASTICITY; EXCITATORY ACTIONS; TRANSGENIC MICE; SILENT SYNAPSES; NEURONS; NEOCORTEX; GABA	Feedforward inhibitory GABAergic transmission is critical for mature cortical circuit function; in the neonate, however, GABA is depolarizing and believed to have a different role. Here we show that the GABA(A) receptor-mediated conductance is depolarizing in excitatory (stellate) cells in neonatal (postnatal day [P]3-5) layer IV barrel cortex, but GABAergic transmission at this age is not engaged by thalamocortical input in the feedforward circuit and has no detectable circuit function. However, recruitment occurs at P6-7 as a result of coordinated increases in thalamic drive to fast-spiking interneurons, fast-spiking interneuron-stellate cell connectivity and hyperpolarization of the GABA(A) receptor-mediated response. Thus, GABAergic circuits are not engaged by thalamocortical input in the neonate, but are poised for a remarkably coordinated development of feedforward inhibition at the end of the first postnatal week, which has profound effects on circuit function at this critical time in development.	Univ Bristol, Dept Anat, MRC, Ctr Synap Plast, Bristol BS8 1TD, Avon, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Isaac, JTR (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synap Plast, Bristol BS8 1TD, Avon, England.	isaacj@ninds.nih.gov		Daw, Michael/0000-0002-8374-5977; Ashby, Michael/0000-0002-8593-8473	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003011, ZIANS003011] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Agmon A, 1996, J NEUROSCI, V16, P4684; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; AKEMAN CJ, 2006, J NEUROSCI, V26, P5117; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Bannister NJ, 2005, J NEUROSCI, V25, P5259, DOI 10.1523/JNEUROSCI.0827-05.2005; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Beierlein M, 2002, J NEUROSCI, V22, P9885; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BURGARD EC, 1993, J NEUROPHYSIOL, V69, P230, DOI 10.1152/jn.1993.69.1.230; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Daw MI, 2006, J NEUROSCI, V26, P4178, DOI 10.1523/JNEUROSCI.0150-06.2006; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KELLER A, 1987, J COMP NEUROL, V262, P1, DOI 10.1002/cne.902620102; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; KIM HG, 1995, CEREB CORTEX, V5, P148, DOI 10.1093/cercor/5.2.148; KRIEGSTEIN AR, 1987, DEV BRAIN RES, V34, P161, DOI 10.1016/0165-3806(87)90206-9; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P201; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wells JE, 2000, J NEUROSCI, V20, P8822; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	47	133	134	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					453	461		10.1038/nn1866	http://dx.doi.org/10.1038/nn1866			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351636				2022-12-24	WOS:000245228600016
J	Jordan, BA; Fernholz, BD; Khatri, L; Ziff, EB				Jordan, Bryen A.; Fernholz, Brian D.; Khatri, Latika; Ziff, Edward B.			Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; PROTEOMIC ANALYSIS; LATE-PHASE; SYNAPTIC PLASTICITY; NMDA RECEPTORS; MESSENGER-RNA; DENTATE GYRUS; TRANSCRIPTION; ISOFORM; BINDING	Neuronal development, plasticity and survival require activity-dependent synapse-to-nucleus signaling. Most studies implicate an activity-dependent regulation of gene expression in this phenomenon. However, little is known about other nuclear functions that are regulated by synaptic activity. Here we show that a newly identified component of rat postsynaptic densities (PSDs), AIDA-1d, can regulate global protein synthesis by altering nucleolar numbers. AIDA-1d binds to the first two postsynaptic density-95/Discs large/zona occludens-1 (PDZ) domains of the scaffolding protein PSD-95 via its C-terminal three amino acids. Stimulation of NMDA receptors (NMDARs), which are also bound to PSD-95, results in a Ca2+-independent translocation of AIDA-1d to the nucleus, where it couples to Cajal bodies and induces Cajal body-nucleolar association. Long-term neuronal stimulation results in an AIDA-1-dependent increase in nucleolar numbers and protein synthesis. We propose that AIDA-1d mediates a link between synaptic activity and control of protein biosynthetic capacity by regulating nucleolar assembly.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA	New York University; New York University	Jordan, BA (corresponding author), NYU, Sch Med, Dept Biochem, 550 1St Ave, New York, NY 10016 USA.	jordab01@med.nyu.edu		Ziff, Edward/0000-0001-7389-8649; Jordan, Bryen/0000-0002-4967-444X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067229, K01MH073759] Funding Source: NIH RePORTER; NIMH NIH HHS [K01 MH073759-02, R01 MH67229] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cajal S. R., 1903, TRAB LAB INVEST BIOL, V2, P129, DOI DOI 10.1037/H0069505; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DUFFY C, 1981, SCIENCE, V212, P1148, DOI 10.1126/science.7233208; FAZELI MS, 1993, J NEUROSCI, V13, P1346; FREY S, 1991, BIOMED BIOCHIM ACTA, V50, P1231; Fu XY, 1999, ONCOGENE, V18, P4920, DOI 10.1038/sj.onc.1202874; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; HYSON RL, 1995, BRAIN RES, V672, P196, DOI 10.1016/0006-8993(94)01390-4; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jordan B.A., 2006, FRON NEUROS; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; LAFARGA M, 1995, ANAT EMBRYOL, V191, P359, DOI 10.1007/BF00534689; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Prieto JL, 2005, BIOCHEM SOC T, V33, P1441, DOI 10.1042/BST0331441; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Solovei I, 2004, CYTOGENET GENOME RES, V105, P302, DOI 10.1159/000078202; STEWARD O, 1986, J NEUROSCI, V6, P412; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Vickers CA, 2005, J PHYSIOL-LONDON, V568, P803, DOI 10.1113/jphysiol.2005.092924; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Xu HZ, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-23; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; Zatsepina O, 2003, DEV BIOL, V253, P66, DOI 10.1006/dbio.2002.0865	50	89	91	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					427	435		10.1038/nn1867	http://dx.doi.org/10.1038/nn1867			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17334360				2022-12-24	WOS:000245228600013
J	Hyngstrom, AS; Johnson, MD; Miller, JF; Heckman, CJ				Hyngstrom, Allison S.; Johnson, Michael D.; Miller, Jack F.; Heckman, C. J.			Intrinsic electrical properties of spinal motoneurons vary with joint angle	NATURE NEUROSCIENCE			English	Article							EFFECTIVE SYNAPTIC CURRENTS; TRICEPS SURAE MOTONEURONS; IN-VIVO; RECIPROCAL INHIBITION; SYSTEMATIC VARIATIONS; MEDIAL GASTROCNEMIUS; HINDLIMB MOTONEURONS; FICTIVE LOCOMOTION; DECEREBRATE CATS; INPUT	The dendrites of spinal motoneurons amplify synaptic inputs to a marked degree through persistent inward currents (PICs). Dendritic amplification is subject to neuromodulatory control from the brainstem by axons releasing the monoamines serotonin and norepinephrine; however, the monoaminergic projection to the cord is diffusely organized and does not allow independent adjustment of amplification in different motor pools. Using in vivo voltage-clamp techniques, here we show that dendritic PICs in ankle extensor motoneurons in the cat are reduced about 50% by small rotations (+/- 10 degrees) of the ankle joint. This reduction is primarily due to reciprocal inhibition, a tightly focused input shared only among strict muscle antagonists. These results demonstrate how a specific change in limb position can regulate intrinsic cellular properties set by a background of diffuse descending neuromodulation.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Heckman, CJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	c-heckman@northwestern.edu	Johnson, Mark/B-6921-2009	Heckman, CJ/0000-0002-1324-7278	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS048757] Funding Source: NIH RePORTER; NINDS NIH HHS [NS034282, 5F31NS048757-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alaburda A, 2002, ADV EXP MED BIOL, V508, P219; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2023, DOI 10.1152/jn.1998.80.4.2023; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2038, DOI 10.1152/jn.1998.80.4.2038; Binder MD, 1998, J NEUROPHYSIOL, V80, P241, DOI 10.1152/jn.1998.80.1.241; BINDER MD, 1981, SPINAL SUPRASPINAL M, V8, P72; Bjorklund AS, 1982, BRAIN STEM CONTROL S, P55; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; BROWNSTONE RM, 1994, EXP BRAIN RES, V102, P34; Carlin KP, 2000, EUR J NEUROSCI, V12, P1635, DOI 10.1046/j.1460-9568.2000.00055.x; Chen XY, 2006, J NEUROPHYSIOL, V96, P2144, DOI 10.1152/jn.00253.2006; Chen Y, 2005, J NEUROSCI, V25, P6898, DOI 10.1523/JNEUROSCI.1684-05.2005; CLELAND CL, 1990, J NEUROPHYSIOL, V64, P1303, DOI 10.1152/jn.1990.64.4.1303; CRONE C, 1987, J PHYSIOL-LONDON, V389, P163, DOI 10.1113/jphysiol.1987.sp016652; CULLHEIM S, 1987, J COMP NEUROL, V255, P82, DOI 10.1002/cne.902550107; Curtis DR, 1998, EXP BRAIN RES, V121, P319, DOI 10.1007/s002210050465; Cushing S, 2005, J NEUROPHYSIOL, V94, P3465, DOI 10.1152/jn.00439.2005; Fedirchuk B, 2004, J PHYSIOL-LONDON, V557, P355, DOI 10.1113/jphysiol.2004.064022; Fyffe REW, 2001, METH NE FRO NEUROSCI, P21; Hammar I, 2003, J NEUROSCI, V23, P332; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; HECKMAN CJ, 1988, J NEUROPHYSIOL, V60, P1946, DOI 10.1152/jn.1988.60.6.1946; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; HOUNSGAARD J, 1993, J PHYSIOL-LONDON, V468, P245, DOI 10.1113/jphysiol.1993.sp019769; Hultborn H, 2004, PROG BRAIN RES, V143, P77, DOI 10.1016/S0079-6123(03)43008-2; Hultborn H, 2003, J PHYSIOL-LONDON, V552, P945, DOI 10.1113/jphysiol.2003.050971; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Krawitz S, 2001, J PHYSIOL-LONDON, V532, P271, DOI 10.1111/j.1469-7793.2001.0271g.x; Kuo JJ, 2003, J NEUROPHYSIOL, V90, P3617, DOI 10.1152/jn.00521.2003; LABELLA LA, 1990, J NEUROPHYSIOL, V64, P403, DOI 10.1152/jn.1990.64.2.403; Lee RH, 2003, J NEUROPHYSIOL, V89, P27, DOI 10.1152/jn.00137.2002; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lee RH, 1996, J NEUROPHYSIOL, V76, P2107, DOI 10.1152/jn.1996.76.3.2107; Lee RH, 2000, J NEUROSCI, V20, P6734, DOI 10.1523/JNEUROSCI.20-17-06734.2000; Machacek DW, 2001, J PHYSIOL-LONDON, V537, P201, DOI 10.1111/j.1469-7793.2001.0201k.x; Matthews P. B. C., 1972, MONOGR PHYSL SOC, V23, P1; Nichols T. Richard, 1999, P255; NIELSEN J, 1995, EXP BRAIN RES, V104, P99; POWERS RK, 1993, J NEUROPHYSIOL, V70, P1460, DOI 10.1152/jn.1993.70.4.1460; Powers RK, 2001, REV PHYSIOL BIOCH P, V143, P137, DOI 10.1007/BFb0115594; ROSE PK, 1985, J COMP NEUROL, V239, P89, DOI 10.1002/cne.902390108; SHEFCHYK SJ, 1985, J NEUROPHYSIOL, V54, P1101, DOI 10.1152/jn.1985.54.5.1101; STEPHENS JA, 1975, J NEUROPHYSIOL, V38, P1217, DOI 10.1152/jn.1975.38.5.1217; Svirskis G, 1997, J NEUROPHYSIOL, V78, P1740, DOI 10.1152/jn.1997.78.3.1740; Svirskis G, 1998, J NEUROPHYSIOL, V79, P45, DOI 10.1152/jn.1998.79.1.45; Wargon I, 2006, EXP BRAIN RES, V168, P203, DOI 10.1007/s00221-005-0088-9	50	92	92	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					363	369		10.1038/nn1852	http://dx.doi.org/10.1038/nn1852			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293858				2022-12-24	WOS:000244480300019
J	Suto, F; Tsuboi, M; Kamiya, H; Mizuno, H; Kiyama, Y; Komai, S; Shimizu, M; Sanbo, M; Yagi, T; Hiromi, Y; Chedotal, A; Mitchell, KJ; Manabe, T; Fujisawa, H				Suto, Fumikazu; Tsuboi, Miu; Kamiya, Haruyuki; Mizuno, Hidenobu; Kiyama, Yuji; Komai, Shoji; Shimizu, Masayuki; Sanbo, Makoto; Yagi, Takeshi; Hiromi, Yasushi; Chedotal, Alain; Mitchell, Kevin J.; Manabe, Toshiya; Fujisawa, Hajime			Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers	NEURON			English	Article							LONG-TERM POTENTIATION; SECRETED SEMAPHORINS; DENTATE GYRUS; GUIDANCE; RECEPTORS; NEURONS; MICE; NEUROPILIN-2; GROWTH; TRANSMISSION	Hippocampal mossy fibers project preferentially to the stratum lucidum, the proximal-most lamina of the suprapyramidal region of CA3. The molecular mechanisms that govern this lamina-restricted projection are still unknown. We examined the projection pattern of mossy fibers in mutant mice for semaphorin receptors plexin-A2 and plexin-A4, and their ligand, the transmembrane semaphorin Sema6A. We found that plexin-A2 deficiency causes a shift of mossy fibers from the suprapyramidal region to the infra- and intrapyramidal regions, while plexin-A4 deficiency induces inappropriate spreading of mossy fibers within CA3. We also report that the plexin-A2 loss-of-function phenotype is genetically suppressed by Sema-6A loss of function. Based on these results, we propose a model for the lamina-restricted projection of mossy fibers: the expression of plexinA4 on mossy fibers prevents them from entering the Sema6A-expressing suprapyramidal region of CA3 and restricts them to the proximal-most part, where Sema6A repulsive activity is attenuated by plexin-A2.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, 21st Century COE Program, Nagoya, Aichi 4648602, Japan; Natl Inst Genet, Div Dev Genet, Mishima, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Grp Dev Neurobiol, Nagoya, Aichi 4648602, Japan; Hokkaido Univ, Grad Sch Med, Dept Mol Neuroanat, Sapporo, Hokkaido 0608637, Japan; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Neuronal Network, Tokyo 1088639, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kumamoto Univ, Div Cellular Interact, Inst Embryol & Genet, Kumamoto 8600811, Japan; Natl Inst Physiol Sci, Lab Neurobiol & Behav Genet, Okazaki, Aichi 4448585, Japan; Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; Univ Paris 06, CNRS, UMR 7102, F-75005 Paris, France; Trinity Coll Dublin, Smufit Inst Genet, Dublin 2, Ireland	Nagoya University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST); Nagoya University; Hokkaido University; University of Tokyo; Nara Institute of Science & Technology; Kumamoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka University; Graduate University for Advanced Studies - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Trinity College Dublin	Fujisawa, H (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, 21st Century COE Program, Nagoya, Aichi 4648602, Japan.	fujisawa@bio.nagoya-u.ac.jp	Komai, Shoji/L-9273-2018; Chedotal, Alain/F-2750-2017; Kamiya, Haruyuki/E-7199-2010	Komai, Shoji/0000-0002-8474-7800; Chedotal, Alain/0000-0001-7577-3794; Kamiya, Haruyuki/0000-0002-2618-3146; Mitchell, Kevin/0000-0002-3433-4530				Amaral David G., 1995, P443; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goslin K., 1998, CULTURING NERVE CELL, P339; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mizuhashi S, 2001, J NEUROSCI, V21, P6181, DOI 10.1523/JNEUROSCI.21-16-06181.2001; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pozas E, 2001, MOL CELL NEUROSCI, V18, P26, DOI 10.1006/mcne.2001.0999; Sahay A, 2003, J NEUROSCI, V23, P6671; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Skutella T, 2001, TRENDS NEUROSCI, V24, P107, DOI 10.1016/S0166-2236(00)01717-3; Stein E, 1999, J NEUROSCI, V19, P8885, DOI 10.1523/JNEUROSCI.19-20-08885.1999; Steup A, 1999, EUR J NEUROSCI, V11, P729, DOI 10.1046/j.1460-9568.1999.00517.x; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhao ST, 2003, J NEUROSCI, V23, P7351; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	40	148	157	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					535	547		10.1016/j.neuron.2007.01.028	http://dx.doi.org/10.1016/j.neuron.2007.01.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296555	Bronze			2022-12-24	WOS:000245126900012
J	Johnston, K; Levin, HM; Koval, MJ; Everling, S				Johnston, Kevin; Levin, Helen M.; Koval, Michael J.; Everling, Stefan			Top-down control-signal dynamics in anterior cingulate and prefrontal cortex neurons following task switching	NEURON			English	Article							ANTI-SACCADES; CONFLICT; PERFORMANCE; LESIONS; MONKEY; ATTENTION; RESPONSES; CELLS; MODEL; RULE	The prefrontal cortex (PFC) and anterior cingulate cortex (ACC) have both been implicated in cognitive control, but their relative roles remain unclear. Here we recorded the activity of single neurons in both areas while monkeys performed a task that required them to switch between trials in which they had to look toward a flashed stimulus (prosaccades) and trials in which they had to look away from the stimulus (antisaccades). We found that ACC neurons had a higher level of task selectivity than PFC neurons during the preparatory period on trials immediately following a task switch. In ACC neurons, task selectivity was strongest after the task switch and declined throughout the task block, whereas task selectivity remained constant in the PFC. These results demonstrate that the ACC is recruited when cognitive demands increase and suggest a role for both areas in task maintenance and the implementation of top-down control.	John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; Univ Western Ontario, Grad Program Neurosci, London, ON N6G 2V4, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Everling, S (corresponding author), John P Robarts Res Inst, POB 5015, London, ON N6A 5K8, Canada.	severlin@uwo.ca	Everling, Stefan/K-5208-2013; Everling, Stefan/AAR-8687-2020	Everling, Stefan/0000-0001-9714-9757; Johnston, Kevin/0000-0001-9481-6251				ALLPORT A, 1994, SHIFTING INT SET EXP, P421; Amador N, 2004, J NEUROPHYSIOL, V91, P1672, DOI 10.1152/jn.00138.2003; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Condy C, 2007, CEREB CORTEX, V17, P221, DOI 10.1093/cercor/bhj140; DeSouza JFX, 2004, J NEUROPHYSIOL, V91, P855, DOI 10.1152/jn.00273.2003; Dias R, 1996, BEHAV NEUROSCI, V110, P872, DOI 10.1037/0735-7044.110.5.872; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 2005, J COGNITIVE NEUROSCI, V17, P1483, DOI 10.1162/0898929054985455; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Gaymard B, 2003, ANN NEUROL, V53, P542, DOI 10.1002/ana.10560; Gaymard B, 1998, EXP BRAIN RES, V120, P173, DOI 10.1007/s002210050391; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Johnston K, 2006, J NEUROSCI, V26, P12471, DOI 10.1523/JNEUROSCI.4101-06.2006; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LEICHNETZ GR, 1981, NEUROSCIENCE, V6, P1023, DOI 10.1016/0306-4522(81)90068-3; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Luks TL, 2004, NEUROIMAGE, V22, P1515, DOI 10.1016/j.neuroimage.2004.04.008; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Sohn MH, 2001, J EXP PSYCHOL GEN, V130, P764, DOI 10.1037//0096-3445.130.4.764; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wang Y, 2004, NEUROREPORT, V15, P1559, DOI 10.1097/01.wnr.0000133300.62031.9b; Wiese H, 2004, NEUROSCI LETT, V371, P220, DOI 10.1016/j.neulet.2004.08.078; Woodward TS, 2006, BRAIN RES, V1068, P161, DOI 10.1016/j.brainres.2005.10.094; Wylie GR, 2004, HUM BRAIN MAPP, V21, P279, DOI 10.1002/hbm.20003; Yeung N, 2003, J EXP PSYCHOL HUMAN, V29, P455, DOI 10.1037/0096-1523.29.2.455	49	204	206	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					453	462		10.1016/j.neuron.2006.12.023	http://dx.doi.org/10.1016/j.neuron.2006.12.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270740	Bronze			2022-12-24	WOS:000245126800014
J	Russell, IJ; Legan, PK; Lukashkina, VA; Lukashkin, AN; Goodyear, RJ; Richardson, GP				Russell, Ian J.; Legan, P. Kevin; Lukashkina, Victoria A.; Lukashkin, Andrei N.; Goodyear, Richard J.; Richardson, Guy P.			Sharpened cochlear tuning in a mouse with a genetically modified tectorial membrane	NATURE NEUROSCIENCE			English	Article							INNER-EAR; DISTORTION-PRODUCT; FREQUENCY MAP; HAIR-CELLS; RESPONSES; ORGAN; CORTI; STIMULATION; BEHAVIOR; DEAFNESS	Frequency tuning in the cochlea is determined by the passive mechanical properties of the basilar membrane and active feedback from the outer hair cells, sensory- effector cells that detect and amplify sound- induced basilar membrane motions. The sensory hair bundles of the outer hair cells are imbedded in the tectorial membrane, a sheet of extracellular matrix that overlies the cochlea's sensory epithelium. The tectorial membrane contains radially organized collagen fibrils that are imbedded in an unusual striated- sheet matrix formed by two glycoproteins, alpha-tectorin ( Tecta) and beta-tectorin ( Tectb). In Tectb(-/-) mice the structure of the striated- sheet matrix is disrupted. Although these mice have a low- frequency hearing loss, basilar- membrane and neural tuning are both significantly enhanced in the high-frequency regions of the cochlea, with little loss in sensitivity. These findings can be attributed to a reduction in the acting mass of the tectorial membrane and reveal a new function for this structure in controlling interactions along the cochlea.	Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Russell, IJ (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	I.J.Russell@sussex.ac.uk; G.P.Richardson@sussex.ac.uk	Lukashkin, Andrei N/N-1447-2017	Lukashkin, Andrei N/0000-0003-4577-8716; Russell, Ian/0000-0002-4915-2772; Lukashkina, Victoria/0000-0002-9154-8746; Legan, P. Kevin/0000-0002-7403-6415	MRC [G0301057] Funding Source: UKRI; Medical Research Council [G0801693, G0301057] Funding Source: Medline; Wellcome Trust [071394] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALLEN JB, 1993, J ACOUST SOC AM, V94, P809, DOI 10.1121/1.408182; ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; BONFILS P, 1986, HEARING RES, V24, P277, DOI 10.1016/0378-5955(86)90026-2; BROWN AM, 1992, P ROY SOC B-BIOL SCI, V250, P29, DOI 10.1098/rspb.1992.0126; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; CRANE HD, 1982, J ACOUST SOC AM, V72, P93, DOI 10.1121/1.388029; Dallos P, 2003, JARO-J ASSOC RES OTO, V4, P416, DOI 10.1007/s10162-002-3049-z; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; Dallos P., 1996, COCHLEA, P1; EHRET G, 1984, HEARING RES, V14, P45, DOI 10.1016/0378-5955(84)90068-6; Freeman DM, 2003, HEARING RES, V180, P11, DOI 10.1016/S0378-5955(03)00072-8; Freeman DM, 2003, HEARING RES, V180, P1, DOI 10.1016/S0378-5955(03)00073-X; Fridberger A, 2006, P NATL ACAD SCI USA, V103, P1918, DOI 10.1073/pnas.0507231103; GASKILL SA, 1990, J ACOUST SOC AM, V88, P821, DOI 10.1121/1.399732; Geisler C. D., 1998, SOUND SYNAPSE; GOODYEAR R, 1992, J COMP NEUROL, V325, P243, DOI 10.1002/cne.903250208; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; HASKO JA, 1988, HEARING RES, V35, P21, DOI 10.1016/0378-5955(88)90037-8; Hemmert W, 2000, BIOPHYS J, V78, P2285, DOI 10.1016/S0006-3495(00)76775-0; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Knipper M, 2001, J BIOL CHEM, V276, P39046, DOI 10.1074/jbc.M103385200; KOSSL M, 1995, P NATL ACAD SCI USA, V92, P276, DOI 10.1073/pnas.92.1.276; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lukashkin AN, 2005, J NEUROSCI METH, V148, P122, DOI 10.1016/j.jneumeth.2005.04.014; LUKASHKIN AN, IN PRESS J ACOUST SO; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Naidu RC, 1998, HEARING RES, V124, P124, DOI 10.1016/S0378-5955(98)00133-6; Nowotny M, 2006, P NATL ACAD SCI USA, V103, P2120, DOI 10.1073/pnas.0511125103; Rau A, 1999, J COMP NEUROL, V405, P271; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Rueda J, 1996, ANAT EMBRYOL, V194, P501; Russell IJ, 1999, J NEUROPHYSIOL, V82, P676, DOI 10.1152/jn.1999.82.2.676; SELLICK PM, 1980, HEARING RES, V2, P439, DOI 10.1016/0378-5955(80)90080-5; Shera CA, 2004, EAR HEARING, V25, P86, DOI 10.1097/01.AUD.0000121200.90211.83; Shera CA, 2003, J ACOUST SOC AM, V114, P244, DOI 10.1121/1.1575750; Shoelson B, 2004, BIOPHYS J, V87, P2768, DOI 10.1529/biophysj.104.040774; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Steele CR, 2005, INT J SOLIDS STRUCT, V42, P5887, DOI 10.1016/j.ijsolstr.2005.03.056; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; von Bekesy G, 1960, EXPT HEARING; ZWISLOCKI J, 2002, AUDITORY SOUND TRANS; ZWISLOCKI JJ, 1980, HEARING RES, V2, P171, DOI 10.1016/0378-5955(80)90055-6; ZWISLOCKI JJ, 1986, HEARING RES, V22, P155, DOI 10.1016/0378-5955(86)90091-2; ZWISLOCKI JJ, 1989, HEARING RES, V42, P211, DOI 10.1016/0378-5955(89)90146-9	49	138	142	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					215	223		10.1038/nn1828	http://dx.doi.org/10.1038/nn1828			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220887	Green Accepted			2022-12-24	WOS:000244175200016
J	Xu, W; Wong, TP; Chery, N; Gaertner, T; Wang, YT; Baudry, M				Xu, Wei; Wong, Tak Pan; Chery, Nadege; Gaertner, Tara; Wang, Yu Tian; Baudry, Michel			Calpain-mediated mGluR1 alpha truncation: A key step in excitotoxicity	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; OXIDATIVE STRESS; NEURONAL APOPTOSIS; CELL-DEATH; ACTIVATION; PROTEINS; INJURY; GLUTAMATE-RECEPTOR-1; NEUROPROTECTION; INHIBITION	Excitotoxicity mediated by glutamate receptors plays crucial roles in ischemia and other neurodegenerative diseases. Whereas overactivation of ionotropic glutamate receptors is neurotoxic, the role of metabotropic glutamate receptors (mGluRs), and especially mGluR1, remains equivocal. Here we report that activation of NMDA receptors results in calpain-mediated truncation of the C-terminal domain of mGluR1 alpha at Ser(936). The truncated mGluR1 alpha maintains its ability to increase cytosolic calcium while it no longer activates the neuroprotective PI3K-Akt signaling pathways. Full-length and truncated forms of mGluR1 alpha play distinct roles in excitotoxic neuronal degeneration in cultured neurons. A fusion peptide derived from the calpain cleavage site of mGluR1 alpha efficiently blocks NMDA-incluced truncation of mGluR1 alpha in primary neuronal cultures and exhibits neuroprotection against excitotoxicity both in vitro and in vivo. These findings shed light on the relationship between NMDA and mGluR1 a and indicate the existence of a positive feedback regulation in excitotoxicity involving calpain and mGluR1 alpha.	Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of Southern California; University of British Columbia	Baudry, M (corresponding author), Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA.	baudry@usc.edu	Wang, Yu Tian/J-8255-2015	Wong, Tak Pan/0000-0001-8611-4911; xu, wei/0000-0003-0987-2481	NINDS NIH HHS [NS048521-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048521] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Baskys A, 2005, NEUROPHARMACOLOGY, V49, P146, DOI 10.1016/j.neuropharm.2005.04.029; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; Blaabjerg M, 2003, EXP NEUROL, V183, P573, DOI 10.1016/S0014-4886(03)00204-8; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; Calo L, 2005, J NEUROSCI, V25, P2245, DOI 10.1523/JNEUROSCI.4956-04.2005; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P107, DOI 10.2174/156720206776875830; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Herrero I, 1998, J BIOL CHEM, V273, P1951, DOI 10.1074/jbc.273.4.1951; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Holcik M, 2000, P NATL ACAD SCI USA, V97, P2286, DOI 10.1073/pnas.040469797; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kitano J, 2003, J BIOL CHEM, V278, P25101, DOI 10.1074/jbc.M303266200; KOH JY, 1991, P NATL ACAD SCI USA, V88, P9431, DOI 10.1073/pnas.88.21.9431; Lan JY, 2001, J NEUROSCI, V21, P6058, DOI 10.1523/JNEUROSCI.21-16-06058.2001; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Moroni F, 1998, EUR J PHARMACOL, V347, P189, DOI 10.1016/S0014-2999(98)00124-1; Newcomb JK, 2000, METH MOL B, V144, P219; Pellegrini-Giampietro DE, 2003, TRENDS PHARMACOL SCI, V24, P461, DOI 10.1016/S0165-6147(03)00231-1; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Sagara Y, 1998, J NEUROSCI, V18, P6662; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Scholzke MN, 2003, EUR J NEUROSCI, V18, P3305, DOI 10.1111/j.1460-9568.2003.03079.x; Schroder UH, 1999, NEUROPHARMACOLOGY, V38, P209, DOI 10.1016/S0028-3908(98)00180-4; SILIPRANDI R, 1992, EUR J PHARMACOL, V219, P173, DOI 10.1016/0014-2999(92)90598-X; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vincent AM, 2000, EXP NEUROL, V166, P65, DOI 10.1006/exnr.2000.7487; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Zhu PM, 2004, J NEUROSCI RES, V77, P525, DOI 10.1002/jnr.20175	42	131	135	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					399	412		10.1016/j.neuron.2006.12.020	http://dx.doi.org/10.1016/j.neuron.2006.12.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270736	Bronze			2022-12-24	WOS:000245126800010
J	Zolles, G; Klocker, N; Wenzel, D; Weisser-Thomas, J; Fleischmann, BK; Roeper, J; Fakler, B				Zolles, Gerd; Kloecker, Nikolaj; Wenzel, Daniela; Weisser-Thomas, Jutta; Fleischmann, Bernd K.; Roeper, Jochen; Fakler, Bernd			Pacemaking by HCN channels requires interaction with phosphoinositides	NEURON			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNELS; RABBIT SINOATRIAL NODE; RECTIFIER K+ CHANNELS; VENTRICULAR MYOCYTES; CATION CHANNELS; DENDRITIC I(H); ATP CHANNELS; CELLS; MODULATION; NEURONS	Hyperpolarization-activated, cyclic-nucleotide-gated (HCN) channels mediate the depolarizing cation current (termed I-h or If) that initiates spontaneous rhythmic activity in heart and brain. This function critically depends on the reliable opening of HCN channels in the subthreshold voltage-range. Here we show that activation of HCN channels at physiologically relevant voltages requires interaction with phosphoinositides such as phosphatidylinositol-4,5-bisphosphate (PIP2). PIP2 acts as a ligand that allosterically opens HCN channels by shifting voltage-dependent channel activation similar to 20 mV toward depolarized potentials. Allosteric gating by PIP2 occurs in all HCN subtypes and is independent of the action of cyclic nucleotides. In CNS neurons and cardiomyocytes, enzymatic degradation of phospholipids results in reduced channel activation and slowing of the spontaneous firing rate. These results demonstrate that gating by phospholipids is essential for the pacemaking activity of HCN channels in cardiac and neuronal rhythmogenesis.	Univ Marburg, Inst Physiol, Div Neurophysiol, D-35037 Marburg, Germany; Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Univ Bonn, Inst Physiol, Life & Brain Ctr, D-53105 Bonn, Germany	Philipps University Marburg; University of Freiburg; University of Bonn	Roeper, J (corresponding author), Univ Marburg, Inst Physiol, Div Neurophysiol, Deutschhausstr 1-2, D-35037 Marburg, Germany.	roeper@mailer.uni-marburg.de; bernd.fakler@physiologie.uni-freiburg.de	Wenzel, Daniela/B-7613-2014	Wenzel, Daniela/0000-0003-1100-6363; Roeper, Jochen/0000-0003-2145-8742				Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Cerbai E, 1999, CARDIOVASC RES, V42, P416, DOI 10.1016/S0008-6363(99)00037-1; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fleischmann BK, 2004, J CLIN INVEST, V114, P994, DOI 10.1172/JCI200415925; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Qu JH, 2001, CIRC RES, V89, pE8, DOI 10.1161/hh1301.094395; Robinson RB, 1997, PFLUG ARCH EUR J PHY, V433, P533, DOI 10.1007/s004240050309; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Woscholski R, 1995, J BIOL CHEM, V270, P31001, DOI 10.1074/jbc.270.52.31001; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	43	122	126	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1027	1036		10.1016/j.neuron.2006.12.005	http://dx.doi.org/10.1016/j.neuron.2006.12.005			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178405	Bronze			2022-12-24	WOS:000243115100010
J	Darrow, KN; Maison, SF; Liberman, MC				Darrow, Keith N.; Maison, Stephane F.; Liberman, M. Charles			Cochlear efferent feedback balances interaural sensitivity	NATURE NEUROSCIENCE			English	Article							BRAIN-STEM; OLIVOCOCHLEAR; PATHWAYS; SYSTEM; CAT	Neurons in the lateral superior olive (LSO) compute sound location based on differences in interaural intensity, coded in ascending signals from the two cochleas. Unilateral destruction of the neuronal feedback from the LSO to the cochlea, the lateral olivocochlear efferents, disrupted the normal interaural correlation in response amplitudes to sounds of equal intensity. Thus, lateral olivocochlear feedback maintains the binaural balance in neural excitability required for accurate localization of sounds in space.	Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; Harvard & MIT, Program Speech & Hearing Biosci & Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard University; Harvard Medical School	Liberman, MC (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, 243 Charles St, Boston, MA 02114 USA.	Charles_Liberman@meei.harvard.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000038, P30DC005209, R01DC000188] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC000188, P30 DC005209, T32 DC000038, P30 DC5209, R01 DC0188, T32 DC0038] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BROWN MC, 1993, J COMP NEUROL, V337, P600, DOI 10.1002/cne.903370406; CHEN QC, 1995, J EXP BIOL, V198, P2007; EHRET G, 1984, J EXP BIOL, V109, P163; Groff JA, 2003, J NEUROPHYSIOL, V90, P3178, DOI 10.1152/jn.00537.2003; GUINAN JJ, 1996, SPRINGER VERLAG HDB, V8; Le Prell CG, 2003, JARO-J ASSOC RES OTO, V4, P276, DOI 10.1007/s10162-002-3018-6; LU SM, 1987, HEARING RES, V31, P137, DOI 10.1016/0378-5955(87)90119-5; May BJ, 2004, ARCH OTOLARYNGOL, V130, P660, DOI 10.1001/archotol.130.5.660; Melcher JR, 1996, HEARING RES, V93, P1, DOI 10.1016/0378-5955(95)00178-6; Mills DM, 2003, J ACOUST SOC AM, V113, P914, DOI 10.1121/1.1535942; SCHARF B, 1994, HEARING RES, V75, P11, DOI 10.1016/0378-5955(94)90051-5; SCHOFIELD BR, 1994, J COMP NEUROL, V344, P83, DOI 10.1002/cne.903440107; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Warr WB, 1997, HEARING RES, V108, P89, DOI 10.1016/S0378-5955(97)00044-0	14	105	105	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1474	1476		10.1038/nn1807	http://dx.doi.org/10.1038/nn1807			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115038	Green Accepted			2022-12-24	WOS:000242404000009
J	Mumm, JS; Williams, PR; Godinho, L; Koerber, A; Pittman, AJ; Roeser, T; Chien, CB; Baier, H; Wong, ROL				Mumm, Jeff S.; Williams, Philip R.; Godinho, Leanne; Koerber, Amy; Pittman, Andrew J.; Roeser, Tobias; Chien, Chi-Bin; Baier, Herwig; Wong, Rachel O. L.			In vivo imaging reveals dendritic targeting of laminated afferents by zebrafish retinal ganglion cells	NEURON			English	Article							GROWTH CONE; DIFFERENTIATION; STRATIFICATION; PATHWAYS; DYNAMICS; AXONS; SPECIFICITY; MATURATION; RESPONSES; CIRCUITS	Targeting of axons and dendrites to particular synaptic laminae is an important mechanism by which precise patterns of neuronal connectivity are established. Although axons target specific laminae during development, dendritic lamination has been thought to occur largely by pruning of inappropriately placed arbors. We discovered by in vivo time-lapse imaging that retinal ganglion cell (RGC) dendrites in zebrafish show growth patterns implicating dendritic targeting as a mechanism for contacting appropriate synaptic partners. Populations of RGCs labeled in transgenic animals establish distinct dendritic strata sequentially, predominantly from the inner to outer retina. Imaging individual cells over successive days confirmed that multistratified RGCs generate strata sequentially, each arbor elaborating within a specific lamina. Simultaneous imaging of RGCs and subpopulations of presynaptic amacrine interneurons revealed that RGC dendrites appear to target amacrine plexuses that had already laminated. Dendritic targeting of prepatterned afferents may thus be a novel mechanism for establishing proper synaptic connectivity.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Inst Brain, Salt Lake City, UT 84112 USA; Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Physiol, Dept Genet & Dev Biol, San Francisco, CA 94158 USA	Washington University (WUSTL); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mumm, JS (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	jeff@luminomics.com; wongr2@u.washington.edu	Mumm, Jeff S/F-3125-2013	Mumm, Jeff/0000-0002-2575-287X	NEI NIH HHS [EY14358, R01 EY014358, EY12873, EY13855, R01 EY012873, F32 EY014084, EY12406, R01 EY013855, R01 EY012406] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012873, R01EY014358, F32EY014084, R01EY013855, R01EY012406] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bansal A, 2000, J NEUROSCI, V20, P7672; Bodnarenko SR, 1999, NEUROREPORT, V10, P2955, DOI 10.1097/00001756-199909290-00015; BODNARENKO SR, 1995, J NEUROSCI, V15, P7037; BURRILL JD, 1995, J NEUROSCI, V15, P2935; Chalupa LM, 2004, PROG RETIN EYE RES, V23, P31, DOI 10.1016/j.preteyeres.2003.10.001; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; DANN JF, 1988, J NEUROSCI, V8, P1485; Easter SS, 1996, DEV BIOL, V180, P646; Easter SS, 1997, DEV PSYCHOBIOL, V31, P267, DOI 10.1002/(SICI)1098-2302(199712)31:4<267::AID-DEV4>3.0.CO;2-P; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Lin JW, 2004, DEV BIOL, V274, P490, DOI 10.1016/j.ydbio.2004.07.002; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; LOHMANN C, 2005, IMAGING NEUROSCIENCE, P171; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mangrum WI, 2002, VISUAL NEUROSCI, V19, P767, DOI 10.1017/S0952523802196076; MASLIM J, 1986, J COMP NEUROL, V254, P382, DOI 10.1002/cne.902540310; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Miller B, 2001, J COMP NEUROL, V436, P17; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P271, DOI 10.1007/BF00522528; Mumm JS, 2005, PROG BRAIN RES, V147, P155, DOI 10.1016/S0079-6123(04)47012-5; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Ozaki S, 1997, J COMP NEUROL, V380, P215; Peterson RE, 2001, J COMP NEUROL, V429, P530, DOI 10.1002/1096-9861(20010122)429:4<530::AID-CNE2>3.0.CO;2-C; Rajan I, 1998, J NEUROSCI, V18, P7836; RAMOA AS, 1988, J NEUROSCI, V8, P4239; Ramon y Cajal S, 1972, STRUCTURE RETINA; Reese BE, 2001, VISUAL NEUROSCI, V18, P559, DOI 10.1017/S0952523801184063; Ren JQ, 2002, VISION RES, V42, P293, DOI 10.1016/S0042-6989(01)00284-X; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; VAUGHN JE, 1988, SYNAPSE, V2, P69, DOI 10.1002/syn.890020110; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1999, J NEUROSCI, V19, P4472; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Xu HP, 2004, NEUROSCIENTIST, V10, P337, DOI 10.1177/1073858404265254; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	62	121	124	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					609	621		10.1016/j.neuron.2006.10.004	http://dx.doi.org/10.1016/j.neuron.2006.10.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114046	Bronze, Green Accepted			2022-12-24	WOS:000242413100009
J	Ward, B; McGuinness, L; Akerman, CJ; Fine, A; Bliss, TVP; Emptage, NJ				Ward, Bonnie; McGuinness, Lindsay; Akerman, Colin J.; Fine, Alan; Bliss, Tim V. P.; Emptage, Nigel J.			State-dependent mechanisms of LTP expression revealed by optical quantal analysis	NEURON			English	Article							LONG-TERM POTENTIATION; SILENT SYNAPSES; NEUROTRANSMITTER RELEASE; AMPA RECEPTORS; POSTSYNAPTIC EXPRESSION; PRESYNAPTIC COMPONENT; NEUROTROPHIC FACTOR; CALCIUM TRANSIENTS; MEMBRANE-PROTEIN; DENDRITIC SPINES	The expression mechanism of long-term potentiation (LTP) remains controversial. Here we combine electrophysiology and Ca2+ imaging to examine the role of silent synapses in LTP expression. Induction of LTP fails to change p(r) at these synapses but instead mediates an unmasking process that is sensitive to the inhibition of postsynaptic membrane fusion. Once unmasked, however, further potentiation of formerly silent synapses leads to an increase in p(r). The state of the synapse thus determines how LTP is expressed.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Natl Inst Med Res, MRC, Div Neurophysiol, London NW7 1AA, England; Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	University of Oxford; MRC National Institute for Medical Research; Dalhousie University	Emptage, NJ (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	nigel.emptage@pharm.ox.ac.uk	Fine, Alan/P-5936-2014	Fine, Alan/0000-0002-4960-6973	Medical Research Council [MC_U117512674, G0501572] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0501572, MC_U117512674] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Arancio O, 1996, J PHYSIOLOGY-PARIS, V90, P321, DOI 10.1016/S0928-4257(97)87907-7; ARCHER BT, 1990, J BIOL CHEM, V265, P17267; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Broutman G, 2001, J NEUROSCI, V21, P27, DOI 10.1523/JNEUROSCI.21-01-00027.2001; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P283; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Isaac JTR, 2003, NEUROPHARMACOLOGY, V45, P450, DOI 10.1016/S0028-3908(03)00229-6; Isaac JTR, 1999, CAN J PHYSIOL PHARM, V77, P735, DOI 10.1139/cjpp-77-9-735; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kauer JS, 1998, CURR BIOL, V8, pR282, DOI 10.1016/S0960-9822(98)70173-3; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kullmann DM, 2003, PHILOS T R SOC B, V358, P727, DOI 10.1098/rstb.2002.1229; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Li YX, 1998, J NEUROSCI, V18, P10231; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6814; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCLAUGHLIN A, 1978, BIOCHIM BIOPHYS ACTA, V513, P338, DOI 10.1016/0005-2736(78)90203-1; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; PORTIS A, 1979, BIOCHEMISTRY-US, V18, P780, DOI 10.1021/bi00572a007; Pothos EN, 1998, J NEUROSCI, V18, P5575; Reid CA, 2004, J NEUROSCI, V24, P3618, DOI 10.1523/JNEUROSCI.3567-03.2004; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Rumpel S, 1998, J NEUROSCI, V18, P8863; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stoop R, 1996, J NEUROSCI, V16, P3256; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wang S, 1999, CAN J PHYSIOL PHARM, V77, P651, DOI 10.1139/cjpp-77-9-651; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	74	46	47	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					649	661		10.1016/j.neuron.2006.10.007	http://dx.doi.org/10.1016/j.neuron.2006.10.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114049	Bronze			2022-12-24	WOS:000242413100012
J	Yang, L; Bashaw, GJ				Yang, Long; Bashaw, Greg J.			Son of sevenless directly links the robo receptor to Rac activation to control axon repulsion at the midline	NEURON			English	Article							GROWTH CONE GUIDANCE; ROUNDABOUT RECEPTOR; TYROSINE KINASE; RHO GTPASES; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; CNS MIDLINE; R-RAS; SLIT; PROTEIN	Son of sevenless (Sos) is a dual specificity guanine nucleotide exchange factor (GEF) that regulates both Ras and Rho family GTPases and thus is uniquely poised to integrate signals that affect both gene expression and cytoskeletal reorganization. Here, using genetics, biochemistry, and cell biology, we demonstrate that Sos is recruited to the plasma membrane, where it forms a ternary complex with the Roundabout receptor and the SH3-SH2 adaptor protein Dreadlocks (Dock) to regulate Rac-dependent cytoskeletal rearrangement in response to the Slit ligand. Intriguingly, the Ras and Rac-GEF activities of Sos can be uncoupled during Robo-mediated axon repulsion; Sos axon guidance function depends on its Rac-GEF activity, but not its Ras-GEF activity. These results provide in vivo evidence that the Ras and RhoGEF domains of Sos are separable signaling modules and support a model in which Robo recruits Sos to the membrane via Dock to activate Rac during midline repulsion.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 421 Curie Blvd, Philadelphia, PA 19104 USA.	gbashaw@mail.med.upenn.edu			NINDS NIH HHS [NS046333, R01 NS046333] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS046333, R01NS046333] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Englund C, 2002, DEVELOPMENT, V129, P4941; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; HU QJ, 1995, MOL CELL BIOL, V15, P1169; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; Matsuura R, 2004, EUR J NEUROSCI, V19, P21, DOI 10.1046/j.1460-9568.2003.03084.x; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; NIMNUAL A, 2002, SCI STKE, pPE36, DOI DOI 10.1126/STKE.2002.145; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okada S, 1996, J BIOL CHEM, V271, P25533, DOI 10.1074/jbc.271.41.25533; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Silver SJ, 2004, GENESIS, V39, P263, DOI 10.1002/gene.20054; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	47	78	80	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					595	607		10.1016/j.neuron.2006.09.039	http://dx.doi.org/10.1016/j.neuron.2006.09.039			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114045	Bronze			2022-12-24	WOS:000242413100008
J	Ma, WJ; Beck, JM; Latham, PE; Pouget, A				Ma, Wei Ji; Beck, Jeffrey M.; Latham, Peter E.; Pouget, Alexandre			Bayesian inference with probabilistic population codes	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; INTEGRATION; NEURONS; INFORMATION; RESPONSES; CORTEX; REPRESENTATION; COMPUTATION; DECISION; NOISE	Recent psychophysical experiments indicate that humans perform near-optimal Bayesian inference in a wide variety of tasks, ranging from cue integration to decision making to motor control. This implies that neurons both represent probability distributions and combine those distributions according to a close approximation to Bayes' rule. At first sight, it would seem that the high variability in the responses of cortical neurons would make it difficult to implement such optimal statistical inference in cortical circuits. We argue that, in fact, this variability implies that populations of neurons automatically represent probability distributions over the stimulus, a type of code we call probabilistic population codes. Moreover, we demonstrate that the Poisson-like variability observed in cortex reduces a broad class of Bayesian inference to simple linear combinations of populations of neural activity. These results hold for arbitrary probability distributions over the stimulus, for tuning curves of arbitrary shape and for realistic neuronal variability.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of Rochester; University of London; University College London	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365; Ma, Wei Ji/0000-0002-9835-9083	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447, T32MH019942] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anastasio TJ, 2000, NEURAL COMPUT, V12, P1165, DOI 10.1162/089976600300015547; ANDERSON CH, 1994, COMPUTATIONAL INTELL, P213; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BARLOW HB, 1969, ANN NY ACAD SCI, V156, P872, DOI 10.1111/j.1749-6632.1969.tb14019.x; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Clark J.J., 1990, DATA FUSION SENSORY; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; DENEVE S, 2005, NEURAL INFORM PROCES; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hinton GE, 1999, IEE CONF PUBL, P1, DOI 10.1049/cp:19991075; HOYER PO, 2003, NEURAL INFORM PROCES, P277; HUYS Q, IN PRESS NEURAL COMP; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; Knill DC, 1996, PERCEPTION BAYESIAN; Koechlin E, 1999, BIOL CYBERN, V80, P25, DOI 10.1007/s004220050502; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Sahani M, 2003, NEURAL COMPUT, V15, P2255, DOI 10.1162/089976603322362356; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SIMONCELLI EP, 1991, IEEE C COMP VIS PATT, P310, DOI 10.1109/CVPR.1991.139707; Snippe HP, 1996, NEURAL COMPUT, V8, P511, DOI 10.1162/neco.1996.8.3.511; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Weiss Y, 2002, NEU INF PRO, P77; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	48	856	860	3	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1432	1438		10.1038/nn1790	http://dx.doi.org/10.1038/nn1790			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057707				2022-12-24	WOS:000242403800022
J	Rust, NC; Mante, V; Simoncelli, EP; Movshon, JA				Rust, Nicole C.; Mante, Valerio; Simoncelli, Eero P.; Movshon, J. Anthony			How MT cells analyze the motion of visual patterns	NATURE NEUROSCIENCE			English	Article							CATS STRIATE CORTEX; MACAQUE V1 NEURONS; RECEPTIVE-FIELD STRUCTURE; AREA MT; COMPLEX CELLS; FUNCTIONAL ARCHITECTURE; RESPONSE PROPERTIES; SPATIAL SUMMATION; CORTICAL-NEURONS; MONKEY	Neurons in area MT ( V5) are selective for the direction of visual motion. In addition, many are selective for the motion of complex patterns independent of the orientation of their components, a behavior not seen in earlier visual areas. We show that the responses of MT cells can be captured by a linear-nonlinear model that operates not on the visual stimulus, but on the afferent responses of a population of nonlinear V1 cells. We fit this cascade model to responses of individual MT neurons and show that it robustly predicts the separately measured responses to gratings and plaids. The model captures the full range of pattern motion selectivity found in MT. Cells that signal pattern motion are distinguished by having convergent excitatory input from V1 cells with a wide range of preferred directions, strong motion opponent suppression and a tuned normalization that may reflect suppressive input from the surround of V1 cells.	NYU, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Federal Inst Technol, CH-8057 Zurich, Switzerland	Howard Hughes Medical Institute; New York University; New York University; University of Zurich	Rust, NC (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rust@mit.edu		Simoncelli, Eero/0000-0002-1206-527X	NATIONAL EYE INSTITUTE [R01EY004440, R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY004440, EY02017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Bair W, 2004, J NEUROSCI, V24, P7305, DOI 10.1523/JNEUROSCI.0554-04.2004; Britten KH, 1999, J NEUROSCI, V19, P5074; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 1997, J NEUROSCI, V17, P8621; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Collins CE, 2003, J NEUROSCI, V23, P2251; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; EFRON B, 1993, INTRO BOOTHSTRAP; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1212, DOI 10.1152/jn.1987.58.6.1212; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Lennie P, 2005, J OPT SOC AM A, V22, P2013, DOI 10.1364/JOSAA.22.002013; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; MANTTE V, 2000, THESIS U ZURICH; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Movshon Adelson, 1985, PATTERN RECOGNITION, V54, P117, DOI 10.1098/rstb.1998.0333; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Movshon JA, 1996, J NEUROSCI, V16, P7733; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; ROCKLAND KS, 1989, VISUAL NEUROSCI, V3, P155, DOI 10.1017/S0952523800004466; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; RODMAN HR, 1989, J NEUROSCI, V9, P2033; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tinsley CJ, 2003, J NEUROPHYSIOL, V90, P930, DOI 10.1152/jn.00708.2002; VANDENBERG AV, 1993, EXP BRAIN RES, V96, P519, DOI 10.1007/BF00234120; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	50	354	357	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1421	1431		10.1038/nn1786	http://dx.doi.org/10.1038/nn1786			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041595				2022-12-24	WOS:000242403800021
J	Deinhardt, K; Salinas, S; Verastegui, C; Watson, R; Worth, D; Hanrahan, S; Bucci, C; Schiavo, G				Deinhardt, Katrin; Salinas, Sara; Verastegui, Carole; Watson, Rose; Worth, Daniel; Hanrahan, Sarah; Bucci, Cecilia; Schiavo, Giampietro			Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway	NEURON			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; TETANUS TOXIN; ANDROGEN RECEPTOR; LATE ENDOSOMES; NEURONS; MOTOR; PROTEIN; INTERNALIZATION; PROGRESSION	Vesicular pathways coupling the neuromuscular junction with the motor neuron soma are essential for neuronal function and survival. To characterize the organelles responsible for this long-distance crosstalk, we developed a purification strategy based on a fragment of tetanus neurotoxin (TeNT H-C) conjugated to paramagnetic beads. This approach enabled us to identify, among other factors, the small GTPase Rab7 as a functional marker of a specific pool of axonal retrograde carriers, which transport neurotrophins and their receptors. Furthermore, Rab5 is essential for an early step in TeNT H-C sorting but is absent from axonally transported vesicles. Our data demonstrate that TeNT H-C uses a retrograde transport pathway shared with p75(NTR), TrkB, and BDNF, which is strictly dependent on the activities of both Rab5 and Rab7. Therefore, Rab7 plays an essential role in axonal retrograde transport by controlling a vesicular compartment implicated in neurotrophin traffic.	Canc Res UK London Res Inst, Mol Neuropathol Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Electron Microscopy Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Prot Anal Lab, London WC2A 3PX, England; Univ Lecce, Dipartimento Sci & Tecnol Biol Ambientali, I-73100 Lecce, Italy	Cancer Research UK; Cancer Research UK; Cancer Research UK; University of Salento	Schiavo, G (corresponding author), Canc Res UK London Res Inst, Mol Neuropathol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	giampietro.schiavo@cancer.org.uk	Bucci, Cecilia/F-6699-2012; Salinas, Sara/O-1856-2013; Salinas, Sara/O-1150-2019	Bucci, Cecilia/0000-0002-6232-6183; Salinas, Sara/0000-0003-4492-2093; Salinas, Sara/0000-0003-4492-2093; Deinhardt, Katrin/0000-0002-6473-5298; Schiavo, Giampietro/0000-0002-4319-8745	Telethon [GGP05160] Funding Source: Medline	Telethon(Fondazione Telethon)		Adachi H, 2003, J NEUROSCI, V23, P2203; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Bronfman FC, 2003, J NEUROSCI, V23, P3209; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CLAUDE P, 1982, J NEUROSCI, V2, P431; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Devon RS, 2006, P NATL ACAD SCI USA, V103, P9595, DOI 10.1073/pnas.0510197103; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GROB PM, 1985, J BIOL CHEM, V260, P8044; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Holzbaur ELF, 2004, TRENDS CELL BIOL, V14, P233, DOI 10.1016/j.tcb.2004.03.009; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; JOHNSON EM, 1987, J NEUROSCI, V7, P923; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; MECKLER RL, 1990, NEUROSCIENCE, V36, P823, DOI 10.1016/0306-4522(90)90025-Y; Perlson E, 2004, MOL CELL PROTEOMICS, V3, P510, DOI 10.1074/mcp.M400004-MCP200; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Roux S, 2005, MOL CELL NEUROSCI, V30, P79, DOI 10.1016/j.mcn.2005.05.008; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Samuels IS, 2001, J CELL BIOCHEM, V82, P452, DOI 10.1002/jcb.1177; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; Snider MD, 2003, MOL CELL, V12, P796, DOI 10.1016/S1097-2765(03)00401-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Tucker BA, 2005, BRAIN RES PROTOC, V16, P50, DOI 10.1016/j.brainresprot.2005.10.004; Ure DR, 1997, J NEUROSCI, V17, P1282; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vidricaire G, 2005, J IMMUNOL, V175, P6517, DOI 10.4049/jimmunol.175.10.6517; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Whitaker HC, 2004, CLIN CANCER RES, V10, P7392, DOI 10.1158/1078-0432.CCR-04-0388; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	52	348	353	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					293	305		10.1016/j.neuron.2006.08.018	http://dx.doi.org/10.1016/j.neuron.2006.08.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046692	Bronze			2022-12-24	WOS:000241799900010
J	Huberman, AD; Speer, CM; Chapman, B				Huberman, Andrew D.; Speer, Colenso M.; Chapman, Barbara			Spontaneous retinal activity mediates development of ocular dominance columns and binocular receptive fields in V1	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CAT VISUAL-CORTEX; EYE-SPECIFIC SEGREGATION; SUBPLATE NEURONS; EPHRIN-AS; CORTICAL COLUMNS; CRITICAL PERIOD; STRIATE CORTEX; IN-VIVO; FERRET	The mechanisms that give rise to ocular dominance columns (ODCs) during development are controversial. Early experiments indicated a key role for retinal activity in ODC formation. However, later studies showed that in those early experiments, the retinal activity perturbation was initiated afterODCs had already formed. Moreover, recent studies concluded that early eye removals do not impact ODC segregation. Here we blocked spontaneous retinal activity during the very early stages of ODC development. This permanently disrupted the anatomical organization of ODCs and led to a dramatic increase in receptive field size for binocular cells in primary visual cortex. Our data suggest that early spontaneous retinal activity conveys crucial information about whether thalamocortical axons represent one or the other eye and that this activity mediates binocular competition important for shaping receptive fields in primary visual cortex.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chapman, B (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	bxchapman@ucdavis.edu		Speer, Colenso/0000-0002-3076-7072	NEI NIH HHS [R01 EY011369-11, R01 EY011369] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011369] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams DL, 2006, J NEUROPHYSIOL, V96, P2253, DOI 10.1152/jn.00131.2006; Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GRUBB MS, 2003, NEURON, V30, P1151; GUILLERY RW, 1985, DEV BRAIN RES, V20, P221, DOI 10.1016/0165-3806(85)90109-9; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; LEVAY S, 1985, J NEUROSCI, V5, P486; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; LOWEL S, 1994, J NEUROSCI, V14, P7451; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Ruthazer ES, 1999, J COMP NEUROL, V407, P151; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	43	92	94	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					247	254		10.1016/j.neuron.2006.07.028	http://dx.doi.org/10.1016/j.neuron.2006.07.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046688	Green Accepted, Bronze			2022-12-24	WOS:000241799900006
J	Wang, XQ; Deriy, LV; Foss, S; Huang, P; Lamb, FS; Kaetzel, MA; Bindokas, V; Marks, JD; Nelson, DJ				Wang, Xue Qing; Deriy, Ludmila V.; Foss, Sarah; Huang, Ping; Lamb, Fred S.; Kaetzel, Marcia A.; Bindokas, Vytautas; Marks, Jeremy D.; Nelson, Deborah J.			CLC-3 channels modulate excitatory synaptic transmission in hippocampal neurons	NEURON			English	Article							CHLORIDE CHANNEL; COTRANSPORTER KCC2; SK CHANNELS; VESICLES; ANION; IDENTIFICATION; CONDUCTANCE; ACTIVATION; PORES; BLOCK	It is well established that ligand-gated chloride flux across the plasma membrane modulates neuronal excitability. We find that a voltage-dependent Cl- conductance increases neuronal excitability in immature rodents as well, enhancing the time course of NMDA receptor-mediated miniature excitatory postsynaptic potentials (mEPSPs). This Cl- conductance is activated by CaMKII, is electrophysiologically identical to the CaMKII-activated CLC-3 conductance in non-neuronal cells, and is absent in clc-3(-/-) mice. Systematically decreasing [CI-](i) to mimic postnatal [CI-](i) regulation progressively decreases the amplitude and decay time constant of spontaneous mEPSPs. This Cl--dependent change in synaptic strength is absent in clc-3(-/-) mice. Using surface biotinylation, immunohistochemistry, electron microscopy, and coimmuno-precipitation studies, we find that CLC-3 channels are localized on the plasma membrane, at postsynaptic sites, and in association with NMDA receptors. This is the first demonstration that a voltage-dependent chloride conductance modulates neuronal excitability. By increasing postsynaptic potentials in a Cl(-)dependent fashion, CLC-3 channels regulate neuronal excitability postsynaptically in immature neurons.	Univ Chicago, Dept Neurobiol Physiol & Pharmacol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Cincinnati, Dept Genome Sci, Cincinnati, OH 45267 USA	University of Chicago; University of Chicago; University of Iowa; University System of Ohio; University of Cincinnati	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Physiol & Pharmacol, Chicago, IL 60637 USA.	nelson@uchicago.edu	Marks, Jeremy/W-2087-2019	Marks, Jeremy/0000-0002-2644-5257; Lamb, Fred/0000-0003-2955-5133	NIDDK NIH HHS [DK57882] Funding Source: Medline; NIGMS NIH HHS [GM36823] Funding Source: Medline; NINDS NIH HHS [R01 NS038547-02, R01 NS038547, R01 NS038547-04, R01 NS038547-05S1, R01 NS38547, R01 NS038547-05, R01 NS038547-03] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038547] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BLATZ AL, 1991, J PHYSIOL-LONDON, V441, P1; CURRIE KPM, 1995, J PHYSIOL-LONDON, V482, P291, DOI 10.1113/jphysiol.1995.sp020518; Davis KE, 1998, J NEUROSCI, V18, P2475; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; Huang LQ, 2005, J BIOL CHEM, V280, P36150, DOI 10.1074/jbc.M507706200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Ludewig U, 1997, BIOPHYS J, V73, P789, DOI 10.1016/S0006-3495(97)78111-6; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; MARKS JD, 1988, BRAIN RES DEV BRIAN, V124, P101; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nobile M, 2000, FEBS LETT, V479, P10, DOI 10.1016/S0014-5793(00)01876-7; Pusch M, 2001, J GEN PHYSIOL, V118, P45, DOI 10.1085/jgp.118.1.45; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Sacchi O, 1999, J NEUROPHYSIOL, V82, P1662, DOI 10.1152/jn.1999.82.4.1662; SANCHEZVIVES MV, 1994, J PHYSIOL-LONDON, V475, P391, DOI 10.1113/jphysiol.1994.sp020080; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Thoidis G, 1998, P NATL ACAD SCI USA, V95, P183, DOI 10.1073/pnas.95.1.183; Wang GX, 2003, AM J PHYSIOL-HEART C, V285, pH1453, DOI 10.1152/ajpheart.00244.2003; WATSON JB, 1994, MOL BRAIN RES, V27, P323, DOI 10.1016/0169-328X(94)90017-5; WHITE MM, 1979, J BIOL CHEM, V254, P161; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x	35	66	70	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					321	333		10.1016/j.neuron.2006.08.035	http://dx.doi.org/10.1016/j.neuron.2006.08.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046694	Bronze			2022-12-24	WOS:000241799900012
J	Etkin, A; Egner, T; Peraza, DM; Kandel, ER; Hirsch, J				Etkin, Amit; Egner, Tobias; Peraza, Daniel M.; Kandel, Eric R.; Hirsch, Joy			Resolving emotional conflict: A role for the rostral anterior cingulate cortex in modulating activity in the amygdala	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE CONTROL; FRONTAL-CORTEX; SUBCORTICAL PROJECTIONS; FUNCTIONAL-INTEGRATION; BASOLATERAL AMYGDALA; SURPRISED FACES; VISUAL-STIMULI; FEARFUL FACES	Effective mental functioning requires that cognition be protected from emotional conflict due to interference by task-irrelevant emotionally salient stimuli. The neural mechanisms by which the brain detects and resolves emotional conflict are still largely unknown, however. Drawing on the classic Stroop conflict task, we developed a protocol that allowed us to dissociate the generation and monitoring of emotional conflict from its resolution. Using functional magnetic resonance imaging (fMRI), we find that activity in the amygdala and dorsomedial and dorsolateral prefrontal cortices reflects the amount of emotional conflict. By contrast, the resolution of emotional conflict is associated with activation of the rostral anterior cingulate cortex. Activation of the rostral cingulate is predicted by the amount of previous-trial conflict-related neural activity and is accompanied by a simultaneous and correlated reduction of amygdalar activity. These data suggest that emotional conflict is resolved through top-down inhibition of amygdalar activity by the rostral cingulate cortex.	Columbia Univ, Med Ctr, Neurol Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Kavli Inst Brain Sci, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Funct MRI Res Ctr, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Dept Radiol, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Dept Psychol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Etkin, A (corresponding author), Columbia Univ, Med Ctr, Neurol Inst, Ctr Neurobiol & Behav, Box 108,710 W 168th St, New York, NY 10032 USA.	ae157@columbia.edu; jh2155@columbia.edu	Egner, Tobias/A-5237-2009; Etkin, Amit/ABD-5761-2021; Egner, Tobias/AAD-5864-2022	Egner, Tobias/0000-0001-7956-3241; Egner, Tobias/0000-0001-7956-3241; Hirsch, Joy/0000-0002-1418-6489	NICHD NIH HHS [HD 07430] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Carroll NC, 2005, Q J EXP PSYCHOL-A, V58, P1173, DOI 10.1080/02724980443000539; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Ekman P., 1976, PICTURES FACIAL AFFE; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Etkin A, 2005, J NEUROPSYCH CLIN N, V17, P145, DOI 10.1176/appi.neuropsych.17.2.145; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; James W., 1890, PRINCIPLES PSYCHOL; Kawasaki H, 2005, J COGNITIVE NEUROSCI, V17, P1509, DOI 10.1162/089892905774597182; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Kumari V, 2003, BIOL PSYCHIAT, V54, P777, DOI 10.1016/S0006-3223(02)01785-7; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; MCKENNA F P, 1986, Current Psychological Research and Reviews, V5, P3, DOI 10.1007/BF02686591; MUSIL SY, 1988, J COMP NEUROL, V272, P219, DOI 10.1002/cne.902720206; MUSIL SY, 1988, J COMP NEUROL, V272, P203, DOI 10.1002/cne.902720205; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Oya H, 2002, J NEUROSCI, V22, P9502; Paxinos G., 1990, HUMAN NERVOUS SYSTEM; Penny WD, 2004, NEUROIMAGE, V23, pS264, DOI 10.1016/j.neuroimage.2004.07.041; Pessoa L, 2003, J NEUROSCI, V23, P3990; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Posner MI, 1998, ATTENTIVE BRAIN, P401; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tipples J, 2000, BRIT J PSYCHOL, V91, P87, DOI 10.1348/000712600161691; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Weissman DH, 2004, J NEUROSCI, V24, P10941, DOI 10.1523/JNEUROSCI.3669-04.2004; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009	83	928	955	2	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					871	882		10.1016/j.neuron.2006.07.029	http://dx.doi.org/10.1016/j.neuron.2006.07.029			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	091AM	16982430	Bronze			2022-12-24	WOS:000240997900023
J	Fulton, S; Pissios, P; Manchon, RP; Stiles, L; Frank, L; Pothos, EN; Maratos-Flier, E; Flier, JS				Fulton, Stephanie; Pissios, Pavlos; Manchon, Ramon Pinol; Stiles, Linsey; Frank, Lauren; Pothos, Emmanuel N.; Maratos-Flier, Eleftheria; Flier, Jeffrey S.			Leptin regulation of the mesoaccumbens dopamine pathway	NEURON			English	Article							BRAIN REWARD CIRCUITRY; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; OB/OB MICE; BODY-WEIGHT; EXTRACELLULAR DOPAMINE; TYROSINE-HYDROXYLASE; PREFRONTAL CORTEX; NEUROPEPTIDE-Y; FOOD REWARD	Leptin is an adipose-derived hormone that acts on hypothalamic leptin receptors to regulate energy balance. Leptin receptors are also expressed in extra-hypothalamic sites including the ventral tegmental area (VTA), critical to brain reward circuitry. We report that leptin targets DA and GABA neurons of the VTA, inducing phosphorylation of signal-transducer-and-activator-of-transcription-3 (STAT3). Retrograde tracing combined with pSTAT3 immunohistochemistry show leptin-responsive VTA neurons projecting to nucleus accumbens (NAc). Assessing leptin function in the VTA, we showed that ob/ob mice had diminished locomotor response to amphetamine and lacked locomotor sensitization to repeated amphetamine injections, both defects reversed by leptin infusion. Electrically stimulated DA release from NAc shell terminals was markedly reduced in ob/ob slice preparations, and NAc DA levels and TH expression were lower. These data define a role for leptin in mesoaccumbens DA signaling and indicate that the mesoaccumbens DA pathway, critical to integrating motivated behavior, responds to this adipose-derived signal.	Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Tufts Univ, Sch Med, Program Neurosci, Boston, MA 02111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Tufts University; Tufts University	Maratos-Flier, E (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.	emaratos@bidmc.harvard.edu	Jansen, Heiko T./A-5770-2008; Flier, jeffrey/AAG-6223-2019; Chee, Melissa/G-4150-2014	Jansen, Heiko T./0000-0003-0178-396X; Chee, Melissa/0000-0003-3815-9095; Pothos, Emmanuel/0000-0001-8825-7852; Stiles, Linsey/0000-0002-1514-458X; Pinol, Ramon/0000-0002-8877-8444	NIDDK NIH HHS [DK069983, 1R01DK065872] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069983, R01DK065872] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahn S, 2002, J NEUROSCI, V22, P10958; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bassareo V, 1999, EUR J NEUROSCI, V11, P4389, DOI 10.1046/j.1460-9568.1999.00843.x; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CIOLKOWSKI EL, 1994, ANAL CHEM, V66, P3611, DOI 10.1021/ac00093a013; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; FARNEBO LO, 1971, ACTA PHYSIOL SCAND, P35; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2004, BEHAV BRAIN RES, V155, P319, DOI 10.1016/j.bbr.2004.05.021; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hao J, 2004, PHYSIOL BEHAV, V83, P377, DOI 10.1016/j.physbeh.2004.08.007; Harada K, 1996, J NEUROCHEM, V67, P629; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Hay-Schmidt A, 2001, NEUROENDOCRINOLOGY, V73, P215, DOI 10.1159/000054638; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; HOEBEL BG, 1983, PSYCHOPHARMACOLOGY, V81, P158, DOI 10.1007/BF00429012; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jedynak JP, 2002, J NEUROCHEM, V82, P382, DOI 10.1046/j.1471-4159.2002.00982.x; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Martel P, 1996, PHARMACOL BIOCHEM BE, V53, P221, DOI 10.1016/0091-3057(95)00187-5; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PHILLIPSON OT, 1985, NEUROSCIENCE, V16, P275, DOI 10.1016/0306-4522(85)90002-8; POTHOS EN, 1995, J NEUROSCI, V15, P6640; Pothos EN, 1998, APPETITE, V31, P405, DOI 10.1006/appe.1998.0210; Robinson S, 2005, BEHAV NEUROSCI, V119, P5, DOI 10.1037/0735-7044.119.1.5; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Scislowski PWD, 1999, INT J OBESITY, V23, P425, DOI 10.1038/sj.ijo.0800893; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; Shalev U, 2001, J NEUROSCI, V21; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Zaborszky L, 2001, BEHAV GENET, V31, P47, DOI 10.1023/A:1010257808945; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885	60	490	498	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					811	822		10.1016/j.neuron.2006.09.006	http://dx.doi.org/10.1016/j.neuron.2006.09.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982425	Bronze			2022-12-24	WOS:000240997900018
J	Granseth, B; Odermatt, B; Royle, SJ; Lagnado, L				Granseth, Bjorn; Odermatt, Benjamin; Royle, Stephen J.; Lagnado, Leon			Clathrin-mediated endocytosis is the dominant mechanism of vesicle retrieval at hippocampal synapses	NEURON			English	Article							RETINAL BIPOLAR CELLS; KISS-AND-RUN; SINGLE SYNAPTIC VESICLES; READILY RELEASABLE POOL; CENTRAL-NERVOUS-SYSTEM; NEUROTRANSMITTER RELEASE; QUANTAL ANALYSIS; EXOCYTOSIS; MEMBRANE; KINETICS	The maintenance of synaptic transmission requires that vesicles be recycled after releasing neurotransmitter. Several modes of retrieval have been proposed to operate at small synaptic terminals of central neurons, including a fast "kiss-and-run" mechanism that releases neurotransmitter through a fusion pore. Using an improved fluorescent reporter comprising pHluorin fused to synaptophysin, we find that only a slow mode of endocytosis (tau = 15 s) operates at hippocampal synapses when vesicle fusion is triggered by a single nerve impulse or short burst. This retrieval mechanism is blocked by overexpression of the C-terminal fragment of AP180 or by knockdown of clathrin using RNAi, and it is associated with the movement of clathrin and vesicle proteins out of the synapse. These results indicate that clathrin-mediated endocytosis is the major, if not exclusive, mechanism of vesicle retrieval after physiological stimuli.	MRC, Lab Mol Biol, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Lab Mol Biol, Hills Rd, Cambridge CB2 2QH, England.	ll1@mrc-lmb.cam.ac.uk	Granseth, Björn/AAG-2142-2020	Granseth, Bjorn/0000-0001-7526-923X; Royle, Stephen/0000-0001-8927-6967	MRC [MC_U105178794] Funding Source: UKRI; Medical Research Council [MC_U105178794] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aravanis AM, 2003, NEUROPHARMACOLOGY, V45, P797, DOI 10.1016/S0028-3908(03)00310-1; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bekkers John M., 1994, Current Opinion in Neurobiology, V4, P360, DOI 10.1016/0959-4388(94)90097-3; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Franks KM, 2003, J NEUROSCI, V23, P3186; Frerking M, 2005, J NEUROPHYSIOL, V94, P1528, DOI 10.1152/jn.00108.2005; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Katz B., 1969, RELEASE NEURAL TRANS; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Llobet A, 2003, NEURON, V40, P1075, DOI 10.1016/S0896-6273(03)00765-7; Marte B, 2002, NAT CELL BIOL, V4, pE123, DOI 10.1038/ncb0502-e123; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Mundigl O, 1998, J NEUROSCI, V18, P93; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rizzoli SO, 2003, NATURE, V423, P591, DOI 10.1038/423591a; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tyler WJ, 2004, CURR BIOL, V14, pR294, DOI 10.1016/j.cub.2004.03.046; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; van Santen RA, 1995, CHEM KINETICS CATALY; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Yao PJ, 2003, NEUROSCIENCE, V121, P25, DOI 10.1016/S0306-4522(03)00431-7; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	61	461	471	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					773	786		10.1016/j.neuron.2006.08.029	http://dx.doi.org/10.1016/j.neuron.2006.08.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982422	Bronze			2022-12-24	WOS:000240997900015
J	Karsten, SL; Sang, TK; Gehman, LT; Chatterjee, S; Liu, JK; Lawless, GM; Sengupta, S; Berry, RW; Pomakian, J; Oh, HS; Schulz, C; Hui, KS; Wiedau-Pazos, M; Vinters, HV; Binder, LI; Geschwind, DH; Jackson, GR				Karsten, Stanislav L.; Sang, Tzu-Kang; Gehman, Lauren T.; Chatterjee, Shreyasi; Liu, Jiankai; Lawless, George M.; Sengupta, Soma; Berry, Robert W.; Pomakian, Justine; Oh, Hyun S.; Schulz, Cordula; Hui, Koon-Sea; Wiedau-Pazos, Martina; Vinters, Harry V.; Binder, Lester I.; Geschwind, Daniel H.; Jackson, George R.			A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration	NEURON			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; POSTTRANSLATIONAL MODIFICATIONS; DROSOPHILA-MELANOGASTER; GENETIC-ANALYSIS; EXPRESSION; BRAIN	Neurofibrillary tangles (NFT) containing tau are a hallmark of neurodegenerative diseases, including Alzheimer's disease (AD). NFT burden correlates with cognitive decline and neurodegeneration in AD. However, little is known about mechanisms that protect against tau-induced neurodegeneration. We used a cross species functional genomic approach to analyze gene expression in multiple brain regions in mouse, in parallel with validation in Drosophila, to identify tau modifiers, including the highly conserved protein puromycin-sensitive aminopeptidase (PSA/Npepps). PSA protected against tau-induced neurodegeneration in vivo, whereas PSA loss of function exacerbated neurodegeneration. We further show that human PSA directly proteolyzes tau in vitro. These data highlight the utility of using both evolutionarily distant species for genetic screening and functional assessment to identify modifiers of neurodegeneration. Further investigation is warranted in defining the role of PSA and other genes identified here as potential therapeutic targets in tauopathy.	Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Kungwon Univ, Dept Appl Stat, Sungnam, South Korea; Cold Spring Harbor Labs, Cold Spring Harbor, NY 11724 USA; NYU, Nathan S Kline Inst Psychiat Res, Sch Med, Orangeburg, NY 10962 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine; Cold Spring Harbor Laboratory; Nathan Kline Institute for Psychiatric Research; New York University	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu; dhg@mednet.ucla.edu	Karsten, Stan/AAI-4076-2021	Sang, Tzu-Kang/0000-0001-7924-9359; Karsten, Stanislav/0000-0001-7387-4874	NIA NIH HHS [AG 14453, AG 016570, AG 026938] Funding Source: Medline; NINDS NIH HHS [NS 046489, R01 NS046489] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570, R37AG014453, R01AG026938] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amadoro G, 2004, CELL DEATH DIFFER, V11, P217, DOI 10.1038/sj.cdd.4401314; Arai T, 2005, J BIOL CHEM, V280, P5145, DOI 10.1074/jbc.M409234200; Arrasate M, 1999, FEBS LETT, V446, P199, DOI 10.1016/S0014-5793(99)00210-0; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; Chen F, 2004, CURR DRUG TARGETS, V5, P503, DOI 10.2174/1389450043345236; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; Doglio LE, 2006, NEURON, V50, P359, DOI 10.1016/j.neuron.2006.03.038; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hui M, 2003, NEUROCHEM RES, V28, P855, DOI 10.1023/A:1023263123911; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; IQBAL K, 1991, MOL NEUROBIOL, V5, P399, DOI 10.1007/BF02935561; Ishizawa T, 2003, AM J PATHOL, V163, P1057, DOI 10.1016/S0002-9440(10)63465-7; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kosik KS, 2005, BBA-MOL BASIS DIS, V1739, P298, DOI 10.1016/j.bbadis.2004.10.011; Kosik KS, 2002, J MOL NEUROSCI, V19, P261, DOI 10.1385/JMN:19:3:261; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lin WL, 2003, J NEUROCYTOL, V32, P1091, DOI 10.1023/B:NEUR.0000021904.61387.95; Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lomen-Hoerth C, 2004, DEMENT GERIATR COGN, V17, P337, DOI 10.1159/000077167; MCLELLAN S, 1988, J NEUROCHEM, V51, P1552, DOI 10.1111/j.1471-4159.1988.tb01124.x; MERCKEN M, 1995, FEBS LETT, V368, P10, DOI 10.1016/0014-5793(95)00590-6; Minnasch Petra, 2003, Leg Med (Tokyo), V5 Suppl 1, pS285, DOI 10.1016/S1344-6223(02)00151-7; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Mirnics K, 2001, NAT REV NEUROSCI, V2, P444, DOI 10.1038/35077587; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAFAVI A, 1995, J NEUROCHEM, V65, P389; Sang TK, 2005, HUM MOL GENET, V14, P357, DOI 10.1093/hmg/ddi032; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHONLEIN C, 1994, BIOCHEM BIOPH RES CO, V201, P45, DOI 10.1006/bbrc.1994.1667; Schulz C, 2001, DEV GENES EVOL, V211, P581, DOI 10.1007/s00427-001-0194-z; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Shulman JM, 2003, GENETICS, V165, P1233; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; SMITH DE, 1989, J CELL BIOL, V108, P255, DOI 10.1083/jcb.108.2.255; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tobler AR, 1997, J NEUROCHEM, V68, P889; Wang JZ, 1996, NAT MED, V2, P871, DOI 10.1038/nm0896-871; Wilczak N, 2003, LANCET, V361, P1007, DOI 10.1016/S0140-6736(03)12828-0; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200	69	108	112	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					549	560		10.1016/j.neuron.2006.07.019	http://dx.doi.org/10.1016/j.neuron.2006.07.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950154	Bronze			2022-12-24	WOS:000240623400005
J	Grill-Spector, K; Sayres, R; Ress, D				Grill-Spector, Kalanit; Sayres, Rory; Ress, David			High-resolution imaging reveals highly selective nonface clusters in the fusiform face area	NATURE NEUROSCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; LATERAL OCCIPITAL COMPLEX; HUMAN OBJECT AREAS; MACAQUE; FMRI; ORGANIZATION; PERCEPTION; REPRESENTATIONS; EXPERTISE; GYRUS	A region in ventral human cortex (fusiform face area, FFA) thought to be important for face perception responds strongly to faces and less strongly to nonface objects. This pattern of response may reflect a uniform face-selective neural population or activity averaged across populations with heterogeneous selectivity. Using high-resolution functional magnetic resonance imaging (MRI), we found that the FFA has a reliable heterogeneous structure: localized subregions within the FFA highly selective to faces are spatially interdigitated with localized subregions highly selective to different object categories. We found a preponderance of face-selective responses in the FFA, but no difference in selectivity to faces compared to nonfaces. Thus, standard fMRI of the FFA reflects averaging of heterogeneous highly selective neural populations of differing sizes, rather than higher selectivity to faces. These results suggest that visual processing in this region is not exclusive to faces. Overall, our approach provides a framework for understanding the fine-scale structure of neural representations in the human brain.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Stanford University; Stanford University; Brown University	Grill-Spector, K (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	kalanit@psych.stanford.edu		Grill-Spector, Kalanit/0000-0002-5404-9606	NATIONAL EYE INSTITUTE [F31EY015937, R21EY016199] Funding Source: NIH RePORTER; NEI NIH HHS [1 R21EY016199-0, 5 F31 EY015937] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Duda R.O., 2006, PATTERN CLASSIFICATI; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Gauthier I, 2001, CURR OPIN NEUROBIOL, V11, P219, DOI 10.1016/S0959-4388(00)00200-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hasson U, 2001, J COGNITIVE NEUROSCI, V13, P744, DOI 10.1162/08989290152541412; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	39	149	150	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1177	1185		10.1038/nn1745	http://dx.doi.org/10.1038/nn1745			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892057				2022-12-24	WOS:000240080800020
J	Shaban, H; Humeau, Y; Herry, C; Cassasus, G; Shigemoto, R; Ciocchi, S; Barbieri, S; van der Putten, H; Kaupmann, K; Bettler, B; Luthi, A				Shaban, Hamdy; Humeau, Yann; Herry, Cyril; Cassasus, Guillaume; Shigemoto, Ryuichi; Ciocchi, Stephane; Barbieri, Samuel; van der Putten, Herman; Kaupmann, Klemens; Bettler, Bernhard; Luethi, Andreas			Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT LATERAL AMYGDALA; GABA(B) RECEPTORS; BASOLATERAL AMYGDALA; STIMULUS-GENERALIZATION; AUDITORY-CORTEX; IN-VITRO; NEURONS; INDUCTION; LOCALIZATION	Pavlovian fear conditioning, a simple form of associative learning, is thought to involve the induction of associative, NMDA receptor dependent long-term potentiation (LTP) in the lateral amygdala. Using a combined genetic and electrophysiological approach, we show here that lack of a specific GABA(B) receptor subtype, GABA(B(1a, 2)), unmasks a nonassociative, NMDA receptor-independent form of presynaptic LTP at cortico-amygdala afferents. Moreover, the level of presynaptic GABA(B(1a, 2)) receptor activation, and hence the balance between associative and nonassociative forms of LTP, can be dynamically modulated by local inhibitory activity. At the behavioral level, genetic loss of GABA(B(1a)) results in a generalization of conditioned fear to nonconditioned stimuli. Our findings indicate that presynaptic inhibition through GABA(B(1a, 2)) receptors serves as an activity-dependent constraint on the induction of homosynaptic plasticity, which may be important to prevent the generalization of conditioned fear.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; CNRS, UMR 7168, F-67084 Strasbourg, France; Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Japan; Univ Basel, Dept Clin Biol Sci, Pharmazentrum, CH-4056 Basel, Switzerland; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); University of Basel; Novartis	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch	shaban, Hamdy/C-1939-2014; Shaban, Hamdy/ABD-5617-2021; Shigemoto, Ryuichi/E-3628-2013; Herry, Cyril/AAP-9902-2020; bettler, bernhard/AAO-8018-2020	shaban, Hamdy/0000-0003-3760-6113; Shaban, Hamdy/0000-0003-3760-6113; Shigemoto, Ryuichi/0000-0001-8761-9444; Herry, Cyril/0000-0003-2973-0843; Ciocchi, Stephane/0000-0002-5701-9250; Bettler, Bernhard/0000-0003-0842-8207; Kaupmann, Klemens/0000-0001-8903-2508				Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; ASPRODINI EK, 1992, J PHARMACOL EXP THER, V262, P1011; Baldi E, 2004, NEUROBIOL LEARN MEM, V81, P162, DOI 10.1016/j.nlm.2004.02.004; Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dittman JS, 1997, J NEUROSCI, V17, P9048; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lang EJ, 1997, J NEUROPHYSIOL, V77, P353, DOI 10.1152/jn.1997.77.1.353; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McDonald AJ, 2004, BRAIN RES, V1018, P147, DOI 10.1016/j.brainres.2004.05.053; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pelletier JG, 2004, BIOL PSYCHIAT, V55, P559, DOI 10.1016/j.biopsych.2003.08.019; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; SUGITA S, 1993, BRAIN RES, V612, P151, DOI 10.1016/0006-8993(93)91655-C; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Szinyei C, 2000, J NEUROSCI, V20, P8909; THOMPSON RF, 1962, J COMP PHYSIOL PSYCH, V55, P279, DOI 10.1037/h0047856; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4; Zhu PJ, 2005, J NEUROSCI, V25, P6199, DOI 10.1523/JNEUROSCI.1148-05.2005	48	153	156	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1028	1035		10.1038/nn1732	http://dx.doi.org/10.1038/nn1732			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819521				2022-12-24	WOS:000240080300015
J	Hippenmeyer, S; Huber, RM; Ladle, DR; Murphy, K; Arber, S				Hippenmeyer, Simon; Huber, Roland M.; Ladle, David R.; Murphy, Kenneth; Arber, Silvia			ETS transcription factor erm controls subsynaptic gene expression in skeletal muscles	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CONGENITAL MYASTHENIC SYNDROME; EPSILON-SUBUNIT GENE; GA-BINDING PROTEIN; NEUROMUSCULAR-JUNCTION; POSTSYNAPTIC DIFFERENTIATION; SYNAPTIC EXPRESSION; MOTOR-NEURONS; IN-VIVO; VERTEBRATE LIMB	Accumulation of specific proteins at synaptic structures is essential for synapse assembly and function, but mechanisms regulating local protein enrichment remain poorly understood. At the neuromuscular junction (NMJ), subsynaptic nuclei underlie motor axon terminals within extrafusal muscle fibers and are transcriptionally distinct from neighboring nuclei. In this study, we show that expression of the ETS transcription factor Erm is highly concentrated at subsynaptic nuclei, and its mutation in mice leads to severe downregulation of many genes with normally enriched subsynaptic expression. Erm mutant mice display an expansion of the muscle central domain in which acetylcholine receptor (AChR) clusters accumulate, show gradual fragmentation of AChR clusters, and exhibit symptoms of muscle weakness mimicking congenital myasthenic syndrome (CMS). Together, our findings define Erm as an upstream regulator of a transcriptional program selective to subsynaptic nuclei at the NMJ and underscore the importance of transcriptional control of local synaptic protein accumulation.	Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Basel; Friedrich Miescher Institute for Biomedical Research; Howard Hughes Medical Institute; Washington University (WUSTL)	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch		Arber, Silvia/0000-0002-6261-250X; Hippenmeyer, Simon/0000-0003-2279-1061				Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Burden SJ, 2002, J NEUROBIOL, V53, P501, DOI 10.1002/neu.10137; CALDWELL JH, 1986, J GEN PHYSIOL, V87, P907, DOI 10.1085/jgp.87.6.907; Chakkalakal JV, 2003, BIOESSAYS, V25, P25, DOI 10.1002/bies.10205; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; d'Exaerde AD, 2002, EMBO REP, V3, P1075, DOI 10.1093/embo-reports/kvf220; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DELAPEYRIERE O, 1993, DEVELOPMENT, V118, P601; Duclert A, 1996, J BIOL CHEM, V271, P17433, DOI 10.1074/jbc.271.29.17433; Engel AG, 2003, J NEUROCYTOL, V32, P1017, DOI 10.1023/B:NEUR.0000020639.22895.28; Fromm L, 1998, GENE DEV, V12, P3074, DOI 10.1101/gad.12.19.3074; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Jaworski A, 2007, MOL CELL BIOL, V27, P5040, DOI 10.1128/MCB.02228-06; Jevsek M, 2006, P NATL ACAD SCI USA, V103, P6374, DOI 10.1073/pnas.0601468103; Kardon G, 2002, DEV CELL, V3, P533, DOI 10.1016/S1534-5807(02)00291-5; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; KOIKE S, 1995, P NATL ACAD SCI USA, V92, P10624, DOI 10.1073/pnas.92.23.10624; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; MOSS SJ, 1987, EMBO J, V6, P3917, DOI 10.1002/j.1460-2075.1987.tb02732.x; Nazarian J, 2005, PHYSIOL GENOMICS, V21, P70, DOI 10.1152/physiolgenomics.00227.2004; Nichols P, 1999, ANN NEUROL, V45, P439, DOI 10.1002/1531-8249(199904)45:4<439::AID-ANA4>3.0.CO;2-W; O'Leary DA, 2007, MOL CELL BIOL, V27, P3470, DOI 10.1128/MCB.00659-06; Ohno K, 1999, NEUROMUSCULAR DISORD, V9, P131, DOI 10.1016/S0960-8966(99)00007-3; Pang YW, 2006, J COMP NEUROL, V498, P129, DOI 10.1002/cne.21047; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	50	37	37	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 6	2007	55	5					726	740		10.1016/j.neuron.2007.07.028	http://dx.doi.org/10.1016/j.neuron.2007.07.028			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785180	Bronze			2022-12-24	WOS:000249857000009
J	Carl, M; Bianco, IH; Bajoghli, B; Aghaallaei, N; Czerny, T; Wilson, SW				Carl, Matthias; Bianco, Isaac H.; Bajoghli, Baubak; Aghaallaei, Narges; Czerny, Thomas; Wilson, Stephen W.			Wnt/Axin1/beta-catenin signaling regulates asymmetric nodal activation, elaboration, and concordance of CNS asymmetries	NEURON			English	Article							LEFT-RIGHT DIFFERENCE; KUPFFERS VESICLE; ZEBRAFISH; EXPRESSION; WNT; TELENCEPHALON; SPECIFICATION; ESTABLISHMENT; GASTRULATION; GROUCHO/TLE	Nodal activity in the left lateral plate mesoderm (LPM) is required to activate left-sided Nodal signaling in the epithalamic region of the zebrafish forebrain. Epithalamic Nodal signaling subsequently determines the laterality of neuroanatomical asymmetries. We show that overactivation of Wnt/Axin1/beta-catenin signaling during late gastrulation leads to bilateral epithalamic expression of Nodal pathway genes independently of LPM Nodal signaling. This is consistent with a model whereby epithalamic Nodal signaling is normally bilaterally repressed, with Nodal signaling from the LPM unilaterally alleviating repression. We suggest that Wnt signaling regulates the establishment of the bilateral repression. We identify a second role for the Wnt pathway in the left/right regulation of LPM Nodal pathway gene expression, and finally, we show that at later stages Axin1 is required for the elaboration of concordant neuroanatomical asymmetries.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Vet Med, Inst Genet & Anim Breeding, A-1210 Vienna, Austria; Univ Appl Sci, Vienna Bioctr, A-1030 Vienna, Austria	University of London; University College London; University of Veterinary Medicine Vienna; Vienna Biocenter (VBC)	Carl, M (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	m.carl@ucl.ac.uk; s.wilson@ucl.ac.uk	Wilson, Stephen W/B-9404-2008; Bajoghli, Baubak/AAF-8388-2020; Zebrafish, UCL/A-3125-2009	Wilson, Stephen W/0000-0002-8557-5940; Bajoghli, Baubak/0000-0002-7368-7523; Bianco, Isaac/0000-0002-3149-4862; Bajoghli, Baubak/0000-0003-1395-6362; Carl, Matthias/0000-0002-9936-5813; Aghaallaei, Narges/0000-0002-9890-3229	MRC [G0501487] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G19181, BB/C51454X/1] Funding Source: Medline; Medical Research Council [G0501487, G0501487(76596)] Funding Source: Medline; Wellcome Trust [074376, 078047] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aghaallaei N, 2005, DEV DYNAM, V234, P143, DOI 10.1002/dvdy.20510; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Bajoghli B, 2007, DEV BIOL, V303, P347, DOI 10.1016/j.ydbio.2006.11.020; Branford WW, 2002, CURR BIOL, V12, P2136, DOI 10.1016/S0960-9822(02)01360-X; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Dufourcq P, 2004, GENE EXPR PATTERNS, V4, P53, DOI 10.1016/S1567-133X(03)00148-0; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Halpern ME, 2003, TRENDS NEUROSCI, V26, P308, DOI 10.1016/S0166-2236(03)00129-2; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inbal A, 2007, NEURON, V55, P407, DOI 10.1016/j.neuron.2007.06.037; IWAMATSU T, 1994, ZOOL SCI, V11, P825; Kim SH, 2002, DEVELOPMENT, V129, P4443; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Kuan YS, 2007, DEVELOPMENT, V134, P857, DOI 10.1242/dev.02791; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Liang JO, 2000, DEVELOPMENT, V127, P5101; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Nascone N, 1997, DEV BIOL, V189, P68, DOI 10.1006/dbio.1997.8635; Nusse R, 2005, NATURE, V438, P747, DOI 10.1038/438747a; Ohi Y, 2007, DEV BIOL, V301, P447, DOI 10.1016/j.ydbio.2006.08.021; Rodriguez-Esteban C, 2001, DEVELOPMENT, V128, P3189; Sanders LH, 2003, DEV DYNAM, V227, P291, DOI 10.1002/dvdy.10308; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Soroldoni D, 2007, GENE EXPR PATTERNS, V7, P93, DOI 10.1016/j.modgep.2006.05.013; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; van de Water S, 2001, DEVELOPMENT, V128, P3877; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yamamoto M, 2003, DEVELOPMENT, V130, P1795, DOI 10.1242/dev.00408	53	74	75	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					393	405		10.1016/j.neuron.2007.07.007	http://dx.doi.org/10.1016/j.neuron.2007.07.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678853	Green Published, hybrid			2022-12-24	WOS:000248711000008
J	Wang, WY; Takimoto, JK; Louie, GV; Baiga, TJ; Noel, JP; Lee, KF; Slesinger, PA; Wang, L				Wang, Wenyuan; Takimoto, Jeffrey K.; Louie, Gordon V.; Baiga, Thomas J.; Noel, Joseph P.; Lee, Kuo-Fen; Slesinger, Paul A.; Wang, Lei			Genetically encoding unnatural amino acids for cellular and neuronal studies	NATURE NEUROSCIENCE			English	Article							TRANSFER-RNA-SYNTHETASE; GREEN FLUORESCENT PROTEINS; POLYMERASE-III; K+ CHANNEL; POTASSIUM CHANNELS; INACTIVATION GATE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; BINDING-SITE; CODE	Proteins participate in various biological processes and can be harnessed to probe and control biological events selectively and reproducibly, but the genetic code limits the building block to 20 common amino acids for protein manipulation in living cells. The genetic encoding of unnatural amino acids will remove this restriction and enable new chemical and physical properties to be precisely introduced into proteins. Here we present new strategies for generating orthogonal tRNA-synthetase pairs, which made possible the genetic encoding of diverse unnatural amino acids in different mammalian cells and primary neurons. Using this new methodology, we incorporated unnatural amino acids with extended side chains into the K(+) channel Kv1.4, and found that the bulkiness of residues in the inactivation peptide is essential for fast channel inactivation, a finding that had not been possible using conventional mutagenesis. This technique will stimulate and facilitate new molecular studies using tailored unnatural amino acids for cell biology and neurobiology.	Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Proteom, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Wang, L (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Proteom, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slesinger@salk.edu; lwang@salk.edu	Noel, Joseph P/A-9459-2009; wang, wenyuan/F-7218-2011; Wang, Lei/E-7912-2011	Wang, Lei/0000-0002-5859-2526	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060833] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R01 HD034534-10A2, R01 HD034534, R01 HD034534-11] Funding Source: Medline; NINDS NIH HHS [R01 NS060833, R01 NS060833-01A1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Beene DL, 2004, J NEUROSCI, V24, P9097, DOI 10.1523/JNEUROSCI.2429-04.2004; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; CORNISH VW, 1995, ANGEW CHEM INT EDIT, V34, P621, DOI 10.1002/anie.199506211; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; DOCTOR BP, 1963, J BIOL CHEM, V238, P3677; Drabkin HJ, 1996, MOL CELL BIOL, V16, P907; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; GALLI G, 1981, NATURE, V294, P626, DOI 10.1038/294626a0; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Kondoh S, 1997, J BIOL CHEM, V272, P19333, DOI 10.1074/jbc.272.31.19333; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Summerer D, 2006, P NATL ACAD SCI USA, V103, P9785, DOI 10.1073/pnas.0603965103; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; YUAN Y, 1991, BIOCHIM BIOPHYS ACTA, V1089, P33, DOI 10.1016/0167-4781(91)90081-V; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	38	122	129	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1063	1072		10.1038/nn1932	http://dx.doi.org/10.1038/nn1932			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603477	Green Accepted			2022-12-24	WOS:000248357500021
J	Benucci, A; Frazor, RA; Carandini, M				Benucci, Andrea; Frazor, Robert A.; Carandini, Matteo			Standing waves and traveling waves distinguish two circuits in visual cortex	NEURON			English	Article							CAT STRIATE CORTEX; SIMPLE CELLS; SPATIAL-FREQUENCY; COMPLEX CELLS; RETINOTOPIC ORGANIZATION; ORIENTATION SELECTIVITY; SPATIOTEMPORAL PATTERNS; RECEPTIVE-FIELDS; PRIMATE STRIATE; HORIZONTAL PROPAGATION	The visual cortex represents stimuli through the activity of neuronal populations. We measured the evolution of this activity in space and time by imaging voltage-sensitive dyes in cat area V1. Contrast-reversing stimuli elicit responses that oscillate at twice the stimulus frequency, indicating that signals originate mostly in complex cells. These responses stand clear of the noise, whose amplitude decreases as 1/frequency, and yield high-resolution maps of orientation preference and retinotopy. We first show how these maps are combined to yield the responses to focal, oriented stimuli. We then study the evolution of the oscillating activity in space and time. In the orientation domain, it is a standing wave. In the spatial domain, it is a traveling wave propagating at 0.2-0.5 m/s. These different dynamics indicate a fundamental distinction in the circuits underlying selectivity for position and orientation, two key stimulus attributes.	Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	The Smith-Kettlewell Eye Research Institute	Carandini, M (corresponding author), Smith Kettlewell Eye Res Inst, 2318 Filmore St, San Francisco, CA 94115 USA.	matteo@ski.org	Carandini, Matteo/ABD-8296-2021; Benucci, Andrea/N-6361-2015; Carandini, Matteo/C-1922-2008	Carandini, Matteo/0000-0003-4880-7682; Benucci, Andrea/0000-0002-7698-6289; Carandini, Matteo/0000-0003-4880-7682	NEI NIH HHS [R21 EY016441-01, R01-EY017396, R01 EY017396, R21 EY016441, R21-EY016441, R01 EY017396-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R21EY016441, R01EY017396] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams DL, 2003, J NEUROSCI, V23, P5984, DOI 10.1523/JNEUROSCI.23-14-05984.2003; Adams DL, 2003, J NEUROSCI, V23, P3771; ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Balasubramanian M, 2002, NEURAL NETWORKS, V15, P1157, DOI 10.1016/S0893-6080(02)00094-1; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Buzas P, 2003, EUR J NEUROSCI, V18, P957, DOI 10.1046/j.1460-9568.2003.02808.x; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; DEAN AF, 1986, EXP BRAIN RES, V62, P143; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Frazor RA, 2004, J NEUROPHYSIOL, V91, P2607, DOI 10.1152/jn.00858.2003; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; Gillespie DC, 2001, NAT NEUROSCI, V4, P1014, DOI 10.1038/nn731; GRANNAN ER, 1993, NEURAL COMPUT, V5, P550, DOI 10.1162/neco.1993.5.4.550; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBERMAN Michael, 2002, CAT PRIMARY VISUAL C, P146; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KITANO M, 1995, EXP BRAIN RES, V104, P297; Mante V, 2005, J NEUROPHYSIOL, V94, P788, DOI 10.1152/jn.01094.2004; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Mel BW, 1998, J NEUROSCI, V18, P4325; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Movshon JA, 1978, J PHYSIOL-LONDON, V283, P78; MURAKOSHI T, 1993, NEUROSCI LETT, V163, P211, DOI 10.1016/0304-3940(93)90385-X; NELSON DA, 1995, NEURON, V15, P23, DOI 10.1016/0896-6273(95)90061-6; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; PRITCHARD WS, 1992, INT J NEUROSCI, V66, P119, DOI 10.3109/00207459208999796; REGAN D, 1988, VISION RES, V28, P187, DOI 10.1016/S0042-6989(88)80018-X; REID RC, 1992, VISUAL NEUROSCI, V9, P39, DOI 10.1017/S0952523800006350; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Ringach DL, 2002, J NEUROPHYSIOL, V87, P1018, DOI 10.1152/jn.00614.2001; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Senseman DM, 1999, VISUAL NEUROSCI, V16, P65, DOI 10.1017/S0952523899161030; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; Sharon D, 2002, SCIENCE, V295, P512, DOI 10.1126/science.1065916; SHARON D, 2007, IN PRESS CEREB CORTE; SHEVELEV IA, 1993, NEUROSCIENCE, V56, P865, DOI 10.1016/0306-4522(93)90133-Z; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Telfeian AE, 2003, NEUROSCI LETT, V343, P121, DOI 10.1016/S0304-3940(03)00379-3; Tucker TR, 2003, J NEUROPHYSIOL, V89, P488, DOI 10.1152/jn.00869.2001; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; VOLGUSHEV M, 1995, VISUAL NEUROSCI, V12, P621, DOI 10.1017/S0952523800008919; Wu JY, 2001, J NEUROPHYSIOL, V86, P2461, DOI 10.1152/jn.2001.86.5.2461; Yuste R, 1997, CEREB CORTEX, V7, P546, DOI 10.1093/cercor/7.6.546; ZEMON V, 1982, P NATL ACAD SCI-BIOL, V79, P5723, DOI 10.1073/pnas.79.18.5723	81	162	164	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					103	117		10.1016/j.neuron.2007.06.017	http://dx.doi.org/10.1016/j.neuron.2007.06.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610820	Green Accepted, Bronze			2022-12-24	WOS:000248010700011
J	Rasin, MR; Gazula, VR; Breunig, JJ; Kwan, KY; Johnson, MB; Liu-Chen, S; Li, HS; Jan, LY; Jan, YN; Rakic, P; Sestan, N				Rasin, Mladen-Roko; Gazula, Valeswara-Rao; Breunig, Joshua J.; Kwan, Kenneth Y.; Johnson, Matthew B.; Liu-Chen, Susan; Li, Hua-Shun; Jan, Lily Yeh; Jan, Yuh-Nung; Rakic, Pasko; Sestan, Nenad			Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors	NATURE NEUROSCIENCE			English	Article							ASYMMETRIC CELL-DIVISION; FATE DETERMINANT NUMB; RADIAL GLIA; NEUROEPITHELIAL CELLS; CEREBRAL-CORTEX; CORTICAL NEUROGENESIS; ADHERENS JUNCTIONS; ENDOCYTIC PROTEIN; STEM-CELLS; BRAIN	The polarity and adhesion of radial glial cells (RGCs), which function as progenitors and migrational guides for neurons, are critical for morphogenesis of the cerebral cortex. These characteristics largely depend on cadherin-based adherens junctions, which anchor apical end-feet of adjacent RGCs to each other at the ventricular surface. Here, we show that mouse numb and numb-like are required for maintaining radial glial adherens junctions. Numb accumulates in the apical end-feet, where it localizes to adherens junction-associated vesicles and interacts with cadherins. Numb and Numbl inactivation in RGCs decreases proper basolateral insertion of cadherins and disrupts adherens junctions and polarity, leading to progenitor dispersion and disorganized cortical lamination. Conversely, overexpression of Numb prolongs RGC polarization, in a cadherin-dependent manner, beyond the normal neurogenic period. Thus, by regulating RGC adhesion and polarity, Numb and Numbl are required for the tissue architecture of neurogenic niches and the cerebral cortex.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA; Coll Med, Inst Mol Med & Genet, Dev Neurobiol Program, Augusta, GA 30912 USA	Yale University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Breunig, Joshua/F-8490-2012; Kwan, Kenneth/AAI-2841-2021; Kwan, Kenneth Y/F-8489-2011	Kwan, Kenneth/0000-0003-4711-071X; Kwan, Kenneth Y/0000-0003-4711-071X; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Breunig, Joshua/0000-0002-3735-3390	NIA NIH HHS [AG019394] Funding Source: Medline; NICHD NIH HHS [HD045481] Funding Source: Medline; NINDS NIH HHS [NS047200] Funding Source: Medline; Autism Speaks [AS1672] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019394] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; CHENN, 1998, MOL CELL NEUOSCI, V11, P183; Doe CQ, 1998, J NEUROBIOL, V36, P111, DOI 10.1002/(SICI)1097-4695(199808)36:2<111::AID-NEU2>3.0.CO;2-4; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Ganzler-Odenthal SII, 1998, J NEUROSCI, V18, P5415; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; LANGFORD LA, 1986, ACTA NEUROPATHOL, V71, P136, DOI 10.1007/BF00687975; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Mashayekhi F, 2002, BRAIN, V125, P1859, DOI 10.1093/brain/awf182; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Osanai Makoto, 2004, Medical Electron Microscopy, V37, P193; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	50	251	268	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					819	827		10.1038/nn1924	http://dx.doi.org/10.1038/nn1924			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17589506				2022-12-24	WOS:000247560200011
J	Chattopadhyaya, B; Di Cristo, G; Wu, CZ; Knott, G; Kuhlman, S; Fu, Y; Palmiter, RD; Huang, ZJ				Chattopadhyaya, Bidisha; Di Cristo, Graziella; Wu, Cai Zhi; Knott, Graham; Kuhlman, Sandra; Fu, Yu; Palmiter, Richard D.; Huang, Z. Josh			GAD67-Mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex	NEURON			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; EXPERIENCE-DEPENDENT PLASTICITY; HIPPOCAMPAL-NEURONS; MESSENGER-RNA; GROWTH CONES; CHOLINE-ACETYLTRANSFERASE; GABAERGIC INNERVATION; POSTNATAL-DEVELOPMENT; ORGANOTYPIC CULTURES	The development of GABAergic inhibitory circuits is shaped by neural activity, but the underlying mechanisms are unclear. Here, we demonstrate a novel function of GABA in regulating GABAergic innervation in the adolescent brain, when GABA is mainly known as an inhibitory transmitter. Conditional knockdown of the rate-limiting synthetic enzyme GAD67 in basket interneurons in adolescent visual cortex resulted in cell autonomous deficits in axon branching, perisomatic synapse formation around pyramidal neurons, and complexity of the innervation fields; the same manipulation had little influence on the subsequent maintenance of perisomatic synapses. These effects of GABA deficiency were rescued by suppressing GABA reuptake and by GABA receptor agonists. Germline knockdown of GAD67 but not GAD65 showed similar deficits, suggesting a specific role of GAD67 in the maturation of perisomatic innervation. Since intracellular GABA levels are modulated by neuronal activity, our results implicate GAD67-mediated GABA synthesis in activity-dependent regulation of inhibitory innervation patterns.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Neurosci Program, Stony Brook, NY 11790 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Lausanne; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu	Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282; Knott, Graham W/0000-0002-2956-9052; Huang, Z. Josh/0000-0003-0592-028X	NATIONAL EYE INSTITUTE [R01EY013564] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY 13564-01, R01 EY013564-05, R01 EY013564] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Battaglioli G, 2003, J NEUROCHEM, V86, P879, DOI 10.1046/j.1471-4159.2003.01910.x; Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; BENSON DL, 1989, MOL BRAIN RES, V5, P279, DOI 10.1016/0169-328X(89)90062-4; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; Chiu CS, 2002, J NEUROSCI, V22, P10251; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; Dupuy ST, 1996, J NEUROSCI, V16, P6919; Echevarria D, 2000, DEV BRAIN RES, V123, P151, DOI 10.1016/S0165-3806(00)00089-4; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; FELDBLUM S, 1993, J NEUROSCI RES, V34, P689, DOI 10.1002/jnr.490340612; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Gao XB, 2000, J PHYSIOL-LONDON, V523, P629, DOI 10.1111/j.1469-7793.2000.t01-1-00629.x; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gierdalski M, 2001, CEREB CORTEX, V11, P806, DOI 10.1093/cercor/11.9.806; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ikeda M, 2003, BRAIN RES, V984, P149, DOI 10.1016/S0006-8993(03)03126-3; Jensen R.P., 2001, INT J GEOMECH, V1, P1, DOI [10.1061/(ASCE)1532-3641(2001)1:1(1), DOI 10.1061/(ASCE)1532-3641(2001)1:1(1)]; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kiser PJ, 1998, J COMP NEUROL, V402, P62; Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Liang F, 1996, EXP BRAIN RES, V110, P163; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Morales B, 2002, J NEUROSCI, V22, P8084; Murphy DD, 1998, J NEUROSCI, V18, P2550; NILSSON M, 1993, NEUROSCIENCE, V54, P605, DOI 10.1016/0306-4522(93)90232-5; Overstreet LS, 2000, J NEUROSCI, V20, P7914; Owens DF, 2002, NEURON, V36, P989, DOI 10.1016/S0896-6273(02)01136-4; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Patz S, 2003, EUR J NEUROSCI, V18, P1, DOI 10.1046/j.1460-9568.2003.02702.x; Pinal CS, 1998, PERSPECT DEV NEUROBI, V5, P109; RIMVALL K, 1994, J NEUROCHEM, V62, P1375; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPOERRI PE, 1988, SYNAPSE, V2, P11, DOI 10.1002/syn.890020104; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tanaka D, 2003, DEVELOPMENT, V130, P5803, DOI 10.1242/dev.00825; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Wei JN, 2004, BIOCHEMISTRY-US, V43, P6182, DOI 10.1021/bi0496992; WOLFF JR, 1978, NATURE, V274, P72, DOI 10.1038/274072a0; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	74	228	228	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2007	54	6					889	903		10.1016/j.neuron.2007.05.015	http://dx.doi.org/10.1016/j.neuron.2007.05.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582330	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000247645600009
J	Kim, JY; Jung, SC; Clemens, AM; Petralia, RS; Hoffman, DA				Kim, Jinhyun; Jung, Sung-Cheri; Clemens, Ann M.; Petralia, Ronald S.; Hoffman, Dax A.			Regulation of dendritic excitability by activity-dependent trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal neurons	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; IONOTROPIC GLUTAMATE RECEPTORS; TEMPORAL-LOBE EPILEPSY; LONG-TERM DEPRESSION; AMPA RECEPTORS; SYNAPTIC PLASTICITY; POTASSIUM CHANNELS; NMDA RECEPTORS; DIFFERENTIAL EXPRESSION; EXCITATORY SYNAPSES	Voltage-gated A-type K+ channel Kv4.2 sub-units are highly expressed in the dendrites of hippocampal CA1 neurons. However, little is known about the subcellular distribution and trafficking of Kv4.2-containing channels. Here we provide evidence for activity-dependent trafficking of Kv4.2 in hippocampal spines and dendrites. Live imaging and electrophysiological recordings showed that Kv4.2 internalization is induced rapidly upon glutamate receptor stimulation. Kv4.2 internalization was clathrin mediated and required NMDA receptor activation and Ca2+ influx. In dissociated hippocampal neurons, mEPSC amplitude depended on functional Kv4.2 expression level and was enhanced by stimuli that induced Kv4.2 internalization. Long-term potentiation (LTP) induced by brief glycine application resulted in synaptic insertion of GluR1-containing AMPA receptors along with Kv4.2 internalization. We also found evidence of Kv4.2 internalization upon synaptically evoked LTP in CA1 neurons of hippocampal slice cultures. These results present an additional mechanism for synaptic integration and plasticity through the activity-dependent regulation of Kv4.2 channel surface expression.	NICHHD, Mol Neurophysiol & Biophys Unit, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; NIDCD, Sect Neurotransmitter Receptor Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Kim, JY (corresponding author), NICHHD, Mol Neurophysiol & Biophys Unit, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.	kimji@mail.nih.gov; hoffmand@mail.nih.gov	Hoffman, Dax A/E-5155-2011	Hoffman, Dax A/0000-0001-6999-2157; Clemens, Ann/0000-0001-5488-0902	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HD999999, Z01 HD008755-05] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Alonso G, 1997, NEUROSCIENCE, V77, P617; BARRETT JN, 1974, J PHYSIOL-LONDON, V239, P325, DOI 10.1113/jphysiol.1974.sp010571; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Burkhalter A, 2006, J NEUROSCI, V26, P12274, DOI 10.1523/JNEUROSCI.2599-06.2006; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; CARNEVALE NT, 1982, J NEUROPHYSIOL, V47, P606, DOI 10.1152/jn.1982.47.4.606; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Cash S, 1998, J NEUROSCI, V18, P10; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Damke H, 1996, FEBS LETT, V389, P48, DOI 10.1016/0014-5793(96)00517-0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Halpain S, 1998, J NEUROSCI, V18, P9835; Hering H, 2003, J NEUROSCI, V23, P11759; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jinno S, 2005, NEUROSCIENCE, V134, P483, DOI 10.1016/j.neuroscience.2005.04.065; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Kollo M, 2006, J NEUROSCI, V26, P2684, DOI 10.1523/JNEUROSCI.5257-05.2006; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Lissin DV, 1999, J NEUROSCI, V19, P1263; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Magee J. C., 1999, DENDRITES, P139; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Singh B, 2006, NEUROBIOL DIS, V24, P245, DOI 10.1016/j.nbd.2006.07.001; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	56	247	251	2	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 21	2007	54	6					933	947		10.1016/j.neuron.2007.05.026	http://dx.doi.org/10.1016/j.neuron.2007.05.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582333	Bronze, Green Accepted			2022-12-24	WOS:000247645600012
J	Reiman, EM; Webster, JA; Myers, AJ; Hardy, J; Dunckley, T; Zismann, VL; Joshipura, KD; Pearson, JV; Hu-Lince, D; Huentelman, MJ; Craig, DW; Coon, KD; Liang, WS; Herbert, RH; Beach, T; Rohrer, KC; Zhao, AS; Leung, D; Bryden, L; Marlowe, L; Kaleem, M; Mastroeni, D; Grover, A; Heward, CB; Ravid, R; Rogers, J; Hutton, ML; Melquist, S; Petersen, RC; Alexander, GE; Caselli, RJ; Kukull, W; Papassotiropoulos, A; Stephan, DA				Reiman, Eric M.; Webster, Jennifer A.; Myers, Amanda J.; Hardy, John; Dunckley, Travis; Zismann, Victoria L.; Joshipura, Keta D.; Pearson, John V.; Hu-Lince, Diane; Huentelman, Matthew J.; Craig, David W.; Coon, Keith D.; Liang, Winnie S.; Herbert, RiLee H.; Beach, Thomas; Rohrer, Kristen C.; Zhao, Alice S.; Leung, Doris; Bryden, Leslie; Marlowe, Lauren; Kaleem, Mona; Mastroeni, Diego; Grover, Andrew; Heward, Christopher B.; Ravid, Rivka; Rogers, Joseph; Hutton, Michael L.; Melquist, Stacey; Petersen, Ron C.; Alexander, Gene E.; Caselli, Richard J.; Kukull, Walter; Papassotiropoulos, Andreas; Stephan, Dietrich A.			GAB2 alleles modify Alzheimer's risk in APOE epsilon 4 carriers	NEURON			English	Article							MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E; HIPPOCAMPAL VOLUME; DISEASE; GENOME; GENE; ASSOCIATION; POPULATION; GENOTYPE; BRAIN	The apolipoprotein E (APOE) epsilon 4 allele is the best established genetic risk factor for late-onset Alzheimer's disease (LOAD). We conducted genome-wide surveys of 502,627 single-nucleotide polymorphisms (SNPs) to characterize and confirm other LOAD susceptibility genes. In epsilon 4 carriers from neuropathologically verified discovery, neuropathologically verified replication, and clinically characterized replication cohorts of 1411 cases and controls, LOAD was associated with six SNPs from the GRB-associated binding protein 2 (GAB2) gene and a common haplotype encompassing the entire GAB2 gene. SNP rs2373115 (p = 9 x 10(-11)) was associated with an odds ratio of 4.06 (confidence interval 2.81-14.69), which interacts with APOE epsilon 4 to further modify risk. GAB2 was overexpressed in pathologically vulnerable neurons; the Gab2 protein was detected in neurons, tangle-bearing neurons, and dystrophic neuritis; and interference with GAB2 gene expression increased tau phosphorylation. Our findings suggest that GAB2 modifies LOAD risk in APOE epsilon 4 carriers and influences Alzheimer's neuropathology.	Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; Banner Alzheimers Inst, Phoenix, AZ 85006 USA; Univ Arizona, Dept Psychiat, Tucson, AZ 85724 USA; Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; NIA, Neurogenet Lab, Bethesda, MD 20892 USA; Inst Neurol, Reta Lila Weston Labs, Dept Mol Neurosci, London WC1N 3BG, England; St Josephs Hosp, Div Thorac Oncol Res, Phoenix, AZ 85013 USA; Sun Hlth Res Inst, Sun City, AZ 85351 USA; Kronos Sci Lab, Phoenix, AZ 85016 USA; Dutch Royal Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Arizona State Univ, Dept Psychol, Tempe, AZ 85281 USA; Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; Univ Basel, Biozentrum, Div Mol Psychol & Life Sci Training Facil, Basel, Switzerland; Univ Washington, Natl Alzheimers Coordinating Ctr, Dept Epidemiol, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA; Arizona Alzheimers Consortium, Phoenix, AZ 85006 USA	Translational Genomics Research Institute; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Arizona; University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; St. Joseph's Hospital and Medical Center; Banner Research; Banner Health; Banner Sun Health Research Institute; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Mayo Clinic; Mayo Clinic; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; University of Basel; University of Washington; University of Washington Seattle	Reiman, EM (corresponding author), Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.	eric.reiman@bannerhealth.com; dstephan@tgen.org	Leung, Doris G/R-5447-2016; Hardy, John/C-2451-2009; Pearson, John/AAT-4211-2020; Myers, Amanda J/B-1796-2010; Craig, David Wesley/K-6961-2019; Pearson, John V/F-2249-2011	Leung, Doris G/0000-0002-2558-7798; Hardy, John/0000-0002-3122-0423; Myers, Amanda J/0000-0002-3100-9396; Craig, David Wesley/0000-0003-2040-1955; Pearson, John V/0000-0003-0904-4598; Papassotiropoulos, Andreas/0000-0002-2210-9651; Kukull, Walter/0000-0001-8761-9014	MRC [G0701075] Funding Source: UKRI; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G0701075] Funding Source: Medline; NHLBI NIH HHS [U01HL084744] Funding Source: Medline; NIA NIH HHS [P50 AG05146, P50 AG05142, P30 AG10161, P50 AG005144, P50 AG25711, P30 AG19610, P50 AG08702, P30-AG12300, P30 AG13846, P50 AG16570, P30 AG010161, P50 AG05144, K01 AG024079, P50 AG08671, P50 AG005128, K01AG024079, P50 AG016574, P50 AG17824, P50 AG05134, P50 AG005136, P30 AG012300, P50 AG025688, P50 AG008702, P30 AG017824, R01 AG023193, U01 AG016976, R21 AG029576, R21 AG029576-01, P50 AG008671, P50 AG005134, P50 AG025711, P50 AG05128, AG025688, P50 AG05136, P50 AG16574, P50 AG016570, P30 AG01542, P30 AG019610, P50 AG005681, P50 AG005146, P30 AG013846, K01 AG024079-01A2, P50 AG 05681, K01 AG024079-02, R01 AG23193, P50 AG005142] Funding Source: Medline; NIMH NIH HHS [R01 MH60451, P50 MH060451] Funding Source: Medline; NINDS NIH HHS [U24NS051872, U24 NS051872, R01 NS39764, P50 NS039764] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764, U24NS051872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG029576, P50AG025688, K01AG024079, P50AG016570, P50AG005681, P30AG013846, P30AG012300, P50AG005146, P50AG005136, P50AG005144, Z01AG000950, P50AG025711, P50AG005134, P50AG016574, P50AG008702, U01AG016976, P50AG005128, P50AG005142, P30AG017824, R01AG023193, P30AG019610, P30AG010161, P50AG008671] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bobinski M, 2000, NEUROSCIENCE, V95, P721; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Hua JP, 2007, BIOINFORMATICS, V23, P57, DOI 10.1093/bioinformatics/btl536; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Johnson SC, 2006, NEUROBIOL AGING, V27, P1604, DOI 10.1016/j.neurobiolaging.2005.09.017; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Koncz G, 2002, IMMUNOL LETT, V82, P41, DOI 10.1016/S0165-2478(02)00017-2; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li KC, 2004, P NATL ACAD SCI USA, V101, P15561, DOI 10.1073/pnas.0402962101; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Papassotiropoulos A, 2006, J CLIN PSYCHIAT, V67, P652, DOI 10.4088/JCP.v67n0418; Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158; Pritchard JK, 2000, GENETICS, V155, P945; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Zompi S, 2004, J LEUKOCYTE BIOL, V76, P896, DOI 10.1189/jlb.0304179	32	378	396	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 7	2007	54	5					713	720		10.1016/j.neuron.2007.05.022	http://dx.doi.org/10.1016/j.neuron.2007.05.022			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553421	Bronze, Green Accepted			2022-12-24	WOS:000247329900006
J	Amedi, A; Stern, WM; Camprodon, JA; Bermpohl, F; Merabet, L; Rotman, S; Hemond, C; Meijer, P; Pascual-Leone, A				Amedi, Amir; Stern, William M.; Camprodon, Joan A.; Bermpohl, Felix; Merabet, Lotfi; Rotman, Stephen; Hemond, Christopher; Meijer, Peter; Pascual-Leone, Alvaro			Shape conveyed by visual-to-auditory sensory substitution activates the lateral occipital complex	NATURE NEUROSCIENCE			English	Article							CORTEX; PERCEPTION; PATHWAY; VISION	The lateral-occipital tactile-visual area (LOtv) is activated when objects are recognized by vision or touch. We report here that the LOtv is also activated in sighted and blind humans who recognize objects by extracting shape information from visual-to-auditory sensory substitution soundscapes. Recognizing objects by their typical sounds or learning to associate specific soundscapes with specific objects do not activate this region. This suggests that LOtv is driven by the presence of shape information.	Harvard Univ, Sch Med, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA; Hebrew Univ Jerusalem, Dept Physiol, IL-91220 Jerusalem, Israel; Hebrew Univ Jerusalem, Program Cognit Sci, IL-91220 Jerusalem, Israel; Charite Univ Med Berlin, Dept Psychiat, D-10117 Berlin, Germany; NXP Semicond, NL-5656 AE Eindhoven, Netherlands	Harvard University; Harvard Medical School; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; NXP Semiconductors	Amedi, A (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, 330 Brookline Ave, Boston, MA 02115 USA.	aamedi@bidmc.harvard.edu; apleone@bidmc.harvard.edu	Merabet, Lotfi B./V-2735-2017; Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011; Hemond, Christopher/AAJ-7568-2020; merabet, lotfi/AAU-8259-2020; Camprodon, Joan Albert/M-9093-2017	Merabet, Lotfi B./0000-0002-8094-9536; Pascual-Leone, Alvaro/0000-0001-8975-0382; Hemond, Christopher/0000-0002-2408-4638; merabet, lotfi/0000-0002-8094-9536; Camprodon, Joan Albert/0000-0003-1282-9257; Amedi, Amir/0000-0001-5042-2533; Bermpohl, Felix/0000-0002-3260-6328	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER; NCRR NIH HHS [K24-RR018875] Funding Source: Medline; NEI NIH HHS [R01-EY12091, R21-EY0116168] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amedi A, 2005, EXP BRAIN RES, V166, P559, DOI 10.1007/s00221-005-2396-5; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Hull J.M., 1992, TOUCHING ROCK EXPERI; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 2001, VISION NEURONS COGNI, pCH27; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Renier L, 2005, NEUROIMAGE, V26, P573, DOI 10.1016/j.neuroimage.2005.01.047; RICCIARDI E, 2007, CEREB, DOI DOI 10.1098/CERC3R/BH7018; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	15	270	272	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					687	689		10.1038/nn1912	http://dx.doi.org/10.1038/nn1912			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515898				2022-12-24	WOS:000246799800010
J	Li, B; Woo, RS; Mei, L; Malinow, R				Li, Bo; Woo, Ran-Sook; Mei, Lin; Malinow, Roberto			The neuregulin-1 receptor ErbB4 controls Glutamatergic synapse maturation and plasticity	NEURON			English	Article							CEREBELLAR GRANULE NEURONS; IN-VIVO; NEURODEVELOPMENTAL HYPOTHESIS; OLIGODENDROCYTE DEVELOPMENT; ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR-JUNCTION; EXPRESSION ANALYSIS; GENE-EXPRESSION; ANIMAL-MODELS; SCHIZOPHRENIA	Neuregulin-1 (NRG1) signaling participates in numerous neurodevelopmental processes. Through linkage analysis, nrg1 has been associated with schizophrenia, although its pathophysiological role is not understood. The prevailing models of schizophrenia invoke hypofunction of the glutamatergic synapse and defects in early development of hippocampal-cortical circuitry. Here, we show that the erbB4 receptor, as a postsynaptic target of NRG1, plays a key role in activity-dependent maturation and plasticity of excitatory synaptic structure and function. Synaptic activity leads to the activation and recruitment of erbB4 into the synapse. Overexpressed erbB4 selectively enhances AMPA synaptic currents and increases dendritic spine size. Preventing NRG1/erbB4 signaling destabilizes synaptic AMPA receptors and leads to loss of synaptic NMDA currents and spines. Our results indicate that normal activity-driven glutamatergic synapse development is impaired by genetic deficits in NRG1/erbB4 signaling leading to glutamatergic hypofunction. These findings link proposed effectors in schizophrenia: NRG1/erbB4 signaling perturbation, neurodevelopmental deficit, and glutamatergic hypofunction.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Med Coll Georgia, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA; Med Coll Georgia, Inst Mol Med & Genet, Dept Neurol, Augusta, GA 30912 USA	Cold Spring Harbor Laboratory; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.edu	Mei, Lin/G-8755-2012	Li, Bo/0000-0002-0154-3088	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049159, R37MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG032132-14, R01 AG032132-15, R01 AG032132] Funding Source: Medline; NIMH NIH HHS [R37 MH049159, R37 MH049159-17, R01 MH049159-09, R01 MH049159] Funding Source: Medline; NINDS NIH HHS [R01 NS032827-13, R01 NS032827] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott C, 2006, CURR OPIN PSYCHIATR, V19, P135, DOI 10.1097/01.yco.0000214337.29378.cd; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Anton ES, 1997, DEVELOPMENT, V124, P3501; ARNOLD D, 1994, P NATL ACAD SCI USA, V91, P9970, DOI 10.1073/pnas.91.21.9970; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bertolino A, 1997, CEREB CORTEX, V7, P740, DOI 10.1093/cercor/7.8.740; Bressan RA, 2000, EUR J NUCL MED, V27, P1723, DOI 10.1007/s002590000372; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; Coyle JT, 2004, INT REV NEUROBIOL, V59, P491; Daenen EWPM, 2003, EUR NEUROPSYCHOPHARM, V13, P187, DOI 10.1016/S0924-977X(03)00007-5; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; EHLRICH I, 2004, J NEUROSCI, V24, P916; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; El-Hussein AE, 2000, SCIENCE, V290, P1364; Escher P, 2005, SCIENCE, V308, P1920, DOI 10.1126/science.1108258; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fernandez PA, 2000, NEURON, V28, P81, DOI 10.1016/S0896-6273(00)00087-8; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gerecke KM, 2004, MOL CELL NEUROSCI, V27, P379, DOI 10.1016/j.mcn.2004.08.001; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Han B, 1999, PHILOS T ROY SOC B, V354, P411, DOI 10.1098/rstb.1999.0394; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Harrison PJ, 2003, ANN NY ACAD SCI, V1003, P94, DOI 10.1196/annals.1300.006; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Law AJ, 2004, NEUROSCIENCE, V127, P125, DOI 10.1016/j.neuroscience.2004.04.026; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Lewis DA, 2003, ANN NY ACAD SCI, V1003, P102, DOI 10.1196/annals.1300.007; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lipska BK, 2004, J PSYCHIATR NEUROSCI, V29, P282; Liu Y, 2001, J NEUROSCI, V21, P5660, DOI 10.1523/JNEUROSCI.21-15-05660.2001; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Ma L, 2003, J NEUROSCI, V23, P3164; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Norton N, 2006, CURR OPIN PSYCHIATR, V19, P158, DOI 10.1097/01.yco.0000214341.52249.59; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Ozaki M, 2000, J NEUROSCI RES, V59, P612; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Pietraszek M, 2003, POL J PHARMACOL, V55, P133; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; Rehn AE, 2005, CLIN EXP PHARMACOL P, V32, P687, DOI 10.1111/j.1440-1681.2005.04257.x; Rieff HI, 2006, EUR J NEUROSCI, V23, P2225, DOI 10.1111/j.1460-9568.2006.04727.x; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Roysommuti S, 2003, NEUROSCIENCE, V121, P779, DOI 10.1016/S0306-4522(03)00503-7; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schmucker J, 2003, GLIA, V44, P67, DOI 10.1002/glia.10275; Scolnick EM, 2006, HARVARD REV PSYCHIAT, V14, P64, DOI 10.1080/10673220600642960; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sugai T, 2004, ANN NY ACAD SCI, V1025, P84, DOI 10.1196/annals.1316.011; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; USDIN TB, 1986, J CELL BIOL, V103, P493, DOI 10.1083/jcb.103.2.493; van den Buuse M, 2003, CURR MOL MED, V3, P459; VARTANIAN T, 1994, P NATL ACAD SCI USA, V91, P11626, DOI 10.1073/pnas.91.24.11626; Vartanian T, 1999, P NATL ACAD SCI USA, V96, P731, DOI 10.1073/pnas.96.2.731; Walss-Bass C, 2006, BIOL PSYCHIAT, V60, P548, DOI 10.1016/j.biopsych.2006.03.017; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xie F, 2004, J NEUROCHEM, V90, P1521, DOI 10.1111/j.1471-4159.2004.02685.x; Xie F, 2007, J NEUROCHEM, V100, P62, DOI 10.1111/j.1471-4159.2006.04182.x; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Yang XL, 2005, MOL CELL NEUROSCI, V28, P335, DOI 10.1016/j.mcn.2004.10.001; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	100	269	279	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 24	2007	54	4					583	597		10.1016/j.neuron.2007.03.028	http://dx.doi.org/10.1016/j.neuron.2007.03.028			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521571	Green Accepted, Bronze			2022-12-24	WOS:000246970800013
J	Clapcote, SJ; Lipina, TV; Millar, JK; Mackie, S; Christie, S; Ogawa, F; Lerch, JP; Trimble, K; Uchiyama, M; Sakuraba, Y; Kaneda, H; Shiroishi, T; Houslay, MD; Henkelman, RM; Sled, JG; Gondo, Y; Porteous, DJ; Roder, JC				Clapcote, Steven J.; Lipina, Tatiana V.; Millar, J. Kirsty; Mackie, Shaun; Christie, Sheila; Ogawa, Fumiaki; Lerch, Jason P.; Trimble, Keith; Uchiyama, Masashi; Sakuraba, Yoshiyuki; Kaneda, Hideki; Shiroishi, Toshihiko; Houslay, Miles D.; Henkelman, R. Mark; Sled, John G.; Gondo, Yoichi; Porteous, David J.; Roder, John C.			Behavioral phenotypes of Disc1 missense mutations in mice	NEURON			English	Article							CHRONIC MILD STRESS; PREPULSE INHIBITION; SCHIZOPHRENIC-PATIENTS; LATENT INHIBITION; BIPOLAR DISORDER; PHOSPHODIESTERASE ENZYME; STRAIN DIFFERENCES; NEURITE OUTGROWTH; GATING DEFICITS; CEREBRAL-CORTEX	To support the role of DISC1 in human psychiatric disorders, we identified and analyzed two independently derived ENU-induced mutations in Exon 2 of mouse Disc1. Mice with mutation Q31L showed depressive-like behavior with deficits in the forced swim test and other measures that were reversed by the antidepressant bupropion, but not by rolipram, a phosphodiesterase-4 (PDE4) inhibitor. In contrast, L100P mutant mice exhibited schizophrenic-like behavior, with profound deficits in prepulse inhibition and latent inhibition that were reversed by antipsychotic treatment. Both mutant DISC1 proteins exhibited reduced binding to the known DISC1 binding partner PDE4B. Q31L mutants had lower PDE4B activity, consistent with their resistance to rolipram, suggesting decreased PDE4 activity as a contributory factor in depression. This study demonstrates that Disc1 missense mutations in mice give rise to phenotypes related to depression and schizophrenia, thus supporting the role of DISC1 in major mental illness.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Edinburgh, Med Genet Sect, Ctr Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Auditory Sci Lab, Toronto, ON M5G 1X8, Canada; RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Univ Glasgow, IBLS, Mol Pharmacol Grp, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Edinburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); RIKEN; University of Glasgow; University of Toronto; University of Toronto	Clapcote, SJ (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	mail.steve@btinternet.com; david.porteous@ed.ac.uk	Roder, John/G-6468-2013; Sakuraba, Yoshiyuki/D-5614-2009; Porteous, David J/C-7289-2013; Gondo, Yoichi/A-5375-2016; Houslay, Miles/AAM-5281-2020; Porteous, David/AAA-3446-2021; Houslay, Miles D/A-6825-2011; Lipina, Tatiana/G-9148-2014; Sled, John G/D-8268-2012; HENKELMAN, MARK/W-6847-2019	Sakuraba, Yoshiyuki/0000-0003-4698-5530; Porteous, David J/0000-0003-1249-6106; Gondo, Yoichi/0000-0003-2184-6489; Porteous, David/0000-0003-1249-6106; Sled, John G/0000-0002-4461-283X; Trimble, Keith/0000-0001-9166-060X; Houslay, Miles/0000-0002-3826-8091	Medical Research Council [G0100266, G0600214] Funding Source: Medline; MRC [G0600214, G0100266] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*AM PSYCH ASS, 1909, DIAGN STAT MAN MENT; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Austin CP, 2003, NEUROREPORT, V14, P951, DOI 10.1097/01.wnr.0000074342.81633.63; Avgustinovich DF, 2000, BEHAV GENET, V30, P101, DOI 10.1023/A:1001999020138; Baillie GS, 2000, BRIT J PHARMACOL, V131, P811, DOI 10.1038/sj.bjp.0703636; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; CADENHEAD KS, 1993, AM J PSYCHIAT, V150, P1862; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Chen XJ, 2006, NEUROIMAGE, V29, P99, DOI 10.1016/j.neuroimage.2005.07.008; Clapcote SJ, 2005, BEHAV GENET, V35, P591, DOI 10.1007/s10519-005-5634-5; Clapcote SJ, 2006, GENETICS, V173, P2407, DOI 10.1534/genetics.106.060749; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; David DJP, 2003, PSYCHOPHARMACOLOGY, V166, P373, DOI 10.1007/s00213-002-1335-4; DAVIS RL, 1981, J CELL BIOL, V90, P101, DOI 10.1083/jcb.90.1.101; Egashira N, 2005, NEUROPSYCHOPHARMACOL, V30, P1996, DOI 10.1038/sj.npp.1300784; Geyer MA, 2003, PROG NEURO-PSYCHOPH, V27, P1071, DOI 10.1016/j.pnpbp.2003.09.003; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hasler G, 2006, BIOL PSYCHIAT, V60, P93, DOI 10.1016/j.biopsych.2005.11.006; Hennah W, 2005, MOL PSYCHIATR, V10, P1097, DOI 10.1038/sj.mp.4001731; Hennah W, 2006, SCHIZOPHRENIA BULL, V32, P409, DOI 10.1093/schbul/sbj079; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huston E, 1997, BIOCHEM J, V328, P549, DOI 10.1042/bj3280549; Insel TR, 2006, MOL PSYCHIATR, V11, P11, DOI 10.1038/sj.mp.4001777; ISHIZUKA K, 2007, IN PRESS MOL PSYCHIA; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Lipina T, 2005, PSYCHOPHARMACOLOGY, V179, P54, DOI 10.1007/s00213-005-2210-x; Maeda K, 2006, BIOL PSYCHIAT, V60, P929, DOI 10.1016/j.biopsych.2006.03.032; MARCHMONT RJ, 1980, BIOCHEM J, V187, P381, DOI 10.1042/bj1870381; MCINTOSH AM, 2006, IN PRESS BIOL PSYCHI; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Michaud EJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-164; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; PERRY W, 1994, AM J PSYCHIAT, V151, P363; Porteous DJ, 2006, BIOL PSYCHIAT, V60, P123, DOI 10.1016/j.biopsych.2006.04.008; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Pouzet B, 2005, PSYCHOPHARMACOLOGY, V178, P9, DOI 10.1007/s00213-004-1976-6; Ralph RJ, 2001, J PHARMACOL EXP THER, V298, P148; Rascle C, 2001, SCHIZOPHR RES, V51, P149, DOI 10.1016/S0920-9964(00)00162-6; ROGERS RJ, 1994, EUR J PHARMACOL, V261, P321; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sakic B, 1996, BRAIN RES BULL, V41, P305, DOI 10.1016/S0361-9230(96)00190-6; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; SCHEIDER HH, 1984, BIOCHEM PHARMACOL, V33, P1690; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strakowski SM, 1999, ARCH GEN PSYCHIAT, V56, P254, DOI 10.1001/archpsyc.56.3.254; SWERDLOW NR, 1994, ARCH GEN PSYCHIAT, V51, P139; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; UEDA T, 1979, J CELL BIOL, V83, P308, DOI 10.1083/jcb.83.2.308; WACHTEL H, 1983, NEUROPHARMACOLOGY, V22, P267, DOI 10.1016/0028-3908(83)90239-3; Weiner I, 2003, PSYCHOPHARMACOLOGY, V169, P257, DOI 10.1007/s00213-002-1313-x; Williams JH, 1998, BRIT J PSYCHIAT, V172, P243, DOI 10.1192/bjp.172.3.243; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	86	411	431	0	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 3	2007	54	3					387	402		10.1016/j.neuron.2007.04.015	http://dx.doi.org/10.1016/j.neuron.2007.04.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481393	Bronze, Green Submitted			2022-12-24	WOS:000246855700010
J	Kindt, KS; Viswanath, V; Macpherson, L; Quast, K; Hu, HZ; Patapoutian, A; Schafer, WR				Kindt, Katie S.; Viswanath, Veena; Macpherson, Lindsey; Quast, Kathleen; Hu, Hongzhen; Patapoutian, Ardem; Schafer, William R.			Caenorhabditis elegans TRPA-1 functions in mechanosensation	NATURE NEUROSCIENCE			English	Article							ION-CHANNEL TRPA1; SENSORY NEURONS; CANDIDATE; ACTIVATION; PROTEIN	Members of the transient receptor potential ( TRP) ion channel family mediate diverse sensory transduction processes in both vertebrates and invertebrates. In particular, members of the TRPA subfamily have distinct thermosensory roles in Drosophila, and mammalian TRPA1 is postulated to have a function in noxious cold sensation and mechanosensation. Here we show that mutations in trpa-1, the C. elegans ortholog of mouse Trpa1, confer specific defects in mechanosensory behaviors related to nosetouch responses and foraging. trpa-1 is expressed and functions in sensory neurons required for these mechanosensory behaviors, and contributes to neural responses of these cells to touch, particularly after repeated mechanical stimulation. Furthermore, mechanical pressure can activate C. elegans TRPA- 1 heterologously expressed in mammalian cells. Collectively, these data demonstrate that trpa-1 encodes an ion channel that can be activated in response to mechanical pressure and is required for mechanosensory neuron function, suggesting a possible role in mechanosensory transduction or modulation.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; MRC Laboratory Molecular Biology; University of California System; University of California San Diego; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Hopkins Rd, San Diego, CA 92121 USA.	apatapou@gnf.org; wschafer@mrc-lmb.cam.ac.uk	Kindt, Katie/AAS-3275-2020	Macpherson, Lindsey/0000-0002-1089-3733; Hu, Hongzhen/0000-0002-8967-7522; Schafer, William/0000-0002-6676-8034; Kindt, Katie/0000-0002-1065-8215	MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: Medline; NIDA NIH HHS [R01DA018341, R01DA016445] Funding Source: Medline; NIDCR NIH HHS [R01DE016927] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341, R01DA016445] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Chakfe Y, 2006, AM J PHYSIOL-REG I, V290, pR1183, DOI 10.1152/ajpregu.00716.2005; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chalfie M, 1997, BIOL BULL, V192, P125, DOI 10.2307/1542584; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Cho HW, 2002, J NEUROSCI, V22, P1238, DOI 10.1523/JNEUROSCI.22-04-01238.2002; Colbert HA, 1997, J NEUROSCI, V17, P8259; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman Miriam B, 2006, WormBook, P1; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hilliard MA, 2005, EMBO J, V24, P1489, DOI 10.1038/sj.emboj.7600639; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Kanzaki M, 1999, SCIENCE, V285, P1493; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McBride D W Jr, 1999, Methods Enzymol, V294, P482; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SACHS F, 1990, J PHYSIOL-LONDON, V431, P103; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	50	157	169	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					568	577		10.1038/nn1886	http://dx.doi.org/10.1038/nn1886			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450139				2022-12-24	WOS:000245948000013
J	Wang, XL; Zhang, MS; Cohen, IS; Goldberg, ME				Wang, Xiaolan; Zhang, Mingsha; Cohen, Ian S.; Goldberg, Michael E.			The proprioceptive representation of eye position in monkey primary somatosensory cortex	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SUPERIOR COLLICULUS; COROLLARY DISCHARGE; MUSCLE PROPRIOCEPTION; VISUAL SPACE; AREA 3A; NEURONS; INFORMATION; MOVEMENTS; LOCALIZATION	The cerebral cortex must have access to an eye position signal, as humans can report passive changes in eye position in total darkness, and visual responses in many cortical areas are modulated by eye position. The source of this signal is unknown. Here we demonstrate a representation of eye position in monkey primary somatosensory cortex, in the representation of the trigeminal nerve, near cells with a tactile representation of the contralateral brow. The neurons have eye position signals that increase monotonically with increasing orbital eccentricity from near the center of gaze, with directionally selectivity tuned in a Gaussian manner. All directions of eye position are represented in a single hemisphere. The signal is proprioceptive, because it can be obliterated by anesthetizing the contralateral orbit. It is not related to foveal or peripheral visual stimulation, and it represents the position of the eye in the head and not the angle of gaze in space.	Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Zhang, MS (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, 1051 Riverside Dr,Unit 87, New York, NY 10032 USA.	mz2132@columbia.edu			NEI NIH HHS [1 R24 EY015634-01, R01 EY017039, R21 EY017938, R24 EY015634, 1 R01 EY014978-01, R01 EY014978] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014978, R24EY015634, R21EY017938, R01EY017039] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Buttner-Ennever JA, 2002, CURR OPIN NEUROL, V15, P35, DOI 10.1097/00019052-200202000-00007; Campos M, 2006, J NEUROPHYSIOL, V95, P505, DOI 10.1152/jn.00639.2005; Dengis CA, 1998, EXP BRAIN RES, V119, P475, DOI 10.1007/s002210050363; Donaldson IML, 2000, PHILOS T R SOC B, V355, P1685, DOI 10.1098/rstb.2000.0732; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Eberhorn AC, 2005, ANN NY ACAD SCI, V1039, P1, DOI 10.1196/annals.1325.001; GAUTHIER GM, 1990, SCIENCE, V249, P58, DOI 10.1126/science.2367852; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Hays AV, 1982, WESCON C P, V2, P1; HENN V, 1984, BRAIN, V107, P619, DOI 10.1093/brain/107.2.619; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Klier EM, 2003, J NEUROPHYSIOL, V89, P2839, DOI 10.1152/jn.00763.2002; Krubitzer L, 2004, J COMP NEUROL, V471, P97, DOI 10.1002/cne.20025; LAL R, 1990, J NEUROPHYSIOL, V63, P502, DOI 10.1152/jn.1990.63.3.502; LEWIS RF, 1994, J NEUROPHYSIOL, V72, P1028, DOI 10.1152/jn.1994.72.2.1028; Lewis RF, 1998, J NEUROPHYSIOL, V80, P1605, DOI 10.1152/jn.1998.80.3.1605; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; PHILLIPS CG, 1971, J PHYSIOL-LONDON, V217, P419, DOI 10.1113/jphysiol.1971.sp009579; PORTER JD, 1983, J COMP NEUROL, V218, P208, DOI 10.1002/cne.902180208; Pouget A, 1999, Prog Brain Res, V121, P81; RICHMOND BJ, 1980, J NEUROPHYSIOL, V43, P1156, DOI 10.1152/jn.1980.43.4.1156; ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393; Rose D, 1999, PERCEPTION, V28, P675, DOI 10.1068/p2881; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; SALINAS E, 1995, J NEUROSCI, V15, P6461; SKAVENSKI AA, 1972, VISION RES, V12, P221, DOI 10.1016/0042-6989(72)90113-7; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; STEINBACH MJ, 1986, ACTA PSYCHOL, V63, P297, DOI 10.1016/0001-6918(86)90049-1; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; Taylor A, 2006, J PHYSIOL-LONDON, V571, P711, DOI 10.1113/jphysiol.2005.101634; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; Widener GL, 1997, J NEUROPHYSIOL, V77, P2446, DOI 10.1152/jn.1997.77.5.2446; WISE SP, 1981, J NEUROPHYSIOL, V45, P482, DOI 10.1152/jn.1981.45.3.482; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P727, DOI 10.1152/jn.1969.32.5.727; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	41	163	164	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					640	646		10.1038/nn1878	http://dx.doi.org/10.1038/nn1878			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396123				2022-12-24	WOS:000245948000021
J	Winocur, G; Moscovitch, M; Sekeres, M				Winocur, Gordon; Moscovitch, Morris; Sekeres, Melanie			Memory consolidation or transformation: context manipulation and hippocampal representations of memory	NATURE NEUROSCIENCE			English	Article							RETROGRADE-AMNESIA; DORSAL HIPPOCAMPAL; SPATIAL MEMORY; LESIONS; FEAR; NEUROANATOMY; ANTEROGRADE; MONKEYS; COMPLEX; DAMAGE	The traditional view is that the hippocampus is necessary for retaining memories until they are consolidated in their original form in the neocortex. An alternative view is that the original memory, which is hippocampus- and context- dependent, becomes transformed with time to one that is more schematic and independent of the hippocampus. By manipulating context in two protocols that are widely used to investigate hippocampal- neocortical interactions in memory, we find evidence for the transformation view.	Rotman Res Inst, Baycrest Ctr, Toronto, ON M6A 2E1, Canada; Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Baycrest; Trent University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Winocur, G (corresponding author), Rotman Res Inst, Baycrest Ctr, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	gwinocur@rotman-baycrest.on.ca		Sekeres, Melanie/0000-0002-7952-3175				ALVAREZ P, 1995, J NEUROSCI, V15, P3796; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GISQUETVERRIER P, 1986, ANIM LEARN BEHAV, V14, P349, DOI 10.3758/BF03200078; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4	15	165	165	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					555	557		10.1038/nn1880	http://dx.doi.org/10.1038/nn1880			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396121				2022-12-24	WOS:000245948000011
J	Gray, MA; Critchley, HD				Gray, Marcus A.; Critchley, Hugo D.			Interoceptive basis to craving	NEURON			English	Editorial Material							NEURAL MECHANISMS; ADDICTION; EMOTION	Awareness of one's physiology is an important component of emotion. How might these processes be related to addiction? In a recent issue of Science, Naqvi et al. demonstrated that smoking addiction is disrupted by damage to the insula cortex. This suggests that brain circuits mediating interoception also contribute to craving states.	Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 6PX, E Sussex, England	University of Brighton; University of Sussex	Gray, MA (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Falmer Campus, Brighton BN1 6PX, E Sussex, England.	m.a.gray@bsms.ac.uk	Gray, Marcus/F-6521-2013; critchley, hugo d/G-9267-2011	Gray, Marcus/0000-0001-8671-6939; critchley, hugo d/0000-0002-2445-9284	Wellcome Trust [074333] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A.R., 1994, DESCARTES ERROR EMOT; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; Kilts CD, 2004, AM J PSYCHIAT, V161, P233, DOI 10.1176/appi.ajp.161.2.233; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99	14	113	115	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					183	186		10.1016/j.neuron.2007.03.024	http://dx.doi.org/10.1016/j.neuron.2007.03.024			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442239	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000246190600003
J	He, BJ; Snyder, AZ; Vincent, JL; Epstein, A; Shulman, GL; Corbetta, M				He, Biyu J.; Snyder, Abraham Z.; Vincent, Justin L.; Epstein, Adrian; Shulman, Gordon L.; Corbetta, Maurizio			Breakdown of functional connectivity in frontoparietal networks underlies behavioral deficits in spatial neglect	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; VISUAL NEGLECT; SUSTAINED ATTENTION; HEMISPATIAL NEGLECT; UNILATERAL NEGLECT; FRONTAL LESIONS; WORKING-MEMORY; HUMAN BRAIN; HUMANS; MECHANISMS	Spatial neglect is a syndrome following stroke manifesting attentional deficits in perceiving and responding to stimuli in the contralesional field. We examined brain network integrity in patients with neglect by measuring coherent fluctuations of fMRI signals (functional connectivity). Connectivity in two largely separate attention networks located in dorsal and ventral frontoparietal areas was assessed at both acute and chronic stages of recovery. Connectivity in the ventral network, part of which directly lesioned, was diffusely disrupted and showed no recovery. In the structurally intact dorsal network, interhemispheric connectivity in posterior parietal cortex was acutely disrupted but fully recovered. This acute disruption, and disrupted connectivity in specific pathways in the ventral network, strongly correlated with impaired attentional processing across subjects. Lastly, disconnection of the white matter tracts connecting frontal and parietal cortices was associated with more severe neglect and more disrupted functional connectivity. These findings support a network view in understanding neglect.	Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Vincent, Justin L/B-5033-2012; He, Biyu J/A-7795-2009	CORBETTA, MAURIZIO/0000-0001-8295-3304; He, Biyu/0000-0003-1549-1351	NIMH NIH HHS [R01 MH71920-06] Funding Source: Medline; NINDS NIH HHS [R01 NS48013] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048013] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Astafiev SV, 2006, EUR J NEUROSCI, V23, P591, DOI 10.1111/j.1460-9568.2005.04573.x; Bartolomeo P, 2007, CEREB CORTEX, V17, P2479, DOI 10.1093/cercor/bhl181; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Diller L, 1977, Adv Neurol, V18, P63; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Gaffan D, 1997, BRAIN, V120, P1647, DOI 10.1093/brain/120.9.1647; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Heilman K.M., 1985, INT J CLIN NEUROPSYC, V2nd, P243; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hillis AE, 2006, NEUROSCIENTIST, V12, P153, DOI 10.1177/1073858405284257; Husain M, 1996, J NEUROL, V243, P652, DOI 10.1007/BF00878662; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Malhotra P, 2006, CURR OPIN NEUROL, V19, P14, DOI 10.1097/01.wco.0000198101.87670.7e; Malhotra PA, 2006, ANN NEUROL, V59, P186, DOI 10.1002/ana.20701; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Milner AD, 2005, CURR OPIN NEUROL, V18, P748, DOI 10.1097/01.wco.0000191512.60368.ee; MORROW LA, 1988, PSYCHOBIOLOGY, V16, P261; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Peers PV, 2005, CEREB CORTEX, V15, P1469, DOI 10.1093/cercor/bhi029; PETRIDES M, 2002, PRINCIPLES FRONTAL L, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; POSNER MI, 1984, J NEUROSCI, V4, P1863; Quigley M, 2003, AM J NEURORADIOL, V24, P208; Quigley M, 2001, AM J NEURORADIOL, V22, P294; Robertson IH, 2001, NEUROIMAGE, V14, pS85, DOI 10.1006/nimg.2001.0838; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Serences JT, 2004, J NEUROPHYSIOL, V92, P3538, DOI 10.1152/jn.00435.2004; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Shapiro K, 2002, CURR BIOL, V12, P1320, DOI 10.1016/S0960-9822(02)01040-0; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Talairach J., 1988, COPLANAR STEREOTAXIC; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Vallar G., 1987, NEUROPHYSIOLOGICAL N, V45, P235; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Whalley HC, 2005, BRAIN, V128, P2097, DOI 10.1093/brain/awh556; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Zar J. H., 1996, BIOSTATISTICAL ANAL	69	702	726	2	178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					905	918		10.1016/j.neuron.2007.02.013	http://dx.doi.org/10.1016/j.neuron.2007.02.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359924	Bronze, Green Submitted			2022-12-24	WOS:000245292800014
J	Zhang, SJ; Steijaert, MN; Lau, D; Schutz, G; Delucinge-Vivier, C; Descombes, P; Bading, H				Zhang, Sheng-Jia; Steijaert, Marvin N.; Lau, David; Schuetz, Guenther; Delucinge-Vivier, Celine; Descombes, Patrick; Bading, Hilmar			Decoding NMDA receptor signaling: Identification of genomic programs specifying neuronal survival and death	NEURON			English	Article							ACTIVITY-DEPENDENT NEUROPROTECTION; BINDING PROTEIN CREB; CENTER B-CELLS; GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; WIDE ANALYSIS; CALCIUM; TRANSCRIPTION; APOPTOSIS	NMDA receptors promote neuronal survival but also cause cell degeneration and neuron loss. The mechanisms underlying these opposite effects on neuronal fate are unknown. Whole-genome expression profiling revealed that NMDA receptor signaling is decoded at the genomic level through activation of two distinct, largely nonoverlapping gene-expression programs. The location of the NMDA receptor activated specifies the transcriptional response: synaptic NMDA receptors induce a coordinate upregulation of newly identified pro-survival genes and downregulation of pro-death genes. Extrasynaptic NMDA receptors fail to activate this neuroprotective program, but instead induce expression of C/ca1, a putative calcium-activated chloride channel that kills neurons. These results help explain the opposing roles of synaptic and extrasynaptic NMDA receptors on neuronal fate. They also demonstrate that the survival function is implemented in neurons through a multicomponent system of functionally related genes, whose coordinate expression is controlled by specific calcium signal initiation sites.	Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Geneva, CH-1211 Geneva, Switzerland	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Geneva	Bading, H (corresponding author), Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany.	hilmar.bading@uni-hd.de						Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carmel JB, 2004, EXP NEUROL, V185, P81, DOI 10.1016/j.expneurol.2003.09.007; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Corrente G, 2002, NEUROREPORT, V13, P417, DOI 10.1097/00001756-200203250-00011; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dong ZZ, 2005, MOL THER, V11, P80, DOI 10.1016/j.ymthe.2004.09.007; DREYER EB, 1995, NEUROREPORT, V6, P942, DOI 10.1097/00001756-199504190-00029; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; IACOPETTI P, 1994, MECH DEVELOP, V47, P127, DOI 10.1016/0925-4773(94)90085-X; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; LIM RW, 1987, ONCOGENE, V1, P263; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	74	238	245	2	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					549	562		10.1016/j.neuron.2007.01.025	http://dx.doi.org/10.1016/j.neuron.2007.01.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296556	Bronze			2022-12-24	WOS:000245126900013
J	Endo, K; Aoki, T; Yoda, Y; Kimura, KI; Hama, C				Endo, Keita; Aoki, Tomoko; Yoda, Yuka; Kimura, Ken-ichi; Hama, Chihiro			Notch signal organizes the Drosophila olfactory circuitry by diversifying the sensory neuronal lineages	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; MOLECULAR-BASIS; ANTENNAL LOBE; AXON GUIDANCE; CELL FATES; FLY BRAIN; MAP; MELANOGASTER; EXPRESSION	An essential feature of the organization and function of the vertebrate and insect olfactory systems is the generation of a variety of olfactory receptor neurons ( ORNs) that have different specificities in regard to both odorant receptor expression and axonal targeting. Yet the underlying mechanisms that generate this neuronal diversity remain elusive. Here we demonstrate that the Notch signal is involved in the diversification of ORNs in Drosophila melanogaster. A systematic clonal analysis showed that a cluster of ORNs housed in each sensillum were differentiated into two classes, depending on the level of Notch activity in their sibling precursors. Notably, ORNs of different classes segregated their axonal projections into distinct domains in the antennal lobes. In addition, both the odorant receptor expression and the axonal targeting of ORNs were specified according to their Notch-mediated identities. Thus, Notch signaling contributes to the diversification of ORNs, thereby regulating multiple developmental events that establish the olfactory map in Drosophila.	RIKEN, Ctr Dev Biol, Lab Neural Network Dev, Chuo Ku, Kobe, Hyogo 6500047, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev, Chiyoda Ku, Tokyo 1028666, Japan; Hokkaido Univ, Iwarnizawa, Hokkaido 0688642, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); Hokkaido University	Hama, C (corresponding author), RIKEN, Ctr Dev Biol, Lab Neural Network Dev, Chuo Ku, 2-2-3 Minatojima Minami, Kobe, Hyogo 6500047, Japan.	hama@cdb.riken.jp						Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Giraldez AJ, 2002, MECH DEVELOP, V115, P101, DOI 10.1016/S0925-4773(02)00124-7; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Schuldt AJ, 1999, DEV BIOL, V205, P287, DOI 10.1006/dbio.1998.9014; Sen A, 2003, DEV BIOL, V254, P79, DOI 10.1016/S0012-1606(02)00021-0; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Yoshikawa S, 2004, CURR OPIN NEUROBIOL, V14, P45, DOI 10.1016/j.conb.2004.01.005	43	85	88	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					153	160		10.1038/nn1832	http://dx.doi.org/10.1038/nn1832			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220884				2022-12-24	WOS:000244175200009
J	Liu, XY; Chu, XP; Mao, LM; Wang, M; Lan, HX; Li, MH; Zhang, GC; Parelkar, NK; Fibuch, EE; Haines, M; Neve, KA; Liu, F; Xiong, ZG; Wang, JQ				Liu, Xian-Yu; Chu, Xiang-Ping; Mao, Li-Min; Wang, Min; Lan, Hong-Xiang; Li, Ming-Hua; Zhang, Guo-Chi; Parelkar, Nikhil K.; Fibuch, Eugene E.; Haines, Michelle; Neve, Kim A.; Liu, Fang; Xiong, Zhi-Gang; Wang, John Q.			Modulation of D2R-NR2B interactions in response to cocaine	NEURON			English	Article							D-ASPARTATE RECEPTOR; PROTEIN-KINASE-II; NMDA RECEPTOR; BEHAVIORAL SENSITIZATION; NR2B SUBUNIT; TYROSINE PHOSPHORYLATION; DOPAMINE D1; MOLECULAR-MECHANISMS; SURFACE EXPRESSION; GLUTAMATE	Dopamine-glutamate interactions in the neostriatum determine psychostimulant action, but the underlying molecular mechanisms remain elusive. Here we found that dopamine stimulation by cocaine enhances a heteroreceptor complex formation between dopamine D2 receptors (D2R) and NMDA receptor NR2B subunits in the neostriatum in vivo. The D2R-NR2B interaction is direct and occurs in the confined postsynaptic density microdomain of excitatory synapses. The enhanced D2R-NR2B interaction disrupts the association of Ca2+/ calmodulin-dependent protein kinase H (CaMKII) with NR2B, reduces NR2B phosphorylation at a CaMKII-sensitive site (Ser1303), and inhibits NMDA receptor-mediated currents in medium-sized striatal neurons. Furthermore, the regulated D2R-NR2B interaction is critical for constructing behavioral responsiveness to cocaine. Our findings here uncover a direct and dynamic D2R-NR2B interaction in striatal neurons in vivo. This type of dopamine-glutamate integration at the receptor level may be responsible for synergistically inhibiting the D2R-mediated circuits in the basal ganglia and fulfilling the stimulative effect of psychostimulants.	Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA; Univ Missouri, Dept Anesthesiol, Sch Med, Kansas City, MO 64108 USA; Robert S Dow Neurobiol Labs, Portland, OR 97232 USA; Univ Toronto, Dept Neurosci, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; Vet Affairs Med Ctr, Portland, OR 97239 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Wang, JQ (corresponding author), Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA.	wangjq@umkc.edu	LIU, XIANYU/B-8111-2014	Liu, Xianyu/0000-0001-6089-8826; Chu, Xiang-Ping/0000-0002-6781-0468	NIDA NIH HHS [DA010355] Funding Source: Medline; NIMH NIH HHS [MH061469] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010355, R29DA010355] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bibb JA, 2005, CELL, V122, P153, DOI 10.1016/j.cell.2005.07.011; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen YK, 2000, ORG LETT, V2, P743, DOI 10.1021/ol9903887; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; GRAYBIEL AM, 1981, NEUROSCIENCE, V6, P377, DOI 10.1016/0306-4522(81)90131-7; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Holmes A, 2004, NEUROPHARMACOLOGY, V47, P1117, DOI 10.1016/j.neuropharm.2004.07.034; HURD YL, 1989, SYNAPSE, V3, P48, DOI 10.1002/syn.890030107; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Kuppenbender KD, 2000, J COMP NEUROL, V419, P407, DOI 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I; LANDWEHRMEYER GB, 1995, J NEUROSCI, V15, P5297; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Standaert DG, 1999, MOL BRAIN RES, V64, P11, DOI 10.1016/S0169-328X(98)00293-9; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Valjent E, 2000, J NEUROSCI, V20, P8701; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; Wang JQ, 1999, ADDICT BIOL, V4, P141, DOI 10.1080/13556219971641; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 1999, J NEUROSCI, V19; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Yung KKL, 2000, SYNAPSE, V38, P413, DOI 10.1002/1098-2396(20001215)38:4<413::AID-SYN6>3.3.CO;2-M; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004; Zorumski CF, 1998, PROG BRAIN RES, V118, P173	62	193	198	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					897	909		10.1016/j.neuron.2006.10.011	http://dx.doi.org/10.1016/j.neuron.2006.10.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145509	Bronze			2022-12-24	WOS:000242856400016
J	Zhou, ZL; Hong, EJ; Cohen, S; Zhao, WN; Ho, HYH; Schmidt, L; Chen, WG; Lin, YX; Savner, E; Griffith, EC; Hu, L; Steen, JAJ; Weitz, CJ; Greenberg, ME				Zhou, Zhaolan; Hong, Elizabeth J.; Cohen, Sonia; Zhao, Wen-ning; Ho, Hsin-yi Henry; Schmidt, Lauren; Chen, Wen G.; Lin, Yingxi; Savner, Erin; Griffith, Eric C.; Hu, Linda; Steen, Judith A. J.; Weitz, Charles J.; Greenberg, Michael E.			Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation	NEURON			English	Article							SEVERE MENTAL-RETARDATION; IMMEDIATE-EARLY GENES; RETT-SYNDROME; DNA METHYLATION; MOUSE MODEL; NEUROLOGICAL SYMPTOMS; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; NEURONS; EXPRESSION	Mutations or duplications in MECP2 cause Rett and Rett-like syndromes, neurodevelopmental disorders characterized by mental retardation, motor dysfunction, and autistic behaviors. MeCP2 is expressed in many mammalian tissues and functions as a global repressor of transcription; however, the molecular mechanisms by which MeCP2 dysfunction leads to the neural-specific phenotypes of RTT remain poorly understood. Here, we show that neuronal activity and subsequent calcium influx trigger the de novo phosphorylation of MeCP2 at serine 421 (S421) by a CaMKII-dependent mechanism. MeCP2 S421 phosphorylation is induced selectively in the brain in response to physiological stimuli. Significantly, we find that S421 phosphorylation controls the ability of MeCP2 to regulate dendritic patterning, spine morphogenesis, and the activity-dependent induction of Bdnf transcription. These findings suggest that, by triggering MeCP2 phosphorylation, neuronal activity regulates a program of gene expression that mediates nervous system maturation and that disruption of this process in individuals with mutations in MeCP2 may underlie the neural-specific pathology of RTT.	Harvard Univ, Sch Med, Childrens Hosp Boston, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Neurobiol Program, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu		/0000-0002-7002-1275; Chen, Wen/0000-0003-0853-7526; Griffith, Eric/0000-0003-0428-3215	NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NINDS NIH HHS [K99 NS058391-01, NS048276, R01 NS043491, K99 NS058391-02, R00 NS058391-04, R00 NS058391, R00 NS058391-05, K99 NS058391, R00 NS058391-03, NS43491, R01 NS048276] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043491, R01NS048276, R00NS058391, K99NS058391] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ariani F, 2004, HUM MUTAT, V24, P172, DOI 10.1002/humu.20065; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gorski JA, 2003, J NEUROSCI, V23, P6856; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kornhauser JM, 1996, BEHAV GENET, V26, P221, DOI 10.1007/BF02359382; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lom B, 1999, J NEUROSCI, V19, P9928; Lugtenberg D, 2006, J MED GENET, V43, P362, DOI 10.1136/jmg.2005.036178; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rett A, 1966, Wien Med Wochenschr, V116, P723; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	54	634	658	0	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					255	269		10.1016/j.neuron.2006.09.037	http://dx.doi.org/10.1016/j.neuron.2006.09.037			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046689	Green Accepted, Bronze			2022-12-24	WOS:000241799900007
J	Mueller-Steiner, S; Zhou, Y; Arai, H; Roberson, ED; Sun, BG; Chen, J; Wang, X; Yu, GQ; Esposito, L; Mucke, L; Gan, L				Mueller-Steiner, Sarah; Zhou, Yungui; Arai, Hideaki; Roberson, Erik D.; Sun, Binggui; Chen, Jennifer; Wang, Xin; Yu, Guiqiu; Esposito, Luke; Mucke, Lennart; Gan, Li			Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease	NEURON			English	Article							AMYLOID-BETA PEPTIDE; REGULATED SECRETORY VESICLES; INSULIN-DEGRADING ENZYME; TRANSGENIC MOUSE MODEL; BRAIN A-BETA; PRECURSOR PROTEIN; EXTRACELLULAR LEVELS; COGNITIVE FUNCTION; CHROMAFFIN CELLS; PLAQUE-FORMATION	Alzheimer's disease (AD) may result from the accumulation of amyloid-beta (A beta) peptides in the brain. The cysteine protease cathepsin B (CatB) is associated with amyloid plaques in AD brains and has been suspected to increase AD production. Here, we demonstrate that CatB actually reduces levels of AD peptides, especially the aggregation-prone species A beta 1-42, through proteolytic cleavage. Genetic inactivation of CatB in mice with neuronal expression of familial AD-mutant human amyloid precursor protein (hAPP) increased the relative abundance of A beta 1-42, worsening plaque deposition and other AD-related pathologies. Lentivirus-mediated expression of CatB in aged hAPP mice reduced preexisting amyloid deposits, even thioflavin S-positive plaques. Under cell-free conditions, CatB effectively cleaved A beta 1-42, generating C-terminally truncated A beta peptides that are less amyloidogenic. Thus, CatB likely fulfills antiamyloidogenic and neuroprotective functions. Insufficient CatB activity might promote AD; increasing CatB activity could counteract the neuropathology of this disease.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Tokyo	Gan, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	Igan@gladstone.ucsf.edu	Sun, Binggui/J-9028-2016; Sun, Binggui/B-2739-2010; Roberson, Erik/A-5718-2009	Sun, Binggui/0000-0002-0386-6569; Roberson, Erik/0000-0002-1810-9763	NIA NIH HHS [R21 AG024447] Funding Source: Medline; NINDS NIH HHS [K08 NS054811-01, K08 NS054811] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024447] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Authier F, 1999, J BIOL CHEM, V274, P33723, DOI 10.1074/jbc.274.47.33723; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Esposito L, 2004, J NEUROCHEM, V91, P1260, DOI 10.1111/j.1471-4159.2004.02816.x; Frautschy SA, 1998, J NEUROSCI, V18, P8311; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gouras GK, 1998, J NEUROCHEM, V71, P1920; HAMILTON RL, 1980, J LIPID RES, V21, P981; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P334, DOI 10.1006/bbrc.2001.4787; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook VYH, 2002, J NEUROCHEM, V81, P237; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; KHOURI HE, 1991, BIOCHEM J, V275, P751, DOI 10.1042/bj2750751; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Mackay EA, 1997, EUR J BIOCHEM, V244, P414, DOI 10.1111/j.1432-1033.1997.00414.x; Marr RA, 2003, J NEUROSCI, V23, P1992; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V208, P353, DOI 10.1006/bbrc.1995.1345; Tucker HM, 2000, J NEUROSCI, V20, P3937; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Yamin R, 1999, J BIOL CHEM, V274, P18777, DOI 10.1074/jbc.274.26.18777; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	66	315	328	1	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					703	714		10.1016/j.neuron.2006.07.027	http://dx.doi.org/10.1016/j.neuron.2006.07.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982417	Bronze			2022-12-24	WOS:000240997900010
J	Volynski, KE; Rusakov, DA; Kullmann, DM				Volynski, Kirill E.; Rusakov, Dmitri A.; Kullmann, Dimitri M.			Presynaptic fluctuations and release-independent depression	NATURE NEUROSCIENCE			English	Article							MEMBRANE-FUSION; VESICLE FUSION; PLASTICITY; PROBABILITY; MODULATION; SYNAPSES; CALCIUM	Although vesicle depletion contributes to short-term depression, several studies have reported that the release probability can be transiently depressed even if an action potential fails to evoke release. Here we argue that stochastic fluctuation in the release machinery can give rise to apparent release-independent depression as a result of sampling bias. The relationship between this apparent depression and the interstimulus interval provides a window on the kinetics of state transitions of the release apparatus.	UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London	Volynski, KE (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	k.volynski@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021	Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Volynski, Kirill/0000-0001-8208-1905	Medical Research Council [G0400627(76527), G0802216, G0900613, G116/147, G0400627(71256), G0600089, G0400627, G0600368(77987), G0600368] Funding Source: Medline; Wellcome Trust [071179] Funding Source: Medline; MRC [G0400627, G0600089, G116/147] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Brody DL, 2000, J NEUROSCI, V20, P2480; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Finley MFA, 2002, J NEUROSCI, V22, P1266, DOI 10.1523/JNEUROSCI.22-04-01266.2002; Hanse E, 2001, J PHYSIOL-LONDON, V531, P481, DOI 10.1111/j.1469-7793.2001.0481i.x; Hanse E, 2001, J NEUROSCI, V21, P8362, DOI 10.1523/JNEUROSCI.21-21-08362.2001; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Thomson AM, 1999, J PHYSIOL-LONDON, V519, P57, DOI 10.1111/j.1469-7793.1999.0057o.x; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	13	9	9	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1091	1093		10.1038/nn1746	http://dx.doi.org/10.1038/nn1746			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16878129	Green Accepted			2022-12-24	WOS:000240080800007
J	Womelsdorf, T; Anton-Erxleben, K; Pieper, F; Treue, S				Womelsdorf, Thilo; Anton-Erxleben, Katharina; Pieper, Florian; Treue, Stefan			Dynamic shifts of visual receptive fields in cortical area MT by spatial attention	NATURE NEUROSCIENCE			English	Article							FOCUSED ATTENTION; PARIETAL CORTEX; EYE-MOVEMENTS; V4; RESOLUTION; NEURONS; SPACE; LOCALIZATION; MECHANISMS; RESPONSES	Voluntary attention is the top-down selection process that focuses cortical processing resources on the most relevant sensory information. Spatial attention - that is, selection based on stimulus position - alters neuronal responsiveness throughout primate visual cortex. It has been hypothesized that it also changes receptive field profiles by shifting their centers toward attended locations and by shrinking them around attended stimuli. Here we examined, at high resolution, receptive fields in cortical area MT of rhesus macaque monkeys when their attention was directed to different locations within and outside these receptive fields. We found a shift of receptive fields, even far from the current location of attention, accompanied by a small amount of shrinkage. Thus, already in early extrastriate cortex, receptive fields are not static entities but are highly modifiable, enabling the dynamic allocation of processing resources to attended locations and supporting enhanced perception within the focus of attention by effectively increasing the local cortical magnification.	Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EN Nijmegen, Netherlands; German Primate Ctr, Cognit Neurosci Lab, D-37077 Gottingen, Germany	Radboud University Nijmegen; Deutsches Primatenzentrum (DPZ)	Womelsdorf, T (corresponding author), Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, Kapittelweg 29, NL-6525 EN Nijmegen, Netherlands.	t.womelsdorf@fcdonders.ru.nl	Womelsdorf, Thilo/C-3096-2015	Womelsdorf, Thilo/0000-0001-6921-4187				Britten KH, 1999, J NEUROSCI, V19, P5074; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Conner CE, 1997, J NEUROSCI, V17, P3201; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Hamed SB, 2002, CEREB CORTEX, V12, P234, DOI 10.1093/cercor/12.3.234; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Krekelberg B, 2003, NEURON, V37, P537, DOI 10.1016/S0896-6273(03)00003-5; LaBerge D, 1997, J EXP PSYCHOL HUMAN, V23, P1380, DOI 10.1037/0096-1523.23.5.1380; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2001, VISUAL ATTENTION AND CORTICAL CIRCUITS, P103; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Musseler J, 2002, VIS COGN, V9, P120, DOI 10.1080/13506280143000359; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Suzuki S, 1997, J EXP PSYCHOL HUMAN, V23, P443, DOI 10.1037/0096-1523.23.2.443; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Tsal Y, 1999, PSYCHON B REV, V6, P292, DOI 10.3758/BF03212332; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	30	218	220	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1156	1160		10.1038/nn1748	http://dx.doi.org/10.1038/nn1748			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16906153				2022-12-24	WOS:000240080800017
J	Yu, FH; Mantegazza, M; Westenbroek, RE; Robbins, CA; Kalume, F; Burton, KA; Spain, WJ; McKnight, GS; Scheuer, T; Catterall, WA				Yu, Frank H.; Mantegazza, Massimo; Westenbroek, Ruth E.; Robbins, Carol A.; Kalume, Franck; Burton, Kimberly A.; Spain, William J.; McKnight, G. Stanley; Scheuer, Todd; Catterall, William A.			Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; SCN1A MUTATIONS; CHANNEL SUBTYPES; NERVOUS-SYSTEM; GENE SCN1A; SUBUNIT; SUSCEPTIBILITY; SEIZURES; MICE; EXPRESSION	Voltage-gated sodium channels (Na-V) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a(-/-) mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a(+/-) mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a(+/-) and Scn1a(-/-) mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a(+/-) heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Inst Neurol Besta, Dept Neurophysiol, I-20126 Milan, Italy	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; IRCCS Istituto Neurologico Besta	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu	Ritter, Stefanie L/D-9312-2012; Mantegazza, Massimo/J-8802-2016	Mantegazza, Massimo/0000-0002-1070-7929; Yu, Frank/0000-0001-9306-1731				BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; BRANDON EP, 1995, RECENT PROG HORM RES, V50, P403; Buckmaster PS, 1999, J NEUROSCI, V19, P9519; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Ceulemans B, 2004, J CHILD NEUROL, V19, P516, DOI 10.1177/08830738040190070701; Claes L, 2003, HUM MUTAT, V21, P615, DOI 10.1002/humu.10217; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Coppola G, 2002, EPILEPSY RES, V49, P45, DOI 10.1016/S0920-1211(02)00010-4; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Dravet Charlotte, 1992, P75; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; FERRARO TN, 1995, EPILEPSIA, V36, P301, DOI 10.1111/j.1528-1157.1995.tb00999.x; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Ferraro TN, 2002, BRAIN RES, V936, P82, DOI 10.1016/S0006-8993(02)02565-9; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; Fukuma G, 2004, EPILEPSIA, V45, P140, DOI 10.1111/j.0013-9580.2004.15103.x; Gong B, 1999, J COMP NEUROL, V412, P342; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Guerrini R, 1998, EPILEPSIA, V39, P508, DOI 10.1111/j.1528-1157.1998.tb01413.x; Isom LL, 2002, FRONT BIOSCI, V7, P12; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Krzemien DM, 2000, J COMP NEUROL, V420, P70; LOTHMAN EW, 1992, EPILEPSY RES, P301; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Nabbout R, 2003, NEUROLOGY, V60, P1961, DOI 10.1212/01.WNL.0000069463.41870.2F; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oguni H, 2001, BRAIN DEV-JPN, V23, P736, DOI 10.1016/S0387-7604(01)00276-5; Ohmori I, 2002, BIOCHEM BIOPH RES CO, V295, P17, DOI 10.1016/S0006-291X(02)00617-4; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; SCHWARTZKROIN PA, 1994, HIPPOCAMPUS, V4, P239, DOI 10.1002/hipo.450040302; Singh R, 2001, EPILEPSIA, V42, P837, DOI 10.1046/j.1528-1157.2001.042007837.x; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Walls A. F., 2001, Clinical and Experimental Allergy Reviews, V1, P68, DOI 10.1046/j.1472-9725.2001.00009.x; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yu FH, 2003, J NEUROSCI, V23, P7577; YU FH, 2004, SCI STKE; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	50	735	802	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1142	1149		10.1038/nn1754	http://dx.doi.org/10.1038/nn1754			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921370				2022-12-24	WOS:000240080800015
J	Gopfert, MC; Albert, JT; Nadrowski, B; Kamikouchi, A				Goepfert, Martin C.; Albert, Joerg T.; Nadrowski, B.; Kamikouchi, A.			Specification of auditory sensitivity by Drosophila TRP channels	NATURE NEUROSCIENCE			English	Article							HAIR-CELLS; TRANSDUCTION CHANNEL; HEARING; MECHANISMS; CANDIDATE	Ears achieve their exquisite sensitivity by means of mechanical feedback: motile mechanosensory cells through their active motion boost the mechanical input from the ear. Examination of the auditory mechanics in Drosophila melanogaster mutants shows that the transient receptor potential (TRP) channel NompC is required to promote this feedback, whereas the TRP vanilloid (TRPV) channels Nan and Iav serve to control the feedback gain. The combined function of these channels specifies the sensitivity of the fly auditory organ.	Univ Cologne, Inst Zool, Volkswagen Fdn Res Grp, D-50923 Cologne, Germany	University of Cologne; Volkswagen; Volkswagen Germany	Gopfert, MC (corresponding author), Univ Cologne, Inst Zool, Volkswagen Fdn Res Grp, Weyertal 119, D-50923 Cologne, Germany.	m.gopfert@uni-koeln.de	Nadrowski, Björn/D-4979-2012	Kamikouchi, Azusa/0000-0003-1552-6892; Gopfert, Martin/0000-0001-8201-5334				Baguley DM, 2002, BRIT MED BULL, V63, P195, DOI 10.1093/bmb/63.1.195; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Frolenkov GI, 2003, CELL CALCIUM, V33, P185, DOI 10.1016/S0143-4160(02)00228-2; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Shin JB, 2005, P NATL ACAD SCI USA, V102, P12572, DOI 10.1073/pnas.0502403102; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Zheng JF, 2003, J NEUROPHYSIOL, V90, P444, DOI 10.1152/jn.00919.2002	15	114	117	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					999	1000		10.1038/nn1735	http://dx.doi.org/10.1038/nn1735			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819519				2022-12-24	WOS:000240080300009
J	Somerville, LH; Heatherton, TF; Kelley, WM				Somerville, Leah H.; Heatherton, Todd F.; Kelley, William M.			Anterior cingulate cortex responds differentially to expectancy violation and social rejection	NATURE NEUROSCIENCE			English	Article								This study investigated human anterior cingulate cortex (ACC) involvement during a task that dissociated expectancy violation from social rejection. Across two studies, participants underwent functional magnetic resonance imaging while making social judgments and receiving fictitious feedback that was either positive or negative and consistent or inconsistent with their expectations. The results demonstrate that the dorsal ACC is sensitive to expectancy violations, whereas the ventral ACC is differentially responsive to social feedback.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Kelley, WM (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	william.kelley@dartmouth.edu	Heatherton, Todd F/H-5478-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059282, R21MH066720] Funding Source: NIH RePORTER; NIMH NIH HHS [R21 MH066720, MH59282, MH66720] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CONDON JW, 1988, J PERS SOC PSYCHOL, V54, P789, DOI 10.1037/0022-3514.54.5.789; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Newcomb T.M, 1961, ACQUAINTANCE PROCESS; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0	7	303	310	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1007	1008		10.1038/nn1728	http://dx.doi.org/10.1038/nn1728			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819523				2022-12-24	WOS:000240080300012
J	Campbell, DS; Stringham, SA; Timm, A; Xiao, T; Law, MY; Baier, H; Nonet, ML; Chien, CB				Campbell, Douglas S.; Stringham, Sydney A.; Timm, Adam; Xiao, Tong; Law, Mei-Yee; Baier, Herwig; Nonet, Michael L.; Chien, Chi-Bin			Slit1a inhibits retinal ganglion cell arborization and synaptogenesis via Robo2-Dependent and -independent pathways	NEURON			English	Article							REPULSIVE AXON GUIDANCE; IN-VIVO; RETINOTECTAL PROJECTION; SYNAPSE FORMATION; EMBRYONIC ZEBRAFISH; ROUNDABOUT; EXPRESSION; RECEPTOR; SYSTEM; GROWTH	Upon arriving at their targets, developing axons cease pathfinding and begin instead to arborize and form synapses. To test whether CNS arborization and synaptogenesis are controlled by Slit-Robo signaling, we followed single retinal ganglion cell (RGC) arbors over time. ast (robo2) mutant and slit1a morphant arbors had more branch tips and greater arbor area and complexity compared to wild-type and concomitantly more presumptive presynaptic sites labeled with YFP-Rab3. Increased arborization in ast was phenocopied by dominant-negative Robo2 expressed in single RGCs and rescued by full-length Robo2, indicating that Robo2 acts cell-autonomously. Time-lapse imaging revealed that ast and slit1a morphant arbors stabilized earlier than wild-type, suggesting a role for Slit-Robo signaling in preventing arbor maturation. Genetic analysis showed that Slit1a acts both through Robo2 and Robo2-independent mechanisms. Unlike previous PNS studies showing that Slits promote branching, our results show that Slits inhibit arborization and synaptogenesis in the CNS.	Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA; Univ Utah, Inst Brain, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Washington University (WUSTL); University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah	Campbell, DS (corresponding author), Univ Utah, Med Ctr, Dept Neurobiol & Anat, 401 MREB,20 N 1900E, Salt Lake City, UT 84132 USA.	douglas.campbell@cantab.net; chi-bin.chien@neuro.utah.edu		Campbell, Douglas/0000-0002-7371-9484	NEI NIH HHS [EY12406, EY12873, EY13855] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012406, R01EY012873, R01EY013855] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Barresi MJF, 2005, DEVELOPMENT, V132, P3643, DOI 10.1242/dev.01929; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Challa AK, 2001, MECH DEVELOP, V101, P249, DOI 10.1016/S0925-4773(00)00570-0; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dwivedy A, 2007, DEVELOPMENT, V134, P2137, DOI 10.1242/dev.002345; Easter SS, 1996, DEV BIOL, V180, P646; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Hutson LD, 2004, METHOD CELL BIOL, V76, P13; Hutson LD, 2003, DEV DYNAM, V228, P358, DOI 10.1002/dvdy.10386; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Jin YS, 2002, CURR OPIN NEUROBIOL, V12, P71, DOI 10.1016/S0959-4388(02)00292-1; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kawahara A, 2002, DEV BIOL, V248, P107, DOI 10.1006/dbio.2002.0709; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liu Y, 2004, J NEUROSCI, V24, P310, DOI 10.1523/JNEUROSCI.4287-03.2004; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Miyashita T, 2004, DEVELOPMENT, V131, P3705, DOI 10.1242/dev.01228; Nguyen-Ba-Charvet KT, 2001, MOL CELL NEUROSCI, V17, P1048, DOI 10.1006/mcne.2001.0994; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nikolenko V, 2003, METHODS, V30, P3, DOI 10.1016/S1046-2023(03)00003-3; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; Schroeter EH, 2006, VISUAL NEUROSCI, V23, P833, DOI 10.1017/S0952523806230219; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tamura K, 1999, MECH DEVELOP, V87, P181, DOI 10.1016/S0925-4773(99)00126-4; Tokuoka H, 2002, J NEUROSCI, V22, P10324; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yeo SY, 2004, MECH DEVELOP, V121, P315, DOI 10.1016/j.mod.2004.03.006; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105	66	67	68	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2007	55	2					231	245		10.1016/j.neuron.2007.06.034	http://dx.doi.org/10.1016/j.neuron.2007.06.034			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NW	17640525	Bronze			2022-12-24	WOS:000248635800008
J	Sia, GM; Beique, JC; Rumbaugh, G; Cho, R; Worley, PF; Huganir, RL				Sia, Gek-Ming; Beique, Jean-Claude; Rumbaugh, Gavin; Cho, Richard; Worley, Paul F.; Huganir, Richard L.			Interaction of the N-terminal domain of the AMPA receptor GIuR4 subunit with the neuronal pentraxin NP1 mediates GluR4 synaptic recruitment	NEURON			English	Article							BINDING PROTEIN 49; NEUROMUSCULAR SYNAPSE; EXCITATORY SYNAPSES; GLUTAMATE-RECEPTOR; GEPHYRIN; NARP; NEUROTRANSMITTER; DIFFERENTIATION; HIPPOCAMPUS; MEMBRANE	Synaptogenesis requires recruitment of neurotransmitter receptors to developing postsynaptic specializations. We developed a coculture system reconstituting artificial synapses between neurons and nonneuronal cells to investigate the molecular components required for AMPA-receptor recruitment to synapses. With this system, we find that excitatory axons specifically express factors that recruit the AMPA receptor GluR4 subunit to sites of contact between axons and GluR4-transfected nonneuronal cells. Furthermore, the N-terminal domain (NTD) of GluR4 is necessary and sufficient for its recruitment to these artificial synapses and also for GluR4 recruitment to native synapses. Moreover, we show that axonally derived neuronal pentraxins NP1 and NPR are required for GluR4 recruitment to artificial and native synapses. RNAi knockdown and knockout of the neuronal pentraxins significantly decreases GluR4 targeting to synapses. Our results indicate that NP1 and NPR secreted from presynaptic neurons bind to the GluR4 NTD and are critical trans-synaptic factors for GluR4 recruitment to synapses.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Sia, Gek Ming/0000-0001-9333-0065				Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Catania MV, 1998, EUR J NEUROSCI, V10, P3479, DOI 10.1046/j.1460-9568.1998.00356.x; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; Seifert G, 2001, Prog Brain Res, V132, P287; Tomita S, 2007, NEUROPHARMACOLOGY, V52, P87, DOI 10.1016/j.neuropharm.2006.07.012; Tsui CC, 1996, J NEUROSCI, V16, P2463; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131	50	127	130	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					87	102		10.1016/j.neuron.2007.06.020	http://dx.doi.org/10.1016/j.neuron.2007.06.020			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610819	Bronze			2022-12-24	WOS:000248010700010
J	Luo, H; Poeppel, D				Luo, Huan; Poeppel, David			Phase patterns of neuronal responses reliably discriminate speech in human auditory cortex	NEURON			English	Article							BRAIN-WAVE RECOGNITION; TEMPORAL ENVELOPE; NATURAL SOUNDS; OSCILLATIONS; MODULATION; REPRESENTATION; ORGANIZATION; FREQUENCY; AMPLITUDE	How natural speech is represented in the auditory cortex constitutes a major challenge for cognitive neuroscience. Although many single-unit and neuroimaging studies have yielded valuable insights about the processing of speech and matched complex sounds, the mechanisms underlying the analysis of speech dynamics in human auditory cortex remain largely unknown. Here, we show that the phase pattern of theta band (4-8 Hz) responses recorded from human auditory cortex with magnetoencephalography (MEG) reliably tracks and discriminates spoken sentences and that this discrimination ability is correlated with speech intelligibility. The findings suggest that an similar to 200 ms temporal window (period of theta oscillation) segments the incoming speech signal, resetting and sliding to track speech dynamics. This hypothesized mechanism for cortical speech analysis is based on the stimulus-induced modulation of inherent cortical rhythms and provides further evidence implicating the syllable as a computational primitive for the representation of spoken language.	Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Dept Linguist, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Poeppel, D (corresponding author), Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA.	dpoeppel@umd.edu		Luo, Huan/0000-0002-8349-9796	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC05660, R01 DC005660-06A1, R01 DC005660-05, R01 DC005660] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; BASAR E, 2005, NAT NEUROSCI, V8, P389; Basar E., 1998, BRAIN FUNCTION OSCIL; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Dau T, 1997, J ACOUST SOC AM, V102, P2906, DOI 10.1121/1.420345; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Elhilali M, 2003, SPEECH COMMUN, V41, P331, DOI 10.1016/S0167-6393(02)00134-6; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; Greenberg S, 2003, J PHONETICS, V31, P465, DOI 10.1016/j.wocn.2003.09.005; GREENBERG S, 2006, LISTENING SPEECH AN; Griffiths TD, 2004, TRENDS NEUROSCI, V27, P181, DOI 10.1016/j.tins.2004.02.005; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LINAS R, 2001, I VORTEX NEURONS SEL; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luo H, 2006, J NEUROPHYSIOL, V96, P2712, DOI 10.1152/jn.01256.2005; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; Machens CK, 2005, NEURON, V47, P447, DOI 10.1016/j.neuron.2005.06.015; Machens CK, 2003, NAT NEUROSCI, V6, P341, DOI 10.1038/nn1036; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Penny WD, 2002, TRENDS NEUROSCI, V25, P387, DOI 10.1016/S0166-2236(02)02202-6; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Price C, 2005, TRENDS COGN SCI, V9, P271, DOI 10.1016/j.tics.2005.03.009; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Suppes P, 1997, P NATL ACAD SCI USA, V94, P14965, DOI 10.1073/pnas.94.26.14965; Suppes P, 1998, P NATL ACAD SCI USA, V95, P15861, DOI 10.1073/pnas.95.26.15861; Suppes P, 1999, P NATL ACAD SCI USA, V96, P12953, DOI 10.1073/pnas.96.22.12953; Suppes P, 2000, P NATL ACAD SCI USA, V97, P8738, DOI 10.1073/pnas.140228397; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102	47	587	594	4	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2007	54	6					1001	1010		10.1016/j.neuron.2007.06.004	http://dx.doi.org/10.1016/j.neuron.2007.06.004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582338	Green Accepted, Bronze			2022-12-24	WOS:000247645600017
J	Sdrulla, AD; Linden, DJ				Sdrulla, Andrei D.; Linden, David J.			Double dissociation between long-term depression and dendritic spine morphology in cerebellar Purkinje cells	NATURE NEUROSCIENCE			English	Article							POTENTIATION; PLASTICITY	Experiments in hippocampal area CA1 suggest that long-term potentiation could be associated with spine addition and enlargement, and long-term depression ( LTD) with spine shrinkage and loss. Is this a general principle of synaptic plasticity? We used two-photon microscopy to measure dendritic spines in rat cerebellar Purkinje cells. Neither local synaptic induction of LTD nor global chemical induction of LTD changed spine number or size. Conversely, a manipulation that evoked persistent dendritic spine retraction did not alter parallel fiber - evoked excitatory postsynaptic currents.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St,916 Hunterian Bldg, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	Sdrulla, Andrei/AAU-7664-2021		NIMH NIH HHS [MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, R37MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	8	48	48	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					546	548		10.1038/nn1889	http://dx.doi.org/10.1038/nn1889			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435753				2022-12-24	WOS:000245948000008
J	Burgos-Robles, A; Vidal-Gonzalez, I; Santini, E; Quirk, GJ				Burgos-Robles, Anthony; Vidal-Gonzalez, Ivan; Santini, Edwin; Quirk, Gregory J.			Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex	NEURON			English	Article							LONG-TERM POTENTIATION; D-CYCLOSERINE; SYNAPTIC PLASTICITY; CONDITIONED FEAR; HIPPOCAMPAL; MEMORY; AMYGDALA; ANTAGONIST; MECHANISMS; SIGNAL	Extinction of conditioned fear is an active learning process requiring N-methyl-D-aspartate receptors (NMDARs), but the timing, location, and neural mechanisms of NMDAR-mediated processing in extinction are a matter of debate. Here we show that infusion of the NMDAR antagonist CPP into the ventromedial prefrontal cortex (vmPFC) prior to, or immediately after, extinction training impaired 24 hr recall of extinction. These findings indicate that consolidation of extinction requires posttraining activation of NMDARs within the vmPFC. Using multichannel unit recording, we observed that CPP selectively reduced burst firing in vmPFC neurons, suggesting that bursting in vmPFC is necessary for consolidation of extinction. In support of this, we found that the degree of bursting in infralimbic vmPFC neurons shortly after extinction predicted subsequent recall of extinction. We suggest that NMDAR-dependent bursting in the infralimbic vmPFC initiates calcium-dependent molecular cascades that stabilize extinction memory, thereby allowing for successful recall of extinction.	Ponce Sch Med, Dept Physiol, Ponce, PR 00732 USA		Quirk, GJ (corresponding author), Univ Puerto Rico, Sch Med, Dept Psychiat, POB 365067, San Juan, PR 00936 USA.	gjquirk@yahoo.com	anand, amit/A-7222-2009		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058883, R21MH072156, T32MH018882, R37MH058883, R29MH058883] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM008236] Funding Source: Medline; NIMH NIH HHS [MH058883, T32 MH018882, R29 MH058883, MH072156, T32MH018882] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; Baker JD, 1996, BEHAV NEUROSCI, V110, P618, DOI 10.1037/0735-7044.110.3.618; Barrett D, 2003, J NEUROSCI, V23, P5740; Berlau DJ, 2006, NEUROBIOL LEARN MEM, V86, P123, DOI 10.1016/j.nlm.2005.12.008; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x; Davis Michael, 2006, NeuroRx, V3, P82, DOI 10.1016/j.nurx.2005.12.008; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; FALLS WA, 1992, J NEUROSCI, V12, P854; Foa EB, 2000, J CLIN PSYCHIAT, V61, P43; GOLD JI, 1994, P NATL ACAD SCI USA, V91, P3941, DOI 10.1073/pnas.91.9.3941; Gureviciene I, 2003, NEUROBIOL LEARN MEM, V79, P72, DOI 10.1016/S1074-7427(02)00012-6; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2006, EUR J NEUROSCI, V24, P261, DOI 10.1111/j.1460-9568.2006.04893.x; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; Hughes S, 2006, SYNAPSE, V60, P280, DOI 10.1002/syn.20291; Hugues S, 2004, LEARN MEMORY, V11, P540, DOI 10.1101/lm.77704; Ishikawa A, 2003, J NEUROSCI, V23, P9987; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lebron K, 2004, LEARN MEMORY, V11, P544, DOI 10.1101/lm.78604; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin CH, 2003, J NEUROSCI, V23, P8310; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MILAD MR, 2006, IN PRESS BIOL PSYCHI; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; ONEILL KA, 1987, BRAIN RES, V435, P371, DOI 10.1016/0006-8993(87)91628-3; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Shi WX, 2003, J PHARMACOL EXP THER, V305, P680, DOI 10.1124/jpet.102.046359; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Wayner MJ, 2000, PHYSIOL BEHAV, V69, P505, DOI 10.1016/S0031-9384(00)00208-0; Zhang XX, 1999, ACTA PHARMACOL SIN, V20, P1125	61	384	393	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					871	880		10.1016/j.neuron.2007.02.021	http://dx.doi.org/10.1016/j.neuron.2007.02.021			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359921	Bronze			2022-12-24	WOS:000245292800011
J	Nagayama, S; Zeng, SQ; Xiong, WH; Fletcher, ML; Masurkar, AV; Davis, DJ; Pieribone, VA; Chen, WR				Nagayama, Shin; Zeng, Shaoqun; Xiong, Wenhui; Fletcher, Max L.; Masurkar, Arjun V.; Davis, Douglas J.; Pieribone, Vincent A.; Chen, Wei R.			In vivo simultaneous tracing and Ca2+ imaging of local neuronal circuits	NEURON			English	Article							DENDRITIC CALCIUM DYNAMICS; OLFACTORY-BULB; ODOR MAPS; CELLS; ELECTROPORATION; LAYER; TRANSMISSION; PROPAGATION; NEOCORTEX; SYSTEM	A central question about the brain is how information is processed by large populations of neurons embedded in intricate local networks. Answering this question requires not only monitoring functional dynamics of many neurons simultaneously, but also interpreting such activity patterns in the context of neuronal circuitry. Here, we introduce a versatile approach for loading Ca2+, indicators in vivo by local electroporation. With this method, Ca2+, imaging can be performed both at neuron population level and with exquisite subcellular resolution down to dendritic spines and axon boutons. This enabled mitral cell odor-evoked ensemble activity to be analyzed simultaneously with revealing their specific connectivity to different glomeruli. Colabeling of Purkinje cell dendrites and intersecting parallel fibers allowed Ca2+, imaging of both presynaptic boutons and postsynaptic dendrites. This approach thus provides an unprecedented capability for in vivo visualizing active cell ensembles and tracing their underlying local neuronal circuits.	Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; Huazhong Univ Sci & Technol, Minist Educ, Wuhan Natl Lab Optoelect, Key Lab Biomed Photon, Wuhan 430074, Peoples R China; John B Pierce Fdn Lab, New Haven, CT 06519 USA; Yale Univ, Dept Mol & Cellular Physiol, New Haven, CT 06510 USA	Yale University; Huazhong University of Science & Technology; Yale University; The John B Pierce Laboratory, Inc; Yale University	Chen, WR (corresponding author), Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA.	wei.chen@yale.edu		Pieribone, Vincent/0000-0002-5836-5454; Masurkar, Arjun/0000-0002-2498-2059	NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH064214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003918] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC003918, DC003918] Funding Source: Medline; NIMH NIH HHS [MH064214, R21 MH064214] Funding Source: Medline; NINDS NIH HHS [T32 NS007224, NS007224] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beierlein M, 2004, J NEUROPHYSIOL, V92, P591, DOI 10.1152/jn.00057.2004; Bonnot AS, 2005, J NEUROPHYSIOL, V93, P1793, DOI 10.1152/jn.00923.2004; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Debarbieux F, 2003, J NEUROSCI, V23, P5553; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Garaschuk O, 2006, PFLUG ARCH EUR J PHY, V453, P385, DOI 10.1007/s00424-006-0150-x; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haugland R.P., 2002, HDB FLUORESCENT PROB; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Lodovichi C, 2003, NEURON, V38, P265, DOI 10.1016/S0896-6273(03)00194-6; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Mulligan SJ, 2001, NEUROSCIENCE, V104, P137, DOI 10.1016/S0306-4522(01)00057-4; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; ODONOVAN MJ, 1993, J NEUROSCI METH, V46, P91, DOI 10.1016/0165-0270(93)90145-H; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sullivan MR, 2005, J NEUROPHYSIOL, V94, P1636, DOI 10.1152/jn.01013.2004; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zeng SQ, 2006, OPT LETT, V31, P1091, DOI 10.1364/OL.31.001091	41	87	94	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					789	803		10.1016/j.neuron.2007.02.018	http://dx.doi.org/10.1016/j.neuron.2007.02.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359915	Green Accepted, Bronze			2022-12-24	WOS:000245292800005
J	Nevian, T; Larkum, ME; Polsky, A; Schiller, J				Nevian, Thomas; Larkum, Matthew E.; Polsky, Alon; Schiller, Jackie			Properties of basal dendrites of layer 5 pyramidal neurons: a direct patch-clamp recording study	NATURE NEUROSCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; ACTION-POTENTIAL INITIATION; DISTAL APICAL DENDRITES; SYNAPTIC PLASTICITY; OBLIQUE DENDRITES; CALCIUM SPIKES; VISUAL-CORTEX; NMDA SPIKES; EVOKED CA2+; IN-VIVO	Basal dendrites receive the majority of synapses that contact neocortical pyramidal neurons, yet our knowledge of synaptic processing in these dendrites has been hampered by their inaccessibility for electrical recordings. A new approach to patch-clamp recordings enabled us to characterize the integrative properties of these cells. Despite the short physical length of rat basal dendrites, synaptic inputs were electrotonically remote from the soma ( > 30- fold excitatory postsynaptic potential ( EPSP) attenuation) and back- propagating action potentials were significantly attenuated. Unitary EPSPs were location dependent, reaching large amplitudes distally ( > 8 mV), yet their somatic contribution was relatively location independent. Basal dendrites support sodium and NMDA spikes, but not calcium spikes, for 75% of their length. This suggests that basal dendrites, despite their proximity to the site of action potential initiation, do not form a single basal- somatic region but rather should be considered as a separate integrative compartment favoring two integration modes: subthreshold, location- independent summation versus local amplification of incoming spatiotemporally clustered information.	Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel; Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Technion Israel Institute of Technology; University of Bern; Max Planck Society	Schiller, J (corresponding author), Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel.	jackie@tx.technion.ac.il		Poleg-Polsky, Alon/0000-0003-1327-5129; Nevian, Thomas/0000-0001-9804-608X; Larkum, Matthew/0000-0001-9799-2656				Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Ariav G, 2003, J NEUROSCI, V23, P7750; Bannister AP, 2005, NEUROSCI RES, V53, P95, DOI 10.1016/j.neures.2005.06.019; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Colbert CM, 1997, J NEUROSCI, V17, P6512; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2001, SCIENCE, V291, P138, DOI 10.1126/science.291.5501.138; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; LARKMAN AU, 1992, J COMP NEUROL, V323, P137, DOI 10.1002/cne.903230202; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Milojkovic BA, 2005, J NEUROSCI, V25, P3940, DOI 10.1523/JNEUROSCI.5314-04.2005; Milojkovic BA, 2004, J PHYSIOL-LONDON, V558, P193, DOI 10.1113/jphysiol.2004.061416; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Rhodes P, 2006, J NEUROSCI, V26, P6704, DOI 10.1523/JNEUROSCI.3791-05.2006; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	50	280	286	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					206	214		10.1038/nn1826	http://dx.doi.org/10.1038/nn1826			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17206140				2022-12-24	WOS:000244175200015
J	Watari-Goshima, N; Ogura, KI; Wolf, FW; Goshima, Y; Garriga, G				Watari-Goshima, Natsuko; Ogura, Ken-ichi; Wolf, Fred W.; Goshima, Yoshio; Garriga, Gian			C-elegans VAB-8 and UNC-73 regulate the SAX-3 receptor to direct cell and growth-cone migrations	NATURE NEUROSCIENCE			English	Article							ANTERIOR-POSTERIOR GUIDANCE; AXON GUIDANCE; CAENORHABDITIS-ELEGANS; NETRIN RECEPTOR; COMMISSURAL AXONS; ROUNDABOUT RECEPTOR; COLORECTAL-CANCER; KINASE UNC-51; IN-VIVO; PROTEIN	During nervous system development, a small number of conserved guidance cues and receptors regulate many axon trajectories. How could a limited number of cues and receptors regulate such complex projection patterns? One way is to modulate receptor function. Here we show that the Caenorhabditis elegans kinesin-related protein VAB-8L, which is necessary and sufficient for posterior cell and growth-cone migrations, directs these migrations by regulating the levels of the guidance receptor SAX-3 ( also known as robo). Genetic experiments indicate that VAB-8L and the Rac guanine nucleotide exchange factor activity of UNC-73 ( trio) increase the ability of the SLT-1 ( slit) and UNC-6 ( netrin) guidance pathways to promote posterior guidance. The observations of higher SAX-3 receptor abundance in animals with increasing amounts of VAB-8L, and of physical interactions between UNC-73 and both VAB-8L and the intracellular domain of the SAX- 3, support a model whereby VAB-8L directs cell and growth- cone migrations by promoting localization of guidance receptors to the cell surface.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Yokohama City University; Japan Science & Technology Agency (JST)	Garriga, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	garriga@berkeley.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032057] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32057] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fleming TC, 2005, DEVELOPMENT, V132, P4857, DOI 10.1242/dev.02020; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Forsthoefel DJ, 2005, DEVELOPMENT, V132, P1983, DOI 10.1242/dev.01736; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jou TS, 2000, MOL BIOL CELL, V11, P287, DOI 10.1091/mbc.11.1.287; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Lai T, 2004, DEVELOPMENT, V131, P5991, DOI 10.1242/dev.01457; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; Merz DC, 2001, GENETICS, V158, P1071; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ogura K, 2006, DEVELOPMENT, V133, P3441, DOI 10.1242/dev.02503; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Spencer AG, 2001, P NATL ACAD SCI USA, V98, P13132, DOI 10.1073/pnas.241504098; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Su MW, 2000, DEVELOPMENT, V127, P585; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wightman B, 1996, DEVELOPMENT, V122, P671; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	50	71	86	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					169	176		10.1038/nn1834	http://dx.doi.org/10.1038/nn1834			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237778				2022-12-24	WOS:000244175200011
J	Ji, DY; Wilson, MA				Ji, Daoyun; Wilson, Matthew A.			Coordinated memory replay in the visual cortex and hippocampus during sleep	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL NEURONS; PHASE-LOCKING; SPATIAL MAP; REACTIVATION; OSCILLATION; SEQUENCES; NETWORK; STATE; EXPERIENCE; PATTERNS	Sleep replay of awake experience in the cortex and hippocampus has been proposed to be involved in memory consolidation. However, whether temporally structured replay occurs in the cortex and whether the replay events in the two areas are related are unknown. Here we studied multicell spiking patterns in both the visual cortex and hippocampus during slow-wave sleep in rats. We found that spiking patterns not only in the cortex but also in the hippocampus were organized into frames, defined as periods of stepwise increase in neuronal population activity. The multicell firing sequences evoked by awake experience were replayed during these frames in both regions. Furthermore, replay events in the sensory cortex and hippocampus were coordinated to reflect the same experience. These results imply simultaneous reactivation of coherent memory traces in the cortex and hippocampus during sleep that may contribute to or reflect the result of the memory consolidation process.	MIT, Picower Inst Learning & Memory, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Wilson, MA (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Bldg 46,Room 5233,43 Vassar St, Cambridge, MA 02139 USA.	dji@mit.edu; mwilson@mit.edu						Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Amzica F, 1998, NEUROSCIENCE, V82, P671; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris JA, 2001, NEURON, V30, P315, DOI 10.1016/S0896-6273(01)00300-2; Hasselmo ME, 1999, CURR OPIN NEUROBIOL, V9, P184, DOI 10.1016/S0959-4388(99)80025-7; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Reilly RC, 2000, HIPPOCAMPUS, V10, P389, DOI 10.1002/1098-1063(2000)10:4<389::AID-HIPO5>3.0.CO;2-P; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Robert C, 1999, J NEUROSCI METH, V88, P111, DOI 10.1016/S0165-0270(99)00027-8; Rolls ET, 2000, HIPPOCAMPUS, V10, P380, DOI 10.1002/1098-1063(2000)10:4<380::AID-HIPO4>3.0.CO;2-0; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steriade M, 1998, J SLEEP RES, V7, P30, DOI 10.1046/j.1365-2869.7.s1.4.x; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Suzuki WA, 2006, NEURON, V50, P19, DOI 10.1016/j.neuron.2006.03.029; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	50	1016	1041	1	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					100	107		10.1038/nn1825	http://dx.doi.org/10.1038/nn1825			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173043				2022-12-24	WOS:000243096100021
J	Ahissar, M; Lubin, Y; Putter-Katz, H; Banai, K				Ahissar, Merav; Lubin, Yedida; Putter-Katz, Hanna; Banai, Karen			Dyslexia and the failure to form a perceptual anchor	NATURE NEUROSCIENCE			English	Article							AUDITORY FREQUENCY DISCRIMINATION; DEVELOPMENTAL DYSLEXIA; PROCESSING DEFICITS; MISMATCH; CHILDREN; MEMORY; BRAIN; PITCH; INTELLIGENCE; REPETITION	In a large subgroup of dyslexic individuals (D-LDs), reading difficulties are part of a broader learning and language disability. Recent studies indicate that D-LDs perform poorly in many psychoacoustic tasks compared with individuals with normal reading ability. We found that D-LDs perform as well as normal readers in speech perception in noise and in a difficult tone comparison task. However, their performance did not improve when these same tasks were performed with a smaller stimulus set. In contrast to normal readers, they did not benefit from stimulus-specific repetitions, suggesting that they have difficulties forming perceptual anchors. These findings are inconsistent with previously suggested static models of dyslexia. Instead, we propose that D-LDs' core deficit is a general difficulty in dynamically constructing stimulus-specific predictions, deriving from deficient stimulus-specific adaptation mechanisms. This hypothesis provides a direct link between D-LDs' high-level difficulties and mechanisms at the level of specific neuronal circuits.	Hebrew Univ Jerusalem, Dept Psychol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Cognit Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Northwestern Univ, Dept Commun Sci, Evanston, IL 60208 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Northwestern University	Ahissar, M (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91904 Jerusalem, Israel.	msmerava@mscc.huji.ac.il	Banai, Karen/J-1448-2019	Banai, Karen/0000-0002-2990-0470; Ahissar, Merav/0000-0001-7694-8111				Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; Amitay S, 2002, JARO-J ASSOC RES OTO, V3, P302, DOI 10.1007/s101620010093; Baldeweg T, 1999, ANN NEUROL, V45, P495, DOI 10.1002/1531-8249(199904)45:4<495::AID-ANA11>3.0.CO;2-M; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; Banai K, 2004, AUDIOL NEURO-OTOL, V9, P328, DOI 10.1159/000081282; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Ben-Yehudah G, 2004, NEUROREPORT, V15, P627, DOI 10.1097/00001756-200403220-00011; Ben-Yehudah G, 2004, VISION RES, V44, P1047, DOI 10.1016/j.visres.2003.12.001; Ben-Yehudah G, 2001, BRAIN, V124, P1381, DOI 10.1093/brain/124.7.1381; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Clement S, 1999, J ACOUST SOC AM, V106, P2805, DOI 10.1121/1.428106; Deary LJ, 2004, AM J PSYCHOL, V117, P1, DOI 10.2307/1423593; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Dreschler WA, 2001, AUDIOLOGY, V40, P148; France SJ, 2002, PERCEPT PSYCHOPHYS, V64, P169, DOI 10.3758/BF03195783; Goswami U, 2003, TRENDS COGN SCI, V7, P534, DOI 10.1016/j.tics.2003.10.003; Goswami U, 2002, P NATL ACAD SCI USA, V99, P10911, DOI 10.1073/pnas.122368599; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Halliday LF, 2005, J SPEECH LANG HEAR R, V48, P1187, DOI 10.1044/1092-4388(2005/083); Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; HARRIS JD, 1948, AM J PSYCHOL, V61, P309, DOI 10.2307/1417151; Hartley DEH, 2002, J ACOUST SOC AM, V112, P2962, DOI 10.1121/1.1512701; Heath SM, 1999, J CHILD PSYCHOL PSYC, V40, P637, DOI 10.1111/1469-7610.00480; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Hulslander J, 2004, J EXP CHILD PSYCHOL, V88, P274, DOI 10.1016/j.jecp.2004.03.006; KONIG E, 1957, J ACOUST SOC AM, V29, P606; Kujala T, 2006, CLIN NEUROPHYSIOL, V117, P885, DOI 10.1016/j.clinph.2006.01.002; LYON GR, 1995, ANN DYSLEXIA, V45, P3, DOI 10.1007/BF02648210; Maurer U, 2003, NEUROREPORT, V14, P2245, DOI 10.1097/00001756-200312020-00022; McAnally KI, 1996, P ROY SOC B-BIOL SCI, V263, P961, DOI 10.1098/rspb.1996.0142; McArthur GM, 2004, J SPEECH LANG HEAR R, V47, P527, DOI 10.1044/1092-4388(2004/041); Mengler ED, 2005, DYSLEXIA, V11, P155, DOI 10.1002/dys.302; MORI S, 1992, J ACOUST SOC AM, V91, P246, DOI 10.1121/1.402768; Naatanen R., 2018, ATTENTION BRAIN FUNC; Putter-Katz H, 2005, PLASTICITY AND SIGNAL REPRESENTATION IN THE AUDITORY SYSTEM, P251, DOI 10.1007/0-387-23181-1_23; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; RAZ N, 1987, PERS INDIV DIFFER, V8, P201, DOI 10.1016/0191-8869(87)90175-9; Renvall H, 2003, ANN NEUROL, V53, P551, DOI 10.1002/ana.10504; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Shovman MM, 2006, VISION RES, V46, P3514, DOI 10.1016/j.visres.2006.05.011; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2004, ANN DYSLEXIA, V54, P281, DOI 10.1007/s11881-004-0014-z; SWANSON HL, 1993, J EXP CHILD PSYCHOL, V56, P87, DOI 10.1006/jecp.1993.1027; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Wechsler D., 1997, WECHSLER ADULT INTEL; Wright BA, 2004, P NATL ACAD SCI USA, V101, P9942, DOI 10.1073/pnas.0401825101	50	161	167	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1558	1564		10.1038/nn1800	http://dx.doi.org/10.1038/nn1800			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	110TP	17115044				2022-12-24	WOS:000242404000021
J	Kampa, BM; Letzkus, JJ; Stuart, GJ				Kampa, Bjorn M.; Letzkus, Johannes J.; Stuart, Greg J.			Cortical feed-forward networks for binding different streams of sensory information	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; HORIZONTAL CONNECTIONS; PYRAMIDAL NEURONS; SYNAPSE LOCATION; STRIATE CORTEX; ORGANIZATION; PROJECTIONS; INHIBITION; PLASTICITY; EXCITATION	Different streams of sensory information are transmitted to the cortex where they are merged into a percept in a process often termed 'binding.' Using recordings from triplets of rat cortical layer 2/3 and layer 5 pyramidal neurons, we show that specific subnetworks within layer 5 receive input from different layer 2/3 subnetworks. This cortical microarchitecture may represent a mechanism that enables the main output of the cortex (layer 5) to bind different features of a sensory stimulus.	Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Kampa, BM (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Mills Rd, Canberra, ACT 0200, Australia.	kampa@hifo.inizh.ch	Kampa, Bjoern/GWC-5714-2022; stuart, greg j/F-7328-2011; Kampa, Bjoern M/D-6213-2015; Kampa, Bjoern/A-1612-2008	Kampa, Bjoern/0000-0002-4343-2634; Kampa, Bjoern M/0000-0002-4343-2634; Letzkus, Johannes/0000-0001-5678-3030; stuart, greg/0000-0001-9395-2219				BERMAN N, 1982, J NEUROPHYSIOL, V48, P1362, DOI 10.1152/jn.1982.48.6.1362; Bosking WH, 1997, J NEUROSCI, V17, P2112; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Sincich LC, 2001, J NEUROSCI, V21, P4416, DOI 10.1523/JNEUROSCI.21-12-04416.2001; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	15	97	99	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1472	1473		10.1038/nn1798	http://dx.doi.org/10.1038/nn1798			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17099707				2022-12-24	WOS:000242404000008
J	Hahn, TTG; Sakmann, B; Mehta, MR				Hahn, Thomas T. G.; Sakmann, Bert; Mehta, Mayank R.			Phase-locking of hippocampal interneurons' membrane potential to neocortical up-down states	NATURE NEUROSCIENCE			English	Article							SLEEP	During quiet wakefulness and sleep, and under anesthesia, the membrane potentials of neocortical pyramidal neurons show synchronous, slow oscillations, so-called up-down states ( UDS), that can be detected in the local field potential ( LFP). The influence of this synchronized, spontaneous neocortical activity on the hippocampus is largely unknown. We performed the first in vivo whole-cell recordings from hippocampal dorsal CA1 interneurons and found that their membrane potentials were phase-locked to neocortical up- down states with a small delay. These results provide strong evidence for cortico-hippocampal interaction and suggest that neocortical activity drives hippocampal interneurons during UDS.	Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Max Planck Society; Brown University	Hahn, TTG (corresponding author), Max Planck Inst Med Res, Dept Cell Physiol, Jahnstr 29, D-69120 Heidelberg, Germany.	thahn@mpimf-heidelberg.mpg.de; Mayank@brown.edu		Mehta, Mayank/0000-0003-2005-2468				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Miller R., 1991, CORTICO HIPPOCAMPAL; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	15	106	107	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1359	1361		10.1038/nn1788	http://dx.doi.org/10.1038/nn1788			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041594				2022-12-24	WOS:000242403800009
J	Boyden, ES; Katoh, A; Pyle, JL; Chatila, TA; Tsien, RW; Raymond, JL				Boyden, Edward S.; Katoh, Akira; Pyle, Jason L.; Chatila, Tallal A.; Tsien, Richard W.; Raymond, Jennifer L.			Selective engagement of plasticity mechanisms for motor memory storage	NEURON			English	Article							LONG-TERM DEPRESSION; CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; VESTIBULO-OCULAR REFLEX; CEREBELLAR PURKINJE-CELLS; PURSUIT EYE-MOVEMENTS; RAT CEREBELLUM; NITRIC-OXIDE; MUTANT MICE; LATE-PHASE; DYNAMIC CHARACTERISTICS	The number and diversity of plasticity mechanisms in the brain raises a central question: does a neural circuit store all memories by stereotyped application of the available plasticity mechanisms, or can subsets of these mechanisms be selectively engaged for specific memories? The uniform architecture of the cerebellum has inspired the idea that plasticity mechanisms like cerebellar long-term depression (LTD) contribute universally to memory storage. To test this idea, we investigated a set of closely related, cerebellum-dependent motor memories. In mutant mice lacking Ca2+/calmodulin-dependent protein kinase IV (CaMKIV), the maintenance of cerebellar LTD is abolished. Although memory for an increase in the gain of the vestibulo-ocular reflex (VOR) induced with high-frequency stimuli was impaired in these mice, memories for decreases in VOR gain and increases in gain induced with low-frequency stimuli were intact. Thus, a particular plasticity mechanism need not support all cerebellum-dependent memories, but can be engaged selectively according to the parameters of training.	Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Dept Pediat, David Geffen Sch Med, Los Angeles, CA USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Raymond, JL (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	jenr@stanford.edu	Katoh, Akira/B-2683-2010	Katoh, Akira/0000-0001-7867-2964; Raymond, Jennifer/0000-0002-8145-747X; Chatila, Talal/0000-0001-7439-2762	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS053862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004154, F31DC007006] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004154, R01 DC04154, F31 DC07006] Funding Source: Medline; NINDS NIH HHS [P01 NS053862] Funding Source: Medline; PHS HHS [R01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Balaban CD, 2000, NEUROSCIENCE, V99, P669, DOI 10.1016/S0306-4522(00)00232-3; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Caria MA, 2001, NEUROREPORT, V12, P2353, DOI 10.1097/00001756-200108080-00014; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Coesmans M, 2003, ANN NEUROL, V53, P325, DOI 10.1002/ana.10451; Cohen MR, 2004, LEARN MEMORY, V11, P559, DOI 10.1101/lm.82304; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dow ER, 1996, NEUROREPORT, V7, P1305, DOI 10.1097/00001756-199605170-00018; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; ITO M, 1974, P JPN ACAD, V50, P85, DOI 10.2183/pjab1945.50.85; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; JAGER J, 1981, EXP BRAIN RES, V41, P108; JANDE SS, 1981, NATURE, V294, P765, DOI 10.1038/294765a0; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P4050, DOI 10.1073/pnas.88.9.4050; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kimpo RR, 2005, J NEUROPHYSIOL, V94, P3092, DOI 10.1152/jn.00048.2005; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Kuki Y, 2004, NEUROREPORT, V15, P1007, DOI 10.1097/00001756-200404290-00015; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; LI J, 1995, J NEUROPHYSIOL, V74, P489, DOI 10.1152/jn.1995.74.1.489; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P954, DOI 10.1152/jn.1994.72.2.954; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; Maffei A, 2003, J NEUROPHYSIOL, V90, P2478, DOI 10.1152/jn.00399.2003; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Means AR, 1997, RECENT PROG HORM RES, V52, P389; MILES FA, 1980, J NEUROPHYSIOL, V43, P1406, DOI 10.1152/jn.1980.43.5.1406; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; MORII E, 1992, DEV BRAIN RES, V65, P123, DOI 10.1016/0165-3806(92)90016-P; MUGNAINI E, 1987, ARCH ITAL BIOL, V126, P41; NAGAO S, 1991, NEUROREPORT, V2, P193, DOI 10.1097/00001756-199104000-00008; NAGAO S, 1983, EXP BRAIN RES, V53, P36; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; Pastor AM, 1997, PROG BRAIN RES, V114, P359; Paxinos G, 2000, MOUSE BRAIN STEREOTA; Peters M, 2003, J NEUROSCI, V23, P9752; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, J NEUROSCI, V16, P7791; Raymond JL, 1997, LEARN MEMORY, V3, P503, DOI 10.1101/lm.3.6.503; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; Ruigrok TJH, 2000, J COMP NEUROL, V426, P209, DOI 10.1002/1096-9861(20001016)426:2<209::AID-CNE4>3.0.CO;2-0; SAKAGAMI H, 1992, MOL BRAIN RES, V16, P20, DOI 10.1016/0169-328X(92)90189-I; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith SL, 2003, J NEUROSCI, V23, P367, DOI 10.1523/JNEUROSCI.23-02-00367.2003; Stahl JS, 2004, J NEUROPHYSIOL, V91, P2066, DOI 10.1152/jn.01068.2003; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; TORTE MP, 1994, EXP BRAIN RES, V99, P441; van Alphen AM, 2002, EUR J NEUROSCI, V16, P486, DOI 10.1046/j.1460-9568.2002.02094.x; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; Wall MJ, 2003, EUR J NEUROSCI, V18, P869, DOI 10.1046/j.1460-9568.2003.02822.x; Welsh JP, 2005, P NATL ACAD SCI USA, V102, P17166, DOI 10.1073/pnas.0508191102; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2	82	105	105	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					823	834		10.1016/j.neuron.2006.08.026	http://dx.doi.org/10.1016/j.neuron.2006.08.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982426	Bronze			2022-12-24	WOS:000240997900019
J	Korman, M; Doyon, J; Doljansky, J; Carrier, J; Dagan, Y; Karni, A				Korman, Maria; Doyon, Julien; Doljansky, Julia; Carrier, Julie; Dagan, Yaron; Karni, Avi			Daytime sleep condenses the time course of motor memory consolidation	NATURE NEUROSCIENCE			English	Article							SKILL; ACQUISITION; PLASTICITY; PERFORMANCE; ADAPTATION; SEQUENCE; PERFECT; SYSTEMS; CORTEX	Two behavioral phenomena characterize human motor memory consolidation: diminishing susceptibility to interference by a subsequent experience and the emergence of delayed, offline gains in performance. A recent model proposes that the sleep-independent reduction in interference is followed by the sleep-dependent expression of offline gains. Here, using the finger-opposition sequence-learning task, we show that an interference experienced at 2 h, but not 8 h, following the initial training prevented the expression of delayed gains at 24 h post-training. However, a 90-min nap, immediately post-training, markedly reduced the susceptibility to interference, with robust delayed gains expressed overnight, despite interference at 2 h post-training. With no interference, a nap resulted in much earlier expression of delayed gains, within 8 h post-training. These results suggest that the evolution of robustness to interference and the evolution of delayed gains can coincide immediately post-training and that both effects reflect sleep-sensitive processes.	Univ Haifa, Brain Behav Res Ctr, IL-31905 Haifa, Israel; Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; Sheba Med Ctr, Chronobiol & Sleep Lab, IL-52662 Tel Aviv, Israel	University of Haifa; Universite de Montreal; Chaim Sheba Medical Center	Korman, M (corresponding author), Univ Haifa, Brain Behav Res Ctr, IL-31905 Haifa, Israel.	mariakorman@yahoo.com	Korman, Maria/GWQ-3314-2022; Korman, Maria/N-6515-2019	Korman, Maria/0000-0003-1895-0189; Korman, Maria/0000-0003-1895-0189; Carrier, Julie/0000-0001-5311-2370				ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Censor N, 2006, VISION RES, V46, P4071, DOI 10.1016/j.visres.2006.07.022; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Goedert KM, 2002, LEARN MEMORY, V9, P279, DOI 10.1101/lm.50102; Hauptmann B, 2005, COGNITIVE BRAIN RES, V24, P181, DOI 10.1016/j.cogbrainres.2005.01.012; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Korman M, 2005, BEHAV BRAIN SCI, V28, P74, DOI 10.1017/S0140525X05320024; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nudo RJ, 1996, J NEUROSCI, V16, P785; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rechtschaffen A, 1968, MANUAL STANDARIZED T; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Walker M. P., 2005, BEHAV BRAIN SCI, V28, P64, DOI [DOI 10.1017/S0140525X05000026, 10.1017/s0140525x05000026]; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2005, CLIN SPORT MED, V24, P301, DOI 10.1016/j.csm.2004.11.002; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	51	279	280	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1206	1213		10.1038/nn1959	http://dx.doi.org/10.1038/nn1959			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694051				2022-12-24	WOS:000249144000024
J	Xu, WF; Huang, XY; Takagaki, K; Wu, JY				Xu, Weifeng; Huang, Xiaoying; Takagaki, Kentaroh; Wu, Jian-young			Compression and reflection of visually evoked cortical waves	NEURON			English	Article							CYTOCHROME-OXIDASE STRIPES; VOLTAGE-SENSITIVE DYES; MACAQUE STRIATE CORTEX; TURTLE OLFACTORY-BULB; BARREL CORTEX; IN-VIVO; SPATIOTEMPORAL DYNAMICS; INTRINSIC CONNECTIONS; SOMATOSENSORY CORTEX; ELECTRICAL-ACTIVITY	Neuronal interactions between primary and secondary visual cortical areas are important for visual processing, but the spatiotemporal patterns of the interaction are not well understood. We used voltage-sensitive dye imaging to visualize neuronal activity in rat visual cortex and found visually evoked waves propagating from V1 to other visual areas. A primary wave originated in the monocular area of V1 and was "compressed" when propagating to V2. A reflected wave initiated after compression and propagated backward into V1. The compression occurred at the V1/V2 border, and local GABAA inhibition is important for the compression. The compression/reflection pattern provides a two-phase modulation: V1 is first depolarized by the primary wave, and then V1 and V2 are simultaneously depolarized by the reflected and primary waves, respectively. The compression/reflection pattern only occurred for evoked waves and not for spontaneous waves, suggesting that it is organized by an internal mechanism associated with visual processing.	Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20057 USA	Georgetown University	Wu, JY (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20057 USA.	wuj@georgetown.edu	xu, weifeng/A-2364-2011; Huang, Xiao-Ying/E-5994-2011; Takagaki, Kentaroh/A-9829-2009	Huang, Xiao-Ying/0000-0002-3514-216X; Takagaki, Kentaroh/0000-0002-1852-529X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036447] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS036447, R01 NS036447-08, NS36447] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelucci A, 2002, J NEUROSCI, V22, P8633; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Bao WL, 2003, J NEUROPHYSIOL, V90, P333, DOI 10.1152/jn.00715.2002; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; CHERVIN RD, 1988, J NEUROPHYSIOL, V60, P1695, DOI 10.1152/jn.1988.60.5.1695; Civillico EF, 2006, J NEUROPHYSIOL, V96, P336, DOI 10.1152/jn.00128.2006; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Derdikman D, 2003, J NEUROSCI, V23, P3100; Ermentrout GB, 1996, SIAM J APPL MATH, V56, P1107, DOI 10.1137/S0036139994276793; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; Golomb D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061911; GRANNAN ER, 1993, NEURAL COMPUT, V5, P550, DOI 10.1162/neco.1993.5.4.550; GRINVALD A, 1982, J PHYSIOL-LONDON, V333, P269, DOI 10.1113/jphysiol.1982.sp014453; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jin WJ, 2002, J NEUROSCI METH, V115, P13, DOI 10.1016/S0165-0270(01)00511-8; KENNEDY H, 1985, J NEUROSCI, V5, P2815; KLEINFELD D, 1994, J NEUROPHYSIOL, V72, P1402, DOI 10.1152/jn.1994.72.3.1402; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Laaris N, 2000, J NEUROSCI, V20, P1529; Lam YW, 2003, EUR J NEUROSCI, V17, P436, DOI 10.1046/j.1460-9568.2003.02457.x; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; LIPPERT MT, 2007, IN PRESS J NEUROPHYS; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3371; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P2830; LONDON JA, 1989, J NEUROSCI, V9, P2182; Ma HT, 2004, J NEUROPHYSIOL, V91, P934, DOI 10.1152/jn.00274.2003; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Olavarria JF, 2003, J COMP NEUROL, V459, P156, DOI 10.1002/cne.10615; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Prechtl JC, 2000, P NATL ACAD SCI USA, V97, P877, DOI 10.1073/pnas.97.2.877; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; ROCKLAND KS, 1981, BRAIN RES, V212, P249, DOI 10.1016/0006-8993(81)90461-3; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Senseman D M, 1999, J Neurosci, V19, pRC3; Shmuel A, 2005, J NEUROSCI, V25, P2117, DOI 10.1523/JNEUROSCI.4137-04.2005; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Sincich LC, 2003, J NEUROSCI, V23, P5684; Sincich LC, 2002, SCIENCE, V295, P1734, DOI 10.1126/science.1067902; Sincich LC, 2002, J COMP NEUROL, V447, P18, DOI 10.1002/cne.10174; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Toth LJ, 1996, P NATL ACAD SCI USA, V93, P9869, DOI 10.1073/pnas.93.18.9869; TRAUB RD, 1987, NEUROSCIENCE, V21, P457, DOI 10.1016/0306-4522(87)90135-7; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; WADMAN WJ, 1993, NEUROSCIENCE, V52, P255, DOI 10.1016/0306-4522(93)90154-8; Wu Jian-Young, 1993, P389; Wu JY, 1999, J NEUROSCI, V19, P5005; Wu JY, 2001, J NEUROPHYSIOL, V86, P2461, DOI 10.1152/jn.2001.86.5.2461; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	66	162	163	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					119	129		10.1016/j.neuron.2007.06.016	http://dx.doi.org/10.1016/j.neuron.2007.06.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610821	Bronze, Green Accepted			2022-12-24	WOS:000248010700012
J	Snutch, TP; Monteil, A				Snutch, Terrance P.; Monteil, Arnaud			The sodium "leak" has finally been plugged	NEURON			English	Editorial Material							CATION CHANNEL	Most electrophysiologists generally do not speak highly of leak currents. In reality, these conductances represent a crucial functional mechanism by which neurons control resting membrane potentials. A new study in Cell by Lu et al. has surprisingly confirmed the identity of the long-sought voltage-insensitive sodium leak conductance to be encoded by the third branch of the voltage-gated sodium and calcium channel family.	Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ Montpellier I, CNRS, UMR5203, INSERM,U661,Dept Physiol,Inst Genom Fonct, F-34094 Montpellier 5, France; Univ Montpellier 2, CNRS, UMR5203, INSERM,U661,Dept Physiol,Inst Genom Fonct, F-34094 Montpellier 5, France	University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Snutch, TP (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.	snutch@msl.ubc.ca	Monteil, Arnaud/G-3113-2012; Snutch, Terrance P/L-3464-2019	Monteil, Arnaud/0000-0003-1632-7318; Snutch, Terrance P/0000-0001-5182-1296				Catterall WA, 2006, J RECEPT SIG TRANSD, V26, P577, DOI 10.1080/10799890600915100; Hayden EP, 2006, GENES BRAIN BEHAV, V5, P85, DOI 10.1111/j.1601-183X.2005.00138.x; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Mir B, 1997, GENETICS, V147, P701; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Nishikawa K, 1999, ANESTHESIOLOGY, V90, P1691, DOI 10.1097/00000542-199906000-00026; Yamaoka I, 2006, FASEB J, V20, pA161	11	17	17	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 24	2007	54	4					505	507		10.1016/j.neuron.2007.05.005	http://dx.doi.org/10.1016/j.neuron.2007.05.005			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521564	Bronze			2022-12-24	WOS:000246970800006
J	Kee, N; Teixeira, CM; Wang, AH; Frankland, PW				Kee, Nohjin; Teixeira, Catia M.; Wang, Afra H.; Frankland, Paul W.			Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL NEUROGENESIS; RETROGRADE-AMNESIA; NEURONS; INTEGRATION; EXPRESSION; MATURATION; BRAIN; YOUNG; BORN; TIME	Throughout adulthood, new neurons are continuously added to the dentate gyrus, a hippocampal subregion that is important in spatial learning. Whether these adult-generated granule cells become functionally integrated into memory networks is not known. We used immunohistochemical approaches to visualize the recruitment of new neurons into circuits supporting water maze memory in intact mice. We show that as new granule cells mature, they are increasingly likely to be incorporated into circuits supporting spatial memory. By the time the cells are 4 or more weeks of age, they are more likely than existing granule cells to be recruited into circuits supporting spatial memory. This preferential recruitment supports the idea that new neurons make a unique contribution to memory processing in the dentate gyrus.	Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; Univ Porto, Grad Program Areas Basic & Appl Biol, P-4050465 Oporto, Portugal	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Universidade do Porto	Frankland, PW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	paul.frankland@sickkids.ca		Teixeira, Catia/0000-0002-6577-0730				Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Song HJ, 2005, J NEUROSCI, V25, P10366, DOI 10.1523/JNEUROSCI.3452-05.2005; Takehara K, 2003, J NEUROSCI, V23, P9897; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Zhang WP, 2005, LEARN MEMORY, V12, P239, DOI 10.1101/lm.90005; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	50	676	696	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					355	362		10.1038/nn1847	http://dx.doi.org/10.1038/nn1847			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17277773				2022-12-24	WOS:000244480300018
J	Zurborg, S; Yurgionas, B; Jira, JA; Caspani, O; Heppenstall, PA				Zurborg, Sandra; Yurgionas, Brian; Jira, Julia A.; Caspani, Ombretta; Heppenstall, Paul A.			Direct activation of the ion channel TRPA1 by Ca2+	NATURE NEUROSCIENCE			English	Article							CATION CHANNEL; CA2+-BINDING PROTEINS; COLD; SENSITIVITY; ANKTM1; TRPM5	TRPA1 is an ion channel expressed by nociceptors and activated by irritant compounds such as mustard oil. The endogenous function of TRPA1 has remained unclear, a fact highlighted by ongoing debate over its potential role as a sensor of noxious cold. Here we show that intracellular Ca2+ activates human TRPA1 via an EF-hand domain and that cold sensitivity occurs indirectly ( and nonphysiologically) through increased [Ca2+](i) during cooling in heterologous systems.	Charite Univ Med Berlin, Klin Anaesthesiol & Operat Intens Med, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heppenstall, PA (corresponding author), Charite Univ Med Berlin, Klin Anaesthesiol & Operat Intens Med, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	paul.heppenstall@charite.de	Yurgionas, Brian/AAD-3551-2019	Caspani, Ombretta/0000-0002-9700-3149				Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	15	369	383	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					277	279		10.1038/nn1843	http://dx.doi.org/10.1038/nn1843			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259981				2022-12-24	WOS:000244480300007
J	Mallucci, GR; White, MD; Farmer, M; Dickinson, A; Khatun, H; Powell, AD; Brandner, S; Jefferys, JGR; Collinge, J				Mallucci, Giovanna R.; White, Melanie D.; Farmer, Michael; Dickinson, Andrew; Khatun, Husna; Powell, Andrew D.; Brandner, Sebastian; Jefferys, John G. R.; Collinge, John			Targeting cellular prion protein reverses early coanitive deficits and neurophysiological dysfunction in prion-infected mice	NEURON			English	Article							EARLY BEHAVIORAL-CHANGES; OBJECT RECOGNITION TASK; LONG-TERM POTENTIATION; TRANSGENIC MICE; ALZHEIMERS-DISEASE; COGNITIVE DEFICITS; PLAQUE-FORMATION; MOUSE MODEL; IN-VIVO; MEMORY	Currently, no treatment can prevent the cognitive and motor decline associated with widespread neurodegeneration in prion disease. However, we previously showed that targeting endogenous neuronal prion protein (PrPc) (the precursor of its disease-associated isoform, PrPsc) in mice with early prion infection reversed spongiform change and prevented clinical symptoms and neuronal loss. We now show that cognitive and behavioral deficits and impaired neurophysiological function accompany early hippocampal spongiform pathology. Remarkably, these behavioral and synaptic impairments recover when neuronal PrPc is depleted, in parallel with reversal of spongiosis. Thus, early functional impairments precede neuronal loss in prion disease and can be rescued. Further, they occur before extensive PrPsc deposits accumulate and recover rapidly after PrPc depletion, supporting the concept that they are caused by a transient neurotoxic species, distinct from aggregated PrPsc. These data suggest that early intervention in human prion disease may lead to recovery of cognitive and behavioral symptoms.	Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Univ Birmingham, Dept Neurophysiol, Div Neurosci, Birmingham B15 2TT, W Midlands, England	University of London; University College London; University of London; University College London; University of Birmingham	Mallucci, GR (corresponding author), Inst Neurol, MRC, Prion Unit, Queen Sq, London WC1N 3BG, England.	g.mallucci@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014; White, Melanie/J-5565-2019; Jefferys, John G R/AAF-1164-2021; Powell, Andrew/A-7472-2010; Jefferys, John/E-6132-2012	Brandner, Sebastian/0000-0002-9821-0342; White, Melanie/0000-0002-7399-8348; Jefferys, John G R/0000-0003-0106-4412; Jefferys, John/0000-0003-0106-4412; Mallucci, Giovanna/0000-0001-8504-1191	Medical Research Council [MC_U123160654, MC_U123192748, MC_U132692719] Funding Source: Medline; MRC [MC_U123160654] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Betmouni S, 1999, PSYCHOBIOLOGY, V27, P63; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; BRACE HM, 1985, J PHYSIOL-LONDON, V368, P343, DOI 10.1113/jphysiol.1985.sp015861; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Buttini M, 2002, J NEUROSCI, V22, P10539; Chiti Z, 2006, NEUROBIOL DIS, V22, P363, DOI 10.1016/j.nbd.2005.12.002; Clark RE, 2000, J NEUROSCI, V20, P8853; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Deacon RMJ, 2001, NEUROREPORT, V12, P2053, DOI 10.1097/00001756-200107030-00052; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Giese KP, 1998, LEARN MEMORY, V5, P257; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Jamieson E, 2001, NEUROREPORT, V12, P2147, DOI 10.1097/00001756-200107200-00021; Jeffrey M, 1997, NEUROPATH APPL NEURO, V23, P93, DOI 10.1111/j.1365-2990.1997.tb01191.x; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Morgan SL, 2001, J NEUROPHYSIOL, V86, P1289, DOI 10.1152/jn.2001.86.3.1289; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mumby DG, 2005, HIPPOCAMPUS, V15, P1050, DOI 10.1002/hipo.20122; Roesler R, 1999, MOL BRAIN RES, V71, P349, DOI 10.1016/S0169-328X(99)00193-X; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Winegar BD, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-5; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	48	192	199	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					325	335		10.1016/j.neuron.2007.01.005	http://dx.doi.org/10.1016/j.neuron.2007.01.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270731	Bronze			2022-12-24	WOS:000245126800005
J	Glykys, J; Peng, ZC; Chandra, D; Homanics, GE; Houser, CR; Mody, I				Glykys, Joseph; Peng, Zechun; Chandra, Dev; Homanics, Gregg E.; Houser, Carolyn R.; Mody, Istvan			A new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanol	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; DELTA-SUBUNIT; TONIC INHIBITION; DENTATE GYRUS; GRANULE CELLS; A RECEPTORS; ALPHA-1 SUBUNIT; DEFICIENT MICE; KNOCKOUT MICE; RAT-BRAIN	According to the rules of GABA(A) receptor (GABA(A)R) subunit assembly, alpha 4 and alpha 6 subunits are considered to be the natural partners of delta subunits. These GABA(A)Rs are a preferred target of low, sobriety-impairing concentrations of ethanol. Here we demonstrate a new naturally occurring GABAAR subunit partnership: d subunits of hippocampal interneurons are coexpressed and colocalized with alpha 1 subunits, but not with alpha 4, alpha 6 or any other alpha subunits. Ethanol potentiates the tonic inhibition mediated by such native alpha 1/delta GABA(A)Rs in wild-type and in alpha 4 subunit-deficient (Gabra4(-/-)) mice, but not in delta subunit - deficient (Gabrd(-/-)) mice. We also ruled out any compensatory upregulation of alpha 6 subunits that might have accounted for the ethanol effect in Gabra4(-/-) mice. Thus, alpha 1/delta subunit assemblies represent a new neuronal GABA(A)R subunit partnership present in hippocampal interneurons, mediate tonic inhibitory currents and are highly sensitive to low concentrations of ethanol.	Univ Calif Los Angeles, David Geffen Sch Med, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; VA Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Mody, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA.	mody@ucla.edu		Glykys, Joseph/0000-0002-1499-9172; Homanics, Gregg/0000-0003-3641-8153	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, R37NS030549, R01NS051311, R56NS051311] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000404] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA14003] Funding Source: Medline; NINDS NIH HHS [NS051311, NS30549, NS35958] Funding Source: Medline; BLRD VA [I01 BX000404] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BLRD VA		Araujo F, 1998, EUR J PHARMACOL, V347, P347, DOI 10.1016/S0014-2999(98)00122-8; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Esclapez M, 1996, HIPPOCAMPUS, V6, P225; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; GAO B, 1994, EUR J NEUROSCI, V6, P837, DOI 10.1111/j.1460-9568.1994.tb00994.x; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Goldstein PA, 2002, J NEUROPHYSIOL, V88, P3208, DOI 10.1152/jn.00885.2001; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; Hanchar HJ, 2004, LIFE SCI, V76, P1, DOI 10.1016/j.lfs.2004.05.035; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jones A, 1997, J NEUROSCI, V17, P1350; Korpi ER, 2002, NEUROSCIENCE, V109, P733, DOI 10.1016/S0306-4522(01)00527-9; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Ogris W, 2006, J NEUROCHEM, V96, P136, DOI 10.1111/j.1471-4159.2005.03509.x; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sun CS, 2004, BRAIN RES, V1029, P207, DOI 10.1016/j.brainres.2004.09.056; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Sur C, 2001, J NEUROSCI, V21, P3409, DOI 10.1523/JNEUROSCI.21-10-03409.2001; Wafford KA, 2004, BIOCHEM SOC T, V32, P553, DOI 10.1042/BST0320553; Wall MJ, 2002, NEUROPHARMACOLOGY, V43, P737, DOI 10.1016/S0028-3908(02)00085-0; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wei WZ, 2003, J NEUROSCI, V23, P10650; Weiner JL, 1997, J NEUROPHYSIOL, V77, P1306, DOI 10.1152/jn.1997.77.3.1306; Weiner JL, 1997, J NEUROCHEM, V68, P1949; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002	52	200	202	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					40	48		10.1038/nn1813	http://dx.doi.org/10.1038/nn1813			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159992				2022-12-24	WOS:000243096100014
J	Haynes, SE; Hollopeter, G; Yang, G; Kurpius, D; Dailey, ME; Gan, WB; Julius, D				Haynes, Sharon E.; Hollopeter, Gunther; Yang, Guang; Kurpius, Dana; Dailey, Michael E.; Gan, Wen-Biao; Julius, David			The P2Y(12) receptor regulates microglial activation by extracellular nucleotides	NATURE NEUROSCIENCE			English	Article							ANTITHROMBOTIC DRUGS; IN-VIVO; ADP; ATP; INJURY; BRAIN; CELLS; IDENTIFICATION; RELEASE; CHEMOTAXIS	Microglia are primary immune sentinels of the CNS. Following injury, these cells migrate or extend processes toward sites of tissue damage. CNS injury is accompanied by release of nucleotides, serving as signals for microglial activation or chemotaxis. Microglia express several purinoceptors, including a G(i)-coupled subtype that has been implicated in ATP- and ADP-mediated migration in vitro. Here we show that microglia from mice lacking G(i)-coupled P2Y(12) receptors exhibit normal baseline motility but are unable to polarize, migrate or extend processes toward nucleotides in vitro or in vivo. Microglia in P2ry(12)(-/-) mice show significantly diminished directional branch extension toward sites of cortical damage in the living mouse. Moreover, P2Y(12) expression is robust in the 'resting' state, but dramatically reduced after microglial activation. These results imply that P2Y(12) is a primary site at which nucleotides act to induce microglial chemotaxis at early stages of the response to local CNS injury.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; NYU, Sch Med, Skirball Inst, Program Mol Neurobiol,Dept Physiol & Neurosci, New York, NY 10016 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York University; University of Iowa	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, 600 16th St, San Francisco, CA 94158 USA.	julius@cmp.ucsf.edu		Yang, Guang/0000-0002-5739-9126	NCRR NIH HHS [S10 RR017941] Funding Source: Medline; NINDS NIH HHS [R01 NS043468, NS434468] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043468] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Brass S, 2001, NATURE, V409, P145, DOI 10.1038/35051688; Burnstock G, 1996, CIBA F SYMP, V198, P1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chakfe Y, 2002, J NEUROSCI, V22, P3061, DOI 10.1523/JNEUROSCI.22-08-03061.2002; CHAO CC, 1992, J IMMUNOL, V149, P2736; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hanisch Uwe-Karsten, 2002, P79; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Herbert Jean-Marc, 2003, Semin Vasc Med, V3, P113; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; Lee JC, 2005, GLIA, V50, P168, DOI 10.1002/glia.20164; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Moller T, 2000, BRAIN RES, V853, P49, DOI 10.1016/S0006-8993(99)02244-1; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Salimi K, 2002, BRAIN RES, V946, P283, DOI 10.1016/S0006-8993(02)02896-2; Sasaki Y, 2003, GLIA, V44, P242, DOI 10.1002/glia.10293; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Streit Wolfgang J., 2002, P1; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Zhang FL, 2001, J BIOL CHEM, V276, P8608, DOI 10.1074/jbc.M009718200	34	929	955	2	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1512	1519		10.1038/nn1805	http://dx.doi.org/10.1038/nn1805			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115040	Green Published			2022-12-24	WOS:000242404000015
J	Palop, JJ; Chin, J; Roberson, ED; Wang, J; Thwin, MT; Bien-Ly, N; Yoo, J; Ho, KO; Yu, GQ; Kreitzer, A; Finkbeiner, S; Noebels, JL; Mucke, L				Palop, Jorge J.; Chin, Jeannie; Roberson, Erik D.; Wang, Jun; Thwin, Myo T.; Bien-Ly, Nga; Yoo, Jong; Ho, Kaitlyn O.; Yu, Gui-Qiu; Kreitzer, Anatol; Finkbeiner, Steven; Noebels, Jeffrey L.; Mucke, Lennart			Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; DENTATE GRANULE CELLS; NEUROPEPTIDE-Y; TRANSGENIC MICE; RAT HIPPOCAMPUS; SYNAPTIC-TRANSMISSION; FASCIA-DENTATA; NMDA RECEPTOR	Neural network dysfunction may play an important role in Alzheimer's disease (AD). Neuronal circuits vulnerable to AD are also affected in human amyloid precursor protein (hAPP) transgenic mice. hAPP mice with high levels of amyloid-beta peptides in the brain develop AD-like abnormalities, including cognitive deficits and depletions of calcium-related proteins in the dentate gyrus, a region critically involved in learning and memory. Here, we report that hAPP mice have spontaneous nonconvulsive seizure activity in cortical and hippocampal networks, which is associated with GABAergic sprouting, enhanced synaptic inhibition, and synaptic plasticity deficits in the dentate gyrus. Many Ab-induced neuronal alterations could be simulated in nontransgenic mice by excitotoxin challenge and prevented in hAPP mice by blocking overexcitation. Aberrant increases in network excitability and compensatory inhibitory mechanisms in the hippocampus may contribute to A beta-induced neurological deficits in hAPP mice and, possibly, also in humans with AD.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; Baylor Coll Med, Dept Neurol, Dev Neurogenet Lab, Houston, TX 77030 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Baylor College of Medicine	Palop, JJ (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	jpalop@gladstone.ucsf.edu; jpalop@gladstone.ucsf.edu; Imucke@gladstone.ucsf.edu	Palop, Jorge/AAH-9014-2020; Palop, Jorge J./D-8128-2011; Wang, Jun/M-2337-2016; Wang, Jun/N-8472-2015; Roberson, Erik/A-5718-2009	Wang, Jun/0000-0002-0085-4722; Wang, Jun/0000-0002-0085-4722; Roberson, Erik/0000-0002-1810-9763; Noebels, Jeffrey/0000-0002-2887-0839; Chin, Jeannie/0000-0001-9902-3744; Palop, Jorge/0000-0001-6086-1070	NCRR NIH HHS [C06 RR018928, RR018928] Funding Source: Medline; NIA NIH HHS [P50 AG023501, AG023501, P01 AG022074, AG011385, AG022074, R01 AG011385, R37 AG011385] Funding Source: Medline; NICHD NIH HHS [HD024064, P30 HD024064] Funding Source: Medline; NINDS NIH HHS [NS54811, R01 NS041787, NS39074, NS29709, K08 NS054811-02, NS041787, R01 NS039074, R01 NS029709, K08 NS054811] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054811, R01NS041787, R01NS039074, R01NS029709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011385, P50AG023501, P01AG022074, R37AG011385] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; BAKST I, 1986, J NEUROSCI, V6, P1452; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; Bijak Maria, 1995, Polish Journal of Pharmacology, V47, P461; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; COLMERS WF, 1987, J PHYSIOL-LONDON, V383, P285; Dawson HN, 2001, J CELL SCI, V114, P1179; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Diez M, 2003, NEUROBIOL DIS, V14, P579, DOI 10.1016/j.nbd.2003.08.003; Diez M, 2000, NEUROSCIENCE, V100, P259, DOI 10.1016/S0306-4522(00)00261-X; Edwards-Lee T, 2005, NEUROLOGY, V64, P377, DOI 10.1212/01.WNL.0000149761.70566.3E; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gariboldi M, 1998, EUR J NEUROSCI, V10, P757, DOI 10.1046/j.1460-9568.1998.00061.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; He J, 2002, NEUROPSYCHOPHARMACOL, V26, P259, DOI 10.1016/S0893-133X(01)00332-3; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KLAPSTEIN GJ, 1993, HIPPOCAMPUS, V3, P103, DOI 10.1002/hipo.450030111; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Lee KW, 2004, J NEUROSCI RES, V76, P572, DOI 10.1002/jnr.20127; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Lozsadi DA, 2006, DEMENT GERIATR COGN, V22, P121, DOI 10.1159/000093664; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Marcon G, 2004, J NEUROPATH EXP NEUR, V63, P199, DOI 10.1093/jnen/63.3.199; MARK RJ, 1995, NEUROBIOL AGING, V16, P187, DOI 10.1016/0197-4580(94)00150-2; MARKSTEINER J, 1990, NEUROSCI LETT, V112, P143, DOI 10.1016/0304-3940(90)90193-D; MATHERN GW, 1995, J NEUROSCI, V15, P3990; MATTSON MP, 1993, TRENDS NEUROSCI, V16, P409, DOI 10.1016/0166-2236(93)90009-B; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; Molinari S, 1996, P NATL ACAD SCI USA, V93, P8028, DOI 10.1073/pnas.93.15.8028; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Nagerl UV, 2000, J NEUROSCI, V20, P1831; OKEEFE J, 1975, EXP NEUROL, V48, P152, DOI 10.1016/0014-4886(75)90230-7; OLNEY JW, 1995, NEUROBIOL AGING, V16, P459, DOI 10.1016/0197-4580(94)00185-4; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Qian J, 1997, J NEUROSCI, V17, P8169; Rabinowicz AL, 2000, ALZ DIS ASSOC DIS, V14, P231, DOI 10.1097/00002093-200010000-00008; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Richichi C, 2004, J NEUROSCI, V24, P3051, DOI 10.1523/JNEUROSCI.4056-03.2004; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schwarzer C, 1998, MOL PHARMACOL, V53, P6, DOI 10.1124/mol.53.1.6; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shao LR, 2005, J NEUROPHYSIOL, V94, P952, DOI 10.1152/jn.01342.2004; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Smialowska M, 1996, NEUROPEPTIDES, V30, P7; Snider BJ, 2005, ARCH NEUROL-CHICAGO, V62, P1821, DOI 10.1001/archneur.62.12.1821; SNYER EM, 2005, NAT NEUROSCI, V8, P1051; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TONDER N, 1994, EPILEPSIA, V35, P1299, DOI 10.1111/j.1528-1157.1994.tb01802.x; TONDER N, 1994, HIPPOCAMPUS, V4, P79, DOI 10.1002/hipo.450040110; Tu B, 2006, NEUROSCIENCE, V143, P1085, DOI 10.1016/j.neuroscience.2006.08.036; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Vezzani A, 2004, NEUROPEPTIDES, V38, P245, DOI 10.1016/j.npep.2004.05.004; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	87	1071	1102	1	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 6	2007	55	5					697	711		10.1016/j.neuron.2007.07.025	http://dx.doi.org/10.1016/j.neuron.2007.07.025			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785178	Green Accepted			2022-12-24	WOS:000249857000007
J	Lazarus, M; Yoshida, K; Coppari, R; Bass, CE; Mochizuki, T; Lowell, BB; Saper, CB				Lazarus, Michael; Yoshida, Kyoko; Coppari, Roberto; Bass, Caroline E.; Mochizuki, Takatoshi; Lowell, Bradford B.; Saper, Clifford B.			EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses	NATURE NEUROSCIENCE			English	Review							BROWN ADIPOSE-TISSUE; FEBRILE RESPONSE; MICE; LIPOPOLYSACCHARIDE; THERMOGENESIS; TEMPERATURE; RAPHE	Fever is a result of the action of prostaglandin E2 ( PGE2) on the brain and appears to require EP3 prostaglandin receptors ( EP3Rs), but the specific neurons on which PGE2 acts to produce fever have not been definitively established. Here we report that selective genetic deletion of the EP3Rs in the median preoptic nucleus of mice resulted in abrogation of the fever response. These observations demonstrate that the EP3R-bearing neurons in the median preoptic nucleus are required for fever responses.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; Wake Forest Univ Hlth Sci, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Wake Forest University; Wake Forest University School of Medicine	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02215 USA.	csaper@bidmc.harvard.edu	Saper, Clifford/L-3815-2019; Mochizuki, Takatoshi/AAB-2522-2020; Coppari, Roberto/B-4799-2014; Lazarus, Michael/G-3130-2010	Lazarus, Michael/0000-0003-3863-4474; COPPARI, Roberto/0000-0003-1288-6948; Yoshida-Court, Kyoko/0000-0002-7558-9943; Bass, Caroline/0000-0002-5856-6387; Mochizuki, Takatoshi/0000-0001-6976-7240; Lazarus, Michael/0000-0003-4700-7894	NHLBI NIH HHS [HL60292] Funding Source: Medline; NIDA NIH HHS [F32 DA017543] Funding Source: Medline; NINDS NIH HHS [NS33987] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA017543] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Lu J, 2001, J NEUROSCI, V21, P4864, DOI 10.1523/JNEUROSCI.21-13-04864.2001; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Oka T, 2000, J COMP NEUROL, V428, P20, DOI 10.1002/1096-9861(20001204)428:1<20::AID-CNE3>3.0.CO;2-X; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Oka T, 2003, BRAIN RES, V968, P256, DOI 10.1016/S0006-8993(03)02268-6; Romanovsky AA, 2003, AM J PHYSIOL-REG I, V285, pR420, DOI 10.1152/ajpregu.00757.2002; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Tanaka M, 2005, AM J PHYSIOL-REG I, V289, pR1592, DOI 10.1152/ajpregu.00141.2005; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233	15	230	238	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1131	1133		10.1038/nn1949	http://dx.doi.org/10.1038/nn1949			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676060				2022-12-24	WOS:000249144000013
J	Stalnaker, TA; Roesch, MR; Franz, TM; Calu, DJ; Singh, T; Schoenbaum, G				Stalnaker, Thomas A.; Roesch, Matthew R.; Franz, Theresa M.; Calu, Donna J.; Singh, Teghpal; Schoenbaum, Geoffrey			Cocaine-induced decisionmaking deficits are mediated by miscoding in basolateral amygdala	NATURE NEUROSCIENCE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; SEEKING BEHAVIOR; LESIONS; RATS; ACQUISITION; IMPAIRMENTS; EXTINCTION; NEURONS; MONKEYS	Addicts and drug-experienced animals have decision-making deficits in reversal-learning tasks and more complex 'gambling' variants. Here we show evidence that these deficits are mediated by persistent encoding of outdated associative information in the basolateral amygdala. Cue-selective neurons in the basolateral amygdala, recorded in cocaine-treated rats, failed to change cue preference during reversal learning. Further, the presence of these neurons was critical to the expression of the reversal-learning deficit in the cocaine-treated rats.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Stalnaker, TA (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St,HSF-2 S251, Baltimore, MD 21201 USA.	tstal002@umaryland.edu		Calu, Donna/0000-0003-2377-9494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA015718-05, R01 DA015718, DA015718] Funding Source: Medline; NIDCD NIH HHS [T32 DC000054, T32-DC00054] Funding Source: Medline; NINDS NIH HHS [T32 NS007375, T32-NS07375] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Calu DJ, 2007, LEARN MEMORY, V14, P325, DOI 10.1101/lm.534807; Carelli RM, 2003, J NEUROSCI, V23, P8204; Fuchs RA, 2006, EUR J NEUROSCI, V23, P2809, DOI 10.1111/j.1460-9568.2006.04806.x; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; Jentsch JD, 2002, NEUROPSYCHOPHARMACOL, V26, P183, DOI 10.1016/S0893-133X(01)00355-4; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Schoenbaum G, 2004, EUR J NEUROSCI, V19, P1997, DOI 10.1111/j.1460-9568.2004.03274.x; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; See RE, 2003, NEUROSCIENCE, V117, P477, DOI 10.1016/S0306-4522(02)00665-6; Stalnaker TA, 2007, NEURON, V54, P51, DOI 10.1016/j.neuron.2007.02.014	15	49	49	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					949	951		10.1038/nn1931	http://dx.doi.org/10.1038/nn1931			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603478	Green Accepted			2022-12-24	WOS:000248357500008
J	Wulff, P; Goetz, T; Leppa, E; Linden, AM; Renzi, M; Swinny, JD; Vekovischeva, OY; Sieghart, W; Somogyi, P; Korpi, ER; Farrant, M; Wisden, W				Wulff, Peer; Goetz, Thomas; Leppa, Elli; Linden, Anni-Maija; Renzi, Massimiliano; Swinny, Jerome D.; Vekovischeva, Olga Y.; Sieghart, Werner; Somogyi, Peter; Korpi, Esa R.; Farrant, Mark; Wisden, William			From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; AMINOBUTYRIC ACID(A) RECEPTOR; ZOLPIDEM BINDING-SITES; SUBUNIT MESSENGER-RNAS; POINT MUTATION; RAT-BRAIN; IN-VIVO; REVERSIBLE INACTIVATION; BENZODIAZEPINE SITE; NEURAL CIRCUITRY	In mammals, identifying the contribution of specific neurons or networks to behavior is a key challenge. Here we describe an approach that facilitates this process by enabling the rapid modulation of synaptic inhibition in defined cell populations. Binding of zolpidem, a systemically active allosteric modulator that enhances the function of the GABAA receptor, requires a phenylalanine residue (Phe77) in the gamma 2 subunit. Mice in which this residue is changed to isoleucine are insensitive to zolpidem. By Cre recombinase-induced swapping of the gamma 2 subunit (that is, exchanging Ile77 for Phe77), zolpidem sensitivity can be restored to GABAA receptors in chosen cell types. We demonstrate the power of this method in the cerebellum, where zolpidem rapidly induces significant motor deficits when Purkinje cells are made uniquely sensitive to its action. This combined molecular and pharmacological technique has demonstrable advantages over targeted cell ablation and will be invaluable for investigating many neuronal circuits.	Univ Heidelberg, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; Univ Helsinki, Inst Biomed, Biomed Helsinki, FIN-00014 Helsinki, Finland; UCL, Dept Pharmacol, London WC1E 6BT, England; Univ Oxford, MRC Anatom Neuropharmacol Unit, Oxford OX1 3TH, England; Med Univ Vienna, Ctr Brain Res, Sect Biochem & Mol Biol Nervous Syst, A-1090 Vienna, Austria; Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	Ruprecht Karls University Heidelberg; University of Helsinki; University of London; University College London; University of Oxford; Medical University of Vienna; University of Aberdeen	Wulff, P (corresponding author), Univ Heidelberg, Dept Clin Neurobiol, Im Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	p.wulff@abdn.ac.uk	Wisden, William/A-4071-2011; Sieghart, Werner/A-4877-2013	Wisden, William/0000-0003-4743-0334; Sieghart, Werner/0000-0002-0443-0302; Linden, Anni-Maija/0000-0003-1573-8051; RENZI, MASSIMILIANO/0000-0001-6973-3569; Wulff, Peer/0000-0002-0282-7832; Farrant, Mark/0000-0002-9918-0376; Korpi, Esa R./0000-0003-0683-4009; Swinny, Jerome/0000-0002-8194-5481	Medical Research Council [G0501584, MC_U138135973, G0601498(79979), G0601498] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0601498, MC_U138135973, G0501584] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; BENAVIDES J, 1988, J PHARMACOL EXP THER, V245, P1033; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Cope DW, 2005, EUR J NEUROSCI, V21, P3002, DOI 10.1111/j.1460-9568.2005.04127.x; Cope DW, 2004, NEUROPHARMACOLOGY, V47, P17, DOI 10.1016/j.neuropharm.2004.03.007; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; Crestani F, 2000, NAT NEUROSCI, V3, P1059, DOI 10.1038/80553; Crick F, 1999, PHILOS T ROY SOC B, V354, P2021, DOI 10.1098/rstb.1999.0541; De Vasconcelos AP, 2006, NEUROSCIENCE, V141, P1649, DOI 10.1016/j.neuroscience.2006.05.023; DUNCAN GE, 1995, NEUROSCIENCE, V64, P1113, DOI 10.1016/0306-4522(94)00433-6; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Korpi ER, 1999, EUR J NEUROSCI, V11, P233, DOI 10.1046/j.1460-9568.1999.00421.x; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leppa E, 2005, NEUROPHARMACOLOGY, V48, P469, DOI 10.1016/j.neuropharm.2004.11.007; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; McCartney MR, 2007, MOL PHARMACOL, V71, P539, DOI 10.1124/mol.106.028597; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; NIDDAM R, 1987, J NEUROCHEM, V49, P890, DOI 10.1111/j.1471-4159.1987.tb00977.x; OERTEL WH, 1981, NEUROSCIENCE, V6, P2715, DOI 10.1016/0306-4522(81)90115-9; Ogris W, 2004, BIOCHEM PHARMACOL, V68, P1621, DOI 10.1016/j.bcp.2004.07.020; Perrais D, 1999, J NEUROSCI, V19, P578; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sancar F, 2007, MOL PHARMACOL, V71, P38, DOI 10.1124/mol.106.029595; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Thomson AM, 2000, EUR J NEUROSCI, V12, P425, DOI 10.1046/j.1460-9568.2000.00915.x; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Whiting PJ, 2006, CURR OPIN PHARMACOL, V6, P24, DOI 10.1016/j.coph.2005.08.005; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wulff P, 2005, TRENDS NEUROSCI, V28, P44, DOI 10.1016/j.tins.2004.11.004; Yamamoto M, 2003, J NEUROSCI, V23, P6759; ZEZULA J, 1991, BRAIN RES, V563, P325, DOI 10.1016/0006-8993(91)91556-G; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	90	90	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					923	929		10.1038/nn1927	http://dx.doi.org/10.1038/nn1927			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17572671	Green Accepted			2022-12-24	WOS:000247560200024
J	Cheng, HYM; Papp, JW; Varlamova, O; Dziema, H; Russell, B; Curfman, JP; Nakazawa, T; Shimizu, K; Okamura, H; Impey, S; Obrietan, K				Cheng, Hai-Ying M.; Papp, Joseph W.; Varlamova, Olga; Dziema, Heather; Russell, Brandon; Curfman, John P.; Nakazawa, Takanobu; Shimizu, Kimiko; Okamura, Hitoshi; Impey, Soren; Obrietan, Karl			microRNA modulation of circadian-clock period and entrainment	NEURON			English	Article							DEFICIENT MICE LACKING; SUPRACHIASMATIC NUCLEUS; RESPONSE ELEMENT; GENE-EXPRESSION; PHOTIC RESPONSIVENESS; DEPENDENT MECHANISM; BIOLOGICAL CLOCK; MESSENGER-RNAS; C-ELEGANS; PROTEIN	microRNAs (miRNAs) are a class of small, noncoding RNAs that regulate the stability or translation of mRNA transcripts. Although recent work has implicated miRNAs in development and in disease, the expression and function of miRNAs in the adult mammalian nervous system have not been extensively characterized. Here, we examine the role of two brain-specific miRNAs, miR-219 and miR-132, in modulating the circadian clock located in the suprachiasmatic nucleus. miR-219 is a target of the CLOCK and BMAL1 complex, exhibits robust circadian rhythms of expression, and the in vivo knockdown of miR-219 lengthens the circadian period. miR-132 is induced by photic entrainment cues via a MAPK/CREB-dependent mechanism, modulates clock-gene expression, and attenuates the entraining effects of light. Collectively, these data reveal miRNAs; as clock- and light-regulated genes and provide a mechanistic examination of their roles as effectors of pacemaker activity and entrainment.	Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan	University System of Ohio; Ohio State University; Oregon Health & Science University; University of Tokyo; University of Washington; University of Washington Seattle; Kobe University	Cheng, HYM (corresponding author), Ohio State Univ, Dept Neurosci, 333 W 10th Ave, Columbus, OH 43210 USA.	hymcheng@yahoo.ca; obrietan.1@osu.edu	Shimizu, Kimiko/G-4956-2014; Nakazawa, Takanobu/E-1012-2014; Kimiko, Shimizu/ACS-9013-2022	Shimizu, Kimiko/0000-0003-4943-2552; Nakazawa, Takanobu/0000-0002-5049-9140; Kimiko, Shimizu/0000-0003-4943-2552; NAKAZAWA, Takanobu/0000-0003-4863-1277	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062335, K01MH064954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758, R01NS047176] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64954, MH62335, R01 MH062335, K01 MH064954, R01 MH062335-06, R01 MH062335-05] Funding Source: Medline; NINDS NIH HHS [P30 NS045758, R01 NS047176-03, R01 NS047176, NS47176, 5P30NS045758] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Araki R, 2004, J BIOL CHEM, V279, P10237, DOI 10.1074/jbc.M312761200; Araki R, 2006, BRAIN RES, V1098, P9, DOI 10.1016/j.brainres.2006.04.096; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Cheng HYM, 2006, J NEUROSCI, V26, P12984, DOI 10.1523/JNEUROSCI.4253-06.2006; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Comas M, 2006, J BIOL RHYTHM, V21, P362, DOI 10.1177/0748730406292446; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Masubuchi S, 2005, J NEUROSCI, V25, P4719, DOI 10.1523/JNEUROSCI.4761-04.2005; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; MCMAHON DG, 1987, J COMP PHYSIOL A, V161, P335, DOI 10.1007/BF00603959; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	44	436	467	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 7	2007	54	5					813	829		10.1016/j.neuron.2007.05.017	http://dx.doi.org/10.1016/j.neuron.2007.05.017			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553428	Bronze, Green Accepted			2022-12-24	WOS:000247329900013
J	Tesco, G; Koh, YH; Kang, EL; Cameron, AN; Das, S; Sena-Esteves, M; Hiltunen, M; Yang, SH; Zhong, ZY; Shen, Y; Simpkins, JW; Tanzi, RE				Tesco, Giuseppina; Koh, Young Ho; Kang, Eugene L.; Cameron, Andrew N.; Das, Shinjita; Sena-Esteves, Miguel; Hiltunen, Mikko; Yang, Shao-Hua; Zhong, Zhenyu; Shen, Yong; Simpkins, James W.; Tanzi, Rudolph E.			Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSIENT CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; A-BETA; OXIDATIVE STRESS; FOCAL ISCHEMIA; CYTOSOLIC DOMAIN; CLEAVING ENZYME; SORTING SIGNAL; MESSENGER-RNA	beta-site APP-cleaving enzyme (BACE) is required for production of the Alzheimer's disease (AD)-associated AD protein. BACE levels are elevated in AD brain, and increasing evidence reveals BACE as a stress-related protease that is upregulated following cerebral ischemia. However, the molecular mechanism responsible is unknown. We show that increases in BACE and beta-secretase activity are due to posttranslational stabilization following caspase activation. We also found that during cerebral ischemia, levels of GGA3, an adaptor protein involved in BACE trafficking, are reduced, while BACE levels are increased. RNAi silencing of GGA3 also elevated levels of BACE and AD. Finally, in AD brain samples, GGA3 protein levels were significantly decreased and inversely correlated with increased levels of BACE. In summary, we have elucidated a GGA3-dependent mechanism regulating BACE levels and beta-secretase activity. This mechanism may explain increased cerebral levels of BACE and AD following cerebral ischemia and existing in AD.	Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Neurosci, Charlestown, MA 02129 USA; Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; Sun Hlth Res Inst, Sun City, AZ 85351 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of North Texas System; University of North Texas Health Science Center; Banner Research; Banner Health; Banner Sun Health Research Institute	Tesco, G (corresponding author), Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA.	tescog@helix.mgh.harvard.edu; tanzi@helix.mgh.harvard.edu	Yang, Shaohua/D-1738-2013; Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060009, K12MH069281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025888, R01AG025952, R01AG033016] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG033016, R01 AG025888, 1R01AG025952, R01 AG025952-01A2, R01 AG025952] Funding Source: Medline; NIMH NIH HHS [R37 MH060009, 1R37MH60009, R37 MH060009-08, 1K12MH069281, K12 MH069281-04, K12 MH069281] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; BANATI RB, 1995, J CEREBR BLOOD F MET, V15, P647, DOI 10.1038/jcbfm.1995.80; Barnes NY, 1998, J NEUROSCI, V18, P5869; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brancolini C, 1998, CELL DEATH DIFFER, V5, P1042, DOI 10.1038/sj.cdd.4400443; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Cribbs DH, 2004, AM J PATHOL, V165, P353, DOI 10.1016/S0002-9440(10)63302-0; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; De Strooper B, 2000, J CELL SCI, V113, P1857; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Galli C, 1998, P NATL ACAD SCI USA, V95, P1247, DOI 10.1073/pnas.95.3.1247; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Grupe A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851; Guo Q, 2001, J BIOL CHEM, V276, P16040, DOI 10.1074/jbc.M010996200; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; KALARIA RN, 1993, NEUROREPORT, V4, P211, DOI 10.1097/00001756-199302000-00025; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kim HS, 1998, NEUROREPORT, V9, P533; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Koistinaho J, 1996, NEUROREPORT, V7, P2727, DOI 10.1097/00001756-199611040-00064; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LeBlanc Andrea C., 2005, Current Alzheimer Research, V2, P389, DOI 10.2174/156720505774330573; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; Liu R, 2002, STROKE, V33, P2485, DOI 10.1161/01.STR.0000030317.43597.C8; Namura S, 1998, J NEUROSCI, V18, P3659; Nolan KA, 1998, J AM GERIATR SOC, V46, P597, DOI 10.1111/j.1532-5415.1998.tb01076.x; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Petrovitch H, 2005, ANN NEUROL, V57, P98, DOI 10.1002/ana.20318; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Riekse RG, 2004, J AM GERIATR SOC, V52, P1442, DOI 10.1111/j.1532-5415.2004.52405.x; Rippon GA, 2006, NEUROLOGY, V66, P35, DOI 10.1212/01.wnl.0000191300.38571.3e; Shi J, 2000, BRAIN RES, V853, P1, DOI 10.1016/S0006-8993(99)02113-7; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sodhi CP, 2004, MOL BRAIN RES, V128, P201, DOI 10.1016/j.molbrainres.2004.06.012; STEPHENSON DT, 1992, BRAIN RES, V593, P128, DOI 10.1016/0006-8993(92)91274-I; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Tamagno E, 2003, NEUROBIOL DIS, V14, P291, DOI 10.1016/S0969-9961(03)00131-1; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; WAKITA H, 1992, NEUROSCI LETT, V146, P135, DOI 10.1016/0304-3940(92)90061-B; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zlokovic BV, 2002, ADV DRUG DELIVER REV, V54, P1553, DOI 10.1016/S0169-409X(02)00150-3	69	298	306	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 7	2007	54	5					721	737		10.1016/j.neuron.2007.05.012	http://dx.doi.org/10.1016/j.neuron.2007.05.012			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553422	Bronze, Green Accepted			2022-12-24	WOS:000247329900007
J	Kiyonaka, S; Wakamori, M; Miki, T; Uriu, Y; Nonaka, M; Bito, H; Beedle, AM; Mori, E; Hara, Y; De Waard, M; Kanagawa, M; Itakura, M; Takahashi, M; Campbell, KP; Mori, Y				Kiyonaka, Shigeki; Wakamori, Minoru; Miki, Takafumi; Uriu, Yoshitsugu; Nonaka, Mio; Bito, Haruhiko; Beedle, Aaron M.; Mori, Emiko; Hara, Yuji; De Waard, Michel; Kanagawa, Motoi; Itakura, Makoto; Takahashi, Masami; Campbell, Kevin P.; Mori, Yasuo			RIM1 confers sustained activity and neurotransmitter vesicle anchring to presynaptic Ca+2 channels	NATURE NEUROSCIENCE			English	Article							VOLTAGE-DEPENDENT INACTIVATION; NEURONAL CALCIUM-CHANNELS; I-II-LOOP; CA2+ CHANNELS; BETA-SUBUNIT; N-TYPE; SYNAPTIC-TRANSMISSION; RAB3 EFFECTOR; PROTEIN; RELEASE	The molecular organization of presynaptic active zones is important for the neurotransmitter release that is triggered by depolarization-induced Ca2+ influx. Here, we demonstrate a previously unknown interaction between two components of the presynaptic active zone, RIM1 and voltage-dependent Ca2+ channels (VDCCs), that controls neurotransmitter release in mammalian neurons. RIM1 associated with VDCC beta-subunits via its C terminus to markedly suppress voltage-dependent inactivation among different neuronal VDCCs. Consistently, in pheochromocytoma neuroendocrine PC12 cells, acetylcholine release was significantly potentiated by the full-length and C-terminal RIM1 constructs, but membrane docking of vesicles was enhanced only by the full-length RIM1. The beta construct beta-AID dominant negative, which disrupts the RIM1-beta association, accelerated the inactivation of native VDCC currents, suppressed vesicle docking and acetylcholine release in PC12 cells, and inhibited glutamate release in cultured cerebellar neurons. Thus, RIM1 association with b in the presynaptic active zone supports release via two distinct mechanisms: sustaining Ca2+ influx through inhibition of channel inactivation, and anchoring neurotransmitter-containing vesicles in the vicinity of VDCCs.	Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; INSERM, U607, Lab Canaux Calc Fonct & Pathol, F-38054 Grenoble 09, France; Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 2288555, Japan	Kyoto University; University of Tokyo; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Institut National de la Sante et de la Recherche Medicale (Inserm); Kitasato University	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Katsura Campus,Nishikyo Ku, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Beedle, Aaron M/K-1902-2015; De Waard, Michel/G-7406-2014; Beedle, Aaron/AAI-7014-2020; Bito, Haruhiko/A-8635-2008; Kiyonaka, Shigeki/AAM-7303-2021; Wakamori, Minoru/AAE-2661-2019	Beedle, Aaron M/0000-0002-1019-3235; De Waard, Michel/0000-0002-2782-9615; Kanagawa, Motoi/0000-0003-0984-6398; Bito, Haruhiko/0000-0001-6315-9594; Campbell, Kevin/0000-0003-2066-5889; Wakamori, Minoru/0000-0001-8574-3310				Atwood HL, 2006, SCIENCE, V312, P1008, DOI 10.1126/science.1128445; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Burgess DL, 1999, MOL CELL NEUROSCI, V13, P293, DOI 10.1006/mcne.1999.0748; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Geib S, 2002, J BIOL CHEM, V277, P10003, DOI 10.1074/jbc.M106231200; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Kang MG, 2006, P NATL ACAD SCI USA, V103, P5561, DOI 10.1073/pnas.0601289103; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Liu HY, 1996, J NEUROSCI, V16, P7557; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nishiki T, 1997, BIOCHEM BIOPH RES CO, V239, P57, DOI 10.1006/bbrc.1997.7427; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nonaka M, 2006, J NEUROSCI, V26, P763, DOI 10.1523/JNEUROSCI.2489-05.2006; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Stanley EF, 2003, EUR J NEUROSCI, V17, P1303, DOI 10.1046/j.1460-9568.2003.02536.x; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; WANG L, 2000, CHEM J INTERNET, V2, P44; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	50	164	170	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					691	701		10.1038/nn1904	http://dx.doi.org/10.1038/nn1904			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17496890	Green Accepted, Green Submitted			2022-12-24	WOS:000246799800011
J	Rouw, R; Scholte, HS				Rouw, Romke; Scholte, H. Steven			Increased structural connectivity in grapheme-color synesthesia	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; INDIVIDUAL-DIFFERENCES; VISUAL-PERCEPTION; SYNAESTHESIA; CORTEX; FMRI; ACTIVATION; MECHANISMS; CONSCIOUSNESS; IMAGES	Diffusion tensor imaging allowed us to validate for the first time the hypothesis that hyperconnectivity causes the added sensations in synesthesia. Grapheme- color synesthetes (n = 18), who experience specific colors with particular letters or numbers (for example, 'R is sky blue'), showed greater anisotropic diffusion compared with matched controls. Greater anisotropic diffusion indicates more coherent white matter. Anisotropy furthermore differentiated subtypes of grapheme-color synesthesia. Greater connectivity in the inferior temporal cortex was particularly strong for synesthetes who see synesthetic color in the outside world ('projectors') as compared with synesthetes who see the color in their 'mind's eye' only ('associators'). In contrast, greater connectivity (as compared with non-synesthetes) in the superior parietal or frontal cortex did not differentiate between subtypes of synesthesia. In conclusion, we found evidence that increased structural connectivity is associated with the presence of grapheme-color synesthesia, and has a role in the subjective nature of synesthetic color experience.	Univ Amsterdam, Dept Psychol, NL-1018 WB Amsterdam, Netherlands	University of Amsterdam	Rouw, R (corresponding author), Univ Amsterdam, Dept Psychol, Roetersstr 15, NL-1018 WB Amsterdam, Netherlands.	R.Rouw@uva.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788				BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; DAY S, 2005, SYNESTHESIA PERSPECT, P11; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2005, NEURON, V45, P821, DOI 10.1016/j.neuron.2005.03.007; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Esterman M, 2006, J COGNITIVE NEUROSCI, V18, P1570, DOI 10.1162/jocn.2006.18.9.1570; Evans A. C., 1992, Society for Neuroscience Abstracts, V18, P408; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mondloch CJ, 2004, COGN AFFECT BEHAV NE, V4, P133, DOI 10.3758/CABN.4.2.133; Muggleton N, 2007, NEUROPSYCHOLOGIA, V45, P1582, DOI 10.1016/j.neuropsychologia.2006.11.021; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sperling JM, 2006, CORTEX, V42, P295, DOI 10.1016/S0010-9452(08)70355-1; WARD J, 2006, CORTEX, V42; Weiss PH, 2005, NEUROIMAGE, V28, P859, DOI 10.1016/j.neuroimage.2005.06.052; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	45	277	282	9	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					792	797		10.1038/nn1906	http://dx.doi.org/10.1038/nn1906			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515901				2022-12-24	WOS:000246799800023
J	Mirabella, G; Bertini, G; Samengo, I; Kilavik, BE; Frilli, D; Della Libera, C; Chelazzi, L				Mirabella, Giovanni; Bertini, Giuseppe; Samengo, Ines; Kilavik, Bjorg E.; Frilli, Deborah; Della Libera, Chiara; Chelazzi, Leonardo			Neurons in area V4 of the macaque translate attended visual features into behaviorally relevant categories	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; FEATURE-BASED ATTENTION; NEURAL MECHANISMS; SELECTIVE ATTENTION; COLOR; REPRESENTATION; INFORMATION; RESPONSES; SEARCH; V2	Neural processing at most stages of the primate visual system is modulated by selective attention, such that behaviorally relevant information is emphasized at the expenses of irrelevant, potentially distracting information. The form of attention best understood at the cellular level is when stimuli at a given location in the visual field must be selected (space-based attention). In contrast, fewer single-unit recording studies have so far explored the cellular mechanisms of attention operating on individual stimulus features, specifically when one feature (e.g., color) of an object must guide behavioral responses while a second feature (e.g., shape) of the same object is potentially interfering and therefore must be ignored. Here we show that activity of neurons in macaque area V4 can underlie the selection of elemental object features and their "translation" into a categorical format that can directly contribute to the control of the animal's behavior.	Univ Verona, Physiol Sect, Dept Neurol & Vis Sci, I-37134 Verona, Italy; Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, I-00185 Rome, Italy; Univ Verona, Sect Anat, Dept Morphol Biomed Sci, I-37134 Verona, Italy; Ctr Atom Bariloche, Dept Stat Phys, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; CNRS, INCM, F-13402 Marseille 20, France	University of Verona; Sapienza University Rome; University of Verona; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Centre National de la Recherche Scientifique (CNRS)	Chelazzi, L (corresponding author), Univ Verona, Physiol Sect, Dept Neurol & Vis Sci, Strada Grazie 8, I-37134 Verona, Italy.	leonardo.chelazzi@univr.it	Della Libera, Chiara/B-5102-2010; Chelazzi, Leonardo/B-6084-2011; Mirabella, Giovanni/AAB-2818-2019; Bertini, Giuseppe/L-4576-2013	Della Libera, Chiara/0000-0003-0286-0883; Chelazzi, Leonardo/0000-0001-8566-0611; Mirabella, Giovanni/0000-0002-4405-2609; Bertini, Giuseppe/0000-0002-6031-5130; Kilavik, Bjorg/0000-0002-8235-4624				Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Conner CE, 1997, J NEUROSCI, V17, P3201; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Dayan P., 2001, THEORETICAL NEUROSCI; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Fanini A, 2006, VIS COGN, V14, P584, DOI 10.1080/13506280500195367; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Hinkle DA, 2005, J NEUROPHYSIOL, V94, P2726, DOI 10.1152/jn.00341.2005; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Kleinbaum D, 1988, APPL REGRESSION ANAL; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MAUNSELL JHR, 1991, CHANNELS IN THE VISUAL NERVOUS SYSTEM : NEUROPHYSIOLOGY, PSYCHOPHYSICS AND MODELS, P447; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McClurkin JW, 1996, J NEUROPHYSIOL, V75, P481, DOI 10.1152/jn.1996.75.1.481; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nobre AC, 2006, J COGNITIVE NEUROSCI, V18, P539, DOI 10.1162/jocn.2006.18.4.539; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; ROBINSON DA, 1963, IEEE T BIOMED ENG, V101, P131; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; Shannon C., 1964, MATH THEORY COMMUNIC; Shannon CE, 1948, AT&T TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takeda M, 2005, NEURON, V48, P839, DOI 10.1016/j.neuron.2005.09.028; Thomas E, 2001, J COGNITIVE NEUROSCI, V13, P190, DOI 10.1162/089892901564252; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0; ZEKI SM, 1971, BRAIN RES, V34, P19, DOI 10.1016/0006-8993(71)90348-9	49	81	81	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					303	318		10.1016/j.neuron.2007.04.007	http://dx.doi.org/10.1016/j.neuron.2007.04.007			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442250	Bronze			2022-12-24	WOS:000246190600014
J	Eisenman, LN; Shu, HJ; Akk, G; Wang, C; Manion, BD; Kress, GJ; Evers, AS; Steinbach, JH; Covey, DF; Zorumski, CF; Mennerick, S				Eisenman, Lawrence N.; Shu, Hong-Jin; Akk, Gustav; Wang, Cunde; Manion, Brad D.; Kress, Geraldine J.; Evers, Alex S.; Steinbach, Joe Henry; Covey, Douglas F.; Zorumski, Charles F.; Mennerick, Steven			Anticonvulsant and anesthetic effects of a fluorescent neurosteroid analog activated by visible light	NATURE NEUROSCIENCE			English	Article							GABA-A; NEUROACTIVE STEROIDS; MODULATION; RECEPTORS; CURRENTS; BRAIN	Most photoactivatable compounds suffer from the limitations of the ultraviolet wavelengths that are required for activation. We synthesized a neuroactive steroid analog with a fluorescent (7-nitro-2,1,3-benzoxadiazol-4-yl) amino (NBD) group in the beta configuration at the C2 position of (3 alpha, 5 alpha)-3-hydroxypregnan-20-one (allopregnanolone, 3 alpha 5 alpha P). Light wavelengths (480 nm) that excite compound fluorescence strongly potentiate GABA(A) receptor function. Potentiation is limited by photodepletion of the receptor-active species. Photopotentiation is long-lived and stereoselective and shows single-channel hallmarks similar to steroid potentiation. Other NBD-conjugated compounds also generate photopotentiation, albeit with lower potency. Thus, photopotentiation does not require a known ligand for neurosteroid potentiating sites on the GABA(A) receptor. Photoactivation of a membrane-impermeant, fluorescent steroid analog demonstrates that membrane localization is critical for activity. The photoactivatable steroid silences pathological spiking in cultured rat hippocampal neurons and anesthetizes tadpoles. Fluorescent steroids photoactivated by visible light may be useful for modulating GABA(A) receptor function in a spatiotemporally defined manner.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid Ave, St Louis, MO 63110 USA.	menneris@psychiatry.wustl.edu	Mennerick, Steven/O-2806-2017; Akk, Gustav/CAG-1703-2022	Mennerick, Steven/0000-0003-0868-0664; Kress, Geraldine/0000-0001-9442-8734; Evers, Alex/0000-0002-0342-0575	NIAAA NIH HHS [AA12951, AA12952, AA14707] Funding Source: Medline; NIGMS NIH HHS [P01 GM047969, GM 47969] Funding Source: Medline; NIMH NIH HHS [MH78823] Funding Source: Medline; NINDS NIH HHS [NS54174, NS44041] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS044041, R01NS054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA014707, R01AA012951, R01AA012952] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Akk G, 2005, J NEUROSCI, V25, P11605, DOI 10.1523/JNEUROSCI.4173-05.2005; Akk G, 2004, J PHYSIOL-LONDON, V558, P59, DOI 10.1113/jphysiol.2004.066571; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Chang YH, 2001, J PHYSIOL-LONDON, V536, P471, DOI 10.1111/j.1469-7793.2001.0471c.xd; Covey DF, 2001, BRAIN RES REV, V37, P91, DOI 10.1016/S0165-0173(01)00126-6; DODT HU, 2002, SCI STKE, pPL2; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eisenman LN, 2003, J PHYSIOL-LONDON, V550, P679, DOI 10.1113/jphysiol.2003.043810; Gasior M, 1999, TRENDS PHARMACOL SCI, V20, P107, DOI 10.1016/S0165-6147(99)01318-8; HARRISON NL, 1987, J NEUROSCI, V7, P604; Hess GP, 2003, BIOPHYS CHEM, V100, P493, DOI 10.1016/S0301-4622(02)00301-0; Leszkiewicz DN, 2003, EUR J NEUROSCI, V17, P2077, DOI 10.1046/j.1460-9568.2003.02656.x; MAJEWSKA MD, 1988, NEUROSCI LETT, V90, P279, DOI 10.1016/0304-3940(88)90202-9; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Morrell M, 2006, CURR OPIN NEUROL, V19, P164, DOI 10.1097/01.wco.0000218233.60217.84; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; PHILLIPPS GH, 1975, J STEROID BIOCHEM, V6, P607, DOI 10.1016/0022-4731(75)90041-2; Shembekar VR, 2005, BIOCHEMISTRY-US, V44, P7107, DOI 10.1021/bi047665o; Shu HJ, 2007, BRIT J PHARMACOL, V150, P164, DOI 10.1038/sj.bjp.0706973; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; Wang MD, 2002, J NEUROSCI, V22, P3366; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wittmer LL, 1996, MOL PHARMACOL, V50, P1581; WOODWARD RM, 1992, MOL PHARMACOL, V41, P89; Zorumski C F, 2000, Curr Opin Investig Drugs, V1, P360	26	17	19	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					523	530		10.1038/nn1862	http://dx.doi.org/10.1038/nn1862			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17322875				2022-12-24	WOS:000245228600024
J	Shen, H; Gong, QH; Aoki, C; Yuan, ML; Ruderman, Y; Dattilo, M; Williams, K; Smith, SS				Shen, Hui; Gong, Qi Hua; Aoki, Chiye; Yuan, Maoli; Ruderman, Yevgeniy; Dattilo, Michael; Williams, Keith; Smith, Sheryl S.			Reversal of neurosteroid effects at alpha 4 beta 2 delta GABA(A) receptors triggers anxiety at puberty	NATURE NEUROSCIENCE			English	Article							TONIC INHIBITION; ALLOPREGNANOLONE LEVELS; NEURONS; BRAIN; STEROIDS; CHANNEL; METABOLITES; MODULATION; WITHDRAWAL; NUCLEUS	Puberty is characterized by mood swings and anxiety, which are often produced by stress. Here we show that THP ( allopregnanolone), a steroid that is released as a result of stress, increases anxiety in pubertal female mice, in contrast to its anxiety-reducing effect in adults. Anxiety is regulated by GABAergic inhibition in limbic circuits. Although this inhibition is increased by THP administration before puberty and in adults, during puberty THP reduces the tonic inhibition of pyramidal cells in hippocampal region CA1, leading to increased excitability. This paradoxical effect of THP results from inhibition of alpha 4 beta delta GABA(A) receptors. These receptors are normally expressed at very low levels, but at puberty, their expression is increased in hippocampal area CA1, where they generate outward currents. THP also decreases the outward current at recombinant alpha 4 beta 2 delta receptors, and this effect depends on arginine 353 in the alpha 4 subunit, a putative site for modulation by Cl-. Therefore, inhibition of alpha 4 beta 2 delta GABA(A) receptors by THP provides a mechanism for the generation of anxiety at puberty.	Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Smith, SS (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	sheryl.smith@downstate.edu	Aoki, Chiye/T-9405-2019	Aoki, Chiye/0000-0003-4010-9425; Smith, Sheryl/0000-0003-4308-3267	NEI NIH HHS [R01 EY008055-09, P30 EY013079-079003, R01 EY013145, P30 EY013079, R01 EY013145-04] Funding Source: Medline; NIAAA NIH HHS [R01 AA012958] Funding Source: Medline; NIDA NIH HHS [R01 DA009618] Funding Source: Medline; NINDS NIH HHS [R25 NS080686, R01 NS041091, R01 NS041091-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY013079, R01EY008055, R01EY013145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; Andreen L, 2005, PSYCHONEUROENDOCRINO, V30, P212, DOI 10.1016/j.psyneuen.2004.07.003; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Bitran D, 1999, BRAIN RES, V850, P217, DOI 10.1016/S0006-8993(99)02150-2; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Corpechot C, 1997, BRAIN RES, V766, P276, DOI 10.1016/S0006-8993(97)00749-X; Fadalti M, 1999, PEDIATR RES, V46, P323, DOI 10.1203/00006450-199909000-00013; Freeman EW, 2002, J CLIN PSYCHOPHARM, V22, P516, DOI 10.1097/00004714-200210000-00013; FREEMAN EW, 1993, NEUROENDOCRINOLOGY, V58, P478, DOI 10.1159/000126579; Girdler SS, 2006, PSYCHOPHYSIOLOGY, V43, P331, DOI 10.1111/j.1469-8986.2006.00410.x; Haas KF, 1999, J PHYSIOL-LONDON, V514, P27, DOI 10.1111/j.1469-7793.1999.027af.x; Hayward C, 2002, J ADOLESCENT HEALTH, V30, P49, DOI 10.1016/S1054-139X(02)00336-1; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; LAMBERT NA, 1991, J NEUROPHYSIOL, V66, P1538, DOI 10.1152/jn.1991.66.5.1538; Lundgren P, 2003, BRAIN RES, V982, P45, DOI 10.1016/S0006-8993(03)02939-1; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; McEwen BS, 2005, J PSYCHIATR NEUROSCI, V30, P315; Mele P, 2004, J NEUROCHEM, V89, P1471, DOI 10.1111/j.1471-4159.2004.02444.x; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MODESTI PA, 1994, ANGIOLOGY, V45, P443, DOI 10.1177/000331979404500605; OLSEN RW, 1982, J NEUROSCI, V2, P1812; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Romeo RD, 2005, VITAM HORM, V71, P1, DOI 10.1016/S0083-6729(05)71001-3; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Schmidt PJ, 1998, NEW ENGL J MED, V338, P209, DOI 10.1056/NEJM199801223380401; Smith SS, 2006, PSYCHOPHARMACOLOGY, V186, P323, DOI 10.1007/s00213-005-0168-3; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Ulrich D, 1997, J NEUROSCI, V17, P2348; Wei WZ, 2003, J NEUROSCI, V23, P10650; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Wu YM, 2001, J NEUROSCI, V21, P2630, DOI 10.1523/JNEUROSCI.21-08-02630.2001	50	187	191	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					469	477		10.1038/nn1868	http://dx.doi.org/10.1038/nn1868			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351635	Green Accepted			2022-12-24	WOS:000245228600018
J	Ferkey, DM; Hyde, R; Haspel, G; Dionne, HM; Hess, HA; Suzuki, H; Schafer, WR; Koelle, MR; Hart, AC				Ferkey, Denise M.; Hyde, Rhonda; Haspel, Gal; Dionne, Heather M.; Hess, Heather A.; Suzuki, Hiroshi; Schafer, William R.; Koelle, Michael R.; Hart, Anne C.			C-elegans G protein regulator RGS-3 controls sensitivity to sensory stimuli	NEURON			English	Article							HETEROTRIMERIC G-PROTEINS; NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; MECHANOSENSORY RESPONSES; NERVOUS-SYSTEM; ASH NEURONS; GLUTAMATE; CHEMOSENSATION; SEROTONIN; OLFACTION	Signal transduction through heterotrimeric G proteins is critical for sensory response across species. Regulator of G protein signaling (RGS) proteins are negative regulators of signal transduction. Herein we describe a role for C. elegans RGS-3 in the regulation of sensory behaviors. rgs-3 mutant animals fail to respond to intense sensory stimuli but respond normally to low concentrations of specific odorants. We find that loss of RGS-3 leads to aberrantly increased G protein-coupled calcium signaling but decreased synaptic output, ultimately leading to behavioral defects. Thus, rgs-3 responses are restored by decreasing G protein-coupled signal transduction, either genetically or by exogenous dopamine, by expressing a calcium-binding protein to buffer calcium levels in sensory neurons or by enhancing glutamatergic synaptic transmission from sensory neurons. Therefore, while RGS proteins generally act to downregulate signaling, loss of a specific RGS protein in sensory neurons can lead to defective responses to external stimuli.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Harvard University; Massachusetts General Hospital; Harvard University; Yale University; University of California System; University of California San Diego; Yale University	Hart, AC (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	hart@helix.mgh.harvard.edu	Haspel, Gal/AAH-1269-2019	Haspel, Gal/0000-0001-6701-697X; Dionne, Heather/0000-0001-7700-8885; Schafer, William/0000-0002-6676-8034	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057918, R55GM057918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER; MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: Medline; NIDA NIH HHS [R01DA016445-01, R01 DA016445] Funding Source: Medline; NIGMS NIH HHS [R01 GM057918, GM057918] Funding Source: Medline; NIMH NIH HHS [T32 MH018882] Funding Source: Medline; NINDS NIH HHS [NS036918, R01 NS036918] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Barger AJ, 1998, J NEUROSCI, V18, P2871; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cuppen E, 2003, COMP FUNCT GENOM, V4, P479, DOI 10.1002/cfg.318; Dong MQ, 2000, GENE DEV, V14, P2003; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Kunitomo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r17; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lints R, 1999, DEVELOPMENT, V126, P5819; Luo X, 2001, MOL CELL, V7, P651, DOI 10.1016/S1097-2765(01)00211-8; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Nuttley WM, 2001, LEARN MEMORY, V8, P170, DOI 10.1101/lm.36501; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Rios M, 1999, J NEUROSCI, V19, P3519; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Vazquez G, 2004, BBA-MOL CELL RES, V1742, P21, DOI 10.1016/j.bbamcr.2004.08.015; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zwaal RR, 1997, GENETICS, V145, P715	70	46	56	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					39	52		10.1016/j.neuron.2006.11.015	http://dx.doi.org/10.1016/j.neuron.2006.11.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196529	Green Accepted, Bronze			2022-12-24	WOS:000245126500007
J	Russo, SJ; Bolanos, CA; Theobald, DE; DeCarolis, NA; Renthal, W; Kumar, A; Winstanley, CA; Renthal, NE; Wiley, MD; Self, DW; Russell, DS; Neve, RL; Eisch, AJ; Nestler, EJ				Russo, Scott J.; Bolanos, Carlos A.; Theobald, David E.; DeCarolis, Nathan A.; Renthal, William; Kumar, Arvind; Winstanley, Catharine A.; Renthal, Nora E.; Wiley, Matthew D.; Self, David W.; Russell, David S.; Neve, Rachael L.; Eisch, Amelia J.; Nestler, Eric J.			IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; PHOSPHOLIPASE-C-GAMMA; NEUROTROPHIC FACTOR; CHRONIC MORPHINE; DRUG-ADDICTION; NUCLEUS-ACCUMBENS; COCAINE; WITHDRAWAL; REWARD; RATS	Chronic morphine administration ( via subcutaneous pellet) decreases the size of dopamine neurons in the ventral tegmental area (VTA), a key reward region in the brain, yet the molecular basis and functional consequences of this effect are unknown. In this study, we used viral-mediated gene transfer in rat to show that chronic morphine-induced downregulation of the insulin receptor substrate 2 (IRS2)-thymoma viral proto-oncogene (Akt) signaling pathway in the VTA mediates the decrease in dopamine cell size seen after morphine exposure and that this downregulation diminishes morphine reward, as measured by conditioned place preference. We further show that the reduction in size of VTA dopamine neurons persists up to 2 weeks after morphine withdrawal, which parallels the tolerance to morphine's rewarding effects caused by previous chronic morphine exposure. These findings directly implicate the IRS2-Akt signaling pathway as a critical regulator of dopamine cell morphology and opiate reward.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Neurosci Program, Tallahassee, FL 32306 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02178 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Yale University; Harvard University; McLean Hospital	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Kumar, Arvind/B-6094-2009; Russo, Scott/R-7107-2019; Winstanley, Catharine/K-5003-2015	Russo, Scott/0000-0002-6470-1805; Winstanley, Catharine/0000-0001-7032-4471; Kumar, Arvind/0000-0003-2879-3826; Eisch, Amelia/0000-0001-6476-5385; Renthal, William/0000-0003-0206-2101	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA019727, K08DA000302] Funding Source: NIH RePORTER; NIDA NIH HHS [K08 DA000302-05, F32 DA019727] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Aston-Jones G, 2004, NEUROPHARMACOLOGY, V47, P167, DOI 10.1016/j.neuropharm.2004.06.020; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BECHARA A, 1992, BEHAV NEUROSCI, V106, P364, DOI 10.1037/0735-7044.106.2.364; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Bolanos CA, 2003, J NEUROSCI, V23, P7569; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Georges F, 2006, J NEUROSCI, V26, P5720, DOI 10.1523/JNEUROSCI.5032-05.2006; Glass MJ, 2004, SYNAPSE, V53, P191, DOI 10.1002/syn.20049; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P292, DOI 10.1038/sj.npp.1300037; Horger BA, 1999, J NEUROSCI, V19, P4110; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; Olson VG, 2005, J NEUROSCI, V25, P5553, DOI 10.1523/JNEUROSCI.0345-05.2005; Paladini CA, 2004, J NEUROSCI, V24, P5209, DOI 10.1523/JNEUROSCI.1079-04.2004; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; ROSNOW RL, 1989, AM PSYCHOL, V44, P1276, DOI 10.1037/0003-066X.44.10.1276; Russo SJ, 2003, NEUROSCIENCE, V120, P523, DOI 10.1016/S0306-4522(03)00317-8; SELF DW, 1995, SYNAPSE, V21, P312, DOI 10.1002/syn.890210405; SHIPPENBERG TS, 1988, PSYCHOPHARMACOLOGY, V96, P110, DOI 10.1007/BF02431542; SklairTavron L, 1996, P NATL ACAD SCI USA, V93, P11202, DOI 10.1073/pnas.93.20.11202; Spiga S, 2003, EUR J NEUROSCI, V17, P605, DOI 10.1046/j.1460-9568.2003.02435.x; Walker JR, 2003, PHARMACOL BIOCHEM BE, V75, P349, DOI 10.1016/S0091-3057(03)00094-7; WISE RA, 1989, NEUROSCI BIOBEHAV R, V13, P129, DOI 10.1016/S0149-7634(89)80021-1; Wolf DH, 1999, J NEUROCHEM, V73, P1520, DOI 10.1046/j.1471-4159.1999.0731520.x; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Ziolkowska B, 2006, BRAIN RES, V1069, P1, DOI 10.1016/j.brainres.2005.11.042	40	168	172	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					93	99		10.1038/nn1812	http://dx.doi.org/10.1038/nn1812			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17143271				2022-12-24	WOS:000243096100020
J	Leshchyns'ka, I; Sytnyk, V; Richter, M; Andreyeva, A; Puchkov, D; Schachner, M				Leshchyns'ka, Iryna; Sytnyk, Vladimir; Richter, Melanie; Andreyeva, Aksana; Puchkov, Dmytro; Schachner, Melitta			The adhesion molecule CHL1 regulates uncoating of clathrin-coated synaptic vesicles	NEURON			English	Article							CLOSE HOMOLOG; L1 CHL1; MICE DEFICIENT; CALL GENE; NEUROTRANSMITTER EXOCYTOSIS; PRESYNAPTIC TERMINALS; NEURITE OUTGROWTH; NERVE-TERMINALS; IN-VITRO; SCHIZOPHRENIA	In searching for binding partners of the intracellular domain of the immunoglobulin superfamily adhesion molecule CHL1, we identified the clathrin-uncoating ATPase Hsc70. CHL1 gene ablation resulted in reduced targeting of Hsc70 to the synaptic plasma membrane and synaptic vesicles, suggesting CHL1 as a synapse-targeting cue for Hsc70. CHL1 accumulates in presynaptic membranes and, in response to synapse activation, is targeted to synaptic vesicles by endocytosis. CHL1 deficiency or disruption of the CHL1/Hsc70 complex results in accumulation of abnormally high levels of clathrin-coated synaptic vesicles with a reduced ability to release clathrin. Generation of new clathrin-coated synaptic vesicles in an activity-dependent manner is inhibited when the CHL1/Hsc70 complex is disrupted, resulting in impaired uptake and release of FM dyes in synaptic boutons. Abnormalities in clathrin-dependent synaptic vesicle recycling may thus underlie brain malfunctions in humans and mice that carry mutations in the CHL1 gene.	Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Gimenez, Luis E Diaz/D-9291-2011; Sytnyk, Vladimir/A-3523-2009; Leshchyns'ka, Iryna/A-3579-2009; Sytnyk, Vladimir/A-3878-2010	Puchkov, Dmytro/0000-0001-8341-4847; Leshchyns'ka, Iryna/0000-0002-2025-5831; Richter, Melanie/0000-0003-0575-9625; Sytnyk, Vladimir/0000-0003-1927-2199				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Angeloni D, 1999, PSYCHIATR GENET, V9, P165, DOI 10.1097/00041444-199909000-00011; APPEL F, 1993, J NEUROSCI, V13, P4764; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CARTER LL, 1993, J CELL BIOL, V120, P37, DOI 10.1083/jcb.120.1.37; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; Irintchev A, 2004, BRAIN RES, V1029, P131, DOI 10.1016/j.brainres.2004.09.042; MAHAFFEY DT, 1989, J CELL BIOL, V108, P1615, DOI 10.1083/jcb.108.5.1615; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Morgan JR, 2001, NEURON, V32, P289, DOI 10.1016/S0896-6273(01)00467-6; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pimm J, 2005, AM J HUM GENET, V76, P902, DOI 10.1086/430095; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; SMYTHE E, 1989, J CELL BIOL, V108, P843, DOI 10.1083/jcb.108.3.843; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sytnyk V, 2004, J CELL SCI, V117, P381, DOI 10.1242/jcs.00956; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; Yao PJ, 2002, J COMP NEUROL, V447, P152, DOI 10.1002/cne.10217; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zinsmaier KE, 2001, BIOCHEM PHARMACOL, V62, P1, DOI 10.1016/S0006-2952(01)00648-7	49	71	72	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					1011	1025		10.1016/j.neuron.2006.10.020	http://dx.doi.org/10.1016/j.neuron.2006.10.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178404	Bronze			2022-12-24	WOS:000243115100009
J	Clark, E; Vacher, H; Trimmer, JS				Clark, Eliana; Vacher, Helene; Trimmer, James S.			Kv1.1 Takes a deTOR from the Axon to the Dendrite	NEURON			English	Editorial Material							POTASSIUM CHANNELS; SYNAPTIC PLASTICITY; MESSENGER-RNA; LOCALIZATION; MECHANISMS; EXPRESSION; BRAIN	In the October 6th issue of Science, Raab-Graham et al. described two surprising findings. They discovered that local dendritic translation of Kv1.1 occurs in CA1 dendrites of rat hippocampal slices and in cultured neurons. This local translation is inhibited by NMDA receptor-mediated synaptic signaling acting through the mTOR kinase.	Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Clark, E (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.				NINDS NIH HHS [R37 NS034383-12, R37 NS034383] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034383] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; WANG H, 1994, J NEUROSCI, V14, P4588; Yuan LL, 2006, PROG NEUROBIOL, V78, P374, DOI 10.1016/j.pneurobio.2006.03.003	13	0	0	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					399	401		10.1016/j.neuron.2006.10.014	http://dx.doi.org/10.1016/j.neuron.2006.10.014			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088206	Bronze			2022-12-24	WOS:000242269700003
J	Meredith, AL; Wiler, SW; Miller, BH; Takahashi, JS; Fodor, AA; Ruby, NF; Aldrich, RW				Meredith, Andrea L.; Wiler, Steven W.; Miller, Brooke H.; Takahashi, Joseph S.; Fodor, Anthony A.; Ruby, Norman F.; Aldrich, Richard W.			BK calcium-activated potassium channels regulate circadian behavioral rhythms and pacemaker output	NATURE NEUROSCIENCE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CA2+-ACTIVATED K+ CHANNEL; VPAC(2) RECEPTOR; EXPLANTS INVITRO; CLOCK MUTATION; SCN NEURONS; FIRING RATE; IN-VITRO; PERIOD; MOUSE	Spontaneous action potentials in the suprachiasmatic nucleus (SCN) are necessary for normal circadian timing of behavior in mammals. The SCN exhibits a daily oscillation in spontaneous firing rate (SFR), but the ionic conductances controlling SFR and the relationship of SFR to subsequent circadian behavioral rhythms are not understood. We show that daily expression of the large conductance Ca2+ activated K+ channel (BK) in the SCN is controlled by the intrinsic circadian clock. BK channel-null mice (Kcnma1(-/-)) have increased SFRs in SCN neurons selectively at night and weak circadian amplitudes in multiple behaviors timed by the SCN. Kcnma1(-/-) mice show normal expression of clock genes such as Arnt1 (Bmal1), indicating a role for BK channels in SCN pacemaker output, rather than in intrinsic time- keeping. Our findings implicate BK channels as important regulators of the SFR and suggest that the SCN pacemaker governs the expression of circadian behavioral rhythms through SFR modulation.	Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Northwestern University; Howard Hughes Medical Institute; Northwestern University; Stanford University	Meredith, AL (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	ameredith@som.umaryland.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Meredith, Andrea/0000-0003-1061-2302	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL102758-01, R01 HL102758] Funding Source: Medline; NIMH NIH HHS [MH-60385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060385] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Antle MC, 2005, DEV BRAIN RES, V157, P8, DOI 10.1016/j.devbrainres.2005.02.017; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cloues RK, 2003, J NEUROSCI, V23, P1593; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; de Jeu M, 1998, NEUROREPORT, V9, P3725, DOI 10.1097/00001756-199811160-00028; EARNEST DJ, 1991, BRAIN RES BULL, V26, P677, DOI 10.1016/0361-9230(91)90160-L; EARNEST DJ, 1986, BRAIN RES, V382, P129, DOI 10.1016/0006-8993(86)90119-8; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kuhlman SJ, 2004, EUR J NEUROSCI, V20, P1113, DOI 10.1111/j.1460-9568.2004.03555.x; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lundkvist GB, 2005, METHOD ENZYMOL, V393, P623, DOI 10.1016/S0076-6879(05)93033-4; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RATTRAY M, 1998, IN SITU HYBRIDISATIO, P23; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Shinohara K, 1998, NEUROREPORT, V9, P137, DOI 10.1097/00001756-199801050-00027; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	50	178	179	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1041	1049		10.1038/nn1740	http://dx.doi.org/10.1038/nn1740			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845385	Green Accepted			2022-12-24	WOS:000240080300017
J	Remedios, R; Huilgol, D; Saha, B; Hari, P; Bhatnagar, L; Kowalczyk, T; Hevner, RF; Suda, Y; Aizawa, S; Ohshima, T; Stoykova, A; Tole, S				Remedios, Ryan; Huilgol, Dhananjay; Saha, Bhaskar; Hari, Padmanabhan; Bhatnagar, Lahar; Kowalczyk, Thomas; Hevner, Robert F.; Suda, Yoko; Aizawa, Shinichi; Ohshima, Toshio; Stoykova, Anastassia; Tole, Shubha			A stream of cells migrating from the caudal telencephalon reveals a link between the amygdala and neocortex	NATURE NEUROSCIENCE			English	Article							EMBRYONIC CEREBRAL-CORTEX; GANGLIONIC EMINENCE; MOUSE TELENCEPHALON; NEURONAL MIGRATION; SIGNALING PATHWAY; EVOLUTION; EXPRESSION; REELIN; GENES; ORGANIZATION	The amygdaloid complex consists of diverse nuclei that belong to distinct functional systems, yet many issues about its development are poorly understood. Here, we identify a stream of migrating cells that form specific amygdaloid nuclei in mice. In utero electroporation showed that this caudal amygdaloid stream ( CAS) originated in a unique domain at the caudal telencephalic pole that is contiguous with the dorsal pallium, which was previously thought to generate only neocortical cells. The CAS and the neocortex share mechanisms for specification ( transcription factors Tbr1, Lhx2 and Emx1/ 2) and migration ( reelin and Cdk5). Reelin, a critical cue for migration in the neocortex, and Cdk5, which is specifically required for migration along radial glia in the neocortex, were both selectively required for the normal migration of the CAS, but not for that of other amygdaloid nuclei. This is first evidence of a dorsal pallial contribution to the amygdala, demonstrating a developmental and mechanistic link between the amygdala and the neocortex.	Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA; Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; RIKEN, Ctr Dev Biol, Lab Vertebrate Body Plan, Chou Ku, Kobe, Hyogo 6500047, Japan; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Saitama 3510198, Japan; Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1698555, Japan; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Tata Institute of Fundamental Research (TIFR); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; RIKEN; RIKEN; Waseda University; Max Planck Society	Tole, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd,B-304, Bombay 400005, Maharashtra, India.	stole@tifr.res.in	Remedios, Ryan/AAA-2389-2020; Huilgol, Dhananjay/AAM-7793-2020	Huilgol, Dhananjay/0000-0003-4393-7242; Padmanabhan, Hari/0000-0002-2289-0249; Remedios, Ryan/0000-0001-6004-808X	Wellcome Trust [056684/Z/99/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aboitiz F, 2002, BRAIN RES REV, V39, P141, DOI 10.1016/S0165-0173(02)00180-7; Aboitiz F, 1999, CEREB CORTEX, V9, P655, DOI 10.1093/cercor/9.7.655; ALHEID GF, 1995, RAT NERVOUS SYSTEM, V2, P495; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Bar I, 2000, TRENDS NEUROSCI, V23, P633, DOI 10.1016/S0166-2236(00)01675-1; Barton RA, 2003, P ROY SOC B-BIOL SCI, V270, P539, DOI 10.1098/rspb.2002.2276; Beffert U, 2004, J NEUROSCI, V24, P1897, DOI 10.1523/JNEUROSCI.4084-03.2004; Broccoli Vania, 1999, Bioessays, V21, P974, DOI 10.1002/(SICI)1521-1878(199911)21:11<974::AID-BIES10>3.0.CO;2-8; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Caviness V S Jr, 1982, Brain Res, V256, P293; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; Martinez-Garcia F, 2002, BRAIN RES BULL, V57, P463, DOI 10.1016/S0361-9230(01)00665-7; MARTINEZGARCIA F, 1991, J COMP NEUROL, V305, P337, DOI 10.1002/cne.903050214; MCCONNELL J, 1983, BRAIN RES, V272, P150, DOI 10.1016/0006-8993(83)90372-4; McDonald AJ, 2003, ANN NY ACAD SCI, V985, P1; Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141; Molnar Z, 2002, BIOESSAYS, V24, P530, DOI 10.1002/bies.10100; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Porter FD, 1997, DEVELOPMENT, V124, P2935; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Remedios R, 2004, J NEUROSCI, V24, P6986, DOI 10.1523/JNEUROSCI.0001-04.2004; Rice DS, 1998, DEVELOPMENT, V125, P3719; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Santiago AC, 2004, J COMP NEUROL, V471, P314, DOI 10.1002/cne.20028; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Stenman J, 2003, DEVELOPMENT, V130, P1113, DOI 10.1242/dev.00328; Striedter GF, 1997, BRAIN BEHAV EVOLUT, V49, P179, DOI 10.1159/000112991; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Swanson LW, 2003, ANN NY ACAD SCI, V985, P174; Tissir F, 2002, BRAZ J MED BIOL RES, V35, P1473, DOI 10.1590/S0100-879X2002001200007; Tole S, 2005, J NEUROSCI, V25, P2753, DOI 10.1523/JNEUROSCI.3014-04.2005; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Vyas A, 2003, J COMP NEUROL, V466, P545, DOI 10.1002/cne.10900; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yamamoto K, 2005, BRAIN RES BULL, V66, P341, DOI 10.1016/j.brainresbull.2005.02.016; Yun K, 2001, DEVELOPMENT, V128, P193	50	72	76	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1141	1150		10.1038/nn1955	http://dx.doi.org/10.1038/nn1955			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694053	Green Published			2022-12-24	WOS:000249144000016
J	Grill, B; Bienvenut, WV; Brown, HM; Ackley, BD; Quadroni, M; Jin, YS				Grill, Brock; Bienvenut, Willy V.; Brown, Heather M.; Ackley, Brian D.; Quadroni, Manfredo; Jin, Yishi			C-elegans RPM-1 regulates axon termination and synaptogenesis through the Rab GEF GLO-4 and the Rab GTPase GLO-1	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SYNAPTIC VESICLE FORMATION; RETINITIS-PIGMENTOSA RP3; CAENORHABDITIS-ELEGANS; HORSERADISH-PEROXIDASE; SYMPATHETIC NEURONS; HOMEODOMAIN PROTEIN; EXPRESSION ANALYSIS; LYSOSOMAL ACTIVITY; GENETIC-ANALYSIS	C. elegans RPM-1 (for Regulator of Presynaptic Morphology) is a member of a conserved protein family that includes Drosophila Highwire and mammalian Pam and Phr1. These are large proteins recently shown to regulate synaptogenesis through E3 ubiquitin ligase activities. Here, we report the identification of an RCC1-like guanine nucleotide exchange factor, GLO-4, from mass spectrometry analysis of RPM-1-associated proteins. GLO-4 colocalizes with RPM-1 at presynaptic terminals. Loss of function in glo-4 or in its target Rab GTPase, glo-1, causes neuronal defects resembling those in rpm-1 mutants. We show that the glo pathway functions downstream of rpm-1 and acts in parallel to fsn-1, a partner of RPM-1 E3 ligase function. We find that late endosomes are specifically disorganized at the presynaptic terminals of glo-4 mutants. Our data suggest that RPM-1 positively regulates a Rab GTPase pathway to promote vesicular trafficking via late endosomes.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; Univ Lausanne, Prot Anal Facil, CH-1066 Epalinges, Switzerland; Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of California System; University of California Santa Cruz; University of California System; University of California San Diego; University of Lausanne; Beatson Institute	Jin, YS (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	yijin@ucsd.edu		Ackley, Brian/0000-0002-1257-2407; Bienvenut, Willy/0000-0003-4192-3920; Quadroni, Manfredo/0000-0002-2720-4084; Grill, Brock/0000-0002-0379-3267; Jin, Yishi/0000-0002-9371-9860	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS35546] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035546] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Bienvenut WV, 1999, ANAL CHEM, V71, P4800, DOI 10.1021/ac990448m; Blumstein J, 2001, J NEUROSCI, V21, P8034, DOI 10.1523/JNEUROSCI.21-20-08034.2001; BRENNER S, 1974, GENETICS, V77, P71; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Cohen-Solal KA, 2003, BBA-PROTEINS PROTEOM, V1651, P68, DOI 10.1016/S1570-9639(03)00236-X; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Collins RN, 2003, MOL MEMBR BIOL, V20, P105, DOI 10.1080/0968768031000085892; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Ehnert C, 2004, J NEUROCHEM, V88, P948, DOI 10.1046/j.1471-4159.2003.02229.x; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Faundez VV, 2000, MOL BIOL CELL, V11, P2591, DOI 10.1091/mbc.11.8.2591; GATZINSKY KP, 1991, BRAIN RES, V566, P131, DOI 10.1016/0006-8993(91)91690-3; GATZINSKY KP, 1990, J NEUROCYTOL, V19, P989, DOI 10.1007/BF01186826; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Kirschner R, 2001, HUM GENET, V109, P271, DOI 10.1007/s004390100572; Leenders AGM, 2002, NEUROSCIENCE, V109, P195, DOI 10.1016/S0306-4522(01)00450-X; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Ma JP, 2004, P NATL ACAD SCI USA, V101, P11652, DOI 10.1073/pnas.0401926101; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nakatsu F, 2004, J CELL BIOL, V167, P293, DOI 10.1083/jcb.200405032; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Osanai K, 2005, BIOL CHEM, V386, P143, DOI 10.1515/BC.2005.018; Overly CC, 1996, J NEUROSCI, V16, P6056; Owen HR, 2005, J PROTEOME RES, V4, P1381, DOI 10.1021/pr0500713; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pujol N, 2000, DEVELOPMENT, V127, P3361; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Seong E, 2005, MOL BIOL CELL, V16, P128, DOI 10.1091/mbc.E04-10-0892; Shi GY, 1998, J CELL BIOL, V143, P947, DOI 10.1083/jcb.143.4.947; Shimizu F, 1997, CYTOGENET CELL GENET, V77, P261, DOI 10.1159/000134591; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TEUCHERTNOODT G, 1991, DEV NEUROSCI-BASEL, V13, P151, DOI 10.1159/000112153; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Uhlmann J, 1999, FEBS LETT, V460, P153, DOI 10.1016/S0014-5793(99)01333-2; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; West AE, 1997, J CELL BIOL, V139, P917, DOI 10.1083/jcb.139.4.917; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	62	96	106	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2007	55	4					587	601		10.1016/j.neuron.2007.07.009	http://dx.doi.org/10.1016/j.neuron.2007.07.009			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698012	Bronze			2022-12-24	WOS:000249159200008
J	Aguirre, A; Dupree, JL; Mangin, JM; Gallo, V				Aguirre, Adan; Dupree, Jeff L.; Mangin, J. M.; Gallo, Vittorio			A functional role for EGFR signaling in myelination and remyelination	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-RECEPTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; OLIGODENDROCYTE LINEAGE; MULTIPLE-SCLEROSIS; NEURAL PROGENITORS; TYROSINE KINASE; ADULT FOREBRAIN; NERVOUS-SYSTEM; WHITE-MATTER	Cellular strategies for oligodendrocyte regeneration and remyelination involve characterizing endogenous neural progenitors that are capable of generating oligodendrocytes during normal development and after demyelination, and identifying the molecular signals that enhance oligodendrogenesis from these progenitors. Using both gain- and loss-of-function approaches, we explored the role of epidermal growth factor receptor (EGFR) signaling in adult myelin repair and in oligodendrogenesis. We show that 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase (CNP) promoter-driven overexpression of human EGFR (hEGFR) accelerated remyelination and functional recovery following focal demyelination of mouse corpus callosum. Lesion repopulation by Cspg(4+) (also known as NG2) Ascl1(+) (also known as Mash1) Olig2(+) progenitors and functional remyelination were accelerated in CNP-hEGFR mice compared with wild-type mice. EGFR overexpression in subventricular zone (SVZ) and corpus callosum during early postnatal development also expanded this NG2(+)Mash1(+)Olig2(+) progenitor population and promoted SVZ-to-lesion migration, enhancing oligodendrocyte generation and axonal myelination. Analysis of hypomorphic EGFR-mutant mice confirmed that EGFR signaling regulates oligodendrogenesis and remyelination by NG2(+)Mash1(+)Olig2(+) progenitors. EGFR targeting holds promise for enhancing oligodendrocyte regeneration and myelin repair.	Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA	Children's National Health System; Virginia Commonwealth University	Gallo, V (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, 111 Michigan Ave,NW, Washington, DC 20010 USA.	vgallo@cnmcresearch.org	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Mangin, Jean-Marie/0000-0002-7804-0251	NICHD NIH HHS [P30HD40677] Funding Source: Medline; NINDS NIH HHS [5P30NS047463, R01NS045702, R21NS050463] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045702, P30NS047463, R21NS050463] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Armstrong RC, 2002, J NEUROSCI, V22, P8574; Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Coskun V, 2002, J NEUROSCI RES, V69, P795, DOI 10.1002/jnr.10336; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ferrer I, 1996, PROG NEUROBIOL, V49, P99; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Goddard DR, 2001, MOL CELL NEUROSCI, V18, P557, DOI 10.1006/mcne.2001.1025; Hidalgo A, 2002, TRENDS NEUROSCI, V25, P365, DOI 10.1016/S0166-2236(02)02186-0; Irvin DK, 2003, DEV NEUROSCI-BASEL, V25, P162, DOI 10.1159/000072265; Jin KL, 2002, J NEUROSCI, V22, P5365; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Knapp PE, 2004, EXP CELL RES, V296, P135, DOI 10.1016/j.yexcr.2004.02.007; Kornblum HI, 2000, DEV NEUROSCI-BASEL, V22, P16, DOI 10.1159/000017423; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Lisovoski F, 1997, J NEUROPATH EXP NEUR, V56, P459, DOI 10.1097/00005072-199705000-00001; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Mason JL, 2003, J NEUROSCI, V23, P7710; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; MATTHIEU JM, 1992, J NEUROIMMUNOL, V40, P231, DOI 10.1016/0165-5728(92)90138-B; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Murtie JC, 2005, NEUROBIOL DIS, V19, P171, DOI 10.1016/j.nbd.2004.12.006; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; NIETOSAMPEDRO M, 1988, NEUROSCI LETT, V91, P276, DOI 10.1016/0304-3940(88)90693-3; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; Stangel M, 2002, PROG NEUROBIOL, V68, P361, DOI 10.1016/S0301-0082(02)00105-3; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368	50	267	272	3	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					990	1002		10.1038/nn1938	http://dx.doi.org/10.1038/nn1938			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618276				2022-12-24	WOS:000248357500013
J	Mak, GK; Enwere, EK; Gregg, C; Pakarainen, T; Poutanen, M; Huhtaniemi, I; Weiss, S				Mak, Gloria K.; Enwere, Emeka K.; Gregg, Christopher; Pakarainen, Tomi; Poutanen, Matti; Huhtaniemi, Ilpo; Weiss, Samuel			Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior	NATURE NEUROSCIENCE			English	Article							MAIN OLFACTORY EPITHELIUM; NEWLY GENERATED NEURONS; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; LUTEINIZING-HORMONE; MAMMALIAN BRAIN; ENRICHED ENVIRONMENT; PROLACTIN PRL; MICE; RECEPTOR	The regulation of female reproductive behaviors may involve memories of male pheromone signatures, formed in part by neural circuitry involving the olfactory bulb and hippocampus. These neural structures are the principal sites of adult neurogenesis; however, previous studies point to their independent regulation by sensory and physiological stimuli. Here we report that the pheromones of dominant (but not subordinate) males stimulate neuronal production in both the olfactory bulb and hippocampus of female mice, which are independently mediated by prolactin and luteinizing hormone, respectively. Neurogenesis induced by dominant-male pheromones correlates with a female preference for dominant males over subordinate males, whereas blocking neurogenesis with the mitotic inhibitor cytosine arabinoside eliminated this preference. These results suggest that male pheromones are involved in regulating neurogenesis in both the olfactory bulb and hippocampus, which may be important for female reproductive success.	Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Univ Turku, Inst Biomed, Dept Physiol, FIN-20520 Turku, Finland; Univ London Imperial Coll Sci & Technol, Inst Reprod & Dev Biol, London W12 0NN, England; Childrens Hosp Eastern Ontario, Res Inst 2, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Calgary; University of Turku; Imperial College London; University of Ottawa; Children's Hospital of Eastern Ontario; Harvard University; Howard Hughes Medical Institute	Weiss, S (corresponding author), Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	weiss@ucalgary.ca	Oka, Yoshitaka/C-9670-2010; Poutanen, Matti/I-1700-2018	Oka, Yoshitaka/0000-0002-3482-3051; Poutanen, Matti/0000-0002-8953-1734				Bakker J, 2003, J NEUROENDOCRINOL, V15, P615, DOI 10.1046/j.1365-2826.2003.01036.x; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Bigiani A, 2005, REV PHYSIOL BIOCH P, V154, P1, DOI 10.1007/s10254-004-0038-0; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brennan PA, 2004, CURR BIOL, V14, pR81, DOI 10.1016/j.cub.2003.12.052; Brennan PA, 2004, HORM BEHAV, V46, P231, DOI 10.1016/j.yhbeh.2004.01.010; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Foster D L., 1994, PHYSL REPROD, V2; Ganem G, 2005, BIOL J LINN SOC, V84, P461, DOI 10.1111/j.1095-8312.2005.00447.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Grammer K, 2005, EUR J OBSTET GYN R B, V118, P135, DOI 10.1016/j.ejogrb.2004.08.010; GRANT E. C, 1963, BEHAVIOUR, V21, P246, DOI 10.1163/156853963X00185; Huhtaniemi I, 2002, MOL CELL ENDOCRINOL, V187, P49, DOI 10.1016/S0303-7207(01)00698-0; Kavaliers M, 2005, NEUROSCI BIOBEHAV R, V29, P1347, DOI 10.1016/j.neubiorev.2005.04.011; Keller M, 2006, CHEM SENSES, V31, P315, DOI 10.1093/chemse/bjj035; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mossman CA, 1996, J COMP PSYCHOL, V110, P131, DOI 10.1037/0735-7036.110.2.131; Mucignat-Caretta C, 1999, BEHAVIOUR, V136, P331, DOI 10.1163/156853999501351; Rao CV, 2002, MOL CELL ENDOCRINOL, V187, P57, DOI 10.1016/S0303-7207(01)00694-3; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Slotnick B, 2001, TRENDS COGN SCI, V5, P216, DOI 10.1016/S1364-6613(00)01625-9; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	50	246	252	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1003	1011		10.1038/nn1928	http://dx.doi.org/10.1038/nn1928			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603480				2022-12-24	WOS:000248357500014
J	Vinckier, F; Dehaene, S; Jobert, A; Dubus, JP; Sigman, M; Cohen, L				Vinckier, Fabien; Dehaene, Stanislas; Jobert, Antoinette; Dubus, Jean Philippe; Sigman, Mariano; Cohen, Laurent			Hierarchical coding of letter strings in the ventral stream: Dissecting the inner organization of the visual word-form system	NEURON			English	Article							OBJECT-PROCESSING STAGES; MEDIAL TEMPORAL-LOBE; LEFT FUSIFORM GYRUS; OCCIPITOTEMPORAL CORTEX; FIELD POTENTIALS; WRITTEN WORDS; NEURAL CODE; RECOGNITION; BRAIN; AREA	Visual word recognition has been proposed to rely on a hierarchy of increasingly complex neuronal detectors, from individual letters to bigrams and morphemes. We used fMR1 to test whether such a hierarchy is present in the left occipitotemporal cortex, at the site of the visual word-form area, and with an anterior-to-posterior progression. We exposed adult readers to (1) false-font strings; (2) strings of infrequent letters; (3) strings of frequent letters but rare bigrams; (4) strings with frequent bigrams but rare quadrigrams; (5) strings with frequent quadrigrams; (6) real words. A gradient of selectivity was observed through the entire span of the occipitotemporal cortex, with activation becoming more selective for higher-level stimuli toward the anterior fusiform region. A similar gradient was also seen in left inferior frontoinsular cortex. Those gradients were asymmetrical in favor of the left hemisphere. We conclude that the left occipitotemporal visual word-form area, far from being a homogeneous structure, presents a high degree of functional and spatial hierarchical organization which must result from a tuning process during reading acquisition.	INSERM, U562, Orsay, France; Coll France, F-75231 Paris, France; Hop La Pitie Salpetriere, Dept Neurol, AP HP, F-75013 Paris, France; Univ Paris 06, Fac Med Pitie Salpetriere, IFR 70, F-75005 Paris, France; CEA, DSV, IFR 49, F-91401 Orsay, France; Univ Paris Sud, IFR49, F-91191 Gif Sur Yvette, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Cohen, L (corresponding author), INSERM, U562, Orsay, France.	laurent.cohen@psl.aphp.fr		cohen, laurent/0000-0002-5010-9085; Vinckier, Fabien/0000-0003-4984-6296				Aghababian V, 2000, J EXP CHILD PSYCHOL, V76, P123, DOI 10.1006/jecp.1999.2540; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; DiVirgilio G, 1997, HUM BRAIN MAPP, V5, P347, DOI 10.1002/(SICI)1097-0193(1997)5:5<347::AID-HBM3>3.0.CO;2-3; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Giraud AL, 2001, J COGNITIVE NEUROSCI, V13, P754, DOI 10.1162/08989290152541421; Goswami U, 2006, TRENDS COGN SCI, V10, P142, DOI 10.1016/j.tics.2006.02.006; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hillis AE, 2004, BRAIN, V127, P1479, DOI 10.1093/brain/awh172; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Maurer U, 2006, NEUROIMAGE, V33, P749, DOI 10.1016/j.neuroimage.2006.06.025; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; Mukamel R, 2004, CEREB CORTEX, V14, P575, DOI 10.1093/cercor/bhh019; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; NOBRE AC, 1995, J NEUROSCI, V15, P1090; Nobre AC, 1998, BRAIN, V121, P1357, DOI 10.1093/brain/121.7.1357; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; PRINZMETAL W, 1990, J EXP PSYCHOL HUMAN, V16, P584; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Starrfelt R, 2007, NEUROIMAGE, V35, P334, DOI 10.1016/j.neuroimage.2006.12.003; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; TANKAKA K, 1996, ANNU REV NEUROSCI, V19, P109; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; WARRINGTON EK, 1980, BRAIN, V103, P99, DOI 10.1093/brain/103.1.99; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; Wydell TN, 2003, J COGNITIVE NEUROSCI, V15, P1052, DOI 10.1162/089892903770007434; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267	50	489	494	2	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					143	156		10.1016/j.neuron.2007.05.031	http://dx.doi.org/10.1016/j.neuron.2007.05.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	189TF	17610823	Bronze			2022-12-24	WOS:000248010700014
J	Williams, MA; Dang, S; Kanwisher, NG				Williams, Mark A.; Dang, Sabin; Kanwisher, Nancy G.			Only some spatial patterns of fMRI response are read out in task performance	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; MICROSTIMULATION; REPRESENTATIONS; RECOGNITION	Classification methods show that the spatial pattern of a functional magnetic resonance imaging response across the cortex contains category information, but whether such patterns are used, or 'read out', in behavioral performance remains untested. We show that although the spatial pattern in both the retinotopic and lateral occipital cortex (LOC) in humans contains category information, only in the LOC is the pattern stronger for correct than for incorrect trials. Thus, some, but not all, spatial patterns are read out during task performance.	MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Macquarie University; Harvard University; Massachusetts General Hospital	Williams, MA (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	markaw@mit.edu		Williams, Mark/0000-0002-3897-5167	NEI NIH HHS [R01 EY013455, R01 EY013455-05A1] Funding Source: Medline; PHS HHS [13455] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Chambers CD, 2005, TRENDS COGN SCI, V9, P542, DOI 10.1016/j.tics.2005.09.010; Cohen MR, 2004, CURR OPIN NEUROBIOL, V14, P169, DOI 10.1016/j.conb.2004.03.016; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006	14	145	145	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					685	686		10.1038/nn1900	http://dx.doi.org/10.1038/nn1900			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486103	Green Accepted			2022-12-24	WOS:000246799800009
J	Ehlers, MD; Heine, M; Groc, L; Lee, MC; Choquet, D				Ehlers, Michael D.; Heine, Martin; Groc, Laurent; Lee, Ming-Chia; Choquet, Daniel			Diffusional trapping of GluR1 AMPA receptors by input-specific synaptic activity	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; DENDRITIC SPINES; LATERAL DIFFUSION; NEURAL ACTIVITY; SYNAPSES; TRAFFICKING; MEMBRANE; NMDA; PLASTICITY	Synaptic activity regulates the postsynaptic accumulation of AMPA receptors over timescales ranging from minutes to days. Indeed, the regulated trafficking and mobility of GluR1 AMPA receptors underlies many forms of synaptic potentiation at glutamatergic synapses throughout the brain. However, the basis for synapse-specific accumulation of GluR1 is unknown. Here we report that synaptic activity locally immobilizes GluR1 AMPA receptors at individual synapses. Using single-molecule tracking together with the silencing of individual presynaptic boutons, we demonstrate that local synaptic activity reduces diffusional exchange of GluR1 between synaptic and extraynaptic domains, resulting in postsynaptic accumulation of GluR1. At neighboring inactive synapses, GluR1 is highly mobile with individual receptors frequently escaping the synapse. Within the synapse, spontaneous activity confines the diffusional movement of GluR1 to restricted subregions of the postsynaptic membrane. Thus, local activity restricts GluR1 mobility on a submicron scale, defining an input-specific mechanism for regulating AMPA receptor composition and abundance.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France	Duke University; Duke University; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/K-7893-2018; Choquet, Daniel/E-4203-2013	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; 	NIA NIH HHS [R01 AG024492-01, R01 AG024492-03, AG024492, R01 AG024492-02, R01 AG024492] Funding Source: Medline; NIMH NIH HHS [R01 MH064748-01, MH046478, R01 MH064748, R01 MH064748-02, R01 MH064748-03, R01 MH064748-04, R01 MH064748-05] Funding Source: Medline; NINDS NIH HHS [NS047574, R01 NS047574-02, R01 NS047574-03, R01 NS047574, R01 NS039402-08, R01 NS039402-07, R01 NS039402-06, R01 NS047574-01A2, R01 NS039402] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574, R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; COGNET L, 2006, SCI STKE 2006, P13, DOI DOI 10.1126/STKE.327006PE13; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Franks KM, 2003, J NEUROSCI, V23, P3186; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Harms KJ, 2005, J NEUROSCI, V25, P6379, DOI 10.1523/JNEUROSCI.0302-05.2005; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Kharazia VN, 1997, NEUROSCI LETT, V238, P41, DOI 10.1016/S0304-3940(97)00846-X; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Mammen AL, 1997, J NEUROSCI, V17, P7351; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Petersen JD, 2003, J NEUROSCI, V23, P11270; Petralia RS, 2003, EUR J NEUROSCI, V18, P3207, DOI 10.1111/j.1460-9568.2003.03074.x; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Richards DA, 2004, J PHYSIOL-LONDON, V558, P503, DOI 10.1113/jphysiol.2004.062091; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shouval HZ, 2005, P NATL ACAD SCI USA, V102, P14440, DOI 10.1073/pnas.0506934102; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Tovar KR, 2002, NEURON, V34, P253; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; ZONA C, 1994, SYNAPSE, V18, P1, DOI 10.1002/syn.890180102	71	221	225	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 3	2007	54	3					447	460		10.1016/j.neuron.2007.04.010	http://dx.doi.org/10.1016/j.neuron.2007.04.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481397	Bronze, Green Accepted			2022-12-24	WOS:000246855700014
J	Petreanu, L; Huber, D; Sobczyk, A; Svoboda, K				Petreanu, Leopoldo; Huber, Daniel; Sobczyk, Aleksander; Svoboda, Karel			Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections	NATURE NEUROSCIENCE			English	Article							SYNAPTIC CONNECTIONS; CORPUS-CALLOSUM; OPTICAL CONTROL; NEURONS; RAT; ORGANIZATION; SYNAPSES; PHOTOSTIMULATION; INTERNEURONS; RESPONSES	The functions of cortical areas depend on their inputs and outputs, but the detailed circuits made by long- range projections are unknown. We show that the light- gated channel channelrhodopsin- 2 ( ChR2) is delivered to axons in pyramidal neurons in vivo. In brain slices from ChR2- expressing mice, photostimulation of ChR2- positive axons can be transduced reliably into single action potentials. Combining photostimulation with whole- cell recordings of synaptic currents makes it possible to map circuits between presynaptic neurons, defined by ChR2 expression, and postsynaptic neurons, defined by targeted patching. We applied this technique, ChR2- assisted circuit mapping ( CRACM), to map long- range callosal projections from layer ( L) 2/3 of the somatosensory cortex. L2/3 axons connect with neurons in L5, L2/3 and L6, but not L4, in both ipsilateral and contralateral cortex. In both hemispheres the L2/3- to- L5 projection is stronger than the L2/3- to- L2/3 projection. Our results suggest that laminar specificity may be identical for local and longrange cortical projections.	Howard Hughes Med Inst, Ashburn, VA 20147 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Petreanu, Leopoldo/0000-0003-1434-4691; Huber, Daniel/0000-0002-0744-7679				Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CZEIGER D, 1993, J COMP NEUROL, V330, P502, DOI 10.1002/cne.903300406; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Dantzker JL, 1998, J NEUROSCI, V18, P4145; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; IVY GO, 1979, BRAIN RES, V173, P532, DOI 10.1016/0006-8993(79)90247-6; Karayannis T, 2007, CEREB CORTEX, V17, P1213, DOI 10.1093/cercor/bhl035; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kumar SS, 2001, J NEUROPHYSIOL, V86, P2973, DOI 10.1152/jn.2001.86.6.2973; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; VOGT BA, 1982, J NEUROPHYSIOL, V48, P1257, DOI 10.1152/jn.1982.48.6.1257; WHITE EL, 1991, J COMP NEUROL, V303, P233, DOI 10.1002/cne.903030206; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	45	625	635	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					663	668		10.1038/nn1891	http://dx.doi.org/10.1038/nn1891			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435752				2022-12-24	WOS:000245948000024
J	Zhong, J; Li, XY; McNamee, C; Chen, AP; Baccarini, M; Snider, WD				Zhong, Jian; Li, Xiaoyan; McNamee, Cara; Chen, Adele P.; Baccarini, Manuela; Snider, William D.			Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo	NATURE NEUROSCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; B-RAF; A-RAF; MUTATIONS; ERK; CELLS; BRAF; NEUROTROPHIN; EXPRESSION; INSIGHTS	To define the role of the Raf serine/ threonine kinases in nervous system development, we conditionally targeted B-Raf and C-Raf, two of the three known mammalian Raf homologs, using a mouse line expressing Cre recombinase driven by a nestin promoter. Targeting of B-Raf, but not C-Raf, markedly attenuated baseline phosphorylation of Erk in neural tissues and led to growth retardation. Conditional elimination of B-Raf in dorsal root ganglion (DRG) neurons did not interfere with survival, but instead caused marked eduction in expression of the glial cell line - derived neurotrophic factor receptor Ret at postnatal stages, associated with a profound reduction in levels of transcription factor CBF-beta. Elimination of both alleles of Braf, which encodes B-Raf, and one allele of Raf1, which encodes C-Raf, affected DRG neuron maturation as well as proprioceptive axon projection toward the ventral horn in the spinal cord. Finally, conditional elimination of all Braf and Raf1 alleles strongly reduced neurotrophin-dependent axon growth in vitro as well as cutaneous axon terminal arborization in vivo. We conclude that Raf function is crucial for several aspects of DRG neuron development, including differentiation and axon growth.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Vienna Bioctr, A-1030 Vienna, Austria	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Vienna Biocenter (VBC)	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.	william_snider@med.unc.edu	Baccarini, Manuela/B-6481-2014	Baccarini, Manuela/0000-0002-3033-391X	Austrian Science Fund FWF [P 18712] Funding Source: Medline; NINDS NIH HHS [NS45892] Funding Source: Medline; PHS HHS [R01N0S31768] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Althini S, 2004, MOL CELL NEUROSCI, V25, P345, DOI 10.1016/j.mcn.2003.10.015; BARNIER JV, 1995, J BIOL CHEM, V270, P23381, DOI 10.1074/jbc.270.40.23381; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Jesenberger V, 2001, J EXP MED, V193, P353, DOI 10.1084/jem.193.3.353; Klinz FJ, 1996, J NEUROSCI RES, V46, P720, DOI 10.1002/(SICI)1097-4547(19961215)46:6<720::AID-JNR8>3.0.CO;2-H; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LU XY, 1994, EMBO J, V13, P2592, DOI 10.1002/j.1460-2075.1994.tb06549.x; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Marek L, 2004, J CELL PHYSIOL, V201, P459, DOI 10.1002/jcp.20087; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; MELNICK MB, 1993, DEVELOPMENT, V118, P127; Mercer K, 2002, ONCOGENE, V21, P347, DOI 10.1038/sj.onc.1205101; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morice C, 1999, EUR J NEUROSCI, V11, P1995, DOI 10.1046/j.1460-9568.1999.00609.x; MURAKAMI MS, 2001, SCI STKE, pPE30; Nekrasova T, 2005, J IMMUNOL, V175, P2374, DOI 10.4049/jimmunol.175.4.2374; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Pierchala BA, 2007, J NEUROCHEM, V100, P1169, DOI 10.1111/j.1471-4159.2006.04292.x; RODRIGUEZVICIAN.P, 2006, SCIENCE; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wettschureck N, 2005, MOL CELL BIOL, V25, P1942, DOI 10.1128/MCB.25.5.1942-1948.2005; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 2000, MECH DEVELOP, V91, P97, DOI 10.1016/S0925-4773(99)00276-2; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	50	73	78	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					598	607		10.1038/nn1898	http://dx.doi.org/10.1038/nn1898			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396120				2022-12-24	WOS:000245948000016
J	Arenkiel, BR; Peca, J; Davison, IG; Feliciano, C; Deisseroth, K; Augustine, GJ; Ehlers, MD; Feng, GP				Arenkiel, Benjamin R.; Peca, Joao; Davison, Ian G.; Feliciano, Catia; Deisseroth, Karl; Augustine, George J.; Ehlers, Michael D.; Feng, Guoping			In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2	NEURON			English	Article							MAMMALIAN OLFACTORY-BULB; MITRAL CELLS; ODORANT REPRESENTATIONS; CAENORHABDITIS-ELEGANS; BEHAVIORAL-RESPONSES; LATERAL INHIBITION; PIRIFORM CORTEX; REMOTE-CONTROL; SENSORY MAP; NEURONS	Channelrhodopsin-2 (ChR2) is a light-gated, cation-selective ion channel isolated from the green algae Chlamydomonas reinhardtii. Here, we report the generation of transgenic mice that express a ChR2-YFP fusion protein in the CNS for in vivo activation and mapping of neural circuits. Using focal illumination of the cerebral cortex and olfactory bulb, we demonstrate a highly reproducible, light-dependent activation of neurons and precise control of firing frequency in vivo. To test the feasibility of mapping neural circuits, we exploited the circuitry formed between the olfactory bulb and the piriform cortex in anesthetized mice. In the olfactory bulb, individual mitral cells fired action potentials in response to light, and their firing rate was not influenced by costimulated glomeruli. However, in piriform cortex, the activity of target neurons increased as larger areas of the bulb were illuminated to recruit additional glomeruli. These results support a model of olfactory processing that is dependent upon mitral cell convergence and integration onto cortical cells. More broadly, these findings demonstrate a system for precise manipulation of neural activity in the intact mammalian brain with light and illustrate the use of ChR2 mice in exploring functional connectivity of complex neural circuits in vivo.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; Gulbenkian Inst Sci, Gulbenkian PhD Programme Biomed, P-2781901 Oeiras, Portugal; Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Duke University; Howard Hughes Medical Institute; Duke University; Universidade de Coimbra; Stanford University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Feng, Guoping/Y-2827-2019; Augustine, George James/J-9228-2013; Oka, Yoshitaka/C-9670-2010; Peça, João/K-7900-2013	Oka, Yoshitaka/0000-0002-3482-3051; Peça, João/0000-0003-4989-2129; Arenkiel, Benjamin/0000-0001-9047-2420; Feliciano, Catia/0000-0001-7545-6924	NINDS NIH HHS [K99 NS064171] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS064171] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLISON AC, 1953, BIOL REV, V28, P195, DOI 10.1111/j.1469-185X.1953.tb01376.x; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; FENG G, 2004, METHODS MOL MED, V9, P255; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Flusberg BA, 2005, OPT LETT, V30, P2272, DOI 10.1364/OL.30.002272; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hamada S, 1998, MOL BRAIN RES, V54, P199, DOI 10.1016/S0169-328X(97)00322-7; Hardy A, 2005, NEUROSCIENCE, V131, P717, DOI 10.1016/j.neuroscience.2004.10.034; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Kandel ER., 2000, PRINCIPLES NEUROSCIE, V4; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; MCLEAN JH, 1995, J COMP NEUROL, V353, P371, DOI 10.1002/cne.903530305; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Piyawattanametha W, 2006, OPT LETT, V31, P2018, DOI 10.1364/OL.31.002018; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; WANG H, 2007, IN PRESS P NATL ACAD; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	64	535	584	1	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					205	218		10.1016/j.neuron.2007.03.005	http://dx.doi.org/10.1016/j.neuron.2007.03.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442243	Green Accepted, Bronze			2022-12-24	WOS:000246190600007
J	Crepel, V; Aronov, D; Jorquera, I; Represa, A; Ben-Ari, Y; Cossart, R				Crepel, Valerie; Aronov, Dmitriy; Jorquera, Isabel; Represa, Alfonso; Ben-Ari, Yehezkel; Cossart, Rosa			A parturition-associated nonsynaptic coherent activity pattern in the developing hippocampus	NEURON			English	Article							GIANT DEPOLARIZING POTENTIALS; DEVELOPING RAT HIPPOCAMPUS; ACTIVATED CATION CURRENT; MOUSE CORTICAL-NEURONS; IN-VITRO; DEVELOPING NEOCORTEX; CALCIUM-CHANNELS; GAP-JUNCTIONS; POSTNATAL-DEVELOPMENT; SUPRAOPTIC NUCLEUS	Correlated neuronal activity is instrumental in the formation of networks, but its emergence during maturation is poorly understood. We have used multibeam two-photon calcium microscopy combined with targeted electrophysiological recordings in order to determine the development of population coherence from embryonic to postnatal stages in the hippocampus. At embryonic stages (E16-E19), synchronized activity is absent, and neurons are intrinsically active and generate L-type channel-mediated calcium spikes. At birth, small cell assemblies coupled by gap junctions spontaneously generate synchronous nonsynaptic calcium plateaus associated to recurrent burst discharges. The emergence of coherent calcium plateaus at birth is controlled by oxytocin, a maternal hormone initiating labour, and progressively shut down a few days later by the synapse-driven giant depolarizing potentials (GDPs) that synchronize the entire network. Therefore, in the developing hippocampus, delivery is an important signal that triggers the first coherent activity pattern, which is silenced by the emergence of synaptic transmission.	Univ Mediterranee, INSERM, INMED, U29, F-13273 Marseille 09, France; MIT, Cambridge, MA 02139 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Massachusetts Institute of Technology (MIT)	Cossart, R (corresponding author), Univ Mediterranee, INSERM, INMED, U29, Parc Sci Luminy,BP 13, F-13273 Marseille 09, France.	cossart@inmed.univ-mrs.fr	Cossart, Rosa/E-7674-2014; Crépel, Valérie/E-1870-2016; Cossart, Rosa/AAT-7934-2020; Represa, Alfonso/M-7383-2016	Cossart, Rosa/0000-0003-2111-6638; Crépel, Valérie/0000-0003-0408-3766; Cossart, Rosa/0000-0003-2111-6638; Represa, Alfonso/0000-0002-5096-8939; Ben-Ari, Yehezkel/0000-0001-6208-8480				ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; Arumugam H, 2005, NAT NEUROSCI, V8, P1720, DOI 10.1038/nn1588; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bender RA, 2005, EUR J NEUROSCI, V22, P2669, DOI 10.1111/j.1460-9568.2005.04407.x; Bittman K, 1997, J NEUROSCI, V17, P7037; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Brun ICL, 2004, J PHYSIOL-LONDON, V559, P129, DOI 10.1113/jphysiol.2004.065060; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cossart R, 2005, CELL CALCIUM, V37, P451, DOI 10.1016/j.ceca.2005.01.013; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; DI PE, 2001, EUR J NEUROSCI, V13, P1403; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hatton GI, 1996, J NEUROSCI, V16, P123; Jiang M, 2005, NEUROSCIENCE, V135, P839, DOI 10.1016/j.neuroscience.2005.06.073; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; Kandler K, 1998, J NEUROSCI, V18, P1419; Kasyanov AM, 2004, P NATL ACAD SCI USA, V101, P3967, DOI 10.1073/pnas.0305974101; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Leinekugel X, 1998, J NEUROSCI, V18, P6349; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Leznik E, 2005, J NEUROPHYSIOL, V94, P2447, DOI 10.1152/jn.00353.2005; Liljelund P, 2000, J NEUROSCI, V20, P7394; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.3.CO;2-L; McCabe AK, 2006, J PHYSIOL-LONDON, V577, P155, DOI 10.1113/jphysiol.2006.117523; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Nielsen T, 2001, J MICROSC-OXFORD, V201, P368, DOI 10.1046/j.1365-2818.2001.00852.x; Nita DA, 2003, J PHYSIOL-LONDON, V552, P325, DOI 10.1113/jphysiol.2003.050310; ODONOVAN MJ, 1989, J NEUROSCI, V9, P943; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Peinado A, 2000, J NEUROSCI, V20; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Raggenbass M, 2001, PROG NEUROBIOL, V64, P307, DOI 10.1016/S0301-0082(00)00064-2; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; Rozental R, 2000, BRAIN RES REV, V32, P57, DOI 10.1016/S0165-0173(99)00096-X; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Theodosis DT, 2006, MOL CELL NEUROSCI, V31, P785, DOI 10.1016/j.mcn.2006.01.006; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	74	142	143	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					105	120		10.1016/j.neuron.2007.03.007	http://dx.doi.org/10.1016/j.neuron.2007.03.007			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408581	Bronze			2022-12-24	WOS:000245848400013
J	Doyere, V; Debiec, J; Monfils, MH; Schafe, GE; LeDoux, JE				Doyere, Valerie; Debiec, Jacek; Monfils, Marie-H; Schafe, Glenn E.; LeDoux, Joseph E.			Synapse-specific reconsolidation of distinct fear memories in the lateral amygdala	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RETRIEVAL	When reactivated, memories enter a labile, protein synthesis dependent state, a process referred to as reconsolidation. Here, we show in rats that fear memory retrieval produces a synaptic potentiation in the lateral amygdala that is selective to the reactivated memory, and that disruption of reconsolidation is correlated with a reduction of synaptic potentiation in the lateral amygdala. Thus, both retrieval and reconsolidation alter memories via synaptic plasticity at selectively targeted synapses.	NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA; Univ Paris 11, CNRS, UMR8620, NAMC, F-91405 Orsay, France; Yale Univ, Dept Psychol, New Haven, CT 06520 USA	New York University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Yale University	LeDoux, JE (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, 4 Washington Pl, New York, NY 10003 USA.	ledoux@cns.nyu.edu	Monfils, Marie/F-1282-2013; Debiec, Jacek/B-6820-2008	Debiec, Jacek/0000-0002-8473-1534; Doyere, Valerie/0000-0002-3851-669X; Monfils, Marie-H./0000-0001-8971-6651	NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH067048, R37MH038774, R01MH046516, P50MH058911] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH38774, K05 MH067048, P50 MH58911, R01 MH46516] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lindquist DH, 2004, J NEUROSCI, V24, P3610, DOI 10.1523/JNEUROSCI.4839-03.2004; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022	13	141	144	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					414	416		10.1038/nn1871	http://dx.doi.org/10.1038/nn1871			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17351634				2022-12-24	WOS:000245228600009
J	Segura, I; Essmann, CL; Weinges, S; Acker-Palmer, A				Segura, Inmaculada; Essmann, Clara L.; Weinges, Stefan; Acker-Palmer, Amparo			Grb4 and GIT1 transduce ephrinB reverse signals modulating spine morphogenesis and synapse formation	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINES; EPH RECEPTOR; KINASE; ACTIVATION; PLASTICITY; SRC; PROTEIN; HIPPOCAMPUS; COMPLEXES; MOTILITY	Dendritic spines are small protrusions emerging from dendrites that receive excitatory input. The process of spine morphogenesis occurs both in the developing brain and during synaptic plasticity. Molecules regulating the cytoskeleton are involved in spine formation and maintenance. Here we show that reverse signaling by the transmembrane ligands for Eph receptors, ephrinBs, is required for correct spine morphogenesis. The molecular mechanism underlying this function of ephrinBs involves the SH2 and SH3 domain-containing adaptor protein Grb4 and the G protein-coupled receptor kinase-interacting protein (GIT) 1. Grb4 binds by its SH2 domain to Tyr392 in the synaptic localization domain of GIT1. Phosphorylation of Tyr392 and the recruitment of GIT1 to synapses are regulated by ephrinB activation. Disruption of this pathway in cultured rat hippocampal neurons impairs spine morphogenesis and synapse formation. We thus show an important role for ephrinB reverse signaling in spine formation and have mapped the downstream pathway involved in this process.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Acker-Palmer, A (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	palmer@neuro.mpg.de	Segura, Inmaculada/D-2878-2013; Segura, Inmaculada/AAA-7958-2020	Segura, Inmaculada/0000-0003-1849-5569				Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; Bauer A, 2003, EUR J BIOCHEM, V270, P570, DOI 10.1046/j.1432-1033.2003.03428.x; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	33	111	115	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					301	310		10.1038/nn1858	http://dx.doi.org/10.1038/nn1858			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310244				2022-12-24	WOS:000244480300012
J	Gonzalez-Maeso, J; Weisstaub, NV; Zhou, MM; Chan, P; Ivic, L; Ang, R; Lira, A; Bradley-Moore, M; Ge, YC; Zhou, Q; Sealfon, SC; Gingrich, JA				Gonzalez-Maeso, Javier; Weisstaub, Noelia V.; Zhou, Mingming; Chan, Pokman; Ivic, Lidija; Ang, Rosalind; Lira, Alena; Bradley-Moore, Maria; Ge, Yongchao; Zhou, Qiang; Sealfon, Stuart C.; Gingrich, Jay A.			Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior	NEURON			English	Article							LYSERGIC-ACID DIETHYLAMIDE; RAT-BRAIN; MONOAMINERGIC RECEPTOR; ANTIPARKINSON AGENTS; DIFFERENTIAL ACTIONS; MULTIPLE CLASSES; KINASE PATHWAY; MESSENGER-RNA; LISURIDE; AGONIST	Hallucinogens, including mescaline, psilocybin, and lysergic acid diethylamide (LSD), profoundly affect perception, cognition, and mood. All known drugs of this class are 5-HT2A receptor (2AR) agonists, yet closely related 2AR agonists such as lisuride lack comparable psychoactive properties. Why only certain 2AR agonists are hallucinogens and which neural circuits mediate their effects are poorly understood. By genetically expressing 2AR only in cortex, we show that 2AR-regulated pathways on cortical neurons are sufficient to mediate the signaling pattern and behavioral response to hallucinogens. Hallucinogenic and nonhallucinogenic 2AR agonists both regulate signaling in the same 2AR-expressing cortical neurons. However, the signaling and behavioral responses to the hallucinogens are distinct. While lisuride and LSD both act at 2AR expressed by cortex neurons to regulate phospholipase C, LSD responses also involve pertussis toxin-sensitive heterotrimeric G(i/o) proteins and Src. These studies identify the long-elusive neural and signaling mechanisms responsible for the unique effects of hallucinogens.	Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Sackler Inst Labs, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Lieber Ctr Schizophrenia Res, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute	Sealfon, SC (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	Weisstaub, Noelia/ABA-1706-2021; Ge, Yongchao/AAG-9317-2021	Ge, Yongchao/0000-0001-6448-5703; SEALFON, Stuart/0000-0001-5791-1217	NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135, P01DA012923] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA12923, T32 DA07135, P01 DA012923, T32 DA007135] Funding Source: Medline; NIMH NIH HHS [K08 MH01711] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS LM, 1985, BEHAV NEUROSCI, V99, P881, DOI 10.1037/0735-7044.99.5.881; ADAMS LM, 1985, PHARMACOL BIOCHEM BE, V23, P461, DOI 10.1016/0091-3057(85)90022-X; Banes A, 1999, J PHARMACOL EXP THER, V291, P1179; BARKAI E, 1994, J NEUROPHYSIOL, V72, P644, DOI 10.1152/jn.1994.72.2.644; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; CALLAHAN PM, 1990, PSYCHOPHARMACOLOGY, V100, P13, DOI 10.1007/BF02245782; Chan P, 2005, J COMP NEUROL, V482, P50, DOI 10.1002/cne.20377; CORNE SJ, 1967, PSYCHOPHARMACOLOGIA, V11, P65, DOI 10.1007/BF00401509; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DARMANI NA, 1990, PHARMACOL BIOCHEM BE, V37, P95, DOI 10.1016/0091-3057(90)90047-L; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Ebersole BJ, 2003, MOL PHARMACOL, V63, P36, DOI 10.1124/mol.63.1.36; Egan CT, 1998, PSYCHOPHARMACOLOGY, V136, P409, DOI 10.1007/s002130050585; FIORELLA D, 1995, PSYCHOPHARMACOLOGY, V121, P364, DOI 10.1007/BF02246076; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; GONALEZMAESO J, 2006, ENDOCRINOLOGY, P177; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2002, MOL PSYCHIATR, V7, P755, DOI 10.1038/sj.mp.4001067; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gresch PJ, 2002, NEUROSCIENCE, V114, P707, DOI 10.1016/S0306-4522(02)00349-4; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; HOROWSKI R, 1976, EUR J PHARMACOL, V36, P373, DOI 10.1016/0014-2999(76)90091-1; HOYER D, 1994, PHARMACOL REV, V46, P157; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; JOHNSON AR, 1982, APPL MULTIVARIATE ST; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; Kurrasch-Orbaugh DM, 2003, J NEUROCHEM, V86, P980, DOI 10.1046/j.1471-4159.2003.01921.x; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Lopez-Gimenez JF, 2001, J COMP NEUROL, V429, P571, DOI 10.1002/1096-9861(20010122)429:4<571::AID-CNE5>3.0.CO;2-X; LopezGimenez JF, 1997, N-S ARCH PHARMACOL, V356, P446, DOI 10.1007/PL00005075; MAJ J, 1977, J NEURAL TRANSM, V41, P253, DOI 10.1007/BF01252020; Marek GJ, 2001, NEUROSCIENCE, V105, P379, DOI 10.1016/S0306-4522(01)00199-3; Marona-Lewicka D, 2002, PSYCHOPHARMACOLOGY, V164, P93, DOI 10.1007/s00213-002-1141-z; McLoughlin DJ, 2000, J NEUROCHEM, V74, P347, DOI 10.1046/j.1471-4159.2000.0740347.x; MILLAN MJ, 1991, J PHARMACOL EXP THER, V256, P973; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; MOKLER DJ, 1984, PHARMACOL BIOCHEM BE, V21, P281, DOI 10.1016/0091-3057(84)90227-2; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P805, DOI 10.1124/jpet.102.039875; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; NIELSEN EB, 1986, EUR J PHARMACOL, V125, P85, DOI 10.1016/0014-2999(86)90086-5; Nocjar C, 2002, NEUROSCIENCE, V111, P163, DOI 10.1016/S0306-4522(01)00593-0; PAZOS A, 1985, BRAIN RES, V346, P231, DOI 10.1016/0006-8993(85)90857-1; PIERI L, 1978, NATURE, V272, P278, DOI 10.1038/272278a0; Prioleau C, 2002, J BIOL CHEM, V277, P36577, DOI 10.1074/jbc.M206223200; Quinn JC, 2002, J PHARMACOL EXP THER, V303, P746, DOI 10.1124/jpet.102.038083; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Rex A, 1998, PHARMACOL BIOCHEM BE, V59, P677, DOI 10.1016/S0091-3057(97)00461-9; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Ruf F, 2004, TRENDS ENDOCRIN MET, V15, P331, DOI 10.1016/j.tem.2004.07.008; SAPIENZA S, 1981, EXP BRAIN RES, V43, P47; Scruggs JL, 2000, J NEUROSCI, V20, P8846; Scruggs JL, 2003, NEUROSCI LETT, V346, P137, DOI 10.1016/S0304-3940(03)00547-0; SILVA MTA, 1975, PSYCHOPHARMACOLOGIA, V42, P163, DOI 10.1007/BF00429548; TRULSON ME, 1984, DEV PSYCHOBIOL, V17, P329, DOI 10.1002/dev.420170402; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; VETULANI J, 1979, POL J PHARMACOL PHAR, V31, P413; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Willins DL, 1997, J PHARMACOL EXP THER, V282, P699	63	509	530	6	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					439	452		10.1016/j.neuron.2007.01.008	http://dx.doi.org/10.1016/j.neuron.2007.01.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270739	Bronze			2022-12-24	WOS:000245126800013
J	Shin, JB; Streijger, F; Beynon, A; Peters, T; Gadzala, L; McMillen, D; Bystrom, C; Van der Zee, CEEM; Wallimann, T; Gillespie, PG				Shin, Jung-Bum; Streijger, Femke; Beynon, Andy; Peters, Theo; Gadzala, Laura; McMillen, Debra; Bystrom, Cory; Van der Zee, Catharina E. E. M.; Wallimann, Theo; Gillespie, Peter G.			Hair bundles are specialized for ATP delivery via creatine kinase	NEURON			English	Article							PHOTORECEPTOR OUTER SEGMENTS; PLASMA-MEMBRANE; GLYCOLYTIC-ENZYMES; CELL STEREOCILIA; INNER-EAR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MECHANOELECTRICAL-TRANSDUCTION; ADENOSINE TRIPHOSPHATE; SHOTGUN PROTEOMICS; DEAFWADDLER MICE	When stimulated strongly, a hair cell's mechanically sensitive hair bundle may consume ATP too rapidly for replenishment by diffusion. To provide a broad view of the bundle's protein complement, including those proteins participating in energy metabolism, we used shotgun mass spectrometry methods to identify proteins of purified chicken vestibular bundles. In addition to cytoskeletal proteins, proteins involved in Ca2+ regulation, and stress-response proteins, many of the most abundant bundle proteins that were identified by mass spectrometry were involved in ATP synthesis. After beta-actin, the cytosolic brain isoform of creatine kinase was the next most abundant bundle protein; at similar to 0.5 mM, creatine kinase is capable of maintaining high ATP levels despite 1 mM/s ATP consumption by the plasma-membrane Ca2+-ATPase. Consistent with this critical role in hair bundle function, the creatine kinase circuit is essential for high-sensitivity hearing as demonstrated by hearing loss in creatine kinase knockout mice.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NCMLS, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; Oregon Hlth & Sci Univ, Proteom Shared Resource, Portland, OR 97239 USA; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	Oregon Health & Science University; Oregon Health & Science University; Radboud University Nijmegen; Radboud University Nijmegen; Oregon Health & Science University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	gillespp@ohsu.edu	Van der Zee, Catharina E.E.M./L-4773-2015; Beynon, Andy/D-3476-2009; Peters, T.A./L-4571-2015; Beynon, Andy/L-4198-2015; Wallimann, Theo/C-6047-2008	Beynon, Andy/0000-0002-3191-6113; Peters, T.A./0000-0001-8443-5500; Beynon, Andy/0000-0002-3191-6113; Wallimann, Theo/0000-0003-4957-5836; Barr-Gillespie, Peter/0000-0002-9787-5860	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R21DC006097, R01DC002368] Funding Source: NIH RePORTER; NIDCD NIH HHS [R21 DC006097, R01 DC002368, P30 DC005983] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARNOLD H, 1971, EUR J BIOCHEM, V22, P121, DOI 10.1111/j.1432-1033.1971.tb01522.x; BOWEN WJ, 1964, ARCH BIOCHEM BIOPHYS, V107, P30, DOI 10.1016/0003-9861(64)90265-6; BRONSTEIN WW, 1981, CAN J BIOCHEM CELL B, V59, P494, DOI 10.1139/o81-069; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; COREY DP, 1983, J NEUROSCI, V3, P942; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Dzeja PP, 1996, J BIOL CHEM, V271, P12847, DOI 10.1074/jbc.271.22.12847; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Goodyear RJ, 1999, J NEUROCYTOL, V28, P851, DOI 10.1023/A:1007070121751; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; HEMMER W, 1993, J CELL SCI, V106, P671; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hornemann T, 2000, BBA-PROTEIN STRUCT M, V1480, P365, DOI 10.1016/S0167-4838(00)00098-4; HSU SC, 1994, J BIOL CHEM, V269, P17954; HSU SC, 1990, J BIOL CHEM, V265, P13308; INFANTE AA, 1965, J BIOL CHEM, V240, P3996; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Jones SM, 1996, J VESTIBUL RES-EQUIL, V6, P71, DOI 10.1016/0957-4271(95)02008-X; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Kaldis P, 1996, J CELL SCI, V109, P2079; Kay L, 2000, J BIOL CHEM, V275, P6937, DOI 10.1074/jbc.275.10.6937; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Kraft T, 2000, J MUSCLE RES CELL M, V21, P691, DOI 10.1023/A:1005623002979; KRZANOWSKI JJ, 1971, J HISTOCHEM CYTOCHEM, V19, P321, DOI 10.1177/19.5.321; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Liang P, 1997, J CELL SCI, V110, P1431; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Lumpkin EA, 1997, P NATL ACAD SCI USA, V94, P10997, DOI 10.1073/pnas.94.20.10997; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; MEJEAN C, 1989, BIOCHEM J, V264, P671, DOI 10.1042/bj2640671; MEYER RA, 1984, AM J PHYSIOL, V246, P365; NEELY JG, 1991, HEARING RES, V52, P403, DOI 10.1016/0378-5955(91)90028-8; NEUGEBAUER DC, 1984, J NEUROCYTOL, V13, P797, DOI 10.1007/BF01148494; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; ROSSI AM, 1990, J BIOL CHEM, V265, P5258; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; SPICER SS, 1992, J HISTOCHEM CYTOCHEM, V40, P185, DOI 10.1177/40.2.1313059; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Streijger F, 2005, BEHAV BRAIN RES, V157, P219, DOI 10.1016/j.bbr.2004.07.002; TILNEY MS, 1989, J CELL BIOL, V109, P1711, DOI 10.1083/jcb.109.4.1711; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yamoah EN, 1998, J NEUROSCI, V18, P610; YOSHIZAKI K, 1987, JPN J PHYSIOL, V37, P923, DOI 10.2170/jjphysiol.37.923	72	94	98	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					371	386		10.1016/j.neuron.2006.12.021	http://dx.doi.org/10.1016/j.neuron.2006.12.021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270734	Green Accepted, Bronze			2022-12-24	WOS:000245126800008
J	Yoshida, Y; Han, B; Mendelsohn, M; Jessell, TM				Yoshida, Yutaka; Han, Barbara; Mendelsohn, Monica; Jessell, Thomas M.			PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord	NEURON			English	Article							DORSAL-ROOT-GANGLIA; PERIPHERAL-NERVE PROJECTION; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; SEMAPHORIN-III; MOTOR-NEURONS; NOGO RECEPTOR; NEURAL MAP; RAT; AFFERENTS	As different classes of sensory neurons project into the CNS, their axons segregate and establish distinct trajectories and target zones. One striking instance of axonal segregation is the projection of sensory neurons into the spinal cord, where proprioceptive axons avoid the superficial dorsal horn-the target zone of many cutaneous afferent fibers. PlexinA1 is a proprioceptive sensory axon-specific receptor for sema6C and sema6D, which are expressed in a dynamic pattern in the dorsal horn. The loss of plexinA1 signaling causes the shafts of proprioceptive axons to invade the superficial dorsal horn, disrupting the organization of cutaneous afferents. This disruptive influence appears to involve the intermediary action of oligodendrocytes, which accompany displaced proprioceptive axon shafts into the dorsal horn. Our findings reveal a dedicated program of axonal shaft positioning in the mammalian CNS and establish a role for plexinA1-mediated axonal exclusion in organizing the projection pattern of spinal sensory afferents.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Yoshida, Y (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.	yy2032@columbia.edu; tmj1@columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH050733] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Blagburn JM, 2004, ANNU REV NEUROSCI, V27, P29, DOI 10.1146/annurev.neuro.27.070203.144143; Brown AG, 1981, ORG SPINAL CORD; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; DURNITRIU D, IN PRESS CEREB CORTE; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; FITZGERALD M, 1987, J COMP NEUROL, V261, P98, DOI 10.1002/cne.902610108; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Fu SY, 2000, J NEUROBIOL, V45, P227, DOI 10.1002/1097-4695(200012)45:4<227::AID-NEU4>3.0.CO;2-N; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Hunt D, 2002, MOL CELL NEUROSCI, V20, P537, DOI 10.1006/mcne.2002.1153; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kawasaki T, 2006, DEVELOPMENT, V133, P845, DOI 10.1242/dev.02257; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Koerber HR, 1992, SENSORY NEURONS DIVE, P77; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lefcort F, 1996, J NEUROSCI, V16, P3704; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MIKOSHIBA K, 1991, ANNU REV NEUROSCI, V14, P201, DOI 10.1146/annurev.ne.14.030191.001221; MIMICS K, 1995, J COMP NEUROL, V355, P601; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Ozaki S, 1997, J COMP NEUROL, V380, P215; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Perrin FE, 2001, NEURON, V30, P707, DOI 10.1016/S0896-6273(01)00315-4; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; REN K, 1993, BRAIN RES BULL, V31, P13, DOI 10.1016/0361-9230(93)90004-U; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHOLES JH, 1979, NATURE, V278, P620, DOI 10.1038/278620a0; Schouenborg J, 2004, CURR OPIN NEUROBIOL, V14, P693, DOI 10.1016/j.conb.2004.10.009; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Watanabe K, 2006, DEVELOPMENT, V133, P1379, DOI 10.1242/dev.02312; Woodruff RH, 1998, J NEUROCYTOL, V27, P683, DOI 10.1023/A:1006972316697; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Zhong JA, 2006, NEURON, V49, P325, DOI 10.1016/j.neuron.2006.01.013	60	100	101	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					775	788		10.1016/j.neuron.2006.10.032	http://dx.doi.org/10.1016/j.neuron.2006.10.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145500	Green Accepted, Bronze			2022-12-24	WOS:000242856400007
J	Huber, R; Ghilardi, MF; Massimini, M; Ferrarelli, F; Riedner, BA; Peterson, MJ; Tononi, G				Huber, Reto; Ghilardi, M. Felice; Massimini, Marcello; Ferrarelli, Fabio; Riedner, Brady A.; Peterson, Michael J.; Tononi, Giulio			Arm immobilization causes cortical plastic changes and locally decreases sleep slow wave activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; EEG; STIMULATION; MEMORY; OSCILLATIONS; EXCITABILITY; MECHANISM; RAT	Sleep slow wave activity (SWA) is thought to reflect sleep need, increasing after wakefulness and decreasing after sleep. We showed recently that a learning task involving a circumscribed brain region produces a local increase in sleep SWA. We hypothesized that increases in cortical SWA reflect synaptic potentiation triggered by learning. To further investigate the link between synaptic plasticity and sleep, we asked whether a procedure leading to synaptic depression would cause instead a decrease in sleep SWA. We show here that if a subject's arm is immobilized during the day, motor performance deteriorates and both somatosensory and motor evoked potentials decrease over contralateral sensorimotor cortex, indicative of local synaptic depression. Notably, during subsequent sleep, SWA over the same cortical area is markedly reduced. Thus, cortical plasticity is linked to local sleep regulation without learning in the classical sense. Moreover, when synaptic strength is reduced, local sleep need is also reduced.	CUNY City Coll, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA; Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; Univ Wisconsin, Neurosci Training Program, Madison, WI 53719 USA	City University of New York (CUNY) System; City College of New York (CUNY); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), CUNY City Coll, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA.	mg79@columbia.edu; gtononi@wisc.edu	ferrarelli, fabio/C-2945-2011; Ferrarelli, Fabio/D-3219-2019; Tononi, Giulio/B-8387-2009; Peterson, Michael J./A-8834-2009; Massimini, Marcello/T-8115-2017	Ferrarelli, Fabio/0000-0003-0560-0227; Peterson, Michael J./0000-0001-9181-1009; Massimini, Marcello/0000-0003-2271-957X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055185] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01 NS 055 185-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; Candia V, 2003, P NATL ACAD SCI USA, V100, P7942, DOI 10.1073/pnas.1231193100; Cirelli C, 2005, J NEUROSCI, V25, P4503, DOI 10.1523/JNEUROSCI.4845-04.2005; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Datta S, 2000, J NEUROSCI, V20, P8607, DOI 10.1523/JNEUROSCI.20-22-08607.2000; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Facchini S, 2002, CLIN NEUROPHYSIOL, V113, P367, DOI 10.1016/S1388-2457(02)00009-3; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Huber R, 2000, NEUROREPORT, V11, P3321, DOI 10.1097/00001756-200010200-00012; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; KRYGER MH, 2006, PRINCIPLES PRACTICE; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Mauguiere F, 1999, EEG CL N SU, P255; Miyamoto H, 2003, NAT NEUROSCI, V6, P553, DOI 10.1038/nn1064; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Rechtschaffen A., 1968, MANUAL STANDARDIZED; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; WALKER MP, 2005, ANN REV PSYCHOL; Werhahn KJ, 2002, BRAIN, V125, P1402, DOI 10.1093/brain/awf140; Werth E, 1996, AM J PHYSIOL-REG I, V271, pR501, DOI 10.1152/ajpregu.1996.271.3.R501; Werth E, 1997, J SLEEP RES, V6, P102, DOI 10.1046/j.1365-2869.1997.d01-36.x; Ziemann U, 2004, REV NEUROSCIENCE, V15, P253; Ziemann U, 2002, J NEUROSCI, V22, P5563	49	397	406	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1169	1176		10.1038/nn1758	http://dx.doi.org/10.1038/nn1758			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16936722				2022-12-24	WOS:000240080800019
J	Wienisch, M; Klingauf, J				Wienisch, Martin; Klingauf, Jurgen			Vesicular proteins exocytosed and subsequently retrieved by compensatory endocytosis are nonidentical	NATURE NEUROSCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLE ENDOCYTOSIS; CULTURED HIPPOCAMPAL-NEURONS; NERVE-TERMINALS; TRANSMITTER RELEASE; MEMBRANE-PROTEINS; CLATHRIN; SYNAPSES; KINETICS; DYNAMIN	Upon exocytosis, synaptic vesicle proteins are released into the plasma membrane and have to be retrieved by compensatory endocytosis. When green fluorescent protein-labeled versions of the vesicle proteins synaptobrevin-2 and synaptotagmin-1 are overexpressed in rat hippocampal neurons, up to 30% are found on axonal membranes under resting conditions. To test whether and to what extent these plasma membrane-stranded proteins participate in exo-endocytic cycling, a new proteolytic approach was used to visualize the fate of newly exocytosed proteins separately from that of the plasma membrane-stranded ones. We found that both pools were mixed and that endocytosed vesicles were largely composed of previously stranded molecules. The degree of nonidentity of vesicular proteins exo-and endocytosed depended on stimulus duration. By using an antibody to the external domain of synaptotagmin-1, we estimated that under physiological conditions a few percent of vesicular proteins were located near the active zone, from where they were preferentially recycled upon stimulation.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.	J.Klingauf@mpi-bpc.mpg.de						Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Estes PS, 1996, J NEUROSCI, V16, P5443; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Loerke D, 2005, TRAFFIC, V6, P918, DOI 10.1111/j.1600-0854.2005.00329.x; Martin TFJ, 2000, NAT CELL BIOL, V2, pE9, DOI 10.1038/71392; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 1997, J NEUROSCI, V17, P5858; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vanden Berghe P, 2006, J PHYSIOL-LONDON, V572, P707, DOI 10.1113/jphysiol.2005.100842; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1	49	171	175	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1019	1027		10.1038/nn1739	http://dx.doi.org/10.1038/nn1739			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845386	Green Published			2022-12-24	WOS:000240080300014
J	Graham, DL; Edwards, S; Bachtell, RK; DiLeone, RJ; Rios, M; Self, DW				Graham, Danielle L.; Edwards, Scott; Bachtell, Ryan K.; DiLeone, Ralph J.; Rios, Maribel; Self, David W.			Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse	NATURE NEUROSCIENCE			English	Article							D-3 RECEPTOR EXPRESSION; FACTOR PROTEIN-LEVELS; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; SEROTONIN METABOLISM; RETROGRADE TRANSPORT; DENDRITIC SPINES; MOUSE-BRAIN; DELTA-FOSB; IN-VIVO	A single exposure to cocaine rapidly induces the brief activation of several immediate early genes, but the role of such short-term regulation in the enduring consequences of cocaine use is poorly understood. We found that 4 h of intravenous cocaine self-administration in rats induced a transient increase in brain-derived neurotrophic factor (BDNF) and activation of TrkB-mediated signaling in the nucleus accumbens (NAc). Augmenting this dynamic regulation with five daily NAc BDNF infusions caused enduring increases in cocaine self-administration, and facilitated relapse to cocaine seeking in withdrawal. In contrast, neutralizing endogenous BDNF regulation with intra-NAc infusions of antibody to BDNF subsequently reduced cocaine self-administration and attenuated relapse. Using localized inducible BDNF knockout in mice, we found that BDNF originating from NAc neurons was necessary for maintaining increased cocaine self-administration. These findings suggest that dynamic induction and release of BDNF from NAc neurons during cocaine use promotes the development and persistence of addictive behavior.	Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA; Yale Univ, Sch Med, Connecticut Mental Hlth Ctr, Dept Psychiat, New Haven, CT 06508 USA; Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Tufts University	Self, DW (corresponding author), Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA.	david.self@utsouthwestern.edu	Bachtell, Ryan/H-7436-2013; Graham, Danielle L/K-8459-2014	Bachtell, Ryan/0000-0001-5268-5927; DiLeone, Ralph/0000-0002-4770-2590	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA016857, R01DA010460, R29DA010460, R01DA018743, P01DA008227] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 18743, DA 10460, DA 08227, DA 016857] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Altar C A, 1998, Adv Pharmacol, V42, P915; ALTAR CA, 1992, P NATL ACAD SCI USA, V89, P11347, DOI 10.1073/pnas.89.23.11347; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; CASTREN E, 1995, NEUROSCIENCE, V64, P71, DOI 10.1016/0306-4522(94)00386-J; Choi KH, 2006, NEUROSCIENCE, V137, P373, DOI 10.1016/j.neuroscience.2005.10.049; Colby CR, 2003, J NEUROSCI, V23, P2488; Conner JM, 1997, J NEUROSCI, V17, P2295; DSM-IV-TR, 2000, DIAGN STAT MAN MENT, V4th; Elmer E, 1998, NEUROSCIENCE, V83, P351, DOI 10.1016/S0306-4522(97)00387-4; Filip M, 2006, BRAIN RES, V1071, P218, DOI 10.1016/j.brainres.2005.11.099; GALL CM, 1992, TRENDS PHARMACOL SCI, V13, P401, DOI 10.1016/0165-6147(92)90123-N; Grimm JW, 2003, J NEUROSCI, V23, P742; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Horger BA, 1999, J NEUROSCI, V19, P4110; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; JAFFE JH, 1989, PSYCHOPHARMACOLOGY, V97, P59, DOI 10.1007/BF00443414; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kuppers E, 2001, NEUROREPORT, V12, P1175; Le Foll B, 2005, NEUROREPORT, V16, P175, DOI 10.1097/00001756-200502080-00022; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; MARTINIVERSON MT, 1994, J NEUROSCI, V14, P1262, DOI 10.1523/JNEUROSCI.14-03-01262.1994; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Mufson EJ, 1996, NEUROSCIENCE, V71, P179, DOI 10.1016/0306-4522(95)00431-9; MUFSON EJ, 1994, EXP NEUROL, V129, P15, DOI 10.1006/exnr.1994.1143; NAKAO N, 1995, EXP NEUROL, V131, P1, DOI 10.1016/0014-4886(95)90002-0; Narita M, 2003, NEUROSCIENCE, V119, P767, DOI 10.1016/S0306-4522(03)00099-X; Pandey SC, 2004, J NEUROSCI, V24, P5022, DOI 10.1523/JNEUROSCI.5557-03.2004; Piazza PV, 2000, J NEUROSCI, V20, P4226; Pu L, 2006, NAT NEUROSCI, V9, P605, DOI 10.1038/nn1687; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249	47	302	309	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1029	1037		10.1038/nn1929	http://dx.doi.org/10.1038/nn1929			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618281				2022-12-24	WOS:000248357500017
J	Mitchell, JF; Sundberg, KA; Reynolds, JH				Mitchell, Jude F.; Sundberg, Kristy A.; Reynolds, John H.			Differential attention-dependent response modulation across cell classes in macaque visual area V4	NEURON			English	Article							FAST-SPIKING INTERNEURONS; DORSOLATERAL PREFRONTAL CORTEX; RAT FRONTAL-CORTEX; PYRAMIDAL CELLS; INHIBITORY NEURONS; CORTICAL-NEURONS; MORPHOLOGICAL-CHARACTERISTICS; SYNAPTIC CONNECTIONS; NEOCORTICAL NEURONS; SELECTIVE ATTENTION	The cortex contains multiple cell types, but studies of attention have not distinguished between them, limiting understanding of the local circuits that transform attentional feedback into improved visual processing. Parvalbumin-expressing inhibitory interneurons can be distinguished from pyramidal neurons based on their briefer action potential durations. We recorded neurons in area V4 as monkeys performed an attention-demanding task. We find that the distribution of action potential durations is strongly bimodal. Neurons with narrow action potentials have higher firing rates and larger attention-dependent increases in absolute firing rate than neurons with broad action potentials. The percentage increase in response is similar across the two classes. We also find evidence that attention increases the reliability of the neuronal response. This modulation is more than twofold stronger among putative interneurons. These findings lead to the surprising conclusion that the strongest attentional modulation occurs among local interneurons that do not transmit signals between areas.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Mitchell, JF (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA.	jude@salk.edu; reynolds@salk.edu		Mitchell, Jude/0000-0003-0197-7545	NATIONAL EYE INSTITUTE [R01EY016161] Funding Source: NIH RePORTER; NEI NIH HHS [EY016161] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Berry MJ, 1998, J NEUROSCI, V18, P2200; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Bruno RM, 2002, J NEUROSCI, V22, P10966; BUZSAKI G, 1982, J NEUROPHYSIOL, V48, P597, DOI 10.1152/jn.1982.48.3.597; Cauli B, 1997, J NEUROSCI, V17, P3894; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Contreras D, 2003, J NEUROSCI, V23, P6936; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; FOEHRING RC, 1991, J NEUROPHYSIOL, V66, P1825, DOI 10.1152/jn.1991.66.6.1825; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Gonzalez-Burgos G, 2004, CEREB CORTEX, V14, P530, DOI 10.1093/cercor/bhh015; Gur M, 1997, J NEUROSCI, V17, P2914; Gur M, 1999, J NEUROPHYSIOL, V82, P1451, DOI 10.1152/jn.1999.82.3.1451; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Krimer LS, 2005, J NEUROPHYSIOL, V94, P3009, DOI 10.1152/jn.00156.2005; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 1998, J NEUROSCI, V18, P8111; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Povysheva NV, 2006, CEREB CORTEX, V16, P541, DOI 10.1093/cercor/bhj002; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Spinks RL, 2003, J NEUROPHYSIOL, V90, P1324, DOI 10.1152/jn.00169.2003; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tamura H, 2004, J NEUROPHYSIOL, V91, P2782, DOI 10.1152/jn.01267.2003; Tasker JG, 1996, J NEUROPHYSIOL, V75, P931, DOI 10.1152/jn.1996.75.2.931; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	64	451	457	1	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					131	141		10.1016/j.neuron.2007.06.018	http://dx.doi.org/10.1016/j.neuron.2007.06.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610822	Bronze, Green Submitted			2022-12-24	WOS:000248010700013
J	Luo, WQ; Wickramasinghe, SR; Savitt, JM; Griffin, JW; Dawson, TM; Ginty, DD				Luo, Wenqin; Rasika Wickramasinghe, S.; Savitt, Joseph M.; Griffin, John W.; Dawson, Ted M.; Ginty, David D.			A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; ROOT GANGLION NEURONS; NEUROTROPHIC FACTOR; SENSORY NEURONS; TYROSINE KINASE; SYMPATHETIC NEURONS; FUNCTIONAL RECEPTOR; NEURTURIN RECEPTOR; IN-VIVO; GDNF	NGF controls survival, differentiation, and target innervation of both peptidergic and nonpeptidergic DRG sensory neurons. The common receptor for GDNF family ligands, Ret, is highly expressed in nonpeptidergic neurons, but its function during development of these neurons is unclear. Here, we show that expression of Ret and its coreceptors GFR alpha 1 and GFR alpha 2 is dependent on NGF. GFR/Ret signaling, in turn, autoregulates expression of both GFR alpha 1 and GFR alpha 2 and promotes expression of TrpA1, MrgA1, MrgA3, and MrgB4, acquisition of normal neuronal size, axonal innervation of the epidermis, and postnatal extinction of the NGF receptor TrkA. Moreover, NGF controls expression of several other genes characteristic of nonpeptidergic neurons, such as TrpC3, TrpM8, MrgD, and the transcription factor Runx1, via a Ret-independent signaling pathway. These findings support a model in which NGF controls maturation of nonpeptidergic DRG neurons through a combination of GFR/Ret-dependent and -independent signaling pathways.	Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, R29NS034814, P50NS038377, R37NS034814, K08NS052624] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM07309] Funding Source: Medline; NINDS NIH HHS [K08NS052624, NS34814, NS38377] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler JE, 1998, J NEUROCHEM, V71, P170; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Enokido Y, 1998, CURR BIOL, V8, P1019, DOI 10.1016/S0960-9822(07)00422-8; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Forgie A, 1999, MOL CELL NEUROSCI, V13, P430, DOI 10.1006/mcne.1999.0760; Fundin BT, 1999, DEVELOPMENT, V126, P2597; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindfors PH, 2006, J NEUROSCI, V26, P1953, DOI 10.1523/JNEUROSCI.4065-05.2006; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Matheson CR, 1997, J NEUROBIOL, V32, P22, DOI 10.1002/(SICI)1097-4695(199701)32:1<22::AID-NEU3>3.3.CO;2-B; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; MOLLIVER DC, 1995, J COMP NEUROL, V361, P404, DOI 10.1002/cne.903610305; Molliver DC, 1997, J COMP NEUROL, V381, P428, DOI 10.1002/(SICI)1096-9861(19970519)381:4<428::AID-CNE3>3.0.CO;2-4; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Priestley JV, 2002, CAN J PHYSIOL PHARM, V80, P495, DOI 10.1139/y02-034; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; SCHUCHARDT A, 1994, RET NATURE, V367, P380; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; White FA, 1996, J NEUROSCI, V16, P4662; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	46	185	190	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 7	2007	54	5					739	754		10.1016/j.neuron.2007.04.027	http://dx.doi.org/10.1016/j.neuron.2007.04.027			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553423	Bronze			2022-12-24	WOS:000247329900008
J	Yokota, Y; Ring, C; Cheung, R; Pevny, L; Anton, ES				Yokota, Yukako; Ring, Colleen; Cheung, Rocky; Pevny, Larysa; Anton, E. S.			Nap1-regulated neuronal cytoskeletal dynamics is essential for the final differentiation of neurons in cerebral cortex	NEURON			English	Article							DOUBLECORTIN-LIKE-KINASE; HUMAN NAP1 NCKAP1; CELL-MIGRATION; ARP2/3 COMPLEX; ACTIN REORGANIZATION; CORTICAL DEVELOPMENT; SIGNALING COMPLEX; MOLECULAR-CLONING; GENETIC-BASIS; GROWTH CONES	The cytoskeletal regulators that mediate the change in the neuronal cytoskeletal machinery from one that promotes oriented motility to one that facilitates differentiation at the appropriate locations in the developing neocortex remain unknown. We found that Nck-associated protein 1 (Nap1), an adaptor protein thought to modulate actin nucleation, is selectively expressed in the developing cortical plate, where neurons terminate their migration and initiate laminar-specific differentiation. Loss of Nap1 function disrupts neuronal differentiation. Premature expression of Nap1 in migrating neurons retards migration and promotes postmigratory differentiation. Nap1 gene mutation in mice leads to neural tube and neuronal differentiation defects. Disruption of Nap1 retards the ability to localize key actin cytoskeletal regulators such as WAVE1 to the protrusive edges where they are needed to elaborate process outgrowth. Thus, Nap1 plays an essential role in facilitating neuronal cytoskeletal changes underlying the postmigratory differentiation of cortical neurons, a critical step in functional wiring of the cortex.	Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Anton, ES (corresponding author), Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	anton@med.unc.edu		Cheung, Rocky/0000-0001-6736-9687	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060929] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH060929, MH060929] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; BAUMGARTNER S, 1995, J MOL BIOL, V251, P41, DOI 10.1006/jmbi.1995.0414; BAYER SA, 1991, NEOCORTICAL DEV, P73; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Blagg SL, 2004, NAT CELL BIOL, V6, P279, DOI 10.1038/ncb0404-279; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a; Dahl JP, 2003, J NEUROSCI, V23, P3343; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Echarri A, 2004, MOL CELL BIOL, V24, P4979, DOI 10.1128/MCB.24.11.4979-4993.2004; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Hahne P, 2001, FEBS LETT, V492, P215, DOI 10.1016/S0014-5793(01)02239-6; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Hummel T, 2000, GENE DEV, V14, P863; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Insall RH, 2006, NAT CELL BIOL, V8, P776, DOI 10.1038/ncb0806-776; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kitamura T, 1996, BIOCHEM BIOPH RES CO, V219, P509, DOI 10.1006/bbrc.1996.0264; Kitamura Y, 1997, BIOCHEM J, V322, P873, DOI 10.1042/bj3220873; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; MILLER M, 1981, J NEUROCYTOL, V10, P859, DOI 10.1007/BF01262658; MILLIKEN J, 1904, U CALIFORNIA PUBLICA, V2, P1; Mochida GH, 2004, ARCH NEUROL-CHICAGO, V61, P637, DOI 10.1001/archneur.61.5.637; Nakagawa H, 2001, J CELL SCI, V114, P1555; Rakeman AS, 2006, DEVELOPMENT, V133, P3075, DOI 10.1242/dev.02473; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schmid RS, 2005, CEREB CORTEX, V15, P1632, DOI 10.1093/cercor/bhi041; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Sossey-Alaoui K, 2003, MAMM GENOME, V14, P314, DOI 10.1007/s00335-002-2247-7; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Suzuki T, 2000, GENOMICS, V63, P246, DOI 10.1006/geno.1999.6053; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Yamamoto A, 2001, GENE, V271, P159, DOI 10.1016/S0378-1119(01)00521-2	72	62	62	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 3	2007	54	3					429	445		10.1016/j.neuron.2007.04.016	http://dx.doi.org/10.1016/j.neuron.2007.04.016			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481396	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000246855700013
J	Howard, RJ; Clark, KA; Holton, JM; Minor, DL				Howard, Rebecca J.; Clark, Kimberly A.; Holton, James M.; Minor, Daniel L., Jr.			Structural Insight into KCNQ (Kv7) Channel Assembly and Channelopathy	NEURON			English	Article							LONG-QT SYNDROME; POTASSIUM CHANNEL; K+ CHANNEL; GENOMIC ORGANIZATION; SURFACE EXPRESSION; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; COILED COILS; MUTATIONS; SUBUNIT	Kv7.x (KCNQ) voltage-gated potassium channels form the cardiac and auditory l(Ks) current and the neuronal M-current. The five Kv7 subtypes have distinct assembly preferences encoded by a C-terminal cytoplasmic assembly domain, the A-domain Tail. Here, we present the high-resolution structure of the Kv7.4 Adomain Tail together with biochemical experiments that show that the domain is a selfassembling, parallel, four-stranded coiled coil. Structural analysis and biochemical studies indicate conservation of the coiled coil in all Kv7 subtypes and that a limited set of interactions encode assembly specificity determinants. Kv7 mutations have prominent roles in arrhythmias, deafness, and epilepsy. The structure together with biochemical data indicate that A-domain Tail arrhythmia mutations cluster on the solvent-accessible surface of the subunit interface at a likely site of action for modulatory proteins. Together, the data provide a framework for understanding Kv7 assembly specificity and the molecular basis of a distinct set of Kv7 channelopathies.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Minor, DL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	daniel.minor@ucsf.edu		Howard, Rebecca/0000-0003-2049-3378	NIDCD NIH HHS [R01 DC007664-03, R01 DC007664] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007664] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen S, 2003, CLIN GENET, V63, P273, DOI 10.1034/j.1399-0004.2003.00048.x; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Friedrich T, 2002, BIOPHYS J, V82, p577A; Grunnet M, 2005, HEART RHYTHM, V2, P1238, DOI 10.1016/j.hrthm.2005.07.025; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HARBURY PB, 1995, P NATL ACAD SCI USA, V92, P8408, DOI 10.1073/pnas.92.18.8408; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Huang LQ, 2001, CARDIOVASC RES, V51, P670, DOI 10.1016/S0008-6363(01)00350-9; Itoh T, 1998, HUM GENET, V103, P290, DOI 10.1007/s004390050819; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kass RS, 2003, TRENDS CARDIOVAS MED, V13, P52, DOI 10.1016/S1050-1738(02)00211-6; Kissinger CR, 2001, ACTA CRYSTALLOGR D, V57, P1474, DOI 10.1107/S0907444901012458; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Liu J, 2006, J MOL BIOL, V361, P168, DOI 10.1016/j.jmb.2006.05.063; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Neyroud N, 1999, CIRC RES, V84, P290, DOI 10.1161/01.RES.84.3.290; Novotny T, 2006, Vnitr Lek, V52, P116; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Piippo K, 2001, J AM COLL CARDIOL, V37, P562, DOI 10.1016/S0735-1097(00)01124-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yamashita F, 2001, J MOL CELL CARDIOL, V33, P197, DOI 10.1006/jmcc.2000.1300; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100	69	132	138	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					663	675		10.1016/j.neuron.2007.02.010	http://dx.doi.org/10.1016/j.neuron.2007.02.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329207	Green Accepted, Bronze			2022-12-24	WOS:000245127100008
J	Hommel, JD; Trinko, R; Sears, RM; Georgescu, D; Liu, ZW; Gao, XB; Thurmon, JJ; Marinelli, M; DiLeone, RJ				Hommel, Jonathan D.; Trinko, Richard; Sears, Robert M.; Georgescu, Dan; Liu, Zong-Wu; Gao, Xiao-Bing; Thurmon, Jeremy J.; Marinelli, Michela; DiLeone, Ralph J.			Leptin receptor signaling in midbrain dopamine neurons regulates feeding	NEURON			English	Article							VENTRAL TEGMENTAL AREA; MESSENGER-RNA EXPRESSION; NUCLEUS-ACCUMBENS; FOOD-INTAKE; ARCUATE NUCLEUS; BODY-WEIGHT; SYNAPTIC PLASTICITY; PLACE PREFERENCE; BRAIN-STEM; OBESE GENE	The leptin hormone is critical for normal food intake and metabolism. While leptin receptor (Lept) function has been well studied in the hypothalamus, the functional relevance of Lepr expression in the ventral tegmental area (VTA) has not been investigated. The VTA contains dopamine neurons that are important in modulating motivated behavior, addiction, and reward. Here, we show that VTA dopamine neurons express Lepr mRNA and respond to leptin with activation of an intracellular JAK-STAT pathway and a reduction in firing rate. Direct administration of leptin to the VTA caused decreased food intake while long-term RNAi-mediated knockdown of Lepr in the VTA led to increased food intake, locomotor activity, and sensitivity to highly palatable food. These data support a critical role for VTA Lepr in regulating feeding behavior and provide functional evidence for direct action of a peripheral metabolic signal on VTA dopamine neurons.	Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06519 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Yunyang Med Coll, Dept Neurobiol, Shiyan 442000, Hubei, Peoples R China; Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06520 USA; Rosalind Franklin Univ Med & Sci, Dept Cellular & Mol Pharmacol, N Chicago, IL 60064 USA	Yale University; Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Rosalind Franklin University Medical & Science	DiLeone, RJ (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 333 Cedar St, New Haven, CT 06519 USA.	ralph.dileone@yale.edu	Marinelli, Michela/P-7645-2018; Chee, Melissa/G-4150-2014; Gao, Xiao-Bing/C-3121-2011; Liu, Zhong-Wu/C-2794-2011; Jansen, Heiko T./A-5770-2008	Marinelli, Michela/0000-0002-1903-1937; Chee, Melissa/0000-0003-3815-9095; Gao, Xiao-Bing/0000-0002-2035-4936; Jansen, Heiko T./0000-0003-0178-396X; DiLeone, Ralph/0000-0002-4770-2590; Hommel, Jonathan/0000-0001-8305-3746; , robert/0000-0001-5688-1853	NIDDK NIH HHS [DK071205] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK071205] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BADIANI A, 1995, BRAIN RES, V690, P112, DOI 10.1016/0006-8993(95)00607-R; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks WA, 2000, AM J PHYSIOL-ENDOC M, V278, pE1158, DOI 10.1152/ajpendo.2000.278.6.E1158; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berhow MT, 1996, J NEUROSCI, V16, P8019; Blendy JA, 2005, PSYCHOPHARMACOLOGY, V180, P306, DOI 10.1007/s00213-005-2167-9; Bolanos CA, 2003, BIOL PSYCHIAT, V54, P1317, DOI 10.1016/S0006-3223(03)00570-5; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Echo JA, 2002, PHYSIOL BEHAV, V76, P107, DOI 10.1016/S0031-9384(02)00690-X; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Figlewicz DP, 2003, AM J PHYSIOL-REG I, V284, pR882, DOI 10.1152/ajpregu.00602.2002; Figlewicz DP, 2001, PHYSIOL BEHAV, V73, P229, DOI 10.1016/S0031-9384(01)00486-3; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HENRY DJ, 1989, J PHARMACOL EXP THER, V251, P833; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077; Huang XF, 1996, NEUROREPORT, V7, P2635, DOI 10.1097/00001756-199611040-00045; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Krugel U, 2003, EUR J PHARMACOL, V482, P185, DOI 10.1016/j.ejphar.2003.09.047; Levin BE, 2000, BRAIN RES, V874, P158, DOI 10.1016/S0006-8993(00)02573-7; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Marinelli M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P79, DOI 10.2174/187152706784111542; Marinelli M, 2000, J NEUROSCI, V20, P8876; MOGENSON GJ, 1991, ADV EXP MED BIOL, V295, P267; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; MUCHA RF, 1986, BRAIN RES, V397, P214, DOI 10.1016/0006-8993(86)90622-0; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; NOEL MB, 1995, BRAIN RES, V673, P304, DOI 10.1016/0006-8993(94)01442-K; NOEL MB, 1995, SYNAPSE, V21, P110, DOI 10.1002/syn.890210204; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Satoh N, 1997, NEUROSCI LETT, V224, P149, DOI 10.1016/S0304-3940(97)00163-8; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Shalev U, 2001, J NEUROSCI, V21; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	61	670	682	0	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					801	810		10.1016/j.neuron.2006.08.023	http://dx.doi.org/10.1016/j.neuron.2006.08.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982424	Bronze			2022-12-24	WOS:000240997900017
J	Schrick, C; Fischer, A; Srivastava, DP; Tronson, NC; Penzes, P; Radulovic, J				Schrick, Christina; Fischer, Andre; Srivastava, Deepak P.; Tronson, Natalie C.; Penzes, Peter; Radulovic, Jelena			N-cadherin regulates cytoskeletally associated lQGAP1/ERK signaling and memory formation	NEURON			English	Article							CELL-CELL ADHESION; LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOGENESIS; SYNAPTIC PLASTICITY; BETA-CATENIN; FACTOR RECEPTOR; NERVOUS-SYSTEM; FEAR MEMORY; MAP KINASE; ACTIVATION	Cadherin-mediated interactions are integral to synapse formation and potentiation. Here we show that N-cadherin is required for memory formation and regulation of a subset of underlying biochemical processes. N-cadherin antagonistic peptide containing the His-Ala-Val motif (HAV-N) transiently disrupted hippocampal N-cadherin dimerization and impaired the formation of long-term contextual fear memory while sparing short-term memory, retrieval, and extinction. HAV-N impaired the learning-induced phosphorylation of a distinctive, cytoskeletally associated fraction of hippocampal Erk-1/2 and altered the distribution of IQGAP1, a scaffold protein linking cadherin-mediated cell adhesion to the cytoskeleton. This effect was accompanied by reduction of N-cadherin/ IQGAP1/Erk-2 interactions. Similarly, in primary neuronal cultures, HAV-N prevented NMDA-induced dendritic Erk-1/2 phosphorylation and caused relocation of IQGAP1 from dendritic spines into the shafts. The data suggest that the newly identified role of hippocampal N-cadherin in memory consolidation may be mediated, at least in part, by cytoskeletal IQGAP1/Erk signaling.	Northwestern Univ, Feinberg Sch & Med, Asher Ctr Depress Disorders, Dept Psychiat & Biobehav Sci, Chicago, IL 60611 USA; European Neurosci Inst, Neuropathol Grp, D-37077 Gottingen, Germany; Northwestern Univ, Feinberg Sch & Med, Dept Pathol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Radulovic, J (corresponding author), Northwestern Univ, Feinberg Sch & Med, Asher Ctr Depress Disorders, Dept Psychiat & Biobehav Sci, Chicago, IL 60611 USA.	j-radulovic@northwestern.edu	Fischer, Andre/AAU-7487-2021; Penzes, Peter/L-3987-2016	Penzes, Peter/0000-0001-5449-1640; Srivastava, Deepak Prakash/0000-0001-6512-9065; Radulovic, Jelena/0000-0002-0268-2426; Fischer, Andre/0000-0001-8546-1161; Tronson, Natalie/0000-0001-5676-1579	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073669] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH073669-02, R01 MH073669] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Angst BD, 2001, J CELL SCI, V114, P629; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Benes FM, 2004, MOL PSYCHIATR, V9, P932, DOI 10.1038/sj.mp.4001524; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Edsbagge J, 2004, MOL CELL NEUROSCI, V25, P524, DOI 10.1016/j.mcn.2003.12.005; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fischer A, 2002, J NEUROSCI, V22, P3700; Fischer A, 2007, NEUROBIOL LEARN MEM, V87, P149, DOI 10.1016/j.nlm.2006.08.003; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Hagler DJ, 1998, NEURON, V20, P1059, DOI 10.1016/S0896-6273(00)80486-9; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harrison OJ, 2005, J CELL SCI, V118, P4123, DOI 10.1242/jcs.02539; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kaech S, 1997, J NEUROSCI, V17, P9565; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kim YJ, 2005, CELL COMMUN ADHES, V12, P23, DOI 10.1080/15419060500305971; Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin CH, 2003, J NEUROSCI, V23, P1574; Makagiansar IT, 2002, J BIOL CHEM, V277, P16002, DOI 10.1074/jbc.M200916200; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Nakao K, 2004, P NATL ACAD SCI USA, V101, P14270, DOI 10.1073/pnas.0405709101; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Radulovic J, 1998, J NEUROSCI, V18, P7452; Radulovic J, 1999, J NEUROSCI, V19, P5016; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Renaud-Young M, 2002, J BIOL CHEM, V277, P39609, DOI 10.1074/jbc.M201256200; Retta SF, 2006, EUR J CELL BIOL, V85, P283, DOI 10.1016/j.ejcb.2005.09.007; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sananbenesi F, 2003, J NEUROSCI, V23, P11436; Sekino Y, 1997, J NEUROPHYSIOL, V78, P1662, DOI 10.1152/jn.1997.78.3.1662; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Williams E, 2000, J BIOL CHEM, V275, P4007, DOI 10.1074/jbc.275.6.4007; Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200; Wilson MT, 1998, J NEUROSCI RES, V52, P599, DOI 10.1002/(SICI)1097-4547(19980601)52:5<599::AID-JNR12>3.3.CO;2-X; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zaidel DW, 1999, ANAT REC, V254, P87, DOI 10.1002/(SICI)1097-0185(19990101)254:1<87::AID-AR11>3.0.CO;2-T	68	76	78	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 6	2007	55	5					786	798		10.1016/j.neuron.2007.07.034	http://dx.doi.org/10.1016/j.neuron.2007.07.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785185	Green Accepted, Bronze			2022-12-24	WOS:000249857000014
J	de Quervain, DJF; Kolassa, IT; Ertl, V; Onyut, PL; Neuner, F; Elbert, T; Papassotiropoulos, A				de Quervain, Dominique J-F; Kolassa, Iris-Tatjana; Ertl, Verena; Onyut, P. Lamaro; Neuner, Frank; Elbert, Thomas; Papassotiropoulos, Andreas			A deletion variant of the alpha 2b-adrenoceptor is related to emotional memory in Europeans and Africans	NATURE NEUROSCIENCE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; DECLARATIVE MEMORY	Emotionally arousing events are recalled better than neutral events. This phenomenon, which helps us to remember important and potentially vital information, depends on the activation of noradrenergic transmission in the brain. Here we show that a deletion variant of ADRA2B, the gene encoding the alpha 2b-adrenergic receptor, is related to enhanced emotional memory in healthy Swiss subjects and in survivors of the Rwandan civil war who experienced highly aversive emotional situations.	Univ Zurich, Div Psychiat Res, CH-8032 Zurich, Switzerland; Univ Konstanz, Dept Psychol, D-78457 Constance, Germany; Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; Mbarara Univ Sci & Technol, Fac Sci & Educ, Mbarara, Uganda; Univ Basel, Div Mol Psychol, CH-4055 Basel, Switzerland; Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland	University of Zurich; University of Konstanz; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Mbarara University of Science & Technology; University of Basel; University of Basel	de Quervain, DJF (corresponding author), Univ Zurich, Div Psychiat Res, Lenggstr 31, CH-8032 Zurich, Switzerland.	quervain@bli.unizh.ch; andreas.papas@unibas.ch	Kolassa, Iris Tatjana/Y-3032-2018; Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939; Papassotiropoulos, Andreas/0000-0002-2210-9651; Neuner, Frank/0000-0001-5427-3432; de Quervain, Dominique/0000-0001-7131-2464				Brickenkamp R., 1998, D2 TEST ATTENTION, V1st; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; LANG PJ, 1999, A4 CTR RES PSYCH U F; Maheu FS, 2004, BEHAV NEUROSCI, V118, P420, DOI 10.1037/0735-7044.118.2.420; McGaugh J. L., 2003, MEMORY EMOTION MAKIN; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x	14	145	145	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1137	1139		10.1038/nn1945	http://dx.doi.org/10.1038/nn1945			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660814	Green Submitted			2022-12-24	WOS:000249144000015
J	Hodge, LK; Klassen, MP; Han, BX; Yiu, G; Hurrell, J; Howell, A; Rousseau, G; Lemaigre, F; Tessier-Lavigne, M; Wang, F				Hodge, Liberty K.; Klassen, Matthew P.; Han, Bao-Xia; Yiu, Glenn; Hurrell, Joanna; Howell, Audrey; Rousseau, Guy; Lemaigre, Frederic; Tessier-Lavigne, Marc; Wang, Fan			Retrograde BMP signaling regulates trigeminal sensory neuron identities and the formation of precise face maps	NEURON			English	Article							GENE-RELATED PEPTIDE; CONDITIONAL KNOCKOUT MICE; EMBRYONIC CHICK HINDLIMBS; ROOT GANGLION NEURONS; TRANSCRIPTION FACTORS; MOUSE EMBRYO; IN-VIVO; INNERVATION PATTERNS; NERVOUS-SYSTEM; OUTFLOW-TRACT	Somatosensory information from the face is transmitted to the brain by trigeminal sensory neurons. It was previously unknown whether neurons innervating distinct areas of the face possess molecular differences. We have identified a set of genes differentially expressed along the dorsoventral axis of the embryonic mouse trigeminal ganglion and thus can be considered trigeminal positional identity markers. Interestingly, establishing some of the spatial patterns requires signals from the developing face. We identified bone morphogenetic protein 4 (BMP4) as one of these target-derived factors and showed that spatially defined retrograde BMP signaling controls the differential gene expressions in trigeminal neurons through both Smad4-independent and Smad4-dependent pathways. Mice lacking one of the BMP4-regulated transcription factors, Onecut2 (OC2), have defects in the trigeminal central projections representing the whiskers. Our results provide molecular evidence for both spatial patterning and retrograde regulation of gene expression in sensory neurons during the development of the somatosensory map.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dev Biol Training Program, Durham, NC 27710 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Harvard Univ, Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Univ Catholique Louvain, Inst Cellular Pathol, B-1200 Brussels, Belgium; Genentech Inc, San Francisco, CA 94080 USA	Duke University; Duke University; Stanford University; Harvard University; Boston Children's Hospital; Universite Catholique Louvain; Roche Holding; Genentech	Wang, F (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	f.wang@cellbio.duke.edu	Yiu, Glenn/AAF-2858-2020	Yiu, Glenn/0000-0003-3061-3310	NIDCR NIH HHS [R01 5R01DE16550] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016550] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Adamska M, 2001, DEV GENES EVOL, V211, P338, DOI 10.1007/s004270100162; Ai XB, 1999, MOL CELL NEUROSCI, V14, P506, DOI 10.1006/mcne.1999.0798; Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; AYERLELIEVRE CS, 1982, DEV BIOL, V94, P291, DOI 10.1016/0012-1606(82)90349-9; Baker CVH, 2002, DEV BIOL, V249, P219, DOI 10.1006/dbio.2002.0767; Baker CVH, 1999, DEVELOPMENT, V126, P147; BEAUDREA.DE, 1968, ARCH ORAL BIOL, V13, P247, DOI 10.1016/0003-9969(68)90124-6; Begbie J, 2002, MOL CELL NEUROSCI, V21, P502, DOI 10.1006/mcne.2002.1197; Biondi CA, 2007, BIOCHEM J, V404, P235, DOI 10.1042/BJ20061830; Borsook D, 2003, J NEUROSCI, V23, P7897; CAMPENOT RB, 1982, DEV BIOL, V93, P13, DOI 10.1016/0012-1606(82)90233-0; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Clotman F, 2002, DEVELOPMENT, V129, P1819; Collantes Eduardo, 2002, BMC Fam Pract, V3, P10, DOI 10.1186/1471-2296-3-10; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; ERZURUMLU RS, 1992, J NEUROSCI, V12, P3946; FRANK E, 1993, NEURON, V10, P779, DOI 10.1016/0896-6273(93)90194-V; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Guha U, 2004, DEVELOPMENT, V131, P1175, DOI 10.1242/dev.01013; Hall AK, 2001, DEV BIOL, V229, P263, DOI 10.1006/dbio.2000.9966; Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Jacquemin P, 2003, GENE EXPR PATTERNS, V3, P639, DOI 10.1016/S1567-133X(03)00110-8; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Ritter AM, 1999, J NEUROBIOL, V41, P471, DOI 10.1002/(SICI)1097-4695(199912)41:4<471::AID-NEU3>3.0.CO;2-3; Scott L, 1999, J ANAT, V195, P137, DOI 10.1046/j.1469-7580.1999.19510137.x; Stottmann RW, 2004, DEVELOPMENT, V131, P2205, DOI 10.1242/dev.01086; Waite Phil M. E., 1995, P705; Wang G, 1999, DEV BIOL, V208, P324, DOI 10.1006/dbio.1999.9212; Wang GY, 1997, DEV BIOL, V186, P27, DOI 10.1016/S0012-1606(97)98583-3; Wenner P, 1995, J NEUROSCI, V15, P8191; Wu P, 2004, SCIENCE, V305, P1465, DOI 10.1126/science.1098109; Xu P, 2005, J NEUROSCI, V25, P9227, DOI 10.1523/JNEUROSCI.3051-05.2005; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007	66	85	86	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2007	55	4					572	586		10.1016/j.neuron.2007.07.010	http://dx.doi.org/10.1016/j.neuron.2007.07.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698011	Bronze			2022-12-24	WOS:000249159200007
J	Lee, SH; Blake, R; Heeger, DJ				Lee, Sang-Hun; Blake, Randolph; Heeger, David J.			Hierarchy of cortical responses underlying binocular rivalry	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; NEURONAL-ACTIVITY; TRAVELING-WAVES; PERCEPTION; INTEGRATION; HUMANS; BRAIN; CONSCIOUSNESS; CONNECTIONS	During binocular rivalry, physical stimulation is dissociated from conscious visual awareness. Human brain imaging reveals a tight linkage between the neural events in human primary visual cortex (V1) and the dynamics of perceptual waves during transitions in dominance during binocular rivalry. Here, we report results from experiments in which observers' attention was diverted from the rival stimuli, implying that: competition between two rival stimuli involves neural circuits in V1, and attention is crucial for the consequences of this neural competition to advance to higher visual areas and promote perceptual waves.	Seoul Natl Univ, Dept Psychol, Seoul 151746, South Korea; Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; NYU, Ctr Neural Sci, Dept Psychol, New York, NY 10003 USA	Seoul National University (SNU); Vanderbilt University; New York University	Lee, SH (corresponding author), Seoul Natl Univ, Dept Psychol, Seoul 151746, South Korea.	visionsl@snu.ac.kr	Lee, Sang-Hun/B-9898-2008		NEI NIH HHS [R01-EY16752, R01-EY13356, R01 EY016752-02, R01-EY12741, R03-EY14437, R01 EY012741-12, R03 EY014437, R01 EY016752] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016752, R01EY012741, R03EY014437] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angelucci A, 2002, J NEUROSCI, V22, P8633; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; EFRON B, 1985, BIOMETRIKA, V72, P45, DOI 10.1093/biomet/72.1.45; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Haynes JD, 2005, P NATL ACAD SCI USA, V102, P14925, DOI 10.1073/pnas.0501684102; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee SH, 2002, J VISION, V2, P618, DOI 10.1167/2.9.4; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Nguyen VA, 2001, PERCEPT PSYCHOPHYS, V63, P348, DOI 10.3758/BF03194475; Nishida S, 2003, J NEUROPHYSIOL, V90, P3242, DOI 10.1152/jn.00693.2003; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tse PU, 2005, P NATL ACAD SCI USA, V102, P17178, DOI 10.1073/pnas.0508010102; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554	46	111	111	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1048	1054		10.1038/nn1939	http://dx.doi.org/10.1038/nn1939			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17632508	Green Accepted			2022-12-24	WOS:000248357500019
J	Takemoto-Kimura, S; Ageta-Ishihara, N; Nonaka, M; Adachi-Morishima, A; Mano, T; Okamura, M; Fujii, H; Fuse, T; Hoshino, M; Suzuki, S; Kojima, M; Mishina, M; Okuno, H; Bito, H				Takemoto-Kimura, Sayaka; Ageta-Ishihara, Natsumi; Nonaka, Mio; Adachi-Morishima, Aki; Mano, Tatsuo; Okamura, Michiko; Fujii, Hajime; Fuse, Toshimitsu; Hoshino, Mikio; Suzuki, Shingo; Kojima, Masami; Mishina, Masayoshi; Okuno, Hiroyuki; Bito, Haruhiko			Regulation of dendritogenesis via a lipid-raft-associated Ca2+/calmodulin-dependent protein kinase CLICK-III/CaMKl gamma	NEURON			English	Article							DENDRITIC MORPHOGENESIS; MOUSE MODEL; IN-VIVO; GROWTH; RECEPTOR; PALMITOYLATION; CAMKII; SPINES; CREB; TRAFFICKING	Ca2+ signaling plays a central role in activity-dependent regulation of dendritic arborization, but key molecular mechanisms downstream of calcium elevation remain poorly understood. Here we show that the C-terminal region of the Ca2+/calmodulin-dependent protein kinase CLICK-III (CL3)/CaMKl gamma, a membrane-anchored CaMK, was uniquely modified by two sequential lipidification steps: prenylation followed by a kinase-activity-regulated palmitoylation. These modifications were essential for CL3 membrane anchoring and targeting into detergent-resistant lipid microdomains (or rafts) in the dendrites. We found that CL3 critically contributed to BDNF-stimulated dendritic growth. Raft insertion of CL3 specifically promoted dendritogenesis of cortical neurons by acting upstream of RacGEF STEF and Rac, both present in lipid rafts. Thus, CL3 may represent a key element in the Ca2+-dependent and lipid-raft-delineated switch that turns on extrinsic activity-regulated dendrite formation in developing cortical neurons.	Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Ctr Integrated Brain Med Sci, Bunkyo Ku, Tokyo 1130033, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; AIST, Res Inst Cell Engn, Ikeda, Osaka 5638577, Japan; JST, SORST, Kawaguchi 3320012, Japan; Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Tokyo	Bito, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan.	hbito@m.u-tokyo.ac.jp	Bito, Haruhiko/A-8635-2008	Bito, Haruhiko/0000-0001-6315-9594; OKUNO, HIROYUKI/0000-0001-6237-6503				Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; DeSouza S, 2002, J NEUROSCI, V22, P3493; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fan QW, 2002, J NEUROCHEM, V80, P178, DOI 10.1046/j.0022-3042.2001.00686.x; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Furuyashiki T, 2002, P NATL ACAD SCI USA, V99, P14458, DOI 10.1073/pnas.212148999; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hering H, 2003, J NEUROSCI, V23, P3262; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Kuhn TB, 1998, J NEUROSCI, V18, P184; Kumanogoh H, 2001, NEUROSCI RES, V39, P189, DOI 10.1016/S0168-0102(00)00211-X; Linder ME, 2004, J CELL SCI, V117, P521, DOI 10.1242/jcs.00989; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Matsuo N, 2002, J BIOL CHEM, V277, P2860, DOI 10.1074/jbc.M106186200; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nishimura H, 2003, J NEUROCHEM, V85, P1216, DOI 10.1046/j.1471-4159.2003.01760.x; Ohmae S, 2006, J BIOL CHEM, V281, P20427, DOI 10.1074/jbc.M513212200; Pelled D, 2003, NEUROPATH APPL NEURO, V29, P341, DOI 10.1046/j.1365-2990.2003.00455.x; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Schwarz A, 1998, DEV BRAIN RES, V108, P125, DOI 10.1016/S0165-3806(98)00041-8; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Suzuki T, 2001, MOL BRAIN RES, V89, P20, DOI 10.1016/S0169-328X(01)00051-1; Takemoto-Kimura S, 2003, J BIOL CHEM, V278, P18597, DOI 10.1074/jbc.M300578200; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	62	93	95	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 7	2007	54	5					755	770		10.1016/j.neuron.2007.05.021	http://dx.doi.org/10.1016/j.neuron.2007.05.021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553424	Bronze			2022-12-24	WOS:000247329900009
J	Szapiro, G; Barbour, B				Szapiro, German; Barbour, Boris			Multiple climbing fibers signal to molecular layer interneurons exclusively via glutamate spillover	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; AMPA RECEPTORS; SYNAPTIC-TRANSMISSION; PRESYNAPTIC INHIBITION; NMDA RECEPTORS; GABA RELEASE; ACTIVATION; SYNAPSES; TRANSPORTERS; RAT	Spillover of glutamate under physiological conditions has only been established as an adjunct to conventional synaptic transmission. Here we describe a pure spillover connection between the climbing fiber and molecular layer interneurons in the rat cerebellar cortex. We show that, instead of acting via conventional synapses, multiple climbing fibers activate AMPA- and NMDA-type glutamate receptors on interneurons exclusively via spillover. Spillover from the climbing fiber represents a form of glutamatergic volume transmission that could be triggered in a regionalized manner by experimentally observed synchronous climbing fiber activity. Climbing fibers are known to direct parallel fiber synaptic plasticity in interneurons, so one function of this spillover is likely to involve controlling synaptic plasticity.	Ecole Normale Super, CNRS, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Barbour, B (corresponding author), Ecole Normale Super, CNRS, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	barbour@ens.fr		Barbour, Boris/0000-0002-1911-0539				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Atluri PP, 1998, J NEUROSCI, V18, P8214; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Glitsch M, 1999, J NEUROSCI, V19, P511; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Kollo M, 2006, J NEUROSCI, V26, P2684, DOI 10.1523/JNEUROSCI.5257-05.2006; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Lang EJ, 1999, J NEUROSCI, V19, P2728; Lewis PAW, 1966, STAT ANAL SERIES EVE; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Marcaggi P, 2005, NEUROPHARMACOLOGY, V49, P843, DOI 10.1016/j.neuropharm.2005.07.011; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; Palay S.L., 1974, CEREBELLAR CORTEX; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Satake S, 2006, J NEUROSCI, V26, P2278, DOI 10.1523/JNEUROSCI.4894-05.2006; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Satake S, 2004, EUR J NEUROSCI, V19, P2464, DOI 10.1111/j.0953-816X.2004.03347.x; SATO Y, 1992, J NEUROPHYSIOL, V68, P2051, DOI 10.1152/jn.1992.68.6.2051; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Sugihara I, 1999, J COMP NEUROL, V414, P131; Takayasu Y, 2006, J NEUROSCI, V26, P6563, DOI 10.1523/JNEUROSCI.5342-05.2006; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000	47	170	171	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					735	742		10.1038/nn1907	http://dx.doi.org/10.1038/nn1907			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515900	Green Submitted			2022-12-24	WOS:000246799800016
J	Verhagen, JV; Wesson, DW; Netoff, TI; White, JA; Wachowiak, M				Verhagen, Justus V.; Wesson, Daniel W.; Netoff, Theoden I.; White, John A.; Wachowiak, Matt			Sniffing controls an adaptive filter of sensory input to the olfactory bulb	NATURE NEUROSCIENCE			English	Article							RECEPTOR NEURON INPUT; MUCOSAL ACTIVITY PATTERNS; RESPONSE PROPERTIES; GLOMERULAR LAYER; UNIT-ACTIVITY; MITRAL CELLS; ODOR; RATS; REPRESENTATIONS; CORTEX	Most sensory stimuli are actively sampled, yet the role of sampling behavior in shaping sensory codes is poorly understood. Mammals sample odors by sniffing, a complex behavior that controls odorant access to receptor neurons. Whether sniffing shapes the neural code for odors remains unclear. We addressed this question by imaging receptor input to the olfactory bulb of awake rats performing odor discriminations that elicited different sniffing behaviors. High- frequency sniffing of an odorant attenuated inputs encoding that odorant, whereas lower sniff frequencies caused little attenuation. Odorants encountered later in a sniff bout were encoded as the combination of that odorant and the background odorant during low- frequency sniffing, but were encoded as the difference between the two odorants during high- frequency sniffing. Thus, sniffing controls an adaptive filter for detecting changes in the odor landscape. These data suggest an unexpected functional role for sniffing and show that sensory codes can be transformed by sampling behavior alone.	Boston Univ, Dept Biol, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University	Wachowiak, M (corresponding author), Boston Univ, Dept Biol, 24 Cummington St, Boston, MA 02215 USA.	dmattw@bu.edu	Wesson, Daniel/AAJ-6719-2020	Wesson, Daniel/0000-0002-3192-3866; White, John/0000-0003-1073-2638; Netoff, Theoden/0000-0002-0115-1930	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008197] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03 DC008197] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1951, J PHYSIOL-LONDON, V114, pP4; ADRIAN ED, 1950, BRIT MED BULL, V6, P330, DOI 10.1093/oxfordjournals.bmb.a073625; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kadohisa M, 2006, J NEUROPHYSIOL, V95, P1888, DOI 10.1152/jn.00812.2005; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kent PF, 1996, J NEUROSCI, V16, P345; KENT PF, 1992, J NEUROPHYSIOL, V68, P1804, DOI 10.1152/jn.1992.68.5.1804; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MACRIDES F, 1975, BEHAV BIOL, V14, P295, DOI 10.1016/S0091-6773(75)90419-8; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; SCHMITT BC, 1979, SCIENCE, V205, P204, DOI 10.1126/science.205.4402.204; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Sobel N, 2000, CHEM SENSES, V25, P1, DOI 10.1093/chemse/25.1.1; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VANDERWOLF CH, 1987, PHARMACOL BIOCHEM BE, V26, P299, DOI 10.1016/0091-3057(87)90122-5; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Walker JKL, 1997, RESP PHYSIOL, V107, P241, DOI 10.1016/S0034-5687(96)02520-0; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zhao K, 2006, CHEM SENSES, V31, P107, DOI 10.1093/chemse/bjj008	46	245	246	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					631	639		10.1038/nn1892	http://dx.doi.org/10.1038/nn1892			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450136				2022-12-24	WOS:000245948000020
J	Gauthier, AS; Furstoss, O; Araki, T; Chan, R; Neel, BG; Kaplan, DR; Miller, FD				Gauthier, Andree S.; Furstoss, Olivia; Araki, Toshiyuki; Chan, Richard; Neel, Benjamin G.; Kaplan, David R.; Miller, Freda D.			Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome	NEURON			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CENTRAL-NERVOUS-SYSTEM; DIFFERENTIATION; PATHWAY; GLIOGENESIS; ASTROCYTES; ACTIVATION; SURVIVAL; MUTATION; RECEPTOR	Within the developing mammalian CNS, growth factors direct multipotent precursors to generate neurons versus glia, a process that if perturbed might lead to neural dysfunction. In this regard, genetic mutations resulting in constitutive activation of the protein tyrosine phosphatase SHP-2 cause Noonan Syndrome (NS), which is associated with learning disabilities and mental retardation. Here, we demonstrate that genetic knockdown of SHP-2 in cultured cortical precursors or in the embryonic cortex inhibited basal neurogenesis and caused enhanced and precocious astrocyte formation. Conversely, expression of an NS SHP-2 mutant promoted neurogenesis and inhibited astrogenesis. Neural cell-fate decisions were similarly perturbed in a mouse knockin model that phenocopies human NS. Thus, SHP-2 instructs precursors to make neurons and not astrocytes during the neurogenic period, and perturbations in the relative ratios of these two cell types upon constitutive SHIP-2 activation may contribute to the cognitive impairments in NS patients.	Hosp Sick Children, Dev Biol Program, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Harvard Univ, Sch Med, Beth Israel Med Ctr, Dept Med, Boston, MA 02215 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Miller, FD (corresponding author), Hosp Sick Children, Dev Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca		Gauthier-Fisher, Andree/0000-0002-1932-4684; Araki, Toshiyuki/0000-0002-1179-4534	NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA049152, R37CA49152] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; BALL MJ, 1982, J NEUROL NEUROSUR PS, V45, P753; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; GLOSTER A, 1994, J NEUROSCI, V14, P7319; GORKE W, 1980, KLIN PADIATR, V192, P577, DOI 10.1055/s-2008-1035646; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; HEYE N, 1995, J NEUROL NEUROSUR PS, V59, P338, DOI 10.1136/jnnp.59.3.338-a; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Jongmans M, 2005, AM J MED GENET A, V134A, P165, DOI 10.1002/ajmg.a.30598; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Lee DA, 2005, DEV MED CHILD NEUROL, V47, P35, DOI 10.1017/S00121622050006X; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NOONAN JA, 1994, CLIN PEDIATR, V33, P548, DOI 10.1177/000992289403300907; Paquin A, 2005, J NEUROSCI, V25, P10747, DOI 10.1523/JNEUROSCI.2662-05.2005; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Saito Y, 1997, PEDIATR NEUROL, V17, P266, DOI 10.1016/S0887-8994(97)00094-5; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Uemura A, 2002, CYTOKINE, V18, P1, DOI 10.1006/cyto.2002.1006; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Yoshida R, 2004, J CLIN ENDOCR METAB, V89, P3359, DOI 10.1210/jc.2003-032091	30	108	110	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					245	262		10.1016/j.neuron.2007.03.027	http://dx.doi.org/10.1016/j.neuron.2007.03.027			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442246	Bronze, Green Accepted			2022-12-24	WOS:000246190600010
J	Plested, AJR; Mayer, ML				Plested, Andrew J. R.; Mayer, Mark L.			Structure and mechanism of kainate receptor modulation by anions	NEURON			English	Article							LIGAND-BINDING CORE; PARTIAL AGONIST ACTION; AMINO-ACID RECEPTORS; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; NMDA RECEPTORS; AMPA RECEPTORS; SYNAPTIC PLASTICITY; ALPHA-AMYLASE; BIPOLAR CELLS	L-glutamate, the major excitatory neurotransmitter in the human brain, activates a family of ligand-gated ion channels, the major subtypes of which are named AMPA, kainate, and NMDA receptors. In common with many signal transduction proteins, glutamate receptors are modulated by ions and small molecules, including Ca2+, Mg2+, Zn2+, protons, polyamines, and ste roids. Strikingly, the activation of kainate receptors by glutamate requires the presence of both Na+ and Cl- in the extracellular solution, and in the absence of these ions, receptor activity is abolished. Here, we identify the site and mechanism of action of anions. Surprisingly, we find that Cl- ions are essential structural components of kainate receptors. Cl- ions bind in a cavity formed at the interface between subunits in a dimer pair. In the absence of Cl-, dinner stability is reduced, the rate of desensitization increases, and the fraction of receptors competent for activation by glutamate drops precipitously.	NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mayer, ML (corresponding author), NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	mlm@helix.nih.gov	Mayer, Mark L/H-5500-2013; Mayer, Mark/AAE-7356-2019	Mayer, Mark/0000-0003-4378-8451; Plested, Andrew/0000-0001-6062-0832	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; Bowie D, 2002, J PHYSIOL-LONDON, V539, P725, DOI 10.1113/jphysiol.2001.013407; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; D'Amico S, 2000, GENE, V253, P95, DOI 10.1016/S0378-1119(00)00229-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Fleck MW, 2003, J NEUROSCI, V23, P1219; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; JIANG C, 1992, J PHYSIOL-LONDON, V448, P697, DOI 10.1113/jphysiol.1992.sp019065; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Lobet S, 2006, EMBO J, V25, P24, DOI 10.1038/sj.emboj.7600909; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Numao S, 2002, BIOCHEMISTRY-US, V41, P215, DOI 10.1021/bi0115636; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paternain AV, 2003, J NEUROSCI, V23, P8641; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; POWELL DH, 1988, FARADAY DISCUSS, V85, P137, DOI 10.1039/dc9888500137; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Strobl S, 1998, J MOL BIOL, V278, P617, DOI 10.1006/jmbi.1998.1667; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; Watchorn E, 1935, Biochem J, V29, P2291; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Wong AYC, 2006, J NEUROSCI, V26, P5750, DOI 10.1523/JNEUROSCI.0301-06.2006	54	89	90	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					829	841		10.1016/j.neuron.2007.02.025	http://dx.doi.org/10.1016/j.neuron.2007.02.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359918	Bronze			2022-12-24	WOS:000245292800008
J	Dkhissi-Benyahya, O; Gronfier, C; De Vanssay, W; Flamant, F; Cooper, HM				Dkhissi-Benyahya, Ouria; Gronfier, Claude; De Vanssay, Wena; Flamant, Frederic; Cooper, Howard M.			Modeling the role of mid-wavelength cones in circadian responses to light	NEURON			English	Article							RETINAL GANGLION-CELLS; THYROID-HORMONE RECEPTOR; SPECTRAL SENSITIVITY; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; PHASE-SHIFTS; NON-ROD; MELANOPSIN; PHOTORECEPTORS; MICE	Nonvisual responses to light, such as entrainment of the circadian clock, involve trinsically light-sensitive melanopsin-expressing ganglion cells as well as rod and cone toreceptors. However, previous studies been unable to demonstrate aspecific contribution of cones in the photic control of responses to light. Using a mouse model specifically lacks mid-wavelength (MW) we show that these photoreceptors; icant role in light entrainment and in phase ing of the circadian oscillator. The of MW cones is mainly observed for light sures of short duration and toward the wavelength region of the spectrum, with the known properties of this opsin. Modeling the contributions of the various tors stresses the importance of the particular spectral, temporal, and response domains of the photopigments assessing their role and contribution in than responses to light.	Stem Cell & Brain Res Inst, INSERM U846, Dept Chronobiol, F-69500 Bron, France; Univ Lyon 1, F-69000 Lyon, France; ENS, Biol Cellulaire & Mol Lab, F-69000 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON)	Cooper, HM (corresponding author), Stem Cell & Brain Res Inst, INSERM U846, Dept Chronobiol, F-69500 Bron, France.	cooper@lyon.inserm.fr	Gronfier, Claude/C-1243-2008; COOPER, HOWARD/M-7304-2014; Dkhissi-Benyahya, Ouria/M-5665-2014	Gronfier, Claude/0000-0002-6549-799X; Dkhissi-Benyahya, Ouria/0000-0001-9168-3801				Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; ARGAMASO SM, 1995, BIOPHYS CHEM, V56, P3, DOI 10.1016/0301-4622(95)00009-M; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; BROWMAN HI, 1992, VISION RES, V32, P2303, DOI 10.1016/0042-6989(92)90094-Y; Bullough JD, 2005, ZOOL SCI, V22, P223, DOI 10.2108/zsj.22.223; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dkhissi-Benyahya O, 2000, J NEUROSCI, V20, P7790; EBIHARA S, 1980, PHYSIOL BEHAV, V24, P523, DOI 10.1016/0031-9384(80)90246-2; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Kaiser P.K, 1996, HUMAN COLOR VISION; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, J COMP PHYSIOL A, V189, P69, DOI 10.1007/s00359-002-0378-7; Mrosovsky N, 2001, CHRONOBIOL INT, V18, P613, DOI 10.1081/CBI-100106076; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; NEWELL FW, 1977, KLIN MONATSBL AUGENH, V171, P731; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Roberts SGE, 2005, CURR OPIN GENET DEV, V15, P542, DOI 10.1016/j.gde.2005.08.004; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Sevilla-Romero E, 2002, OPHTHALMIC RES, V34, P181, DOI 10.1159/000063885; SHIMOMURA K, 1994, J BIOL RHYTHM, V9, P97, DOI 10.1177/074873049400900201; SZEL A, 1986, EXP EYE RES, V43, P871, DOI 10.1016/0014-4835(86)90066-7; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3489; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	51	115	117	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					677	687		10.1016/j.neuron.2007.02.005	http://dx.doi.org/10.1016/j.neuron.2007.02.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329208	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000245127100009
J	Navalpakkam, V; Itti, L				Navalpakkam, Vidhya; Itti, Laurent			Search goal tunes visual features optimally	NEURON			English	Article							FEATURE-BASED ATTENTION; NEURAL MECHANISMS; TOP-DOWN; SELECTIVE ATTENTION; SPATIAL ATTENTION; AREA V4; CORTICAL AREAS; CORTEX; COLOR; INTEGRATION	How does a visual search goal modulate the activity of neurons encoding different visual features (e.g., color, direction of motion)? Previous research suggests that goal-driven attention enhances the gain of neurons representing the target's visual features. Here, we present mathematical and behavioral evidence that this strategy is suboptimal and that humans do not deploy it. We formally derive the optimal feature gain modulation theory, which combines information from both the target and distracting clutter to maximize the relative salience of the target. We qualitatively validate the theory against existing electrophysiological and psychophysical literature. A surprising prediction is that it is sometimes optimal to enhance nontarget features. We provide experimental evidence toward this through psychophysics experiments on human subjects, thus suggesting that humans deploy the optimal gain modulation strategy.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ So Calif, Dept Comp Sci, Viterbi Sch Engn, Los Angeles, CA 90089 USA	California Institute of Technology; University of Southern California	Navalpakkam, V (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	vidhya@klab.caltech.edu; itti@usc.edu						Bauer B, 1996, VISION RES, V36, P1439, DOI 10.1016/0042-6989(95)00207-3; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bichot NP, 2002, J NEUROSCI, V22, P4675, DOI 10.1523/JNEUROSCI.22-11-04675.2002; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Braithwaite JJ, 2003, PERCEPT PSYCHOPHYS, V65, P213, DOI 10.3758/BF03194796; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cave KR, 1999, PSYCHOL RES-PSYCH FO, V62, P182, DOI 10.1007/s004260050050; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; DECO G, 2002, COMPUTATIONAL NEUROS; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1989, PERCEPTION, V18, P457, DOI 10.1068/p180457; DZMURA M, 1991, VISION RES, V31, P951, DOI 10.1016/0042-6989(91)90203-H; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Hamker FH, 2004, VISION RES, V44, P501, DOI 10.1016/j.visres.2003.09.033; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hodsoll J, 2001, PERCEPT PSYCHOPHYS, V63, P918, DOI 10.3758/BF03194447; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Itti L, 2001, J ELECTRON IMAGING, V10, P161, DOI 10.1117/1.1333677; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NAGY AL, 1990, J OPT SOC AM A, V7, P1209, DOI 10.1364/JOSAA.7.001209; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Navalpakkam V., 2006, P IEEE C COMP VIS PA, V1, P1; PASHLER H, 1987, PERCEPT PSYCHOPHYS, V41, P285, DOI 10.3758/BF03208228; Rao RPN, 2002, VISION RES, V42, P1447, DOI 10.1016/S0042-6989(02)00040-8; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; TREISMAN A, 1991, J EXP PSYCHOL HUMAN, V17, P652, DOI 10.1037/0096-1523.17.3.652; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Vickery TJ, 2005, J VISION, V5, P81, DOI 10.1167/5.1.8; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483; Wolfe JM, 2004, VISION RES, V44, P1411, DOI 10.1016/j.visres.2003.11.024; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	54	220	237	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					605	617		10.1016/j.neuron.2007.01.018	http://dx.doi.org/10.1016/j.neuron.2007.01.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	149DJ	17296560	Bronze			2022-12-24	WOS:000245126900017
J	Friederici, AD; von Cramon, DY; Kotz, SA				Friederici, Angela D.; von Cramon, D. Yves; Kotz, Sonja A.			Role of the corpus callosum in speech comprehension: Interfacing syntax and prosody	NEURON			English	Article							BRAIN POTENTIALS; RIGHT-HEMISPHERE; SENTENCE COMPREHENSION; LANGUAGE; LATERALIZATION; PERCEPTION; DISTURBANCES; MICROBLEEDS; MORPHOLOGY; RESPONSES	The role of the corpus callosurn (CC) in the interhemispheric interaction of prosodic and syntactic information during speech comprehension was investigated in patients with lesions in the CC, and in healthy controls. The event-related brain potential experiment examined the effect of prosodic phrase structure on the processing of a verb whose argument structure matched or did not match the prior prosody-induced syntactic structure. While controls showed an N400-like effect for prosodically mismatching verb argument structures, thus indicating a stable interplay between prosody and syntax, patients with lesions in the posterior third of the CC did not show this effect. Because these patients displayed a prosody- independent semantic N400 effect, the present data indicate that the posterior third of the CC is the crucial neuroanatomical structure for the interhemispheric interplay of suprasegmental prosodic information and syntactic information.	Univ Leipzig, Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; Univ Leipzig, Day Care Clin Cognit Neurol, D-04103 Leipzig, Germany	Leipzig University; Max Planck Society; Leipzig University	Friederici, AD (corresponding author), Univ Leipzig, Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany.	angelafr@cbs.mpg.de						BEHRENS SJ, 1985, BRAIN LANG, V26, P332, DOI 10.1016/0093-934X(85)90047-1; Blumstein S. E., 1974, CORTEX, V10, P246; BRADVIK B, 1991, ACTA NEUROL SCAND, V84, P114, DOI 10.1111/j.1600-0404.1991.tb04919.x; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; BRYAN KL, 1989, APHASIOLOGY, V3, P285, DOI 10.1080/02687038908249000; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; DUARA R, 1991, ARCH NEUROL-CHICAGO, V48, P410, DOI 10.1001/archneur.1991.00530160078018; EMMOREY KD, 1987, BRAIN LANG, V30, P305, DOI 10.1016/0093-934X(87)90105-2; Fabbro F, 2002, NEUROPSYCHOLOGIA, V40, P1541, DOI 10.1016/S0028-3932(02)00026-X; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Friederici AD, 2000, HUM BRAIN MAPP, V11, P1, DOI 10.1002/1097-0193(200009)11:1<1::AID-HBM10>3.0.CO;2-B; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Friederici AD, 1999, BRAIN, V122, P1033, DOI 10.1093/brain/122.6.1033; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gross J, 1998, BRAIN TOPOGR, V10, P273, DOI 10.1023/A:1022223007231; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; HOLCOMB PJ, 1992, DEV NEUROPSYCHOL, V8, P203, DOI 10.1080/87565649209540525; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; KIRKBRIDE V, 1994, PEDIATR RES, V36, pA20; KLOUDA GV, 1988, BRAIN LANG, V35, P154, DOI 10.1016/0093-934X(88)90106-X; Kruggel F, 1996, INT CONGR SER, V1124, P323; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Meyer M, 2003, J NEUROLINGUIST, V16, P277, DOI 10.1016/S0911-6044(03)00026-5; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; NIJOKIKTJIEN C, 1990, ACTA PAEDOPSYCHIATR, V53, P126; Nosarti C, 2004, BRAIN, V127, P2080, DOI 10.1093/brain/awh230; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pell MD, 1997, BRAIN LANG, V57, P195, DOI 10.1006/brln.1997.1736; Pell MD, 1998, NEUROPSYCHOLOGIA, V36, P701, DOI 10.1016/S0028-3932(98)00008-6; Perkins JM, 1996, APHASIOLOGY, V10, P343, DOI 10.1080/02687039608248416; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Pollmann S, 2002, NEUROPSYCHOLOGY, V16, P56, DOI 10.1037//0894-4105.16.1.56; Roob G, 1999, NERVENARZT, V70, P1082, DOI 10.1007/s001150050542; Rumsey JM, 1996, BIOL PSYCHIAT, V39, P769, DOI 10.1016/0006-3223(95)00225-1; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; SHAPIRO LP, 1987, COGNITION, V27, P219, DOI 10.1016/S0010-0277(87)80010-0; SHAPIRO LP, 1993, BRAIN LANG, V45, P423, DOI 10.1006/brln.1993.1053; SHARBROUGH F, 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI DOI 10.1097/00004691-199104000-00007; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; STNYER MA, 2005, MED IMAGE COMPUT C 2, V8, P765; SUGISHITA M, 1995, BRAIN, V118, P417, DOI 10.1093/brain/118.2.417; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; VANLANCKER D, 1992, J SPEECH HEAR RES, V35, P963, DOI 10.1044/jshr.3505.963; WEINTRAUB S, 1981, ARCH NEUROL-CHICAGO, V38, P742, DOI 10.1001/archneur.1981.00510120042004	50	69	69	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					135	145		10.1016/j.neuron.2006.11.020	http://dx.doi.org/10.1016/j.neuron.2006.11.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196536	Bronze			2022-12-24	WOS:000245126500014
J	Gu, C; Zhou, W; Puthenveedu, MA; Xu, MX; Jan, YN; Jan, LY				Gu, Chen; Zhou, Wei; Puthenveedu, Manojkumar A.; Xu, Mingxuan; Jan, Yuh Nung; Jan, Lily Yeh			The microtubule plus-end tracking protein EB1 is required for Kv1 voltage-gated K+ channel axonal targeting	NEURON			English	Article							BINDING-PROTEIN; SURFACE EXPRESSION; POTASSIUM CHANNELS; BETA-SUBUNITS; KINESIN; APC; MECHANISMS; TRANSPORT; MOTOR; DETERMINANTS	Axonal Kv1 channels regulate action potential propagation-an evolutionarily conserved function important for the control of motor behavior as evidenced from the linkage of human Kv1 channel mutations to myokymia/episodic ataxia type 1 (EA1) and the Shaker mutant phenotype in Drosophila. To search for the machinery that mediates axonal targeting of Kv1 channels composed of both alpha and beta subunits, we first demonstrate that Kv beta 2 is responsible for targeting Kv1 channels to the axon. Next, we show that Kv beta 2 axonal targeting depends on its ability to associate with the microtubule (MT) plus-end tracking protein (+TIP) EB1. Not only do Kv beta 2 and EB1 move in unison down the axon, Brefeldin A-sensitive Kv1-containing vesicles can also be found at microtubule ends near the cell membrane. In addition, we found that Kv beta 2 associates with KIF3/kinesin II as well. Indeed, Kv1 channels rely on both KIF3/kinesin II and EB1 for their axonal targeting.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gu, C (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	gu.49@osu.edu; lily.jan@ucsf.edu	Gu, Chen/E-3163-2011; xu, mingxuan/B-9787-2011; Puthenveedu, Manojkumar/A-3795-2016	Jan, Lily/0000-0003-3938-8498; Puthenveedu, Manojkumar/0000-0002-3177-4231; Jan, Yuh Nung/0000-0003-1367-6299	NIDA NIH HHS [DA10154, DA10711] Funding Source: Medline; PHS HHS [R01 65334] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R29DA010711, R37DA010711, R01DA010711] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Baccus SA, 2000, J NEUROPHYSIOL, V83, P1693, DOI 10.1152/jn.2000.83.3.1693; Berezuk MA, 2004, TRAFFIC, V5, P503, DOI 10.1111/j.1398-9219.2004.00197.x; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Chiu SY, 1999, J NEUROCYTOL, V28, P349, DOI 10.1023/A:1007013731231; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Elliott SL, 2005, MOL BIOL CELL, V16, P891, DOI 10.1091/mbc.e04-07-0633; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Grosse G, 2000, J NEUROSCI, V20, P1869; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu C, 2001, CURR BIOL, V11, P185, DOI 10.1016/S0960-9822(01)00044-6; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Heinemann Stefan H, 2006, Sci STKE, V2006, ppe33, DOI 10.1126/stke.3502006pe33; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lang B, 2003, AUTOIMMUN REV, V2, P94, DOI 10.1016/S1568-9972(02)00146-5; Ma YT, 2004, CURR BIOL, V14, P725, DOI 10.1016/j.cub.2004.03.061; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Southan AP, 2000, J NEUROSCI, V20, P114, DOI 10.1523/JNEUROSCI.20-01-00114.2000; Stepanova T, 2003, J NEUROSCI, V23, P2655; SU LK, 1995, CANCER RES, V55, P2972; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; TIMAUER JS, 2000, J CELL BIOL, V149, P761; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zhou L, 1998, J NEUROSCI, V18, P7200	53	107	107	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					803	816		10.1016/j.neuron.2006.10.022	http://dx.doi.org/10.1016/j.neuron.2006.10.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145502	Bronze			2022-12-24	WOS:000242856400009
J	Vrontou, E; Nilsen, SP; Demir, E; Kravitz, EA; Dickson, BJ				Vrontou, Eleftheria; Nilsen, Steven P.; Demir, Ebru; Kravitz, Edward A.; Dickson, Barry J.			fruitless regulates aggression and dominance in Drosophila	NATURE NEUROSCIENCE			English	Article							MALE SEXUAL-BEHAVIOR; MELANOGASTER; GENE; ORIENTATION; PATHWAY	When competing for resources, two Drosophila melanogaster flies of the same sex fight each other. Males and females fight with distinctly different styles, and males but not females establish dominance relationships. Here we show that sex-specific splicing of the fruitless gene plays a critical role in determining who and how a fly fights, and whether a dominance relationship forms.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Harvard University; Harvard Medical School	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072411, R01GM067645] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM072411, GM067645] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; Lee G, 2000, BEHAV GENET, V30, P263, DOI 10.1023/A:1026541215546; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259	13	129	130	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1469	1471		10.1038/nn1809	http://dx.doi.org/10.1038/nn1809			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115036				2022-12-24	WOS:000242404000007
J	Hooks, BM; Chen, CF				Hooks, Bryan M.; Chen, Chinfei			Distinct roles for spontaneous and visual activity in remodeling of the retinogeniculate synapse	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; EYE-SPECIFIC SEGREGATION; POSTNATAL-DEVELOPMENT; RETINAL ACTIVITY; CLIMBING FIBER; MULTIPLE INNERVATION; CORTICAL CIRCUITS; RECEPTIVE-FIELDS; RAT CEREBELLUM; NMDA RECEPTORS	Sensory experience and spontaneous activity play important roles in development of sensory circuits; however, their relative contributions are unclear. Here, we test the role of different forms of activity on remodeling of the mouse retinogeniculate synapse. We found that the bulk of maturation occurs without patterned sensory activity over 4 days spanning eye opening. During this early developmental period, blockade of spontaneous retinal activity by tetrodotoxin, but not visual deprivation, retarded synaptic strengthening and inhibited pruning of excess retinal afferents. Later in development, synaptic remodeling becomes sensitive to changes in visually evoked activity, but only if there has been previous visual experience. Synaptic strengthening and pruning were disrupted by visual deprivation following 1 week of vision, but not by chronic deprivation from birth. Thus, spontaneous activity is necessary to drive the bulk of synaptic refinement around the time of eye opening, while sensory experience is important for the subsequent maintenance of connections.	Harvard Univ, Sch Med, Dept Neurol, Neurobiol Program,Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Chen, CF (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Neurobiol Program,Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	chinfei.chen@childrens.harvard.edu			NEI NIH HHS [R01 EY013613, R01EY013613] Funding Source: Medline; NICHD NIH HHS [P01HD18655, P30 HD018655] Funding Source: Medline; NINDS NIH HHS [F31 NS048630] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS048630] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; BLAKEMORE C, 1986, J PHYSIOL-LONDON, V380, P453, DOI 10.1113/jphysiol.1986.sp016297; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Carrasco MM, 2005, J NEUROPHYSIOL, V94, P1962, DOI 10.1152/jn.00166.2005; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; CYNADER M, 1976, EXP BRAIN RES, V25, P139; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; Demas J, 2003, J NEUROSCI, V23, P2851; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Gandhi SP, 2005, NAT NEUROSCI, V8, P9, DOI 10.1038/nn0105-9; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gomperts SN, 2000, J NEUROSCI, V20, P2229; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; JACKSON H, 1982, J NEUROSCI, V2, P1736; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Kandel E., 2000, PRINCIPLES NEURAL SC; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Prusky GT, 1999, J NEUROSCI METH, V87, P105, DOI 10.1016/S0165-0270(98)00172-1; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Sugihara I, 2005, J COMP NEUROL, V487, P93, DOI 10.1002/cne.20531; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212; ZHOU YF, 1995, J NEUROSCI, V15, P689	56	207	211	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					281	291		10.1016/j.neuron.2006.07.007	http://dx.doi.org/10.1016/j.neuron.2006.07.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046691	Bronze			2022-12-24	WOS:000241799900009
J	Cappello, S; Attardo, A; Wu, XW; Iwasato, T; Itohara, S; Wilsch-Brauninger, M; Eilken, HM; Rieger, MA; Schroeder, TT; Huttner, WB; Brakebusch, C; Gotz, M				Cappello, Silvia; Attardo, Alessio; Wu, Xunwei; Iwasato, Takuji; Itohara, Shigeyoshi; Wilsch-Braeuninger, Michaela; Eilken, Hanna M.; Rieger, Michael A.; Schroeder, Timm T.; Huttner, Wieland B.; Brakebusch, Cord; Goetz, Magdalena			The Rho-GTPase cdc42 regulates neural progenitor fate at the apical surface	NATURE NEUROSCIENCE			English	Article							CELL-CYCLE; NEUROEPITHELIAL CELLS; SUBVENTRICULAR ZONE; RADIAL GLIA; ASYMMETRIC DISTRIBUTION; ADHERENS JUNCTIONS; BRAIN-DEVELOPMENT; LAYER NEURONS; BETA-CATENIN; MOUSE-BRAIN	Stem cell persistence into adulthood requires self-renewal from early developmental stages. In the developing mouse brain, only apical progenitors located at the ventricle are self-renewing, whereas basal progenitors gradually deplete. However, nothing is known about the mechanisms regulating the fundamental difference between these progenitors. Here we show that the conditional deletion of the small Rho-GTPase cdc42 at different stages of neurogenesis in mouse telencephalon results in an immediate increase in basal mitoses. Whereas cdc42-deficient progenitors have normal cell cycle length, orientation of cell division and basement membrane contact, the apical location of the Par complex and adherens junctions are gradually lost, leading to an increasing failure of apically directed interkinetic nuclear migration. These cells then undergo mitoses at basal positions and acquire the fate of basal progenitors. Thus, cdc42 has a crucial role at the apical pole of progenitors, thereby regulating the position of mitoses and cell fate.	GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Munich, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Copenhagen, Inst Mol Pathol, Fac Hlth Sci, DK-2100 Copenhagen, Denmark; RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; Univ Munich, Inst Physiol, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Max Planck Society; University of Copenhagen; RIKEN; University of Munich	Gotz, M (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Munich, Germany.	magdalena.goetz@gsf.de	Wu, Xunwei/J-9014-2018; Huttner, Wieland B./P-4080-2018; Rieger, Michael A/L-8324-2017; Schroeder, Timm/F-8448-2010; Itohara, Shigeyoshi/I-8769-2012; Cappello, Silvia/AAQ-4590-2021	Wu, Xunwei/0000-0002-0822-1700; Rieger, Michael A/0000-0002-4158-5872; Schroeder, Timm/0000-0001-9320-0252; Itohara, Shigeyoshi/0000-0002-2410-9989; Cappello, Silvia/0000-0003-1553-6775; Attardo, Alessio/0000-0003-0665-6011; Brakebusch, Cord/0000-0002-9342-1634				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; ETO K, 1995, DEV GROWTH DIFFER, V37, P123, DOI 10.1046/j.1440-169X.1995.t01-1-00001.x; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SMART IHM, 1976, J ANAT, V121, P71; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	50	305	314	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1099	1107		10.1038/nn1744	http://dx.doi.org/10.1038/nn1744			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892058				2022-12-24	WOS:000240080800010
J	Rudebeck, PH; Walton, ME; Smyth, AN; Bannerman, DM; Rushworth, MFS				Rudebeck, Peter H.; Walton, Mark E.; Smyth, Angharad N.; Bannerman, David M.; Rushworth, Matthew F. S.			Separate neural pathways process different decision costs	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; NEURONAL SIGNALS; VENTRAL STRIATUM; RAT; LESIONS; SENSITIVITY	Behavioral ecologists and economists emphasize that potential costs, as well as rewards, influence decision making. Although neuroscientists assume that frontal areas are central to decision making, the evidence is contradictory and the critical region remains unclear. Here it is shown that frontal lobe contributions to cost-benefit decision making can be understood by positing the existence of two independent systems that make decisions about delay and effort costs. Anterior cingulate cortex lesions affected how much effort rats decided to invest for rewards. Orbitofrontal cortical lesions affected how long rats decided to wait for rewards. The pattern of disruption suggested the deficit could be related to impaired associative learning. Impairments of the two systems may underlie apathetic and impulsive choice patterns in neurological and psychiatric illnesses. Although the existence of two systems is not predicted by economic accounts of decision making, our results suggest that delay and effort may exert distinct influences on decision making.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Rudebeck, PH (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	peter.rudebeck@psy.ox.ac.uk	de Cates, Angharad/N-6550-2013; Rudebeck, Peter/G-7931-2012	de Cates, Angharad/0000-0001-7848-1295; Bannerman, David/0000-0002-3024-7595; Rudebeck, Peter/0000-0002-1411-7555; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0300665] Funding Source: UKRI; Medical Research Council [G0300665] Funding Source: Medline; Wellcome Trust [087736] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aoki N, 2006, BEHAV BRAIN RES, V168, P1, DOI 10.1016/j.bbr.2005.10.002; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Barbelivien A, 2001, CEREB CORTEX, V11, P1056, DOI 10.1093/cercor/11.11.1056; Bautista LM, 2001, P NATL ACAD SCI USA, V98, P1089, DOI 10.1073/pnas.98.3.1089; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; BURNS SM, 1985, BRAIN RES, V340, P71, DOI 10.1016/0006-8993(85)90774-7; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; CARDINAL RN, IN PRESS NEURAL NETW; Chudasama Y, 2003, J NEUROSCI, V23, P8771; COUSINS MS, 1994, PHARMACOL BIOCHEM BE, V49, P85, DOI 10.1016/0091-3057(94)90460-X; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Denk F, 2005, PSYCHOPHARMACOLOGY, V179, P587, DOI 10.1007/s00213-004-2059-4; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Floresco SB, 2007, CEREB CORTEX, V17, P251, DOI 10.1093/cercor/bhj143; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Kacelnik A, 2003, TIME DECISION EC PSY, P115; Kacelnik A, 1997, TRENDS COGN SCI, V1, P304, DOI 10.1016/S1364-6613(97)01093-0; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kheramin S, 2003, BEHAV PROCESS, V64, P239, DOI 10.1016/S0376-6357(03)00142-6; KOLB B, 1974, BEHAV BIOL, V10, P329, DOI 10.1016/S0091-6773(74)91924-5; Long A, 2005, CURR BIOL, V15, pR874, DOI 10.1016/j.cub.2005.10.024; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; NIV Y, 2005, ADV NEURAL INFORMATI, P1019; Passetti F, 2002, CEREB CORTEX, V12, P1254, DOI 10.1093/cercor/12.12.1254; ROESCH M, IN PRESS NEURON; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schweimer J, 2005, LEARN MEMORY, V12, P334, DOI 10.1101/lm.90605; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Stevens JR, 2005, CURR BIOL, V15, P1855, DOI 10.1016/j.cub.2005.09.016; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; THIEBOT MH, 1985, PSYCHOPHARMACOLOGY, V86, P147, DOI 10.1007/BF00431700; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996; WALTON ME, IN PRESS NEURAL NETW; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004	50	419	427	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1161	1168		10.1038/nn1756	http://dx.doi.org/10.1038/nn1756			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921368				2022-12-24	WOS:000240080800018
J	Kole, MHP; Letzkus, JJ; Stuart, GJ				Kole, Maarten H. P.; Letzkus, Johannes J.; Stuart, Greg J.			Axon initial segment Kv1 channels control axonal action potential waveform and synaptic efficacy	NEURON			English	Article							POTASSIUM CHANNELS; PYRAMIDAL NEURONS; K+ CHANNELS; TRANSMITTER RELEASE; ION CHANNELS; FACILITATION; MODULATION; CELLS; CONDUCTANCE; RECORDINGS	Action potentials are binary signals that transmit information via their rate and temporal pattern. In this context, the axon is thought of as a transmission line, devoid of a role in neuronal computation. Here, we show a highly localized role of axonal Kv1 potassium channels in shaping the action potential waveform in the axon initial segment (AIS) of layer 5 pyramidal neurons independent of the soma. Cell-attached recordings revealed a 10-fold increase in Kv1 channel density over the first 50 mu m of the AIS. Inactivation of AIS and proximal axonal Kv1 channels, as occurs during slow subthreshold somatodendritic depolarizations, led to a distance-dependent broadening of axonal action potentials, as well as an increase in synaptic strength at proximal axonal terminals. Thus, Kv1 channels are strategically positioned to integrate slow subthreshold signals, providing control of the presynaptic action potential waveform and synaptic coupling in local cortical circuits.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia.	greg.stuart@anu.edu.au	stuart, greg j/F-7328-2011	Letzkus, Johannes/0000-0001-5678-3030; stuart, greg/0000-0001-9395-2219; Kole, Maarten/0000-0002-3883-5682				Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Baccus SA, 1998, P NATL ACAD SCI USA, V95, P8345, DOI 10.1073/pnas.95.14.8345; Bekkers JM, 2001, J NEUROSCI, V21, P6553, DOI 10.1523/JNEUROSCI.21-17-06553.2001; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P593, DOI 10.1111/j.1469-7793.2000.t01-1-00593.x; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Byrne JH, 1996, J NEUROSCI, V16, P425; CHIU SY, 1981, J PHYSIOL-LONDON, V313, P415, DOI 10.1113/jphysiol.1981.sp013674; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Dodson PD, 2003, J PHYSIOL-LONDON, V550, P27, DOI 10.1113/jphysiol.2003.046250; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Ishikawa T, 2003, J NEUROSCI, V23, P10445; JACKSON MB, 1993, J NEUROPHYSIOL, V69, P692, DOI 10.1152/jn.1993.69.3.692; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Rasband M, 1998, J NEUROSCI, V18, P36; Rasband MN, 2000, J PHYSIOL-LONDON, V525, P63, DOI 10.1111/j.1469-7793.2000.00063.x; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; Schaefer AT, 2007, J PHYSIOL-LONDON, V579, P737, DOI 10.1113/jphysiol.2006.122564; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P173, DOI 10.1098/rstb.1979.0004; Southan AP, 1998, J NEUROSCI, V18, P948; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Van Brederode JFM, 2001, NEUROSCIENCE, V103, P921, DOI 10.1016/S0306-4522(01)00041-0; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; WELLER U, 1985, N-S ARCH PHARMACOL, V330, P77, DOI 10.1007/BF00499898; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Wolff M, 1998, J PHYSIOL-LONDON, V509, P767, DOI 10.1111/j.1469-7793.1998.767bm.x	57	293	294	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2007	55	4					633	647		10.1016/j.neuron.2007.07.031	http://dx.doi.org/10.1016/j.neuron.2007.07.031			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698015	Bronze			2022-12-24	WOS:000249159200011
J	Sananbenesi, F; Fischer, A; Wang, XY; Schrick, C; Neve, R; Radulovic, J; Tsai, LH				Sananbenesi, Farahnaz; Fischer, Andre; Wang, Xinyu; Schrick, Christina; Neve, Rachael; Radulovic, Jelena; Tsai, Li-Huei			A hippocampal Cdk5 pathway regulates extinction of contextual fear	NATURE NEUROSCIENCE			English	Article							CYCLIN-DEPENDENT KINASE-5; DENDRITIC SPINE; MEMORY CONSOLIDATION; PREFRONTAL CORTEX; PROTEIN-SYNTHESIS; ADENYLYL-CYCLASE; P35/CDK5 KINASE; TRANSGENIC MICE; LIM-KINASE; IN-VIVO	Treatment of emotional disorders involves the promotion of extinction processes, which are defined as the learned reduction of fear. The molecular mechanisms underlying extinction have only begun to be elucidated. By employing genetic and pharmacological approaches in mice, we show here that extinction requires downregulation of Rac-1 and cyclin-dependent kinase 5 (Cdk5), and upregulation of p21 activated kinase-1 (PAK-1) activity. This is physiologically achieved by a Rac-1-dependent relocation of the Cdk5 activator p35 from the membrane to the cytosol and dissociation of p35 from PAK-1. Moreover, our data suggest that Cdk5/p35 activity prevents extinction in part by inhibition of PAK-1 activity in a Rac-1-dependent manner. We propose that extinction of contextual fear is regulated by counteracting components of a molecular pathway involving Rac-1, Cdk5 and PAK-1. Our data suggest that this pathway could provide a suitable target for therapeutic treatment of emotional disorders.	MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ Gottingen, Sch Med, European Neurosci Inst, Max Planck Soc, D-37077 Gottingen, Germany; Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; McLean Hosp, Belmont, MA 02478 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Max Planck Society; University of Gottingen; Northwestern University; Feinberg School of Medicine; Harvard University; McLean Hospital	Tsai, LH (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	andre.fischer@mpi-mail.mpg.de; j-radulovic@northwestern.edu; lhtsai@mit.edu	Fischer, Andre/AAU-7487-2021	Radulovic, Jelena/0000-0002-0268-2426; Fischer, Andre/0000-0001-8546-1161	NIMH NIH HHS [R01 MH073669, MH073669, R01 MH073669-02, R01 MH073669-01A2] Funding Source: Medline; NINDS NIH HHS [R01 NS051874, NS051874] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874, R37NS051874] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Berlau DJ, 2006, NEUROBIOL LEARN MEM, V86, P123, DOI 10.1016/j.nlm.2005.12.008; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Davis M, 2006, BIOL PSYCHIAT, V60, P369, DOI 10.1016/j.biopsych.2006.03.084; Delamater AR, 2004, Q J EXP PSYCHOL-B, V57, P97, DOI 10.1080/02724990344000097; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; FALLS WA, 1992, J NEUROSCI, V12, P854; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fischer A, 2002, J NEUROSCI, V22, P3700; Fischer A, 2007, NEUROBIOL LEARN MEM, V87, P149, DOI 10.1016/j.nlm.2006.08.003; Fischer A, 2003, CNS NEUROL DISORD-DR, V2, P375, DOI 10.2174/1568007033482706; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; HAWASLI AH, 2007, NAT NEUROSCI    0527; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Howell D, 2002, STAT METHODS PSYCHOL; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; KITAGAWA M, 1993, ONCOGENE, V8, P2425; Lattal KM, 2006, BIOL PSYCHIAT, V60, P344, DOI 10.1016/j.biopsych.2006.05.038; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lin CH, 2003, J NEUROSCI, V23, P1574; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Vianna MR, 2004, CURR NEUROVASC RES, V1, P55, DOI 10.2174/1567202043480170; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x	49	117	131	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1012	1019		10.1038/nn1943	http://dx.doi.org/10.1038/nn1943			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17632506	Green Accepted, Green Submitted			2022-12-24	WOS:000248357500015
J	Banissy, MJ; Ward, J				Banissy, Michael J.; Ward, Jamie			Mirror-touch synesthesia is linked with empathy	NATURE NEUROSCIENCE			English	Editorial Material							AUTISM SPECTRUM DISORDERS; SIMULATION; QUOTIENT; SYSTEM; FMRI; MIND	Watching another person being touched activates a similar neural circuit to actual touch and, for some people with 'mirror-touch' synesthesia, can produce a felt tactile sensation on their own body. In this study, we provide evidence for the existence of this type of synesthesia and show that it correlates with heightened empathic ability. This is consistent with the notion that we empathize with others through a process of simulation.	UCL, Dept Psychol, Bedford WC1H OAP, England	University of London; University College London	Banissy, MJ (corresponding author), UCL, Dept Psychol, 26 Bedford Way, Bedford WC1H OAP, England.	m.banissy@ucl.ac.uk	Ward, Jamie/F-3609-2011	Ward, Jamie/0000-0001-7007-1902				Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	14	154	158	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					815	816		10.1038/nn1926	http://dx.doi.org/10.1038/nn1926			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17572672				2022-12-24	WOS:000247560200009
J	Yao, HS; Shi, L; Han, F; Gao, HF; Dan, Y				Yao, Haishan; Shi, Lei; Han, Feng; Gao, Hongfeng; Dan, Yang			Rapid learning in cortical coding of visual scenes	NATURE NEUROSCIENCE			English	Article							UNDERLYING CONTRAST ADAPTATION; TIMING-DEPENDENT PLASTICITY; IN-VIVO; SYNAPTIC MODIFICATION; CORTEX; NEURONS; SLEEP; REPLAY; EXPERIENCE; SEQUENCES	Experience-dependent plasticity in adult visual cortex is believed to have important roles in visual coding and perceptual learning. Here we show that repeated stimulation with movies of natural scenes induces a rapid improvement in response reliability in cat visual cortex, whereas stimulation with white noise or flashed bar stimuli does not. The improved reliability can be accounted for by a selective increase in spiking evoked by preferred stimuli, and the magnitude of improvement depends on the sparseness of the response. The increase in reliability persists for at least several minutes in the absence of further movie stimulation. During this period, spontaneous spiking activity shows detectable reverberation of the movie-evoked responses. Thus, repeated exposure to natural stimuli not only induces a rapid improvement in cortical response reliability, but also leaves a 'memory trace' in subsequent spontaneous activity.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X	NEI NIH HHS [EY 015180] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015180] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Eysel UT, 1998, NEUROREPORT, V9, P949, DOI 10.1097/00001756-199803300-00034; Fahle M, 2002, PERCEPTUAL LEARNING; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; HEBBB DO, 1949, ORG BEHAV; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; RAO RPN, 2000, PREDICTIV SEAQUENCE; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Touryan J, 2002, J NEUROSCI, V22, P10811; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3	50	89	91	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					772	778		10.1038/nn1895	http://dx.doi.org/10.1038/nn1895			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468750	Green Submitted			2022-12-24	WOS:000246799800020
J	DeBruyne, JP; Weaver, DR; Reppert, SM				DeBruyne, Jason P.; Weaver, David R.; Reppert, Steven M.			CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock	NATURE NEUROSCIENCE			English	Article							EXPRESSION; MAMMALS; MICE	Heterodimers of CLOCK and BMAL1, bHLH-PAS transcription factors, are believed to be the major transcriptional regulators of the circadian clock mechanism in mammals. However, a recent study shows that CLOCK-deficient mice continue to exhibit robust behavioral and molecular rhythms. Here we report that the transcription factor NPAS2 ( MOP4) is able to functionally substitute for CLOCK in the master brain clock in mice to regulate circadian rhythmicity.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Weaver, David/0000-0001-7941-6719; DeBruyne, Jason/0000-0001-9803-9568	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047141, R01NS056125] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM074277-02, F32 GM074277] Funding Source: Medline; NINDS NIH HHS [R01 NS056125-01, R01 NS056125, R01 NS047141, R01 NS047141-05, R01 NS056125-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Green CB, 2003, SCIENCE, V301, P319, DOI 10.1126/science.1087824; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	13	334	350	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					543	545		10.1038/nn1884	http://dx.doi.org/10.1038/nn1884			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417633	Green Accepted, Green Published			2022-12-24	WOS:000245948000007
J	Petkov, CI; O'Connor, KN; Sutter, ML				Petkov, Christopher I.; O'Connor, Kevin N.; Sutter, Mitchell L.			Encoding of illusory continuity in primary auditory cortex	NEURON			English	Article							CORTICAL DEAFNESS; AMODAL COMPLETION; MACAQUE MONKEYS; GAP DETECTION; NOISE; SOUNDS; CAT; INDUCTION; RESPONSES; NEURONS	When interfering objects occlude a scene, the visual system restores the occluded information. Similarly, when a sound of interest (a "foreground" sound) is interrupted (occluded) by loud noise, the auditory system restores the occluded information. This process, called auditory induction, can be exploited to create a continuity illusion. When a segment of a foreground sound is deleted and loud noise fills the missing portion, listeners incorrectly report hearing the foreground continuing through the noise. Here we reveal the neurophysiological underpinnings of illusory continuity in single-neuron responses from awake macaque monkeys' primary auditory cortex (A1). A1 neurons represented the missing segment of occluded tonal foregrounds by responding to discontinuous foregrounds interrupted by intense noise as if they were responding to the complete foregrounds. By comparison, simulated peripheral responses represented only the noise and not the occluded foreground. The results reveal that many A1 single-neuron responses closely follow the illusory percept.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Sutter, ML (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	mlsutter@ucdavis.edu	Petkov, Christopher/O-5318-2015	Petkov, Christopher/0000-0002-4932-7907	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002514, R01DC002514] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002514, DC-02514, R29 DC002514] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; BASHFORD JA, 1988, J ACOUST SOC AM, V84, P1635, DOI 10.1121/1.397178; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1977, CAN J PSYCHOL, V31, P151, DOI 10.1037/h0081658; Brosch M, 1998, NEUROREPORT, V9, P2551, DOI 10.1097/00001756-199808030-00023; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DAY RH, 1983, PERCEPT PSYCHOPHYS, V33, P355, DOI 10.3758/BF03205882; Eggermont JJ, 1999, J NEUROPHYSIOL, V81, P2570, DOI 10.1152/jn.1999.81.5.2570; ERULKER SD, 1956, J HOPKINS HOSP B, V39, P55; Fishbach A, 2001, J NEUROPHYSIOL, V85, P2303, DOI 10.1152/jn.2001.85.6.2303; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; GRAHAM J, 1980, J NEUROL SCI, V48, P35, DOI 10.1016/0022-510X(80)90148-3; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HOUTGAST T, 1972, J ACOUST SOC AM, V51, P1885, DOI 10.1121/1.1913048; Husain FT, 2005, J COGNITIVE NEUROSCI, V17, P1275, DOI 10.1162/0898929055002472; KANIZSA G, 1979, ORG VISION ESSAYS GE; KATSUKI Y, 1959, J NEUROPHYSIOL, V22, P343, DOI 10.1152/jn.1959.22.4.343; KLUENDER KR, 1992, PERCEPT PSYCHOPHYS, V51, P231, DOI 10.3758/BF03212249; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; MEDDIS R, 1990, J ACOUST SOC AM, V87, P1813, DOI 10.1121/1.399379; MEDDIS R, 1986, J ACOUST SOC AM, V79, P702, DOI 10.1121/1.393460; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MICHEL F, 1980, BRAIN LANG, V10, P367, DOI 10.1016/0093-934X(80)90062-0; Micheyl C, 2003, J COGNITIVE NEUROSCI, V15, P747, DOI 10.1162/089892903322307456; Miller CT, 2001, NAT NEUROSCI, V4, P783, DOI 10.1038/90481; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O'Connor KN, 2000, J COMP PHYSIOL A, V186, P903, DOI 10.1007/s003590000145; O'Connor KN, 2005, J NEUROPHYSIOL, V94, P4051, DOI 10.1152/jn.00046.2005; PATTERSON RD, 1992, ADV BIOSCI, V83, P429; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Paxinos G., 2000, RHESUS MONKEY BRAIN; Pessoa L., 2003, FILLING IN PERCEPTUA; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Petkov CI, 2003, J NEUROSCI, V23, P9155; PICKETT JM, 1959, J ACOUST SOC AM, V31, P127, DOI 10.1121/1.1930194; Pressnitzer D, 2001, J NEUROSCI, V21, P6377, DOI 10.1523/JNEUROSCI.21-16-06377.2001; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; RHODE WS, 1978, J NEUROPHYSIOL, V41, P692, DOI 10.1152/jn.1978.41.3.692; Rossi AF, 1996, VISION RES, V36, P1391, DOI 10.1016/0042-6989(95)00206-5; SCHREINER C, 1980, HEARING RES, V3, P265, DOI 10.1016/0378-5955(80)90022-2; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Sivonen P, 2006, NEUROSCI LETT, V408, P220, DOI 10.1016/j.neulet.2006.09.001; Slaney M., 1993, 35 APPL COMP, P1; Slaney M., 1998, 1998010 INT RES CORP, P1; STEINSCHNEIDER M, 1995, BRAIN RES, V674, P147, DOI 10.1016/0006-8993(95)00008-E; Sugita Y, 1997, NEUROREPORT, V8, P1155, DOI 10.1097/00001756-199703240-00019; Sutter ML, 2005, INT REV NEUROBIOL, V70, P253, DOI 10.1016/S0074-7742(05)70008-8; Walton JP, 1997, J COMP PHYSIOL A, V181, P161, DOI 10.1007/s003590050103; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WARREN RM, 1988, J ACOUST SOC AM, V84, P1338, DOI 10.1121/1.396632; WARREN RM, 1994, PERCEPT PSYCHOPHYS, V55, P313, DOI 10.3758/BF03207602; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; WRIGHTSON JM, 1981, J ACOUST SOC AM, V69, pS105	63	84	85	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					153	165		10.1016/j.neuron.2007.02.031	http://dx.doi.org/10.1016/j.neuron.2007.02.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408584	Green Accepted, Bronze			2022-12-24	WOS:000245848400016
J	Putignano, E; Lonetti, G; Cancedda, L; Ratto, G; Costa, M; Maffei, L; Pizzorusso, T				Putignano, Elena; Lonetti, Giuseppina; Cancedda, Laura; Ratto, Gianmichele; Costa, Mario; Maffei, Larnberto; Pizzorusso, Tommaso			Developmental Downregulation of histone posttranslational modifications regulates visual cortical plasticity	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; STRESS-INDUCED PHOSPHORYLATION; CRITICAL PERIOD PLASTICITY; MAMMALIAN CIRCADIAN CLOCK; MEDIATED GENE-EXPRESSION; GROWTH-FACTOR; TRANSCRIPTIONAL REGULATION; BINDING PROTEIN; MAP KINASE	The action of visual experience on visual cortical circuits is maximal during a critical period of postnatal development. The long-term effects of this experience are likely mediated by signaling cascades regulating experiencedependent gene transcription. Developmental modifications of these pathways could explain the difference in plasticity between the young and adult cortex. We studied the pathways linking experience-dependent activation of ERK to CREB-mediated gene expression in vivo. In juvenile mice, visual stimulation that activates CREB-mediated gene transcription also induced ERK-dependent MSK and histone H3 phosphorylation and H3-H4 acetylation, an epigenetic mechanism of gene transcription activation. In adult animals, ERK and MSK were still inducible; however, visual stimulation induced weak CREB-mediated gene expression and H3-H4 posttranslational modifications. Stimulation of histone acetylation in adult animals by means of trichostatin promoted ocular dominance plasticity. Thus, differing, experiencedependent activations of signaling molecules might be at the basis of the differences in experience-dependent plasticity between juvenile and adult cortex.	CNR, Area Ric, Ist Neurosci, I-56125 Pisa, Italy; Univ Florence, Dept Psychol, I-50125 Florence, Italy; Scuola Normale Super Pisa, CNRS, Area Ric, Neurobiol Lab, I-56125 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Florence; Scuola Normale Superiore di Pisa	Pizzorusso, T (corresponding author), CNR, Area Ric, Ist Neurosci, Via Moruzzi,1, I-56125 Pisa, Italy.	tommaso@in.cnr.it	Costa, Mario/AAC-2362-2022; Ratto, Gian Michele/AAX-8514-2020; Ratto, Gian Michele/AAB-8719-2021; Pizzorusso, Tommaso/D-1399-2013	Ratto, Gian Michele/0000-0001-9632-7769; Pizzorusso, Tommaso/0000-0001-5614-0668; COSTA, Mario/0000-0001-5821-9871; Putignano, Elena/0000-0002-4313-408X; Cancedda, Laura/0000-0003-0566-057X				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; BODE AM, 2005, SCI STKE, DOI DOI 10.1126/ST5E.2812005RE4; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Butcher GQ, 2004, EUR J NEUROSCI, V19, P907, DOI 10.1111/j.0953-816X.2004.03155.x; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; Chang JH, 2006, J NEUROCHEM, V99, P1517, DOI 10.1111/j.1471-4159.2006.04196.x; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; Gordon JA, 1996, J NEUROSCI, V16, P3274; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Kaminska B, 1999, MOL CELL NEUROSCI, V13, P405, DOI 10.1006/mcne.1999.0757; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lachance PED, 2004, J NEUROCHEM, V88, P1455, DOI 10.1046/j.1471-4159.2003.02274.x; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Neely KE, 2002, MOL GENET METAB, V76, P1, DOI 10.1016/S1096-7192(02)00014-8; Ossipow V, 2004, MOL CELL NEUROSCI, V27, P70, DOI 10.1016/j.mcn.2004.05.003; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Prasad SS, 2002, NEUROSCIENCE, V111, P35, DOI 10.1016/S0306-4522(01)00570-X; Prusky GT, 2000, EUR J NEUROSCI, V12, P3781, DOI 10.1046/j.1460-9568.2000.00236.x; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schuett S, 2002, J NEUROSCI, V22, P6549; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Suzuki S, 2004, J COMP NEUROL, V479, P70, DOI 10.1002/cne.20310; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wood MA, 2006, LEARN MEMORY, V13, P241, DOI 10.1101/lm.278206; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	75	154	161	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					747	759		10.1016/j.neuron.2007.02.007	http://dx.doi.org/10.1016/j.neuron.2007.02.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329213	Bronze			2022-12-24	WOS:000245127100014
J	Karmarkar, UR; Buonomano, DV				Karmarkar, Urna R.; Buonomano, Dean V.			Timing in the absence of clocks: Encoding time in neural network states	NEURON			English	Article							TEMPORAL INFORMATION; WORKING-MEMORY; REPRESENTATION; DISCRIMINATION; INTERVAL; MECHANISMS; CORTEX; AREA; PERCEPTION; ACTIVATION	Decisions based on the timing of sensory events are fundamental to sensory processing. However, the mechanisms by which the brain measures time over ranges of milliseconds to seconds remain unclear. The dominant model of temporal processing proposes that an oscillator emits events that are integrated to provide a linear metric of time. We examine an alternate model in which cortical networks are inherently able to tell time as a result of time-dependent changes in network state. Using computer simulations we show that within this framework, there is no linear metric of time, and that a given interval is encoded in the context of preceding events. Human psychophysical studies were used to examine the predictions of the model. Our results provide theoretical and experimental evidence that, for short intervals, there is no linear metric of time, and that time may be encoded in the high-dimensional state of local neural networks.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	dbuono@ucla.edu			NIMH NIH HHS [R01 MH060163, MH60163] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060163] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; Brody CD, 2002, PHILOS T R SOC B, V357, P1843, DOI 10.1098/rstb.2002.1167; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; CHURCH RM, 1984, PROPERTIES INTERNAL, V423, P556; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Grondin S, 2003, Q J EXP PSYCHOL-A, V56, P731, DOI 10.1080/02724980244000611; GRONDIN S, 1991, PERCEPT PSYCHOPHYS, V49, P245, DOI 10.3758/BF03214309; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; KRUSEL P, 2004, NEURAL COMPUT, V16, P2079; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; MACAR F, 1994, MEM COGNITION, V22, P673, DOI 10.3758/BF03209252; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; MECK WH, 1984, ANN NY ACAD SCI, V423, P528, DOI 10.1111/j.1749-6632.1984.tb23457.x; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Meegan DV, 2000, NAT NEUROSCI, V3, P860, DOI 10.1038/78757; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Rammsayer T, 2001, PSYCHON B REV, V8, P270, DOI 10.3758/BF03196161; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; Reyes A, 1999, J NEUROSCI, V19, P3827; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wright BA, 1997, J NEUROSCI, V17, P3956; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; ZAKAY D, 1989, B PSYCHONOMIC SOC, V27, P209, DOI 10.3758/BF03334586; Zhang ZW, 2004, J NEUROPHYSIOL, V91, P1171, DOI 10.1152/jn.00855.2003; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	66	352	358	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					427	438		10.1016/j.neuron.2007.01.006	http://dx.doi.org/10.1016/j.neuron.2007.01.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	149DI	17270738	Bronze, Green Accepted			2022-12-24	WOS:000245126800012
J	Edenfeld, G; Volohonsky, G; Krukkert, K; Naffin, E; Lammel, U; Grimm, A; Engelen, D; Reuveny, A; Volk, T; Klambt, C				Edenfeld, Gundula; Volohonsky, Gloria; Krukkert, Karin; Naffin, Elke; Lammel, Uwe; Grimm, Alexandra; Engelen, Daniel; Reuveny, Adriana; Volk, Talila; Klaembt, Christian			The splicing factor crooked neck associates with the RNA-binding protein HOW to control glial cell maturation in Drosophila	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; TRANSMEMBRANE PROTEIN; SIGNAL-TRANSDUCTION; CYCLE PROGRESSION; HNRNPA/B HOMOLOG; 2 ISOFORMS; GENE; QUAKING; SPLICEOSOME; ENCODES	In both vertebrates and invertebrates, glial cells wrap axonal processes to ensure electrical conductance. Here we report that Crooked neck (Crn), the Drosophila homolog of the yeast Clf1p splicing factor, is directing peripheral glial cell maturation. We show that crooked neck is expressed and required in glial cells to control migration and axonal wrapping. Within the cytoplasm, Crn interacts with the RNA-binding protein HOW and then translocates to the nucleus where the Crn/HOW complex controls glial differentiation by facilitating splicing of specific target genes. By using a GFP-exon trap approach, we identified some of the in vivo target genes that encode proteins localized in autocellular septate junctions. In conclusion, here we show that glial cell differentiation is controlled by a cytoplasmic assembly of splicing components, which upon translocation to the nucleus promote the splicing of genes involved in the assembly of cellular junctions.	Univ Munster, Inst Neurobiol, D-48149 Munster, Germany; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	University of Munster; Weizmann Institute of Science	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, D-48149 Munster, Germany.	klaembt@uni-muenster.de						AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Ben-Yehuda S, 2000, GENETICS, V154, P61; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodu V, 2004, DEV CELL, V7, P885, DOI 10.1016/j.devcel.2004.10.016; Burnette JM, 1999, GENETICS, V151, P1517; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Chung SY, 2002, BBA-GENE STRUCT EXPR, V1576, P287, DOI 10.1016/S0167-4781(02)00368-8; Cox RD, 1999, GENOMICS, V57, P333, DOI 10.1006/geno.1999.5804; Davis AD, 1999, NATURE, V398, P571, DOI 10.1038/19212; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; EDENFELD E, 2006, IN PRESS DEVC BIOL; Edenfeld G, 2005, CURR OPIN NEUROBIOL, V15, P34, DOI 10.1016/j.conb.2005.01.007; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Gasch A, 2006, J BIOL CHEM, V281, P356, DOI 10.1074/jbc.M508047200; Granderath S, 2000, MECH DEVELOP, V91, P197, DOI 10.1016/S0925-4773(99)00304-4; GRANDERATH S, 1999, GLIAL CELL DEVEL, P245; Hardy RJ, 1998, J NEUROSCI RES, V51, P417, DOI 10.1002/(SICI)1097-4547(19980215)51:4<417::AID-JNR1>3.0.CO;2-F; Hidalgo A, 2003, MECH DEVELOP, V120, P1311, DOI 10.1016/j.mod.2003.06.004; Hummel T, 1999, DEVELOPMENT, V126, P771; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Jones BW, 2005, DEV BIOL, V278, P265, DOI 10.1016/j.ydbio.2004.11.022; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; Lee BP, 2005, MECH DEVELOP, V122, P849, DOI 10.1016/j.mod.2005.01.002; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; Lenz PH, 2000, J COMP PHYSIOL A, V186, P337, DOI 10.1007/s003590050434; Lo PCH, 1997, DEV BIOL, V190, P241, DOI 10.1006/dbio.1997.8699; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nabel-Rosen H, 2005, CURR BIOL, V15, P295, DOI 10.1016/j.cub.2005.01.045; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pielage J, 2004, DEV BIOL, V275, P245, DOI 10.1016/j.ydbio.2004.07.039; POZZOLI U, 2005, CELL MOL LIFE SCI, P62; Raisin-Tani S, 2002, BIOCHEM BIOPH RES CO, V296, P288, DOI 10.1016/S0006-291X(02)00863-X; Russell CS, 2000, RNA, V6, P1565, DOI 10.1017/S1355838200000984; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Sepp KJ, 2003, J NEUROSCI, V23, P8221; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2003, DEVELOPMENT, V130, P1825, DOI 10.1242/dev.00413; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Stollewerk A, 1996, MICROSC RES TECHNIQ, V35, P294, DOI 10.1002/(SICI)1097-0029(19961015)35:3&lt;294::AID-JEMT8&gt;3.0.CO;2-N; Stollewerk A, 1997, DEV GENES EVOL, V207, P402, DOI 10.1007/s004270050129; TEPASS U, 1994, DEVELOPMENT, V120, P579; Van de Bor V, 2002, CURR OPIN GENET DEV, V12, P465, DOI 10.1016/S0959-437X(02)00327-1; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; VOLOHONSKY G, 2007, IN PRESS DEVELOPMENT; Wang Q, 2003, J BIOL CHEM, V278, P7875, DOI 10.1074/jbc.M210839200; Weatherby TM, 2000, J COMP PHYSIOL A, V186, P347, DOI 10.1007/s003590050435; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Zaffran S, 1997, DEVELOPMENT, V124, P2087; ZHANG K, 1991, GENE DEV, V5, P1080, DOI 10.1101/gad.5.6.1080; Zhu WG, 2002, GENETICS, V160, P1319	71	49	50	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					969	980		10.1016/j.neuron.2006.10.029	http://dx.doi.org/10.1016/j.neuron.2006.10.029			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178401	Bronze			2022-12-24	WOS:000243115100006
J	Priel, A; Selak, S; Lerma, J; Stern-Bach, Y				Priel, Avi; Selak, Sanja; Lerma, Juan; Stern-Bach, Yael			Block of kainate receptor desensitization uncovers a key trafficking checkpoint	NEURON			English	Article							LIGAND-BINDING CORE; AMINO-ACID-RESIDUES; GLUTAMATE-RECEPTOR; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; CRYSTAL-STRUCTURES; REDUCES DESENSITIZATION; MOLECULAR-MECHANISMS; SURFACE EXPRESSION; AMPA RECEPTORS	A prominent feature of ionotropic glutamate receptors from the AMPA and kainate subtypes is their profound desensitization in response to glutamate-a process thought to protect the neuron from overexcitation. In AMPA receptors, it is well established that desensitization results from rearrangements of the interface formed between agonist-binding domains of adjacent subunits; however, it is unclear how this mechanism applies to kainate receptors. Here we show that stabilization of the binding domain dimer by the generation of intermolecular disulfide bonds apparently blocked desensitization of the kainate receptor GluR6. This result establishes a common desensitization mechanism in both AMPA and kainate receptors. Surprisingly, however, surface expression of these nondesensitizing mutants was drastically reduced and did not depend on channel activity. Therefore, in addition to its role at the synapse, we now propose an intracellular role for desensitization in controlling maturation and trafficking of glutamate receptors.	Hebrew Univ Jerusalem, Hadassah Dent Sch, Inst Basic Dent Sci, IL-91120 Jerusalem, Israel; UMH, CSIC, Inst Neurosci Alicante, Alacant 03550, Spain	Hebrew University of Jerusalem; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Stern-Bach, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Dent Sch, Inst Basic Dent Sci, IL-91120 Jerusalem, Israel.	yaelb@cc.huji.ac.il	Priel, Avi/ABB-1721-2020; Lerma, Juan/G-7907-2015	Priel, Avi/0000-0002-6105-5035; Lerma, Juan/0000-0001-7838-5199				Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fleck MW, 2003, J NEUROSCI, V23, P1219; Frandsen A, 2003, NEUROCHEM RES, V28, P1495, DOI 10.1023/A:1025666207754; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Holm MM, 2005, J BIOL CHEM, V280, P35469, DOI 10.1074/jbc.M507800200; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Ratnam J, 2005, J NEUROCHEM, V92, P878, DOI 10.1111/j.1471-4159.2004.02936.x; Ren Z, 2003, J NEUROSCI, V23, P6608; Robert A, 2002, NEUROSCIENCE, V115, P1199, DOI 10.1016/S0306-4522(02)00534-1; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Selak S, 2006, NEUROSCIENCE, V143, P953, DOI 10.1016/j.neuroscience.2006.10.014; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Vandenberghe W, 2004, CURR OPIN CELL BIOL, V16, P134, DOI 10.1016/j.ceb.2004.01.003; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004; Zhang YH, 2006, J NEUROSCI, V26, P10033, DOI 10.1523/JNEUROSCI.2750-06.2006	48	51	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1037	1046		10.1016/j.neuron.2006.12.006	http://dx.doi.org/10.1016/j.neuron.2006.12.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178406	Bronze			2022-12-24	WOS:000243115100011
J	Park, M; Salgado, JM; Ostroff, L; Helton, TD; Robinson, CG; Harris, KM; Ehlers, MD				Park, Mikyoung; Salgado, Jennifer M.; Ostroff, Linnaea; Helton, Thomas D.; Robinson, Camenzind G.; Harris, Kristen M.; Ehlers, Michael D.			Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes	NEURON			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTORS; MEMBRANE; DYNAMICS; MORPHOGENESIS; LTP; ORGANIZATION; MODULATION; ACTIVATION; INDUCTION	Dendritic spines are micron-sized membrane protrusions receiving most excitatory synaptic inputs in the mammalian brain. Spines form and grow during long-term potentiation (LTP) of synaptic strength. However, the source of membrane for spine formation and enlargement is unknown. Here we report that membrane trafficking from recycling endosomes is required for the growth and maintenance of spines. Using live-cell imaging and serial section electron microscopy, we demonstrate that LTP-inducing stimuli promote the mobilization of recycling endosomes and vesicles into spines. Preventing recycling endosomal transport abolishes LTP-induced spine formation. Using a pH-sensitive recycling cargo, we show that exocytosis from recycling endosomes occurs locally in spines, is triggered by activation of synaptic NMDA receptors, and occurs concurrently with spine enlargement. Thus, recycling endosomes provide membrane for activity-dependent spine growth and remodeling, defining a novel membrane trafficking mechanism for spine morphological plasticity and providing a mechanistic link between structural and functional plasticity during LTP.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Med Coll Georgia, Dept Neurol, Synapses & Cognit Neurosci Ctr, Augusta, GA 30912 USA; Univ Texas, Neurobiol Sect, Ctr Learning & Memory, Austin, TX 78712 USA	Duke University; Duke University; Howard Hughes Medical Institute; University System of Georgia; Augusta University; University of Texas System; University of Texas Austin	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Robinson, Camenzind G/O-5097-2018	Robinson, Camenzind G/0000-0002-7277-692X; Harris, Kristen/0000-0002-1943-4744; Ostroff, Linnaea/0000-0002-3348-342X	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021184, R37NS021184, R01NS047574, R01NS033574, R23NS021184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG024492, R01 AG024492-03, AG024492, R01 AG024492-02, R01 AG024492-01] Funding Source: Medline; NIBIB NIH HHS [R01 EB002170, EB002170] Funding Source: Medline; NIMH NIH HHS [R01 MH064748, R01 MH064748-05, R01 MH064748-01, R01 MH064748-03, R01 MH064748-04, R01 MH064748-02, MH064748] Funding Source: Medline; NINDS NIH HHS [R01 NS021184, R37 NS021184, NS33574, R01 NS047574-01A2, R01 NS047574, NS21184, R01 NS033574] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Prekeris R, 1999, J NEUROSCI, V19, P10324; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541	48	369	380	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					817	830		10.1016/j.neuron.2006.09.040	http://dx.doi.org/10.1016/j.neuron.2006.09.040			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145503	Green Accepted, Bronze			2022-12-24	WOS:000242856400010
J	Schenk, T				Schenk, Thomas			An allocentric rather than perceptual deficit in patient DF	NATURE NEUROSCIENCE			English	Article							VISUAL FORM AGNOSIA; OPTIC ATAXIA; ILLUSIONS	The perception/action model states that vision for perception and vision for action are processed in separate pathways. This model was inspired by observations in patient D. F. who seemed unable to use vision for perceptual tasks while retaining 'normal' visuomotor capacity. I found that D.F.'s performance is preserved in perceptual and visuomotor tasks when the required spatial information is hand-centered and impaired when the information is object-centered.	Univ Durham, Wolfson Res Inst, Cognit Neurosci Res Unit, Stockton On Tees TS17 6BH, England	Durham University	Schenk, T (corresponding author), Univ Durham, Wolfson Res Inst, Cognit Neurosci Res Unit, Queens Campus, Stockton On Tees TS17 6BH, England.	thomas.schenk@dur.ac.uk	S, T/GXF-0648-2022; S, T/GRY-0013-2022		MRC [G0401090] Funding Source: UKRI; Medical Research Council [G0401090] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bruno N, 2001, TRENDS COGN SCI, V5, P379, DOI 10.1016/S1364-6613(00)01725-3; Carey DP, 1996, NEUROPSYCHOLOGIA, V34, P329, DOI 10.1016/0028-3932(95)00169-7; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Franz VH, 2001, J EXP PSYCHOL HUMAN, V27, P1124, DOI 10.1037//0096-1523.27.5.1124; Glover S, 2002, TRENDS COGN SCI, V6, P288, DOI 10.1016/S1364-6613(02)01920-4; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; JACOB P, 2003, WAYS SEEING SCOPE LI; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Milner A. D., 1995, VISUAL BRAIN ACTION; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Norman J, 2002, BEHAV BRAIN SCI, V25, P73, DOI 10.1017/S0140525X0200002X; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549	15	120	120	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1369	1370		10.1038/nn1784	http://dx.doi.org/10.1038/nn1784			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028584	Green Accepted			2022-12-24	WOS:000242403800013
J	Uemura, M; Nakao, S; Suzuki, ST; Takeichi, M; Hirano, S				Uemura, Masato; Nakao, Shinsuke; Suzuki, Shintaro T.; Takeichi, Masatoshi; Hirano, Shinji			OL-protocadherin is essential for growth of striatal axons and thalamocortical projections	NATURE NEUROSCIENCE			English	Article							GANGLIONIC EMINENCE; GAMMA-PROTOCADHERINS; INTERMEDIATE TARGET; MOUSE-BRAIN; CORTEX; MICE; CONNECTIVITY; EXPRESSION; NEURONS; SYSTEM	The ventral telencephalon in the embryonic brain is thought to provide guidance cues for navigation of thalamocortical axons, but the mechanisms involved remain largely elusive. OL-protocadherin ( OL-pc), a member of the cadherin superfamily, is highly expressed by striatal neurons in the developing ventral telencephalon. Here we show that OL-pc-deficient ( Pcdh10(-/-)) mice have defects in axon pathways through the ventral telencephalon; for example, thalamocortical and corticothalamic projections cannot cross the ventral telencephalon. In the ventral telencephalon, striatal axons fail to grow out, and, concomitantly, the caudal portion of the globus pallidus and the associated 'corridor' thought to be important for thalamocortical fiber navigation do not form. The inability of the striatum to extend axons is also observed in vitro. These results show that OL-pc is essential for both elongation of striatal axons and patterning of the putative guidance cues for thalamocortical projections.	Ctr Dev Biol, RIKEN, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan; Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	RIKEN; Kyoto University; Kwansei Gakuin University; Japan Science & Technology Agency (JST)	Takeichi, M (corresponding author), Ctr Dev Biol, RIKEN, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp; s-hirano@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378				Aoki E, 2003, NEUROSCIENCE, V117, P593, DOI 10.1016/S0306-4522(02)00944-2; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Garel S, 1999, DEVELOPMENT, V126, P5285; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Hanashima C, 2006, CELL, V125, P24, DOI 10.1016/j.cell.2006.03.021; Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972; Hirano S, 1999, J NEUROSCI, V19, P995; Hogan B, 1994, MANIPULATING MOUSE E; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jones L, 2002, DEVELOPMENT, V129, P5041; Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Luckner R, 2001, CELL TISSUE RES, V303, P159, DOI 10.1007/s004410000292; Metin C, 1996, J NEUROSCI, V16, P3219; Metin C, 1997, DEVELOPMENT, V124, P5063; MITROFANIS J, 1993, TRENDS NEUROSCI, V16, P240, DOI 10.1016/0166-2236(93)90163-G; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Muller K, 2004, J COMP NEUROL, V470, P240, DOI 10.1002/cne.11044; Nakao S, 2005, MOL BRAIN RES, V134, P294, DOI 10.1016/j.molbrainres.2004.11.017; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Phillips GR, 2003, J NEUROSCI, V23, P5096; Polleux F, 2005, NEURON, V46, P395, DOI 10.1016/j.neuron.2005.04.017; Redies C, 2005, CELL MOL LIFE SCI, V62, P2840, DOI 10.1007/s00018-005-5320-z; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Ulupinar E, 1999, MOL CELL NEUROSCI, V13, P281, DOI 10.1006/mcne.1999.0747; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; Yun KS, 2003, J COMP NEUROL, V461, P151, DOI 10.1002/cne.10685	42	120	120	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1151	1159		10.1038/nn1960	http://dx.doi.org/10.1038/nn1960			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17721516				2022-12-24	WOS:000249144000017
J	Mrsic-Flogel, TD; Hofer, SB; Ohki, K; Reid, RC; Bonhoeffer, T; Hubener, M				Mrsic-Flogel, Thomas D.; Hofer, Sonja B.; Ohki, Kenichi; Reid, R. Clay; Bonhoeffer, Tobias; Huebener, Mark			Homeostatic regulation of eye-specific responses in visual cortex during ocular dominance plasticity	NEURON			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; MONOCULAR DEPRIVATION; IN-VIVO; NEURONAL POPULATIONS; DENDRITIC SPINES; MOUSE; METAPLASTICITY; COMPETITION; NETWORKS	Experience-dependent plasticity is crucial for the precise formation of neuronal connections during development. It is generally thought to depend on Hebbian forms of synaptic plasticity. In addition, neurons possess other, homeo-static means of compensating for changes in sensory input, but their role in cortical plasticity is unclear. We used two-photon calcium imaging to investigate whether homeostatic response regulation contributes to changes of eye-specific responsiveness after monocular deprivation (MD) in mouse visual cortex. Short MD durations decreased deprived-eye responses in neurons with binocular input. Longer MD periods strengthened open-eye responses, and surprisingly, also increased deprived-eye responses in neurons devoid of open-eye input. These bidirectional response adjustments effectively preserved the net visual drive for each neuron. Our finding that deprived-eye responses were either weaker or stronger after MD, depending on the amount of open-eye input a cell received, argues for both Hebbian and homeostatic mechanisms regulating neuronal responsiveness during experience-dependent plasticity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Martinsried, Germany	Harvard University; Harvard Medical School; Max Planck Society	Mrsic-Flogel, TD (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	flogel@neuro.mpg.de; mark@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Antonini A, 1999, J NEUROSCI, V19, P4388; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blais BS, 1999, P NATL ACAD SCI USA, V96, P1083, DOI 10.1073/pnas.96.3.1083; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; CLOTHIAUX EE, 1991, J NEUROPHYSIOL, V66, P1785, DOI 10.1152/jn.1991.66.5.1785; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Desai NS, 2003, J PHYSIOL-PARIS, V97, P391, DOI 10.1016/j.jphysparis.2004.01.005; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; DRAGER UC, 1974, BRAIN RES, V82, P284, DOI 10.1016/0006-8993(74)90607-6; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; Gordon JA, 1996, J NEUROSCI, V16, P3274; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; METIN C, 1988, EXP BRAIN RES, V69, P594; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schuett S, 2002, J NEUROSCI, V22, P6549; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yang YP, 2005, NAT NEUROSCI, V8, P791, DOI 10.1038/nn1464	48	236	238	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2007	54	6					961	972		10.1016/j.neuron.2007.05.028	http://dx.doi.org/10.1016/j.neuron.2007.05.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582335	Bronze			2022-12-24	WOS:000247645600014
J	Wilmer, JB; Nakayama, K				Wilmer, Jeremy B.; Nakayama, Ken			Two distinct visual motion mechanisms for smooth pursuit: Evidence from individual differences	NEURON			English	Article							TRACKING EYE-MOVEMENTS; 2ND-ORDER MOTION; APPARENT MOTION; TEMPORAL PROPERTIES; TARGET SELECTION; AREA MT; PERCEPTION; INITIATION; VELOCITY; POSITION	Smooth-pursuit eye velocity to a moving target is more accurate after an initial catch-up saccade than before, an enhancement that is poorly understood. We present an individual-differences-based method for identifying mechanisms underlying a physiological response and use it to test whether visual motion signals driving pursuit differ pre- and postsaccade. Correlating moment-to-moment measurements of pursuit over time with two psychophysical measures of speed estimation during fixation, we find two independent associations across individuals. Presaccadic pursuit acceleration is predicted by the precision of low-level (motion-energy-based) speed estimation, and postsaccadic pursuit precision is predicted by the precision of high-level (position-tracking) speed estimation. These results provide evidence that a low-level motion signal influences presaccadic acceleration and an independent high-level motion signal influences postsaccadic precision, thus presenting a plausible mechanism for postsaccadic enhancement of pursuit.	Univ Penn, Sch Arts & Sci, Dept Psychol, Philadelphia, PA 19104 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Pennsylvania; Harvard University	Wilmer, JB (corresponding author), Univ Penn, Sch Arts & Sci, Dept Psychol, Philadelphia, PA 19104 USA.	wilmer@sas.upenn.edu			NEI NIH HHS [F32 EY016933-02, F32 EY016933, F32 EY016933-03, F32 EY016933-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY016933] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ANSTIS SM, 1980, PHILOS T ROY SOC B, V290, P153, DOI 10.1098/rstb.1980.0088; Baker CL, 1998, VISION RES, V38, P291, DOI 10.1016/S0042-6989(97)00069-2; Battelli L, 2001, NEURON, V32, P985, DOI 10.1016/S0896-6273(01)00536-0; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; Butzer F, 1997, EXP BRAIN RES, V115, P61, DOI 10.1007/PL00005686; CARL JR, 1987, J NEUROPHYSIOL, V57, P1446, DOI 10.1152/jn.1987.57.5.1446; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Claeys KG, 2003, NEURON, V40, P631, DOI 10.1016/S0896-6273(03)00590-7; Culham JC, 2000, NEURON, V28, P607, DOI 10.1016/S0896-6273(00)00137-9; FISCHER B, 1984, EXP BRAIN RES, V57, P191; Gardner JL, 2002, NAT NEUROSCI, V5, P892, DOI 10.1038/nn897; Gardner JL, 2001, J NEUROSCI, V21, P2075, DOI 10.1523/JNEUROSCI.21-06-02075.2001; Hawken MJ, 2001, J OPT SOC AM A, V18, P2282, DOI 10.1364/JOSAA.18.002282; Heinen SJ, 1998, VISION RES, V38, P3785, DOI 10.1016/S0042-6989(97)00422-7; Kosslyn SM, 2002, AM PSYCHOL, V57, P341, DOI 10.1037//0003-066X.57.5.341; KOWLER E, 1987, VISION RES, V27, P993, DOI 10.1016/0042-6989(87)90014-9; KRAUZLIS RJ, 1994, J NEUROPHYSIOL, V72, P150, DOI 10.1152/jn.1994.72.1.150; Lindner A, 2000, EXP BRAIN RES, V133, P450, DOI 10.1007/s002210000459; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918, DOI 10.1152/jn.1998.79.4.1918; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; MANDLER MB, 1984, VISION RES, V24, P1881, DOI 10.1016/0042-6989(84)90021-X; Masson GS, 2002, J NEUROPHYSIOL, V88, P2869, DOI 10.1152/jn.00987.2001; MCKEE SP, 1986, VISION RES, V26, P609, DOI 10.1016/0042-6989(86)90009-X; Merchant H, 2005, EXP BRAIN RES, V161, P532, DOI 10.1007/s00221-004-2100-1; MORRIS EJ, 1987, J NEUROPHYSIOL, V58, P1351, DOI 10.1152/jn.1987.58.6.1351; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; NAKAYAMA K, 1981, VISION RES, V21, P427, DOI 10.1016/0042-6989(81)90089-4; NISHIDA S, 1995, VISION RES, V35, P477, DOI 10.1016/0042-6989(94)00144-B; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Peterzell DH, 2000, VISION RES, V40, P417, DOI 10.1016/S0042-6989(99)00187-X; POLA J, 1980, VISION RES, V20, P523, DOI 10.1016/0042-6989(80)90127-3; Priebe NJ, 2001, J NEUROSCI, V21, P3196, DOI 10.1523/JNEUROSCI.21-09-03196.2001; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Schmidt FL, 1996, PSYCHOL METHODS, V1, P199, DOI 10.1037/1082-989X.1.2.199; Schoppik D, 2006, J NEUROSCI, V26, P7607, DOI 10.1523/JNEUROSCI.1719-06.2006; SEGRAVES MA, 1994, VISION RES, V34, P2477, DOI 10.1016/0042-6989(94)90291-7; Seiffert AE, 1998, VISION RES, V38, P3569, DOI 10.1016/S0042-6989(98)00035-2; Seiffert AE, 1999, VISION RES, V39, P4172, DOI 10.1016/S0042-6989(99)00129-7; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; TYCHSEN L, 1986, J NEUROPHYSIOL, V56, P953, DOI 10.1152/jn.1986.56.4.953; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; YASUI S, 1975, SCIENCE, V190, P906, DOI 10.1126/science.1188373	51	46	48	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 21	2007	54	6					987	1000		10.1016/j.neuron.2007.06.007	http://dx.doi.org/10.1016/j.neuron.2007.06.007			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582337	Bronze, Green Accepted			2022-12-24	WOS:000247645600016
J	Bendor, D; Wang, XQ				Bendor, Daniel; Wang, Xiaoqin			Differential neural coding of acoustic flutter within primate auditory cortex	NATURE NEUROSCIENCE			English	Article							AMPLITUDE-MODULATED SOUNDS; PERCEPTUAL DISCRIMINATION; FREQUENCY DISCRIMINATION; SOMATOSENSORY CORTEX; TEMPORAL MODULATIONS; SINGLE NEURONS; MACAQUE MONKEY; VISUAL-CORTEX; STIMULI; REPRESENTATIONS	A sequence of acoustic events is perceived either as one continuous sound or as a stream of temporally discrete sounds (acoustic flutter), depending on the rate at which the acoustic events repeat. Acoustic flutter is perceived at repetition rates near or below the lower limit for perceiving pitch, and is akin to the discrete percepts of visual flicker and tactile flutter caused by the slow repetition of sensory stimulation. It has been shown that slowly repeating acoustic events are represented explicitly by stimulus-synchronized neuronal firing patterns in primary auditory cortex (AI). Here we show that a second neural code for acoustic flutter exists in the auditory cortex of marmoset monkeys (Callithrix jacchus), in which the firing rate of a neuron is a monotonic function of an acoustic event's repetition rate. Whereas many neurons in AI encode acoustic flutter using a dual temporal/rate representation, we find that neurons in cortical fields rostral to AI predominantly use a monotonic rate code and lack stimulus-synchronized discharges. These findings indicate that the neural representation of acoustic flutter is transformed along the caudal-to-rostral axis of auditory cortex.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA	Johns Hopkins University	Bendor, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, 720 Rutland Ave,Traylor Bldg 412, Baltimore, MD 21205 USA.	dbendor@jhu.edu; xiaoqin.wang@jhu.edu		Bendor, Daniel/0000-0001-6621-793X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180, F31DC006528] Funding Source: NIH RePORTER; NIDCD NIH HHS [F31 DC006528, F31 DC 006528, DC 03180, R01 DC003180] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; BESSER GM, 1967, NATURE, V214, P17, DOI 10.1038/214017a0; Bieser A, 1996, EXP BRAIN RES, V108, P273; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; DiMattina C, 2006, J NEUROPHYSIOL, V95, P1244, DOI 10.1152/jn.00818.2005; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; Fishman YI, 2000, J ACOUST SOC AM, V108, P235, DOI 10.1121/1.429460; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6485, DOI 10.1523/JNEUROSCI.5061-05.2006; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; HARTMANN E, 1979, VISION RES, V19, P1019, DOI 10.1016/0042-6989(79)90227-X; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Lu T, 2004, J NEUROPHYSIOL, V91, P301, DOI 10.1152/jn.00022.2003; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Mardia K. V., 2000, DIRECTIONAL STAT; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MILLER GA, 1948, J ACOUST SOC AM, V20, P171, DOI 10.1121/1.1906360; MOODY DB, 1994, J ACOUST SOC AM, V95, P3499, DOI 10.1121/1.409967; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; MOUNTCAS.VB, 1967, SCIENCE, V155, P597, DOI 10.1126/science.155.3762.597; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Pistorio AL, 2006, J ACOUST SOC AM, V120, P1655, DOI 10.1121/1.2225899; POLLACK I, 1968, J ACOUST SOC AM, V43, P1107, DOI 10.1121/1.1910945; POLLACK I, 1969, J ACOUST SOC AM, V46, P422, DOI 10.1121/1.1911706; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Salinas E, 2006, PLOS BIOL, V4, P2383, DOI 10.1371/journal.pbio.0040387; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Williams PE, 2004, J NEUROSCI, V24, P8278, DOI 10.1523/JNEUROSCI.2716-04.2004	50	107	109	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					763	771		10.1038/nn1888	http://dx.doi.org/10.1038/nn1888			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468752				2022-12-24	WOS:000246799800019
J	Rokni, U; Richardson, AG; Bizzi, E; Seung, HS				Rokni, Uri; Richardson, Andrew G.; Bizzi, Emilio; Seung, H. Sebastian			Motor learning with unstable neural representations	NEURON			English	Article							DIRECT CORTICAL CONTROL; NEURONAL-ACTIVITY; CORTEX; STABILITY; PREMOTOR; FIELD; AREA; ORGANIZATION; ENVIRONMENT; RECORDINGS	It is often assumed that learning takes place by changing an otherwise stable neural representation. To test this assumption, we studied changes in the directional tuning of primate motor cortical neurons during reaching movements performed in familiar and novel environments. During the familiar task, tuning curves exhibited slow random drift. During learning of the novel task, random drift was accompanied by systematic shifts of tuning curves. Our analysis suggests that motor learning is based on a surprisingly unstable neural representation. To explain these results, we propose that motor cortex is a redundant neural network, i.e., any single behavior can be realized by multiple configurations of synaptic strengths. We further hypothesize that synaptic modifications underlying learning contain a random component, which causes wandering among synaptic configurations with equivalent behaviors but different neural representations. We use a simple model to explore the implications of these assumptions.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Rokni, U (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	rokniu@mit.edu	Richardson, Andrew G./AAI-1645-2020	Richardson, Andrew G./0000-0002-4752-3867; /0000-0002-7644-4498				Amirikian B, 2003, P NATL ACAD SCI USA, V100, P12474, DOI 10.1073/pnas.2037719100; Ben-Shaul Y, 2003, J NEUROPHYSIOL, V89, P1136, DOI 10.1152/jn.00364.2002; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P786, DOI 10.1152/jn.1985.53.3.786; CHRISTENSEN R, 2001, ADV LINEAR MODELING, P1; Cohen D, 2004, J NEUROSCI, V24, P3574, DOI 10.1523/JNEUROSCI.5361-03.2004; Fiete IR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048104; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Greenberg PA, 2004, J NEUROPHYSIOL, V92, P1042, DOI 10.1152/jn.00062.2004; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; MITZ AR, 1991, J NEUROSCI, V11, P1855; Montgomery D.C., 2002, APPL STAT PROBABILIT; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; OJAKANGAS CL, 1992, J NEUROPHYSIOL, V68, P2222, DOI 10.1152/jn.1992.68.6.2222; Padoa-Schioppa C, 2004, J NEUROPHYSIOL, V91, P449, DOI 10.1152/jn.00876.2002; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Paz R, 2004, J PHYSIOL-PARIS, V98, P331, DOI 10.1016/j.jphysparis.2005.09.005; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Salinas E, 2004, J NEUROSCI, V24, P1113, DOI 10.1523/JNEUROSCI.4569-03.2004; SALINAS E, 1995, J NEUROSCI, V15, P6461; SCHMIDT EM, 1976, EXP NEUROL, V52, P496, DOI 10.1016/0014-4886(76)90220-X; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Williams JC, 1999, NEUROCOMPUTING, V26-7, P1069, DOI 10.1016/S0925-2312(99)00106-X; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Xiao J, 2006, EXP BRAIN RES, V168, P106, DOI 10.1007/s00221-005-0074-2; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	38	159	161	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 24	2007	54	4					653	666		10.1016/j.neuron.2007.04.030	http://dx.doi.org/10.1016/j.neuron.2007.04.030			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521576	Bronze			2022-12-24	WOS:000246970800018
J	Young, LJ				Young, Larry J.			Regulating the social brain: A new role for CD38	NEURON			English	Editorial Material							OXYTOCIN; BEHAVIOR	Centrally released oxytocin regulates maternal behavior, social memory, and social bonding. A recent paper by Jin et al. published in Nature demonstrates that the transmembrane receptor CD38 plays a critical role in regulating social behaviors by regulating the release of OT from hypothalamic neurons.	Emory Univ, Yerkes Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Ctr Behav Neurosci, Atlanta, GA 30322 USA	Emory University	Young, LJ (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Ctr Behav Neurosci, Atlanta, GA 30322 USA.	lyoun03@emory.edu	Young, Larry/HGE-5031-2022					Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; Burbach JPH, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3055; Deaglio S, 2006, BLOOD, V108, P1135, DOI 10.1182/blood-2006-01-013003; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; PEDERSEN CA, 1979, P NATL ACAD SCI USA, V76, P6661, DOI 10.1073/pnas.76.12.6661; Winslow JT, 2003, NEUROPSYCHOPHARMACOL, V28, P910, DOI 10.1038/sj.npp.1300128; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	13	24	25	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 3	2007	54	3					353	356		10.1016/j.neuron.2007.04.011	http://dx.doi.org/10.1016/j.neuron.2007.04.011			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481389	Bronze			2022-12-24	WOS:000246855700006
J	Bonnin, A; Torii, M; Wang, L; Rakic, P; Levitt, P				Bonnin, Alexandre; Torii, Masaaki; Wang, Lilly; Rakic, Pasko; Levitt, Pat			Serotonin modulates the response of embryonic thalamocortical axons to netrin-1	NATURE NEUROSCIENCE			English	Article							THALAMIC NEURONS; CORTICAL DEVELOPMENT; EXPRESSION PATTERNS; PROTEIN-KINASE; MUTANT MICE; GROWTH; PROJECTIONS; RECEPTOR; RAT; ACTIVATION	Modifying serotonin ( 5- HT) abundance in the embryonic mouse brain disrupts the precision of sensory maps formed by thalamocortical axons ( TCAs), suggesting that 5- HT influences their growth. We investigated the mechanism by which 5- HT influences TCAs during development. 5- HT1B and 5- HT1D receptor expression in the fetal forebrain overlaps with that of the axon guidance receptors DCC and Unc5c. In coculture assays, axons originating from anterior and posterior halves of the embryonic day 14.5 dorsal thalamus responded differently to netrin- 1, reflecting the patterns of DCC and Unc5c expression. 5- HT converts the attraction exerted by netrin- 1 on posterior TCAs to repulsion. Pharmacological manipulation of 5- HT1B/1D receptors and intracellular cAMP showed the signaling cascade through which this modulation occurs. An in vivo correlate of altered TCA pathfinding was obtained by transient manipulation of 5- HT1B/1D receptor expression abundance in the dorsal thalamus by in utero electroporation. These data demonstrate that serotonergic signaling has a previously unrecognized role in the modulation of axonal responsiveness to a classic guidance cue.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Yale University; Yale University; Vanderbilt University	Levitt, P (corresponding author), Vanderbilt Univ, Dept Pharmacol, 465 21st Ave S, Nashville, TN 37232 USA.	pat.levitt@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NICHD NIH HHS [P30HD15052] Funding Source: Medline; NIMH NIH HHS [MH65299] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADHAM N, 1992, MOL PHARMACOL, V41, P1; AITKEN AR, 1988, J COMP NEUROL, V274, P32, DOI 10.1002/cne.902740105; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CRANDALL JE, 1984, J COMP NEUROL, V228, P542, DOI 10.1002/cne.902280407; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Geerts IS, 1999, BRIT J PHARMACOL, V127, P1327, DOI 10.1038/sj.bjp.0702684; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lotto B, 1999, NEUROSCI LETT, V269, P87, DOI 10.1016/S0304-3940(99)00422-X; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Persico AM, 2006, BRAIN RES, V1095, P17, DOI 10.1016/j.brainres.2006.04.006; Price GW, 1997, N-S ARCH PHARMACOL, V356, P312, DOI 10.1007/PL00005056; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Rehn AE, 2005, CLIN EXP PHARMACOL P, V32, P687, DOI 10.1111/j.1440-1681.2005.04257.x; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110	49	191	194	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					588	597		10.1038/nn1896	http://dx.doi.org/10.1038/nn1896			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450135				2022-12-24	WOS:000245948000015
J	Schlief, ML; Wilson, RI				Schlief, Michelle L.; Wilson, Rachel I.			Olfactory processing and behavior downstream from highly selective receptor neurons	NATURE NEUROSCIENCE			English	Article							DROSOPHILA ANTENNAL LOBE; PHEROMONE-SENSITIVE NEURONS; COURTSHIP BEHAVIOR; HOST-ODOR; BRAIN; MELANOGASTER; SYSTEM; COMBINATORIAL; INFORMATION; FLY	In both the vertebrate nose and the insect antenna, most olfactory receptor neurons ( ORNs) respond to multiple odors. However, some ORNs respond to just a single odor, or at most to a few highly related odors. It has been hypothesized that narrowly tuned ORNs project to narrowly tuned neurons in the brain, and that these dedicated circuits mediate innate behavioral responses to a particular ligand. Here we have investigated neural activity and behavior downstream from two narrowly tuned ORN types in Drosophila melanogaster. We found that genetically ablating either of these ORN types impairs innate behavioral attraction to their cognate ligand. Neurons in the antennal lobe postsynaptic to one of these ORN types are, like their presynaptic ORNs, narrowly tuned to a pheromone. However, neurons postsynaptic to the second ORN type are broadly tuned. These results demonstrate that some narrowly tuned ORNs project to dedicated central circuits, ensuring a tight connection between stimulus and behavior, whereas others project to central neurons that participate in the ensemble representations of many odors.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC008174-02, R01 1R01DC008174-01, R01 DC008174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANTON S, 1994, J COMP NEUROL, V350, P199, DOI 10.1002/cne.903500205; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Baxi KN, 2006, TRENDS NEUROSCI, V29, P1, DOI 10.1016/j.tins.2005.10.002; BOECKH J, 1965, COLD SPRING HARB SYM, V30, P263, DOI 10.1101/SQB.1965.030.01.028; BOECKH J, 1979, J COMP PHYSIOL, V132, P235, DOI 10.1007/BF00614495; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; CHRISTENSEN TA, 1991, J COMP PHYSIOL A, V169, P259; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DERBY CD, 1984, J NEUROPHYSIOL, V51, P906, DOI 10.1152/jn.1984.51.5.906; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Guerenstein PG, 2004, J COMP PHYSIOL A, V190, P707, DOI 10.1007/s00359-004-0529-0; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Laissue PP, 1999, J COMP NEUROL, V405, P543; Light DM, 1999, J CHEM ECOL, V25, P2757, DOI 10.1023/A:1020855625244; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schneider D., 1968, Symposia of the Zoological Society of London, VNo. 23, P279; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	49	108	108	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					623	630		10.1038/nn1881	http://dx.doi.org/10.1038/nn1881			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417635	Green Accepted			2022-12-24	WOS:000245948000019
J	Lerchner, W; Xiao, C; Nashmi, R; Slimko, EM; van Trigt, L; Lester, HA; Anderson, DJ				Lerchner, Walter; Xiao, Cheng; Nashmi, Raad; Slimko, Eric M.; van Trigt, Laurent; Lester, Henry A.; Anderson, David J.			Reversible silencing of neuronal excitability in behaving mice by a genetically targeted, ivermectin-gated Cl- channel	NEURON			English	Article							MAMMALIAN NEURONS; IN-VIVO; STRIATAL NEURONS; EXPRESSION; RAT; SYSTEM; DROSOPHILA; RECEPTOR; INACTIVATION; SUPPRESSION	Several genetic strategies for inhibiting neuronal function in mice have been described, but no system that directly suppresses membrane excitability and is triggered by a systemically administered drug, has been validated in awake behaving animals. We expressed unilaterally in mouse striatum a modified heteromeric ivermectin (IVM)-gated chloride channel from C. elegans (GluCl alpha beta), systemically administered IVM, and then assessed amphetamine-induced rotational behavior. Rotation was observed as early as 4 hr after a single intraperitoneal IVM injection (10 mg/kg), reached maximal levels by 12 hr, and was almost fully reversed by 4 days. Multiple cycles of silencing and recovery could be performed in a single animal. In striatal slice preparations from GluCl alpha beta-expressing animals, IVM rapidly suppressed spiking. The two-subunit GluCl/IVM system permits "intersectional" strategies designed to increase the cellular specificity of silencing in transgenic animals.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Xiao, Cheng/O-5696-2015	Xiao, Cheng/0000-0001-9649-7450; Nashmi, Raad/0000-0001-6596-2620; Lerchner, Walter/0000-0003-0842-4409	NIMH NIH HHS [MH-67867] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH067867] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P306, DOI 10.1111/j.1748-1716.1966.tb03317.x; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Burdett EC, 1997, CONTEMP TOP LAB ANIM, V36, P73; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; CHABALA JC, 1980, J MED CHEM, V23, P1134, DOI 10.1021/jm00184a014; Conole J, 2003, CONTEMP TOP LAB ANIM, V42, P42; Davis JA, 1999, LAB ANIM SCI, V49, P288; Dawson GR, 2000, J PHARMACOL EXP THER, V295, P1051; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Geary TG, 2005, TRENDS PARASITOL, V21, P530, DOI 10.1016/j.pt.2005.08.014; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; Johns DC, 1999, J NEUROSCI, V19, P1691; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; OBERLANDER C, 1983, J PHARMACOL-PARIS, V14, P401; Olds ME, 2006, SYNAPSE, V59, P532, DOI 10.1002/syn.20270; Roder Joseph D., 1998, Veterinary and Human Toxicology, V40, P369; Schafer WR, 2005, CURR BIOL, V15, pR723, DOI 10.1016/j.cub.2005.08.020; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHWARCZ R, 1979, BRAIN RES, V170, P485, DOI 10.1016/0006-8993(79)90966-1; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Willis GL, 2004, REV NEUROSCIENCE, V15, P75; Wilson C.J., 1998, SYNAPTIC ORG BRAIN, P329; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang X, 2001, HISTOCHEM CELL BIOL, V115, P455	42	132	137	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					35	49		10.1016/j.neuron.2007.02.030	http://dx.doi.org/10.1016/j.neuron.2007.02.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408576	Bronze			2022-12-24	WOS:000245848400008
J	Aksay, E; Olasagasti, I; Mensh, BD; Baker, R; Goldman, MS; Tank, DW				Aksay, Emre; Olasagasti, Itsaso; Mensh, Brett D.; Baker, Robert; Goldman, Mark S.; Tank, David W.			Functional dissection of circuitry in a neural integrator	NATURE NEUROSCIENCE			English	Article							NUCLEUS-PREPOSITUS-HYPOGLOSSI; PERSISTENT ACTIVITY; PERCEPTUAL DECISION; WORKING-MEMORY; EYE-POSITION; TEMPORAL INTEGRATION; SYNAPTIC PLASTICITY; RECURRENT NETWORK; OCULOMOTOR SYSTEM; NEURONAL-ACTIVITY	In neural integrators, transient inputs are accumulated into persistent firing rates that are a neural correlate of short-term memory. Integrators often contain two opposing cell populations that increase and decrease sustained firing as a stored parameter value rises. A leading hypothesis for the mechanism of persistence is positive feedback through mutual inhibition between these opposing populations. We tested predictions of this hypothesis in the goldfish oculomotor velocity-to-position integrator by measuring the eye position and firing rates of one population, while pharmacologically silencing the opposing one. In complementary experiments, we measured responses in a partially silenced single population. Contrary to predictions, induced drifts in neural firing were limited to half of the oculomotor range. We built network models with synaptic-input thresholds to demonstrate a new hypothesis suggested by these data: mutual inhibition between the populations does not provide positive feedback in support of integration, but rather coordinates persistent activity intrinsic to each population.	Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Wellesley Coll, Dept Phys, Wellesley, MA 02481 USA; Wellesley Coll, Program Neurosci, Wellesley, MA 02481 USA; Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02139 USA; NYU, Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA	Cornell University; Princeton University; Princeton University; Wellesley College; Wellesley College; Harvard University; Harvard Medical School; New York University	Goldman, MS (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, 1300 York Ave,Box 75, New York, NY 10021 USA.	mgoldma2@wellesley.edu		Aksay, Emre/0000-0002-4561-4175; Baker, Robert/0000-0001-7920-1769; Olasagasti, Itsaso/0000-0002-5172-5373	NIMH NIH HHS [R01 MH069726, R01 MH069726-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069726] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2003, J NEUROSCI, V23, P10852; Aksay E, 2003, CEREB CORTEX, V13, P1173, DOI 10.1093/cercor/bhg099; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; Arnold DB, 1999, VISION RES, V39, P4286, DOI 10.1016/S0042-6989(99)00142-X; Brown E, 2005, INT J BIFURCAT CHAOS, V15, P803, DOI 10.1142/S0218127405012478; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; CHERON G, 1986, J PHYSIOL-LONDON, V372, P75, DOI 10.1113/jphysiol.1986.sp015998; CRAWFORD JD, 1993, EXP BRAIN RES, V96, P443; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; ESCUDERO M, 1992, J PHYSIOL-LONDON, V458, P539, DOI 10.1113/jphysiol.1992.sp019433; Fall CP, 2006, J COMPUT NEUROSCI, V20, P97, DOI 10.1007/s10827-006-4791-8; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P210, DOI 10.1152/jn.1984.51.2.210; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Idoux E, 2006, J NEUROPHYSIOL, V96, P175, DOI 10.1152/jn.01355.2005; Kaneko CRS, 1997, J NEUROPHYSIOL, V78, P1753, DOI 10.1152/jn.1997.78.4.1753; Kiehn O, 1998, CURR OPIN NEUROBIOL, V8, P746, DOI 10.1016/S0959-4388(98)80117-7; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; LOPEZBARNEO J, 1982, J NEUROPHYSIOL, V47, P329, DOI 10.1152/jn.1982.47.2.329; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Major G, 2004, P NATL ACAD SCI USA, V101, P7745, DOI 10.1073/pnas.0401992101; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McCrea RA, 2006, PROG BRAIN RES, V151, P205, DOI 10.1016/S0079-6123(05)51007-0; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; METTENS P, 1994, J NEUROPHYSIOL, V72, P785, DOI 10.1152/jn.1994.72.2.785; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; Navarro-Lopez JD, 2004, J NEUROSCI, V24, P5109, DOI 10.1523/JNEUROSCI.0235-04.2004; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Seung HS., 2003, HDB BRAIN THEORY NEU, V2, P94; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Sklavos SG, 2002, BIOL CYBERN, V86, P97, DOI 10.1007/S004220100281; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	50	83	83	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					494	504		10.1038/nn1877	http://dx.doi.org/10.1038/nn1877			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369822	Green Accepted			2022-12-24	WOS:000245228600021
J	Schlack, A; Albright, TD				Schlack, Anja; Albright, Thomas D.			Remembering visual motion: Neural correlates of associative plasticity and motion recall in cortical area MT	NEURON			English	Article							LONG-TERM-MEMORY; PSYCHOPHYSICAL EVIDENCE; STIMULUS ASSOCIATIONS; PERCEPTION; IMAGERY; MACAQUE; REPRESENTATION; NEURONS; OBJECTS; CORTEX	The pictorial content of visual memories recalled by association is embodied by neuronal activity at the highest processing stages of primate visual cortex. This activity is elicited by top-down signals from the frontal lobe and recapitulates the bottom-up pattern normally obtained by the recalled stimulus. To explore the generality and mechanisms of this phenomenon, we recorded motion-sensitive neurons at an early stage of cortical processing. After monkeys learned to associate directions of motion with static shapes, these neurons exhibited unprecedented selectivity for the shapes. This emergent shape selectivity reflects activation of neurons representing the motion stimuli recalled by association, and it suggests that recall-related activity may be a general feature of neurons in visual cortex.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Schlack, A (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA.	anja@salk.edu; tom@salk.edu						Albright T D, 1993, Rev Oculomot Res, V5, P177; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BALL K, 1980, PSYCHOL REV, V87, P435, DOI 10.1037/0033-295X.87.5.435; BARLOW H, 1990, VISION RES, V30, P1561, DOI 10.1016/0042-6989(90)90144-A; BARTLESON CJ, 1960, J OPT SOC AM, V50, P73, DOI 10.1364/JOSA.50.000073; Batschelet E, 1981, CIRCULAR STAT BIOL; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRNSWIK E, 1956, PERCEPTION REPRESENT; BRUNER JS, 1951, AM J PSYCHOL, V64, P216, DOI 10.2307/1418668; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; DAVIES P, 1982, PERCEPTION, V11, P663, DOI 10.1068/p110663; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Erickson CA, 1999, J NEUROSCI, V19, P10404; FARAH MJ, 1985, J EXP PSYCHOL GEN, V114, P91, DOI 10.1037/0096-3445.114.1.91; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FREYD JJ, 1987, PSYCHOL REV, V94, P427, DOI 10.1037/0033-295X.94.4.427; GAFFAN D, 1983, Q J EXP PSYCHOL-B, V35, P149, DOI 10.1080/14640748308400901; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; HERING E, 1978, LEHRE LICHTSINNE; HURLBERT AC, 2005, J VIS, V5, pA787; Ishai A, 1997, J COGNITIVE NEUROSCI, V9, P734, DOI 10.1162/jocn.1997.9.6.734; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Ishai A, 1997, J COGNITIVE NEUROSCI, V9, P476, DOI 10.1162/jocn.1997.9.4.476; James W., 1890, PRINCIPLES PSYCHOL; James W., 1910, PRINCIPLES PSYCHOL; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 1996, PERCEPTION BAYESIAN; Kosslyn S. M., 1994, IMAGE BRAIN; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P2822, DOI 10.1152/jn.1996.76.5.2822; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Mast FW, 2001, PERCEPTION, V30, P945, DOI 10.1068/p3088; Messinger A, 2005, NEURON, V48, P359, DOI 10.1016/j.neuron.2005.08.035; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Qi HJ, 2006, P NATL ACAD SCI USA, V103, P483, DOI 10.1073/pnas.0506728103; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Shulman GL, 1999, J NEUROSCI, V19, P9480; SIPLE P, 1983, PERCEPT PSYCHOPHYS, V34, P363, DOI 10.3758/BF03203049; Thiele A, 1999, J NEUROSCI, V19, P6571; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Van Wezel RJA, 2002, NEUROSCIENCE, V111, P739, DOI 10.1016/S0306-4522(02)00036-2; von Helmholtz H., 1924, HELMHOLTZS TREATISE	49	69	69	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					881	890		10.1016/j.neuron.2007.02.028	http://dx.doi.org/10.1016/j.neuron.2007.02.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	151LV	17359922	Bronze			2022-12-24	WOS:000245292800012
J	Ihara, M; Yamasaki, N; Hagiwara, A; Tanigaki, A; Kitano, A; Hikawa, R; Tomimoto, H; Noda, M; Masashi, T; Mori, H; Hattori, N; Miyakawa, T; Kinoshita, M				Ihara, Masafumi; Yamasaki, Nobuyuki; Hagiwara, Akari; Tanigaki, Ai; Kitano, Ayumi; Hikawa, Rie; Tomimoto, Hidekazu; Noda, Makoto; Takanashi, Masashi; Mori, Hideo; Hattori, Nobutaka; Miyakawa, Tsuyoshi; Kinoshita, Makoto			Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity	NEURON			English	Article							PARKINSONS-DISEASE; NEUROTRANSMITTER RELEASE; MAMMALIAN SEPTIN; MICE LACKING; DOPAMINE; CDCREL-1; PROTEIN; NEURODEGENERATION; BINDING; BRAIN	In Parkinson disease (PID), alpha-synuclein aggregates called Lewy bodies often involve and sequester Septin4 (Sept4), a polymerizing scaffold protein. However, the pathophysiological significance of this phenomenon is unclear. Here, we show the physiological association of Sept4 with alpha-synuclein, the dopamine transporter, and other presynaptic proteins in dopaminergic neurons; mice lacking Sept4 exhibit diminished dopaminergic neurotransmission due to scarcity of these presynaptic proteins. These data demonstrate an important role for septin scaffolds in the brain. In transgenic mice that express human alpha-synuclein(A53T) (a mutant protein responsible for familial PD), loss of Sept4 significantly enhances neuropathology and locomotor deterioration. In this PID model, insoluble deposits of Ser(129)-phosphorylated alpha-synuclein(A53T) are negatively correlated with the dosage of Sept4. In vitro, direct association with Sept4 protects alpha-synuclein against self-aggregation and Ser(129) phosphorylation. Taken together, these data show that Sept4 may be involved in PID as a dual susceptibility factor, as its insufficiency can diminish dopaminergic neurotransmission and enhance alpha-synuclein neurotoxicity.	Kyoto Univ, Grad Sch Med, Biochem & Cell Biol Unit, HMRO, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Genet Engn & Funct Genom Unit, HMRO, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Neurol, HMRO, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Oncol, HMRO, Kyoto 6068501, Japan; Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138431, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Juntendo University; Japan Science & Technology Agency (JST)	Ihara, M (corresponding author), Kyoto Univ, Grad Sch Med, Biochem & Cell Biol Unit, HMRO, Kyoto 6068501, Japan.	ihara@kuhp.kyoto-u.ac.jp; mkinoshita@hmro.med.kyoto-u.ac.jp	Hattori, Nobutaka/ACR-0069-2022; Ihara, Masafumi/O-5020-2019; Miyakawa, Tsuyoshi/A-7741-2008	Ihara, Masafumi/0000-0002-7102-4048; Miyakawa, Tsuyoshi/0000-0003-0137-8200; KINOSHITA, MAKOTO/0000-0002-7592-2400				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Dong ZZ, 2003, P NATL ACAD SCI USA, V100, P12438, DOI 10.1073/pnas.2132992100; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; FUJISHIMA K, 2007, IN PRESS J NEUROCHEM; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kinoshita A, 2000, J COMP NEUROL, V428, P223, DOI 10.1002/1096-9861(20001211)428:2<223::AID-CNE3>3.0.CO;2-M; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Peng XR, 2002, MOL CELL BIOL, V22, P378, DOI 10.1128/MCB.22.1.378-387.2002; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Son JH, 2005, J NEUROCHEM, V94, P1040, DOI 10.1111/j.1471-4159.2005.03257.x; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x; Zhang JH, 2000, PSYCHOPHARMACOLOGY, V149, P181, DOI 10.1007/s002130000369; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	43	130	137	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					519	533		10.1016/j.neuron.2007.01.019	http://dx.doi.org/10.1016/j.neuron.2007.01.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296554	Bronze			2022-12-24	WOS:000245126900011
J	Levy-Strumpf, N; Culotti, JG				Levy-Strumpf, Naomi; Culotti, Joseph G.			VAB-8, UNC-73 and MIG-2 regulate axon polarity and cell migration functions of UNC-40 in C-elegans	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; COLORECTAL-CANCER; NETRIN CUES; LIPID RAFTS; RAC GTPASE; GUIDANCE; RECEPTOR; DCC; ACTIVATION; OUTGROWTH	One of the most intriguing features of axons is their ability to pioneer precise paths to their targets. How guidance-cue information is interpreted and integrated to form intricate neuronal networks has not been fully deciphered. Using Caenorhabditis elegans, we show that highly conserved receptors that guide pioneer axons along the dorsoventral axis, such as UNC-40 and SAX-3 ( receptors for UNC-6 and SLT-1 guidance cues, respectively), can be co-opted to affect axon and cell migrations along the anterior-posterior axis. We further identify the kinesin-related VAB-8 protein as an upstream regulator of UNC-40, illuminating VAB-8' s mechanism of action in determining the polarity of cell and axon migration. Finally, we show that UNC-73 and its target MIG-2 function with VAB-8 as upstream regulators of UNC-40 and that MIG-2 activity specifies UNC-40 subcellular localization. These data are indicative of previously unidentified regulatory roles for VAB-8 and small GTPases, which act together to regulate guidance receptor functions.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Culotti, JG (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	culotti@mshri.on.ca	Culotti, Joseph/G-6467-2013	Levy-Strumpf, Naomi/0000-0002-5454-8800; Culotti, Joseph/0000-0001-6325-4612	NINDS NIH HHS [R01NS41397] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041397] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Buck KB, 2002, J NEUROSCI, V22, P9358; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Dalpe G, 2004, DEVELOPMENT, V131, P2073, DOI 10.1242/dev.01063; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Honigberg L, 2000, DEVELOPMENT, V127, P4655; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Kishore RS, 2002, DEV BIOL, V241, P339, DOI 10.1006/dbio.2001.0513; Kubiseski TJ, 2003, MOL CELL BIOL, V23, P6823, DOI 10.1128/MCB.23.19.6823-6835.2003; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MANSER J, 1990, DEV GENET, V11, P49, DOI 10.1002/dvg.1020110107; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Su MW, 2000, DEVELOPMENT, V127, P585; Sulston J.E., 1998, METHODS NEMATODE CAE; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vignal E, 2001, MOL CELL BIOL, V21, P8022, DOI 10.1128/MCB.21.23.8022-8034.2001; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Wightman B, 1996, DEVELOPMENT, V122, P671; Wolf FW, 1998, NEURON, V20, P655, DOI 10.1016/S0896-6273(00)81006-5; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0; Zou YM, 2006, NEURON, V49, P787, DOI 10.1016/j.neuron.2006.03.004	45	65	74	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					161	168		10.1038/nn1835	http://dx.doi.org/10.1038/nn1835			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237777				2022-12-24	WOS:000244175200010
J	Urgesi, C; Candidi, M; Ionta, S; Aglioti, SM				Urgesi, Cosimo; Candidi, Matteo; Ionta, Silvio; Aglioti, Salvatore M.			Representation of body identity and body actions in extrastriate body area and ventral premotor cortex	NATURE NEUROSCIENCE			English	Article							PERSPECTIVE	Although inherently linked, body form and body action may be represented in separate neural substrates. Using repetitive transcranial magnetic stimulation in healthy individuals, we show that interference with the extrastriate body area impairs the discrimination of bodily forms, and interference with the ventral premotor cortex impairs the discrimination of bodily actions. This double dissociation suggests that whereas extrastriate body area mainly processes actors' body identity, premotor cortex is crucial for visual discriminations of actions.	Univ Roma La Sapienza, Dipartimento Piscol, I-00185 Rome, Italy; Ist Ricovero & Cura Carattere Sci E Medea, I-33078 San Vito Al Tagliamento, Pordenone, Italy; Ist Ricovero & Cura Carattere Sci Fdn St Lucia, I-00179 Rome, Italy	Sapienza University Rome; IRCCS Eugenio Medea; IRCCS Santa Lucia	Aglioti, SM (corresponding author), Univ Roma La Sapienza, Dipartimento Piscol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	urgesi@sv.lnf.it; salvatoremaria.aglioti@uniroma1.it	ionta, silvio/AGB-3634-2022; Urgesi, Cosimo/K-4688-2016; Candidi, Matteo/K-9245-2016; Aglioti, Salvatore M/E-9829-2012	ionta, silvio/0000-0003-2078-4861; Urgesi, Cosimo/0000-0003-0572-1328; CANDIDI, MATTEO/0000-0001-8201-7954; Aglioti, Salvatore Maria/0000-0001-8175-7563				Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Peelen MV, 2005, NAT NEUROSCI, V8, P125, DOI 10.1038/nn0205-125a; Peelen MV, 2006, NEURON, V49, P815, DOI 10.1016/j.neuron.2006.02.004; Pobric G, 2006, CURR BIOL, V16, P524, DOI 10.1016/j.cub.2006.01.033; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Urgesi C, 2004, CURR BIOL, V14, P2130, DOI 10.1016/j.cub.2004.11.031; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460	15	212	216	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					30	31		10.1038/nn1815	http://dx.doi.org/10.1038/nn1815			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159990	Green Published			2022-12-24	WOS:000243096100012
J	Huesmann, GR; Clayton, DF				Huesmann, Graham R.; Clayton, David F.			Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation	NEURON			English	Article							SYNAPTIC PLASTICITY; LINKED INHIBITOR; GENE-EXPRESSION; MOUSE-BRAIN; ACTIVATION; MEMORY; APOPTOSIS; PATHWAYS; CLEAVAGE; CALPAIN	Activation of the protease caspase-3 is commonly thought to cause apoptotic cell death. Here, we show that caspase-3 activity is regulated at postsynaptic sites in brain following stimuli associated with memory (neural activation and subsequent response habituation) instead of cell death. In the zebra finch auditory forebrain, the concentration of caspase-3 active sites increases briefly within minutes after exposure to tape-recorded birdsong. With confocal and immuno-electron microscopy, we localize the activated enzyme to dendritic spines. The activated caspase-3 protein is present even in unstimulated brain but bound to an endogenous inhibitor, BIRC4 (xIAP), suggesting a mechanism for rapid release and sequestering at specific synaptic sites. Caspase-3 activity is necessary to consolidate a persistent physiological trace of the song stimulus, as demonstrated using pharmacological interference and the zenk gene habituation assay. Thus, the brain appears to have adapted a core component of cell death machinery to serve a unique role in learning and memory.	Univ Illinois, Dept Cell & Dev Biol, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Clayton, DF (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Neurosci Program, 405 N Mathews Ave, Urbana, IL 61801 USA.	dclayton@uiuc.edu	Clayton, David/B-2190-2008; Huesmann, Graham/L-6819-2019	Clayton, David/0000-0002-6395-3488; 	NIMH NIH HHS [R01 MH052086, R01 MH52086] Funding Source: Medline; NINDS NIH HHS [R01 NS045264, 1 F30 NS45379-01A2, F30 NS045379, R01 NS051820] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051820, F30NS045379, R01NS045264] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Afford S, 2000, J CLIN PATHOL-MOL PA, V53, P55, DOI 10.1136/mp.53.2.55; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng HY, 2004, J NEUROSCI, V24, P7503, DOI 10.1523/JNEUROSCI.1405-04.2004; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; CLAYTON DF, 2006, IN PRESS HDB NEUROCH, V21; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Ferrer I, 2003, J NEUROPATH EXP NEUR, V62, P329, DOI 10.1093/jnen/62.4.329; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gemma C, 2005, EUR J NEUROSCI, V22, P1751, DOI 10.1111/j.1460-9568.2005.04334.x; Glazner GW, 2000, J NEUROSCI, V20, P3641, DOI 10.1523/JNEUROSCI.20-10-03641.2000; Gulyaeva NV, 2003, J NEUROSCI RES, V73, P853, DOI 10.1002/jnr.10730; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; Korhonen L, 2004, EXP CELL RES, V295, P290, DOI 10.1016/j.yexcr.2003.12.026; Kruse AA, 2000, NEUROBIOL LEARN MEM, V74, P179, DOI 10.1006/nlme.2000.3968; Kruse AA, 2004, NEUROBIOL LEARN MEM, V82, P99, DOI 10.1016/j.nlm.2004.05.001; Kudryashov I E, 2004, Neurosci Behav Physiol, V34, P877, DOI 10.1023/B:NEAB.0000042571.86110.28; Lu CB, 2002, NEUROMOL MED, V1, P69; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Mattson MP, 1999, J NEUROSCI RES, V58, P152, DOI 10.1002/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 2002, J COMP PHYSIOL A, V188, P943, DOI 10.1007/s00359-002-0347-1; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Millin PM, 2001, NAT REV NEUROSCI, V2, P68, DOI 10.1038/35049075; Namura S, 1998, J NEUROSCI, V18, P3659; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Saito A, 2003, J CEREBR BLOOD F MET, V23, P1010, DOI 10.1097/01.WCB.0000080702.47016.FF; Slagsvold HH, 2003, BRAIN RES, V984, P111, DOI 10.1016/S0006-8993(03)03119-6; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Stepanichev MY, 2005, NEUROSCIENCE, V136, P579, DOI 10.1016/j.neuroscience.2005.08.010; Stoddard Philip Kraft, 1996, P356; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Wain HM, 2004, NUCLEIC ACIDS RES, V32, pD255, DOI 10.1093/nar/gkh072; Wain HM, 2002, NUCLEIC ACIDS RES, V30, P169, DOI 10.1093/nar/30.1.169; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Zhuang SG, 1999, EXP CELL RES, V250, P203, DOI 10.1006/excr.1999.4501	60	94	100	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1061	1072		10.1016/j.neuron.2006.10.033	http://dx.doi.org/10.1016/j.neuron.2006.10.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178408	Green Accepted, Bronze			2022-12-24	WOS:000243115100013
J	Sarkisian, MR; Bartley, CM; Chi, H; Nakamura, F; Hashimoto-Torii, K; Torii, M; Flavell, RA; Rakic, P				Sarkisian, Matthew R.; Bartley, Christopher M.; Chi, Hongbo; Nakamura, Fumihiko; Hashimoto-Torii, Kazue; Torii, Masaaki; Flavell, Richard A.; Rakic, Pasko			MEKK4 signaling regulates filamin expression and neuronal migration	NEURON			English	Article							PERIVENTRICULAR NODULAR HETEROTOPIA; KINASE KINASE KINASE; STRESS-INDUCED ACTIVATION; CELL-MIGRATION; RADIAL MIGRATION; MOUSE EMBRYO; RNA INTERFERENCE; CEREBRAL-CORTEX; JNK PATHWAY; ANNEXIN-II	Periventricular heterotopia (PVH) is a congenital malformation of human cerebral cortex frequently associated with Filamin-A (FLN-A) mutations but the pathogenetic mechanisms remain unclear. Here, we show that the MEKK4 (MAP3K4) pathway is involved in Fln-A regulation and PVH formation. MEKK4(-/-)mice developed PVH associated with breaches in the neuroependymal lining which were largely comprised of neurons that failed to reach the cortical plate. RNA interference (RNAi) targeting MEKK4 also impaired neuronal migration. Expression of Fin was elevated in MEKK4(-/-) forebrain, most notably near sites of failed neuronal migration. Importantly, recombinant MKK4 protein precipitated a complex containing MEKK4 and Fln-A, and MKK4 mediated signaling between MEKK4 and Fln-A, suggesting that MKK4 may bridge these molecules during development. Finally, we showed that wild-type FLN-A overexpression inhibited neuronal migration. Collectively, our results demonstrate a link between MEKK4 and Fln-A that impacts neuronal migration initiation and provides insight into the pathogenesis of human PVH.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Hematol Div, Boston, MA 02115 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	pasko.rakic@yale.edu	Chi, Hongbo/M-9397-2018; Bartley, Christopher/G-4226-2012; Nakamura, Fumihiko/N-5476-2016	Chi, Hongbo/0000-0002-9997-2496; Nakamura, Fumihiko/0000-0002-6872-4246; Bartley, Christopher/0000-0002-1391-4130	NEI NIH HHS [R01 EY002593] Funding Source: Medline; NIA NIH HHS [R01 AG019394] Funding Source: Medline; NIGMS NIH HHS [T32 GM007205] Funding Source: Medline; NINDS NIH HHS [R01 NS038296, R01 NS014841] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038296, R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019394] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Bachmann AS, 2006, CANCER SCI, V97, P1359, DOI 10.1111/j.1349-7006.2006.00327.x; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Chan-Hui PY, 1998, BIOCHEM J, V336, P599, DOI 10.1042/bj3360599; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200; Derbyshire ZE, 2005, MOL CELL BIOCHEM, V271, P77, DOI 10.1007/s11010-005-5386-9; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Garcia E, 2006, ARCH BIOCHEM BIOPHYS, V446, P140, DOI 10.1016/j.abb.2005.12.006; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; Goetsch SC, 2005, STEM CELLS DEV, V14, P181, DOI 10.1089/scd.2005.14.181; Halfter UM, 2005, BIOCHEM J, V388, P17, DOI 10.1042/BJ20041236; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirai S, 2005, GENE EXPR PATTERNS, V5, P517, DOI 10.1016/j.modgep.2004.12.002; Hirai S, 2002, DEVELOPMENT, V129, P4483; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; Kaufman MH, 1995, ATLAS MOUSE DEV; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lu J, 2006, J COMP NEUROL, V494, P476, DOI 10.1002/cne.20806; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1988, PROG BRAIN RES, V73, P15; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Sato Makoto, 2005, Anatomical Science International, V80, P19; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Sheen VL, 2005, NEUROLOGY, V64, P254, DOI 10.1212/01.WNL.0000149512.79621.DF; Sheen VL, 2003, NEUROLOGY, V60, P1108, DOI 10.1212/01.WNL.0000055898.00349.02; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Sheen VL, 2004, BRAIN DEV-JPN, V26, P326, DOI 10.1016/j.braindev.2003.09.004; Sheen VL, 2003, NEUROLOGY, V60, P1033, DOI 10.1212/01.WNL.0000052689.03214.61; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yuzyuk T, 2003, MOL BIOL CELL, V14, P3013, DOI 10.1091/mbc.E02-11-0747; Zenker M, 2004, AM J HUM GENET, V74, P731, DOI 10.1086/383094; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004	70	95	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					789	801		10.1016/j.neuron.2006.10.024	http://dx.doi.org/10.1016/j.neuron.2006.10.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145501	Bronze, Green Accepted			2022-12-24	WOS:000242856400008
J	Wu, GY; Li, PY; Tao, HZW; Zhang, LI				Wu, Guangying K.; Li, Pingyang; Tao, Huizhong W.; Zhang, Li I.			Nonmonotonic synaptic excitation and imbalanced inhibition underlying cortical intensity tuning	NEURON			English	Article							PRIMARY AUDITORY-CORTEX; MEDIAL GENICULATE-BODY; INFERIOR COLLICULUS; POSTERIOR FIELD; SINGLE NEURONS; RESPONSE PROPERTIES; TONAL STIMULATION; PYRAMIDAL NEURONS; RECEPTIVE-FIELDS; COCHLEAR NUCLEUS	Intensity-tuned neurons, characterized by their nonmonotonic response-level function, may play important roles in the encoding of sound intensity-related information. The synaptic mechanisms underlying intensity tuning remain unclear. Here, in vivo whole-cell recordings in rat auditory cortex revealed that intensity-tuned neurons, mostly clustered in a posterior zone, receive imbalanced tone-evoked excitatory and inhibitory synaptic inputs. Excitatory inputs exhibit nonmonotonic intensity tuning, whereas with tone intensity increments, the temporally delayed inhibitory inputs increase monotonically in strength. In addition, this delay reduces with the increase of intensity, resulting in an enhanced suppression of excitation at high intensities and a significant sharpening of intensity tuning. In contrast, non-intensity-tuned neurons exhibit covaried excitatory and inhibitory inputs, and the relative time interval between them is stable with intensity increments, resulting in monotonic response-level function. Thus, cortical intensity tuning is primarily determined by excitatory inputs and shaped by cortical inhibition through a dynamic control of excitatory and inhibitory timing.	Univ So Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA; Univ So Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90033 USA; Univ So Calif, Dept Ophthalmol, Keck Sch Med, Los Angeles, CA 90033 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhang, LI (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA.	liizhang@usc.edu	Wu, Guangying/E-8117-2010; Tao, Huizhong W/HDM-9767-2022; Li, Ping/GYV-4914-2022	Wu, Guangying/0000-0002-7243-5412	NIDCD NIH HHS [R01 DC008983, R03 DC006814] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006814, R01DC008983] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AITKIN L, 1991, J NEUROPHYSIOL, V65, P383, DOI 10.1152/jn.1991.65.2.383; AITKIN LM, 1972, J NEUROPHYSIOL, V35, P365, DOI 10.1152/jn.1972.35.3.365; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Bao SW, 2003, J NEUROSCI, V23, P10765; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brudzynski SM, 2002, J COMP PSYCHOL, V116, P73, DOI 10.1037//0735-7036.116.1.73; BRUDZYNSKI SM, 1993, PHYSIOL BEHAV, V54, P215, DOI 10.1016/0031-9384(93)90102-L; BRUGGE JF, 1969, J NEUROPHYSIOL, V32, P1005, DOI 10.1152/jn.1969.32.6.1005; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; ERULKAR SD, 1956, B JOHNS HOPKINS HOSP, V99, P55; EVANS EF, 1964, J PHYSIOL-LONDON, V171, P476, DOI 10.1113/jphysiol.1964.sp007391; FAINGOLD CL, 1991, HEARING RES, V52, P201, DOI 10.1016/0378-5955(91)90200-S; GREENWOOD DD, 1965, J NEUROPHYSIOL, V28, P863, DOI 10.1152/jn.1965.28.5.863; Hashimoto H, 2004, EXP ANIM TOKYO, V53, P409, DOI 10.1538/expanim.53.409; Heil P, 1998, CEREB CORTEX, V8, P125, DOI 10.1093/cercor/8.2.125; HEIL P, 1994, HEARING RES, V76, P188, DOI 10.1016/0378-5955(94)90099-X; Heil P, 2004, CURR OPIN NEUROBIOL, V14, P461, DOI 10.1016/j.conb.2004.07.002; Kalatsky VA, 2005, P NATL ACAD SCI USA, V102, P13325, DOI 10.1073/pnas.0505592102; KALTWASSER MT, 1990, J COMP PSYCHOL, V104, P227, DOI 10.1037/0735-7036.104.3.227; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kiang NYS, 1965, DISCHARGE PATTERNS S; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kitzes LM, 1996, HEARING RES, V100, P120, DOI 10.1016/0378-5955(96)00103-7; KUWABARA N, 1993, J NEUROPHYSIOL, V69, P1713, DOI 10.1152/jn.1993.69.5.1713; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; NYBY J, 1978, NEUROSCI BIOBEHAV R, V2, P1, DOI 10.1016/0149-7634(78)90003-9; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; PHILLIPS DP, 1989, HEARING RES, V37, P269, DOI 10.1016/0378-5955(89)90027-0; PHILLIPS DP, 1995, J NEUROPHYSIOL, V73, P674, DOI 10.1152/jn.1995.73.2.674; PHILLIPS DP, 1984, J NEUROPHYSIOL, V51, P147, DOI 10.1152/jn.1984.51.1.147; POLLAK GD, 1993, HEARING RES, V65, P99, DOI 10.1016/0378-5955(93)90205-F; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; ROUILLER E, 1983, HEARING RES, V11, P235, DOI 10.1016/0378-5955(83)90081-3; Sales GD, 1974, ULTRASONIC COMMUNICA; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; SHAMMA SA, 1985, J ACOUST SOC AM, V78, P1622, DOI 10.1121/1.392800; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sivaramakrishnan S, 2004, J NEUROSCI, V24, P5031, DOI 10.1523/JNEUROSCI.0357-04.2004; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SUGA N, 1982, J NEUROPHYSIOL, V47, P225, DOI 10.1152/jn.1982.47.2.225; Sutter ML, 2003, J NEUROPHYSIOL, V90, P2629, DOI 10.1152/jn.00722.2002; SUTTER ML, 1995, J NEUROPHYSIOL, V73, P190, DOI 10.1152/jn.1995.73.1.190; TAN AY, 2006, ARXIVQBIONC0607036; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; YOUNG ED, 1976, J NEUROPHYSIOL, V39, P282, DOI 10.1152/jn.1976.39.2.282; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	58	112	117	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					705	715		10.1016/j.neuron.2006.10.009	http://dx.doi.org/10.1016/j.neuron.2006.10.009			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114053	Bronze, Green Accepted			2022-12-24	WOS:000242413100016
J	Pasalar, S; Roitman, AV; Durfee, WK; Ebner, TJ				Pasalar, S.; Roitman, A. V.; Durfee, W. K.; Ebner, T. J.			Force field effects on cerebellar Purkinje cell discharge with implications for internal models	NATURE NEUROSCIENCE			English	Article							CIRCULAR MANUAL TRACKING; SIMPLE SPIKE DISCHARGE; PRIMARY MOTOR CORTEX; NEURONAL-ACTIVITY; REACHING MOVEMENTS; VENTRAL PARAFLOCCULUS; VOLUNTARY MOVEMENT; ARM MOVEMENTS; MONKEY; DYNAMICS	The cerebellum has been hypothesized to provide internal models for limb movement control. If the cerebellum is the site of an inverse dynamics model, then cerebellar neural activity should signal limb dynamics and be coupled to arm muscle activity. To address this, we recorded from 166 task-related Purkinje cells in two monkeys performing circular manual tracking under varying viscous and elastic loads. Hand forces and arm muscle activity increased with the load, and their spatial tuning differed markedly between the viscous and elastic fields. In contrast, the simple spike firing of 91.0% of the Purkinje cells was not significantly modulated by the force nor was their spatial tuning affected. For the 15 cells with a significant force effect, changes were small and isolated. These results do not support the hypothesis that Purkinje cells represent the output of an inverse dynamics model of the arm. Instead these neurons provide a kinematic representation of arm movements.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ebner, TJ (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	ebner001@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018338] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS-18338] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Batschelet E, 1981, CIRCULAR STAT BIOL; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Coltz JD, 1999, J NEUROSCI, V19, P1782; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FORTIER PA, 1989, J NEUROPHYSIOL, V62, P198, DOI 10.1152/jn.1989.62.1.198; FRYSINGER RC, 1984, J NEUROPHYSIOL, V51, P32, DOI 10.1152/jn.1984.51.1.32; Fu QG, 1997, J NEUROPHYSIOL, V78, P478, DOI 10.1152/jn.1997.78.1.478; Gomi H, 1998, J NEUROPHYSIOL, V80, P818, DOI 10.1152/jn.1998.80.2.818; Goodkin HP, 2003, J NEUROPHYSIOL, V89, P896, DOI 10.1152/jn.00115.2002; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Liu XG, 2003, J NEUROPHYSIOL, V89, P1223, DOI 10.1152/jn.00817.2002; MARPLEHORVAT DE, 1990, J PHYSIOL-LONDON, V428, P595, DOI 10.1113/jphysiol.1990.sp018230; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; Mason CR, 2006, J NEUROPHYSIOL, V95, P144, DOI 10.1152/jn.00492.2005; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Monzee J, 2004, J NEUROPHYSIOL, V91, P1230, DOI 10.1152/jn.01120.2002; Norris SA, 2004, J NEUROPHYSIOL, V92, P1867, DOI 10.1152/jn.01251.2003; Ostry DJ, 2003, EXP BRAIN RES, V153, P275, DOI 10.1007/s00221-003-1624-0; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Richter S, 2004, J MOTOR BEHAV, V36, P28, DOI 10.3200/JMBR.36.1.28-38; Roitman AV, 2005, J NEUROSCI, V25, P9244, DOI 10.1523/JNEUROSCI.1886-05.2005; SCHIEBER MH, 1985, J NEUROPHYSIOL, V54, P1228, DOI 10.1152/jn.1985.54.5.1228; Schweighofer N, 1998, EUR J NEUROSCI, V10, P86, DOI 10.1046/j.1460-9568.1998.00006.x; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; SMITH AM, 1981, J NEUROPHYSIOL, V45, P286, DOI 10.1152/jn.1981.45.2.286; Suh M, 2000, J NEUROPHYSIOL, V84, P1835, DOI 10.1152/jn.2000.84.4.1835; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Timmann D, 1996, BEHAV BRAIN RES, V81, P99, DOI 10.1016/S0166-4328(96)89075-9; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Xiao J, 2006, EXP BRAIN RES, V168, P106, DOI 10.1007/s00221-005-0074-2	47	136	136	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1404	1411		10.1038/nn1783	http://dx.doi.org/10.1038/nn1783			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028585				2022-12-24	WOS:000242403800018
J	Veruki, ML; Morkve, SH; Hartveit, E				Veruki, Margaret Lin; Morkve, Svein Harald; Hartveit, Espen			Activation of a presynaptic glutamate transporter regulates synaptic transmission through electrical signaling	NATURE NEUROSCIENCE			English	Article							AMINO-ACID TRANSPORTER; ROD BIPOLAR CELLS; MAMMALIAN RIBBON SYNAPSE; RAT RETINA; AMACRINE CELLS; EXTRASYNAPTIC GLUTAMATE; TRANSMITTER CLEARANCE; TIGER SALAMANDER; CURRENTS; LOCALIZATION	Whereas glutamate transporters in glial cells and postsynaptic neurons contribute significantly to re-uptake of synaptically released transmitter, the functional role of presynaptic glutamate transporters is poorly understood. Here, we used electrophysiological recording to examine the functional properties of a presynaptic glutamate transporter in rat retinal rod bipolar cells and its role in regulating glutamatergic synaptic transmission between rod bipolar cells and amacrine cells. Release of glutamate activated the presynaptic transporter with a time course that suggested a perisynaptic localization. The transporter was also activated by spillover of glutamate from neighboring rod bipolar cells. By recording from pairs of rod bipolar cells and All amacrine cells, we demonstrate that activation of the transporter-associated anion current hyperpolarizes the presynaptic terminal and thereby inhibits synaptic transmission by suppressing transmitter release. Given the evidence for presynaptic glutamate transporters, similar mechanisms could be of general importance for transmission in the nervous system.	Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Bergen	Hartveit, E (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	espen.hartveit@biomed.uib.no		Hartveit, Espen/0000-0003-1798-1901; Veruki, Margaret/0000-0002-0532-144X				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; ELIASOF S, 1993, J NEUROSCI, V13, P402; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; GUNDERSEN V, 1993, NEUROSCIENCE, V57, P97, DOI 10.1016/0306-4522(93)90114-U; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hasegawa J, 2006, NEURON, V50, P63, DOI 10.1016/j.neuron.2006.02.022; He Y, 2000, J COMP NEUROL, V418, P255; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; Otis TS, 1998, J NEUROSCI, V18, P7099; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; Protti DA, 1998, J NEUROSCI, V18, P3715; Rauen T, 1998, CELL TISSUE RES, V291, P19; RAUEN T, 1994, NEUROSCI LETT, V169, P137, DOI 10.1016/0304-3940(94)90375-1; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; SARANTIS M, 1988, NATURE, V332, P451, DOI 10.1038/332451a0; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; TACHIBANA M, 1988, P NATL ACAD SCI USA, V85, P5315, DOI 10.1073/pnas.85.14.5315; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3; YAMASHITA M, 1991, VISUAL NEUROSCI, V6, P399, DOI 10.1017/S0952523800006635; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	49	136	143	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1388	1396		10.1038/nn1793	http://dx.doi.org/10.1038/nn1793			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041592				2022-12-24	WOS:000242403800016
J	Witten, IB; Bergan, JF; Knudsen, EI				Witten, Ilana B.; Bergan, Joseph F.; Knudsen, Eric I.			Dynamic shifts in the owl's auditory space map predict moving sound location	NATURE NEUROSCIENCE			English	Article							INFERIOR COLLICULUS NEURONS; INTERAURAL PHASE DISPARITY; BINAURAL RESPONSE PROPERTIES; BARN OWL; OPTIC TECTUM; RECEPTIVE-FIELDS; TYTO-ALBA; NEURAL MAPS; TIME; LOCALIZATION	The optic tectum of the barn owl contains a map of auditory space. We found that, in response to moving sounds, the locations of receptive fields that make up the map shifted toward the approaching sound. The magnitude of the receptive field shifts increased systematically with increasing stimulus velocity and, therefore, was appropriate to compensate for sensory and motor delays inherent to auditory orienting behavior. Thus, the auditory space map is not static, but shifts adaptively and dynamically in response to stimulus motion. We provide a computational model to account for these results. Because the model derives predictive responses from processes that are known to occur commonly in neural networks, we hypothesize that analogous predictive responses will be found to exist widely in the central nervous system. This hypothesis is consistent with perceptions of stimulus motion in humans for many sensory parameters.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	eknudsen@stanford.edu			NIDCD NIH HHS [F31 DC007813] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alais D, 2003, CURR BIOL, V13, P59, DOI 10.1016/S0960-9822(02)01402-1; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Borisyuk A, 2002, J NEUROPHYSIOL, V88, P2134, DOI 10.1152/jn.2002.88.4.2134; Brainard MS, 1998, J NEUROSCI, V18, P3929; Cai HM, 1998, J ACOUST SOC AM, V103, P494, DOI 10.1121/1.421130; DeBello WM, 2004, J NEUROSCI, V24, P6853, DOI 10.1523/JNEUROSCI.0480-04.2004; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; Gold JI, 2001, J NEUROPHYSIOL, V85, P1575, DOI 10.1152/jn.2001.85.4.1575; Gutfreund Y, 2006, J NEUROPHYSIOL, V96, P813, DOI 10.1152/jn.01144.2005; Ingham NJ, 2001, J NEUROPHYSIOL, V85, P23, DOI 10.1152/jn.2001.85.1.23; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, SCIENCE, V202, P778, DOI 10.1126/science.715444; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; McAlpine D, 2000, J NEUROPHYSIOL, V83, P1356, DOI 10.1152/jn.2000.83.3.1356; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; OLSEN JF, 1989, J NEUROSCI, V9, P2591; PAYNE RS, 1971, J EXP BIOL, V54, P535; PERROTT DR, 1977, J ACOUST SOC AM, V62, P1463, DOI 10.1121/1.381675; Sheth BR, 2000, NAT NEUROSCI, V3, P489, DOI 10.1038/74865; Spitzer MW, 1998, J NEUROPHYSIOL, V80, P3062, DOI 10.1152/jn.1998.80.6.3062; SPITZER MW, 1993, J NEUROPHYSIOL, V69, P1245, DOI 10.1152/jn.1993.69.4.1245; WAGNER H, 1990, EUR J NEUROSCI, V2, P949, DOI 10.1111/j.1460-9568.1990.tb00007.x; Wilson WW, 1998, J NEUROPHYSIOL, V79, P2040, DOI 10.1152/jn.1998.79.4.2040	30	25	25	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1439	1445		10.1038/nn1781	http://dx.doi.org/10.1038/nn1781			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17013379				2022-12-24	WOS:000242403800023
J	Blake, DT; Heiser, MA; Caywood, M; Merzenich, MM				Blake, David T.; Heiser, Marc A.; Caywood, Matthew; Merzenich, Michael M.			Experience-dependent adult cortical plasticity requires cognitive association between sensation and reward	NEURON			English	Article							PRIMARY AUDITORY-CORTEX; OWL MONKEYS; CEREBRAL-CORTEX; AREA 3B; SOMATOSENSORY CORTEX; DISCRIMINATION TASK; HAND REPRESENTATION; TACTILE STIMULATION; RESPONSE PROPERTIES; MAP REORGANIZATION	We tested the involvement of cognition in adult experience-dependent neuroplasticity using primate cortical implants. In a prior study, learning an operant sensory discrimination increased cortical excitability and target selectivity. Here, the prior task was separated into three behavioral phases. First, naive animals were exposed to stimulus-reward pairings from the prior study. These yoked animals did not have to discriminate to be rewarded and did not learn the discrimination. The plasticity observed in the prior study did not occur. Second, the animals were classically conditioned to discriminate the same stimuli in a simplified format. Learning was accompanied by increased sensory response strength and an increased range of sensory inputs eliciting responses. The third study recreated the original operant discrimination, and selectivity for task targets increased. These studies demonstrate that cognitive association between sensory stimuli and reinforcers accompanies adult experience-dependent cortical plasticity and suggest that selectivity in representation and action are linked.	Med Coll Georgia, Dept Neurol, Ctr Synapses & Cognit Neurosci, Augusta, GA 30912 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, Dept Otolaryngol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University System of Georgia; Augusta University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blake, DT (corresponding author), Med Coll Georgia, Dept Neurol, Ctr Synapses & Cognit Neurosci, Augusta, GA 30912 USA.	dblake@mcg.edu			NIDCD NIH HHS [R03 DC005708-01A1, 5R03DC005708, R03 DC005708, R03 DC005708-03, R03 DC005708-02] Funding Source: Medline; NINDS NIH HHS [5R01NS010413] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC005708] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALLARD T, 1991, J NEUROPHYSIOL, V66, P1048, DOI 10.1152/jn.1991.66.3.1048; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Blake DT, 2005, J NEUROPHYSIOL, V94, P2239, DOI 10.1152/jn.00172.2005; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Blake DT, 2002, BEHAV BRAIN RES, V135, P179, DOI 10.1016/S0166-4328(02)00163-8; deCharms RC, 1999, J NEUROSCI METH, V93, P27, DOI 10.1016/S0165-0270(99)00087-4; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Efron B, 1998, INTRO BOOTSTRAP; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Galvan VV, 2002, NEUROBIOL LEARN MEM, V77, P78, DOI 10.1006/nlme.2001.4044; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; IMIG TJ, 1977, J COMP NEUROL, V171, P111, DOI 10.1002/cne.901710108; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; McDonough R. N., 2004, DETECTION SIGNALS NO; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MOUNTCASTLE VB, 1966, TOUCH HEAT PAIN, P325; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Richardson R T, 1991, Adv Exp Med Biol, V295, P233; Rutkowski RG, 2005, P NATL ACAD SCI USA, V102, P13664, DOI 10.1073/pnas.0506838102; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264; XERRI C, 1994, J NEUROSCI, V14, P1710, DOI 10.1523/JNEUROSCI.14-03-01710.1994; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	46	105	106	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					371	381		10.1016/j.neuron.2006.08.009	http://dx.doi.org/10.1016/j.neuron.2006.08.009			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046698	Green Accepted, Bronze			2022-12-24	WOS:000241799900016
J	Lee, I; Griffin, AL; Zilli, EA; Eichenbaum, H; Hasselmo, ME				Lee, Inah; Griffin, Amy L.; Zilli, Eric A.; Eichenbaum, Howard; Hasselmo, Michael E.			Gradual translocation of spatial correlates of neuronal firing in the hippocampus toward prospective reward locations	NEURON			English	Article							COMPLEX-SPIKE CELLS; PLACE CELLS; ENTORHINAL CORTEX; UNIT-ACTIVITY; MEMORY; EXPERIENCE; SEQUENCES; TASK; RAT; CA1	In a continuous T-maze alternation task, CA1 complex-spike neurons in the hippocampus differentially fire as the rat traverses overlapping segments of the maze (i.e., the stem) repeatedly via alternate routes. The temporal dynamics of this phenomenon were further investigated in the current study. Rats learned the alternation task from the first day of acquisition and the differential firing pattern in the stem was observed accordingly. More importantly, we report a phenomenon in which spatial correlates of CA1 neuronal ensembles gradually changed from their original firing locations, shifting toward prospective goal locations in the continuous T-maze alternation task. The relative locations of simultaneously recorded firing fields, however, were preserved within the ensemble spatial representation during this shifting. The within-session shifts in preferred firing locations in the absence of any changes in the environment suggest that certain cognitive factors can significantly alter the location-bound coding scheme of hippocampal neurons.	Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Lee, I (corresponding author), Univ Iowa, Dept Psychol, E11 Seashore Hall, Iowa City, IA 52242 USA.	inah-lee@uiowa.edu; hasselmo@bu.edu		Griffin, Amy/0000-0002-4524-2156; Hasselmo, Michael/0000-0002-9925-6377	NIDA NIH HHS [DA 16454] Funding Source: Medline; NIMH NIH HHS [MH 60013, 5F32 MH 070184-02, MH 51570, MH 61492] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051570, R01MH061492, F32MH070184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016454] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson MI, 2003, J NEUROSCI, V23, P8827; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bower MR, 2005, J NEUROSCI, V25, P1313, DOI 10.1523/JNEUROSCI.2901-04.2005; BREESE CR, 1989, J NEUROSCI, V9, P1097; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2002, J NEUROSCI, V22, P3817; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Gothard KM, 1996, J NEUROSCI, V16, P823; Hasselmo ME, 2005, J COGNITIVE NEUROSCI, V17, P1115, DOI 10.1162/0898929054475190; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Kobayashi T, 1997, J NEUROPHYSIOL, V78, P597, DOI 10.1152/jn.1997.78.2.597; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Lenck-Santini PP, 2001, HIPPOCAMPUS, V11, P377, DOI 10.1002/hipo.1052; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McClelland JL, 1998, ANN NY ACAD SCI, V843, P153, DOI 10.1111/j.1749-6632.1998.tb08212.x; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Rosenzweig ES, 2003, NAT NEUROSCI, V6, P609, DOI 10.1038/nn1053; SCHULTZ W, 1997, SCIENCE, V275, P1594; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tanila H, 1997, HIPPOCAMPUS, V7, P613, DOI 10.1002/(SICI)1098-1063(1997)7:6<613::AID-HIPO4>3.0.CO;2-F; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WILSON M, 1994, SCIENCE, V261, P1055; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	44	114	117	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					639	650		10.1016/j.neuron.2006.06.033	http://dx.doi.org/10.1016/j.neuron.2006.06.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950161	Bronze			2022-12-24	WOS:000240623400012
J	Kawai, H; Lazar, R; Metherate, R				Kawai, Hideki; Lazar, Ronit; Metherate, Raju			Nicotinic control of axon excitability regulates thalamocortical transmission	NATURE NEUROSCIENCE			English	Article							AUDITORY-CORTEX; ACETYLCHOLINE-RECEPTORS; VISUAL-CORTEX; IN-VITRO; SYNAPTIC-TRANSMISSION; SPECTRAL INTEGRATION; EVOKED-POTENTIALS; TOBACCO SMOKING; RAT NEOCORTEX; SYNAPSES	The thalamocortical pathway, a bundle of myelinated axons that arises from thalamic relay neurons, carries sensory information to the neocortex. Because axon excitation is an obligatory step in the relay of information from the thalamus to the cortex, it represents a potential point of control. We now show that, in adult mice, the activation of nicotinic acetylcholine receptors ( nAChRs) in the initial portion of the auditory thalamocortical pathway modulates thalamocortical transmission of information by regulating axon excitability. Exogenous nicotine enhanced the probability and synchrony of evoked action potential discharges along thalamocortical axons in vitro, but had little effect on synaptic release mechanisms. In vivo, the blockade of nAChRs in the thalamocortical pathway reduced sound-evoked cortical responses, especially those evoked by sounds near the acoustic threshold. These data indicate that endogenous acetylcholine activates nAChRs in the thalamocortical pathway to lower the threshold for thalamocortical transmission and to increase the magnitude of sensory-evoked cortical responses. Our results show that a neurotransmitter can modulate sensory processing by regulating conduction along myelinated thalamocortical axons.	Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Hearing Res, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Metherate, R (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, 2205 McGaugh Hall, Irvine, CA 92697 USA.	rmethera@uci.edu		Kawai, Hideki/0000-0003-2113-6866	NIDA NIH HHS [DA12929] Funding Source: Medline; NIDCD NIH HHS [DC02967, DC08204] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002967, R29DC002967, R03DC008204, R55DC002967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012929] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ARMETT CJ, 1961, J PHYSIOL-LONDON, V155, P372, DOI 10.1113/jphysiol.1961.sp006634; Ashley WH, 2001, HEARING RES, V160, P89; BROWN DA, 1984, J PHYSIOL-LONDON, V353, P101, DOI 10.1113/jphysiol.1984.sp015325; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Chu ZG, 2000, BRAIN RES, V887, P399, DOI 10.1016/S0006-8993(00)03076-6; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; Ding YS, 2004, SYNAPSE, V53, P184, DOI 10.1002/syn.20051; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Domino EF, 2003, BRAIN COGNITION, V53, P66, DOI 10.1016/S0278-2626(03)00204-5; DOSSI RC, 1991, J NEUROPHYSIOL, V65, P393, DOI 10.1152/jn.1991.65.3.393; Edeline JM, 2003, EXP BRAIN RES, V153, P554, DOI 10.1007/s00221-003-1608-0; FRIEDMAN J, 1974, NATURE, V248, P455, DOI 10.1038/248455a0; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; HASHIKAWA T, 1995, J COMP NEUROL, V362, P195, DOI 10.1002/cne.903620204; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; KNOTT VJ, 1985, NEUROPSYCHOBIOLOGY, V13, P74, DOI 10.1159/000118166; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Lan CT, 1996, ANAT EMBRYOL, V194, P177; Lang PM, 2003, J NEUROPHYSIOL, V90, P3295, DOI 10.1152/jn.00512.2003; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Liang K, 2006, EUR J NEUROSCI, V24, P857, DOI 10.1111/j.1460-9568.2006.04945.x; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; MULLERPREUSS P, 1984, HEARING RES, V16, P133, DOI 10.1016/0378-5955(84)90003-0; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAWLINS FA, 1978, J CELL BIOL, V77, P371, DOI 10.1083/jcb.77.2.371; Roerig B, 1997, J NEUROSCI, V17, P8353; Rose HJ, 2005, J NEUROPHYSIOL, V94, P2019, DOI 10.1152/jn.00860.2004; Sarter M, 2000, NEUROSCIENCE, V95, P933; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; VOLGUSHEV M, 1995, EUR J NEUROSCI, V7, P1751, DOI 10.1111/j.1460-9568.1995.tb00695.x; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Wessler I, 1997, N-S ARCH PHARMACOL, V356, P694, DOI 10.1007/PL00005107; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Zhang CL, 2004, J NEUROPHYSIOL, V91, P1025, DOI 10.1152/jn.00769.2003	49	114	117	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1168	1175		10.1038/nn1956	http://dx.doi.org/10.1038/nn1956			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17704774				2022-12-24	WOS:000249144000019
J	Jin, YJ; Kim, SJ; Kim, J; Worley, PF; Linden, DJ				Jin, Yunju; Kim, Sang Jeong; Kim, Jun; Worley, Paul F.; Linden, David J.			Long-term depression of mGluR1 signaling	NEURON			English	Article							CEREBELLAR PURKINJE NEURONS; METABOTROPIC GLUTAMATE RECEPTORS; CELLS; INTERNALIZATION; ACTIVATION; POTENTIATION; CHANNELS; RELEASE; GLUTAMATE-RECEPTOR-1; DESENSITIZATION	Glutamate produces both fast excitation through activation of ionotropic receptors and slower actions through metabotropic receptors (mGluRs). To date, ionotropic but not metabotropic neurotransmission has been shown to undergo long-term synaptic potentiation and depression. Burst stimulation of parallel fibers releases glutamate, which activates perisynaptic mGluR1 in the dendritic spines of cerebellar Purkinje cells. Here, we show that the mGluR1 dependent slow EPSC and its coincident Ca transient were selectively and persistently depressed by repeated climbing fiber-evoked depolarization of Purkinje cells in brain slices. LTD(mGluR1) was also observed when slow synaptic current was evoked by exogenous application of a group I mGluR agonist, implying a postsynaptic expression mechanism. Ca imaging further revealed that LTD(mGluR1) was expressed as coincident attenuation of both limbs of mGluR1 signaling: the slow EPSC and PLC/IP3-mediated dendritic Ca mobilization. Thus, different patterns of neural activity can evoke LTD of either fast ionotropic or slow mGluR1 -mediated synaptic signaling.	Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 151, South Korea; Seoul Natl Univ, Coll Med, Neurosci Res Inst Med Res, Seoul 151, South Korea; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Seoul National University (SNU); Seoul National University (SNU); Johns Hopkins University	Kim, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 151, South Korea.	sangjkim@snu.ac.kr; dlinden@jhmi.edu	Kim, Jun/J-5432-2012; Kim, Sang Jeong/J-2740-2012	Kim, Sang Jeong/0000-0001-8931-3713	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, P50MH068830, R37MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA10309] Funding Source: Medline; NIMH NIH HHS [P50 MH068830, R37 MH051106, P50 MH068830-010003, R01 MH051106, R01 MH051106-08, R29 MH051106] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Debanne D, 2003, J PHYSIOLOGY-PARIS, V97, P403, DOI 10.1016/j.jphysparis.2004.01.004; Doherty AJ, 1999, BIOCHEM J, V341, P415, DOI 10.1042/0264-6021:3410415; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Dzubay JA, 2002, NEURON, V36, P1159, DOI 10.1016/S0896-6273(02)01052-8; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hartmann J, 2004, J NEUROSCI, V24, P5119, DOI 10.1523/JNEUROSCI.4193-03.2004; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Minami I, 2003, EUR J NEUROSCI, V17, P1023, DOI 10.1046/j.1460-9568.2003.02499.x; Mundell SJ, 2001, J NEUROCHEM, V78, P546, DOI 10.1046/j.1471-4159.2001.00421.x; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Sdrulla AD, 2007, NAT NEUROSCI, V10, P546, DOI 10.1038/nn1889; Shen Y, 2005, NEURON, V46, P715, DOI 10.1016/j.neuron.2005.04.033; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Shin JH, 2005, J NEUROPHYSIOL, V94, P4281, DOI 10.1152/jn.00661.2005; Sugiyama T, 1999, BIOCHEM BIOPH RES CO, V265, P473, DOI 10.1006/bbrc.1999.1628; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 2001, J NEUROPHYSIOL, V86, P1389, DOI 10.1152/jn.2001.86.3.1389; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Tempia F, 1996, J NEUROSCI, V16, P456; Welsh JP, 2002, ADV NEUROL, V89, P331; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020	31	31	31	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2007	55	2					277	287		10.1016/j.neuron.2007.06.035	http://dx.doi.org/10.1016/j.neuron.2007.06.035			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NW	17640528	Green Accepted, Bronze			2022-12-24	WOS:000248635800011
J	Douglas, KM; Bilkey, DK				Douglas, Katie M.; Bilkey, David K.			Amusia is associated with deficits in spatial processing	NATURE NEUROSCIENCE			English	Article							CONGENITAL AMUSIA; MENTAL ROTATION; TONE-DEAFNESS; SEX DIFFERENCE; DIGIT RATIO; MUSIC; PERFORMANCE; TASK; TESTOSTERONE; DISORDERS	Amusia (commonly referred to as tone-deafness) is a difficulty in discriminating pitch changes in melodies that affects around 4% of the human population. Amusia cannot be explained as a simple sensory impairment. Here we show that amusia is strongly related to a deficit in spatial processing in adults. Compared to two matched control groups (musicians and non-musicians), participants in the amusic group were significantly impaired on a visually presented mental rotation task. Amusic subjects were also less prone to interference in a spatial stimulus-response incompatibility task and performed significantly faster than controls in an interference task in which they were required to make simple pitch discriminations while concurrently performing a mental rotation task. This indicates that the processing of pitch in music normally depends on the cognitive mechanisms that are used to process spatial representations in other modalities.	Univ Otago, Dept Psychol, Dunedin 9054, New Zealand	University of Otago	Bilkey, DK (corresponding author), Univ Otago, Dept Psychol, 95 Union St,PO Box 56, Dunedin 9054, New Zealand.	dbilkey@psy.otago.ac.nz	Douglas, Katie/AAB-5554-2020	Douglas, Katie/0000-0002-5344-2959				Allen G, 1878, MIND, V3, P157, DOI [DOI 10.1093/MIND/OS-3.10.157, 10.1093/mind/os-3.10.157]; Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Berenbaum SA, 2001, ENDOCRIN METAB CLIN, V30, P173, DOI 10.1016/S0889-8529(08)70025-2; Collins DW, 1997, BEHAV NEUROSCI, V111, P845, DOI 10.1037/0735-7044.111.4.845; Cuddy LL, 2005, ANN NY ACAD SCI, V1060, P311, DOI 10.1196/annals.1360.026; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; GOUCHIE C, 1991, PSYCHONEUROENDOCRINO, V16, P323, DOI 10.1016/0306-4530(91)90018-O; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; HASSLER M, 1992, INT J NEUROSCI, V65, P45, DOI 10.3109/00207459209003277; Hausmann M, 2000, BEHAV NEUROSCI, V114, P1245, DOI 10.1037/0735-7044.114.6.1245; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Kopiez R, 2006, NEUROPSYCHOLOGIA, V44, P1079, DOI 10.1016/j.neuropsychologia.2005.10.023; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel AD, 2005, BRAIN COGNITION, V59, P310, DOI 10.1016/j.bandc.2004.10.003; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peters M, 2007, ARCH SEX BEHAV, V36, P251, DOI 10.1007/s10508-006-9166-8; Pratt CC, 1930, J EXP PSYCHOL, V13, P278, DOI 10.1037/h0072651; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Rauscher FH, 1997, NEUROL RES, V19, P2; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Schellenberg EG, 2005, CURR DIR PSYCHOL SCI, V14, P317, DOI 10.1111/j.0963-7214.2005.00389.x; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sloboda JA, 2005, ANN NY ACAD SCI, V1060, P255, DOI 10.1196/annals.1360.018; Sluming VA, 2000, EVOL HUM BEHAV, V21, P1; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Stewart L, 2006, BRAIN, V129, P2533, DOI 10.1093/brain/awl171; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015	31	93	94	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					915	921		10.1038/nn1925	http://dx.doi.org/10.1038/nn1925			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17589505				2022-12-24	WOS:000247560200023
J	Cobos, I; Borello, U; Rubenstein, JLR				Cobos, Inma; Borello, Ugo; Rubenstein, John L. R.			Dlx transcription factors promote migration through repression of axon and dendrite growth	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; CORTICAL GABAERGIC INTERNEURONS; MENTAL-RETARDATION; HOMEOBOX GENES; MICE LACKING; RHO-GTPASES; MAMMALIAN TELENCEPHALON; P21-ACTIVATED KINASES; MOLECULAR-MECHANISMS; SPINE MORPHOGENESIS	In the mouse telencephalon, DIx homeobox transcription factors are essential for the tangential migration of subpallial-derived GABAergic interneurons to neocortex. However, the mechanisms underlying this process are poorly understood. Here, we demonstrate that DIx1/2 has a central role in restraining neurite growth of subpallial-derived immature interneurons at a stage when they migrate tangentially to cortex. In DIx1(-/-);DIx(2-/-) mutants, neurite length is increased and cells fail to migrate. In DIx1(-/-); DIx2(+/-) mutants, while the tangential migration of immature interneurons appears normal, they develop dendritic and axonal processes with increased length and decreased branching, and have deficits in their neocortical laminar positions. Thus, DIx1/2 is required for coordinating programs of neurite maturation and migration. In this regard, we provide genetic evidence that in immature interneurons DIx1/2 repression of the p21-activated serine/threonine kinase PAK3, a downstream effector of the Rho family of GTPases, is critical in restraining neurite growth and promoting tangential migration.	Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Cobos, I (corresponding author), Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA.	inma.cobos@ucsf.edu; john.rubenstein@ucsf.edu	Borello, Ugo/M-5213-2014	Borello, Ugo/0000-0001-9812-579X; Cobos, Inma/0000-0002-2043-1890	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, K05MH065670] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH49428, R01 MH049428, K05 MH065670] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Boda B, 2006, MOL NEUROBIOL, V34, P67, DOI 10.1385/MN:34:1:67; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; de Melo J, 2005, DEVELOPMENT, V132, P311, DOI 10.1242/dev.01560; Dehmelt L, 2005, GENOME BIOL, V6; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fontaine-Lenoir V, 2006, P NATL ACAD SCI USA, V103, P4711, DOI 10.1073/pnas.0600113103; Fujimori K, 2002, J COMP NEUROL, V449, P330, DOI 10.1002/cne.10286; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Liu JK, 1997, DEV DYNAM, V210, P498, DOI 10.1002/(SICI)1097-0177(199712)210:4<498::AID-AJA12>3.0.CO;2-3; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Tanaka D, 2003, DEVELOPMENT, V130, P5803, DOI 10.1242/dev.00825; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	59	178	179	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 21	2007	54	6					873	888		10.1016/j.neuron.2007.05.024	http://dx.doi.org/10.1016/j.neuron.2007.05.024			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582329	Bronze, Green Accepted			2022-12-24	WOS:000247645600008
J	Sumner, P; Nachev, P; Morris, P; Peters, AM; Jackson, SR; Kennard, C; Husain, M				Sumner, Petroc; Nachev, Parashkev; Morris, Peter; Peters, Andrew M.; Jackson, Stephen R.; Kennard, Christopher; Husain, Masud			Human medial frontal cortex mediates unconscious inhibition of voluntary action	NEURON			English	Article							SUPPLEMENTARY EYE FIELD; CONDITIONAL OCULOMOTOR ASSOCIATIONS; PRESUPPLEMENTARY MOTOR AREA; MONKEY CEREBRAL-CORTEX; NEURONAL-ACTIVITY; RESPONSE FACILITATION; PARKINSONS-DISEASE; MULTIPLE SACCADES; LEARNED MOVEMENTS; PREMOTOR CORTEX	Within the medial frontal cortex, the supplementary eye field (SEF), supplementary motor area (SMA), and pre-SMA have been implicated in the control of voluntary action, especially during motor sequences or tasks involving rapid choices between competing response plans. However, the precise roles of these areas remain controversial. Here, we study two extremely rare patients with microlesions of the SEF and SMA to demonstrate that these areas are critically involved in unconscious and involuntary motor control. We employed masked-prime stimuli that evoked automatic inhibition in healthy people and control patients with lateral premotor or pre-SMA damage. In contrast, our SEF/SMA patients showed a complete reversal of the normal inhibitory effect-ocular or manual-corresponding to the functional subregion lesioned. These findings imply that the SEF and SMA mediate automatic effector-specific suppression of motor plans. This automatic mechanism may contribute to the participation of these areas in the voluntary control of action.	Cardiff Univ, Sch Psychol, Cardiff CF10 3AT, Wales; Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Neurosci, London W6 8RP, England; Univ Nottingham, Magnet Resonance Ctr, Sch Phys & Astron, Nottingham NG7 2RD, England; Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; UCL, Inst Neurol, London WC1N 3AR, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	Cardiff University; Imperial College London; University of Nottingham; University of Nottingham; University of London; University College London; University of London; University College London	Sumner, P (corresponding author), Cardiff Univ, Sch Psychol, Tower Bldg,Pk Pl, Cardiff CF10 3AT, Wales.	sumnerp@cardiff.ac.uk; m.husain@ion.ucl.ac.uk	Jackson, Stephen/B-1233-2009; Sumner, Petroc/A-3563-2010; Husain, Masud/C-2074-2008	Jackson, Stephen/0000-0002-5676-4072; Husain, Masud/0000-0002-6850-9255; Nachev, Parashkev/0000-0002-2718-4423; Peters, Andrew/0000-0002-8106-887X	Biotechnology and Biological Sciences Research Council [BB/C515271/1, BB/C515271/2] Funding Source: Medline; Medical Research Council [G9900259] Funding Source: Medline; Wellcome Trust [061140] Funding Source: Medline; MRC [G9900259] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amador N, 2004, J NEUROPHYSIOL, V91, P1672, DOI 10.1152/jn.00138.2003; Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Chainay H, 2004, NEUROREPORT, V15, P765, DOI 10.1097/00001756-200404090-00005; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; CHEN YC, 1995, EXP BRAIN RES, V102, P461; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Eimer M, 2003, BIOL PSYCHOL, V64, P7, DOI 10.1016/S0301-0511(03)00100-5; Eimer M, 2002, J MOTOR BEHAV, V34, P3, DOI 10.1080/00222890209601926; Eimer M, 2001, J MOTOR BEHAV, V33, P16, DOI 10.1080/00222890109601899; Fujii N, 2002, J NEUROPHYSIOL, V87, P2158, DOI 10.1152/jn.00867.2001; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; GAYMARD B, 1993, ANN NEUROL, V34, P404, DOI 10.1002/ana.410340317; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Heide W, 1996, BRAIN, V119, P1951, DOI 10.1093/brain/119.6.1951; Husain M, 2003, NAT NEUROSCI, V6, P117, DOI 10.1038/nn1005; Isoda M, 2004, J NEUROPHYSIOL, V92, P653, DOI 10.1152/jn.01201.2003; Isoda M, 2002, J NEUROPHYSIOL, V88, P3541, DOI 10.1152/jn.00299.2002; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Jaskowski P, 2005, ACTA NEUROBIOL EXP, V65, P409; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Lau H, 2006, NEUROIMAGE, V29, P446, DOI 10.1016/j.neuroimage.2005.07.050; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Leuthold H, 1998, PSYCHOL SCI, V9, P263, DOI 10.1111/1467-9280.00053; Lleras A, 2004, J EXP PSYCHOL GEN, V133, P475, DOI 10.1037/0096-3445.133.4.475; Lleras A, 2006, J EXP PSYCHOL GEN, V135, P495, DOI 10.1037/0096-3445.135.3.495; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; Matsuzaka Y, 1996, J NEUROPHYSIOL, V76, P2327, DOI 10.1152/jn.1996.76.4.2327; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; NACHEV P, 2007, IN PRESS NEUROIMAGE, DOI DOI 10.1016/J.NEUROIMAGE.2007.1003.1034; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1063, DOI 10.1152/jn.1999.82.2.1063; NEUMANN O, 1994, ATTENTION PERFORM, V15, P123; Olson CR, 2000, J NEUROPHYSIOL, V84, P1369, DOI 10.1152/jn.2000.84.3.1369; Parton A, 2007, NEUROPSYCHOLOGIA, V45, P997, DOI 10.1016/j.neuropsychologia.2006.09.007; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; ROMO R, 1987, EXP BRAIN RES, V67, P656; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sakai K, 1999, J NEUROSCI, V19, P10074; Schlaghecken F, 2006, J EXP PSYCHOL HUMAN, V32, P618, DOI 10.1037/0096-1523.32.3.618; Schlaghecken F, 2006, J EXP PSYCHOL GEN, V135, P484, DOI 10.1037/0096-3445.135.3.484; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Seiss E, 2006, NEUROPSYCHOLOGIA, V44, P869, DOI 10.1016/j.neuropsychologia.2005.09.001; Seiss E, 2004, BRAIN, V127, P330, DOI 10.1093/brain/awh043; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Stuphorn V, 2002, MUSCLE NERVE, V26, P326, DOI 10.1002/mus.10158; SUMNER P, 2007, IN PRESS EXP PSYCHOL; SUMNER P, 2007, IN PRESS ADV COGNITI; Sumner P, 2006, P NATL ACAD SCI USA, V103, P10520, DOI 10.1073/pnas.0601974103; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; THALER D, 1995, EXP BRAIN RES, V102, P445; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Verleger R, 2004, J EXP PSYCHOL GEN, V133, P494, DOI 10.1037/0096-3445.133.4.494; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8; Yamamoto J, 2004, BRAIN, V127, P873, DOI 10.1093/brain/awh110	69	232	240	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 7	2007	54	5					697	711		10.1016/j.neuron.2007.05.016	http://dx.doi.org/10.1016/j.neuron.2007.05.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553420	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000247329900005
J	Barry, C; Hayman, R; Burgess, N; Jeffery, KJ				Barry, Caswell; Hayman, Robin; Burgess, Neil; Jeffery, Kathryn J.			Experience-dependent rescaling of entorhinal grids	NATURE NEUROSCIENCE			English	Article							PATH-INTEGRATION; PLACE FIELDS; CORTEX; HIPPOCAMPUS; REPRESENTATION; CELLS; MODEL; MAP	The firing pattern of entorhinal 'grid cells' is thought to provide an intrinsic metric for space. We report a strong experience-dependent environmental influence: the spatial scales of the grids (which are aligned and have fixed relative sizes within each animal) vary parametrically with changes to a familiar environment's size and shape. Thus grid scale reflects an interaction between intrinsic, path-integrative calculation of location and learned associations to the external environment.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Anat, London WC1E 6BT, England; UCL, Dept Psychol, London WC1H 0AP, England	University of London; University College London; University of London; University College London; University of London; University College London	Barry, C (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.		Jeffery, Kathryn J/C-2409-2008; Burgess, Neil/B-2420-2009	Jeffery, Kathryn J/0000-0002-9495-0378; Burgess, Neil/0000-0003-0646-6584; Hayman, Robin/0000-0003-1075-0430	Medical Research Council [G0501672] Funding Source: Medline; MRC [G0501672] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barry C, 2006, REV NEUROSCIENCE, V17, P71; BROOKINGS T, 2006, PREPINT; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gorchetchnikov A, 2007, NEURAL NETWORKS, V20, P182, DOI 10.1016/j.neunet.2006.11.007; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Kloosterman F, 2004, HIPPOCAMPUS, V14, P1026, DOI 10.1002/hipo.20022; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572	15	336	341	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					682	684		10.1038/nn1905	http://dx.doi.org/10.1038/nn1905			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486102				2022-12-24	WOS:000246799800008
J	Nagai, M; Re, DB; Nagata, T; Chalazonitis, A; Jessell, TM; Wichterle, H; Przedborski, S				Nagai, Makiko; Re, Diane B.; Nagata, Tetsuya; Chalazonitis, Alcmene; Jessell, Thomas M.; Wichterle, Hynek; Przedborski, Serge			Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MOUSE MODEL; EMBRYONIC STEM-CELLS; SPINAL-CORD; EXTEND SURVIVAL; IN-VITRO; DISEASE; MICE; DEGENERATION	Mutations in superoxide dismutase-1 ( SOD1) cause a form of the fatal paralytic disorder amyotrophic lateral sclerosis ( ALS), presumably by a combination of cell-autonomous and non - cell- autonomous processes. Here, we show that expression of mutated human SOD1 in primary mouse spinal motor neurons does not provoke motor neuron degeneration. Conversely, rodent astrocytes expressing mutated SOD1 kill spinal primary and embryonic mouse stem cell - derived motor neurons. This is triggered by soluble toxic factor( s) through a Bax- dependent mechanism. However, mutant astrocytes do not cause the death of spinal GABAergic or dorsal root ganglion neurons or of embryonic stem cell - derived interneurons. In contrast to astrocytes, fibroblasts, microglia, cortical neurons and myocytes expressing mutated SOD1 do not cause overt neurotoxicity. These findings indicate that astrocytes may play a role in the specific degeneration of spinal motor neurons in ALS. Identification of the astrocyte- derived soluble factor( s) may have far- reaching implications for ALS from both a pathogenic and therapeutic standpoint.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Przedborski, S (corresponding author), Columbia Univ, Dept Neurol, 710 W 168th St, New York, NY 10032 USA.	SP30@Columbia.edu		Nagata, Tetsuya/0000-0003-4111-2693; Re, Diane/0000-0002-6842-6759; Wichterle, Hynek/0000-0002-7817-0080	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS038370, P50NS011766, R01NS042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER; NIA NIH HHS [AG 21617, R01 AG021617] Funding Source: Medline; NIDDK NIH HHS [R01 DK058056, DK58056] Funding Source: Medline; NIEHS NIH HHS [ES013177, R21 ES013177] Funding Source: Medline; NINDS NIH HHS [P01 NS011766, NS42269, P50 NS038370, NS38370, R01 NS042269, NS11766] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CHALAZONITIS A, 1988, BRAIN RES, V458, P231, DOI 10.1016/0006-8993(88)90466-0; CHALAZONITIS A, 1992, J NEUROSCI, V12, P583; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; DAS S, 1995, NEURON, V14, P447, DOI 10.1016/0896-6273(95)90300-3; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; KAJI K, 1979, EXP CELL RES, V119, P231, DOI 10.1016/0014-4827(79)90351-3; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lukas TJ, 2006, MOL CELL PROTEOMICS, V5, P1233, DOI 10.1074/mcp.M500431-MCP200; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Przedborski S, 1996, J NEUROCHEM, V67, P1383; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Ricart K, 2006, J NEUROCHEM, V97, P222, DOI 10.1111/j.1471-4159.2006.03739.x; Rideout HJ, 2004, J BIOL CHEM, V279, P46915, DOI 10.1074/jbc.M405146200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Scheffler B, 2003, DEVELOPMENT, V130, P5533, DOI 10.1242/dev.00714; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Silva GA, 1998, J NEUROSCI METH, V80, P75, DOI 10.1016/S0165-0270(97)00198-2; Suurmeijer AJH, 1999, LAB INVEST, V79, P619; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zona C, 2006, J NEUROPHYSIOL, V96, P3314, DOI 10.1152/jn.00566.2006	38	890	922	2	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					615	622		10.1038/nn1876	http://dx.doi.org/10.1038/nn1876			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435755	Green Accepted			2022-12-24	WOS:000245948000018
J	Fernandez, F; Morishita, W; Zuniga, E; Nguyen, J; Blank, M; Malenka, RC; Garner, CC				Fernandez, Fabian; Morishita, Wade; Zuniga, Elizabeth; Nguyen, James; Blank, Martina; Malenka, Robert C.; Garner, Craig C.			Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; TS65DN MOUSE; ABNORMALITIES; STORAGE; MICE; LTP	Ts65Dn mice, a model for Down syndrome, have excessive inhibition in the dentate gyrus, a condition that could compromise synaptic plasticity and mnemonic processing. We show that chronic systemic treatment of these mice with GABA(A) antagonists at non-epileptic doses causes a persistent post-drug recovery of cognition and long-term potentiation. These results suggest that over-inhibition contributes to intellectual disabilities associated with Down syndrome and that GABA(A) antagonists may be useful therapeutic agents for this disorder.	Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA	Stanford University	Garner, CC (corresponding author), Stanford Univ, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94305 USA.	cgarner@stanford.edu		Fernandez, Fabian-Xose/0000-0002-4288-5383; Garner, Craig/0000-0003-1970-5417				Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; HANSON JE, IN PRESS J PHYSL LON; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Ivic L, 2003, J BIOL CHEM, V278, P49279, DOI 10.1074/jbc.M304034200; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; LEVY S, 1953, JAMA-J AM MED ASSOC, V153, P1260, DOI 10.1001/jama.1953.02940310028007; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Seregaza Z, 2006, BEHAV GENET, V36, P387, DOI 10.1007/s10519-006-9056-9; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	15	376	394	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					411	413		10.1038/nn1860	http://dx.doi.org/10.1038/nn1860			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17322876				2022-12-24	WOS:000245228600008
J	Kukley, M; Capetillo-Zarate, E; Dietrich, D				Kukley, Maria; Capetillo-Zarate, Estibaliz; Dietrich, Dirk			Vesicular glutamate release from axons in white matter	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; CORPUS-CALLOSUM; GLIAL-CELLS; MOLECULAR-MECHANISMS; PRESYNAPTIC CALCIUM; ELECTRICAL-ACTIVITY; HIPPOCAMPAL SLICES; TERM DEPRESSION	Vesicular release of neurotransmitter is the universal output signal of neurons in the brain. It is generally believed that fast transmitter release is restricted to nerve terminals that contact postsynaptic cells in the gray matter. Here we show in the rat brain that the neurotransmitter glutamate is also released at discrete sites along axons in white matter in the absence of neurons and nerve terminals. The propagation of single action potentials along axons leads to rapid vesicular release of glutamate, which is detected by ionotropic glutamate receptors on local oligodendrocyte precursor cells. Axonal release of glutamate is reliable, involves highly localized calcium microdomain signaling and is strongly calcium cooperative, similar to vesicle fusion at synapses. This axonal transmitter release represents a widespread mechanism for high-fidelity, activity-dependent signaling at the axon-glia interface in white matter.	Univ Clin Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Clin Bonn, Dept Neuropathol, D-53105 Bonn, Germany	University of Bonn; University of Bonn	Kukley, M (corresponding author), Univ Clin Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	maria.kukley@gmx.de; dirk.dietrich@ukb.uni-bonn.de	Kukley, Maria/I-4064-2017; Capetillo-Zarate, Estibaliz/Z-5772-2019; Messier, Claude/A-2322-2008	Kukley, Maria/0000-0002-4567-1241; Capetillo-Zarate, Estibaliz/0000-0002-8416-0495; Messier, Claude/0000-0002-4791-1763				Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BERGER T, 1991, J NEUROSCI, V11, P3008; BJARTMAR C, 1994, GLIA, V11, P235, DOI 10.1002/glia.440110304; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hille B., 1992, IONIC CHANNELS EXCIT; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; JACOBSON S, 1974, BRAIN RES, V74, P149, DOI 10.1016/0006-8993(74)90118-8; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; Li S, 1999, J Neurosci, V19, pRC16; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Riederer BM, 2004, EUR J NEUROSCI, V19, P2039, DOI 10.1111/j.1460-9568.2004.03305.x; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Stanton PK, 2003, J NEUROSCI, V23, P5936; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Stricker C, 2003, J NEUROSCI METH, V130, P159, DOI 10.1016/j.jneumeth.2003.09.021; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Zhen M, 2004, CURR OPIN NEUROBIOL, V14, P280, DOI 10.1016/j.conb.2004.05.013	50	343	349	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					311	320		10.1038/nn1850	http://dx.doi.org/10.1038/nn1850			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293860				2022-12-24	WOS:000244480300013
J	Murad, A; Emery-Le, M; Emery, P				Murad, Alejandro; Emery-Le, Myai; Emery, Patrick			A subset of dorsal neurons modulates circadian behavior and light responses in Drosophila	NEURON			English	Article							CLOCK PROTEINS PERIOD; PACEMAKER NEURONS; CRYPTOCHROME; TIMELESS; BRAIN; RHYTHMS; PDF; PHOTORECEPTOR; MELANOGASTER; MUTATION	A fundamental property of circadian rhythms is their ability to persist under constant conditions. In Drosophila, the ventral Lateral Neurons (LNvs) are the pacemaker neurons driving circadian behavior under constant darkness. Wildtype flies are arrhythmic under constant illumination, but flies defective for the circadian photoreceptor CRY remain rhythmic. We found that flies overexpressing the pacemaker gene per or the morgue gene are also behaviorally rhythmic under constant light. Unexpectedly, the LNvs do not drive these rhythms: they are molecularly arrhythmic, and PDF-the neuropepticle they secrete to synchronize behavioral rhythms under constant darkness-is dispensable for rhythmicity in constant light. Molecular circadian rhythms are only found in a group of Dorsal Neurons: the DN1s. Thus, a subset of Dorsal Neurons shares with the LNvs the ability to function as pacemakers for circadian behavior, and its importance is promoted by light.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Neurosci Program, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Emery, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 365 Plantat St, Worcester, MA 01605 USA.	patrick.emery@umassmed.edu			NIGMS NIH HHS [5R01GM066777, R01 GM066777] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066777] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Egan ES, 1999, J NEUROSCI, V19, P3665; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Rorth P, 1998, DEVELOPMENT, V125, P1049; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shafer OT, 2002, J NEUROSCI, V22, P5946; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; STOLERU D, 2007, IN PRESS CELL; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x	42	97	99	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					689	701		10.1016/j.neuron.2007.01.034	http://dx.doi.org/10.1016/j.neuron.2007.01.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329209	Green Accepted, Bronze			2022-12-24	WOS:000245127100010
J	d'Avossa, G; Tosetti, M; Crespi, S; Biagi, L; Burr, DC; Morrone, MC				d'Avossa, Giovanni; Tosetti, Michela; Crespi, Sofia; Biagi, Laura; Burr, David C.; Morrone, Maria Concetta			Spatiotopic selectivity of BOLD responses to visual motion in human area MT	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL; CORTICAL AREA; OPTIC FLOW; CORTEX; REPRESENTATION; INTEGRATION; LOCATIONS; SHAPE; FORM	Many neurons in the monkey visual extrastriate cortex have receptive fields that are affected by gaze direction. In humans, psychophysical studies suggest that motion signals may be encoded in a spatiotopic fashion. Here we use functional magnetic resonance imaging to study spatial selectivity in the human middle temporal cortex ( area MT or V5), an area that is clearly implicated in motion perception. The results show that the response of MT is modulated by gaze direction, generating a spatial selectivity based on screen rather than retinal coordinates. This area could be the neurophysiological substrate of the spatiotopic representation of motion signals.	Univ Vita Salute San Raffaele, Fac Psicol, I-20132 Milan, Italy; Washington Univ, Sch Med, St Louis, MO 63110 USA; Fdn Stella Maris, I-56018 Pisa, Italy; Univ Milan, Dept Psychol, I-20126 Milan, Italy; Univ Florence, Dept Psychol, Florence, Italy; Univ Western Australia, Dept Psychol, Nedlands, WA 6009, Australia	Vita-Salute San Raffaele University; Washington University (WUSTL); IRCCS Fondazione Stella Maris; University of Milan; University of Milano-Bicocca; University of Florence; University of Western Australia	Morrone, MC (corresponding author), Univ Vita Salute San Raffaele, Fac Psicol, Via Olgettina 58, I-20132 Milan, Italy.	concetta.morrone@hsr.it	Tosetti, Michela/K-5749-2016; Morrone, Maria Concetta/C-6756-2014; Biagi, Laura/K-5692-2016	Tosetti, Michela/0000-0002-2515-7560; Morrone, Maria Concetta/0000-0002-1025-0316; Biagi, Laura/0000-0003-2159-439X; CRESPI, Sofia Allegra/0000-0001-7429-0440; Burr, David/0000-0003-1541-8832				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; d'Avossa G, 2003, J NEUROPHYSIOL, V90, P360, DOI 10.1152/jn.01040.2002; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; DeSouza JFX, 2002, CEREB CORTEX, V12, P991, DOI 10.1093/cercor/12.9.991; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Goossens J, 2006, J NEUROSCI, V26, P5616, DOI 10.1523/JNEUROSCI.0730-06.2006; Hasnain MK, 1998, HUM BRAIN MAPP, V6, P301, DOI 10.1002/(SICI)1097-0193(1998)6:4<301::AID-HBM8>3.0.CO;2-7; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; Huk AC, 2002, J NEUROSCI, V22, P7195; MCKYTON A, 2006, CEREB CORTEX, DOI DOI 10.1093/CERCORBH1027; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Nieman DR, 2005, VISION RES, V45, P2885, DOI 10.1016/j.visres.2005.06.029; Nishida S, 2003, VISION RES, V43, P639, DOI 10.1016/S0042-6989(03)00007-5; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Sereno MI, 2006, NAT NEUROSCI, V9, P1337, DOI 10.1038/nn1777; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Talairach J., 1988, STEREOTACTIC COPLANA; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Zaksas D, 2005, J NEUROPHYSIOL, V94, P4156, DOI 10.1152/jn.00505.2005; ZEKI S, 1991, J NEUROSCI, V11, P641; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	40	126	125	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					249	255		10.1038/nn1824	http://dx.doi.org/10.1038/nn1824			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17195842				2022-12-24	WOS:000244175200020
J	Isoda, M; Hikosaka, O				Isoda, Masaki; Hikosaka, Okihide			Switching from automatic to controlled action by monkey medial frontal cortex	NATURE NEUROSCIENCE			English	Article							PRESUPPLEMENTARY MOTOR AREA; SUPPLEMENTARY EYE FIELD; MEMORY-GUIDED SACCADES; NEURONAL-ACTIVITY; ELECTRICAL-STIMULATION; MACAQUE MONKEY; SUBTHALAMIC NUCLEUS; RESPONSE-CONFLICT; BASAL GANGLIA; PRE-SMA	Human behavior is mostly composed of habitual actions that require little conscious control. Such actions may become invalid if the environment changes, at which point individuals need to switch behavior by overcoming habitual actions that are otherwise triggered automatically. It is unknown how the brain controls this type of behavioral switching. Here we show that the presupplementary motor area ( pre- SMA) in the medial frontal cortex has a function in switching from automatic to volitionally controlled action in rhesus macaque monkeys. We found that a group of pre- SMA neurons was selectively activated when subjects successfully switched to a controlled alternative action. Electrical stimulation in the pre- SMA replaced automatic incorrect responses with slower correct responses. A further test suggested that the pre- SMA enabled switching by first suppressing an automatic unwanted action and then boosting a controlled desired action. Our data suggest that the pre- SMA resolves response conflict so that the desired action can be selected.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Isoda, M (corresponding author), NEI, Sensorimotor Res Lab, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	isodam@nei.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; Ding L, 2006, J NEUROSCI, V26, P6695, DOI 10.1523/JNEUROSCI.0836-06.2006; DOVE E, 2000, BRAIN RES COGN BRAIN, V9, P103; Fujii N, 2002, J NEUROPHYSIOL, V87, P2158, DOI 10.1152/jn.00867.2001; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1993, EXP BRAIN RES, V95, P457; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; Husain M, 2003, NAT NEUROSCI, V6, P117, DOI 10.1038/nn1005; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Isoda M, 2005, J NEUROPHYSIOL, V93, P3016, DOI 10.1152/jn.01176.2004; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2261, DOI 10.1152/jn.00085.2004; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; LOGAN GD, 1980, COGNITIVE PSYCHOL, V12, P523, DOI 10.1016/0010-0285(80)90019-5; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; LUPPINO G, 1991, J COMP NEUROL, V311, P466; Matsuzaka Y, 1996, J NEUROPHYSIOL, V76, P2327, DOI 10.1152/jn.1996.76.4.2327; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; PARENT A, 1984, BRAIN RES, V303, P385, DOI 10.1016/0006-8993(84)91224-1; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Wang Y, 2005, NEUROSCI RES, V53, P1, DOI 10.1016/j.neures.2005.05.005; Yamamoto J, 2004, BRAIN, V127, P873, DOI 10.1093/brain/awh110; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; [No title captured]	49	335	340	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					240	248		10.1038/nn1830	http://dx.doi.org/10.1038/nn1830			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237780				2022-12-24	WOS:000244175200019
J	Wang, XN; Shaw, R; Tsang, HTH; Reid, E; O'Kane, CJ				Wang, Xinnan; Shaw, Robert; Tsang, Hilda T. H.; Reid, Evan; O'Kane, Cahir J.			Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; II RECEPTOR; PROTEIN; GENE; STABILITY; SPASTIN; FORM; MUTATIONS; PROLIFERATION; LOCALIZATION	To understand the functions of NIPA1, mutated in the neurodegenerative disease hereditary spastic paraplegia, and of ichthyin, mutated in autosomal recessive congenital ichthyosis, we have studied their Drosophila melanogaster ortholog, spichthyin ( Spict). Spict is found on early endosomes. Loss of Spict leads to upregulation of bone morphogenetic protein ( BMP) signaling and expansion of the neuromuscular junction. BMP signaling is also necessary for a normal microtubule cytoskeleton and axonal transport; analysis of loss- and gain- of- function phenotypes indicate that Spict may antagonize this function of BMP signaling. Spict interacts with BMP receptors and promotes their internalization from the plasma membrane, implying that it inhibits BMP signaling by regulating BMP receptor traffic. This is the first demonstration of a role for a hereditary spastic paraplegia protein or ichthyin family member in a specific signaling pathway, and implies disease mechanisms for hereditary spastic paraplegia that involve dependence of the microtubule cytoskeleton on BMP signaling.	Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Cambridge, Dept Med Genet, Cambridge CB2 2XY, England; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge; University of Cambridge; University of Cambridge	O'Kane, CJ (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	c.okane@gen.cam.ac.uk	O'Kane, Cahir J/C-4413-2011; O'Kane, Cahir/Q-6681-2019; Wang, Xinnan/B-2393-2013; Reid, Evan/F-3250-2010	O'Kane, Cahir/0000-0002-3488-2078; Reid, Evan/0000-0003-1623-7304	Wellcome Trust [073483] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Casso D, 2000, MECH DEVELOP, V91, P449; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Chen SH, 2005, AGENT BASED SOC SYST, V1, P135, DOI 10.1007/4-431-26925-8_13; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; DiGiovanna JJ, 2003, AM J CLIN DERMATOL, V4, P81, DOI 10.2165/00128071-200304020-00002; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; Goold RG, 1999, J CELL SCI, V112, P3373; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Kaneko S, 2006, MOVEMENT DISORD, V21, P1531, DOI 10.1002/mds.21005; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Li AG, 2004, EMBO J, V23, P1770, DOI 10.1038/sj.emboj.7600183; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Reed JA, 2005, NEUROGENETICS, V6, P79, DOI 10.1007/s10048-004-0209-9; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Vadlamudi RK, 2005, MOL CELL BIOL, V25, P3726, DOI 10.1128/MCB.25.9.3726-3736.2005; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zeitlmann L, 2001, J BIOL CHEM, V276, P9123, DOI 10.1074/jbc.M009270200; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	50	136	138	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					177	185		10.1038/nn1841	http://dx.doi.org/10.1038/nn1841			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220882	Green Accepted			2022-12-24	WOS:000244175200012
J	Yu, DH; Akalal, DBG; Davis, RL				Yu, Dinghui; Akalal, David-Benjamin G.; Davis, Ronald L.			Drosophila alpha/beta mushroom body neurons form a branch-specific, long-term cellular memory trace after spaced olfactory conditioning	NEURON			English	Article							CONSOLIDATED MEMORY; MUTANT DROSOPHILA; MOLECULAR-BIOLOGY; PROTEIN; RESCUE; NEUROSCIENCE; PATHWAY; BRAIN	Functional optical imaging showed that odor or electric shock stimuli presented to the fly causes transient calcium influx into the two major axon branches of alpha/beta mushroom body (MB) neurons. One pairing of odor and electric shock stimuli or multiple, massed pairings did not alter odor-evoked calcium influx. In contrast, animals that received multiple, spaced pairings exhibited a robust increase in calcium influx into the MB axons when tested at 9 or 24 hr after training, but not at 3 hr. This modification occurred only in the alpha branch of the neurons and was blocked by mutation of the amnesiac gene, inhibition of protein synthesis, or the expression of a protein blocker of the transcription factor Creb. Thus, behavioral long-term olfactory memory appears to be encoded as a branch-specific modification of calcium influx into the alpha/beta MB neurons that occurs after spaced training in a protein synthesis-, Creb-, and amnesiac-dependent way.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904, R01NS052351] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS052351-02, R37 NS019904, R01 NS019904, R01 NS052351-03, NS19904, R01 NS052351-05, R01 NS052351, NS52352, R01 NS052351-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Beck CDO, 2000, J NEUROSCI, V20, P2944; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Roman G, 1999, BIOTECHNIQUES, V27, P54, DOI 10.2144/99271bm09; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037	27	201	203	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					845	855		10.1016/j.neuron.2006.10.030	http://dx.doi.org/10.1016/j.neuron.2006.10.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145505	Bronze, Green Accepted			2022-12-24	WOS:000242856400012
J	Munoz, DP				Munoz, Douglas P.			Stabilizing the visual world	NATURE NEUROSCIENCE			English	Editorial Material							FRONTAL EYE FIELD; BRAIN-STEM TELLS; SUPERIOR COLLICULUS; CORTEX; REPRESENTATION		Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Munoz, DP (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.	doug_munoz@biomed.queensu.ca						DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; SOMMER MA, IN PRESS NATURE; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; VONHELMHOLTZ H, 2000, HELMHOLTZS TREATISE; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988	14	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1467	1468		10.1038/nn1206-1467	http://dx.doi.org/10.1038/nn1206-1467			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17128283				2022-12-24	WOS:000242404000006
J	Gentner, R; Classen, J				Gentner, Reinhard; Classen, Joseph			Modular organization of finger movements by the human central nervous system	NEURON			English	Article							HUMAN MOTOR CORTEX; MUSCLE SYNERGIES; SPINAL-CORD; HAND AREA; PRECENTRAL CORTEX; FORCE-FIELDS; STIMULATION; MICROSTIMULATION; REPRESENTATIONS; COMBINATIONS	The motor system may generate automated movements, such as walking, by combining modular spinal motor synergies. However, it remains unknown whether a modular neuronal architecture is sufficient to generate the unique flexibility of human finger movements, which rely on cortical structures. Here we show that finger movements evoked by transcranial magnetic stimulation (TMS) of the primary motor cortex reproduced distinctive features of the spatial representation of voluntary movements as identified in previous neurolmaging studies, consistent with naturalistic activation of neuronal elements. Principal component analysis revealed that the dimensionality of TMS-evoked movements was low. Principal components extracted from TMS-induced finger movements resembled those derived from end-postures of voluntary movements performed to grasp imagined objects, and a small subset of them was sufficient to reconstruct these movements with remarkable fidelity. The motor system may coordinate even the most dexterous movements by using a modular architecture involving cortical components.	Univ Wurzburg, Huma Cort Physiol & Motor Control Lab, Dept Neurol, D-97080 Wurzburg, Germany; Tech Univ Munich, Inst Measurement Syst & Sensor Technol, D-80333 Munich, Germany	University of Wurzburg; Technical University of Munich	Classen, J (corresponding author), Univ Wurzburg, Huma Cort Physiol & Motor Control Lab, Dept Neurol, D-97080 Wurzburg, Germany.	classen_j@klinik.uni-wuerzburg.de		Classen, Joseph/0000-0001-7182-6967				Aflalo TN, 2006, P NATL ACAD SCI USA, V103, P2909, DOI 10.1073/pnas.0511139103; Aoyagi Y, 2004, IEEE T NEUR SYS REH, V12, P12, DOI 10.1109/TNSRE.2003.823265; Barker AT, 2002, HDB TRANSCRANIAL MAG, P3; Beisteiner R, 2001, NEUROIMAGE, V13, P1016, DOI 10.1006/nimg.2000.0737; Bernstein N.A., 1967, COORDINATION REGULAT; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Deuschl G, 2001, MUSCLE NERVE, V24, P716, DOI 10.1002/mus.1063; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Ethier C, 2006, J NEUROSCI, V26, P5574, DOI 10.1523/JNEUROSCI.5332-05.2006; Fetz EE, 2002, ADV EXP MED BIOL, V508, P265; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; GISZTER SF, 1993, J NEUROSCI, V13, P467; Golub GH., 2013, MATRIX COMPUTATIONS; Graziano MSA, 2005, J NEUROPHYSIOL, V94, P4209, DOI 10.1152/jn.01303.2004; Graziano MSA, 2004, J NEUROPHYSIOL, V92, P395, DOI 10.1152/jn.01241.2003; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Hlustik P, 2001, CEREB CORTEX, V11, P312, DOI 10.1093/cercor/11.4.312; HOMMEL G, 1994, 4 INT SCI C WWDU94 M; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Jerde TE, 2003, IEEE T BIO-MED ENG, V50, P265, DOI 10.1109/TBME.2002.807640; Kleinschmidt A, 1997, EUR J NEUROSCI, V9, P2178, DOI 10.1111/j.1460-9568.1997.tb01384.x; KWAN HC, 1978, J NEUROPHYSIOL, V41, P1120, DOI 10.1152/jn.1978.41.5.1120; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; Mason CR, 2001, J NEUROPHYSIOL, V86, P2896, DOI 10.1152/jn.2001.86.6.2896; Mushahwar VK, 2004, CAN J PHYSIOL PHARM, V82, P702, DOI 10.1139/Y04-079; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Poliakov AV, 1999, J NEUROPHYSIOL, V82, P3488, DOI 10.1152/jn.1999.82.6.3488; PORTER R, 1995, CORTICOSPINAL FUNCTI, V45; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; Saltiel P, 1998, J NEUROPHYSIOL, V80, P2323, DOI 10.1152/jn.1998.80.5.2323; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Santello M, 1998, J NEUROSCI, V18, P10105; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Soechting JF, 1997, J COMPUT NEUROSCI, V4, P29, DOI 10.1023/A:1008812426305; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; STRICK PL, 1982, J NEUROPHYSIOL, V48, P139, DOI 10.1152/jn.1982.48.1.139; Strick PL, 2002, NAT NEUROSCI, V5, P714, DOI 10.1038/nn0802-714; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908	54	108	109	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					731	742		10.1016/j.neuron.2006.09.038	http://dx.doi.org/10.1016/j.neuron.2006.09.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114055	Bronze			2022-12-24	WOS:000242413100018
J	Prado, VF; Martins-Silva, C; de Castro, BM; Lima, RF; Barros, DM; Amaral, E; Ramsey, AJ; Sotnikova, TD; Ramirez, MR; Kim, HG; Rossato, JI; Koenen, J; Hui, Q; Cota, VR; Moraes, MFD; Gomez, MV; Guatimosim, C; Wetsel, WC; Kushmerick, C; Pereira, GS; Gainetdinov, RR; Izquierdo, I; Caron, MG; Prado, MAM				Prado, Vania F.; Martins-Silva, Cristina; de Castro, Braulio M.; Lima, Ricardo F.; Barros, Daniela M.; Amaral, Ernani; Ramsey, Amy J.; Sotnikova, Tatyana D.; Ramirez, Maria R.; Kim, Hyung-Gun; Rossato, Janine I.; Koenen, Janaina; Hui Quan; Cota, Vinicius R.; Moraes, Marcio F. D.; Gomez, Marcus V.; Guatimosim, Cristina; Wetsel, William C.; Kushmerick, Christopher; Pereira, Grace S.; Gainetdinov, Raul R.; Izquierdo, Ivan; Caron, Marc G.; Prado, Marco A. M.			Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition	NEURON			English	Article							CHOLINERGIC GENE LOCUS; KNOCKOUT MICE; ALZHEIMERS-DISEASE; NEUROMUSCULAR-TRANSMISSION; SYNAPTIC VESICLES; MEMORY DEFICITS; ACETYLTRANSFERASE; RECEPTOR; LACKING; RATS	An important step for cholinergic transmission involves the vesicular storage of acetylcholine (ACh), a process mediated by the vesicular acetylcholine transporter (VAChT). In order to understand the physiological roles of the VAChT, we developed a genetically altered strain of mice with reduced expression of this transporter. Heterozygous and homozygous VAChT knockdown mice have a 45% and 65% decrease in VAChT protein expression, respectively. VAChT deficiency alters synaptic vesicle filling and affects ACh release. Whereas VAChT homozygous mutant mice demonstrate major neuromuscular deficits, VAChT heterozygous mice appear normal in that respect and could be used for analysis of central cholinergic function. Behavioral analyses revealed that aversive learning and memory are not altered in mutant mice; however, performance in cognitive tasks involving object and social recognition is severely impaired. These observations suggest a critical role of VAChT in the regulation of ACh release and physiological functions in the peripheral and central nervous system.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Univ Fed Minas Gerais, Dept Bioquim Imunol, BR-31270901 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Farmacol, BR-31270901 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Fisiol Biofis, BR-31270901 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Morphol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil; Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Inst Pesquisas Biomed, Ctr Memoria, BR-90610000 Porto Alegre, RS, Brazil	Duke University; Duke University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Pontificia Universidade Catolica Do Rio Grande Do Sul	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu; mprado@icb.ufmg.br	Lima, Ricardo/G-2946-2013; Pereira, Grace Schenatto/O-6860-2019; Pereira, Grace S/B-9698-2013; Rossato, Janine/E-9543-2014; Prado, Marco Antonio Maximo/K-7638-2013; Cota, Vinícius Rosa/F-1752-2018; Amaral, Ernani/GSN-9499-2022; Gomez, Marcus Vinicius/I-4081-2012; Prado, Vania Ferreira/K-7630-2013; Rossato, Janine Inez/AHD-3513-2022; Sotnikova, Tatyana D/T-9992-2017; Moraes, Marcio FD/D-5285-2014; Kushmerick, Christopher/G-3578-2012; Gainetdinov, Raul R/G-5875-2011; de Freitas Lima, Ricardo/T-7825-2017; Martins-Silva, Cristina/F-8053-2016	Pereira, Grace Schenatto/0000-0003-4371-7020; Pereira, Grace S/0000-0003-4371-7020; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Cota, Vinícius Rosa/0000-0002-2338-5949; Amaral, Ernani/0000-0001-8314-9393; Gomez, Marcus Vinicius/0000-0002-6082-930X; Prado, Vania Ferreira/0000-0003-4994-6393; Rossato, Janine Inez/0000-0002-7980-5842; Moraes, Marcio FD/0000-0002-2034-1836; Gainetdinov, Raul R/0000-0003-2951-6038; de Freitas Lima, Ricardo/0000-0003-0250-5945; Izquierdo, Ivan/0000-0002-7208-0869; Ramsey, Amy/0000-0002-2717-5279	FOGARTY INTERNATIONAL CENTER [R03TW007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013551] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW 007025-01A1] Funding Source: Medline; NIDA NIH HHS [DA 13551] Funding Source: Medline; NIMH NIH HHS [MH 60451] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barros DM, 2002, BEHAV PHARMACOL, V13, P163, DOI 10.1097/00008877-200203000-00008; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; Brandon EP, 2004, J NEUROSCI, V24, P5459, DOI 10.1523/JNEUROSCI.1106-04.2004; Brandon EP, 1998, J NEUROSCI, V18, P3639; Cho GW, 2000, J BIOL CHEM, V275, P19942, DOI 10.1074/jbc.M902174199; Choleris E, 2003, P NATL ACAD SCI USA, V100, P6192, DOI 10.1073/pnas.0631699100; COLLIER B, 1986, J NEUROCHEM, V46, P822, DOI 10.1111/j.1471-4159.1986.tb13046.x; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; Csernansky JG, 2005, NEUROPSYCHOPHARMACOL, V30, P2135, DOI 10.1038/sj.npp.1300761; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; de Lima MNM, 2005, EXP NEUROL, V196, P177, DOI 10.1016/j.expneurol.2005.07.017; Dewachter I, 2002, J NEUROSCI, V22, P3445; Eiden LE, 1998, J NEUROCHEM, V70, P2227; ELMQVIST D, 1965, J PHYSIOL-LONDON, V177, P463, DOI 10.1113/jphysiol.1965.sp007605; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Fowler SC, 2002, INT J DEV NEUROSCI, V20, P309, DOI 10.1016/S0736-5748(02)00009-6; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Izquierdo I, 2002, TRENDS NEUROSCI, V25, P77, DOI 10.1016/S0166-2236(02)02090-8; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Paban V, 2005, NEUROSCIENCE, V132, P13, DOI 10.1016/j.neuroscience.2004.11.024; Parent MB, 2004, LEARN MEMORY, V11, P9, DOI 10.1101/lm.69104; PARSONS SM, 1993, INT REV NEUROBIOL, V35, P279, DOI 10.1016/S0074-7742(08)60572-3; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; PATON WDM, 1967, J PHYSIOL-LONDON, V191, P59, DOI 10.1113/jphysiol.1967.sp008237; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Prado MAM, 2002, NEUROCHEM INT, V41, P291, DOI 10.1016/S0197-0186(02)00044-X; Prediger RDS, 2006, EUR J PHARMACOL, V531, P176, DOI 10.1016/j.ejphar.2005.12.032; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; Ribeiro FM, 2006, J NEUROCHEM, V97, P1, DOI 10.1111/j.1471-4159.2006.03695.x; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; ROGHANI A, 1994, P NATL ACAD SCI USA, V91, P10620, DOI 10.1073/pnas.91.22.10620; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Van der Kloot W, 2003, PROG NEUROBIOL, V71, P269, DOI 10.1016/j.pneurobio.2003.10.003; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; WAUD DR, 1975, AM J PHYSIOL, V229, P1632, DOI 10.1152/ajplegacy.1975.229.6.1632; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626; Winslow JT, 2004, CURR OPIN NEUROBIOL, V14, P248, DOI 10.1016/j.conb.2004.03.009	53	185	187	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					601	612		10.1016/j.neuron.2006.08.005	http://dx.doi.org/10.1016/j.neuron.2006.08.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950158	Bronze			2022-12-24	WOS:000240623400009
J	Li, J; Ashley, J; Budnik, V; Bhat, MA				Li, Jingjun; Ashley, James; Budnik, Vivian; Bhat, Manzoor A.			Crucial role of drosophila neurexin in proper active zone apposition to postsynaptic densities, synaptic growth, and synaptic transmission	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; STRAND BREAK REPAIR; SEPTATE JUNCTION; ALPHA-NEUREXINS; TRANSMITTER RELEASE; MYELINATED AXONS; SYNAPTOTAGMIN-I; NEUROLIGIN; ADHESION; ORGANIZATION	Neurexins have been proposed to function as major mediators of the coordinated pre- and postsynaptic apposition. However, key evidence for this role in vivo has been lacking, particularly due to gene redundancy. Here, we have obtained null mutations in the single Drosophila neurexin gene (dnrx). dnrx loss of function prevents the normal proliferation of synaptic boutons at glutamatergic neuromuscular junctions, while dnrx gain of function in neurons has the opposite effect. DNRX mostly localizes to the active zone of presynaptic terminals. Conspicuously, dnrx null mutants display striking defects in synaptic ultrastructure, with the presence of detachments between pre- and postsynaptic membranes, abnormally long active zones, and increased number of T bars. These abnormalities result in corresponding alterations in synaptic transmission with reduced quantal content. Together, our results provide compelling evidence for an in vivo role of neurexins in the modulation of synaptic architecture and adhesive interactions between pre- and postsynaptic compartments.	Univ N Carolina, Sch Med, Neurodev Disorders Res Ctr, UNC Neurosci Ctr,Dept Cell & Mol Physiol,Curricul, Chapel Hill, NC 27599 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Massachusetts System; University of Massachusetts Worcester	Bhat, MA (corresponding author), Univ N Carolina, Sch Med, Neurodev Disorders Res Ctr, UNC Neurosci Ctr,Dept Cell & Mol Physiol,Curricul, Chapel Hill, NC 27599 USA.	manzoor_bhat@med.unc.edu	BHAT, MANZOOR/S-9273-2018	BHAT, MANZOOR/0000-0003-0989-1498; Ashley, James/0000-0002-6693-1014	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070000, R01MH070000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030072, R01NS050356] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063074-06A1, GM63074, R01 GM063074] Funding Source: Medline; NIMH NIH HHS [R37 MH070000, R01 MH070000, MH070000] Funding Source: Medline; NINDS NIH HHS [NS050356, R01 NS050356, R01 NS050356-02, R01 NS030072] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; BELLEN HJ, 2000, NEUROMUSCULAR JUCTIO, P175; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; CONNOLLY JB, 1998, BEHAV LEARNING MEMOR, P265; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Griffith LC, 2006, INT REV NEUROBIOL, V75, P237, DOI 10.1016/S0074-7742(06)75011-5; Harden N, 1996, MOL CELL BIOL, V16, P1896; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Peles E, 1997, CELL, V88, P745, DOI 10.1016/S0092-8674(00)81920-0; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Smith LA, 1996, J NEUROSCI, V16, P7868; Sone M, 2000, DEVELOPMENT, V127, P4157; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stewart BA, 1996, J NEUROSCI, V16, P3877; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Torroja L, 1999, J NEUROSCI, V19, P7793; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	78	119	121	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 6	2007	55	5					741	755		10.1016/j.neuron.2007.08.002	http://dx.doi.org/10.1016/j.neuron.2007.08.002			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785181	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-24	WOS:000249857000010
J	Foltenyi, K; Greenspan, RJ; Newport, JW				Foltenyi, Krisztina; Greenspan, Ralph J.; Newport, John W.			Activation of EGFR and ERK by rhomboid signaling regulates the consolidation and maintenance of sleep in Drosophila	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; CIRCADIAN-RHYTHMS; CORPUS CARDIACUM; PROTEIN-KINASES; MUSHROOM BODIES; DOWN-REGULATION; PATHWAY; MELANOGASTER; COMPONENTS; BRAIN	Epidermal growth factor receptor ( EGFR) signaling in the mammalian hypothalamus is important in the circadian regulation of activity. We have examined the role of this pathway in the regulation of sleep in Drosophila melanogaster. Our results demonstrate that rhomboid ( Rho)- and Star-mediated activation of EGFR and ERK signaling increases sleep in a dose-dependent manner, and that blockade of rhomboid ( rho) expression in the nervous system decreases sleep. The requirement of rho for sleep localized to the pars intercerebralis, a part of the fly brain that is developmentally and functionally analogous to the hypothalamus in vertebrates. These results suggest that sleep and its regulation by EGFR signaling may be ancestral to insects and mammals.	Inst Neurosci, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Greenspan, RJ (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	greenspan@nsi.edu						Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Basyuk E, 2000, Nucleic Acids Res, V28, pE46, DOI 10.1093/nar/28.10.e46; Botella JA, 2003, MOL BIOL CELL, V14, P241, DOI 10.1091/mbc.E02-05-0297; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; De Velasco B, 2004, DEV BIOL, V274, P280, DOI 10.1016/j.ydbio.2004.07.015; de Velasco B, 2007, DEV BIOL, V302, P309, DOI 10.1016/j.ydbio.2006.09.035; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Guichard A, 2002, P NATL ACAD SCI USA, V99, P3752, DOI 10.1073/pnas.052028699; Guichard A, 1999, DEVELOPMENT, V126, P2663; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoeffer CA, 2003, J NEUROSCI, V23, P6362; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kushikata T, 1998, AM J PHYSIOL-REG I, V275, pR509, DOI 10.1152/ajpregu.1998.275.2.R509; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Ng DCH, 2000, J BIOL CHEM, V275, P40856, DOI 10.1074/jbc.M004639200; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SCHEJTER ED, 1986, CELL, V46, P1091, DOI 10.1016/0092-8674(86)90709-9; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sokal R. R., 2012, BIOMETRY; STURTEVANT MA, 1994, DEVELOPMENT, V120, P2593; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Suzuki T, 1999, BRAIN RES, V840, P36, DOI 10.1016/S0006-8993(99)01762-X; SUZUKI T, 1995, NEUROSCI RES, V22, P277, DOI 10.1016/0168-0102(95)00902-6; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Veelaert D, 1998, INT REV CYTOL, V182, P249, DOI 10.1016/S0074-7696(08)62171-3; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	50	181	182	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1160	1167		10.1038/nn1957	http://dx.doi.org/10.1038/nn1957			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694052				2022-12-24	WOS:000249144000018
J	Melcher, D				Melcher, David			Predictive remapping of visual features precedes saccadic eye movements	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; ORIENTATION; TIME; REPRESENTATION; INTEGRATION; ADAPTATION; PERCEPTION; NEURONS; MOTION; FIELD	The frequent occurrence of saccadic eye movements raises the question of how information is combined across separate glances into a stable, continuous percept. Here I show that visual form processing is altered at both the current fixation position and the location of the saccadic target before the saccade. When human observers prepared to follow a displacement of the stimulus with the eyes, visual form adaptation was transferred from current fixation to the future gaze position. This transfer of adaptation also influenced the perception of test stimuli shown at an intermediate position between fixation and saccadic target. Additionally, I found a presaccadic transfer of adaptation when observers prepared to move their eyes toward a stationary adapting stimulus in peripheral vision. The remapping of visual processing, demonstrated here with form adaptation, may help to explain our impression of a smooth transition, with no temporal delay, of visual perception across glances.	Univ Trent, Ctr Mind Brain Studies, Dept Cognit Sci, I-38068 Rovereto, Italy; Oxford Brookes Univ, Dept Psychol, Oxford OX3 0BP, England	University of Trento; Oxford Brookes University	Melcher, D (corresponding author), Univ Trent, Ctr Mind Brain Studies, Dept Cognit Sci, Corso Bettini 31, I-38068 Rovereto, Italy.	david.melcher@form.unitn.it	Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X				BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Carpenter RHS, 1988, MOVEMENTS EYES; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Georgeson M, 2004, CURR BIOL, V14, pR751, DOI 10.1016/j.cub.2004.09.011; GEORGESON MA, 1976, PERCEPTION, V5, P99, DOI 10.1068/p050099; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Khayat PS, 2004, P NATL ACAD SCI USA, V101, P12712, DOI 10.1073/pnas.0301935101; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MCCONKIE GW, 1979, PERCEPT PSYCHOPHYS, V25, P221, DOI 10.3758/BF03202990; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Merriam ER, 2005, NEUROSCIENTIST, V11, P484, DOI 10.1177/1073858405276871; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; PARKER DM, 1972, Q J EXP PSYCHOL, V24, P1, DOI 10.1080/14640747208400260; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373	25	165	166	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					903	907		10.1038/nn1917	http://dx.doi.org/10.1038/nn1917			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17589507				2022-12-24	WOS:000247560200021
J	Wannig, A; Rodriguez, V; Freiwald, WA				Wannig, Aurel; Rodriguez, Valia; Freiwald, Winrich A.			Attention to surfaces modulates motion processing in extrastriate area MT	NEURON			English	Article							SELECTIVE ATTENTION; VISUAL AREA; TRANSPARENT MOTION; CORTICAL AREA; BRAIN POTENTIALS; OBJECT; COLOR; NEURONS; CORTEX; V4	In the visual system, early atomized representations are grouped into higher-level entities through processes of perceptual organization. Here we present neurophysiological evidence that a representation of a simple object, a surface defined by color and motion, can be the unit of attentional selection at an early stage of visual processing. Monkeys were cued by the color of a fixation spot to attend to one of two transparent random-dot surfaces, one red and one green, which occupied the same region of space. Motion of the attended surface drove neurons in the middle temporal (MT) visual area more strongly than physically identical motion of the nonattended surface, even though both occurred within the spotlight of attention. Surface-based effects of attention persisted even without differential surface coloring, but attentional modulation was stronger with color. These results show that attention can select surface representations to modulate visual processing as early as cortical area MT.	Univ Bremen, Inst Brain Res, Ctr Adv Imaging, D-28334 Bremen, Germany; Cuban Neurosci Ctr, Havana, Cuba; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of Bremen; Harvard University; Harvard Medical School	Freiwald, WA (corresponding author), Univ Bremen, Inst Brain Res, Ctr Adv Imaging, POB 330440, D-28334 Bremen, Germany.	winrich.freiwald@googlemail.com		Rodriguez, Valia/0000-0002-6085-285X				Blaser E, 2000, NATURE, V408, P196, DOI 10.1038/35041567; Blaser E, 2005, EUR J NEUROSCI, V21, P2040, DOI 10.1111/j.1460-9568.2005.04032.x; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Croner LJ, 1997, VISION RES, V37, P1415, DOI 10.1016/S0042-6989(96)00299-4; Croner LJ, 1999, J NEUROSCI, V19, P3935; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Efron B., 1994, INTRO BOOTSTRAP; Fallah M, 2007, P NATL ACAD SCI USA, V104, P4165, DOI 10.1073/pnas.0611722104; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; HARTER MR, 1982, NEUROPSYCHOLOGIA, V20, P421, DOI 10.1016/0028-3932(82)90041-0; HE ZJ, 1995, P NATL ACAD SCI USA, V92, P11155, DOI 10.1073/pnas.92.24.11155; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Kramer AF, 1997, J EXP PSYCHOL GEN, V126, P3, DOI 10.1037/0096-3445.126.1.3; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mitchell JF, 2003, VISION RES, V43, P1323, DOI 10.1016/S0042-6989(03)00123-8; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; PHAF RH, 1990, COGNITIVE PSYCHOL, V22, P273, DOI 10.1016/0010-0285(90)90006-P; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; QIAN N, 1994, J NEUROSCI, V14, P7367; QIAN N, 1994, J NEUROSCI, V14, P7357; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rodriguez V, 2006, BRAIN RES, V1072, P110, DOI 10.1016/j.brainres.2005.10.071; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SALTO H, 1989, EXP BRAIN RES, V75, P1; Schoenfeld MA, 2003, P NATL ACAD SCI USA, V100, P11806, DOI 10.1073/pnas.1932820100; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sohn W, 2004, VISION RES, V44, P1437, DOI 10.1016/j.visres.2003.12.010; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Valdes-Sosa M, 1998, J COGNITIVE NEUROSCI, V10, P137, DOI 10.1162/089892998563743; Valdes-Sosa M, 2000, J EXP PSYCHOL HUMAN, V26, P488, DOI 10.1037/0096-1523.26.2.488; VECERA SP, 1994, J EXP PSYCHOL GEN, V123, P146, DOI 10.1037/0096-3445.123.2.146; Watt R. J., 1988, VISUAL PROCESSING CO; Wegener D, 2004, J NEUROSCI, V24, P6106, DOI 10.1523/JNEUROSCI.1459-04.2004; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	48	48	48	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 24	2007	54	4					639	651		10.1016/j.neuron.2007.05.001	http://dx.doi.org/10.1016/j.neuron.2007.05.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521575	Bronze			2022-12-24	WOS:000246970800017
J	Mizrahi, A				Mizrahi, Adi			Dendritic development and plasticity of adult-born neurons in the mouse olfactory bulb	NATURE NEUROSCIENCE			English	Article							NEOCORTEX IN-VIVO; HIPPOCAMPAL DENDRITES; SYNAPTIC PLASTICITY; INDIVIDUAL NEURONS; LENTIVIRAL VECTORS; SPINE STABILITY; NEUROGENESIS; CORTEX; DYNAMICS; RECEPTOR	The mammalian brain maintains few developmental niches where neurogenesis persists into adulthood. One niche is located in the olfactory system where the olfactory bulb continuously receives functional interneurons. In vivo two-photon microscopy of lentivirus-labeled newborn neurons was used to directly image their development and maintenance in the olfactory bulb. Time-lapse imaging of newborn neurons over several days showed that dendritic formation is highly dynamic with distinct differences between spiny neurons and non-spiny neurons. Once incorporated into the network, adult-born neurons maintain significant levels of structural dynamics. This structural plasticity is local, cumulative and sustained in neurons several months after their integration. Thus, I provide a new experimental system for directly studying the pool of regenerating neurons in the intact mammalian brain and suggest that regenerating neurons form a cellular substrate for continuous wiring plasticity in the olfactory bulb.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Mizrahi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	mizrahia@cc.huji.ac.il						Ailles LE, 2002, CURR TOP MICROBIOL, V261, P31; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Dailey ME, 1996, J NEUROSCI, V16, P2983; Davenne M, 2005, CHEM SENSES, V30, pI115, DOI 10.1093/chemse/bjh141; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kasthuri N, 2004, CURR OPIN NEUROBIOL, V14, P105, DOI 10.1016/j.conb.2004.01.013; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kosaka Katsuko, 2005, Anatomical Science International, V80, P80, DOI 10.1111/j.1447-073x.2005.00092.x; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizrahi A, 2006, P NATL ACAD SCI USA, V103, P1912, DOI 10.1073/pnas.0506297103; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Petreanu L, 2002, J NEUROSCI, V22, P6106; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; PURVES D, 1986, J NEUROSCI, V6, P1051; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shepherd GM, 2004, OLFACTORY BULB SYNAP, P165; SHOLL DA, 1953, J ANAT, V87, P387; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Wu GY, 1999, J NEUROSCI, V19, P4472; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	50	97	98	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					444	452		10.1038/nn1875	http://dx.doi.org/10.1038/nn1875			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369823				2022-12-24	WOS:000245228600015
J	Bats, C; Groc, L; Choquet, D				Bats, Cecile; Groc, Laurent; Choquet, Daniel			The interaction between stargazin and PSD-95 regulates AMPA receptor surface trafficking	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; MOLECULAR-MECHANISMS; DEPENDENT REGULATION; DIFFUSION DYNAMICS; LATERAL MOVEMENTS	Accumulation of AMPA receptors at synapses is a fundamental feature of glutamatergic synaptic transmission. Stargazin, a member of the TARP family, is an AMPAR auxiliary subunit allowing interaction of the receptor with scaffold proteins of the postsynaptic density, such as PSD-95. How PSD-95 and Stargazin regulate AMPAR number in synaptic membranes remains elusive. We show, using single quantum dot and FRAP imaging in live hippocampal neurons, that exchange of AMPAR by lateral diffusion between extrasynaptic and synaptic sites mostly depends on the interaction of Stargazin with PSD-95 and not upon the GluR2 AMPAR subunit C terminus. Disruption of interactions between Stargazin and PSD-95 strongly increases AMPAR surface diffusion, preventing AMPAR accumulation at postsynaptic sites. Furthermore, AMPARs and Stargazin diffuse as complexes in and out synapses. These results propose a model in which the StargazinPSD-95 interaction plays a key role to trap and transiently stabilize diffusing AMPARs in the postsynaptic density.	Univ Bordeaux, Inst Francois Magendie, CNRS, UMR 5091, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Choquet, D (corresponding author), Univ Bordeaux, Inst Francois Magendie, CNRS, UMR 5091, F-33077 Bordeaux, France.	dchoquet@u-bordeaux2.fr	Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/K-7893-2018; Choquet, Daniel/E-4203-2013	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Bats, Cecile/0000-0002-2246-7248				Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; AEL DE, 2002, CELL, V108, P849; Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rao A, 1998, J NEUROSCI, V18, P1217; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stein V, 2003, J NEUROSCI, V23, P5503; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Triller A, 2003, BIOL CELL, V95, P465, DOI 10.1016/j.biolcel.2003.07.001; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X	75	405	418	0	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					719	734		10.1016/j.neuron.2007.01.030	http://dx.doi.org/10.1016/j.neuron.2007.01.030			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329211	Bronze			2022-12-24	WOS:000245127100012
J	Hu, XY; Hicks, CW; He, WX; Wong, P; Macklin, WB; Trapp, BD; Yan, RQ				Hu, Xiangyou; Hicks, Caitlin W.; He, Wanxia; Wong, Philip; Macklin, Wendy B.; Trapp, Bruce D.; Yan, Riqiang			Bace1 modulates myelination in the central and peripheral nervous system	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; ASPARTYL PROTEASE; CLEAVING ENZYME; CELL-ADHESION; A-BETA; CLEAVAGE; DISEASE; NEUREGULIN-1; BRAIN	Bace1 is an endopeptidase that cleaves the amyloid precursor protein at the beta-secretase site. Apart from this cleavage, the functional importance of Bace1 in other physiological events is unknown. We show here that Bace1 regulates the process of myelination and myelin sheath thickness in the central and peripheral nerves. In Bace1-null mice, the process of myelination was delayed and myelin thickness was markedly reduced, indicating that genetic deletion of Bace1 causes hypomyelination. Bace1-null mice also showed altered neurological behaviors such as elevated pain sensitivity and reduced grip strength. Further mechanistic studies showed an altered neuregulin-Akt signaling pathway in Bace1-null mice. Full-length neuregulin-1 was increased and its cleavage product was decreased in the CNS of Bace1-null mice. Furthermore, phosphorylated Akt was also reduced. Based upon these and previous studies, we postulate that neuronally enriched Bace1 cleaves neuregulin-1 and that processed neuregulin-1 regulates myelination by means of phosphorylation of Akt in myelin-forming cells.	Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Cleveland Clinic Foundation; Johns Hopkins University	Yan, RQ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	yanr@ccf.org		Yan, Riqiang/0000-0001-7195-7617; Hicks, Caitlin/0000-0001-7638-1936				Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Carteron C, 2006, J CELL SCI, V119, P898, DOI 10.1242/jcs.02799; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lemke Greg, 2006, Sci STKE, V2006, ppe11, DOI 10.1126/stke.3252006pe11; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sussman CR, 2005, J NEUROSCI, V25, P5757, DOI 10.1523/JNEUROSCI.4748-04.2005; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174	39	474	491	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1520	1525		10.1038/nn1797	http://dx.doi.org/10.1038/nn1797			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17099708				2022-12-24	WOS:000242404000016
J	Robbe, D; Montgomery, SM; Thome, A; Rueda-Orozco, PE; McNaughton, BL; Buzsaki, G				Robbe, David; Montgomery, Sean M.; Thome, Alexander; Rueda-Orozco, Pavel E.; McNaughton, Bruce L.; Buzsaki, Gyoergy			Cannabinoids reveal importance of spike timing coordination in hippocampal function	NATURE NEUROSCIENCE			English	Article							IMPAIRS SPATIAL MEMORY; NETWORK OSCILLATIONS; THETA-OSCILLATIONS; ENDOCANNABINOID SYSTEM; ACETYLCHOLINE-RELEASE; WORKING-MEMORY; PHASE-LOCKING; BEHAVING RAT; IN-VITRO; EEG	Cannabinoids impair hippocampus-dependent memory in both humans and animals, but the network mechanisms responsible for this effect are unknown. Here we show that the cannabinoids Delta(9)-tetrahydrocannabinol and CP55940 decreased the power of theta, gamma and ripple oscillations in the hippocampus of head-restrained and freely moving rats. These effects were blocked by a CB1 antagonist. The decrease in theta power correlated with memory impairment in a hippocampus-dependent task. By simultaneously recording from large populations of single units, we found that CP55940 severely disrupted the temporal coordination of cell assemblies in short time windows (< 100 ms) yet only marginally affected population firing rates of pyramidal cells and interneurons. The decreased power of local field potential oscillations correlated with reduced temporal synchrony but not with firing rate changes. We hypothesize that reduced spike timing coordination and the associated impairment of physiological oscillations are responsible for cannabinoid-induced memory deficits.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Arizona, Div Neural Syst Mem & Aging, Tucson, AZ 85724 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University of Arizona	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Rueda, Pavel/GPP-1112-2022; robbe, david/O-5439-2016	robbe, david/0000-0002-9450-0553; Montgomery, Sean/0000-0001-7370-0938; Rueda-Orozco, Pavel/0000-0002-2801-803X; Buzsaki, Gyorgy/0000-0002-3100-4800	NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS20331, NS34994, NS43157] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS020331, R37NS020331, R01NS043157] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BUONAMICI M, 1982, NEUROPHARMACOLOGY, V21, P825, DOI 10.1016/0028-3908(82)90071-5; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2003, CURRENT PRACTICE CLI, P1; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; CONSROE PF, 1975, PHARMACOL BIOCHEM BE, V3, P173, DOI 10.1016/0091-3057(75)90144-6; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Curran HV, 2002, PSYCHOPHARMACOLOGY, V164, P61, DOI 10.1007/s00213-002-1169-0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Egashira N, 2002, EUR J PHARMACOL, V445, P221, DOI 10.1016/S0014-2999(02)01755-7; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hampson RE, 1998, NEUROBIOL DIS, V5, P474, DOI 10.1006/nbdi.1998.0223; Hampson RE, 2000, J NEUROSCI, V20, P8932; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hoffman AF, 2003, EUR J NEUROSCI, V18, P524, DOI 10.1046/j.1460-9568.2003.02773.x; Ilan AB, 2004, PSYCHOPHARMACOLOGY, V176, P214, DOI 10.1007/s00213-004-1868-9; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Lichtman AH, 1996, PSYCHOPHARMACOLOGY, V126, P125, DOI 10.1007/BF02246347; LICHTMAN AH, 1995, PSYCHOPHARMACOLOGY, V119, P282, DOI 10.1007/BF02246292; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MILLER LL, 1983, PSYCHOL BULL, V93, P441, DOI 10.1037/0033-2909.93.3.441; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OLPE HR, 1980, BRAIN RES BULL, V5, P507, DOI 10.1016/0361-9230(80)90082-9; Pisanu A, 2006, NEUROPHARMACOLOGY, V50, P661, DOI 10.1016/j.neuropharm.2005.11.023; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Tzavara ET, 2003, J NEUROSCI, V23, P9374; WILLINSKY MD, 1975, PSYCHOPHARMACOLOGIA, V41, P123, DOI 10.1007/BF00421068	50	241	247	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1526	1533		10.1038/nn1801	http://dx.doi.org/10.1038/nn1801			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115043				2022-12-24	WOS:000242404000017
J	Han, SK; Mancino, V; Simon, MI				Han, Sang-Kyou; Mancino, Valeria; Simon, Melvin I.			Phospholipase C beta 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons	NEURON			English	Article							DORSAL-ROOT-GANGLIA; SENSORY NEURONS; MESSENGER-RNA; MAST-CELLS; CALCIUM HOMEOSTASIS; MOLECULAR-CLONING; NERVE-FIBERS; SUBSTANCE-P; EXPRESSION; PROTEIN	Phospholipase C beta (PLC beta) isozymes represent a family of molecules that link G protein-coupled receptors (GPCRs) to an intracellular signaling network. Here, we investigated the function of PLC beta isozymes in sensory neurons by using mutant mice deficient for specific PLC beta family members. Expression analysis indicated that PLC beta 3, one of the four isoforms, is predominantly expressed in a subpopulation of C-fiber nociceptors. A subset of these neurons expressed the histamine H1 receptor. Ca2+ imaging studies revealed that PLC beta 3 specifically mediates histamineinduced calcium responses through the histamine H1 receptor in cultured sensory neurons. In line with this, we found that PLC beta 3(-/-) mice showed significant defects in scratching behavior induced by histamine; histamine-trifluoromethyl-toluidine(HTMT), a selective H1 agonist; and compound 48/80, a mast cell activator. These results demonstrate that PLC beta 3 is required to mediate "itch" sensation in response to histamine acting on the histamine H1 receptor in C-fiber nociceptive neurons.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Simon, MI (corresponding author), CALTECH, Div Biol, 147-75, Pasadena, CA 91125 USA.	simonm@caltech.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499] Funding Source: NIH RePORTER; NINDS NIH HHS [NS048499] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bachert C, 2002, ALLERGY, V57, P287, DOI 10.1034/j.1398-9995.2002.1r3542.x; Bell JK, 2004, BRIT J PHARMACOL, V142, P374, DOI 10.1038/sj.bjp.0705754; Botchkarev VA, 1997, ARCH DERMATOL RES, V289, P292, DOI 10.1007/s004030050195; Braz JM, 2005, NEURON, V47, P787, DOI 10.1016/j.neuron.2005.08.015; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chopra B, 2000, EUR J NEUROSCI, V12, P911, DOI 10.1046/j.1460-9568.2000.00979.x; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; FJAELLBRANDT N, 1961, J PHYSIOL-LONDON, V156, P578, DOI 10.1113/jphysiol.1961.sp006694; GRAHAM DT, 1951, J CLIN INVEST, V30, P37, DOI 10.1172/JCI102414; Guo Q, 2001, BRAIN RES, V903, P13, DOI 10.1016/S0006-8993(01)02304-6; HAAKSMA EEJ, 1990, PHARMACOL THERAPEUT, V47, P73, DOI 10.1016/0163-7258(90)90046-5; HAGERMARK O, 1979, ACTA DERM-VENEREOL, V59, P297; Hagforsen E, 2000, ARCH DERMATOL RES, V292, P269, DOI 10.1007/s004030000132; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; HANDWERKER HO, 1991, J NEUROPHYSIOL, V66, P307, DOI 10.1152/jn.1991.66.1.307; HANDWERKER HO, 1987, FINE EFFERENT NERVE; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Inagaki N, 2002, EUR J PHARMACOL, V448, P175, DOI 10.1016/S0014-2999(02)01933-7; Inagaki N, 2001, SKIN PHARMACOL APPL, V14, P87, DOI 10.1159/000056338; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Kasai M, 1998, NEUROSCI RES, V32, P231, DOI 10.1016/S0168-0102(98)00092-3; Kashiba H, 1999, MOL BRAIN RES, V66, P24, DOI 10.1016/S0169-328X(98)00346-5; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QP, 2000, NEUROREPORT, V11, P4003, DOI 10.1097/00001756-200012180-00020; MAGERL W, 1991, ALLERGOLOGIE, V14, P395; MAGERL W, 1990, J INVEST DERMATOL, V94, P347, DOI 10.1111/1523-1747.ep12874474; Matsubara M, 2005, BIOCHEM PHARMACOL, V69, P433, DOI 10.1016/j.bcp.2004.10.006; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Miyasaka H, 2003, LIMNOLOGY, V4, P1, DOI 10.1007/s10201-002-0088-4; Miyata M, 2001, EUR J NEUROSCI, V13, P1945, DOI 10.1046/j.0953-816x.2001.01570.x; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Molliver DC, 2002, EUR J NEUROSCI, V16, P1850, DOI 10.1046/j.1460-9568.2002.02253.x; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Nakayama Y, 2002, METHOD FIND EXP CLIN, V24, P267, DOI 10.1358/mf.2002.24.5.802303; Nicolson TA, 2002, NEUROSCIENCE, V110, P329, DOI 10.1016/S0306-4522(01)00561-9; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; OHKUBO T, 1995, EUR J PHARMACOL, V273, P83, DOI 10.1016/0014-2999(94)00668-W; Perez SE, 1999, DEVELOPMENT, V126, P1715; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rees JL, 1999, CLIN EXP DERMATOL, V24, P490; Rubio JP, 1999, GENOMICS, V57, P84, DOI 10.1006/geno.1999.5758; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Schmelz M, 1997, J NEUROSCI, V17, P8003; Schmelz M, 2001, NAT NEUROSCI, V4, P9, DOI 10.1038/82956; Seabrook GR, 1997, NEUROPHARMACOLOGY, V36, P1009, DOI 10.1016/S0028-3908(97)00065-8; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 2004, PAIN, V109, P36, DOI 10.1016/j.pain.2004.01.007; Sugimoto Y, 1998, EUR J PHARMACOL, V351, P1, DOI 10.1016/S0014-2999(98)00288-X; THAYER SA, 1988, J NEUROSCI, V8, P4089; TUCKETT RP, 1987, BRAIN RES, V413, P95, DOI 10.1016/0006-8993(87)90157-0; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; Wallengren Joanna, 2005, Dermatol Ther, V18, P292; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhou YX, 2005, BIOCHEM J, V391, P667, DOI 10.1042/BJ20050839; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	66	129	135	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					691	703		10.1016/j.neuron.2006.09.036	http://dx.doi.org/10.1016/j.neuron.2006.09.036			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114052	Bronze			2022-12-24	WOS:000242413100015
J	Soler-Llavina, GJ; Chang, TH; Swartz, KJ				Soler-Llavina, Gilberto J.; Chang, Tsg-Hui; Swartz, Kenton J.			Functional interactions at the interface between voltage-sensing and pore domains in the shaker K-v channel	NEURON			English	Article							GATED POTASSIUM CHANNELS; GATING CURRENTS; OPEN-STATE; HELICAL STRUCTURE; CHARGE MOVEMENT; ACTIVATION GATE; ION CHANNELS; S4 SEGMENT; SENSOR; PROTEIN	Voltage-activated potassium (K-v) channels contain a central pore domain that is partially surrounded by four voltage-sensing domains. Recent X-ray structures suggest that the two domains lack extensive protein-protein contacts within presumed transmembrane regions, but whether this is the case for functional channels embedded in lipid membranes remains to be tested. We investigated domain interactions in the Shaker Kv channel by systematically mutating the pore domain and assessing tolerance by examining channel maturation, S4 gating charge movement, and channel opening. When mapped onto the X-ray structure of the K(v)1.2 channel the large number of permissive mutations support the notion of relatively independent domains, consistent with crystallographic studies. Inspection of the maps also identifies portions of the interface where residues are sensitive to mutation, an external cluster where mutations hinder voltage sensor activation, and an internal cluster where domain interactions between S4 and S5 helices from adjacent subunits appear crucial for the concerted opening transition.	NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov			Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002945] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bezanilla F, 1998, METHOD ENZYMOL, V293, P331; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; Ding SH, 2001, BIOCHEMISTRY-US, V40, P10707, DOI 10.1021/bi010709y; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Kanevsky M, 1999, J GEN PHYSIOL, V114, P215, DOI 10.1085/jgp.114.2.215; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Piper David R., 2005, V266, P46; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; SCHULTEIS CT, 1995, BIOCHEMISTRY-US, V34, P1725, DOI 10.1021/bi00005a029; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	66	81	81	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					623	634		10.1016/j.neuron.2006.10.005	http://dx.doi.org/10.1016/j.neuron.2006.10.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114047	Bronze			2022-12-24	WOS:000242413100010
J	Garriga-Canut, M; Schoenike, B; Qazi, R; Bergendahl, K; Daley, TJ; Pfender, RM; Morrison, JF; Ockuly, J; Stafstrom, C; Sutula, T; Roopra, A				Garriga-Canut, Mireia; Schoenike, Barry; Qazi, Romena; Bergendahl, Karen; Daley, Timothy J.; Pfender, Rebecca M.; Morrison, John F.; Ockuly, Jeffrey; Stafstrom, Carl; Sutula, Thomas; Roopra, Avtar			2-deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; ADULT-RAT; TRANSCRIPTIONAL REPRESSION; NEURONAL GENES; DENTATE GYRUS; TARGET GENES; SPONTANEOUS SEIZURES; HISTONE DEACETYLASE; MESSENGER-RNA; BDNF	Temporal lobe epilepsy is a common form of drug-resistant epilepsy that sometimes responds to dietary manipulation such as the 'ketogenic diet'. Here we have investigated the effects of the glycolytic inhibitor 2-deoxy-D-glucose ( 2DG) in the rat kindling model of temporal lobe epilepsy. We show that 2DG potently reduces the progression of kindling and blocks seizure-induced increases in the expression of brain-derived neurotrophic factor and its receptor, TrkB. This reduced expression is mediated by the transcription factor NRSF, which recruits the NADH-binding co-repressor CtBP to generate a repressive chromatin environment around the BDNF promoter. Our results show that 2DG has anticonvulsant and antiepileptic properties, suggesting that anti-glycolytic compounds may represent a new class of drugs for treating epilepsy. The metabolic regulation of neuronal genes by CtBP will open avenues of therapy for neurological disorders and cancer.	Univ Wisconsin, Dept Neurol, Med Sci Ctr, Madison, WI 53706 USA; Aga Khan Univ, Dept Pathol & Microbiol, Karachi 74800, Pakistan	University of Wisconsin System; University of Wisconsin Madison; Aga Khan University	Roopra, A (corresponding author), Univ Wisconsin, Dept Neurol, Med Sci Ctr, Room 1715,1300 Univ Ave, Madison, WI 53706 USA.	roopra@neurology.wisc.edu			PHS HHS [R01 25020] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Belyaev ND, 2004, J BIOL CHEM, V279, P556, DOI 10.1074/jbc.M310353200; Binder DK, 1999, J NEUROSCI, V19, P4616; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CHANDRAMOULI V, 1977, BIOCHIM BIOPHYS ACTA, V496, P278, DOI 10.1016/0304-4165(77)90310-5; Conner JM, 1997, J NEUROSCI, V17, P2295; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Golarai G, 1996, J NEUROPHYSIOL, V75, P343, DOI 10.1152/jn.1996.75.1.343; Gowers WR, 1881, EPILEPSY OTHER CHRON; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kim JH, 2005, NAT STRUCT MOL BIOL, V12, P423, DOI 10.1038/nsmb924; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Lahteinen S, 2002, EUR J NEUROSCI, V15, P721; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; Murray KD, 2000, J COMP NEUROL, V418, P411, DOI 10.1002/(SICI)1096-9861(20000320)418:4<411::AID-CNE4>3.0.CO;2-F; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Peterson CL, 2000, FEBS LETT, V476, P68, DOI 10.1016/S0014-5793(00)01673-2; Roopra A, 2001, Mol Interv, V1, P219; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sayin U, 2003, J NEUROSCI, V23, P2759; Scharfman HE, 1999, J NEUROSCI, V19, P5619; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; Sinha SR, 2005, NEUROLOGIST, V11, P161, DOI 10.1097/01.nrl.0000160818.58821.d2; Stafstrom Carl E, 2004, Epilepsy Curr, V4, P215, DOI 10.1111/j.1535-7597.2004.46001.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stryer L, 2002, BIOCHEMISTRY; SUTULA T, 1986, J NEUROPHYSIOL, V56, P732, DOI 10.1152/jn.1986.56.3.732; Sutula TP, 2004, EPILEPSY RES, V60, P161, DOI 10.1016/j.eplepsyres.2004.07.001; TIMMUSK T, 1994, NEUROCHEM INT, V25, P11, DOI 10.1016/0197-0186(94)90046-9; WARBURG O, 1930, METABOLISM TUMORS; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; WICK AN, 1955, P SOC EXP BIOL MED, V89, P579; Wood IC, 2003, J MOL BIOL, V334, P863, DOI 10.1016/j.jmb.2003.10.017; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhang QH, 2002, SCIENCE, V295, P1895	50	320	335	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1382	1387		10.1038/nn1791	http://dx.doi.org/10.1038/nn1791			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17041593				2022-12-24	WOS:000242403800015
J	Nozaki, D; Kurtzer, I; Scott, SH				Nozaki, Daichi; Kurtzer, Isaac; Scott, Stephen H.			Limited transfer of learning between unimanual and bimanual skills within the same limb	NATURE NEUROSCIENCE			English	Article							MOTOR; REPRESENTATION; DYNAMICS	Although a limb's motion appears to be similar across unimanual and bimanual movements, here we demonstrate partial, but not complete, transfer of learning across these behavioral contexts, hidden learning that remains intact ( but invisible) until the original context is again encountered, and the ability to associate two conflicting force fields simultaneously, one with each context. These results suggest partial, but not complete, overlap in the learning processes involved in the acquisition of unimanual and bimanual skills.	Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan; Res Inst Natl Rehabil Ctr Persons Disabilities, Dept Rehabil Movement Funct, Tokorozawa, Saitama 3598555, Japan; Queens Univ, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	University of Tokyo; Queens University - Canada	Scott, SH (corresponding author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo 1130033, Japan.	steve@biomed.queensu.ca	Nozaki, Daichi/B-7909-2010	Nozaki, Daichi/0000-0002-1338-8337				Bagesteiro LB, 2002, J NEUROPHYSIOL, V88, P2408, DOI 10.1152/jn.00901.2001; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Cunningham CL, 2002, ACTA PSYCHOL, V110, P321, DOI 10.1016/S0001-6918(02)00040-9; Donchin O, 2002, J NEUROPHYSIOL, V88, P3498, DOI 10.1152/jn.00335.2001; FINCH M, 2004, TRIATHLON TRAINING; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Kurtzer I, 2005, NAT NEUROSCI, V8, P498, DOI 10.1038/nn1420; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807	12	124	124	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1364	1366		10.1038/nn1785	http://dx.doi.org/10.1038/nn1785			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17028583				2022-12-24	WOS:000242403800011
J	Ipata, AE; Gee, AL; Gottlieb, J; Bisley, JW; Goldberg, ME				Ipata, Anna E.; Gee, Angela L.; Gottlieb, Jacqueline; Bisley, James W.; Goldberg, Michael E.			LIP responses to a popout stimulus are reduced if it is overtly ignored	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; FRONTAL EYE FIELD; DRIVEN ATTENTIONAL CAPTURE; POSTERIOR PARIETAL CORTEX; VISUAL-SEARCH TASK; SALIENT DISTRACTOR; NEURONAL RESPONSES; OCULOMOTOR CAPTURE; TOP-DOWN; SACCADE	Bright objects capture our attention by virtue of 'popping out' from their surroundings. This correlates with strong responses in cortical areas thought to be important in attentional allocation. Previous studies have suggested that with the right mindset or training, humans can ignore popout stimuli. We studied the activity of neurons in monkey lateral intraparietal area while monkeys performed a visual search task. The monkeys were free to move their eyes, and a distractor, but never the search target, popped out. On trials in which the monkeys made a saccade directly to the search target, the popout distractor evoked a smaller response than the non-popout distractors. The intensity of the response to the popout correlated inversely with the monkeys' ability to ignore it. We suggest that this modulation corresponds to a top-down mechanism that the brain uses to adjust the parietal representation of salience.	Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University	Ipata, AE (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Mahoney Ctr Brain & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	ai2019@columbia.edu		Bisley, James/0000-0002-2841-0306	NATIONAL EYE INSTITUTE [R21EY017938, R24EY015634, R01EY014978, P30EY019007] Funding Source: NIH RePORTER; NEI NIH HHS [R24 EY015634, R24 EY015634-01, R24 EY015634-03, R01 EY014978-01, R21 EY017938-02, R21 EY017938-01, R24 EY015634-02, R01 EY014978-04, R21 EY017938, R01 EY014978, R01 EY014978-05, R24 EY015634-04, P30 EY019007] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Bichot NP, 2001, NEUROPSYCHOLOGIA, V39, P972, DOI 10.1016/S0028-3932(01)00022-7; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bisley JW, 2006, J NEUROPHYSIOL, V95, P1696, DOI 10.1152/jn.00848.2005; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Irwin DE, 2000, VISION RES, V40, P1443, DOI 10.1016/S0042-6989(00)00030-4; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Joseph JS, 1996, PERCEPT PSYCHOPHYS, V58, P651, DOI 10.3758/BF03213098; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kim MS, 1999, PERCEPT PSYCHOPHYS, V61, P1009, DOI 10.3758/BF03207609; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Lamy D, 2004, J EXP PSYCHOL HUMAN, V30, P1019, DOI 10.1037/0096-1523.30.6.1019; Lamy D, 2003, PSYCHON B REV, V10, P621, DOI 10.3758/BF03196524; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Pouget P, 2005, J NEUROPHYSIOL, V94, P2086, DOI 10.1152/jn.01097.2004; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Rauschenberger R, 2003, PSYCHON B REV, V10, P814, DOI 10.3758/BF03196545; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; Theeuwes J, 2004, PSYCHON B REV, V11, P551, DOI 10.3758/BF03196609; Theeuwes J, 1998, J EXP PSYCHOL HUMAN, V24, P1342, DOI 10.1037/0096-1523.24.5.1342; Theeuwes J, 2003, PERCEPT PSYCHOPHYS, V65, P735, DOI 10.3758/BF03194810; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wilson DR, 1997, J ARTIF INTELL RES, V6, P1, DOI 10.1613/jair.346; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95	49	112	113	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1071	1076		10.1038/nn1734	http://dx.doi.org/10.1038/nn1734			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819520	Green Accepted			2022-12-24	WOS:000240080300021
J	Durand, JB; Nelissen, K; Joly, O; Wardak, C; Todd, JT; Norman, JF; Janssen, P; Vanduffel, W; Orban, GA				Durand, Jean-Baptiste; Nelissen, Koen; Joly, Olivier; Wardak, Claire; Todd, James T.; Norman, J. Farley; Janssen, Peter; Vanduffel, Wim; Orban, Guy A.			Anterior regions of monkey parietal cortex process visual 3D shape	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; SURFACE-ORIENTATION; CORTICAL CONNECTIONS; NEURAL MECHANISMS; BINOCULAR VISION; MACAQUE MONKEYS; PRIMATE DORSAL; CONTRAST AGENT; EXTRACTING 3D; HAND ACTION	The intraparietal cortex is involved in the control of visually guided actions, like reach-to-grasp movements, which require extracting the 3D shape and position of objects from 2D retinal images. Using fMRI in behaving monkeys, we investigated the role of the intraparietal cortex in processing stereoscopic information for recovering the depth structure and the position in depth of objects. We found that while several areas (CIP, LIP, and AIP on the lateral bank; PIP and MIP on the medial bank) are activated by stereoscopic stimuli, AIP and an adjoining portion of LIP are sensitive only to depth structure. Furthermore, only these two regions are sensitive to both the depth structure and the 2D shape of small objects. These results indicate that extracting 3D spatial information from stereo involves several intraparietal areas, among which AIP and anterior LIP are more specifically engaged in extracting the 3D shape of objects.	Catholic Univ Louvain, Neuro & Psychofysiol Lab, Sch Med, B-3000 Louvain, Belgium; Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; Western Kentucky Univ, Dept Psychol, Bowling Green, KY 42101 USA; Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Universite Catholique Louvain; University System of Ohio; Ohio State University; Western Kentucky University	Orban, GA (corresponding author), Catholic Univ Louvain, Neuro & Psychofysiol Lab, Sch Med, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	guy.orban@med.kuleuven.be	Durand, Jean-Baptiste/ABE-9090-2020; Norman, Farley/A-7169-2012; DURAND, Jean-Baptiste/E-9252-2011; Wardak, Claire/P-6222-2016	Norman, Farley/0000-0001-5877-1914; DURAND, Jean-Baptiste/0000-0003-4780-8691; Wardak, Claire/0000-0001-8847-1859; Orban, Guy/0000-0002-8179-9584; Joly, Olivier/0000-0002-5818-6552	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB000790-06A2, R01 EB000790] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Baker JT, 2006, CEREB CORTEX, V16, P447, DOI 10.1093/cercor/bhi124; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; BOLTZ RL, 1979, EXP BRAIN RES, V37, P87, DOI 10.1007/BF01474256; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; CHEFDHOTEL C, 2002, P IEEE INT S BIOMEDI, V7, P753; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Fize D, 2003, J NEUROSCI, V23, P7395; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Genovesio A, 2004, J NEUROPHYSIOL, V91, P2670, DOI 10.1152/jn.00712.2003; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hermosillo G, 2002, INT J COMPUT VISION, V50, P329, DOI 10.1023/A:1020830525823; Howard I, 2002, DEPTH PERCEPTION, V2; HOWARD IP, 2002, BASIC MECH, V1; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; JEANNEROD M, 1986, BEHAV BRAIN RES, V19, P99, DOI 10.1016/0166-4328(86)90008-2; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeannerod M., 1981, ATTENTION PERFORM, P153; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Mandeville JB, 1999, MAGNET RESON MED, V42, P591, DOI 10.1002/(SICI)1522-2594(199909)42:3<591::AID-MRM23>3.0.CO;2-8; Melmoth DR, 2006, EXP BRAIN RES, V171, P371, DOI 10.1007/s00221-005-0273-x; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; Napier J.R., 1980, HANDS; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; ROGERS B, 1989, NATURE, V339, P135, DOI 10.1038/339135a0; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sakata H, 2005, NEUROPSYCHOLOGIA, V43, P151, DOI 10.1016/j.neuropsychologia.2004.11.003; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sakata H, 1999, EXP BRAIN RES, V128, P160, DOI 10.1007/s002210050831; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SERVOS P, 1992, VISION RES, V32, P1513, DOI 10.1016/0042-6989(92)90207-Y; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Snyder LH, 2000, J NEUROPHYSIOL, V83, P1099, DOI 10.1152/jn.2000.83.2.1099; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tresilian JR, 1998, EXP BRAIN RES, V120, P352, DOI 10.1007/s002210050409; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2005, NEUROSCI RES, V51, P221, DOI 10.1016/j.neures.2004.11.006; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Watt SJ, 2003, J EXP PSYCHOL HUMAN, V29, P404, DOI 10.1037/0096-1523.29.2.404; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Wheatstone C., 1838, PHILOS T ROY SOC LON, V128, P371, DOI DOI 10.1098/RSTL.1838.0019; Zhao FQ, 2006, NEUROIMAGE, V30, P1149, DOI 10.1016/j.neuroimage.2005.11.013	77	135	138	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					493	505		10.1016/j.neuron.2007.06.040	http://dx.doi.org/10.1016/j.neuron.2007.06.040			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678860	Green Accepted, Bronze			2022-12-24	WOS:000248711000015
J	Scott, DJ; Stohler, CS; Egnatuk, CM; Wang, H; Koeppe, RA; Zubieta, JK				Scott, David J.; Stohler, Christian S.; Egnatuk, Christine M.; Wang, Heng; Koeppe, Robert A.; Zubieta, Jon-Kar			Individual differences in reward responding explain placebo-induced expectations and effects	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MU-OPIOID RECEPTORS; DOPAMINE RELEASE; AFFECTIVE DIMENSIONS; VENTRAL STRIATUM; PAIN; RESPONSES; BRAIN; EXPERIENCE; ANALGESIA	Expectations, positive or negative, are modulating factors influencing behavior. They are also thought to underlie placebo effects, impacting perceptions and biological processes. Using healthy human subjects, we examined the role of the nucleus accumbens; (NAC), a region centrally involved in the encoding of reward expectation, in the formation of placebo responses. Employing functional molecular imaging, activation of NAC dopamine (DA) release was observed during placebo administration and related to its anticipated effects, perception-anticipation mismatches, and placebo effect development. In additional functional MRI studies, the expectation of monetary gain increased NAC synaptic activity in a manner proportional to placebo-induced DA release, anticipated effects, perception-anticipation differentials, and actual placebo effects. Individual variations in NAC response to reward expectation accounted for 28% of the variance in the formation of placebo analgesia.	Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Behav Neurosci Inst, Dept Radiol, Ann Arbor, MI 48109 USA; Univ Maryland, Sch Dent, Baltimore, MD 21201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore	Zubieta, JK (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	zubieta@umich.edu	Zubieta, Jon-Kar/AAB-5565-2022; STOHLER, CHRISTIAN/AAQ-7539-2020	Stohler, Christian S/0000-0003-0443-6146	NCCIH NIH HHS [R01 AT 001415] Funding Source: Medline; NIDA NIH HHS [R01 DA 016423] Funding Source: Medline; NIDCR NIH HHS [R01 DE 15396] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016423] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Badiani A, 1999, BEHAV BRAIN RES, V103, P203, DOI 10.1016/S0166-4328(99)00041-8; Benedetti F, 2006, PAIN, V121, P133, DOI 10.1016/j.pain.2005.12.016; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; de Craen AJM, 2000, J NEUROL, V247, P183, DOI 10.1007/s004150050560; de la Fuente-Fernandez R, 2002, BEHAV BRAIN RES, V136, P359, DOI 10.1016/S0166-4328(02)00130-4; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; GREVERT P, 1977, P NATL ACAD SCI USA, V74, P1291, DOI 10.1073/pnas.74.3.1291; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Huppert JD, 2004, AM J PSYCHIAT, V161, P1485, DOI 10.1176/appi.ajp.161.8.1485; Irizarry KJ, 2005, SCIENCE, V307, P1411, DOI 10.1126/science.307.5714.1411; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KALIVAS PW, 1999, ANN NY ACAD SCI, V877, P61; Keck PE, 2000, BIOL PSYCHIAT, V47, P748, DOI 10.1016/S0006-3223(99)00311-X; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; MINOSHIMA S, 1993, J NUCL MED, V34, P322; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; MOGENSON GJ, 1991, ADV EXP MED BIOL, V295, P267; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Robinson TE, 2000, ADDICTION, V95, pS91; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Seeman P, 2006, SYNAPSE, V60, P205, DOI 10.1002/syn.20298; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Smith YR, 2006, J NEUROSCI, V26, P5777, DOI 10.1523/JNEUROSCI.5223-05.2006; Stohler CS, 1999, PAIN, V79, P165, DOI 10.1016/S0304-3959(98)00171-7; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Volkow ND, 2006, NEUROIMAGE, V32, P1782, DOI 10.1016/j.neuroimage.2006.04.192; WAGNER TD, 2004, SCIENCE, V303, P1162, DOI DOI 10.1126/SCIENCE.1093065; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; ZHANG X, 1993, IEEE T BIO-MED ENG, V40, P344, DOI 10.1109/10.222327; Zink CF, 2003, J NEUROSCI, V23, P8092; Zubieta JK, 2006, BRAIN BEHAV IMMUN, V20, P15, DOI 10.1016/j.bbi.2005.08.006; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005; Zubieta JK, 2002, J NEUROSCI, V22, P5100, DOI 10.1523/JNEUROSCI.22-12-05100.2002; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	58	329	340	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2007	55	2					325	336		10.1016/j.neuron.2007.06.028	http://dx.doi.org/10.1016/j.neuron.2007.06.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	198NW	17640532	Bronze			2022-12-24	WOS:000248635800015
J	Muraguchi, T; Takegami, Y; Ohtsuka, T; Kitajima, S; Chandana, EPS; Omura, A; Miki, T; Takahashi, R; Matsumoto, N; Ludwig, A; Noda, M; Takahashi, C				Muraguchi, Teruyuki; Takegami, Yujiro; Ohtsuka, Toshiyuki; Kitajima, Shunsuke; Chandana, Ediriweera P. S.; Omura, Akira; Miki, Takao; Takahashi, Rei; Matsumoto, Naoya; Ludwig, Andreas; Noda, Makoto; Takahashi, Chiaki			RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity	NATURE NEUROSCIENCE			English	Article							CELL-CELL ADHESION; METALLOPROTEINASE INHIBITORS; MATRIX-METALLOPROTEINASE; ALPHA-SECRETASE; DOWN-REGULATION; NERVOUS-SYSTEM; KEY REGULATOR; STEM-CELLS; CLEAVAGE; GENES	We report that during cortical development in the mouse embryo, reversion-inducing cysteine-rich protein with Kazal motifs (RECK) critically regulates Notch signaling by antagonizing the ectodomain shedding of Notch ligands, which is mediated by a disintegrin and metalloproteinase domain 10 (ADAM10). In the embryonic brain, RECK is specifically expressed in Nest-inpositive neural precursor cells (NPCs). Reck-deficient NPCs undergo precocious differentiation that is associated with downregulated Nestin expression, impaired Notch signaling and defective self-renewal. These phenotypes were substantially rescued either by enhancing Notch signaling or by suppressing endogenous ADAM10 activity. Consequently, we found that RECK regulates the ectodomain shedding of Notch ligands by directly inhibiting the proteolytic activity of ADAM10. This mechanism appeared to be essential for Notch ligands to properly induce Notch signaling in neighboring cells. These findings indicate that RECK is a physiological inhibitor of ADAM10, an upstream regulator of Notch signaling and a critical modulator of brain development.	Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Kyoto 606, Japan; Rhein Westfal TH Aachen, Univ Hosp, Inst Mol Cardiovasc Res IMCAR, D-52074 Aachen, Germany; Kanazawa Univ, Canc Res Inst, Ctr Canc & Stem Cell Res, Div Mol Genet, Kanazawa, Ishikawa 920, Japan	Kyoto University; Kyoto University; Kyoto University; RWTH Aachen University; RWTH Aachen University Hospital; Kanazawa University	Takahashi, C (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 606, Japan.	chtakaha@virus.kyoto-u.ac.jp	Ludwig, Andreas/I-5685-2012	Ludwig, Andreas/0000-0001-8536-4986				Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bland CE, 2003, J BIOL CHEM, V278, P13607, DOI 10.1074/jbc.C300016200; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CACCAMO DV, 1989, AM J PATHOL, V135, P801; Chang HC, 2007, CANCER SCI, V98, P169, DOI 10.1111/j.1349-7006.2006.00367.x; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Echizenya M, 2005, ONCOGENE, V24, P5850, DOI 10.1038/sj.onc.1208733; EHEBAUER M, 2006, SCI STKE; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; NYE JS, 1994, DEVELOPMENT, V120, P2421; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	50	119	121	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					838	845		10.1038/nn1922	http://dx.doi.org/10.1038/nn1922			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558399	Green Submitted			2022-12-24	WOS:000247560200013
J	Leung, CT; Coulombe, PA; Reed, RR				Leung, Cheuk T.; Coulombe, Pierre A.; Reed, Randall R.			Contribution of olfactory neural stem cells to tissue maintenance and regeneration	NATURE NEUROSCIENCE			English	Article							GLOBOSE BASAL-CELLS; ADULT MAMMALIAN BRAIN; PROGENITOR CELLS; SUBVENTRICULAR ZONE; IN-VITRO; EPITHELIUM; LINEAGE; NEUROGENESIS; EXPRESSION; EPIDERMIS	The olfactory neuroepithelium undergoes continual neurogenesis and, after extensive lesions, fully regenerates to maintain sensory function. The stem cell population underlying this regenerative capacity remains elusive. Here we show that mouse horizontal basal cells (HBCs) function as adult olfactory neuroepithelium neural stem cells and examine their distinct dynamics in olfactory neuroepithelium maintenance and regeneration. Fate-mapping analysis after olfactory neuroepithelium lesioning shows that HBCs are competent to regenerate both neuronal and non-neuronal olfactory neuroepithelium lineages. HBCs serve as a reservoir of long-lived progenitors that remain largely quiescent during normal neuronal turnover or even after acute, selective loss of mature neurons. Under these conditions, previously identified progenitors are largely responsible for tissue maintenance. Yet after extensive injuries that deplete resident neuronal precursors, HBCs transiently proliferate and their progeny fully reconstitute the neuroepithelium. Our data support a new model of adult neurogenesis in which distinct cell populations mediate normal neuronal turnover and neuronal replacement upon traumatic injury.	Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, 725 N Wolfe St,PCTB 801, Baltimore, MD 21205 USA.	rreed@jhmi.edu		Leung, Cheuk/0000-0002-5838-5535				Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Bergman U, 2002, ARCH TOXICOL, V76, P104, DOI 10.1007/s00204-002-0321-2; Berton TR, 2003, ONCOGENE, V22, P5415, DOI 10.1038/sj.onc.1206825; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; Calof AL, 2002, MICROSC RES TECHNIQ, V58, P176, DOI 10.1002/jemt.10147; CARR VM, 1992, EXP NEUROL, V115, P55, DOI 10.1016/0014-4886(92)90221-B; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cau E, 2002, DEVELOPMENT, V129, P1871; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GORDON MK, 1995, MOL CELL NEUROSCI, V6, P363, DOI 10.1006/mcne.1995.1028; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Huard JMT, 1998, J COMP NEUROL, V400, P469; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jang WC, 2003, J COMP NEUROL, V460, P123, DOI 10.1002/cne.10642; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; LEVEY MS, 1991, J NEUROSCI, V11, P3556; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Manglapus GL, 2004, J COMP NEUROL, V479, P216, DOI 10.1002/cne.20316; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mitchell BD, 2004, DEV NEUROSCI-BASEL, V26, P101, DOI 10.1159/000082131; Miyawaki A, 1996, EMBO J, V15, P2050, DOI 10.1002/j.1460-2075.1996.tb00558.x; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; SCHWOB JE, 1994, CHEM SENSES, V19, P671, DOI 10.1093/chemse/19.6.671; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sicard G, 1998, ANN NY ACAD SCI, V855, P223, DOI 10.1111/j.1749-6632.1998.tb10570.x; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8	38	306	320	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					720	726		10.1038/nn1882	http://dx.doi.org/10.1038/nn1882			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468753				2022-12-24	WOS:000246799800014
J	Fusi, S; Asaad, WF; Miller, EK; Wang, XJ				Fusi, Stefano; Asaad, Wael F.; Miller, Earl K.; Wang, Xiao-Jing			A neural circuit model of flexible sensorimotor mapping: Learning and forgetting on multiple timescales	NEURON			English	Article							CONDITIONAL OCULOMOTOR ASSOCIATIONS; SUPPLEMENTARY EYE FIELD; PRIMATE PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; NEURONAL-ACTIVITY; WORKING-MEMORY; DECISION-MAKING; SINGLE NEURONS; NETWORKS; ACQUISITION	Volitional behavior relies on the brain's ability to remap sensory flow to motor programs whenever demanded by a changed behavioral context. To investigate the circuit basis of such flexible behavior, we have developed a biophysically based decision-making network model of spiking neurons for arbitrary sensorimotor mapping. The model quantitatively reproduces behavioral and prefrontal single-cell data from an experiment in which monkeys learn visuomotor associations that are reversed unpredictably from time to time. We show that when synaptic modifications occur on multiple timescales, the model behavior becomes flexible only when needed: slow components of learning usually dominate the decision process. However, if behavioral contexts change frequently enough, fast components of plasticity take over, and the behavior exhibits a quick forget-and-learn pattern. This model prediction is confirmed by monkey data. Therefore, our work reveals a scenario for conditional associative learning that is distinct from instant switching between sets of well-established sensorimotor associations.	Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06520 USA; Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Inst Learning & Memory, RIKEN, Neurosci Res Ctr, Cambridge, MA 02139 USA; Univ Zurich, ETH, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Yale University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Columbia University	Wang, XJ (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, 333 Cedar St, New Haven, CT 06520 USA.	xjwang@yale.edu	Fusi, Stefano/E-9109-2011; Asaad, Wael/I-8485-2012; Wang, Xiao-Jing/D-2722-2009; Miller, Earl K./AAE-8187-2019	Fusi, Stefano/0000-0002-3035-6652; Asaad, Wael/0000-0003-4406-9096; Miller, Earl K./0000-0002-0582-6958	NIDA NIH HHS [DA016455, R01 DA016455, R01 DA016455-05] Funding Source: Medline; NIMH NIH HHS [R01 MH062349, R01 MH062349-05] Funding Source: Medline; NINDS NIH HHS [R01 NS050944, R01 NS035145, 5R01NS35145-9, NS50944] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035145, R01NS050944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016455] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AMIT DJ, 1994, NEURAL COMPUT, V6, P957, DOI 10.1162/neco.1994.6.5.957; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Deco G, 2005, CEREB CORTEX, V15, P15, DOI 10.1093/cercor/bhh103; Deco G, 2003, EUR J NEUROSCI, V18, P2374, DOI 10.1046/j.1460-9568.2003.02956.x; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; Herrnstein R.J., 1997, MATCHING LAW PAPERS; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Loewenstein Y, 2006, P NATL ACAD SCI USA, V103, P15224, DOI 10.1073/pnas.0505220103; Mansouri FA, 2002, BEHAV BRAIN RES, V136, P415, DOI 10.1016/S0166-4328(02)00182-1; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Meyer P. L., 1965, INTRO PROBABILITY ST; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; PARISI G, 1986, J PHYS A-MATH GEN, V19, pL617, DOI 10.1088/0305-4470/19/10/011; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; PETRIDES M, 1982, BEHAV BRAIN RES, V5, P407, DOI 10.1016/0166-4328(82)90044-4; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Salinas E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-47; Schweighofer N, 2003, NEURAL NETWORKS, V16, P5, DOI 10.1016/S0893-6080(02)00228-9; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Soltani A, 2006, NEURAL NETWORKS, V19, P1075, DOI 10.1016/j.neunet.2006.05.044; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	47	113	114	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					319	333		10.1016/j.neuron.2007.03.017	http://dx.doi.org/10.1016/j.neuron.2007.03.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442251	Green Accepted, Bronze			2022-12-24	WOS:000246190600015
J	Stalnaker, TA; Franz, TM; Singh, T; Schoenbaum, G				Stalnaker, Thomas A.; Franz, Theresa M.; Singh, Teghpal; Schoenbaum, Geoffrey			Basolateral amygdala lesions abolish orbitofrontal-dependent reversal impairments	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; NEURONAL-ACTIVITY; REWARD VALUE; BEHAVIORAL FLEXIBILITY; HIPPOCAMPAL-LESIONS; OUTCOME EXPECTANCY; ANTERIOR CINGULATE; DORSAL STRIATUM; FRONTAL-CORTEX; STIMULUS	Damage to orbitofrontal cortex (OFC) has long been associated with deficits in reversal learning. OFC damage also causes inflexible associative encoding in basolateral amygdala (ABL) during reversal learning. Here we provide a critical test of the hypothesis that the reversal deficit in OFC-lesioned rats is caused by this inflexible encoding in ABL. Rats with bilateral neurotoxic lesions of OFC, ABL, or both areas were tested on a series of two-odor go/no-go discrimination problems, followed by two serial reversals of the final problem. As expected, all groups acquired the initial problems at the same rate, and rats with OFC lesions were slower to acquire the reversals than sham controls. This impairment was abolished by accompanying ABL lesions, while ABL lesions alone had no effect on reversal learning. These results are consistent with the hypothesis that OFC facilitates cognitive flexibility by promoting updating of associative encoding in downstream brain areas.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; Univ Maryland Baltimore Cty, Dept Psychol, Catonsville, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Stalnaker, TA (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	tstal002@umaryland.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER; NIDA NIH HHS [R01-DA015718] Funding Source: Medline; NIDCD NIH HHS [T32-DC00054] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Birrell JM, 2000, J NEUROSCI, V20, P4320; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Bohn I, 2003, BEHAV BRAIN RES, V143, P49, DOI 10.1016/S0166-4328(03)00008-1; Chudasama Y, 2003, J NEUROSCI, V23, P8771; CINELLI AR, 1987, BRAIN RES BULL, V19, P651, DOI 10.1016/0361-9230(87)90051-7; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Featherstone RE, 2004, BEHAV BRAIN RES, V150, P15, DOI 10.1016/S0166-4328(03)00218-3; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Hikosaka K, 2004, EUR J NEUROSCI, V19, P1046, DOI 10.1111/j.0953-816X.2004.03120.x; HOLLAND PC, 1979, J EXP PSYCHOL ANIM B, V5, P65, DOI 10.1037/0097-7403.5.1.65; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2005, EUR J NEUROSCI, V22, P2341, DOI 10.1111/j.1460-9568.2005.04434.x; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kim J, 2005, NEUROBIOL LEARN MEM, V83, P125, DOI 10.1016/j.nlm.2004.10.003; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; KOSAR E, 1986, BRAIN RES, V379, P329, DOI 10.1016/0006-8993(86)90787-0; KRETTEK JE, 1977, J COMP NEUROL, V172, P225; KRUSHEL LA, 1988, J COMP NEUROL, V270, P39, DOI 10.1002/cne.902700105; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McDannald MA, 2005, J NEUROSCI, V25, P4626, DOI 10.1523/JNEUROSCI.5301-04.2005; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mishkin M., 1964, FRONTAL GRANULAR COR, P219; Murray EA, 1998, BEHAV NEUROSCI, V112, P1291, DOI 10.1037/0735-7044.112.6.1291; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pickens CL, 2003, J NEUROSCI, V23, P11078; PRICE JL, 1991, OLFACTION, P101; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Ragozzino ME, 2002, BEHAV NEUROSCI, V116, P105, DOI 10.1037/0735-7044.116.1.105; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schoenbaum G, 2006, J NEUROPHYSIOL, V95, P1509, DOI 10.1152/jn.01052.2005; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schoenbaum G, 2003, J NEUROSCI, V23, P9833; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Stalnaker TA, 2006, EUR J NEUROSCI, V24, P2643, DOI 10.1111/j.1460-9568.2006.05128.x; TEITELBAUM H, 1964, EXP NEUROL, V9, P452, DOI 10.1016/0014-4886(64)90053-6; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	69	148	151	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					51	58		10.1016/j.neuron.2007.02.014	http://dx.doi.org/10.1016/j.neuron.2007.02.014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408577	Bronze			2022-12-24	WOS:000245848400009
J	Groemer, TW; Klingauf, J				Groemer, Teja W.; Klingauf, Jurgen			Synaptic vesicles recycling spontaneously and during activity belong to the same vesicle pool	NATURE NEUROSCIENCE			English	Article							RELEASE; NEUROTRANSMISSION; NEURONS; EVENTS; CA2+	Recently, it has been claimed that vesicles recycling spontaneously and during activity belong to different pools. Here we simultaneously measured, using spectrally separable styryl dyes, the release kinetics of vesicles recycled spontaneously or upon stimulation and the effects of the v-ATPase blocker folimycin on the frequency of miniature postsynaptic currents in rat hippocampal neurons. Our results provide evidence as to the identities of the vesicle pools recycling at rest and during stimulation.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.	J.Klingauf@mpi-bpc.mpg.de		Groemer, Teja/0000-0003-3854-716X				Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Prange O, 1999, J NEUROSCI, V19, P6427; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; VANDENBERGHE P, 2006, J PHYSL; Virmani T, 2005, J NEUROSCI, V25, P10922, DOI 10.1523/JNEUROSCI.3766-05.2005; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	15	107	107	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					145	147		10.1038/nn1831	http://dx.doi.org/10.1038/nn1831			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220885	Green Published			2022-12-24	WOS:000244175200006
J	Yoshiyama, Y; Higuchi, M; Zhang, B; Huang, SM; Iwata, N; Saido, TC; Maeda, J; Suhara, T; Trojanowski, JQ; Lee, VMY				Yoshiyama, Yasumasa; Higuchi, Makoto; Zhang, Bin; Huang, Shu-Ming; Iwata, Nobuhisa; Saido, Takaomi C.; Maeda, Jun; Suhara, Tetsuya; Trojanowski, John Q.; Lee, Virginia M. -Y.			Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model	NEURON			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; AXONAL-TRANSPORT; MICROTUBULE-BINDING; SENILE PLAQUES; GENE MUTATION	Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and related tauopathies, but earlier pathologies may herald disease onset. To investigate this, we studied wild-type and P301S mutant human tau transgenic (Tg) mice. Filamentous tau lesions developed in P301 S Tg mice at 6 months of age, and progressively accumulated in association with striking neuron loss as well as hippocampal and entorhinal cortical atrophy by 9-12 months of age. Remarkably, hippocampal synapse loss and impaired synaptic function were detected in 3 month old P301S Tg mice before fibrillary tau tangles emerged. Prominent microglial activation also preceded tangle formation. Importantly, immunosuppression of young P301 S Tg mice with FK506 attenuated tau pathology and increased lifespan, thereby linking neuro-inflammation to early progression of tauopathies. Thus, hippocampal synaptic pathology and microgliosis may be the earliest manifestations of neurodegenerative tauopathies, and abrogation of tau-induced microglial activation could retard progression of these disorders.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; Chiba E Natl Hosp, Clin Res Ctr, Chiba 2609712, Japan; Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; National Institutes for Quantum Science & Technology; RIKEN	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Yoshiyama, Yasumasa/0000-0002-7992-7436				Akiyama H, 2000, ALZ DIS ASSOC DIS, V14, pS47, DOI 10.1097/00002093-200000001-00008; Allen B, 2002, J NEUROSCI, V22, P9340; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Bigio EH, 2001, J NEUROPATH EXP NEUR, V60, P403, DOI 10.1093/jnen/60.5.403; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Bussiere T, 2003, NEUROSCIENCE, V117, P577, DOI 10.1016/S0306-4522(02)00942-9; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Fukutani Y, 2000, PSYCHIAT CLIN NEUROS, V54, P523, DOI 10.1046/j.1440-1819.2000.00747.x; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HARPIN ML, 1990, J NEUROSCI RES, V27, P587, DOI 10.1002/jnr.490270420; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Kril JJ, 2002, ACTA NEUROPATHOL, V103, P370, DOI 10.1007/s00401-001-0477-5; Lee VMY, 2005, BBA-MOL BASIS DIS, V1739, P251, DOI 10.1016/j.bbadis.2004.06.014; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li YK, 2003, J NEUROSCI, V23, P1605; Lipton AM, 2001, ARCH NEUROL-CHICAGO, V58, P1233, DOI 10.1001/archneur.58.8.1233; Lossos A, 2003, J NEUROL, V250, P733, DOI 10.1007/s00415-003-1074-4; Maeda J, 2004, SYNAPSE, V52, P283, DOI 10.1002/syn.20027; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; Morris HR, 2001, ARCH NEUROL-CHICAGO, V58, P1813, DOI 10.1001/archneur.58.11.1813; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; Murrell JR, 1999, J NEUROPATH EXP NEUR, V58, P1207, DOI 10.1097/00005072-199912000-00002; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rizzini C, 2000, J NEUROPATH EXP NEUR, V59, P990, DOI 10.1093/jnen/59.11.990; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Su JH, 1997, NEUROBIOL DIS, V4, P365, DOI 10.1006/nbdi.1997.0164; Suzuki M, 2002, NEUROLOGY, V58, P1013, DOI 10.1212/WNL.58.7.1013; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Togo T, 2002, ACTA NEUROPATHOL, V104, P398, DOI 10.1007/s00401-002-0569-x; TU PH, 1995, J CELL BIOL, V129, P1629, DOI 10.1083/jcb.129.6.1629; Werber E, 2003, MOVEMENT DISORD, V18, P595, DOI 10.1002/mds.10401; Yasuda M, 2000, NEUROLOGY, V55, P1224, DOI 10.1212/WNL.55.8.1224; Yoshiyama Y, 2000, NEUROSCI LETT, V290, P125, DOI 10.1016/S0304-3940(00)01326-4; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004; Zhang MR, 2003, NUCL MED BIOL, V30, P513, DOI 10.1016/S0969-8051(03)00016-7	62	1236	1292	5	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					337	351		10.1016/j.neuron.2007.01.010	http://dx.doi.org/10.1016/j.neuron.2007.01.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270732	Bronze			2022-12-24	WOS:000245126800006
J	Dux, PE; Ivanoff, J; Asplund, CL; Marois, R				Dux, Paul E.; Ivanoff, Jason; Asplund, Christopher L.; Marois, Rene			Isolation of a central bottleneck of information processing with time-resolved fMRI	NEURON			English	Article							DUAL-TASK INTERFERENCE; PSYCHOLOGICAL REFRACTORY-PERIOD; PREFRONTAL CORTEX; RESPONSE SELECTION; COGNITIVE CONTROL; WORKING-MEMORY; FUNCTIONAL MRI; MENTAL CHRONOMETRY; ANTERIOR CINGULATE; NEURAL MECHANISMS	When humans attempt to perform two tasks at once, execution of the first task usually leads to postponement of the second one. This task delay is thought to result from a bottleneck occurring at a central, amodal stage of information processing that precludes two response selection or decision-making operations from being concurrently executed. Using time-resolved functional magnetic resonance imaging (fMRI), here we present a neural basis for such dual-task limitations, e.g. the inability of the posterior lateral prefrontal cortex, and possibly the superior medial frontal cortex, to process two decision-making operations at once. These results suggest that a neural network of frontal lobe areas acts as a central bottleneck of information processing that severely limits our ability to multitask.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA	Vanderbilt University	Marois, R (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA.	rene.marois@vanderbilt.edu	Dux, Paul/I-1098-2014	Dux, Paul/0000-0002-4270-2583; Asplund, Christopher/0000-0001-5708-6966	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070776] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH70776, R01 MH070776-03, R01 MH070776-01, R01 MH070776-02, R01 MH070776] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Beede KE, 2006, ACCIDENT ANAL PREV, V38, P415, DOI 10.1016/j.aap.2005.10.015; Birn RM, 2004, NEUROIMAGE, V23, P1046, DOI 10.1016/j.neuroimage.2004.07.039; Birn RM, 1999, HUM BRAIN MAPP, V7, P106, DOI 10.1002/(SICI)1097-0193(1999)7:2<106::AID-HBM4>3.0.CO;2-O; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Boxer AL, 2006, J NEUROSCI, V26, P6354, DOI 10.1523/JNEUROSCI.0549-06.2006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; CARRIER LM, 1995, J EXP PSYCHOL LEARN, V21, P1339, DOI 10.1037/0278-7393.21.5.1339; Chun M. M., 2001, LIMITS ATTENTION TEM, P20, DOI [10.1093/acprof:oso/9780198505150.003.0002, DOI 10.1093/ACPROF:OSO/9780198505150.003.0002]; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Diamond A, 2006, TRENDS COGN SCI, V10, P212, DOI 10.1016/j.tics.2006.03.003; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Erickson KI, 2005, NEUROIMAGE, V28, P967, DOI 10.1016/j.neuroimage.2005.06.047; Formisano E, 2003, CURR OPIN NEUROBIOL, V13, P174, DOI 10.1016/S0959-4388(03)00044-8; Fuster J.M., 1989, PREFRONTAL CORTEX; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Ivry RB, 1998, J EXP PSYCHOL HUMAN, V24, P463, DOI 10.1037/0096-1523.24.2.463; Jiang YH, 2004, PSYCHOL SCI, V15, P390, DOI 10.1111/j.0956-7976.2004.00690.x; Jiang YH, 2004, NEUROIMAGE, V22, P748, DOI 10.1016/j.neuroimage.2004.01.043; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; KARLIN L, 1968, Q J EXP PSYCHOL, V20, P167, DOI 10.1080/14640746808400145; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kurata K, 2000, J NEUROPHYSIOL, V84, P1667, DOI 10.1152/jn.2000.84.3.1667; Levy J, 2001, J EXP PSYCHOL HUMAN, V27, P862, DOI 10.1037//0096-1523.27.4.862; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Menon RS, 1998, P NATL ACAD SCI USA, V95, P10902, DOI 10.1073/pnas.95.18.10902; Meyer DE, 1997, PSYCHOL REV, V104, P749, DOI 10.1037/0033-295X.104.4.749; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORALS R, 2005, PSYCHOL RES, V11, P1; Navon D, 2002, COGNITIVE PSYCHOL, V44, P193, DOI 10.1006/cogp.2001.0767; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; PASHLER H, 1994, NEUROREPORT, V5, P2381, DOI 10.1097/00001756-199411000-00042; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1994, J EXP PSYCHOL HUMAN, V20, P330, DOI 10.1037/0096-1523.20.2.330; Pashler HE, 1998, PSYCHOL ATTENTION; Passingham D, 2004, CURR OPIN NEUROBIOL, V14, P163, DOI 10.1016/j.conb.2004.03.003; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Ruge H, 2003, J MAGN RESON IMAGING, V18, P599, DOI 10.1002/jmri.10397; Rushworth MFS, 1998, NEUROPSYCHOLOGIA, V36, P11, DOI 10.1016/S0028-3932(97)00101-2; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; RUTHRUFF E, 1995, J EXP PSYCHOL HUMAN, V21, P552, DOI 10.1037/0096-1523.21.3.552; Ruthruff E, 2003, PERCEPT PSYCHOPHYS, V65, P801, DOI 10.3758/BF03194816; Ruthruff E, 2001, PSYCHON B REV, V8, P73, DOI 10.3758/BF03196141; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Schumacher EH, 2003, J COGNITIVE NEUROSCI, V15, P1111, DOI 10.1162/089892903322598085; Serences JT, 2004, NEUROIMAGE, V21, P1690, DOI 10.1016/j.neuroimage.2003.12.021; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Strayer DL, 2004, HUM FACTORS, V46, P640, DOI 10.1518/hfes.46.4.640.56806; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; van Eimeren T, 2006, NEUROIMAGE, V29, P286, DOI 10.1016/j.neuroimage.2005.07.014; VanSelst M, 1997, COGNITIVE PSYCHOL, V33, P266, DOI 10.1006/cogp.1997.0662; Welford AT, 1952, B J PSYCHOL-GEN SECT, V43, P2, DOI 10.1111/j.2044-8295.1952.tb00322.x; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006	79	250	252	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					1109	1120		10.1016/j.neuron.2006.11.009	http://dx.doi.org/10.1016/j.neuron.2006.11.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	120VS	17178412	Green Accepted, Bronze			2022-12-24	WOS:000243115100017
J	Kirby, BB; Takada, N; Latimer, AJ; Shin, J; Carney, TJ; Kelsh, RN; Appel, B				Kirby, Brandon B.; Takada, Norio; Latimer, Andrew J.; Shin, Jimann; Carney, Thomas J.; Kelsh, Robert N.; Appel, Bruce			In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development	NATURE NEUROSCIENCE			English	Article							MULTIPLE-SCLEROSIS LESIONS; PRECURSOR CELL-MIGRATION; CENTRAL-NERVOUS-SYSTEM; DORSAL SPINAL-CORD; GROWTH-FACTOR; PREMYELINATING OLIGODENDROCYTES; DIFFERENTIATION; NETRIN-1; PROLIFERATION; ASTROCYTES	Myelinating oligodendrocytes arise from migratory and proliferative oligodendrocyte progenitor cells (OPCs). Complete myelination requires that oligodendrocytes be uniformly distributed and form numerous, periodically spaced membrane sheaths along the entire length of target axons. Mechanisms that determine spacing of oligodendrocytes and their myelinating processes are not known. Using in vivo time-lapse confocal microscopy, we show that zebrafish OPCs continuously extend and retract numerous filopodium-like processes as they migrate and settle into their final positions. Process remodeling and migration paths are highly variable and seem to be influenced by contact with neighboring OPCs. After laser ablation of oligodendrocyte-lineage cells, nearby OPCs divide more frequently, orient processes toward the ablated cells and migrate to fill the unoccupied space. Thus, process activity before axon wrapping might serve as a surveillance mechanism by which OPCs determine the presence or absence of nearby oligodendrocyte-lineage cells, facilitating uniform spacing of oligodendrocytes and complete myelination.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England	Vanderbilt University; University of Bath	Appel, B (corresponding author), Vanderbilt Univ, Dept Biol Sci, 465 21st Ave S, Nashville, TN 37232 USA.	b.appel@vanderbilt.edu	Kelsh, Robert/B-6445-2008; Appel, Bruce/X-6418-2019; Messier, Claude/A-2322-2008; Carney, Tom J/H-4389-2011	Kelsh, Robert/0000-0002-9381-0066; Appel, Bruce/0000-0003-4500-0672; Messier, Claude/0000-0002-4791-1763; Carney, Tom J/0000-0003-2371-1924	NINDS NIH HHS [NS046668, R01 NS046668] Funding Source: Medline; CSR NIH HHS [RG 3420] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046668] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Fox MA, 2006, GLIA, V53, P563, DOI 10.1002/glia.20293; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Hardy RJ, 1996, DEV NEUROSCI-BASEL, V18, P243, DOI 10.1159/000111414; Jarjour AA, 2003, J NEUROSCI, V23, P3735; KACHAR B, 1986, CELL TISSUE RES, V244, P27; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Maeda Y, 2001, ANN NEUROL, V49, P776, DOI 10.1002/ana.1015; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; Milner R, 1997, GLIA, V21, P350; Milner R, 1996, J NEUROSCI, V16, P7240; MILNER R, 1994, DEVELOPMENT, V120, P3497; Nelson PJ, 2002, KIDNEY INT S1, V61, P99, DOI DOI 10.1046/J.1523-1755.2002.0610S1099.X; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Pfeifer T, 1997, MICROSYST TECHNOL, V3, P191, DOI 10.1007/s005420050079; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Schmidt C, 1997, GLIA, V20, P284; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Simpson PB, 1999, GLIA, V26, P22, DOI 10.1002/(SICI)1098-1136(199903)26:1<22::AID-GLIA3>3.0.CO;2-M; Sugimoto Y, 2001, DEVELOPMENT, V128, P3321; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhang H, 2004, J CELL SCI, V117, P93, DOI 10.1242/jcs.00827; Zhang H, 1996, J NEUROSCI, V16, P6886	50	284	286	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1506	1511		10.1038/nn1803	http://dx.doi.org/10.1038/nn1803			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17099706				2022-12-24	WOS:000242404000014
J	Chen, YZ; Geisler, WS; Seidemann, E				Chen, Yuzhi; Geisler, Wilson S.; Seidemann, Eyal			Optimal decoding of correlated neural population responses in the primate visual cortex	NATURE NEUROSCIENCE			English	Article							VOLTAGE-SENSITIVE DYES; STRIATE CORTEX; CORTICAL DYNAMICS; FUNCTIONAL ARCHITECTURE; BEHAVING MONKEYS; SINGLE NEURONS; AREA MT; MACAQUE; DISCRIMINATION; ORGANIZATION	Even the simplest environmental stimuli elicit responses in large populations of neurons in early sensory cortical areas. How these distributed responses are read out by subsequent processing stages to mediate behavior remains unknown. Here we used voltage-sensitive dye imaging to measure directly population responses in the primary visual cortex ( V1) of monkeys performing a demanding visual detection task. We then evaluated the ability of different decoding rules to detect the target from the measured neural responses. We found that small visual targets elicit widespread responses in V1, and that response variability at distant sites is highly correlated. These correlations render most previously proposed decoding rules inefficient relative to one that uses spatially antagonistic center-surround summation. This optimal decoder consistently outperformed the monkey in the detection task, demonstrating the sensitivity of our techniques. Overall, our results suggest an unexpected role for inhibitory mechanisms in efficient decoding of neural population responses.	Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Ctr Preceptual Syst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Seidemann, E (corresponding author), Univ Texas, Dept Psychol, 1 Univ Stn,A8000, Austin, TX 78712 USA.	eyal@mail.cps.utexas.edu		Seidemann, Eyal/0000-0003-2841-5948; Geisler, Wilson/0000-0003-4630-6614	NATIONAL EYE INSTITUTE [R01EY016454, R01EY016752] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016454, R01 EY016752, R01 EY016752-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARLOW HB, 1995, COGNITIVE NEUROSCIEN, P401; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; DeValois RL, 1988, SPATIAL VISION; Duda R.O., 2006, PATTERN CLASSIFICATI; Efron B., 1994, INTRO BOOTSTRAP; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GREEN DM, 1966, SIGNAL DETECTION THE; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; Lee D, 1998, J NEUROSCI, V18, P1161; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; MCLLWAIN JT, 1986, TRENDS NEUROSCI, V9, P354, DOI DOI 10.1016/0166-2236(86)90113-X); MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; SNIPPE HP, 1992, BIOL CYBERN, V67, P183, DOI 10.1007/BF00201025; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; SPARKS DL, 1990, COLD SH Q B, V55, P805; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; WOOLSEY CN, 1952, BIOL MENTAL HLTH DIS; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	45	149	150	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1412	1420		10.1038/nn1792	http://dx.doi.org/10.1038/nn1792			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057706	Green Accepted			2022-12-24	WOS:000242403800019
J	Ozdinler, PH; Macklis, JD				Ozdinler, P. Hande; Macklis, Jeffrey D.			IGF-I specifically enhances axon outgrowth of corticospinal motor neurons	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; RETINAL GANGLION-CELLS; NEUROTROPHIC FACTOR; PROJECTION NEURONS; SURVIVAL; EXPRESSION; ALS; PROMOTE; GENES; NEUROGENESIS	Corticospinal motor neurons ( CSMN) are among the most complex CNS neurons; they control voluntary motor function and are prototypical projection neurons. In amyotrophic lateral sclerosis ( ALS), both spinal motor neurons and CSMN degenerate; their damage contributes centrally to the loss of motor function in spinal cord injury. Direct investigation of CSMN is severely limited by inaccessibility in the heterogeneous cortex. Here, using new CSMN purification and culture approaches, and in vivo analyses, we report that insulin-like growth factor-1 ( IGF-I) specifically enhances the extent and rate of murine CSMN axon outgrowth, mediated via the IGF-I receptor and downstream signaling pathways; this is distinct from IGF-I support of neuronal survival. In contrast, brain-derived neurotrophic factor ( BDNF) enhances branching and arborization, but not axon outgrowth. These experiments define specific controls over directed differentiation of CSMN, indicate a distinct role of IGF-I in CSMN axon outgrowth during development, and might enable control over CSMN derived from neural precursors.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Neurosci, Boston, MA 02114 USA; Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Macklis, JD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH HMS Ctr Nervous Syst Repair,Dept Neurosurg, Boston, MA 02114 USA.	jeffrey_macklis@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045523, R01NS049553, R37NS041590, R01NS041590] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41590, NS45523, NS49553] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BLOCHGALLEGO E, 1991, DEVELOPMENT, V111, P221; BONDY CA, 1991, J NEUROSCI, V11, P3442; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Catapano LA, 2004, EUR J NEUROSCI, V19, P2421, DOI 10.1111/j.0953-816X.2004.03303.x; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Clemmons D. R., 1995, Progress in Growth Factor Research, V6, P357, DOI 10.1016/0955-2235(95)00013-5; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Giehl KM, 2001, REV NEUROSCIENCE, V12, P79; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Goldberg JL, 1998, CURR BIOL, V8, pR310, DOI 10.1016/S0960-9822(98)70195-2; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Junger H, 1997, BRAIN RES, V762, P56, DOI 10.1016/S0006-8993(97)00347-8; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; LI SL, 1993, BIOCHEM BIOPH RES CO, V196, P92, DOI 10.1006/bbrc.1993.2220; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lotz B, 1996, NEUROLOGY, V46, P1244; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; NEFF NT, 1993, J NEUROBIOL, V24, P1578, DOI 10.1002/neu.480241203; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Rosler KM, 2000, CLIN NEUROPHYSIOL, V111, P2208, DOI 10.1016/S1388-2457(00)00481-8; ROTWEIN P, 1988, P NATL ACAD SCI USA, V85, P265, DOI 10.1073/pnas.85.1.265; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Winhammar JMC, 2005, LANCET NEUROL, V4, P229, DOI 10.1016/S1474-4422(05)70042-9	50	237	245	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1371	1381		10.1038/nn1789	http://dx.doi.org/10.1038/nn1789			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057708				2022-12-24	WOS:000242403800014
J	Benda, J; Longtin, A; Maler, L				Benda, Jan; Longtin, Andre; Maler, Leonard			A synchronization-desynchronization code for natural communication signals	NEURON			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; AFFERENT NERVE-FIBERS; COINCIDENCE DETECTION; NEURONAL SYNCHRONY; GYMNOTIFORM FISH; APTERONOTUS-LEPTORHYNCHUS; ORGAN DISCHARGE; ELECTRORECEPTORS; OSCILLATIONS	Synchronous spiking of neural populations is hypothesized to play important computational roles in forming neural assemblies and solving the binding problem. Although the opposite phenomenon of desynchronization is well known from EEG studies, it is largely neglected on the neuronal level. We here provide an example of in vivo recordings from weakly electric fish demonstrating that, depending on the social context, different types of natural communication signals elicit transient desynchronization as well as synchronization of the electroreceptor population without changing the mean firing rate. We conclude that, in general, both positive and negative changes in the degree of synchrony can be the relevant signals for neural information processing.	Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany	University of Ottawa; University of Ottawa; Humboldt University of Berlin	Benda, J (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 51 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	j.benda@biologie.hu-berlin.de	Longtin, Andre/D-2443-2009					Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Bastian J, 2001, J EXP BIOL, V204, P1909; BASTIAN J, 1981, J COMP PHYSIOL, V144, P465, DOI 10.1007/BF01326832; Benda J, 2005, J NEUROSCI, V25, P2312, DOI 10.1523/JNEUROSCI.4795-04.2005; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Berman NJ, 1999, J EXP BIOL, V202, P1243; Berman NJ, 1998, J NEUROPHYSIOL, V80, P3173, DOI 10.1152/jn.1998.80.6.3173; BERNANDER O, 1994, NEURAL COMPUT, V6, P622, DOI 10.1162/neco.1994.6.4.622; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; CARR CE, 1982, J COMP NEUROL, V211, P139, DOI 10.1002/cne.902110204; Chacron MJ, 2005, J NEUROSCI, V25, P5521, DOI 10.1523/JNEUROSCI.0445-05.2005; Chacron MJ, 2005, NAT NEUROSCI, V8, P673, DOI 10.1038/nn1433; Chacron MJ, 2003, NATURE, V423, P77, DOI 10.1038/nature01590; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; Doiron B, 2003, NATURE, V421, P539, DOI 10.1038/nature01360; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engler G, 2000, J COMP PHYSIOL A, V186, P645, DOI 10.1007/s003590000118; ERMNTROUT B, 1996, NEURAL COMPUT, V8, P979; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; HAGEDORN M, 1985, ANIM BEHAV, V33, P254, DOI 10.1016/S0003-3472(85)80139-1; HAGIWARA S, 1965, J NEUROPHYSIOL, V28, P784, DOI 10.1152/jn.1965.28.5.784; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; HEILIGENBERG W, 1981, J COMP PHYSIOL, V142, P295, DOI 10.1007/BF00605443; HEILIGENBERG W, 1991, J COMP PHYSIOL A, V169, P151, DOI 10.1007/BF00215862; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; HOPKINS CD, 1976, J COMP PHYSIOL, V111, P171, DOI 10.1007/BF00605531; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Krahe R, 2002, J NEUROSCI, V22, P2374, DOI 10.1523/JNEUROSCI.22-06-02374.2002; Kramer B, 1999, J EXP BIOL, V202, P1387; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Lindner B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061919; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; MALER L, 1974, J COMP NEUROL, V158, P363, DOI 10.1002/cne.901580402; METZNER W, 1991, J COMP PHYSIOL A, V169, P135, DOI 10.1007/BF00215861; MEYER JH, 1987, J COMP PHYSIOL A, V160, P385, DOI 10.1007/BF00613028; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Nelson ME, 1999, J EXP BIOL, V202, P1195; Nelson ME, 1997, J COMP PHYSIOL A, V181, P532, DOI 10.1007/s003590050137; Oestreich J, 2006, NEURON, V49, P577, DOI 10.1016/j.neuron.2006.01.027; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Ratnam R, 2000, J NEUROSCI, V20, P6672, DOI 10.1523/JNEUROSCI.20-17-06672.2000; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; SCHEICH H, 1973, J NEUROPHYSIOL, V36, P39, DOI 10.1152/jn.1973.36.1.39; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; Triefenbach F, 2003, ANIM BEHAV, V65, P19, DOI 10.1006/anbe.2002.2019; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; VIJN PCM, 1991, BRAIN RES, V550, P49, DOI 10.1016/0006-8993(91)90403-I; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; Woertz M, 2004, COGNITIVE BRAIN RES, V20, P256, DOI 10.1016/j.cogbrainres.2004.03.014; Xu Z, 1996, J NEUROPHYSIOL, V76, P2020, DOI 10.1152/jn.1996.76.3.2020; Zakon H, 2002, J PHYSIOL-PARIS, V96, P451, DOI 10.1016/S0928-4257(03)00012-3; ZUPANC GKH, 1993, CAN J ZOOL, V71, P2301, DOI 10.1139/z93-323; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P159, DOI 10.1007/s00359-005-0058-5; Zupanc GKH, 2002, J PHYSIOLOGY-PARIS, V96, P459, DOI 10.1016/S0928-4257(03)00002-0	69	76	76	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					347	358		10.1016/j.neuron.2006.08.008	http://dx.doi.org/10.1016/j.neuron.2006.08.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046696	Bronze			2022-12-24	WOS:000241799900014
J	Kanold, PO; Shatz, CJ				Kanold, Patrick O.; Shatz, Carla J.			Subplate neurons regulate maturation of cortical inhibition and outcome of ocular dominance plasticity	NEURON			English	Article							CAT VISUAL-CORTEX; DEPENDENT SYNAPTIC MODIFICATIONS; GABA(A) RECEPTOR SUBUNIT; CRITICAL-PERIOD; STRIATE CORTEX; COTRANSPORTER KCC2; BARREL CORTEX; RESPONSES; COLUMNS; EXPRESSION	Synaptic plasticity during critical periods of development requires intact inhibitory circuitry. We report that subplate neurons are needed both for maturation of inhibition and for the proper sign of ocular dominance (OD) plasticity. Removal of subplate neurons prevents the developmental upregulation of genes involved in mature, fast GABAergic transmission in cortical layer 4, including GABA receptor subunits and KCC2, and thus prevents the switch to a hyperpolarizing effect of GABA. To understand the implications of these changes, a realistic circuit model was formulated. Simulations predicted that without subplate neurons, monocular deprivation (MD) paradoxically favors LGN axons representing the deprived (less active) eye, exactly what was then observed experimentally. Simulations also account for published results showing that CID plasticity requires mature inhibition. Thus, subplate neurons regulate molecular machinery required to establish an adult balance of excitation and inhibition in layer 4, and thereby influence the outcome of CD plasticity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu		Kanold, Patrick/0000-0002-7529-5435	NEI NIH HHS [F32 EY 1352, F32 EY013526-01, F32 EY013526, R01 EY 02858] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002858, F32EY013526] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; BAUMFALK U, 1987, NEUROSCI LETT, V75, P187, DOI 10.1016/0304-3940(87)90295-3; BEAR MF, 1990, J NEUROSCI, V10, P909; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Chen L, 2001, MOL BRAIN RES, V88, P135, DOI 10.1016/S0169-328X(01)00042-0; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Dan Y, 1996, J NEUROSCI, V16, P3351; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finney EM, 1998, J COMP NEUROL, V398, P105; FRIAUF E, 1990, J NEUROSCI, V10, P2601; FRIAUF E, 1991, J NEUROPHYSIOL, V66, P2059, DOI 10.1152/jn.1991.66.6.2059; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Galuske RAW, 2000, EUR J NEUROSCI, V12, P3315, DOI 10.1046/j.1460-9568.2000.00213.x; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GHOSH A, 1994, J NEUROSCI, V14, P3862; Golshani P, 1997, J COMP NEUROL, V383, P199, DOI 10.1002/(SICI)1096-9861(19970630)383:2<199::AID-CNE7>3.0.CO;2-W; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hennou S, 2002, EUR J NEUROSCI, V16, P197, DOI 10.1046/j.1460-9568.2002.02073.x; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Huntsman MM, 1999, NEUROSCIENCE, V91, P1223, DOI 10.1016/S0306-4522(98)00713-1; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Lee H, 2005, EUR J NEUROSCI, V21, P2593, DOI 10.1111/j.1460-9568.2005.04084.x; Lein ES, 1999, P NATL ACAD SCI USA, V96, P13491, DOI 10.1073/pnas.96.23.13491; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Mathern GW, 2000, EPILEPSIA, V41, pS162, DOI 10.1111/j.1528-1157.2000.tb01575.x; McQuillen PS, 2003, J NEUROSCI, V23, P3308; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Volpe JJ, 1996, PEDIATRICS, V97, P112; Weliky M, 2000, NEURON, V27, P427, DOI 10.1016/S0896-6273(00)00053-2; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	61	156	159	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					627	638		10.1016/j.neuron.2006.07.008	http://dx.doi.org/10.1016/j.neuron.2006.07.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950160	Bronze			2022-12-24	WOS:000240623400011
J	Pugh, JR; Raman, IM				Pugh, Jason R.; Raman, Indira M.			Potentiation of mossy fiber EPSCs in the cerebellar nuclei by NMDA receptor activation followed by postinhibitory rebound current	NEURON			English	Article							LONG-TERM DEPRESSION; HIPPOCAMPAL-NEURONS; CALCIUM CURRENTS; PURKINJE-CELLS; INFERIOR OLIVE; PLASTICITY; RESPONSES; STIMULATION; EXPRESSION; CORTEX	Behavioral and computational studies predict that synaptic plasticity of excitatory mossy fiber inputs to cerebellar nuclear neurons is required for associative learning, but standard tetanization protocols fail to potentiate nuclear cell EPSCs in mouse cerebellar slices. Nuclear neurons fire action potentials spontaneously unless strongly inhibited by Purkinje neurons, raising the possibility that plasticity-triggering signals in these cells differ from those at classical Hebbian synapses. Based on predictions of neuronal activity during delay eyelid conditioning, we developed quasi-physiological induction protocols consisting of high-frequency mossy fiber stimulation and postsynaptic hyperpolarization. Robust, NMDA receptor-dependent potentiation of nuclear cell EPSCs occurred with protocols including a 150-250 ms hyperpolarization in which mossy fiber stimulation preceded a postinhibitory rebound depolarization. Mossy fiber stimulation potentiated EPSCs even when postsynaptic spiking was prevented by voltage-clamp, as long as rebound current was evoked. These data suggest that Purkinje cell inhibition guides the strengthening of excitatory synapses in the cerebellar nuclei.	NW Univ, Inst Neurosci, Evanston, IL 60208 USA; NW Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Raman, IM (corresponding author), NW Univ, Inst Neurosci, Evanston, IL 60208 USA.	i-raman@northwestern.edu	Pugh, Jason/V-9090-2019	Pugh, Jason/0000-0001-9042-7849	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039395] Funding Source: NIH RePORTER; NIMH NIH HHS [MH067564] Funding Source: Medline; NINDS NIH HHS [NS39395] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Anchisi D, 2001, J NEUROPHYSIOL, V85, P323, DOI 10.1152/jn.2001.85.1.323; AUDINAT E, 1990, J PHYSIOL-LONDON, V430, P297, DOI 10.1113/jphysiol.1990.sp018292; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Cull-Candy SG, 1998, NEUROPHARMACOLOGY, V37, P1369, DOI 10.1016/S0028-3908(98)00119-1; Czubayko U, 2001, J NEUROPHYSIOL, V85, P2017, DOI 10.1152/jn.2001.85.5.2017; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; Garcia KS, 1999, J NEUROSCI, V19, P10940, DOI 10.1523/JNEUROSCI.19-24-10940.1999; Gauck V, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-15-j0004.2001; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hesslow G, 1999, NEURON, V24, P179, DOI 10.1016/S0896-6273(00)80831-4; HESSLOW G, 1994, J PHYSIOL-LONDON, V476, P245, DOI 10.1113/jphysiol.1994.sp020127; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P149, DOI 10.1113/jphysiol.1986.sp016002; JAHR CE, 1993, P NATL ACAD SCI USA, V90, P11573, DOI 10.1073/pnas.90.24.11573; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kleim JA, 2002, P NATL ACAD SCI USA, V99, P13228, DOI 10.1073/pnas.202483399; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Kuner T, 1996, J NEUROSCI, V16, P3549; Lavond DG, 2002, ANN NY ACAD SCI, V978, P93, DOI 10.1111/j.1749-6632.2002.tb07558.x; Linden D J, 1994, Learn Mem, V1, P121; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1991, MOL NEUROBIOL, V5, P289, DOI 10.1007/BF02935552; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Momiyama A, 1996, J PHYSIOL-LONDON, V494, P479, DOI 10.1113/jphysiol.1996.sp021507; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MURI R, 1994, J NEUROPHYSIOL, V71, P420, DOI 10.1152/jn.1994.71.1.420; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Ohyama T, 2003, LEARN MEMORY, V10, P346, DOI 10.1101/lm.67103; Ohyama T, 2001, J NEUROSCI, V21, P682, DOI 10.1523/JNEUROSCI.21-02-00682.2001; Raman IM, 2000, J NEUROSCI, V20, P9004; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; STEINMETZ JE, 1989, SYNAPSE, V3, P225, DOI 10.1002/syn.890030308; Telgkamp P, 2002, J NEUROSCI, V22, P8447; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; ZHANG W, 2005, J PHYSL, V561, P703	65	172	173	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					113	123		10.1016/j.neuron.2006.05.021	http://dx.doi.org/10.1016/j.neuron.2006.05.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815336	Bronze			2022-12-24	WOS:000239037700014
J	Beg, AA; Sommer, JE; Martin, JH; Scheiffele, P				Beg, Asim A.; Sommer, Julia E.; Martin, John H.; Scheiffele, Peter			alpha 2-chimaerin is an essential EphA4 effector in the assembly of neuronal locomotor circuits	NEURON			English	Article							GROWTH-CONE COLLAPSE; GTPASE-ACTIVATING PROTEIN; PHORBOL ESTER RECEPTOR; AXON GUIDANCE; TYROSINE KINASE; SPINAL-CORD; CORTICOSPINAL TRACT; N-CHIMAERIN; RHO-GTPASES; DOMAIN	The assembly of neuronal networks during development requires tightly controlled cell-cell interactions. Multiple cell surface receptors that control axon guidance and synapse maturation have been identified. However, the signaling mechanisms downstream of these receptors have remained unclear. Receptor signals might be transmitted through dedicated signaling lines defined by specific effector proteins. Alternatively, a single cell surface receptor might couple to multiple effectors with overlapping functions. We identified the neuronal RacGAP alpha 2-chimaerin as an effector for the receptor tyrosine kinase EphA4. alpha 2-Chimaerin interacts with activated EphA4 and is required for ephrin-induced growth cone collapse in cortical neurons. alpha 2-Chimaerin mutant mice exhibit a rabbit-like hopping gait with synchronous hindlimb movements that phenocopies mice lacking EphA4 kinase activity. Anatomical and functional analyses of corticospinal and spinal interneuron projections reveal that loss of a2-chimaerin results in impairment of EphA4 signaling in vivo. These findings identify alpha 2-chimaerin as an indispensable effector for EphA4 in cortical and spinal motor circuits.	Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Neurosci, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Scheiffele, P (corresponding author), Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Neurosci, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	ps20l8@columbia.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020844] Funding Source: NIH RePORTER; NIDA NIH HHS [DA020844, R01 DA020844] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AHMED S, 1990, BIOCHEM J, V272, P767, DOI 10.1042/bj2720767; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DONG JM, 1995, EUR J BIOCHEM, V227, P636, DOI 10.1111/j.1432-1033.1995.tb20183.x; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; HALL C, 1993, MOL CELL BIOL, V13, P4986, DOI 10.1128/MCB.13.8.4986; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jurney WM, 2002, J NEUROSCI, V22, P6019; KAI M, 2007, IN PRESS BIOCH BIOPH; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Leskow FC, 2006, P NATL ACAD SCI USA, V103, P5373, DOI 10.1073/pnas.0508585103; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Qi RZ, 2004, FEBS LETT, V561, P177, DOI 10.1016/S0014-5793(04)00174-7; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Tanaka M, 2004, EMBO J, V23, P1075, DOI 10.1038/sj.emboj.7600128; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zhang GA, 2006, J PROTEOME RES, V5, P581, DOI 10.1021/pr050362b; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	54	98	105	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 6	2007	55	5					768	778		10.1016/j.neuron.2007.07.036	http://dx.doi.org/10.1016/j.neuron.2007.07.036			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785183	Bronze			2022-12-24	WOS:000249857000012
J	Bellone, C; Nicoll, RA				Bellone, Camilla; Nicoll, Roger A.			Rapid bidirectional switching of synaptic NMDA receptors	NEURON			English	Article							LONG-TERM DEPRESSION; FUNCTIONAL-PROPERTIES; SUBUNIT COMPOSITION; HIPPOCAMPAL; TRAFFICKING; EXPRESSION; AMPA; LTP; LOCALIZATION; MECHANISMS	Synaptic NMDA-type glutamate receptors (NMDARs) play important roles in synaptic plasticity, brain development, and pathology. In the last few years, the view of NMDARs as relatively fixed components of the postsynaptic density has changed. A number of studies have now shown that both the number of receptors and their subunit compositions can be altered. During development, the synaptic NMDARs subunit composition changes, switching from predominance of NR2B-containing to NR2A-containing receptors, but little is known about the mechanisms involved in this developmental process. Here, we report that, depending on the pattern of NMDAR activation, the subunit composition of synaptic NMDARs is under extremely rapid, bidirectional control at neonatal synapses. This switching, which is at least as rapid as that seen with AMPARs, will have immediate and dramatic consequences on the integrative capacity of the synapse.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu		bellone, camilla/0000-0002-6774-6275				Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; CULLCANDY SG, 2004, SCI STKE; Daw MI, 2006, J NEUROSCI, V26, P4178, DOI 10.1523/JNEUROSCI.0150-06.2006; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lin Y, 2006, P NATL ACAD SCI USA, V103, P19902, DOI 10.1073/pnas.0609924104; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Montgomery JM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-48; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; O'Dell T J, 1994, Learn Mem, V1, P129; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tovar KR, 2002, NEURON, V34, P253; Townsend M, 2004, J NEUROSCI, V24, P11098, DOI 10.1523/JNEUROSCI.1207-04.2004; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	43	252	255	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 6	2007	55	5					779	785		10.1016/j.neuron.2007.07.035	http://dx.doi.org/10.1016/j.neuron.2007.07.035			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785184	Bronze			2022-12-24	WOS:000249857000013
J	Lucas, G; Rymar, VV; Du, J; Mnie-Filali, O; Bisgaard, C; Manta, S; Lambas-Senas, L; Wiborg, O; Haddjeri, N; Pineyro, G; Sadikot, AF; Debonnel, G				Lucas, Guillaume; Rymar, Vladimir V.; Du, Jenny; Mnie-Filali, Ouissame; Bisgaard, Christina; Manta, Stella; Lambas-Senas, Laura; Wiborg, Ove; Haddjeri, Nasser; Pineyro, Graciela; Sadikot, Abbas F.; Debonnel, Guy			Serotonin(4) (5-HT4) receptor Agonists are putative antidepressants with a rapid onset of action	NEURON			English	Article							ELEMENT-BINDING PROTEIN; IN-VIVO; RAT-BRAIN; HIPPOCAMPAL NEUROGENESIS; OLFACTORY BULBECTOMY; NUCLEUS-ACCUMBENS; NEURONAL-ACTIVITY; ANIMAL-MODEL; DEPRESSION; CAMP	Current antidepressants are clinically effective only after several weeks of administration. Here, we show that serotonin(4) (5-HT4) agonists reduce immobility in the forced swimming test, displaying an antidepressant potential. Moreover, a 3 day regimen with such compounds modifies rat brain parameters considered to be key markers of antidepressant action, but that are observed only after 2-3 week treatments with classical molecules: desensitization of 5-HT1A autoreceptors, increased tonus on hippocampal postsynaptic 5-HT1A receptors, and enhanced phosphorylation of the CREB protein and neurogenesis in the hippocampus. In contrast, a 3 day treatment with the SSRI citalopram remains devoid of any effect on these parameters. Finally, a 3 day regimen with the 5-HT4 agonist RS 67333 was sufficient to reduce both the hyperlocomotion induced by olfactory bulbectomy and the diminution of sucrose intake consecutive to a chronic mild stress. These findings point out 5-HT4 receptor agonists as a putative class of antidepressants with a rapid onset of action.	McGill Univ, Dept Psychiat, Montreal, PQ H3A 1A1, Canada; McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurochirurg, Montreal, PQ H3A 2B4, Canada; Univ Montreal, Ctr Rech Fernard Seguin, Montreal, PQ H1N 3V2, Canada; Univ Lyon 1, Lab Neuropharmacol & Neurochim, Lyon, France; Aarhus Psychiat Univ Hosp, Ctr Basic Psychiat Res, Aarhus, Denmark; OWn Res Aps, Aarhus, Denmark	McGill University; McGill University; Universite de Montreal; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Aarhus University	Lucas, G (corresponding author), McGill Univ, Dept Psychiat, Batiment Rech & Format,Bureau 207,1033 Ave Pins, Montreal, PQ H3A 1A1, Canada.	guillaume.lucas@gmail.com	Lucas, Guillaume/N-6993-2017; Manta, Stella/U-6929-2017; Manta, Stella/P-8360-2019; Haddjeri, Nasser/M-6377-2014	Lucas, Guillaume/0000-0003-0647-9756; Manta, Stella/0000-0002-6765-7723; Manta, Stella/0000-0002-6765-7723; Haddjeri, Nasser/0000-0002-2161-2204; Pineyro, Graciela/0000-0001-9709-651X				Arborelius L, 2004, PSYCHOPHARMACOLOGY, V176, P248, DOI 10.1007/s00213-004-1883-x; Artigas Francesc, 2002, Psychopharmacol Bull, V36 Suppl 2, P123; Besson A, 2000, EUR NEUROPSYCHOPHARM, V10, P177, DOI 10.1016/S0924-977X(00)00069-9; Blier P, 2001, J CLIN PSYCHIAT, V62, P7; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Blier P, 2003, BIOL PSYCHIAT, V53, P193, DOI 10.1016/S0006-3223(02)01643-8; BLIER P, 1999, NUROPSYCHOPHARMACO S, V21; BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Briejer MR, 2001, EUR J PHARMACOL, V423, P71, DOI 10.1016/S0014-2999(01)01087-1; Castren E, 2004, CURR OPIN PHARMACOL, V4, P58, DOI 10.1016/j.coph.2003.10.004; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cryan JF, 1999, PHARMACOL BIOCHEM BE, V63, P333, DOI 10.1016/S0091-3057(98)00245-7; David DJ, 2007, J PHARMACOL EXP THER, V321, P237, DOI 10.1124/jpet.106.109678; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; Duman RS, 1998, BIOL PSYCHIAT, V44, P324, DOI 10.1016/S0006-3223(98)00031-6; EGLEN RM, 1995, BRIT J PHARMACOL, V115, P1387, DOI 10.1111/j.1476-5381.1995.tb16628.x; El Mansari M, 2005, NEUROPSYCHOPHARMACOL, V30, P1269, DOI 10.1038/sj.npp.1300686; Ge JA, 1996, BRIT J PHARMACOL, V117, P1475, DOI 10.1111/j.1476-5381.1996.tb15309.x; Haddjeri N, 1998, J NEUROSCI, V18, P10150; Haddjeri N, 2004, INT J NEUROPSYCHOPH, V7, P391, DOI 10.1017/S1461145704004377; HADDJERI N, 1995, SYNAPSE, V20, P54, DOI 10.1002/syn.890200109; Hajos M, 1999, BRIT J PHARMACOL, V126, P1741, DOI 10.1038/sj.bjp.0702510; HOLICK KA, 2007, NEUROPSYCHOPHARMACOL; Jaako-Movits K, 2006, CELL MOL NEUROBIOL, V26, P1559, DOI 10.1007/s10571-006-9090-4; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Loiseau F, 2006, EUR NEUROPSYCHOPHARM, V16, P417, DOI 10.1016/j.euroneuro.2005.11.007; Lucas G, 2005, BIOL PSYCHIAT, V57, P918, DOI 10.1016/j.biopsych.2004.12.023; Lucas G, 2002, EUR J NEUROSCI, V16, P817, DOI 10.1046/j.1460-9568.2002.02150.x; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mongeau R, 1997, BRAIN RES REV, V23, P145, DOI 10.1016/S0165-0173(96)00017-3; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nayak S, 2003, PROG NEURO-PSYCHOPH, V27, P441, DOI 10.1016/S0278-5846(03)00031-9; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nibuya M, 1996, J NEUROSCI, V16, P2365; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pineyro G, 2001, MOL PHARMACOL, V60, P816; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Porras G, 2002, NEUROPHARMACOLOGY, V43, P1099, DOI 10.1016/S0028-3908(02)00212-5; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Sadikot AF, 1997, J COMP NEUROL, V389, P193; Sanchez C, 1999, CELL MOL NEUROBIOL, V19, P467, DOI 10.1023/A:1006986824213; Sanchez C, 2003, PSYCHOPHARMACOLOGY, V167, P353, DOI 10.1007/s00213-002-1364-z; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P255, DOI 10.1177/39.3.1671576; Thome J, 2000, J NEUROSCI, V20, P4030; Tiraboschi E, 2004, NEUROPSYCHOPHARMACOL, V29, P1831, DOI 10.1038/sj.npp.1300488; Vilaro MT, 1996, MOL BRAIN RES, V43, P356, DOI 10.1016/S0169-328X(96)00248-3; WAEBER C, 1994, NEUROPHARMACOLOGY, V33, P527, DOI 10.1016/0028-3908(94)90084-1	51	244	258	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 6	2007	55	5					712	725		10.1016/j.neuron.2007.07.041	http://dx.doi.org/10.1016/j.neuron.2007.07.041			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785179	Bronze			2022-12-24	WOS:000249857000008
J	Behrens, TEJ; Woolrich, MW; Walton, ME; Rushworth, MFS				Behrens, Timothy E. J.; Woolrich, Mark W.; Walton, Mark E.; Rushworth, Matthew F. S.			Learning the value of information in an uncertain world	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; DOPAMINE NEURONS; REWARD; PERFORMANCE; HUMANS; NEUROMODULATION; REPRESENTATION; PREDICTION	Our decisions are guided by outcomes that are associated with decisions made in the past. However, the amount of influence each past outcome has on our next decision remains unclear. To ensure optimal decision-making, the weight given to decision outcomes should reflect their salience in predicting future outcomes, and this salience should be modulated by the volatility of the reward environment. We show that human subjects assess volatility in an optimal manner and adjust decision-making accordingly. This optimal estimate of volatility is reflected in the fMRI signal in the anterior cingulate cortex ( ACC) when each trial outcome is observed. When a new piece of information is witnessed, activity levels reflect its salience for predicting future outcomes. Furthermore, variations in this ACC signal across the population predict variations in subject learning rates. Our results provide a formal account of how we weigh our different experiences in guiding our future actions.	Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Behrens, TEJ (corresponding author), Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England.	behrens@fmrib.ox.ac.uk		Woolrich, Mark/0000-0001-8460-8854; Behrens, Timothy/0000-0003-0048-1177; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0600994, G0501316] Funding Source: UKRI; Medical Research Council [G0501316, G0600994] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DICKINSON A, 1978, ANNU REV PSYCHOL, V29, P587, DOI 10.1146/annurev.ps.29.020178.003103; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Gallistel CR, 2001, J EXP PSYCHOL ANIM B, V27, P354, DOI 10.1037//0097-7403.27.4.354; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kahneman D, 2000, CHOICES VALUES FRAME; Kakade S, 2002, PSYCHOL REV, V109, P533, DOI 10.1037//0033-295X.109.3.533; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; KUNISHIO K, 1994, J COMP NEUROL, V350, P337, DOI 10.1002/cne.903500302; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Strick PL, 1998, NOVART FDN SYMP, V218, P64; STRICK PL, 1998, NOVART FDN SYMP, V218, P75; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; VANHOESEN GW, 1993, NEUROBIOLOGY CINGULA; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	51	1116	1120	9	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1214	1221		10.1038/nn1954	http://dx.doi.org/10.1038/nn1954			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676057				2022-12-24	WOS:000249144000025
J	Hampton, AN; Adolphs, R; Tyszka, MJ; O'Doherty, JP				Hampton, Alan N.; Adolphs, Ralph; Tyszka, Michael J.; O'Doherty, John P.			Contributions of the amygdala to reward expectancy and choice signals in human prefrontal cortex	NEURON			English	Article							ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; DECISION-MAKING; RHESUS-MONKEYS; LESIONS; REPRESENTATIONS; CORTICES; VALENCE; DEPENDS; MEMORY	The prefrontal cortex (PFC) receives substantial anatomical input from the amygdala, and these two structures have long been implicated in reward-related learning and decision making. Yet little is known about how these regions interact, especially in humans. We investigated the contribution of the amygdala to reward-related signals in PFC by scanning two rare subjects with focal bilateral amygdala lesions using fMRI. The subjects performed a reversal learning task in which they first had to learn which of two choices was the more rewarding, and then flexibly switch their choices when contingencies changed. Compared with healthy controls, both amygdala lesion subjects showed a profound change in ventromedial prefrontal cortex (vmPFC) activity associated with reward expectation and behavioral choice. These findings support a critical role for the human amygdala in establishing expected reward representations in PFC, which in turn may be used to guide behavioral choice.	CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	O'Doherty, JP (corresponding author), CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	jdoherty@hss.caltech.edu	O'Doherty, John P/F-1204-2013					AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BUCHANAN TW, 2007, IN PRESS HUMAN AMYGD; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gottfried JA, 2004, NEURON, V42, P687, DOI 10.1016/S0896-6273(04)00270-3; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hatfield T, 1996, J NEUROSCI, V16, P5256; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; HOFER PA, 1973, ACTA DERM-VENEREOL, V53, P5; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Iidaka T, 2001, J COGNITIVE NEUROSCI, V13, P1035, DOI 10.1162/089892901753294338; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; Kilpatrick L, 2003, NEUROIMAGE, V20, P2091, DOI 10.1016/j.neuroimage.2003.08.006; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; LUCE DR, 2003, RESPONSE TIMES; Malkova L, 1997, J NEUROSCI, V17, P6011; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; RICE JA, 1995, MATH STAT DATA ANAL, V592; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Stalnaker TA, 2007, NEURON, V54, P51, DOI 10.1016/j.neuron.2007.02.014; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525	41	155	156	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2007	55	4					545	555		10.1016/j.neuron.2007.07.022	http://dx.doi.org/10.1016/j.neuron.2007.07.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698008	Bronze			2022-12-24	WOS:000249159200004
J	Colburn, RW; Lubin, ML; Stone, DJ; Wang, Y; Lawrence, D; D'Andrea, MR; Brandt, MR; Liu, Y; Flores, CM; Qin, N				Colburn, Raymond W.; Lubin, Mary Lou; Stone, Dennis J., Jr.; Wang, Yan; Lawrence, Danielle; D'Andrea, Michael R.; Brandt, Michael R.; Liu, Yi; Flores, Christopher M.; Qin, Ning			Attenuated cold sensitivity in TRPM8 null mice	NEURON			English	Article							NEUROPATHIC PAIN; CAPSAICIN RECEPTOR; ION-CHANNEL; MENTHOL; NEURONS; TRPA1; ACTIVATION; ALLODYNIA; NOCICEPTION; MODEL	Thermosensation is an essential sensory function that is subserved by a variety of transducer molecules, including those from the Transient Receptor Potential (TRP) ion channel superfamily. One of its members, TRPM8 (CMR1), a ligand-gated, nonselective cation channel, is activated by both cold and chemical stimuli in vitro. However, its roles in cold thermosensation and pain in vivo have not been fully elucidated. Here, we show that sensory neurons derived from TRPM8 null mice lack detectable levels of TRPM8 mRNA and protein and that the number of these neurons responding to cold (18 degrees C) and menthol (100 mu M) is greatly decreased. Furthermore, compared with WT mice, TRPM8 null mice display deficiencies in certain behaviors, including icilin-induced jumping and cold sensation, as well as a significant reduction in injury-induced responsiveness to acetone cooling. These results suggest that TRPM8 may play an important role in certain types of cold-induced pain in humans.	Johnson & Johnson Pharmaceut Res & Dev LLC, Analgesics Team, Spring House, PA 19477 USA; Johnson & Johnson Pharmaceut Res & Dev LLC, Target Validat Team, E Coast Res & Early Dev, Spring House, PA 19477 USA	Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Johnson & Johnson USA	Qin, N (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, Analgesics Team, Welsh & McKean Rd,POB 776, Spring House, PA 19477 USA.	nqin@prdus.jnj.com						Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Katsura H, 2006, EXP NEUROL, V200, P112, DOI 10.1016/j.expneurol.2006.01.031; Kim SJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-11; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Martinez-Caro L, 2000, NEUROREPORT, V11, P1213, DOI 10.1097/00001756-200004270-00014; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Munns C, 2007, CELL CALCIUM, V41, P331, DOI 10.1016/j.ceca.2006.07.008; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Smith MP, 2004, NEUROREPORT, V15, P1399, DOI 10.1097/01.wnr.0000126559.35631.54; Sommer C, 1998, BRAIN RES, V784, P154, DOI 10.1016/S0006-8993(97)01327-9; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Thut PD, 2003, NEUROSCIENCE, V119, P1071, DOI 10.1016/S0306-4522(03)00225-2; Vissers K, 2005, ANESTH ANALG, V101, P457, DOI 10.1213/01.ANE.0000158471.41575.F0; Voets T., 2007, V179, P329; Walczak JS, 2006, NEUROSCI LETT, V399, P240, DOI 10.1016/j.neulet.2006.01.058; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Werkheiser JL, 2006, AMINO ACIDS, V30, P307, DOI 10.1007/s00726-005-0306-6	32	536	549	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 3	2007	54	3					379	386		10.1016/j.neuron.2007.04.017	http://dx.doi.org/10.1016/j.neuron.2007.04.017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481392	Bronze			2022-12-24	WOS:000246855700009
J	Tzounopoulos, T; Rubio, ME; Keen, JE; Trussell, LO				Tzounopoulos, Thanos; Rubio, Maria E.; Keen, John E.; Trussell, Laurence O.			Coactivation of pre- and postsynaptic signaling mechanisms determines cell-specific spike-timing-dependent plasticity	NEURON			English	Article							DORSAL COCHLEAR NUCLEUS; BIDIRECTIONAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; ENDOGENOUS CANNABINOIDS; PYRAMIDAL CELLS; STELLATE CELLS; RAT; NEURONS; DEPRESSION; TRANSMISSION	Synapses may undergo long-term increases or decreases in synaptic strength dependent on critical differences in the timing between pre- and postsynaptic activity. Such spike-timing-dependent plasticity (STDP) follows rules that govern how patterns of neural activity induce changes in synaptic strength. Synaptic plasticity in the dorsal cochlear nucleus (DCN) follows Hebbian and anti-Hebbian patterns in a cell-specific manner. Here we show that these opposing responses to synaptic activity result from differential expression of two signaling pathways. Ca2+/calmodulin-dependent protein kinase II (CaMKII) signaling underlies Hebbian postsynaptic LTP in principal cells. By contrast, in interneurons, a temporally precise anti-Hebbian synaptic spike-timing rule results from the combined effects of postsynaptic CaMKII-dependent LTP and endocannabinoid-dependent presynaptic LTD. Cell specificity in the circuit arises from selective targeting of presynaptic CB1 receptors in different axonal terminals. Hence, pre- and postsynaptic sites of expression determine both the sign and timing requirements of long-term plasticity in interneurons.	Rosalind Franklin Univ, Dept Cell Biol & Anat, Chicago Med Sch, N Chicago, IL 60064 USA; Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; University of Connecticut; Oregon Health & Science University; Oregon Health & Science University	Tzounopoulos, T (corresponding author), Rosalind Franklin Univ, Dept Cell Biol & Anat, Chicago Med Sch, N Chicago, IL 60064 USA.	athanasios.tzounopoulos@rosalindfranklin.edu			NIDCD NIH HHS [R01 DC007905-01A1, R01 DC007905, R01 DC006881-01A2, R01 DC006881] Funding Source: Medline; NINDS NIH HHS [R37 NS028901, R37 NS028901-16, R37NS28901, R37 NS028901-15] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007905, R01DC006881] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; BERREBI AS, 1991, ANAT EMBRYOL, V183, P427; BERREBI AS, 1988, J NEUROCYTOL, V17, P465, DOI 10.1007/BF01189803; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Chan LK, 2001, STAT SINICA, V11, P767; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Davis KA, 1996, J NEUROPHYSIOL, V76, P3012, DOI 10.1152/jn.1996.76.5.3012; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Huang YC, 2003, J NEUROSCI, V23, P10311; Karmarkar UR, 2002, J NEUROPHYSIOL, V88, P507, DOI 10.1152/jn.2002.88.1.507; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MANIS PB, 1994, J COMP NEUROL, V348, P261, DOI 10.1002/cne.903480208; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; May BJ, 2000, HEARING RES, V148, P74, DOI 10.1016/S0378-5955(00)00142-8; MUGNAINI E, 1985, J COMP NEUROL, V235, P61, DOI 10.1002/cne.902350106; MUGNAINI E, 1980, J COMP NEUROL, V191, P581, DOI 10.1002/cne.901910406; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nyiri G, 2005, NEUROSCIENCE, V136, P811, DOI 10.1016/j.neuroscience.2005.01.026; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 1998, NEUROBIOL DIS, V5, P462, DOI 10.1006/nbdi.1998.0221; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Roberts PD, 2000, J COMPUT NEUROSCI, V9, P67, DOI 10.1023/A:1008938428112; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Rubio ME, 2004, J COMP NEUROL, V477, P253, DOI 10.1002/cne.20248; Rumsey CC, 2006, J NEUROPHYSIOL, V96, P2307, DOI 10.1152/jn.00149.2006; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2007, NEUROPHARMACOLOGY, V52, P176, DOI 10.1016/j.neuropharm.2006.07.021; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Sutherland DP, 1998, HEARING RES, V120, P86, DOI 10.1016/S0378-5955(98)00056-2; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; TSIEN RW, 1991, ANN NY ACAD SCI, V635, P208, DOI 10.1111/j.1749-6632.1991.tb36493.x; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; WOUTERLOOD FG, 1984, J COMP NEUROL, V227, P136, DOI 10.1002/cne.902270114; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Young ED, 2002, SPR HDB AUD, V15, P160; ZHANG S, 1993, J NEUROPHYSIOL, V69, P1384, DOI 10.1152/jn.1993.69.5.1384; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	75	158	162	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					291	301		10.1016/j.neuron.2007.03.026	http://dx.doi.org/10.1016/j.neuron.2007.03.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442249	Green Accepted, Bronze			2022-12-24	WOS:000246190600013
J	Golarai, G; Ghahremani, DG; Whitfield-Gabrieli, S; Reiss, A; Eberhardt, JL; Gabrieli, JDE; Grill-Spector, K				Golarai, Golijeh; Ghahremani, Dara G.; Whitfield-Gabrieli, S.; Reiss, Allan; Eberhardt, Jennifer L.; Gabrieli, John D. E.; Grill-Spector, Kalanit			Differential development of high-level visual cortex correlates with category-specific recognition memory	NATURE NEUROSCIENCE			English	Article							FUSIFORM FACE AREA; HUMAN EXTRASTRIATE CORTEX; OBJECT-PROCESSING STAGES; OTHER-RACE FACES; BRAIN ACTIVITY; PERCEPTION; FMRI; ACTIVATION; EXPERTISE; CHILDREN	High-level visual cortex in humans includes functionally defined regions that preferentially respond to objects, faces and places. It is unknown how these regions develop and whether their development relates to recognition memory. We used functional magnetic resonance imaging to examine the development of several functionally defined regions including object ( lateral occipital complex, LOC)-, face ('fusiform face area', FFA; superior temporal sulcus, STS)- and place ('parahippocampal place area', PPA)-selective cortices in children (ages 7 - 11), adolescents (12 - 16) and adults. Right FFA and left PPA volumes were substantially larger in adults than in children. This development occurred by expansion of FFA and PPA into surrounding cortex and was correlated with improved recognition memory for faces and places, respectively. In contrast, LOC and STS volumes and object-recognition memory remained constant across ages. Thus, the ventral stream undergoes a prolonged maturation that varies temporally across functional regions, is determined by brain region rather than stimulus category, and is correlated with the development of category-specific recognition memory.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Los Angeles; Harvard University; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University	Golarai, G (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall Bldg 420, Stanford, CA 94305 USA.	ggolarai@psych.stanford.edu	Gabrieli, John/AAJ-2869-2020	Grill-Spector, Kalanit/0000-0002-5404-9606	NEI NIH HHS [R21 EY017741, 1R21EY017741] Funding Source: Medline; NIDA NIH HHS [R21 DA015893, 5R21DA15893] Funding Source: Medline; NIMH NIH HHS [T32 MH19908, 1R21MH66747, R21 MH066747, T32 MH019908] Funding Source: Medline; NATIONAL EYE INSTITUTE [R21EY017741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066747, T32MH019908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015893] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Aylward EH, 2005, J COGNITIVE NEUROSCI, V17, P308, DOI 10.1162/0898929053124884; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; CHANCE JE, 1982, J PSYCHOL, V112, P29, DOI 10.1080/00223980.1982.9923531; Conner IP, 2004, J VISION, V4, P509, DOI 10.1167/4.6.10; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; de Haan M, 1999, DEV PSYCHOL, V35, P1113, DOI 10.1037/0012-1649.35.4.1113; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duvernoy HM, 1999, HUMAN BRAIN; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2006, NEUROPSYCHOLOGIA, V44, P1145, DOI 10.1016/j.neuropsychologia.2005.10.009; Gathers AD, 2004, NEUROREPORT, V15, P1549, DOI 10.1097/01.wnr.0000133299.84901.86; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; GOREN CC, 1975, PEDIATRICS, V56, P544; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; JENKINS WM, 1990, NEUROPSYCHOLOGIA, V28, P573, DOI 10.1016/0028-3932(90)90035-M; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Nichols EA, 2006, HIPPOCAMPUS, V16, P604, DOI 10.1002/hipo.20190; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P454, DOI 10.1006/nimg.2001.0979; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Yue XM, 2006, VISION RES, V46, P3802, DOI 10.1016/j.visres.2006.06.017	50	345	350	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					512	522		10.1038/nn1865	http://dx.doi.org/10.1038/nn1865			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	150PL	17351637	Green Accepted			2022-12-24	WOS:000245228600023
J	Silberberg, G; Markram, H				Silberberg, Gilad; Markram, Henry			Disynaptic inhibition between neocortical pyramidal cells mediated by martinotti cells	NEURON			English	Article							ACTION-POTENTIAL INITIATION; DENDRITIC CALCIUM SPIKES; SOMATOSENSORY CORTEX; SYNAPTIC CONNECTIONS; INTRACELLULAR-RECORDINGS; GABAERGIC INTERNEURONS; VISUAL-CORTEX; BARREL CORTEX; RAT NEOCORTEX; ADULT-RAT	Reliable activation of inhibitory pathways is essential for maintaining the balance between excitation and inhibition during cortical activity. Little is known, however, about the activation of these pathways at the level of the local neocortical microcircuit. We report a disynaptic inhibitory pathway among neocortical pyramidal cells (PCs). Inhibitory responses were evoked in layer 5 PCs following stimulation of individual neighboring PCs with trains of action potentials. The probability for inhibition between PCs was more than twice that of direct excitation, and inhibitory responses increased as a function of rate and duration of presynaptic discharge. Simultaneous somatic and dendritic recordings indicated that inhibition originated from PC apical and tuft dendrites. Multineuron whole-cell recordings from PCs and interneurons combined with morphological reconstructions revealed the mediating interneurons as Martinotti cells. Martinotti cells received facilitating synapses from PCs and formed reliable inhibitory synapses onto dendrites of neighboring PCs. We describe this feedback pathway and propose it as a central mechanism for regulation of cortical activity.	Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, SE-17177 Stockholm, Sweden	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Karolinska Institutet	Silberberg, G (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	gilad.silberberg@ki.se	Silberberg, Gilad/A-1048-2012	Silberberg, Gilad/0000-0001-9964-505X				Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buckmaster PS, 1999, J NEUROSCI, V19, P9519; Carnevale N. T., 1995, Advances in Neural Information Processing Systems 7, P69; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Douglas R. J., 1990, SYNAPTIC ORG BRAIN, P389; Fairen A., 1984, CELLULAR COMPONENTS; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; Goldberg JH, 2004, J PHYSIOL-LONDON, V558, P465, DOI 10.1113/jphysiol.2004.064519; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; KILLACKEY HP, 1989, J COMP NEUROL, V282, P428, DOI 10.1002/cne.902820309; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Marco P, 1996, BRAIN, V119, P1327, DOI 10.1093/brain/119.4.1327; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Oakley JC, 2001, J NEUROPHYSIOL, V86, P514, DOI 10.1152/jn.2001.86.1.514; Oda S, 2004, NEUROSCI LETT, V367, P394, DOI 10.1016/j.neulet.2004.06.042; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Ramon y Cajal S, 1891, CELLULE, V7, P3; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; RINALDI T, 2005, AUTISM DISORDER HYPE; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2003, J NEUROSCI, V23, P7358	63	493	499	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					735	746		10.1016/j.neuron.2007.02.012	http://dx.doi.org/10.1016/j.neuron.2007.02.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329212	Bronze			2022-12-24	WOS:000245127100013
J	Futai, K; Kim, MJ; Hashikawa, T; Scheiffele, P; Sheng, M; Hayashi, Y				Futai, Kensuke; Kim, Myung Jong; Hashikawa, Tsutomu; Scheiffele, Peter; Sheng, Morgan; Hayashi, Yasunori			Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA3 PYRAMIDAL CELLS; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL SYNAPSES; EXCITATORY SYNAPSES; ALPHA-NEUREXINS; POSTSYNAPTIC MATURATION; GLUTAMATERGIC SYNAPSES; DENDRITIC SPINES; BETA-NEUREXINS	The structure and function of presynaptic and postsynaptic components of the synapse are highly coordinated. How such coordination is achieved and the molecules involved in this process have not been clarified. Several lines of evidence suggest that presynaptic functionalities are regulated by retrograde mechanisms from the postsynaptic side. We therefore sought postsynaptic mechanisms responsible for trans- synaptic regulation of presynaptic function at excitatory synapses in rat hippocampal CA1 pyramidal neurons. We show here that the postsynaptic complex of scaffolding protein PSD- 95 and neuroligin can modulate the release probability of transmitter vesicles at synapse in a retrograde way, resulting in altered presynaptic short- term plasticity. Presynaptic beta- neurexin serves as a likely presynaptic mediator of this effect. Our results indicate that trans- synaptic proteinprotein interactions can link postsynaptic and presynaptic function.	MIT, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; RIKEN, Brain Sci Inst, Lab Neural Architecture, Adv Technol Dev Grp, Wako, Saitama 3510198, Japan; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Columbia University	Hayashi, Y (corresponding author), MIT, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yhayashi@mit.edu	Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [R01 NS045014] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045014] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; deKay JGT, 2006, HIPPOCAMPUS, V16, P66, DOI 10.1002/hipo.20132; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kazama H, 2003, NEUROSCIENCE, V117, P615, DOI 10.1016/S0306-4522(02)00923-5; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pavlidis P, 1999, J NEUROPHYSIOL, V81, P2787, DOI 10.1152/jn.1999.81.6.2787; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Regalado MP, 2006, J NEUROSCI, V26, P2343, DOI 10.1523/JNEUROSCI.5247-05.2006; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schermanz K, 2002, CATALY SCI, V2, P1, DOI 10.1142/9781860949654_0001; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	213	221	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					186	195		10.1038/nn1837	http://dx.doi.org/10.1038/nn1837			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237775	Green Accepted			2022-12-24	WOS:000244175200013
J	Bloodgood, BL; Sabatini, BL				Bloodgood, Brenda L.; Sabatini, Bernardo L.			Nonlinear regulation of unitary synaptic signals by CaV2.3 voltage-sensitive calcium channels located in dendritic spines	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; CA2+-ACTIVATED K+ CHANNELS; LONG-TERM POTENTIATION; CA2+ CHANNELS; T-TYPE; ACTIVATION; NMDA; COMPARTMENTALIZATION; INHIBITION; PLASTICITY	The roles of voltage-sensitive sodium (Na) and calcium (Ca) channels located on dendrites and spines in regulating synaptic signals are largely unknown. Here we use 2-photon glutamate uncaging to stimulate individual spines while monitoring uncaging-evoked excitatory postsynaptic potentials (uEPSPs) and Ca transients. We find that, in CA1 pyramidal neurons in acute mouse hippocampal slices, CaV2.3 voltage-sensitive Ca channels (VSCCs) are found selectively on spines and act locally to dampen uncaging-evoked Ca transients and somatic potentials. These effects are mediated by a regulatory loop that requires opening of CaV2.3 channels, voltage-gated Na channels, small conductance Ca-activated potassium (SK) channels, and NMDA receptors. Ca influx through CaV2.3 VSCCS selectively activates SK channels, revealing the presence of functional Ca microdomains within the spine. Our results suggest that synaptic strength can be modulated by mechanisms that regulate voltage-gated conductances within the spine but do not alter the properties or numbers of synaptic glutamate receptors.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu		Bloodgood, Brenda/0000-0002-4797-9119	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS046579, R01 NS046579-01A] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Brenowitz SD, 2006, J NEUROSCI, V26, P6841, DOI 10.1523/JNEUROSCI.1280-06.2006; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; HINKLE PM, 1992, J BIOL CHEM, V267, P25553; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; KOCH C, 1993, J NEUROSCI, V13, P413; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Majewska A, 2000, J NEUROSCI, V20, P1722; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; MILLS LR, 1994, J NEUROSCI, V14, P6815; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	38	206	209	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					249	260		10.1016/j.neuron.2006.12.017	http://dx.doi.org/10.1016/j.neuron.2006.12.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224406	Bronze			2022-12-24	WOS:000245126600010
J	Sweeney, LB; Couto, A; Chou, YH; Berdnik, D; Dickson, BJ; Luo, LQ; Komiyama, T				Sweeney, Lora B.; Couto, Africa; Chou, Ya-Hui; Berdnik, Daniela; Dickson, Barry J.; Luo, Liqun; Komiyama, Takaki			Temporal target restriction of olfactory receptor neurons by Semaphorin-1a/PlexinA-mediated axon-axon interactions	NEURON			English	Article							DROSOPHILA VISUAL-SYSTEM; WIRING SPECIFICITY; GROWTH CONES; SEMAPHORIN RECEPTOR; PROJECTION NEURONS; ANTENNAL LOBE; N-CADHERIN; GUIDANCE; FASCICULATION; PLEXIN	Axon-axon interactions have been implicated in neural circuit assembly, but the underlying mechanisms are poorly understood. Here, we show that in the Drosophila antennal lobe, early-arriving axons of olfactory receptor neurons (ORNs) from the antenna are required for the proper targeting of late-arriving ORN axons; from the maxillary palp (MP). Semaphorin-1 a is required for targeting of all MP but only half of the antennal ORN classes examined. Sema-1 a acts nonautonomously to control ORN axon-axon interactions, in contrast to its cell-autonomous function in olfactory projection neurons. Phenotypic and genetic interaction analyses implicate PlexinA as the Sema-1 a receptor in ORN targeting. Sema-la on antennal ORN axons is required for correct targeting of MP axons within the antennal lobe, while interactions amongst MP axons facilitate their entry into the antennal lobe. We propose that Sema-1a/PlexinA-mediated repulsion provides a mechanism by which early-arriving ORN axons constrain the target choices of late-arriving axons.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	Howard Hughes Medical Institute; Stanford University; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu	Dickson, Barry/AAE-7632-2019; Chou, Ya-Hui/F-3775-2014	Dickson, Barry/0000-0003-0715-892X; Chou, Ya-Hui/0000-0001-6552-8728; Komiyama, Takaki/0000-0001-9609-4600; Couto, Africa/0000-0002-3868-5637; Sweeney, Lora/0000-0001-9242-5601; Luo, Liqun/0000-0001-5467-9264	NIDCD NIH HHS [R01-DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; Chen Y, 1998, DEVELOPMENT, V125, P4943; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083; Jhaveri D, 2000, MECH DEVELOP, V99, P101, DOI 10.1016/S0925-4773(00)00487-1; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; KOMIYAMA T, 2007, IN PRESS CELL; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1995, NEURON, V14, P707, DOI 10.1016/0896-6273(95)90215-5; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; RAPER JA, 1983, J NEUROSCI, V3, P31; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Schwarting GA, 2004, EUR J NEUROSCI, V19, P1800, DOI 10.1111/j.1460-9568.2004.03304.x; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	56	110	110	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					185	200		10.1016/j.neuron.2006.12.022	http://dx.doi.org/10.1016/j.neuron.2006.12.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224402	Bronze			2022-12-24	WOS:000245126600006
J	Knutson, B; Rick, S; Wirnmer, GE; Prelec, D; Loewenstein, G				Knutson, Brian; Rick, Scott; Wirnmer, G. Elliott; Prelec, Drazen; Loewenstein, George			Neural predictors of purchases	NEURON			English	Article							DECISION-MAKING; ACTIVATION; UNCERTAINTY; PREFERENCE; OUTCOMES; FMRI	Microeconomic theory maintains that purchases are driven by a combination of consumer preference and price. Using eventrelated flVlRl, we investigated how people weigh these factors to make purchasing decisions. Consistent with neuroinnaging evidence suggesting that distinct circuits anticipate gain and loss, product preference activated the nucleus accumbens (NAcc), while excessive prices activated the insula and deactivated the mesial prefrontal cortex (MPFC) prior to the purchase decision. Activity from each of these regions independently predicted immediately subsequent purchases above and beyond self-report variables. These findings suggest that activation of distinct neural circuits related to anticipatory affect precedes and supports consumers' purchasing decisions.	Stanford Univ, Stanford, CA 94305 USA; Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; MIT, MIT Sloan Sch Management, Cambridge, MA 02139 USA	Stanford University; Carnegie Mellon University; Massachusetts Institute of Technology (MIT)	Knutson, B (corresponding author), Stanford Univ, Bldg 420,Jordan Hall, Stanford, CA 94305 USA.	knutson@psych.stanford.edu	Loewenstein, George/G-7616-2014; Rick, Scott/A-6296-2011; Wimmer, G. Elliott/AAJ-8537-2020	Loewenstein, George/0000-0003-2790-0474; Rick, Scott/0000-0002-0306-2376; Wimmer, G. Elliott/0000-0002-2227-119X; Knutson, Brian/0000-0002-7669-426X	NIA NIH HHS [P30 AG024957, AG024957-02] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG024957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA020615] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deaton A., 1980, EC CONSUMER BEHAV, DOI DOI 10.1017/CBO9780511805653; Deppe M, 2005, J NEUROIMAGING, V15, P171, DOI 10.1177/1051228405275074; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prelec D, 1998, MARKET SCI, V17, P4, DOI 10.1287/mksc.17.1.4; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Volz KG, 2005, BRAIN RES BULL, V67, P403, DOI 10.1016/j.brainresbull.2005.06.011	35	663	693	7	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					147	156		10.1016/j.neuron.2006.11.010	http://dx.doi.org/10.1016/j.neuron.2006.11.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196537	Bronze, Green Accepted			2022-12-24	WOS:000245126500015
J	Armstead, WM; Nassar, T; Akkawi, S; Smith, DH; Chen, XH; Cines, DB; Higazi, AA				Armstead, William M.; Nassar, Taher; Akkawi, Saed; Smith, Douglas H.; Chen, Xiao-Han; Cines, Douglas B.; Higazi, Abd Al-Roof			Neutralizing the neurotoxic effects of exogenous and endogenous tPA	NATURE NEUROSCIENCE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CENTRAL-NERVOUS-SYSTEM; BRAIN; INHIBITOR; THERAPY; STROKE; INJURY; CEREBROVASODILATION; FIBRINOLYSIS; IMPAIRMENT	The clinical use of tissue-type plasminogen activator (tPA) in the treatment of stroke is profoundly constrained by its serious side effects. We report that the deleterious effects of tPA on cerebral edema and intracranial bleeding are separable from its fibrinolytic activity and can be neutralized. A hexapeptide (EEIIMD) corresponding to amino acids 350-355 of plasminogen activator inhibitor type 1 (PAI-1) abolished the tPA-induced increase in infarct size and intracranial bleeding in both mechanical and embolic models of stroke in rats, and reduced brain edema and neuronal loss after traumatic brain injury in pigs. These experiments suggest mechanisms to reduce the neurotoxic effects of tPA without compromising its fibrinolytic activity, through the use of selective antagonists and new tPA formulations.	Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91120 Jerusalem, Israel; Univ Penn, Dept Anesthesia & Crit Care, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Higazi, AA (corresponding author), Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel.	higazi@mail.med.upenn.edu	smith, douglas/A-1321-2007		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067381, P01HL076406, R01HL076206] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL67381, HL82545, HL076206, HL076406, HL06831] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; AKKAWI S, 2006, AM J PHYSIOL-HEART C, DOI DOI 10.1152/A4PHEART.01042.2005; Anderson Gregory Jon, 2009, CELL MOL LIFE SCI, V66, P3241, DOI [DOI 10.1007/s11910-002-0051-0, 10.1007/s00018-009-0051-1, DOI 10.1007/S00018-009-0051-1]; Armstead WM, 2004, J NEUROTRAUM, V21, P1204, DOI 10.1089/0897715041953849; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Atochin DN, 2004, STROKE, V35, P2177, DOI 10.1161/01.STR.0000137412.35700.0e; Bdeir K, 2000, BLOOD, V96, P1820, DOI 10.1182/blood.V96.5.1820.h8001820_1820_1826; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Ding-Zhou L, 2002, EUR J PHARMACOL, V457, P137, DOI 10.1016/S0014-2999(02)02686-9; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Higazi AA, 1998, BLOOD, V92, P2075, DOI 10.1182/blood.V92.6.2075.418k08_2075_2083; HIGAZI AAR, 1995, J BIOL CHEM, V270, P9472, DOI 10.1074/jbc.270.16.9472; Higazi AAR, 2005, BLOOD, V105, P1021, DOI 10.1182/blood-2004-03-0995; Lapchak PA, 2001, CNS DRUGS, V15, P819, DOI 10.2165/00023210-200115110-00001; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Nagai N, 2001, BLOOD, V97, P3086, DOI 10.1182/blood.V97.10.3086; Nagai N, 1999, CIRCULATION, V100, P2541, DOI 10.1161/01.CIR.100.25.2541; Nassar T, 2004, BLOOD, V103, P897, DOI 10.1182/blood-2003-05-1685; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; REBICH S, 1995, AM J PHYSIOL-HEART C, V268, pH1071, DOI 10.1152/ajpheart.1995.268.3.H1071; THOMAS JM, 1971, GROWTH, V35, P259; Tsirka SE, 1997, P NATL ACAD SCI USA, V94, P9779, DOI 10.1073/pnas.94.18.9779; WAGERLE LC, 1986, PEDIATR RES, V20, P131, DOI 10.1203/00006450-198602000-00007; Zhang LT, 1997, J BIOL CHEM, V272, P27053, DOI 10.1074/jbc.272.43.27053; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41; Zivin JA, 1999, NEUROLOGY, V53, P14, DOI 10.1212/WNL.53.1.14	32	58	61	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1150	1155		10.1038/nn1757	http://dx.doi.org/10.1038/nn1757			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16936723				2022-12-24	WOS:000240080800016
J	Singh, A; Hamedinger, D; Hoda, JC; Gebhart, M; Koschak, A; Romanin, C; Striessnig, J				Singh, Anamika; Hamedinger, Daniel; Hoda, Jean-Charles; Gebhart, Mathias; Koschak, Alexandra; Romanin, Christoph; Striessnig, Joerg			C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels	NATURE NEUROSCIENCE			English	Article							STATIONARY NIGHT BLINDNESS; CALCIUM-DEPENDENT INACTIVATION; MOUSE RETINA; CALMODULIN; CACNA1F; FORM; ROD; DETERMINANTS; LOCALIZATION; FACILITATION	Tonic neurotransmitter release at sensory cell ribbon synapses is mediated by calcium (Ca2+) influx through L-type voltage-gated Ca2+ channels. This tonic release requires the channels to inactivate slower than in other tissues. Ca(v)1.4 L-type voltage-gated Ca2+ channels (LTCCs) are found at high densities in photoreceptor terminals, and alpha 1 subunit mutations cause human congenital stationary night blindness type-2 (CSNB2). Ca(v)1.4 voltage-dependent inactivation is slow and Ca2+-dependent inactivation (CDI) is absent. We show that removal of the last 55 or 122 (C-122) C-terminal amino acid residues of the human alpha 1 subunit restores calmodulin-dependent CDI and shifts voltage of half-maximal activation to more negative potentials. The C terminus must therefore form part of a mechanism that prevents calmodulin-dependent CDI of Ca(v)1.4 and controls voltage-dependent activation. Fluorescence resonance energy transfer experiments in living cells revealed binding of C-122 to C-terminal motifs mediating CDI in other Ca2+ channels. The absence of this modulatory mechanism in the CSNB2 truncation mutant K1591X underlines its importance for normal retinal function in humans.	Univ Innsbruck, Abt Pharmakol & Toxikol, Inst Pharm, A-6020 Innsbruck, Austria; Univ Innsbruck, Ctr Mol Biowissensch Innsbruck, A-6020 Innsbruck, Austria; Univ Linz, Inst Biophys, A-4040 Linz, Austria	University of Innsbruck; University of Innsbruck; Johannes Kepler University Linz	Striessnig, J (corresponding author), Univ Innsbruck, Abt Pharmakol & Toxikol, Inst Pharm, Peter Mayrstr 1-1, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at	Tuluc, Petronel/C-2527-2011; Romanin, Christoph/D-5399-2009; Striessnig, Joerg/S-9334-2017	Romanin, Christoph/0000-0003-3756-4136; Striessnig, Joerg/0000-0002-9406-7120; Bhargava, Anamika/0000-0002-1048-3427	Austrian Science Fund FWF [P 17109, P 17159] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Boycott KM, 2000, CAN J OPHTHALMOL, V35, P204, DOI 10.1016/S0008-4182(00)80031-9; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Firth SI, 2001, CLIN EXP OPHTHALMOL, V29, P183, DOI 10.1046/j.1442-9071.2001.00401.x; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; HULME JT, 2006, J PHYSL, DOI DOI 10.1113/PHYSIOL.2006.111799; Kahr H, 2004, J PHYSIOL-LONDON, V557, P121, DOI 10.1113/jphysiol.2004.062653; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Morgans CW, 2000, IMMUNOL CELL BIOL, V78, P442, DOI 10.1046/j.1440-1711.2000.00923.x; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rabl K, 2002, EUR J NEUROSCI, V16, P2070, DOI 10.1046/j.1460-9568.2002.02277.x; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; vonGersdorff H, 1996, J NEUROSCI, V16, P115; Wilkinson MF, 1996, J GEN PHYSIOL, V107, P621, DOI 10.1085/jgp.107.5.621; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	47	101	101	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1108	1116		10.1038/nn1751	http://dx.doi.org/10.1038/nn1751			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921373				2022-12-24	WOS:000240080800011
J	Morris, G; Nevet, A; Arkadir, D; Vaadia, E; Bergman, H				Morris, Genela; Nevet, Alon; Arkadir, David; Vaadia, Eilon; Bergman, Hagai			Midbrain dopamine neurons encode decisions for future action	NATURE NEUROSCIENCE			English	Article							MATCHING BEHAVIOR; BASAL GANGLIA; REWARD; PREDICTION; REPRESENTATION; PROBABILITY; INHIBITION; MOTIVATION; SUBSTRATE; MODELS	Current models of the basal ganglia and dopamine neurons emphasize their role in reinforcement learning. However, the role of dopamine neurons in decision making is still unclear. We recorded from dopamine neurons in monkeys engaged in two types of trial: reference trials in an instructed-choice task and decision trials in a two-armed bandit decision task. We show that the activity of dopamine neurons in the decision setting is modulated according to the value of the upcoming action. Moreover, analysis of the probability matching strategy in the decision trials revealed that the dopamine population activity and not the reward during reference trials determines choice behavior. Because dopamine neurons do not have spatial or motor properties, we conclude that immediate decisions are likely to be generated elsewhere and conveyed to the dopamine neurons, which play a role in shaping long-term decision policy through dynamic modulation of the efficacy of basal ganglia synapses.	Hebrew Univ Jerusalem, ICNC, IL-91220 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Physiol, IL-91220 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Morris, G (corresponding author), Hebrew Univ Jerusalem, ICNC, POB 12272, IL-91220 Jerusalem, Israel.	genela.morris@charite.de	Morris, Genela/B-7844-2008; Vaadia, Eilon/E-9347-2011; Bergman, Hagai/AAI-4683-2021	Bergman, Hagai/0000-0002-2402-6673; Morris, Genela/0000-0002-5417-8977				Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beiser, 1995, MODELS INFORM PROCES, P215; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Gurney K, 2004, TRENDS NEUROSCI, V27, P453, DOI 10.1016/j.tins.2004.06.003; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Martin RF, 2000, PRIMATE BRAIN MAPS S; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nevet A, 2004, J NEUROPHYSIOL, V92, P1973, DOI 10.1152/jn.01036.2003; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Rummery G. A, 1994, SARSA MODIFIED CONNE; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sokal R. R, 1981, BIOMETRY; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Vulkan N, 2000, J ECON SURV, V14, P101, DOI 10.1111/1467-6419.00106; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Wickens JR, 2005, HAND CHEM N, V21, P199; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolford G, 2000, J NEUROSCI, V20, part. no.	40	305	308	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1057	1063		10.1038/nn1743	http://dx.doi.org/10.1038/nn1743			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16862149				2022-12-24	WOS:000240080300019
J	Gu, Y; DeAngelis, GC; Angelaki, DE				Gu, Yong; DeAngelis, Gregory C.; Angelaki, Dora E.			A functional link between area MSTd and heading perception based on vestibular signals	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL AREA; STEREOSCOPIC DEPTH-PERCEPTION; INNERVATING OTOLITH ORGANS; SELF-MOTION; OPTIC FLOW; SQUIRREL-MONKEY; EYE-MOVEMENTS; PSYCHOPHYSICAL SENSITIVITY; VESTIBULOOCULAR REFLEX; NEURON RESPONSES	Recent findings of vestibular responses in part of the visual cortex - the dorsal medial superior temporal area (MSTd) - indicate that vestibular signals might contribute to cortical processes that mediate the perception of self-motion. We tested this hypothesis in monkeys trained to perform a fine heading discrimination task solely on the basis of inertial motion cues. The sensitivity of the neuronal responses was typically lower than that of psychophysical performance, and only the most sensitive neurons rivaled behavioral performance. Responses recorded in MSTd were significantly correlated with perceptual decisions, and the correlations were strongest for the most sensitive neurons. These results support a functional link between MSTd and heading perception based on inertial motion cues. These cues seem mainly to be of vestibular origin, as labyrinthectomy produced a marked elevation of psychophysical thresholds and abolished MSTd responses. This study provides evidence that links single-unit activity to spatial perception mediated by vestibular signals, and supports the idea that the role of MSTd in self-motion perception extends beyond optic flow processing.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu		DeAngelis, Gregory/0000-0002-1635-1273	NEI NIH HHS [R01 EY017866, R01 EY016178, EY016178, EY017866, R01 EY016178-03] Funding Source: Medline; NIDCD NIH HHS [DC04260, R01 DC004260] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016178, R01EY017866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004260] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Angelaki DE, 2005, NAT REV NEUROSCI, V6, P966, DOI 10.1038/nrn1804; Angelaki DE, 2004, J NEUROPHYSIOL, V92, P20, DOI 10.1152/jn.00047.2004; Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; Ben Hamed S, 2003, J NEUROPHYSIOL, V90, P549, DOI 10.1152/jn.00639.2002; Bremmer F, 1999, ANN NY ACAD SCI, V871, P272, DOI 10.1111/j.1749-6632.1999.tb09191.x; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Chen-Huang C, 2006, EXP BRAIN RES, V168, P410, DOI 10.1007/s00221-005-0098-7; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P985, DOI 10.1152/jn.1976.39.5.985; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; GU Y, 2006, J VIS, V6, pA409; GUEDRY FE, 1974, HDB SENSORY PHYSL, P1; Harris LR, 2000, EXP BRAIN RES, V135, P12, DOI 10.1007/s002210000504; Heuer HW, 2004, J NEUROPHYSIOL, V91, P1314, DOI 10.1152/jn.00637.2003; KARUNARATNE AD, 2006, SOC NEUR ABSTR; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Lappe M, 1996, J NEUROSCI, V16, P6265; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Newlands SD, 2001, EXP BRAIN RES, V140, P25, DOI 10.1007/s002210100810; Ohmi M, 1996, COGNITIVE BRAIN RES, V5, P87, DOI 10.1016/S0926-6410(96)00044-4; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Page WK, 2003, J NEUROPHYSIOL, V89, P1994, DOI 10.1152/jn.00493.2002; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Raphan T, 2002, EXP BRAIN RES, V145, P1, DOI 10.1007/s00221-002-1067-z; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shaikh AG, 2005, J NEUROPHYSIOL, V93, P853, DOI 10.1152/jn.00879.2004; SMITH ST, 2002, SOC NEUR ABSTR; TAKAHASHI K, 2006, SOC NEUR ABSTR; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TELFORD L, 1995, EXP BRAIN RES, V104, P502; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; XU HPW, 2006, SOC NEUR ASTR	50	218	222	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1038	1047		10.1038/nn1935	http://dx.doi.org/10.1038/nn1935			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618278	Green Accepted			2022-12-24	WOS:000248357500018
J	Tu, SC; Shin, Y; Zago, WM; States, BA; Eroshkin, A; Lipton, SA; Tong, GG; Nakanishi, N				Tu, Shichun; Shin, Yeonsook; Zago, Wagner M.; States, Bradley A.; Eroshkin, Alexey; Lipton, Stuart A.; Tong, Gary G.; Nakanishi, Nobuki			Takusan: A large gene family that regulates synaptic activity	NEURON			English	Article							NMDA RECEPTOR SUBUNITS; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; GUANYLATE KINASES; DENDRITIC SPINES; PDZ DOMAINS; AMPA; EXPRESSION; PSD-95; PLASTICITY	We have characterized a rodent-specific gene family designated oc-takusan (meaning "many" in Japanese). We initially identified a member of the family whose expression is upregulated in mice lacking the NMDAR subunit NR3A. We then isolated cDNAs encoding 46 alpha-takusan variants from mouse brains. Most variants share an similar to 130 aa long sequence, which contains the previously identified domain of unknown function 622 (DUF622) and is predicted to form coiled-coil structures. Single-cell PCR analyses indicate that one neuron can express multiple a-takusan variants and particular variants may predominate in certain cell types. Forced expression in cultured hippocampal neurons of two variants, alpha 1 or alpha 2, which bind either directly or indirectly to PSD-95, leads to an increase in PSD-95 clustering, dendritic spine density, GluR1 surface expression, and AMPAR activity. Conversely, treating cultured neurons with RNAi targeting a-takusan variants resulted in the opposite phenotype. Hence, alpha-takusan represents a large gene family that regulates synaptic activity.	Burnham Inst Med Res, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Kanazawa Univ, Sch Med, Dept Mol Pharmacol, Kanazawa, Ishikawa 9208640, Japan; Burnham Inst Med Res, Bioinformat Shared Resource, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Kanazawa University; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Nakanishi, N (corresponding author), Burnham Inst Med Res, Ctr Neurosci & Aging, La Jolla, CA 92037 USA.	nnakanishi@burnham.org	Tong, Gary/AAC-9426-2022	Lipton, Stuart/0000-0002-3490-1259	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K12AG000975] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY005477-22A1, R01 EY005477, R01 EY05477] Funding Source: Medline; NIA NIH HHS [K12 AG000975, K12AG00975] Funding Source: Medline; NICHD NIH HHS [P01 HD029587-150003, P01 HD029587, P01 HD29587] Funding Source: Medline; NIMH NIH HHS [R01 MH053535-07] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Dingledine R, 1999, PHARMACOL REV, V51, P7; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Li B, 2003, J NEUROSCI, V23, P11244; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Niethammer M, 1996, J NEUROSCI, V16, P2157; NOURRY C, 2003, SCI STKE; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Spiess AN, 2003, BIOL REPROD, V68, P2044, DOI 10.1095/biolreprod.102.011593; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; SUCHER NJ, 1995, NEURON, V14, P1095, DOI 10.1016/0896-6273(95)90257-0; SUCHER NJ, 1995, J NEUROSCI, V15, P8509; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314	45	23	23	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 5	2007	55	1					69	85		10.1016/j.neuron.2007.06.021	http://dx.doi.org/10.1016/j.neuron.2007.06.021			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610818	Green Accepted, Bronze			2022-12-24	WOS:000248010700009
J	Jia, YC; Zhou, J; Tai, YL; Wang, YZ				Jia, Yichang; Zhou, Jian; Tai, Yilin; Wang, Yizheng			TRPC channels promote cerebellar granule neuron survival	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH CONES; SIGNALING PATHWAY; CELL-DEATH; CREB PHOSPHORYLATION; TRANSCRIPTION FACTOR; NEUROTROPHIC FACTOR; CALCIUM-CHANNEL; GENE-EXPRESSION; CATION CHANNELS; KINASE PATHWAY	Channels formed by the transient receptor potential (TRP) family of proteins have a variety of physiological functions. Here we report that two members of the TRP cation channel (TRPC) subfamily, TRPC3 and 6, protected cerebellar granule neurons ( CGNs) against serum deprivation - induced cell death in cultures and promoted CGN survival in rat brain. In CGN cultures, blocking TRPC channels or downregulating TRPC3 or 6 suppressed brain- derived neurotrophic factor ( BDNF) - mediated protection, BDNF-triggered intracellular Ca2+ elevation and BDNF-induced CREB activation. By contrast, overexpressing TRPC3 or 6 increased CREB-dependent reporter gene transcription and prevented apoptosis in the neurons deprived of serum, and this protection was blocked by the dominant negative form of CREB. Furthermore, downregulating TRPC3 or 6 induced CGN apoptosis in neonatal rat cerebellum, and this effect was rescued by overexpressing either TRPC3 or 6. Thus, our findings provide in vitro and in vivo evidence that TRPC channels are important in promoting neuronal survival.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Key Lab Neurobiol,Lab Neural Signal Transduct, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, YZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Key Lab Neurobiol,Lab Neural Signal Transduct, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn						Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Atabay C, 1996, J NEUROSCI RES, V43, P465; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; Fahlman CS, 2002, BRAIN RES, V958, P43, DOI 10.1016/S0006-8993(02)03433-9; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Groschner K, 1998, FEBS LETT, V437, P101, DOI 10.1016/S0014-5793(98)01212-5; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MINKE B, 1977, BIOPHYS STRUCT MECH, V3, P59, DOI 10.1007/BF00536455; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	49	194	205	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					559	567		10.1038/nn1870	http://dx.doi.org/10.1038/nn1870			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396124				2022-12-24	WOS:000245948000012
J	Park, S; Intraub, H; Yi, DJ; Widders, D; Chun, MM				Park, Soojin; Intraub, Helene; Yi, Do-Joon; Widders, David; Chun, Marvin M.			Beyond the edges of a view: Boundary extension in human scene-selective visual cortex	NEURON			English	Article							ANTICIPATORY SPATIAL REPRESENTATION; NEURAL FATE; MEMORY; MECHANISMS; OBJECTS	To allow perception of a continuous world, cortical mechanisms extrapolate missing information with highly constrained predictions about the environment just beyond the edges of a view. Here, we report functional magnetic resonance imaging evidence for extrapolation of scene layout information beyond what was physically presented, an illusion known as boundary extension. Consistent with behavioral reports, we observed boundary extension for scene-selective attenuation in the parahippocampal place area (PPA) and retrosplenial cortex (RSC), but no such extrapolation of object representations in the lateral occipital complex (LOC). These results demonstrate that scene layout representations are extrapolated beyond the confines of the perceptual input. Such extrapolation may facilitate perception of a continuous world from discontinuous views.	Univ Delaware, Dept Psychol, Newark, DE 19716 USA; Yale Univ, Dept Psychol, New Haven, CT 06520 USA; Yonsei Univ, Dept Psychol, Seoul 120749, South Korea	University of Delaware; Yale University; Yonsei University	Intraub, H (corresponding author), Univ Delaware, Dept Psychol, 108 Wolf Hall, Newark, DE 19716 USA.	intraub@psych.udel.edu; marvin.chun@yale.edu		Chun, Marvin/0000-0003-1070-7993				Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Beck J., 1982, ORG REPRESENTATION P, P167; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Chun MM, 2000, TRENDS COGN SCI, V4, P170, DOI 10.1016/S1364-6613(00)01476-5; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2005, J COGNITIVE NEUROSCI, V17, P73, DOI 10.1162/0898929052879987; EPSTEIN RA, 2006, IN PRESS CEREB CORTE; Gottesman CV, 2002, J EXP PSYCHOL HUMAN, V28, P589, DOI 10.1037//0096-1523.28.3.589; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; HOCHBERG J, 1986, HDB PERCEPTION HUMAN, V1, P1; Hochberg J. E., 1978, PERCEPTION; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Intraub H, 1996, J MEM LANG, V35, P118, DOI 10.1006/jmla.1996.0007; Intraub H, 2004, COGNITION, V94, P19, DOI 10.1016/j.cognition.2003.10.013; Intraub H, 2002, VIS COGN, V9, P93, DOI 10.1080/13506280143000340; Intraub H, 1996, AM J PSYCHOL, V109, P581, DOI 10.2307/1423396; INTRAUB H, 1989, J EXP PSYCHOL LEARN, V15, P179, DOI 10.1037/0278-7393.15.2.179; INTRAUB H, 1992, J EXP PSYCHOL LEARN, V18, P180, DOI 10.1037/0278-7393.18.1.180; Intraub H, 2006, PERCEPT PSYCHOPHYS, V68, P759, DOI 10.3758/BF03193699; Intraub H, 1997, TRENDS COGN SCI, V1, P217, DOI 10.1016/S1364-6613(97)01067-X; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; Mendola JD, 1999, J NEUROSCI, V19, P8560; Meng M, 2005, NAT NEUROSCI, V8, P1248, DOI 10.1038/nn1518; Miller MB, 1998, NEUROPSYCHOLOGIA, V36, P513, DOI 10.1016/S0028-3932(97)00148-6; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Perna A, 2005, NEURON, V47, P645, DOI 10.1016/j.neuron.2005.07.012; RAMACHANDRAN VS, 1992, NATURE, V356, P115, DOI 10.1038/356115a0; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Talairach I., 1988, COPLANAR STEREOTACTI; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Turk-Browne NB, 2006, NEURON, V49, P917, DOI 10.1016/j.neuron.2006.01.030; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Yi DJ, 2005, J NEUROSCI, V25, P3593, DOI 10.1523/JNEUROSCI.4677-04.2005; Yi DJ, 2004, NAT NEUROSCI, V7, P992, DOI 10.1038/nn1294	45	88	88	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					335	342		10.1016/j.neuron.2007.04.006	http://dx.doi.org/10.1016/j.neuron.2007.04.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	163VF	17442252	Bronze			2022-12-24	WOS:000246190600016
J	Lattemann, M; Zierau, A; Schulte, C; Seidl, S; Kuhlmann, B; Hummel, T				Lattemann, Marc; Zierau, Ariane; Schulte, Claus; Seidl, Sascha; Kuhlmann, Britta; Hummel, Thomas			Semaphorin-1a controls receptor neuron-specific axonal convergence in the primary olfactory center of Drosophila	NEURON			English	Article							GROWTH CONE GUIDANCE; ANTENNAL LOBE; ODORANT RECEPTORS; SENSORY MAP; EXPRESSION PATTERNS; WIRING SPECIFICITY; VOMERONASAL AXONS; TARGET SELECTION; TOPOGRAPHIC MAP; MUSHROOM BODIES	In the olfactory system of Drosophila, 50 functional classes of sensory receptor neurons (ORNs) project in a highly organized fashion into the CNS, where they sort out from one another and converge into distinct synaptic glomeruli. We identified the transmembrane molecule Semaphorin-la (Sema-la) as an essential component to ensure glomerulus-specific axon segregation. Removal of sema-la in ORNs does not affect the pathfinding toward their target area but disrupts local axonal convergence into a single glomerulus, resulting in two distinct targeting phenotypes: axons either intermingle with adjacent ORN classes or segregate according to their odorant receptor identity into ectopic sites. Differential Sema-1 a expression can be detected among neighboring glomeruli, and mosaic analyses show that sema-la functions nonautonomously in ORN axon sorting. These findings provide insights into the mechanism by which afferent interactions lead to synaptic specificity in the olfactory system.	Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Hummel, T (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	hummel@uni-muenster.de						Alenius M, 2003, DEVELOPMENT, V130, P917, DOI 10.1242/dev.00317; Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; de Castro F, 1999, J NEUROSCI, V19, P4428; Elmore T, 2003, J NEUROSCI, V23, P9906; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Khare N, 2000, MECH DEVELOP, V91, P393, DOI 10.1016/S0925-4773(99)00297-X; Knoll B, 2003, DEVELOPMENT, V130, P5073, DOI 10.1242/dev.00726; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Legg AT, 2003, J HISTOCHEM CYTOCHEM, V51, P445, DOI 10.1177/002215540305100406; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Schwarting GA, 2004, EUR J NEUROSCI, V19, P1800, DOI 10.1111/j.1460-9568.2004.03304.x; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Sepp KJ, 1999, GENETICS, V151, P1093; St John JA, 2002, INT J DEV BIOL, V46, P639; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; STORTKUHL KF, 1994, CELL TISSUE RES, V275, P27, DOI 10.1007/BF00305373; Tissot M, 1997, J NEUROBIOL, V32, P281, DOI 10.1002/(SICI)1097-4695(199703)32:3<281::AID-NEU3>3.0.CO;2-3; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; XU T, 1993, DEVELOPMENT, V117, P1223; YANG MY, 1995, NEURON, V15, P45; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yu HH, 2000, GENETICS, V156, P723; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	72	43	43	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					169	184		10.1016/j.neuron.2006.12.024	http://dx.doi.org/10.1016/j.neuron.2006.12.024			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224401	Bronze			2022-12-24	WOS:000245126600005
J	Biederlack, J; Castelo-Branco, M; Neuenschwander, S; Wheeler, DW; Singer, W; Nikolic, D				Biederlack, Julia; Castelo-Branco, Miguel; Neuenschwander, Sergio; Wheeler, Diek W.; Singer, Wolf; Nikolic, Danko			Brightness induction: Rate enhancement and neuronal synchronization as complementary codes	NEURON			English	Article							RECEPTIVE-FIELD PROPERTIES; CAT VISUAL-CORTEX; CORTICAL NEURON; OSCILLATORY RESPONSES; LATERAL INHIBITION; APPARENT CONTRAST; CELLS; ORGANIZATION; SUPPRESSION; INTEGRATOR	In cat visual cortex, we investigated with parallel recordings from multiple units the neuronal correlates of perceived brightness. The perceived brightness of a center grating was changed by varying the orientation or the relative spatial phase of a surrounding grating. Brightness enhancement by orientation contrast is associated with an increase of discharge rates of responses to the center grating but not with changes in spike synchronization. In contrast, if brightness enhancement is induced by phase offset, discharge rates are unchanged but synchronization increases between neurons responding to the center grating. The changes in synchronization correlate well with changes in perceived brightness that were assessed in parallel in human subjects using the same stimuli. These results indicate that in cerebral cortex the modulation of synchronicity of responses is used as a mechanism complementary to rate changes to enhance the saliency of neuronal responses.	Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; Miberg Inst Media, D-50677 Cologne, Germany; Ctr Oftalmol, IBILI, Coimbra, Portugal; Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, Frankfurt, Germany	Max Planck Society; Universidade de Coimbra; Goethe University Frankfurt	Nikolic, D (corresponding author), Max Planck Inst Brain Res, Deutschordenstr 46, D-60528 Frankfurt, Germany.	danko@mpih-frankfurt.mpg.de	Singer, Wolf/D-6874-2012; Castelo-Branco, Miguel/E-5689-2010; Castelo-Branco, Miguel/F-3866-2019; Wheeler, Diek/AAZ-8810-2021; Nikolic, Danko/GZG-9635-2022	Castelo-Branco, Miguel/0000-0003-4364-6373; Wheeler, Diek/0000-0001-8635-0033; Nikolic, Danko/0000-0002-9317-8494; NEUENSCHWANDER, Sergio/0000-0001-7493-121X				ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Agostini T, 2002, PSYCHOL SCI, V13, P89, DOI 10.1111/1467-9280.00417; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; EJIMA Y, 1985, VISION RES, V25, P1223, DOI 10.1016/0042-6989(85)90036-7; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Huang X, 2002, J NEUROSCI, V22, P9618; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; KONIG P, 1994, J NEUROSCI METH, V54, P31, DOI 10.1016/0165-0270(94)90157-0; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; SCHILLEN TB, 1994, BIOL CYBERN, V70, P397, DOI 10.1007/BF00203232; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; Sillito AM, 1996, J PHYSIOL-PARIS, V90, P205, DOI 10.1016/S0928-4257(97)81424-6; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOLOMON JA, 1993, VISION RES, V33, P2671, DOI 10.1016/0042-6989(93)90227-N; TANAKA K, 1987, EXP BRAIN RES, V65, P549; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Williams AL, 2003, J NEUROPHYSIOL, V89, P525, DOI 10.1152/jn.00048.2002; Xu WF, 2005, CEREB CORTEX, V15, P1697, DOI 10.1093/cercor/bhi046; Yu C, 2001, J VISION, V1, P18, DOI 10.1167/1.1.3	40	71	70	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1073	1083		10.1016/j.neuron.2006.11.012	http://dx.doi.org/10.1016/j.neuron.2006.11.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178409	Bronze			2022-12-24	WOS:000243115100014
J	Hall, J; Whalley, HC; Job, DE; Baig, BJ; McIntosh, AM; Evans, KL; Thomson, PA; Porteous, DJ; Cunningham-Owens, DG; Johnstone, EC; Lawrie, SM				Hall, Jeremy; Whalley, Heather C.; Job, Dominic E.; Baig, Ben J.; McIntosh, Andrew M.; Evans, Kathryn L.; Thomson, Pippa A.; Porteous, David J.; Cunningham-Owens, David G.; Johnstone, Eve C.; Lawrie, Stephen M.			A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms	NATURE NEUROSCIENCE			English	Article							BIPOLAR DISORDER; ENHANCED RISK; SCHIZOPHRENIA; SUSCEPTIBILITY; METAANALYSIS; POPULATION; GENE	NRG1, encoding neuregulin 1, is a susceptibility gene for schizophrenia, but no functional mutation causally related to the disorder has yet been identified. Here we investigate the effects of a variant in the human NRG1 promoter region in subjects at high risk of schizophrenia. We show that this variant is associated with (i) decreased activation of frontal and temporal lobe regions, (ii) increased development of psychotic symptoms and (iii) decreased premorbid IQ.	Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Hall, J (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Morningside Pk, Edinburgh EH10 5HF, Midlothian, Scotland.	jhall5@staffmail.ed.ac.uk	McIntosh, Andrew M/B-9379-2008; Evans, Kathryn KL/I-5910-2012; Lawrie, Stephen MacGregor/AAD-1607-2021; Baig, Benjamin J/C-6714-2009; Porteous, David/AAA-3446-2021; Whalley, Heather C/N-1886-2019; Porteous, David J/C-7289-2013	McIntosh, Andrew M/0000-0002-0198-4588; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Porteous, David/0000-0003-1249-6106; Whalley, Heather C/0000-0002-4505-8869; Porteous, David J/0000-0003-1249-6106; Evans, Kathryn/0000-0002-7884-5877; Hall, Jeremy/0000-0002-0403-3278; Baig, Benjamin/0000-0003-2766-9014; Job, Dominic/0000-0002-7829-7217	Medical Research Council [G0100266, G0600429] Funding Source: Medline; MRC [G0100266] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; David AS, 1997, PSYCHOL MED, V27, P1311, DOI 10.1017/S0033291797005680; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Green EK, 2005, ARCH GEN PSYCHIAT, V62, P642, DOI 10.1001/archpsyc.62.6.642; Honey GD, 2003, PSYCHOL MED, V33, P1007, DOI 10.1017/S0033291703007864; Johnstone EC, 2000, SCHIZOPHR RES, V46, P1, DOI 10.1016/S0920-9964(99)00225-X; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; LAWRIE SM, 2004, SCHIZOPHRENIA IMAGIN; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Marjoram D, 2006, NEUROIMAGE, V31, P1850, DOI 10.1016/j.neuroimage.2006.02.011; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Whalley HC, 2004, BRAIN, V127, P478, DOI 10.1093/brain/awh070; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480	15	202	204	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1477	1478		10.1038/nn1795	http://dx.doi.org/10.1038/nn1795			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	110TP	17072305				2022-12-24	WOS:000242404000010
J	Varoqueaux, F; Aramuni, G; Rawson, RL; Mohrmann, R; Missler, M; Gottmann, K; Zhang, WQ; Sudhof, TC; Brose, N				Varoqueaux, Frederique; Aramuni, Gayane; Rawson, Randi L.; Mohrmann, Ralf; Missler, Markus; Gottmann, Kurt; Zhang, Weiqi; Suedhof, Thomas C.; Brose, Nils			Neuroligins determine synapse maturation and function	NEURON			English	Article							ALPHA-NEUREXINS; EXCITATORY SYNAPSES; INHIBITORY SYNAPSES; BETA-NEUREXINS; CA2+ CHANNELS; AUTISM; PSD-95; BINDING; PROTEIN; RECEPTORS	Synaptogenesis, the generation and maturation of functional synapses between nerve cells, is an essential step in the development of neuronal networks in the brain. It is thought to be triggered by members of the neuroligin family of postsynaptic cell adhesion proteins, which may form transsynaptic contacts with presynaptic alpha- and beta-neurexins and have been implicated in the etiology of autism. We show that deletion mutant mice lacking neuroligin expression die shortly after birth due to respiratory failure. This respiratory failure is a consequence of reduced GABAergic/glycinergic and glutamatergic synaptic transmission and network activity in brainstem centers that control respiration. However, the density of synaptic contacts is not altered in neuroligin-deficient brains and cultured neurons. Our data show that neuroligins are required for proper synapse maturation and brain function, but not for the initial formation of synaptic contacts.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; Univ Gottingen, Ctr Physiol & Pathophysiol, D-37073 Gottingen, Germany; Univ Gottingen, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany; Ruhr Univ Bochum, Dept Cell Physiol ND4, D-44780 Bochum, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, Dallas, TX 75390 USA; Univ Magdeburg, Dept Genet & Mol Neurobiol, D-39106 Magdeburg, Germany; Univ Dusseldorf, Inst Neurophysiol & Sensory Physiol, D-40225 Dusseldorf, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen; Ruhr University Bochum; Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Otto von Guericke University; Heinrich Heine University Dusseldorf	Sudhof, TC (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	thomas.sudhof@utsouthwestern.edu; brose@em.mpg.de	Varoqueaux, Frederique/AAC-1834-2021	Varoqueaux, Frederique/0000-0002-3614-3121; Rawson, Randi/0000-0002-5409-7077; Missler, Markus/0000-0001-8008-984X	NIMH NIH HHS [MH52804-08] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052804, R37MH052804] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hata Y, 1996, J NEUROSCI, V16, P2488; Herbert MR, 2005, NEUROSCIENTIST, V11, P417, DOI 10.1177/0091270005278866; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mohrmann R, 1999, J NEUROSCI, V19, P10004; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; RITTER B, 2000, ANNU REV NEUROSCI, V26, P485; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	50	567	591	0	66	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					741	754		10.1016/j.neuron.2006.09.003	http://dx.doi.org/10.1016/j.neuron.2006.09.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982420	Bronze			2022-12-24	WOS:000240997900013
J	Cagniard, B; Beeler, JA; Britt, JP; McGehee, DS; Marinelli, M; Zhuang, XX				Cagniard, Barbara; Beeler, Jeff A.; Britt, Jonathan P.; McGehee, Daniel S.; Marinelli, Michela; Zhuang, Xiaoxi			Dopamine scales performance in the absence of new learning	NEURON			English	Article							MICE LACKING; FOOD REWARD; NEURONS; AMPHETAMINE; REINFORCEMENT; HALOPERIDOL; PIMOZIDE; BEHAVIOR; AUTORECEPTORS; INHIBITION	Learning and motivation are integral in shaping an organism's adaptive behavior. The dopamine system has been implicated in both processes; however, dissociating the two, both experimentally and conceptually, has posed significant challenges. We have developed an animal model that dissociates expression or scaling of a learned behavior from learning itself. An inducible dopamine transporter (DAT) knockdown mouse line has been generated, which exhibits significantly slower reuptake of released dopamine and increased tonic firing of dopamine neurons without altering phasic burst firing. Mice were trained in experimental tasks prior to inducing a hyperdopaminergic tone and then retested. Elevated dopamine enhanced performance in goal-directed operant responses. These data demonstrate that alterations in dopaminergic tone can scale the performance of a previously learned behavior in the absence of new learning.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Rosalind Franklin Univ Med & Sci, Dept Mol & Cellular Pharmacol, N Chicago, IL 60064 USA; Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA	University of Chicago; Rosalind Franklin University Medical & Science; University of Chicago	Zhuang, XX (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	xzhuang@bsd.uchicago.edu	Britt, jonathan/D-8877-2011; Marinelli, Michela/P-7645-2018	Britt, jonathan/0000-0003-3044-9565; Marinelli, Michela/0000-0002-1903-1937; Beeler, Jeff/0000-0002-1344-1337	NIDA NIH HHS [DA 015918, T32 DA 07255-13, F32 DA 020427-01] Funding Source: Medline; NIMH NIH HHS [MH 66216] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA020427, R01DA015918, T32DA007255] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BINDRA D, 1974, PSYCHOL REV, V81, P199, DOI 10.1037/h0036330; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Cannon CM, 2003, J NEUROSCI, V23, P10827; Caul WF, 2001, PHARMACOL BIOCHEM BE, V68, P53, DOI 10.1016/S0091-3057(00)00431-7; Choi WY, 2005, J NEUROSCI, V25, P6729, DOI 10.1523/JNEUROSCI.1498-05.2005; COUSINS MS, 1994, PHARMACOL BIOCHEM BE, V49, P85, DOI 10.1016/0091-3057(94)90460-X; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; ETTENBERG A, 1990, PHARMACOL BIOCHEM BE, V37, P465, DOI 10.1016/0091-3057(90)90014-9; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRACE AA, 1984, J NEUROSCI, V4, P2866; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HORVITZ JC, 1988, PHARMACOL BIOCHEM BE, V31, P861, DOI 10.1016/0091-3057(88)90396-6; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; LUCAS JJ, 1995, TRENDS PHARMACOL SCI, V16, P246, DOI 10.1016/S0165-6147(00)89034-3; Marinelli M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P79, DOI 10.2174/187152706784111542; Mathon DS, 2005, EUR J NEUROSCI, V21, P2883, DOI 10.1111/j.1460-9568.2005.04123.x; Mayorga AJ, 2000, BEHAV BRAIN RES, V109, P59, DOI 10.1016/S0166-4328(99)00165-5; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; McFarland K, 1995, PSYCHOPHARMACOLOGY, V122, P346, DOI 10.1007/BF02246264; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P47, DOI 10.1007/s002130000486; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NIV Y, 2005, NIPS, V18, P1019; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WALL SC, 1995, MOL PHARMACOL, V47, P544; WHITE FJ, 1984, LIFE SCI, V34, P1161, DOI 10.1016/0024-3205(84)90088-2; Wiley JL, 2004, PSYCHOPHARMACOLOGY, V177, P170, DOI 10.1007/s00213-004-1936-1; WISE RA, 1978, CAN J PSYCHOL, V32, P77, DOI 10.1037/h0081678; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1981, PHARMACOL BIOCHEM BE, V15, P655, DOI 10.1016/0091-3057(81)90225-2; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	47	92	93	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					541	547		10.1016/j.neuron.2006.07.026	http://dx.doi.org/10.1016/j.neuron.2006.07.026			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950153	Bronze			2022-12-24	WOS:000240623400004
J	Han, J; Mark, MD; Li, X; Xie, M; Waka, S; Rettig, J; Herlitze, S				Han, Jing; Mark, Melanie D.; Li, Xiang; Xie, Mian; Waka, Sayumi; Rettig, Jens; Herlitze, Stefan			RGS2 determines short-term synaptic plasticity in hippocampal neurons by regulating G(i/o)-mediated inhibition of presynaptic Ca2+ channels	NEURON			English	Article							BETA-GAMMA-SUBUNITS; RECTIFYING POTASSIUM CHANNELS; POLYMERASE CHAIN-REACTION; CALCIUM-CHANNELS; TRANSMITTER RELEASE; GABA(B) RECEPTOR; MODULATION; PROTEINS; FACILITATION; ACTIVATION	RGS2, one of the small members of the regulator of G protein signaling (RGS) family, is highly expressed in brain and regulates G(i/o) as well as G(q)-coupled receptor pathways. RGS2 modulates anxiety, aggression, and blood pressure in mice, suggesting that RGS2 regulates synaptic circuits underlying animal physiology and behavior. How RGS2 in brain influences synaptic activity is unknown. We therefore analyzed the synaptic function of RGS2 in hippocampal neurons by comparing electrophysiological recordings from RGS2 knockout and wild-type mice. Our study provides a general mechanism of the action of the RGS family containing RGS2 by demonstrating that RGS2 increases synaptic vesicle release by downregulating the G(i/o)-mediated presynaptic Ca2+ channel inhibition and therefore provides an explanation of how regulation of RGS2 expression can modulate the function of neuronal circuits underlying behavior.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Univ Saarland, Dept Physiol, D-66421 Homburg, Germany	Case Western Reserve University; Saarland University	Herlitze, S (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Room E 604,10900 Euclid Ave, Cleveland, OH 44106 USA.	sxh106@cwru.edu	Mark, Melanie/ABF-9102-2020; Rettig, Jens/K-5103-2013	Mark, Melanie/0000-0002-2788-6003; Rettig, Jens/0000-0001-6160-3954	NINDS NIH HHS [NS 42523, NS 044775 2] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Burchett SA, 2005, NEUROMOL MED, V7, P101, DOI 10.1385/NMM:7:1-2:101; Burchett SA, 1998, J NEUROCHEM, V70, P2216; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HERLITZE S, 1990, GENE, V91, P143, DOI 10.1016/0378-1119(90)90177-S; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herlitze X, 1999, J PHYSIOL-LONDON, V517, P341, DOI 10.1111/j.1469-7793.1999.0341t.x; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ingi T, 1998, J NEUROSCI, V18, P7178; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mark MD, 2000, J PHYSIOL-LONDON, V528, P65, DOI 10.1111/j.1469-7793.2000.00065.x; Mark MD, 2000, NEUROPHARMACOLOGY, V39, P2360, DOI 10.1016/S0028-3908(00)00080-0; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Mosbacher J, 1998, FEBS LETT, V436, P104, DOI 10.1016/S0014-5793(98)01066-7; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Saugstad JA, 1996, J NEUROSCI, V16, P5979; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stevens CF, 2004, CURR OPIN NEUROBIOL, V14, P341, DOI 10.1016/j.conb.2004.04.004; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Wang XH, 2004, J BIOL CHEM, V279, P133, DOI 10.1074/jbc.M310040200; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Young SM, 2005, P NATL ACAD SCI USA, V102, P2614, DOI 10.1073/pnas.0409656102; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; Zerangue N, 1998, CURR BIOL, V8, pR313, DOI 10.1016/S0960-9822(98)70196-4; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	54	60	63	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					575	586		10.1016/j.neuron.2006.07.012	http://dx.doi.org/10.1016/j.neuron.2006.07.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950156	Bronze			2022-12-24	WOS:000240623400007
J	Tomioka, M; Adachi, T; Suzuki, H; Kunitomo, H; Schafer, WR; Iino, Y				Tomioka, Masahiro; Adachi, Takeshi; Suzuki, Hiroshi; Kunitomo, Hirofumi; Schafer, William R.; Iino, Yuichi			The insulin/PI 3-kinase pathway regulates salt chemotaxis learning in Caenorhabditis elegans	NEURON			English	Article							C-ELEGANS; SYNAPTIC-TRANSMISSION; OLFACTORY ADAPTATION; SIGNALING PATHWAY; LIFE-SPAN; RECEPTOR; NEURONS; PLASTICITY; PROTEIN; DAF-2	The insulin-like signaling pathway is known to regulate fat metabolism, dauer formation, and longevity in Caenorhabditis elegans. Here, we report that this pathway is also involved in salt chemotaxis learning, in which animals previously exposed to a chemoattractive salt under starvation conditions start to show salt avoidance behavior. Mutants of ins-1, daf-2, age-1, pdk-1, and akt-1, which encode the homologs of insulin, insulin/IGF-I receptor, PI 3-kinase, phosphoinositide-dependent kinase, and Akt/PKB, respectively, show severe defects in salt chemotaxis learning. daf-2 and age-1 act in the ASER salt-sensing neuron, and the activity level of the DAF-2/AGE-1 pathway in this neuron determines the extent and orientation of salt chemotaxis. On the other hand, ins-1 acts in AIA interneurons, which receive direct synaptic inputs from sensory neurons and also send synaptic outputs to ASER. These results suggest that INS-1 secreted from AIA interneurons provides feedback to ASER to generate plasticity of chemotaxis.	Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Tokyo; University of Tokyo; University of California System; University of California San Diego	Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iino@gen.s.u-tokyo.ac.jp	IINO, YUICHI/G-4962-2014; TOMIOKA, MASAHIRO/G-4890-2014; KUNITOMO, HIROFUMI/G-4963-2014	TOMIOKA, MASAHIRO/0000-0002-7537-714X; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Schafer, William/0000-0002-6676-8034	MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Bargmann C. I., 1997, C ELEGANS, P717; BRENNER S, 1974, GENETICS, V77, P71; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; DEVASKAR SU, 1994, J BIOL CHEM, V269, P8445; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; Hawasli AH, 2004, GENETICS, V168, P831, DOI 10.1534/genetics.104.030502; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Hobert O, 2003, J NEUROBIOL, V54, P203, DOI 10.1002/neu.10168; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; KABA H, 1994, SCIENCE, V265, P262, DOI 10.1126/science.8023145; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Miller AC, 2005, J NEUROSCI, V25, P3369, DOI 10.1523/JNEUROSCI.5133-04.2005; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nonet ML, 1998, J NEUROSCI, V18, P70; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Riddle DL, 1997, C ELEGANS, P739; Saeki S, 2001, J EXP BIOL, V204, P1757; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Vigh J, 2005, NEURON, V46, P469, DOI 10.1016/j.neuron.2005.03.027; WEI L, 1990, J NEUROCHEM, V54, P1661, DOI 10.1111/j.1471-4159.1990.tb01219.x; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	57	202	231	2	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					613	625		10.1016/j.neuron.2006.07.024	http://dx.doi.org/10.1016/j.neuron.2006.07.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950159	Bronze			2022-12-24	WOS:000240623400010
J	Hojjati, MR; van Woerden, GM; Tyler, WJ; Giese, KP; Silva, AJ; Pozzo-Miller, L; Elgersma, Y				Hojjati, Mohammad Reza; van Woerden, Geeske M.; Tyler, William J.; Giese, Karl Peter; Silva, Alcino J.; Pozzo-Miller, Lucas; Elgersma, Ype			Kinase activity is not required for alpha CaMKII-dependent presynaptic plasticity at CA3-CA1 synapses	NATURE NEUROSCIENCE			English	Review							PROTEIN-KINASE; NEUROTRANSMITTER RELEASE; INHIBITOR	Using targeted mouse mutants and pharmacologic inhibition of alpha CaMKII, we demonstrate that the aCaMKII protein, but not its activation, autophosphorylation or its ability to phosphorylate synapsin I, is required for normal short-term presynaptic plasticity. Furthermore, aCaMKII regulates the number of docked vesicles independent of its ability to be activated. These results indicate that aCaMKII has a nonenzymatic role in short-term presynaptic plasticity at hippocampal CA3-CA1 synapses.	Erasmus Univ, Med Ctr, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands; Shahrekord Univ Med Sci, Dept Physiol, Shahrekord 88155, Iran; Univ Alabama Birmingham, Civitan Int Res Ctr, Mcknight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA; Kings Coll London, Inst Psychiat, London SE5 9NU, England; Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat & Psychol, Los Angeles, CA 90095 USA	Erasmus University Rotterdam; Erasmus MC; Shahrekord University Medical Sciences; University of Alabama System; University of Alabama Birmingham; University of London; King's College London; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Elgersma, Y (corresponding author), Erasmus Univ, Med Ctr, Dept Neurosci, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	y.elgersma@erasmusmc.nl	Tyler, William/J-1818-2012; Hojjati, Mohammad reza/B-9941-2013; Elgersma, Ype/F-5164-2013; Giese, Karl P/A-3112-2011; Silva, Alcino/ABD-7684-2021	Hojjati, Mohammad reza/0000-0001-7889-2545; Elgersma, Ype/0000-0002-3758-1297; Giese, Karl P/0000-0003-4503-7344; Silva, Alcino/0000-0002-1587-4558; Pozzo-Miller, Lucas/0000-0001-6085-5527; Tyler, William/0000-0002-7758-5022; Silva, Alcino/0000-0001-5525-0494	MRC [G0400983] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, R01NS040593, P30NS057098] Funding Source: NIH RePORTER; Medical Research Council [G0400983] Funding Source: Medline; NICHD NIH HHS [P30 HD038985, P30-HD38985] Funding Source: Medline; NINDS NIH HHS [P30-NS47466, P30 NS047466, P30-NS57098, P30 NS057098, R01 NS040593, R01 NS040593-09] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	15	34	35	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1125	1127		10.1038/nn1946	http://dx.doi.org/10.1038/nn1946			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660813	Green Accepted			2022-12-24	WOS:000249144000011
J	Wang, X; Wei, YC; Vaingankar, V; Wang, QB; Koepsell, K; Sommer, FT; Hirsch, JA				Wang, Xin; Wei, Yichun; Vaingankar, Vishal; Wang, Qingbo; Koepsell, Kilian; Sommer, Friedrich T.; Hirsch, Judith A.			Feedforward excitation and inhibition evoke dual modes of firing in the cat's visual thalamus during naturalistic viewing	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; RETINAL GANGLION-CELLS; ELECTROPHYSIOLOGICAL PROPERTIES; CORTICOFUGAL FEEDBACK; RELAY NEURONS; SPIKE TRAINS; LGN BURSTS; INFORMATION; CORTEX	Thalamic relay cells transmit information from retina to cortex by firing either rapid bursts or tonic trains of spikes. Bursts occur when the membrane voltage is low, as during sleep, because they depend on channels that cannot respond to excitatory input unless they are primed by strong hyperpolarization. Cells fire tonically when depolarized, as during waking. Thus, mode of firing is usually associated with behavioral state. Growing evidence, however, suggests that sensory processing involves both burst and tonic spikes. To ask if visually evoked synaptic responses induce each type of firing, we recorded intracellular responses to natural movies from relay cells and developed methods to map the receptive fields of the excitation and inhibition that the images evoked. In addition to tonic spikes, the movies routinely elicited lasting inhibition from the center of the receptive field that permitted bursts to fire. Therefore, naturally evoked patterns of synaptic input engage dual modes of firing.	Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA	University of Southern California; University of Southern California; University of California System; University of California Berkeley	Hirsch, JA (corresponding author), Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA.	jhirsch@usc.edu	Hirsch, Judith/E-9006-2013		NATIONAL EYE INSTITUTE [R29EY009593, R01EY009593] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY009593-15, EY09593, R01 EY009593] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alitto HJ, 2005, J NEUROSCI, V25, P514, DOI 10.1523/JNEUROSCI.3369-04.2005; Blitz DM, 2003, J NEUROPHYSIOL, V90, P2438, DOI 10.1152/jn.00562.2003; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; CRUNELLI V, 1988, J PHYSIOL-LONDON, V399, P153; Cudeiro J, 1996, J PHYSIOL-LONDON, V490, P481, DOI 10.1113/jphysiol.1996.sp021159; Dan Y, 1996, J NEUROSCI, V16, P3351; Denning KS, 2005, J NEUROSCI, V25, P3531, DOI 10.1523/JNEUROSCI.4417-04.2005; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; DUBIN MW, 1977, J NEUROPHYSIOL, V40, P410, DOI 10.1152/jn.1977.40.2.410; FOURMENT A, 1984, NEUROSCIENCE, V12, P453, DOI 10.1016/0306-4522(84)90065-4; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; Granseth B, 2003, J NEUROPHYSIOL, V89, P2952, DOI 10.1152/jn.01160.2002; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199, DOI 10.1152/jn.1992.68.6.2199; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUMPHREY AL, 1988, J COMP NEUROL, V268, P448, DOI 10.1002/cne.902680312; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Lee SC, 2003, J NEUROPHYSIOL, V90, P3888, DOI 10.1152/jn.00477.2003; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; Liu RC, 2001, J NEUROPHYSIOL, V86, P2789, DOI 10.1152/jn.2001.86.6.2789; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MCILWAIN JT, 1967, J NEUROPHYSIOL, V30, P1; PEICHL L, 1983, J PHYSIOL-LONDON, V341, P309, DOI 10.1113/jphysiol.1983.sp014807; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SHERMAN SM, 1988, EXP BRAIN RES, V73, P384; SHOU T, 1986, EXP BRAIN RES, V64, P233; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; Sincich LC, 2007, J NEUROSCI, V27, P2683, DOI 10.1523/JNEUROSCI.5077-06.2007; SINGER W, 1970, EXP BRAIN RES, V10, P311; SOLTESZ I, 1989, BRAIN RES, V479, P49, DOI 10.1016/0006-8993(89)91334-6; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; SWADLOW HA, 1991, J NEUROSCI, V65, P1528; UHLRICH DJ, 1991, J NEUROPHYSIOL, V65, P1528, DOI 10.1152/jn.1991.65.6.1528; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; WIESEL TN, 1959, NATURE, V183, P264, DOI 10.1038/183264a0; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591; Worgotter F, 1998, J PHYSIOL-LONDON, V509, P797, DOI 10.1111/j.1469-7793.1998.797bm.x	54	87	89	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					465	478		10.1016/j.neuron.2007.06.039	http://dx.doi.org/10.1016/j.neuron.2007.06.039			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678858	Green Accepted, Bronze			2022-12-24	WOS:000248711000013
J	Agarwal, N; Pacher, P; Tegeder, I; Amaya, F; Constantin, CE; Brenner, GJ; Rubino, T; Michalski, CW; Marsicano, G; Monory, K; Mackie, K; Marian, C; Batkai, S; Parolaro, D; Fischer, MJ; Reeh, P; Kunos, G; Kress, M; Lutz, B; Woolf, CJ; Kuner, R				Agarwal, Nitin; Pacher, Pal; Tegeder, Irmgard; Amaya, Fumimasa; Constantin, Cristina E.; Brenner, Gary J.; Rubino, Tiziana; Michalski, Christoph W.; Marsicano, Giovanni; Monory, Krisztina; Mackie, Ken; Marian, Claudiu; Batkai, Sandor; Parolaro, Daniela; Fischer, Michael J.; Reeh, Peter; Kunos, George; Kress, Michaela; Lutz, Beat; Woolf, Clifford J.; Kuner, Rohini			Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	NATURE NEUROSCIENCE			English	Article							IN-SITU HYBRIDIZATION; DORSAL-ROOT GANGLIA; NEUROPATHIC PAIN; ENDOGENOUS CANNABINOIDS; SPINAL NEURONS; KNOCKOUT MICE; WIN 55,212-2; RATS; CB1; HYPERALGESIA	Although endocannabinoids constitute one of the first lines of defense against pain, the anatomical locus and the precise receptor mechanisms underlying cannabinergic modulation of pain are uncertain. Clinical exploitation of the system is severely hindered by the cognitive deficits, memory impairment, motor disturbances and psychotropic effects resulting from the central actions of cannabinoids. We deleted the type 1 cannabinoid receptor (CB1) specifically in nociceptive neurons localized in the peripheral nervous system of mice, preserving its expression in the CNS, and analyzed these genetically modified mice in preclinical models of inflammatory and neuropathic pain. The nociceptor-specific loss of CB1 substantially reduced the analgesia produced by local and systemic, but not intrathecal, delivery of cannabinoids. We conclude that the contribution of CB1-type receptors expressed on the peripheral terminals of nociceptors to cannabinoid-induced analgesia is paramount, which should enable the development of peripherally acting CB1 analgesic agonists without any central side effects.	Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; NIH, NIAAA, Lab Physiol Studies, Bethesda, MD 20892 USA; Univ Frankfurt Klinikum, D-60590 Frankfurt, Germany; Massachusetts Gen Hosp, Harvard Med Sch, Dept Anesthesia & Crit Care, Charlestown, MA 02129 USA; Med Univ Innsbruck, Dept Physiol & Med Phys, Div Physiol, A-6020 Innsbruck, Austria; Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Harvard University; Massachusetts General Hospital; Medical University of Innsbruck; Johannes Gutenberg University of Mainz; University of Washington; University of Washington Seattle; University of Erlangen Nuremberg	Kuner, R (corresponding author), Univ Heidelberg, Inst Pharmacol, Im Neuenheimer Feld, D-69120 Heidelberg, Germany.	rohini.kuner@pharma.uni-heidelberg.de	Rubino, Tiziana/AAC-8210-2020; Woolf, Clifford/A-9784-2010; Batkai, Sandor/G-3889-2010; Lutz, Beat/AFK-6229-2022; Mackie, Kenneth P/B-7358-2011; Kuner, Rohini/AGU-0204-2022; Mackie, Ken/E-3715-2013; Lutz, Beat/AAG-4538-2022; Tegeder, Irmgard/AAM-2246-2020; Brenner, Gary/AAI-1293-2019; Michalski, Christoph/U-9167-2019; Pacher, Pal/B-6378-2008; Marsicano, Giovanni/I-9603-2016; amaya, fumimasa/AAD-7176-2020; Tegeder, Irmgard/AAM-2266-2020; Reeh, Peter W./J-8981-2012; Batkai, Sandor/H-7983-2014; Fischer, Michael/F-7976-2010; Fischer, Michael J.M./P-8715-2014	Mackie, Ken/0000-0001-8501-6199; Tegeder, Irmgard/0000-0001-7524-8025; Brenner, Gary/0000-0002-4586-1723; Pacher, Pal/0000-0001-7036-8108; Tegeder, Irmgard/0000-0001-7524-8025; Reeh, Peter W./0000-0002-4367-094X; RUBINO, Tiziana/0000-0002-3128-6377; amaya, fumimasa/0000-0003-2934-0845; Kress, Michaela/0000-0002-8921-7470; Marsicano, Giovanni/0000-0003-3804-1951; Fischer, Michael J.M./0000-0002-3811-7066	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS039518, R01NS038253, R01NS039518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000350, Z01AA000375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000286, R01DA011322] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AA000375-02] Funding Source: Medline; NIDA NIH HHS [K02 DA000286, DA11322, K02 DA000286-04, R01 DA011322, DA00286, R01 DA011322-02] Funding Source: Medline; NINDS NIH HHS [NS039518, R01 NS038253-01S1, R01 NS038253, R37 NS039518, R01 NS039518, NS 038253, R01 NS039518-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Azad SC, 2004, J NEUROSCI, V24, P9953, DOI 10.1523/JNEUROSCI.2134-04.2004; Binzen U, 2006, NEUROSCIENCE, V142, P527, DOI 10.1016/j.neuroscience.2006.06.020; Bridges D, 2003, NEUROSCIENCE, V119, P803, DOI 10.1016/S0306-4522(03)00200-8; Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Coutts AA, 2002, J COMP NEUROL, V448, P410, DOI 10.1002/cne.10270; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dogrul A, 2003, PAIN, V105, P11, DOI 10.1016/S0304-3959(03)00068-X; Finn DP, 2003, NEUROPHARMACOLOGY, V45, P594, DOI 10.1016/S0028-3908(03)00235-1; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Ibrahim MM, 2006, PAIN, V122, P36, DOI 10.1016/j.pain.2005.12.018; Janson W., 2003, Current Pharmaceutical Biotechnology, V4, P270, DOI 10.2174/1389201033489766; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Johanek LM, 2001, PAIN, V93, P303, DOI 10.1016/S0304-3959(01)00336-0; Kolesnikov YA, 1996, J PHARMACOL EXP THER, V279, P502; Kress M, 1999, J NEUROPHYSIOL, V81, P2612, DOI 10.1152/jn.1999.81.6.2612; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MARTIN WJ, 1993, BRAIN RES, V629, P300, DOI 10.1016/0006-8993(93)91334-O; Martin WJ, 1999, PAIN, V82, P199, DOI 10.1016/S0304-3959(99)00045-7; Meng ID, 1998, NATURE, V395, P381, DOI 10.1038/26481; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pascual D, 2005, PAIN, V118, P23, DOI 10.1016/j.pain.2005.07.008; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; PERTWEE RG, 1972, BRIT J PHARMACOL, V46, P753, DOI 10.1111/j.1476-5381.1972.tb06900.x; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Quartilho A, 2003, ANESTHESIOLOGY, V99, P955, DOI 10.1097/00000542-200310000-00031; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Rubino T, 2000, J NEUROCHEM, V75, P2080, DOI 10.1046/j.1471-4159.2000.0752080.x; SHIRE D, 1995, J BIOL CHEM, V270, P3726, DOI 10.1074/jbc.270.8.3726; Sokal DM, 2003, NEUROPHARMACOLOGY, V45, P404, DOI 10.1016/S0028-3908(03)00195-3; TSAY DG, 1987, INVEST RADIOL, V22, P556, DOI 10.1097/00004424-198707000-00005; Ulugol A, 2004, NEUROSCI LETT, V371, P167, DOI 10.1016/j.neulet.2004.08.061; Valiveti S, 2004, PHARM RES-DORDR, V21, P1137, DOI 10.1023/B:PHAM.0000032999.31948.2e; Walker JM, 2005, HANDB EXP PHARMACOL, V168, P509; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	46	421	440	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					870	879		10.1038/nn1916	http://dx.doi.org/10.1038/nn1916			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558404	Green Accepted			2022-12-24	WOS:000247560200017
J	Newman-Norlund, RD; van Schie, HT; van Zuijlen, AMJ; Bekkering, H				Newman-Norlund, Roger D.; van Schie, Hein T.; van Zuijlen, Alexander M. J.; Bekkering, Harold			The mirror neuron system is more active during complementary compared with imitative action	NATURE NEUROSCIENCE			English	Editorial Material							MOTOR	We assessed the role of the human mirror neuron system (MNS) in complementary actions using functional magnetic resonance imaging while participants prepared to execute imitative or complementary actions. The BOLD signal in the right inferior frontal gyrus and bilateral inferior parietal lobes was greater during preparation of complementary than during imitative actions, suggesting that the MNS may be essential in dynamically coupling action observation to action execution.	Radboud Univ Nijmegen, Nijmegen Inst Cognit Res & Informat, NL-6500 HE Nijmegen, Netherlands; Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Newman-Norlund, RD (corresponding author), Radboud Univ Nijmegen, Nijmegen Inst Cognit Res & Informat, PO Box 9104, NL-6500 HE Nijmegen, Netherlands.	rogern@nici.ru.nl	Bekkering, Harold/A-6357-2009; van Schie, Hein T/D-2281-2010; Galantucci, Bruno/E-5770-2010					Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Schutz-Bosbach S, 2006, CURR BIOL, V16, P1830, DOI 10.1016/j.cub.2006.07.048	13	251	254	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					817	818		10.1038/nn1911	http://dx.doi.org/10.1038/nn1911			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529986				2022-12-24	WOS:000247560200010
J	Cheng, LE; Reed, RR				Cheng, Li E.; Reed, Randall R.			Zfp423/OAZ participates in a developmental switch during olfactory neurogenesis	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; RECEPTOR GENE CHOICE; ZINC-FINGER PROTEIN; CELL-DIFFERENTIATION; PROGENITOR CELLS; SENSORY NEURONS; EXPRESSION; PROLIFERATION; PROJECTIONS; DNA	The coordination of gene expression is critical for cell differentiation and the subsequent establishment of tissue function. We show here that a multiple zinc finger transcription factor, Zfp423/OAZ, is transiently expressed in newly differentiating olfactory-receptor neurons (ORNs) and has a key role in coordinating the expression of immature and mature stage-specific genes. OAZ deletion in mice impairs aspects of ORN differentiation, particularly the patterns of axonal projection to the olfactory bulb. OAZ gain-of-function experiments show that sustained OAZ expression throughout ORN maturation arrests ORN development at an immature stage and alters OR gene expression. Importantly, reintroducing OAZ expression in mature ORNs suppresses mature marker expression and reactivates immature-specific markers. Together, these experiments suggest that OAZ participates in a developmental switch regulating the transition from differentiation to maturation in ORNs.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Reed, RR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.	rreed@jhmi.edu			NIDCD NIH HHS [R01 DC008295, R01 DC008295-02] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008295] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Baker H, 1999, J NEUROSCI, V19, P9313; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Calof AL, 2002, MICROSC RES TECHNIQ, V58, P176, DOI 10.1002/jemt.10147; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Cau E, 2002, DEVELOPMENT, V129, P1871; CHENG LE, IN PRESS DEV BIOL; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Garel S, 1999, DEVELOPMENT, V126, P5285; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hentges KE, 2005, ONCOGENE, V24, P1220, DOI 10.1038/sj.onc.1208243; Hirata T, 2006, DEVELOPMENT, V133, P1433, DOI 10.1242/dev.02329; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kawauchi S, 2005, DEVELOPMENT, V132, P5211, DOI 10.1242/dev.02143; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; Ku MC, 2006, J BIOL CHEM, V281, P5277, DOI 10.1074/jbc.M510004200; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lewcock JW, 2003, SCIENCE, V302, P2078, DOI 10.1126/science.1093397; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nicolay DJ, 2006, CELL MOL NEUROBIOL, V26, P803, DOI 10.1007/s10571-006-9058-4; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shim S, 2002, NUCLEIC ACIDS RES, V30, P3107, DOI 10.1093/nar/gkf437; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Shou JY, 2000, DEVELOPMENT, V127, P5403; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsai RYL, 1997, J NEUROSCI, V17, P4159; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VERHAAGEN J, 1990, EUR J NEUROSCI, V2, P397, DOI 10.1111/j.1460-9568.1990.tb00432.x; WANG MM, 1993, MOL CELL BIOL, V13, P5805, DOI 10.1128/MCB.13.9.5805; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; Wang SS, 2004, DEVELOPMENT, V131, P1377, DOI 10.1242/dev.01009; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Zhang DM, 1998, J NEUROSCI, V18, P3314; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	46	49	52	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 24	2007	54	4					547	557		10.1016/j.neuron.2007.04.029	http://dx.doi.org/10.1016/j.neuron.2007.04.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521568	Green Accepted, Bronze			2022-12-24	WOS:000246970800010
J	Semenova, MM; Maki-Hokkonen, AMJ; Cao, J; Komarovski, V; Forsberg, KM; Koistinaho, M; Coffey, ET; Courtney, MJ				Semenova, Maria M.; Maki-Hokkonen, Anu M. J.; Cao, Jiong; Komarovski, Vladislav; Forsberg, K. Marjut; Koistinaho, Milla; Coffey, Eleanor T.; Courtney, Michael J.			Rho mediates calcium-dependent activation of p38 alpha and subsequent excitotoxic cell death	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE NEURONS; N-TERMINAL KINASE; BOTULINUM C3 EXOENZYME; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE; SERINE/THREONINE KINASE; CORTICAL CULTURES; CEREBRAL-ISCHEMIA; AXON REGENERATION; FAMILY GTPASES	Excitotoxic neuronal death contributes to many neurological disorders, and involves calcium influx and stress-activated protein kinases (SAPKs) such as p38 alpha. There is indirect evidence that the small Rho-family GTPases Rac and cdc42 are involved in neuronal death subsequent to the withdrawal of nerve growth factor (NGF), whereas Rho is involved in the inhibition of neurite regeneration and the release of the amyloidogenic A beta(42) peptide. Here we show that Rho is activated in rat neurons by conditions that elevate intracellular calcium and in the mouse cerebral cortex during ischemia. Rho is required for the rapid glutamate-induced activation of p38a and ensuing neuronal death. The ability of RhoA to activate p38 alpha was not expected, and it was specific to primary neuronal cultures. The expression of active RhoA alone not only activated p38 alpha but also induced neuronal death that was sensitive to the anti-apoptotic protein Bcl-2, showing that RhoA was sufficient to induce the excitotoxic pathway. Therefore, Rho is an essential component of the excitotoxic cell death pathway.	Univ Kuopio, AI Virtanen Inst, Dept Neurobiol, FIN-70211 Kuopio, Finland; Medeia Therapeut Ltd, FI-40211 Kuopio, Finland; Abo Akad Univ, Turku Ctr Biotechnol, FIN-20521 Turku, Finland; Univ Turku, FIN-20521 Turku, Finland	University of Eastern Finland; Abo Akademi University; University of Turku	Courtney, MJ (corresponding author), Univ Kuopio, AI Virtanen Inst, Dept Neurobiol, FIN-70211 Kuopio, Finland.	courtney@messi.uku.fi	Courtney, Michael J/D-6648-2016	Courtney, Michael J/0000-0001-8693-3933; Coffey, Eleanor/0000-0002-9717-5610				Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Bazenet CE, 1998, P NATL ACAD SCI USA, V95, P3984, DOI 10.1073/pnas.95.7.3984; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Cao J, 2004, J BIOL CHEM, V279, P35903, DOI 10.1074/jbc.M402353200; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; COURTNEY MJ, 1990, J NEUROSCI, V10, P3873, DOI 10.1523/JNEUROSCI.10-12-03873.1990; Courtney MJ, 1997, J NEUROSCI, V17, P4201; CSERNANSKY CA, 1994, J NEUROSCI RES, V38, P101, DOI 10.1002/jnr.490380113; Dawson VL, 1996, J NEUROSCI, V16, P2479; Didenko VV, 2002, MOL MED, V8, P347, DOI 10.1007/BF03402015; Fukuda T, 1999, NEUROSCI RES, V33, P49, DOI 10.1016/S0168-0102(98)00111-4; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Genth H, 2003, J BIOL CHEM, V278, P28523, DOI 10.1074/jbc.M301915200; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jeon S, 2002, J BIOL CHEM, V277, P16576, DOI 10.1074/jbc.M110380200; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Legos JJ, 2001, BRAIN RES, V892, P70, DOI 10.1016/S0006-8993(00)03228-5; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Lobner D, 1996, NEUROSCIENCE, V72, P335, DOI 10.1016/0306-4522(95)00561-7; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Palmer GC, 2000, AMINO ACIDS, V19, P151, DOI 10.1007/s007260070043; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Sohn S, 1998, NEUROSCI LETT, V240, P147, DOI 10.1016/S0304-3940(97)00936-1; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Wilde C, 2000, J BIOL CHEM, V275, P16478, DOI 10.1074/jbc.M910362199; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154; Zong H, 1999, J BIOL CHEM, V274, P4551, DOI 10.1074/jbc.274.8.4551	50	100	104	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					436	443		10.1038/nn1869	http://dx.doi.org/10.1038/nn1869			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17369826				2022-12-24	WOS:000245228600014
J	Philpot, BD; Cho, KKA; Bear, MF				Philpot, Benjamin D.; Cho, Kathleen K. A.; Bear, Mark F.			Obligatory role of NR2A for metaplasticity in visual cortex	NEURON			English	Article							LONG-TERM-POTENTIATION; D-ASPARTATE RECEPTORS; SYNAPTIC NMDA RECEPTORS; SUBUNIT COMPOSITION; CRITICAL PERIOD; THALAMOCORTICAL SYNAPSES; FUNCTIONAL-PROPERTIES; DEPENDENT REGULATION; HIPPOCAMPAL LTP; EXON 5	Light deprivation lowers the threshold for long-term depression (LTD) and long-term potentiation (LTP) in visual cortex by a process termed metaplasticity, but the mechanism is unknown. The decreased LTD/P threshold correlates with a decrease in the ratio of NR2A to NR2B subunits of cortical NMDA receptors (NMDARs) and a slowing of NMDAR-mediated excitatory postsynaptic currents (EPSCs). However, whether and how changes in NR2 subunit expression contribute to LTD and LTP have been controversial. In the present study, we used an NR2A knockout (KO) mouse to examine the role of this subunit in the experience-dependent modulation of NMDAR properties, LTD, and LTP. We found that deletion of NR2A abrogates the effects of visual experience on NMDAR EPSCs and prevents metaplasticity of LTP and LTD. These data support the hypothesis that experience-dependent changes in NR2A/B are functionally significant and yield a mechanism for an adjustable synaptic modification threshold in visual cortex.	MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ N Carolina, Ctr Neurosci, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bear, MF (corresponding author), MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, 77 Massachusetts Ave,46-3301, Cambridge, MA 02139 USA.	mbear@mit.edu	Cho, Kathleen/AAX-2327-2020	Cho, Kathleen/0000-0003-0215-8779; Bear, Mark/0000-0002-9903-2541	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY012309] Funding Source: Medline; NIMH NIH HHS [P50 MH058880] Funding Source: Medline; NINDS NIH HHS [P01 NS039321] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; CZEPITA D, 1994, J NEUROPHYSIOL, V72, P1220, DOI 10.1152/jn.1994.72.3.1220; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Flint AC, 1997, J NEUROSCI, V17, P2469; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; FOX K, 1992, J NEUROSCI, V12, P2672; Fu ZY, 2005, J PHYSIOL-LONDON, V563, P867, DOI 10.1113/jphysiol.2004.079467; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Morikawa E, 1998, J NEUROSCI, V18, P9727; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Prybylowski K, 2000, J NEUROCHEM, V75, P1140, DOI 10.1046/j.1471-4159.2000.0751140.x; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rumbaugh G, 2000, J NEUROPHYSIOL, V83, P1300, DOI 10.1152/jn.2000.83.3.1300; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2002, MOL PHARMACOL, V61, P595, DOI 10.1124/mol.61.3.595; WATANABE M, 1993, ANN NY ACAD SCI, V707, P463, DOI 10.1111/j.1749-6632.1993.tb38099.x; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	60	145	153	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					495	502		10.1016/j.neuron.2007.01.027	http://dx.doi.org/10.1016/j.neuron.2007.01.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296552	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000245126900009
J	Kadosh, RC; Kadosh, KC; Kaas, A; Henik, A; Goebel, R				Kadosh, Roi Cohen; Kadosh, Kathrin Cohen; Kaas, Amanda; Henik, Avishai; Goebel, Rainer			Notation-dependent and -independent representations of numbers in the parietal lobes	NEURON			English	Article							RESPONSE-SELECTION; ADAPTATION; MECHANISMS; BRAIN; DEGENERACY; ACTIVATION; GENERALITY; NUMEROSITY; REPETITION; MAGNITUDE	It is a commonly held view that numbers are represented in an abstract way in both parietal lobes. This view is based on failures to find differences between various notational representations. Here we show that by using relatively smaller voxels together with an adaptation paradigm and analyzing subjects on an individual basis it is possible to detect specialized numerical representations. The current results reveal a left/right asymmetry in parietal lobe function. In contrast to an abstract representation in the left parietal lobe, the numerical representation in the right parietal lobe is notation dependent and thus includes nonabstract representations. Our results challenge the commonly held belief that numbers are represented solely in an abstract way in the human brain.	Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Birkbeck Coll, Sch Psychol, Ctr Brain & Cognit Dev, London, England; Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; Max Planck Inst Brain Res, Dept Neurophysiol, Frankfurt, Germany	Ben Gurion University; Ben Gurion University; University of London; Birkbeck University London; Maastricht University; Max Planck Society	Kadosh, RC (corresponding author), Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel.	r.cohenkadosh@ucl.ac.uk	HENIK, AVISHAI/F-1176-2012; Kaas, Amanda/K-8565-2012; Cohen Kadosh, Roi/F-7346-2012	Kaas, Amanda/0000-0002-2847-8167; Cohen Kadosh, Roi/0000-0002-5564-5469; Henik, Avishai/0000-0002-5665-6004; Goebel, Rainer/0000-0003-1780-2467				Ansari D, 2006, BRAIN RES, V1067, P181, DOI 10.1016/j.brainres.2005.10.083; Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Bledowski C, 2006, J NEUROSCI, V26, P821, DOI 10.1523/JNEUROSCI.3542-05.2006; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; CAMPBELL JID, 1994, COGNITION, V53, P1, DOI 10.1016/0010-0277(94)90075-2; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1992, COGNITION, V43, P1, DOI 10.1016/0010-0277(92)90030-L; DEHAENE S, 1995, J EXP PSYCHOL LEARN, V21, P314, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Gobel SM, 2004, J COGNITIVE NEUROSCI, V16, P1536, DOI 10.1162/0898929042568442; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2006, NEURON, V49, P170, DOI 10.1016/j.neuron.2006.01.004; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; KADOSH RC, 2007, IN PRESS J COGN NEUR; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Lemer C, 2003, NEUROPSYCHOLOGIA, V41, P1942, DOI 10.1016/S0028-3932(03)00123-4; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Price CJ, 2005, COGN NEUROPSYCHOL, V22, P262, DOI 10.1080/02643290442000095; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028; Schwarz W, 2000, J EXP PSYCHOL HUMAN, V26, P1606, DOI 10.1037//0096-1523.26.5.1606; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Talairach J., 1988, COPLANAR STEREOTAXIC; TZELGOV J, 1992, J EXP PSYCHOL LEARN, V18, P166, DOI 10.1037/0278-7393.18.1.166; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wilkinson D, 2004, NAT REV NEUROSCI, V5, P67, DOI 10.1038/nrn1302; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Zilles Karl, 2003, Adv Neurol, V93, P1	51	184	187	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					307	314		10.1016/j.neuron.2006.12.025	http://dx.doi.org/10.1016/j.neuron.2006.12.025			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224410	Bronze, Green Submitted			2022-12-24	WOS:000245126600014
J	Smear, MC; Tao, HZW; Staub, W; Orger, MB; Gosse, NJ; Liu, Y; Takahashi, K; Poo, MM; Baier, H				Smear, Matthew C.; Tao, Huizhong W.; Staub, Wendy; Orger, Michael B.; Gosse, Nathan J.; Liu, Yan; Takahashi, Koji; Poo, Mu-Ming; Baier, Herwig			Vesicular glutamate transport at a central synapse limits the acuity of visual perception in zebrafish	NEURON			English	Article							RETINAL GANGLION-CELLS; LARVAL ZEBRAFISH; RETINOTECTAL PROJECTION; IN-VIVO; PHOSPHATE TRANSPORTER; POSTNATAL-DEVELOPMENT; CONTRAST SENSITIVITY; SYSTEM DEVELOPMENT; SPATIAL VISION; PREY CAPTURE	The neural circuitry that constrains visual acuity in the CNS has not been experimentally identified. We show here that zebrafish blumenkohl (blu) mutants are impaired in resolving rapid movements and fine spatial detail. The blu gene encodes a vesicular glutamate transporter expressed by retinal ganglion cells. Mutant retinotectal synapses release less glutamate, per vesicle and per terminal, and fatigue more quickly than wild-type in response to high-frequency stimulation. In addition, mutant axons arborize more extensively, thus increasing the number of synaptic terminals and effectively normalizing the combined input to postsynaptic cells in the tectum. This presumably homeostatic response results in larger receptive fields of tectal cells and a degradation of the retinotopic map. As predicted, mutants have a selective deficit in the capture of small prey objects, a behavior dependent on the tecturn. Our studies successfully link the disruption of a synaptic protein to complex changes in neural circuitry and behavior.	Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of Southern California; University of Southern California; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Baier, H (corresponding author), Univ Calif San Francisco, Dept Physiol, Program Neurosci, 1550 4th St, San Francisco, CA 94143 USA.	herwig.baier@ucsf.edu	Tao, Huizhong W/HDM-9767-2022	Orger, Michael/0000-0002-9763-8902	NATIONAL EYE INSTITUTE [R21EY018718, R01EY013855, R01EY014979, R01EY012406] Funding Source: NIH RePORTER; NEI NIH HHS [R21 EY018718, R01 EY013855, R01 EY012406, R01 EY014979, EY014979, EY12406, R21 EY018718-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baier H, 1996, DEVELOPMENT, V123, P415; BANKS MS, 1991, J OPT SOC AM A, V8, P1775, DOI 10.1364/JOSAA.8.001775; BARLOW HB, 1975, NATURE, V258, P199, DOI 10.1038/258199a0; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BILOTTA J, 1989, J GEN PHYSIOL, V93, P1147, DOI 10.1085/jgp.93.6.1147; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Brown SP, 2000, NEURON, V27, P371, DOI 10.1016/S0896-6273(00)00044-1; Burrows PE, 2003, NEUROIMAG CLIN N AM, V13, P13, DOI 10.1016/S1052-5149(02)00061-8; CHICHILNISKY EJ, 1993, VISION RES, V33, P2113, DOI 10.1016/0042-6989(93)90010-T; CLELAND BG, 1979, SCIENCE, V205, P1015, DOI 10.1126/science.472720; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Easter SS, 1996, DEV BIOL, V180, P646; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; GEISLER WS, 1984, J OPT SOC AM A, V1, P775, DOI 10.1364/JOSAA.1.000775; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; HIRSCH J, 1984, VISION RES, V24, P347, DOI 10.1016/0042-6989(84)90060-9; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; JACOBS DS, 1988, VISION RES, V28, P947, DOI 10.1016/0042-6989(88)90104-6; JOHNSONKG, 2000, RESULTS PROBL CELL D, V31, P157; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Keegan BR, 2002, DEVELOPMENT, V129, P1623; KIORPES L, 2003, VISUAL NEUROSCIENCES, P234; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Orger MB, 2005, VISUAL NEUROSCI, V22, P275, DOI 10.1017/S0952523805223039; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Rinner O, 2005, INVEST OPHTH VIS SCI, V46, P137, DOI 10.1167/iovs.04-0682; Roeser T, 2003, J NEUROSCI, V23, P3726; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tokuoka H, 2002, J NEUROSCI, V22, P10324; Trowe T, 1996, DEVELOPMENT, V123, P439; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Watkins J C, 1990, Adv Exp Med Biol, V268, P49; WILLIAMS DR, 1987, J OPT SOC AM A, V4, P1514, DOI 10.1364/JOSAA.4.001514; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	71	73	2	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					65	77		10.1016/j.neuron.2006.12.013	http://dx.doi.org/10.1016/j.neuron.2006.12.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196531	Green Accepted, Bronze			2022-12-24	WOS:000245126500009
J	Churchland, MM; Afshar, A; Shenoy, KV				Churchland, Mark M.; Afshar, Afsheen; Shenoy, Krishna V.			A central source of movement variability	NEURON			English	Article							SIGNAL-DEPENDENT NOISE; MOTOR CORTEX NEURONS; PREMOTOR CORTEX; SENSORIMOTOR CONTROL; REACHING MOVEMENTS; INTENDED MOVEMENT; PRIOR INFORMATION; RHESUS-MONKEYS; CELL-ACTIVITY; DIRECTION	Movements are universally, sometimes frustratingly, variable. When such variability causes error, we typically assume that something went wrong during the movement. The same assumption is made by recent and influential models of motor control. These posit that the principal limit on repeatable performance is neuromuscular noise that corrupts movement as it occurs. An alternative hypothesis is that movement variability arises before movements begin, during motor preparation. We examined this possibility directly by recording the preparatory activity of single cortical neurons during a highly practiced reach task. Small variations in preparatory neural activity were predictive of small variations in the upcoming reach. Effect magnitudes were such that at least half of the observed movement variability likely had its source during motor preparation. Thus, even for a highly practiced task, the ability to repeatedly plan the same movement limits our ability to repeatedly execute the same movement.	Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Shenoy, KV (corresponding author), Stanford Univ, Program Neurosci, Stanford, CA 94305 USA.	shenoy@stanford.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007158] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS007158] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2006, J NEUROPHYSIOL, V96, P2842, DOI 10.1152/jn.00857.2006; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; GODSCHALK M, 1985, BEHAV BRAIN RES, V18, P143, DOI 10.1016/0166-4328(85)90070-1; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; Hamilton AFD, 2002, J NEUROPHYSIOL, V87, P2434, DOI 10.1152/jn.00875.2001; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Harris CM, 2004, MATH BIOSCI, V188, P99, DOI 10.1016/j.mbs.2003.08.011; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; Iguchi N, 2005, BIOL CYBERN, V92, P219, DOI 10.1007/s00422-005-0541-7; Johnson MTV, 1999, J NEUROPHYSIOL, V81, P875, DOI 10.1152/jn.1999.81.2.875; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; KAWATO M, 2004, ADV COMP MOT CONTR 3; KURATA K, 1989, EXP BRAIN RES, V77, P245, DOI 10.1007/BF00274982; Lebedev MA, 2001, EUR J NEUROSCI, V13, P1002, DOI 10.1046/j.0953-816x.2001.01457.x; LECAS JC, 1986, J NEUROPHYSIOL, V56, P1680, DOI 10.1152/jn.1986.56.6.1680; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Osu R, 2004, J NEUROPHYSIOL, V92, P1199, DOI 10.1152/jn.00519.2003; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Simmons G, 2006, BIOL CYBERN, V94, P393, DOI 10.1007/s00422-006-0053-0; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; SOSNOFF JJ, 2005, NEUROSCI LETT, V392, P165, DOI DOI 10.1016/J.NE16ET.2005.09.010; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; WEINRICH M, 1984, BRAIN, V107, P385, DOI 10.1093/brain/107.2.385; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	39	253	253	1	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					1085	1096		10.1016/j.neuron.2006.10.034	http://dx.doi.org/10.1016/j.neuron.2006.10.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178410	Bronze, Green Accepted			2022-12-24	WOS:000243115100015
J	Fertleman, CR; Baker, MD; Parker, KA; Moffatt, S; Elmslie, FV; Abrahamsen, B; Ostman, J; Klugbauer, N; Wood, JN; Gardiner, RM; Rees, M				Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele			SCN9A mutations in paroxysmal extreme pain disorder: Allelic variants underlie distinct channel defects and phenotypes	NEURON			English	Article							FAMILIAL RECTAL PAIN; ALPHA-SUBUNIT; SODIUM-CHANNELS; INACTIVATION; ERYTHERMALGIA; IDENTIFICATION; LINKER; LOOP; PN1	Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing. A genome-wide linkage search followed by mutational analysis of the candidate gene SCN9A, which encodes hNaV(1.7) identified eight missense mutations in 11 families and 2 sporadic cases. Functional analysis in vitro of three of these mutant Na(V)1.7 channels revealed a reduction in fast inactivation, leading to persistent sodium current. Other mutations in SCN9A associated with more negative activation thresholds are known to cause primary erythermalgia (PE). Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current associated with PEPD mutants, but did not affect the negative activation threshold of a PE mutant. PEPD and PE are allelic variants with distinct underlying biophysical mechanisms and represent a separate class of peripheral neuronal sodium channelopathy.	Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, London WC1E 6JJ, England; UCL, Dept Biol, London WC1E 6BT, England; Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England	University of London; University College London; University of London; University College London; University of Freiburg; University of London; Queen Mary University London	Gardiner, RM (corresponding author), Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, 5 Univ St, London WC1E 6JJ, England.	mark.gardiner@ucl.ac.uk	Abrahamsen, Bjarke/ABD-5874-2020	Abrahamsen, Bjarke/0000-0002-6128-8269	Medical Research Council [G9706148, G9717869] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9717869, G9706148] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashcroft FM, 2000, ION CHANNELS DIS; Backonja MM, 2002, NEUROLOGY, V59, pS14, DOI 10.1212/WNL.59.5_suppl_2.S14; Breton H, 2005, J CHROMATOGR B, V828, P80, DOI 10.1016/j.jchromb.2005.09.019; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Carr RW, 2002, J GEN PHYSIOL, V120, P395, DOI 10.1085/jgp.20028628; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Elmslie FV, 1996, J ROY SOC MED, V89, pP290, DOI 10.1177/014107689608900525; Fertleman CR, 2006, J NEUROL NEUROSUR PS, V77, P1294, DOI 10.1136/jnnp.2006.089664; Filatov GN, 1998, J GEN PHYSIOL, V111, P703, DOI 10.1085/jgp.111.6.703; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; HAYDEN R, 1959, AMA J DIS CHILD, V97, P479, DOI 10.1001/archpedi.1959.02070010481013; Kellenberger S, 1997, J GEN PHYSIOL, V109, P589, DOI 10.1085/jgp.109.5.589; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Legroux-Crespel E, 2003, ANN DERMATOL VENER, V130, P429; Lerche H, 1997, J PHYSIOL-LONDON, V505, P345, DOI 10.1111/j.1469-7793.1997.345bb.x; MANN TP, 1972, LANCET, V1, P1016; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Michiels JJ, 2005, ARCH NEUROL-CHICAGO, V62, P1587, DOI 10.1001/archneur.62.10.1587; MOHAMMADI B, 2005, GENOMICS, V15, P235; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; PTACEK LJ, 1991, CELL, V67, P1021; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; SCHUBERT R, 1992, ANN NEUROL, V32, P824, DOI 10.1002/ana.410320620; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Strassman AM, 1999, J NEUROPHYSIOL, V81, P413, DOI 10.1152/jn.1999.81.2.413; Tang LH, 1996, J GEN PHYSIOL, V108, P89, DOI 10.1085/jgp.108.2.89; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Waxman SG, 2005, ANN NEUROL, V57, P785, DOI 10.1002/ana.20511; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wu FF, 2005, J PHYSIOL-LONDON, V565, P371, DOI 10.1113/jphysiol.2005.082909; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	36	537	592	1	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					767	774		10.1016/j.neuron.2006.10.006	http://dx.doi.org/10.1016/j.neuron.2006.10.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145499	Bronze			2022-12-24	WOS:000242856400006
J	Lai, J; Luo, MC; Chen, QM; Ma, SW; Gardell, LR; Ossipov, MH; Porreca, F				Lai, Josephine; Luo, Miaw-Chyi; Chen, Qingmin; Ma, Shouwu; Gardell, Luis R.; Ossipov, Michael H.; Porreca, Frank			Dynorphin A activates bradykinin receptors to maintain neuropathic pain	NATURE NEUROSCIENCE			English	Article							RAT SENSORY NEURONS; DEPENDENT PROTEIN-KINASE; DORSAL-ROOT-GANGLIA; CALCIUM-CHANNELS; SPINAL-CORD; OPIOID RECEPTOR; PROSTAGLANDIN E-2; ENDOGENOUS LIGAND; CELLS; RELEASE	Dynorphin A is an endogenous opioid peptide that produces non-opioid receptor-mediated neural excitation. Here we demonstrate that dynorphin induces calcium influx via voltage-sensitive calcium channels in sensory neurons by activating bradykinin receptors. This action of dynorphin at bradykinin receptors is distinct from the primary signaling pathway activated by bradykinin and underlies the hyperalgesia produced by pharmacological administration of dynorphin by the spinal route in rats and mice. Blockade of spinal B1 or B2 receptor also reverses persistent neuropathic pain but only when there is sustained elevation of endogenous spinal dynorphin, which is required for maintenance of neuropathic pain. These data reveal a mechanism for endogenous dynorphin to promote pain through its agonist action at bradykinin receptors and suggest new avenues for therapeutic intervention.	Univ Arizona, Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona Health Sciences	Lai, J (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Pharmacol, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	lai@u.arizona.edu						Austin CE, 1997, J BIOL CHEM, V272, P11420; Banik RK, 2001, J NEUROPHYSIOL, V86, P2727, DOI 10.1152/jn.2001.86.6.2727; BEAUMONT A, 1979, ANNU REV PHARMACOL, V19, P245, DOI 10.1146/annurev.pa.19.040179.001333; BOTTICELLI LJ, 1981, P NATL ACAD SCI-BIOL, V78, P7783, DOI 10.1073/pnas.78.12.7783; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Cloutier F, 2002, BRIT J PHARMACOL, V135, P1641, DOI 10.1038/sj.bjp.0704632; CORBETT AD, 1982, NATURE, V299, P79, DOI 10.1038/299079a0; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Evans AR, 1996, BRAIN RES, V712, P265, DOI 10.1016/0006-8993(95)01447-0; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; FALCONE RC, 1993, J PHARMACOL EXP THER, V266, P1291; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; Fox A, 2003, PAIN, V104, P683, DOI 10.1016/S0304-3959(03)00141-6; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; Gardell LR, 2002, J NEUROSCI, V22, P6747; GOLDSTEIN A, 1979, P NATL ACAD SCI USA, V76, P6666, DOI 10.1073/pnas.76.12.6666; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; HERMAN BH, 1985, J PHARMACOL EXP THER, V232, P27; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Koetzner L, 2004, J NEUROSCI, V24, P1451, DOI 10.1523/JNEUROSCI.1517-03.2004; LAI J, 1988, LIFE SCI, V42, P2489, DOI 10.1016/0024-3205(88)90348-7; Liebmann C, 1996, BIOCHEM J, V313, P109, DOI 10.1042/bj3130109; Linhart O, 2003, NEUROSCIENCE, V118, P69, DOI 10.1016/S0306-4522(02)00960-0; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016/S0304-3959(00)00243-8; Marceau F, 1998, PHARMACOL REV, V50, P357; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; QUIRION R, 1984, EUR J PHARMACOL, V99, P361, DOI 10.1016/0014-2999(84)90148-1; RUDA MA, 1988, P NATL ACAD SCI USA, V85, P622, DOI 10.1073/pnas.85.2.622; Schwei MJ, 1999, J NEUROSCI, V19, P10886, DOI 10.1523/JNEUROSCI.19-24-10886.1999; Simasko SM, 1999, BRAIN RES, V824, P89, DOI 10.1016/S0006-8993(99)01188-9; SKILLING SR, 1992, BRAIN RES, V575, P272, DOI 10.1016/0006-8993(92)90090-V; STEVENS CW, 1987, EUR J PHARMACOL, V138, P299, DOI 10.1016/0014-2999(87)90449-3; Tang QB, 2000, J NEUROPHYSIOL, V83, P2610, DOI 10.1152/jn.2000.83.5.2610; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; Vanderah TW, 2000, J NEUROSCI, V20, P7074, DOI 10.1523/JNEUROSCI.20-18-07074.2000; VASKO MR, 1994, J NEUROSCI, V14, P4987; WALKER JM, 1982, SCIENCE, V218, P1136, DOI 10.1126/science.6128791; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; Wetzel CH, 2001, EUR J NEUROSCI, V14, P1056, DOI 10.1046/j.0953-816x.2001.01722.x; Wotherspoon G, 2000, NEUROSCI LETT, V294, P175, DOI 10.1016/S0304-3940(00)01561-5; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Zanner R, 2002, AM J PHYSIOL-CELL PH, V282, pC374, DOI 10.1152/ajpcell.00366.2001; Zhang SW, 1998, J PHARMACOL EXP THER, V286, P136	50	118	125	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1534	1540		10.1038/nn1804	http://dx.doi.org/10.1038/nn1804			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115041				2022-12-24	WOS:000242404000018
J	Rubino, D; Robbins, KA; Hatsopoulos, NG				Rubino, Doug; Robbins, Kay A.; Hatsopoulos, Nicholas G.			Propagating waves mediate information transfer in the motor cortex	NATURE NEUROSCIENCE			English	Article							LOCAL-FIELD POTENTIALS; FRONTAL-LOBE INPUTS; SENSORIMOTOR CORTEX; CORTICAL PROJECTIONS; OSCILLATIONS; SYNCHRONIZATION; ACTIVATION; DYNAMICS; REPRESENTATIONS; RESPONSES	High-frequency oscillations in the beta range (10-45 Hz) are most active in motor cortex during motor preparation and are postulated to reflect the steady postural state or global attentive state of the animal. By simultaneously recording multiple local field potential signals across the primary motor and dorsal premotor cortices of monkeys (Macaca mulatta) trained to perform an instructed-delay reaching task, we found that these oscillations propagated as waves across the surface of the motor cortex along dominant spatial axes characteristic of the local circuitry of the motor cortex. Moreover, we found that information about the visual target to be reached was encoded in terms of both latency and amplitude of evoked waves at a time when the field phase-locked with respect to the target onset. These findings suggest that high-frequency oscillations may subserve intra- and intercortical information transfer during movement preparation and execution.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Texas, Dept Comp Sci, San Antonio, TX 78249 USA	University of Chicago; University of Texas System	Hatsopoulos, NG (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	nicho@uchicago.edu			NCRR NIH HHS [2G12RR1364-06A1] Funding Source: Medline; NINDS NIH HHS [R01 NS45853-01, R01 NS045853] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045853] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Cauller LJ, 1998, J COMP NEUROL, V390, P297; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CHERVIN RD, 1988, J NEUROPHYSIOL, V60, P1695, DOI 10.1152/jn.1988.60.5.1695; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; Cover TM, 1991, ELEMENTS INFORM THEO; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Du XX, 2006, IEEE T BIO-MED ENG, V53, P1688, DOI 10.1109/TBME.2006.877796; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FLEET DJ, 1990, INT J COMPUT VISION, V5, P77, DOI 10.1007/BF00056772; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Ghosh S, 1995, SOMATOSENS MOT RES, V12, P359, DOI 10.3109/08990229509093668; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; KURATA K, 1991, NEUROSCI RES, V12, P263, DOI 10.1016/0168-0102(91)90116-G; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 2001, J CLIN NEUROPHYSIOL, V18, P559, DOI 10.1097/00004691-200111000-00006; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Robbins KA, 2004, J COMPUT NEUROSCI, V16, P267, DOI 10.1023/B:JCNS.0000025689.01581.26; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Senseman D M, 1999, J Neurosci, V19, pRC3; Senseman DM, 2002, J NEUROPHYSIOL, V87, P1499, DOI 10.1152/jn.00475.2001; Wang WX, 2005, J COMPUT NEUROSCI, V19, P263, DOI 10.1007/s10827-005-2288-5; Wu JY, 1999, J NEUROSCI, V19, P5005	38	301	303	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1549	1557		10.1038/nn1802	http://dx.doi.org/10.1038/nn1802			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115042				2022-12-24	WOS:000242404000020
J	Sosa, L; Dupraz, S; Laurino, L; Bollati, F; Bisbal, M; Caceres, A; Pfenninger, KH; Quiroga, S				Sosa, Lucas; Dupraz, Sebastian; Laurino, Lisandro; Bollati, Flavia; Bisbal, Mariano; Caceres, Alfredo; Pfenninger, Karl H.; Quiroga, Santiago			IGF-1 receptor is essential for the establishment of hippocampal neuronal polarity	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-I; BETA-SUBUNIT VARIANT; MEMBRANE EXPANSION; ACTIVATION; BRAIN; CONE; GENE	How a neuron becomes polarized remains largely unknown. Results obtained with a function-blocking antibody and an siRNA targeting the insulin-like growth factor-1 (IGF-1) receptor suggest that an essential step in the establishment of hippocampal neuronal polarity and the initiation of axonal outgrowth is the activation of the phosphatidylinositol 3-kinase (PI3k)-Cdc42 pathway by the IGF-1 receptor, but not by the TrkA or TrkB receptors.	Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina; Consejo Nacl Invest Cient & Tecn, CIQUIBIC, Cordoba, Argentina; Consejo Nacl Invest Cient & Tecn, INIMEC, Cordoba, Argentina; Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; Univ Colorado, Ctr Canc, Aurora, CO 80045 USA	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Quiroga, S (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina.	squiroga@dqbfcq.uncor.edu	Bisbal, Mariano/AAE-9308-2021	Bisbal, Mariano/0000-0002-3870-6151; Sosa, Lucas/0000-0002-9153-7537	FOGARTY INTERNATIONAL CENTER [R03TW005763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041029] Funding Source: NIH RePORTER; FIC NIH HHS [1R03 TW05763] Funding Source: Medline; NINDS NIH HHS [R01 NS41029] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Mascotti F, 1997, J NEUROSCI, V17, P1447; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; QUIROGA S, 1995, P NATL ACAD SCI USA, V92, P4309, DOI 10.1073/pnas.92.10.4309; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	15	106	106	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					993	995		10.1038/nn1742	http://dx.doi.org/10.1038/nn1742			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845384				2022-12-24	WOS:000240080300007
J	Lesica, NA; Jin, JZ; Weng, C; Yeh, CI; Butts, DA; Stanley, GB; Alonso, JM				Lesica, Nicholas A.; Jin, Jianzhong; Weng, Chong; Yeh, Chun-I; Butts, Daniel A.; Stanley, Garrett B.; Alonso, Jose-Manuel			Adaptation to stimulus contrast and correlations during natural visual stimulation	NEURON			English	Article							TEMPORAL CONTRAST; GAIN-CONTROL; STATISTICS	In this study, we characterize the adaptation of neurons in the cat lateral geniculate nucleus to changes in stimulus contrast and correlations. By comparing responses to high- and low-contrast natural scene movie and white noise stimuli, we show that an increase in contrast or correlations results in receptive fields with faster temporal dynamics and stronger antagonistic surrounds, as well as decreases in gain and selectivity. We also observe contrast- and correlation-induced changes in the reliability and sparseness of neural responses. We find that reliability is determined primarily by processing in the receptive field (the effective contrast of the stimulus), while sparseness is determined by the interactions between several functional properties. These results reveal a number of adaptive phenomena and suggest that adaptation to stimulus contrast and correlations may play an important role in visual coding in a dynamic natural environment.	Univ Munich, Dept Biol 2, D-82152 Martinsried, Germany; SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	University of Munich; State University of New York (SUNY) System; SUNY Optometry; University of Connecticut; Harvard University	Lesica, NA (corresponding author), Univ Munich, Dept Biol 2, D-82152 Martinsried, Germany.	lesica@zi.biologie.uni-muenchen.de	Butts, Daniel A/B-8346-2008	Butts, Daniel A/0000-0002-0158-5317; Stanley, Garrett/0000-0003-2039-7706; YEH, CHUN-I/0000-0002-2375-0723; Lesica, Nicholas/0000-0001-5238-4462	NATIONAL EYE INSTITUTE [R01EY005253, R37EY005253] Funding Source: NIH RePORTER; NEI NIH HHS [EY-05253, R01 EY005253-21A2, R01 EY005253] Funding Source: Medline; NIEHS NIH HHS [27307C0009] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Haykin S., 2002, ADAPTIVE FILTER THEO; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Kayser C, 2003, NEUROCOMPUTING, V52-4, P117, DOI 10.1016/S0925-2312(02)00789-0; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kremers J, 2004, J VISION, V4, P643, DOI 10.1167/4.7.10; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lesica NA, 2006, NETWORK-COMP NEURAL, V17, P43, DOI 10.1080/09548980500328409; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Nolt MJ, 2004, J NEUROPHYSIOL, V92, P1708, DOI 10.1152/jn.00176.2004; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rucci M, 2005, NETWORK-COMP NEURAL, V16, P121, DOI 10.1080/09548980500300507; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SIMONCELLI E, 2003, COGNITIVE NEUROSCIEN, P113; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Tadmor Y, 2000, VISION RES, V40, P3145, DOI 10.1016/S0042-6989(00)00166-8; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Weng C, 2005, J NEUROPHYSIOL, V93, P3537, DOI 10.1152/jn.00847.2004; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	36	78	82	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					479	491		10.1016/j.neuron.2007.07.013	http://dx.doi.org/10.1016/j.neuron.2007.07.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678859	Green Accepted, Bronze			2022-12-24	WOS:000248711000014
J	Pack-Chung, E; Kurshan, PT; Dickman, DK; Schwarz, TL				Pack-Chung, Eunju; Kurshan, Peri T.; Dickman, Dion K.; Schwarz, Thomas L.			A Drosophila kinesin required for synaptic bouton formation and synaptic vesicle transport	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC ACTIVE ZONES; AXONAL-TRANSPORT; NEUROMUSCULAR-JUNCTION; MOLECULAR-MECHANISMS; TRANSMITTER RELEASE; GROWTH CONE; MOTOR; PROTEIN; RECEPTOR; NEURONS	The morphological transition of growth cones to synaptic boutons characterizes synaptogenesis. Here we have isolated mutations in immaculate connections (imac; CG8566), a previously uncharacterized Drosophila gene encoding a member of the Kinesin-3 family. Whereas earlier studies in Drosophila implicated Kinesin-1 in transporting synaptic vesicle precursors, we find that imac is essential for this transport. An unexpected feature of imac mutants is the failure of synaptic boutons to form. Motor neurons lacking imac properly target to muscles but remain within target fields as thin processes, a structure that is distinct from either growth cones or mature terminals. Few active zones form at these endings. We show that the arrest of synaptogenesis is not a secondary consequence of the absence of transmission. Our data thus indicate that Imac transports components required for synaptic maturation and provide insight into presynaptic maturation as a process that can be differentiated from axon outgrowth and targeting.	Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Schwarz, TL (corresponding author), Childrens Hosp, Program Neurobiol, 300 Longwood Ave, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075058] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH075058] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ackley BD, 2004, TRENDS NEUROSCI, V27, P540, DOI 10.1016/j.tins.2004.07.003; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE KS, 1993, J NEUROSCI, V13, P144; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Chang TN, 1996, J NEUROSCI, V16, P5715; DiAntonio A, 2006, INT REV NEUROBIOL, V75, P165, DOI 10.1016/S0074-7742(06)75008-5; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Featherstone DE, 2000, BRAIN RES BULL, V53, P501, DOI 10.1016/S0361-9230(00)00383-X; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Hurd DD, 1996, GENETICS, V144, P1075; Jacob TC, 2003, J NEUROSCI, V23, P2122; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lee H, 2003, CURR BIOL, V13, pR152, DOI 10.1016/S0960-9822(03)00080-0; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Ma DL, 2000, J NEUROSCI, V20, P2112; Marques G, 2006, INT REV NEUROBIOL, V75, P267, DOI 10.1016/S0074-7742(06)75012-7; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Prokop Andreas, 1993, P33; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Rheuben MB, 1999, INT REV NEUROBIOL, V43, P69, DOI 10.1016/S0074-7742(08)60541-3; Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Schwarz TL, 2006, INT REV NEUROBIOL, V75, P105, DOI 10.1016/S0074-7742(06)75006-1; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Stowers RS, 1999, GENETICS, V152, P1631; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	50	112	113	3	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					980	989		10.1038/nn1936	http://dx.doi.org/10.1038/nn1936			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17643120				2022-12-24	WOS:000248357500012
J	Berton, O; Covington, HE; Ebner, K; Tsankova, NM; Carle, TL; Ulery, P; Bhonsle, A; Barrot, M; Krishnan, V; Singewald, GM; Singewald, N; Birnbaum, S; Neve, RL; Nestler, EJ				Berton, Olivier; Covington, Herbert E., III; Ebner, Karl; Tsankova, Nadia M.; Carle, Tiffany L.; Ulery, Paula; Bhonsle, Akshay; Barrot, Michel; Krishnan, Vaishnav; Singewald, Georg M.; Singewald, Nicolas; Birnbaum, Shari; Neve, Rachael L.; Nestler, Eric J.			Induction of Delta FosB in the periaqueductal gray by stress promotes active coping responses	NEURON			English	Article							SEND PROJECTION FIBERS; SUBSTANCE-P; LEARNED HELPLESSNESS; MESSENGER-RNA; CELLULAR-LOCALIZATION; SEROTONERGIC NEURONS; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; CHRONIC COCAINE; BRAIN	We analyzed the influence of the transcription factor Delta FosB on learned helplessness, an animal model of affective disorder wherein a subset of mice exposed to inescapable stress (IS) develop a deficit in escape behavior. Repeated IS induces Delta FosB in the ventrolateral periaqueductal gray (vIPAG), and levels of the protein are highly predictive of an individual's subsequent behavorial deficit-with the strongest Delta FosB induction observed in the most resilient animals. Induction of Delta FosB by IS predominates in substance P-positive neurons in the vIPAG, and the substance P gene, a direct target for Delta FosB, is downregulated upon Delta FosB induction. Local overexpression of Delta FosB in the vIPAG using viral-mediated gene transfer dramatically reduces depression-like behaviors and inhibits stress-induced release of substance P. These results indicate that IS-induced accumulation of Delta FosB in the vIPAG desensitizes substance P neurons enriched in this area and opposes behavioral despair by promoting active defense responses.	SW Texas State Univ, Med Ctr, Dept Psychiat & Basic Neurosci, Dallas, TX 75390 USA; Univ Strasbourg, Ctr Natl Rech Sci, European Neurosci Inst Strasboung, F-67084 Strasbourg, France; Univ Strasbourg, Ctr Natl Rech Sci, Unit Mixte Rech 7519, F-67084 Strasbourg, France; Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; Univ Innsbruck, Inst Pharm, Dept Pharmacol & Toxicol, A-6020 Innsbruck, Austria; Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria	Texas State University System; Texas State University San Marcos; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; University of Innsbruck; University of Innsbruck	Nestler, EJ (corresponding author), SW Texas State Univ, Med Ctr, Dept Psychiat & Basic Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu		Krishnan, Vaishnav/0000-0002-2847-0069; Singewald, Nicolas/0000-0002-0166-3370				Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Barbaresi P, 1998, J COMP NEUROL, V398, P473, DOI 10.1002/(SICI)1096-9861(19980907)398:4<473::AID-CNE2>3.0.CO;2-#; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bengel D, 1997, BRAIN RES, V778, P338, DOI 10.1016/S0006-8993(97)01080-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Besson A, 1998, PHARMACOL BIOCHEM BE, V60, P519, DOI 10.1016/S0091-3057(98)00002-1; Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046; Boyce S, 2001, NEUROPHARMACOLOGY, V41, P130, DOI 10.1016/S0028-3908(01)00051-X; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; Caldarone BJ, 2000, PHARMACOL BIOCHEM BE, V66, P811, DOI 10.1016/S0091-3057(00)00271-9; CHANPALAY V, 1978, P NATL ACAD SCI USA, V75, P1582, DOI 10.1073/pnas.75.3.1582; CHEN JS, 1995, MOL PHARMACOL, V48, P880; Chen JS, 1997, J NEUROSCI, V17, P4933; Chourbaji S, 2005, BRAIN RES PROTOC, V16, P70, DOI 10.1016/j.brainresprot.2005.09.002; Day HEW, 2004, J COMP NEUROL, V474, P364, DOI 10.1002/cne.20138; DOBRZANSKI P, 1991, MOL CELL BIOL, V11, P5470, DOI 10.1128/MCB.11.11.5470; Ebner K, 2006, AMINO ACIDS, V31, P251, DOI 10.1007/s00726-006-0335-9; Ebner K, 2004, P NATL ACAD SCI USA, V101, P4280, DOI 10.1073/pnas.0400794101; Fiskerstrand CE, 2000, NEUROPEPTIDES, V34, P348, DOI 10.1054/npep.2000.0828; FLUPNIAK NMJ, 2000, NEUROPHARMACOLOGY, V39, P1413; HARLAN RE, 1989, J COMP NEUROL, V287, P179, DOI 10.1002/cne.902870204; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; Hiroi N, 1998, J NEUROSCI, V18, P6952; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Hurd YL, 1999, J COMP NEUROL, V411, P56, DOI 10.1002/(SICI)1096-9861(19990816)411:1<56::AID-CNE5>3.0.CO;2-3; Ishida Y, 2002, SYNAPSE, V45, P46, DOI 10.1002/syn.10086; Jansen ASP, 1998, BRAIN RES, V784, P329, DOI 10.1016/S0006-8993(97)01293-6; Johnson PL, 2004, ANN NY ACAD SCI, V1018, P58, DOI 10.1196/annals.1296.006; JONES EG, 1994, J NEUROSCI, V14, P611; KRAUSE JE, 1987, P NATL ACAD SCI USA, V84, P881, DOI 10.1073/pnas.84.3.881; LI YQ, 1990, NEUROSCI LETT, V120, P124, DOI 10.1016/0304-3940(90)90184-B; LI YQ, 1990, NEUROSCI LETT, V119, P269, DOI 10.1016/0304-3940(90)90850-9; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; Maier SF, 2001, BIOL PSYCHIAT, V49, P763, DOI 10.1016/S0006-3223(00)01095-7; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Mongeau R, 1998, BEHAV NEUROSCI, V112, P1125, DOI 10.1037/0735-7044.112.5.1125; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Neve RL, 2005, BIOTECHNIQUES, V39, P381, DOI 10.2144/05393PS01; Okazaki S, 1998, BIOCHEM BIOPH RES CO, V250, P347, DOI 10.1006/bbrc.1998.9331; PATERSON JM, 1995, NEUROSCIENCE, V66, P921, DOI 10.1016/0306-4522(95)00041-G; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Pennypacker K, 1998, INT REV NEUROBIOL, V42, P169, DOI 10.1016/S0074-7742(08)60610-8; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; SCHUERMANN M, 1991, ONCOGENE, V6, P567; Smith DW, 1999, BRAIN RES, V848, P90, DOI 10.1016/S0006-8993(99)01976-9; STRUHL K, 1988, NATURE, V332, P649, DOI 10.1038/332649a0; Takase LF, 2005, BEHAV BRAIN RES, V162, P299, DOI 10.1016/j.bbr.2005.04.008; Takase LF, 2004, BEHAV BRAIN RES, V153, P233, DOI 10.1016/j.bbr.2003.12.020; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Valentino RJ, 2005, NEUROPEPTIDES, V39, P1, DOI 10.1016/j.npep.2004.09.005; WARDEN MK, 1988, J COMP NEUROL, V272, P90, DOI 10.1002/cne.902720107; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200; Yazgan O, 2001, CANCER RES, V61, P916; YEN J, 1991, P NATL ACAD SCI USA, V88, P5077, DOI 10.1073/pnas.88.12.5077	66	97	99	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2007	55	2					289	300		10.1016/j.neuron.2007.06.033	http://dx.doi.org/10.1016/j.neuron.2007.06.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NW	17640529	Bronze			2022-12-24	WOS:000248635800012
J	Serences, JT; Boynton, GM				Serences, John T.; Boynton, Geoffrey M.			Feature-based attentional modulations in the absence of direct visual stimulation	NEURON			English	Article							VOXEL PATTERN-ANALYSIS; MACAQUE AREA V4; NEURAL MECHANISMS; SPATIAL ATTENTION; SELECTIVE ATTENTION; EXTRASTRIATE CORTEX; PARIETAL CORTEX; BRAIN ACTIVITY; RADIAL MOTION; FMRI DATA	When faced with a crowded visual scene, observers must selectively attend to behaviorally relevant objects to avoid sensory overload. Often this selection process is guided by prior knowledge of a target-defining feature (e.g., the color red when looking for an apple), which enhances the firing rate of visual neurons that are selective for the attended feature. Here, we used functional magnetic resonance imaging and a pattern classification algorithm to predict the attentional state of human observers as they monitored a visual feature (one of two directions of motion). We find that feature-specific attention effects spread across the visual field-even to regions of the scene that do not contain a stimulus. This spread of feature-based attention to empty regions of space may facilitate the perception of behaviorally relevant stimuli by increasing sensitivity to attended features at all locations in the visual field.	Univ Calif Irvine, Ctr Cognit Neurosci, Irvine, CA 92697 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California Irvine; University of Washington; University of Washington Seattle; Salk Institute		john.serences@uci.edu			NATIONAL EYE INSTITUTE [R01EY012925, F32EY017261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012925, F32-EY017261, EY12925] Funding Source: Medline; NIMH NIH HHS [T32-MH20002] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Arman AC, 2006, VISION RES, V46, P2968, DOI 10.1016/j.visres.2006.03.003; Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Beardsley SA, 2005, VISION RES, V45, P1569, DOI 10.1016/j.visres.2004.11.025; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bex PJ, 1997, VISION RES, V37, P3399, DOI 10.1016/S0042-6989(97)00088-6; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hayden BY, 2005, NEURON, V47, P637, DOI 10.1016/j.neuron.2005.07.020; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Huk AC, 2002, J NEUROSCI, V22, P7195; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Liu TS, 2003, CEREB CORTEX, V13, P1334, DOI 10.1093/cercor/bhg080; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; McMains SA, 2004, NEURON, V42, P677, DOI 10.1016/S0896-6273(04)00263-6; Melcher D, 2005, NEURON, V46, P723, DOI 10.1016/j.neuron.2005.04.023; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Peelen MV, 2007, TRENDS COGN SCI, V11, P4, DOI 10.1016/j.tics.2006.10.009; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 1999, J NEUROSCI, V19, P9480; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	59	296	301	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2007	55	2					301	312		10.1016/j.neuron.2007.06.015	http://dx.doi.org/10.1016/j.neuron.2007.06.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	198NW	17640530	Bronze			2022-12-24	WOS:000248635800013
J	Tsetsenis, T; Ma, XH; Lo Iacono, L; Beck, SG; Gross, C				Tsetsenis, Theodoros; Ma, Xiao-Hong; Lo Iacono, Luisa; Beck, Sheryl G.; Gross, Cornelius			Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus	NATURE NEUROSCIENCE			English	Article							5-HT1A RECEPTOR; SEROTONIN(1A) RECEPTOR; CENTRAL NUCLEUS; PYRAMIDAL NEURONS; ANXIETY DISORDER; MICE LACKING; AMYGDALA; RAT; FEAR; HIPPOCAMPUS	Serotonin receptor 1A knockout (Htr1a(KO)) mice show increased anxiety-related behavior in tests measuring innate avoidance. Here we demonstrate that Htr1a(KO) mice show enhanced fear conditioning to ambiguous conditioned stimuli, a hallmark of human anxiety. To examine the involvement of specific forebrain circuits in this phenotype, we developed a pharmacogenetic technique for the rapid tissue- and cell type-specific silencing of neural activity in vivo. Inhibition of neurons in the central nucleus of the amygdala suppressed conditioned responses to both ambiguous and nonambiguous cues. In contrast, inhibition of hippocampal dentate gyrus granule cells selectively suppressed conditioned responses to ambiguous cues and reversed the knockout phenotype. These data demonstrate that Htr1a(KO) mice have a bias in the processing of threatening cues that is moderated by hippocampal mossy-fiber circuits, and suggest that the hippocampus is important in the response to ambiguous aversive stimuli.	European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	European Molecular Biology Laboratory (EMBL); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Gross, C (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	gross@embl.it	Iacono, Luisa Lo/G-8480-2016; MA, XIAO/HHN-5611-2022	Iacono, Luisa Lo/0000-0003-2979-6957; Tsetsenis, Theodoros/0000-0002-4642-6539	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH048125, RC1MH089800, R01MH075047, R21MH099488] Funding Source: NIH RePORTER; NIMH NIH HHS [RC1 MH089800, MH07540407, R21 MH099488, MH048125, R01 MH075047, R01 MH075047-01A1, P01 MH048125] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Beck A.T., 1988, ANXIETY RES, V1, P23, DOI [DOI 10.1080/10615808808248218, 10.1080/10615808808248218]; Beck SG, 2004, J NEUROPHYSIOL, V91, P994, DOI 10.1152/jn.00744.2003; BEST MR, 1976, EXP NEUROL, V51, P564, DOI 10.1016/0014-4886(76)90180-1; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; CHALMERS DT, 1991, BRAIN RES, V561, P51, DOI 10.1016/0006-8993(91)90748-K; Chowdhury N, 2005, BEHAV NEUROSCI, V119, P1396, DOI 10.1037/0735-7044.119.5.1396; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; De Armentia ML, 2004, J NEUROPHYSIOL, V92, P1285, DOI 10.1152/jn.00211.2004; Delgado-Garcia JM, 2006, TRENDS NEUROSCI, V29, P330, DOI 10.1016/j.tins.2006.05.003; Gorman J M, 1996, Depress Anxiety, V4, P160, DOI 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J; Greiner EF, 2000, P NATL ACAD SCI USA, V97, P7160, DOI 10.1073/pnas.97.13.7160; Groenink L, 2003, EUR J PHARMACOL, V463, P185, DOI 10.1016/S0014-2999(03)01281-0; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Haddjeri N, 1998, J NEUROSCI, V18, P10150; HAN JS, 1995, J NEUROSCI, V15, P7323; Hazlett-Stevens H, 2004, BEHAV RES THER, V42, P881, DOI 10.1016/S0005-7967(03)00204-3; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kia HK, 1996, J COMP NEUROL, V365, P289; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; MARTIN KF, 1992, BRIT J PHARMACOL, V107, P15, DOI 10.1111/j.1476-5381.1992.tb14457.x; MATHEWS A, 1989, J ABNORM PSYCHOL, V98, P236, DOI 10.1037/0021-843X.98.3.236; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; Munera A, 2001, J NEUROPHYSIOL, V86, P2571, DOI 10.1152/jn.2001.86.5.2571; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; OKUHARA DY, 1994, J NEUROPHYSIOL, V71, P2161, DOI 10.1152/jn.1994.71.6.2161; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Quinn JJ, 2002, HIPPOCAMPUS, V12, P495, DOI 10.1002/hipo.10029; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Schiess MC, 1999, J NEUROSCI RES, V58, P663, DOI 10.1002/(SICI)1097-4547(19991201)58:5<663::AID-JNR7>3.3.CO;2-1; Sibille E, 2000, J NEUROSCI, V20, P2758; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Veinante P, 1997, NEUROREPORT, V8, P2985, DOI 10.1097/00001756-199709080-00035; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	45	115	116	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					896	902		10.1038/nn1919	http://dx.doi.org/10.1038/nn1919			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558402	Green Accepted			2022-12-24	WOS:000247560200020
J	Kapfer, C; Glickfeld, LL; Atallah, BV; Scanziani, M				Kapfer, Christoph; Glickfeld, Lindsey L.; Atallah, Bassam V.; Scanziani, Massimo			Supralinear increase of recurrent inhibition during sparse activity in the somatosensory cortex	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; CAT VISUAL-CORTEX; RECEPTIVE-FIELD PROPERTIES; IN-VIVO; INTRACELLULAR-RECORDINGS; GABAERGIC INTERNEURONS; SYNAPTIC-INTERACTIONS; PYRAMIDAL NEURONS; CORTICAL-NEURONS; NEOCORTEX	The balance between excitation and inhibition in the cortex is crucial in determining sensory processing. Because the amount of excitation varies, maintaining this balance is a dynamic process; yet the underlying mechanisms are poorly understood. We show here that the activity of even a single layer 2/3 pyramidal cell in the somatosensory cortex of the rat generates widespread inhibition that increases disproportionately with the number of active pyramidal neurons. This supralinear increase of inhibition results from the incremental recruitment of somatostatin-expressing inhibitory interneurons located in layers 2/3 and 5. The recruitment of these interneurons increases tenfold when they are excited by two pyramidal cells. A simple model demonstrates that the distribution of excitatory input amplitudes onto inhibitory neurons influences the sensitivity and dynamic range of the recurrent circuit. These data show that through a highly sensitive recurrent inhibitory circuit, cortical excitability can be modulated by one pyramidal cell.	Univ Calif San Diego, Grad Program Neurosci, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Grad Program Neurosci, Div Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	massimo@ucsd.edu		Atallah, Bassam/0000-0003-2315-7126	NIMH NIH HHS [R01 MH071401, MH71401, MH70058, R01 MH070058] Funding Source: Medline; NINDS NIH HHS [1-F31NS056529-01, F31 NS056529] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070058, R01MH071401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056529] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Carandini M, 1997, J NEUROSCI, V17, P8621; Chu ZG, 2003, J NEUROSCI, V23, P96; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066, DOI 10.1152/jn.1984.52.6.1066; Fairen A., 1984, CEREB CORTEX, V1, P201; FERSTER D, 1992, J NEUROSCI, V12, P1262; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547, DOI 10.1152/jn.1996.75.2.547; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	41	295	297	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					743	753		10.1038/nn1909	http://dx.doi.org/10.1038/nn1909			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515899	Green Accepted			2022-12-24	WOS:000246799800017
J	Takano, T; Tian, GF; Peng, WG; Lou, NH; Lovatt, D; Hansen, AJ; Kasischke, KA; Nedergaard, M				Takano, Takahiro; Tian, Guo-Feng; Peng, Weiguo; Lou, Nanhong; Lovatt, Ditte; Hansen, Anker J.; Kasischke, Karl A.; Nedergaard, Maiken			Cortical spreading depression causes and coincides with tissue hypoxia	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; TRANSGENIC MICE; VISUAL-CORTEX; MIGRAINE; BRAIN; ISCHEMIA; DEPOLARIZATION; MECHANISMS; HYPEREMIA; HEADACHE	Cortical spreading depression (CSD) is a self-propagating wave of cellular depolarization that has been implicated in migraine and in progressive neuronal injury after stroke and head trauma. Using two-photon microscopic NADH imaging and oxygen sensor microelectrodes in live mouse cortex, we find that CSD is linked to severe hypoxia and marked neuronal swelling that can last up to several minutes. Changes in dendritic structures and loss of spines during CSD are comparable to those during anoxic depolarization. Increasing O-2 availability shortens the duration of CSD and improves local redox state. Our results indicate that tissue hypoxia associated with CSD is caused by a transient increase in O-2 demand exceeding vascular O-2 supply.	Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; Novo Nordisk AS, Discovery, DK-2760 Malov, Denmark	University of Rochester; Novo Nordisk	Takano, T (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	takahiro_takano@urmc.rochester.edu		Takano, Takahiro/0000-0002-6235-6673; Kasischke, Karl/0000-0003-0582-4319	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030007, R01NS038073, R29NS030007] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38073, NS30007] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akin R, 2005, TURKISH J PEDIATR, V47, P150; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; Capobianco DJ, 2006, SEMIN NEUROL, V26, P242, DOI 10.1055/s-2006-939925; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; FABRICIUS M, 1993, BRAIN RES, V602, P350, DOI 10.1016/0006-8993(93)90701-N; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; HANSEN AJ, 1988, NEUROCHEM PATHOL, V9, P195; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V109, P1, DOI 10.1111/j.1748-1716.1980.tb06557.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Mayevsky A, 1998, ACT NEUR S, V71, P78; MAYEVSKY A, 1983, ADV EXP MED BIOL, V159, P129; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1982, BRAIN RES, V236, P93, DOI 10.1016/0006-8993(82)90037-3; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; MAYEVSKY A, 1980, J NEUROSCI RES, V5, P173, DOI 10.1002/jnr.490050302; McKendrick AM, 2004, INVEST OPHTH VIS SCI, V45, P1061, DOI 10.1167/iovs.03-0936; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; NEDERGAARD M, 1988, ACTA NEUROL SCAND, V77, P81, DOI 10.1111/j.1600-0404.1988.tb05878.x; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; NICHOLSON C, 1978, ARZNEIMITTEL-FORSCH, V28-1, P874; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Riva D, 2006, CEPHALALGIA, V26, P596, DOI 10.1111/j.1468-2982.2006.01072.x; Schulte ML, 2006, NEUROSCI LETT, V394, P63, DOI 10.1016/j.neulet.2005.10.008; Shepherd AJ, 2005, CEPHALALGIA, V25, P412, DOI 10.1111/j.1468-2982.2004.00831.x; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2005, ADV TECH STAND NEUR, V30, P3, DOI 10.1007/3-211-27208-9_1; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tomita M, 2005, J CEREBR BLOOD F MET, V25, P742, DOI 10.1038/sj.jcbfm.9600074; Umegaki M, 2005, J NEUROSCI, V25, P1387, DOI 10.1523/JNEUROSCI.4182-04.2005; Van Harreveld A, 1970, J Neurobiol, V2, P13, DOI 10.1002/neu.480020103; VANHARREVELD A, 1957, AM J PHYSIOL, V101, P233; Waldie KE, 2002, NEUROLOGY, V59, P904, DOI 10.1212/WNL.59.6.904; Yenice O, 2007, EYE, V21, P218, DOI 10.1038/sj.eye.6702251	50	323	330	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					754	762		10.1038/nn1902	http://dx.doi.org/10.1038/nn1902			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468748				2022-12-24	WOS:000246799800018
J	Yamazaki, D; Horiuchi, J; Nakagami, Y; Nagano, S; Tamura, T; Saitoe, M				Yamazaki, Daisuke; Horiuchi, Junjiro; Nakagami, Yasuko; Nagano, Shintaro; Tamura, Takuya; Saitoe, Minoru			The Drosophila DC0 mutation suppresses age-related memory impairment without affecting lifespan	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-A; SUPEROXIDE DISMUTASE/CATALASE MIMETICS; LONG-TERM POTENTIATION; PREFERENTIAL EXPRESSION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; GENETIC DISSECTION; LEARNING-DEFICITS; CALCIUM-CHANNELS; OXIDATIVE STRESS	The study of age-related memory impairment (AMI) has been hindered by a lack of AMI-specific mutants. In a screen for such mutants in Drosophila melanogaster, we found that heterozygous mutations of DC0 (DC0/+), which encodes the major catalytic subunit of cAMP-dependent protein kinase (PKA), delay AMI more than twofold without affecting lifespan or memory at early ages. AMI is restored when a DC0 transgene is expressed in mushroom bodies, structures important for olfactory memory formation. Furthermore, increasing cAMP and PKA activity in mushroom bodies causes premature AMI, whereas reducing activity suppresses AMI. In Drosophila AMI consists of a specific reduction in memory dependent on the amnesiac (amn) gene. amn encodes putative neuropeptides that have been proposed to regulate cAMP levels in mushroom bodies. Notably, both the memory and AMI defects of amn mutants are restored in amn; DC0/+ double mutants, suggesting that AMI is caused by an age-related disruption of amn-dependent memory via PKA activity in mushroom bodies.	Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; Tokyo Univ Sci, Fac Pharmaceut Sci, Chiba 2788510, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University; Tokyo University of Science; Tokyo Medical & Dental University (TMDU)	Saitoe, M (corresponding author), Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan.	saitoe@tmin.ac.jp		Saitoe, Minoru/0000-0001-9731-4214				Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bhattacharya A, 2004, J BIOL CHEM, V279, P37291, DOI 10.1074/jbc.M403819200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Foster TC, 2002, PROG BRAIN RES, V138, P283, DOI 10.1016/S0079-6123(02)38083-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Horiuchi J, 2005, AGEING RES REV, V4, P83, DOI 10.1016/j.arr.2004.10.001; Kiger JA, 2001, GENETICS, V158, P1157; Kiger JA, 1999, GENETICS, V152, P281; Kim D W, 2000, J Nutr Health Aging, V4, P233; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; Li W, 1996, LEARN MEMORY, V2, P320, DOI 10.1101/lm.2.6.320; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2; Markowska AL, 1999, NEUROBIOL AGING, V20, P177, DOI 10.1016/S0197-4580(99)00031-7; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Rosay P, 2001, NEURON, V30, P759, DOI 10.1016/S0896-6273(01)00323-3; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Saitoe M, 2005, REV NEUROSCIENCE, V16, P137; Sampayo JN, 2003, BIOCHEM SOC T, V31, P1305; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; STRAUBE KT, 1990, NEUROBIOL AGING, V11, P659, DOI 10.1016/0197-4580(90)90033-V; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Tully T, 1996, COLD SPRING HARB SYM, V61, P207; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Yanai S, 2004, NEUROBIOL AGING, V25, P325, DOI 10.1016/S0197-4580(03)00115-5; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	49	59	60	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					478	484		10.1038/nn1863	http://dx.doi.org/10.1038/nn1863			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	150PL	17322874				2022-12-24	WOS:000245228600019
J	Miller, CA; Sweatt, JD				Miller, Courtney A.; Sweatt, J. David			Covalent modification of DNA regulates memory formation	NEURON			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; GENE-EXPRESSION; ACETYLTRANSFERASE ACTIVITY; TRANSCRIPTIONAL REPRESSOR; HISTONE ACETYLTRANSFERASE; METHYLTRANSFERASE GENE; QUANTITATIVE PCR; METHYLATION; BINDING; MECP2	DNA methylation is a covalent chemical modification of DNA catalyzed by DNA methyltransferases (DNMTs). DNA methylation is associated with transcriptional silencing and has been studied extensively as a lifelong molecular information storage mechanism put in place during development. Here we report that DNMT gene expression is upregulated in the adult rat hippocampus following contextual fear conditioning and that DNMT inhibition blocks memory formation. In addition, fear conditioning is associated with rapid methylation and transcriptional silencing of the memory suppressor gene PP1 and demethylation and transcriptional activation of the synaptic plasticity gene reelin, indicating both methyltransferase and demethylase activity during consolidation. DNMT inhibition prevents the PP1 methylation increase, resulting in aberrant transcription of the gene during the memory-consolidation period. These results demonstrate that DNA methylation is dynamically regulated in the adult nervous system and that this cellular mechanism is a crucial step in memory formation.	Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@nrc.uab.edu	Miller, Courtney A/E-8651-2010	Miller, Courtney A/0000-0001-8628-4902; Sweatt, J. David/0000-0003-3567-485X	NIDA NIH HHS [R00 DA024761] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024761] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Brooks PJ, 1996, J NEUROSCI, V16, P939; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Deng J, 1999, MOL BRAIN RES, V71, P23, DOI 10.1016/S0169-328X(99)00147-3; Detich N, 2002, J BIOL CHEM, V277, P35791, DOI 10.1074/jbc.C200408200; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GOTO K, 1994, DIFFERENTIATION, V56, P39, DOI 10.1046/j.1432-0436.1994.56120039.x; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Huang YF, 2002, J NEUROSCI, V22, P8422; Huff NC, 2006, J NEUROSCI, V26, P1616, DOI 10.1523/JNEUROSCI.4964-05.2006; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jouvenceau A, 2006, EUR J NEUROSCI, V24, P564, DOI 10.1111/j.1460-9568.2006.04938.x; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Maciejak P, 2003, BRAIN RES BULL, V62, P39, DOI 10.1016/j.brainresbull.2003.08.003; Marquez VE, 2005, ANN NY ACAD SCI, V1058, P246, DOI 10.1196/annals.1359.037; Melia KR, 1996, NEUROSCIENCE, V74, P313, DOI 10.1016/0306-4522(96)00138-8; MONK M, 1987, DEVELOPMENT, V99, P371; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberson ED, 1999, J NEUROSCI, V19, P4337; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Santos KF, 2005, BRAZ J MED BIOL RES, V38, P1531, DOI 10.1590/S0100-879X2005001000010; Scarano MI, 2005, J CELL PHYSIOL, V204, P21, DOI 10.1002/jcp.20280; Siedlecki P, 2006, ACTA BIOCHIM POL, V53, P245; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; SZYF M, 1985, J BIOL CHEM, V260, P8653; SZYF M, 1991, J BIOL CHEM, V266, P10027; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Veldic M, 2004, P NATL ACAD SCI USA, V101, P348, DOI 10.1073/pnas.2637013100; Weeber Edwin J, 2002, Mol Interv, V2, P376, DOI 10.1124/mi.2.6.376; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605	66	861	908	0	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					857	869		10.1016/j.neuron.2007.02.022	http://dx.doi.org/10.1016/j.neuron.2007.02.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359920	Bronze			2022-12-24	WOS:000245292800010
J	Bekinschtein, P; Cammarota, M; Igaz, LM; Bevilaqua, LRM; Izquierdo, I; Medina, JH				Bekinschtein, Pedro; Cammarota, Martin; Igaz, Lionel Muller; Bevilaqua, Lia R. M.; Izquierdo, Ivan; Medina, Jorge H.			Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus	NEURON			English	Review							MEDIAL PREFRONTAL CORTEX; ELEMENT-BINDING PROTEIN; CONTEXTUAL FEAR MEMORY; 2 CRITICAL PERIODS; NEUROTROPHIC FACTOR; SPATIAL MEMORY; NMDA RECEPTOR; SYNAPTIC PLASTICITY; RETROGRADE-AMNESIA; RAT HIPPOCAMPUS	Persistence is the most characteristic attribute of long-term memory (LTM). To understand LTM, we must understand how memory traces persist over time despite the short-lived nature and rapid turnover of their molecular substrates. It is widely accepted that LTM formation is dependent upon hippocampal de novo protein synthesis and Brain-Derived Neurotrophic Factor (BDNF) signaling during or early after acquisition. Here we show that 12 hr after acquisition of a one-trial associative learning task, there is a novel protein synthesis and BDNF-dependent phase in the rat hippocampus that is critical for the persistence of LTM storage. Our findings indicate that a delayed stabilization phase is specifically required for maintenance, but not formation, of the memory trace. We propose that memory formation and memory persistence share some of the same molecular mechanisms and that recurrent rounds of consolidation-like events take place in the hippocampus for maintenance of the memory trace.	UBA, Fac Med, Inst Biol Celular & Neurociencias, Buenos Aires, DF, Argentina; UBA, Fac Med, Dept Fisiol, Buenos Aires, DF, Argentina; Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Ctr Memoria, BR-90610000 Porto Alegre, RS, Brazil	University of Buenos Aires; University of Buenos Aires; Pontificia Universidade Catolica Do Rio Grande Do Sul	Medina, JH (corresponding author), UBA, Fac Med, Inst Biol Celular & Neurociencias, Paraguay 2155 30 Piso,C1121ABG, Buenos Aires, DF, Argentina.	jmedina@fmed.uba.ar	Cammarota, Martin/AAC-7478-2021; Igaz, Lionel/AAP-3059-2020	Cammarota, Martin/0000-0001-9741-5074; Izquierdo, Ivan/0000-0002-7208-0869; Igaz, Lionel Muller/0000-0001-9988-3242; Bevilaqua, Lia/0000-0001-8537-1289; Bekinschtein, Pedro/0000-0002-0004-9619				Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alder J, 2003, J NEUROSCI, V23, P10800; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bilang-Bleuel A, 2002, EUR J NEUROSCI, V15, P1048, DOI 10.1046/j.1460-9568.2002.01934.x; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Brown AS, 2002, PSYCHON B REV, V9, P403, DOI 10.3758/BF03196300; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Burwell RD, 2004, J NEUROSCI, V24, P11023, DOI 10.1523/JNEUROSCI.3781-04.2004; Cammarota M, 2000, MOL BRAIN RES, V76, P36, DOI 10.1016/S0169-328X(99)00329-0; Countryman RA, 2005, NEUROBIOL LEARN MEM, V84, P175, DOI 10.1016/j.nlm.2005.07.005; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS HP, 1976, PHARMACOL BIOCHEM BE, V4, P13, DOI 10.1016/0091-3057(76)90168-4; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duvarci S, 2006, EUR J NEUROSCI, V24, P249, DOI 10.1111/j.1460-9568.2006.04907.x; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fleischmann A, 2003, J NEUROSCI, V23, P9116; FLOOD JF, 1975, PHYSIOL BEHAV, V14, P177, DOI 10.1016/0031-9384(75)90163-8; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Glorioso C, 2006, MOL PSYCHIATR, V11, P633, DOI 10.1038/sj.mp.4001835; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; GRECKSCH G, 1980, PHARMACOL BIOCHEM BE, V12, P663, DOI 10.1016/0091-3057(80)90145-8; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; He J, 2002, NEUROPSYCHOPHARMACOL, V26, P259, DOI 10.1016/S0893-133X(01)00332-3; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Igaz LM, 2002, J NEUROSCI, V22, P6781; Igaz LM, 2004, MOL BRAIN RES, V132, P1, DOI 10.1016/j.molbrainres.2004.08.016; Izquierdo I, 1998, TRENDS NEUROSCI, V21, P423, DOI 10.1016/S0166-2236(98)01279-X; Izquierdo I, 1999, EUR J NEUROSCI, V11, P3323, DOI 10.1046/j.1460-9568.1999.00742.x; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Johnston ANB, 1999, NEUROSCIENCE, V88, P1033, DOI 10.1016/S0306-4522(98)00362-5; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martinez A, 1998, J NEUROSCI, V18, P7336; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Merhav M, 2006, LEARN MEMORY, V13, P571, DOI 10.1101/lm.282406; MINIACI MC, 2005, SOC NEUROSCIENCE PRO; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Morrow BA, 1999, J NEUROSCI, V19, P5666; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Power AE, 2006, LEARN MEMORY, V13, P27, DOI 10.1101/lm.91206; Qiao XX, 1998, J NEUROSCI, V18, P6990; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Ring RH, 2006, J NEUROBIOL, V66, P361, DOI 10.1002/neu.20223; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sangha S, 2005, BEHAV NEUROSCI, V119, P787, DOI 10.1037/0735-7044.119.3.787; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Squire L R, 1987, Int J Neurol, V21-22, P218; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tiunova AA, 1998, LEARN MEMORY, V4, P401, DOI 10.1101/lm.4.5.401; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Tronel S, 2005, PLOS BIOL, V3, P1630, DOI 10.1371/journal.pbio.0030293; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Valjent E, 2006, J NEUROSCI, V26, P4956, DOI 10.1523/JNEUROSCI.4601-05.2006; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Viola HE, 2000, J NEUROSCI, V20; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Yasoshima Y, 2006, P NATL ACAD SCI USA, V103, P7106, DOI 10.1073/pnas.0600869103; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	126	458	466	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					261	277		10.1016/j.neuron.2006.11.025	http://dx.doi.org/10.1016/j.neuron.2006.11.025			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224407	Bronze			2022-12-24	WOS:000245126600011
J	Tojima, T; Akiyama, H; Itofusa, R; Li, Y; Katayama, H; Miyawaki, A; Kamiguchi, H				Tojima, Takuro; Akiyama, Hiroki; Itofusa, Rurika; Li, Yan; Katayama, Hiroyuki; Miyawaki, Atsushi; Kamiguchi, Hiroyuki			Attractive axon guidance involves asymmetric membrane transport and exocytosis in the growth cone	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH; FLUORESCENT PROTEIN; SIGNAL-TRANSDUCTION; TRPC CHANNELS; RHO-GTPASES; DYNAMICS; FILOPODIA; ADHESION; NEURONS; SNARE	Asymmetric elevation of the Ca2+ concentration in the growth cone can mediate both attractive and repulsive axon guidance. Ca2+ signals that are accompanied by Ca2+-induced Ca2+ release (CICR) trigger attraction, whereas Ca2+ signals that are not accompanied by CICR trigger repulsion. The molecular machinery downstream of Ca2+ signals, however, remains largely unknown. Here we report that asymmetric membrane trafficking mediates growth cone attraction. Local photolysis of caged Ca2+, together with CICR, on one side of the growth cone of a chick dorsal root ganglion neuron facilitated the microtubule-dependent centrifugal transport of vesicles towards the leading edge and their subsequent vesicle-associated membrane-protein 2 (VAMP2)-mediated exocytosis on the side with an elevated Ca2+ concentration. In contrast, Ca2+ signals without CICR had no effect on the vesicle transport. Furthermore, pharmacological inhibition of VAMP2-mediated exocytosis prevented growth cone attraction, but not repulsion. These results strongly suggest that growth cone attraction and repulsion are driven by distinct mechanisms, rather than using the same molecular machinery with opposing polarities.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama 3510198, Japan; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan	RIKEN; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; RIKEN	Kamiguchi, H (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Neuronal Growth Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamiguchi@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014; Kamiguchi, Hiroyuki/N-5409-2015; Tojima, Takuro/C-3667-2017	Miyawaki, Atsushi/0000-0002-2329-3235; Kamiguchi, Hiroyuki/0000-0003-1802-6324; Tojima, Takuro/0000-0002-9140-3205				Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Buck KB, 2002, J NEUROSCI, V22, P9358; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Diefenbach TJ, 1999, J NEUROSCI, V19, P9436; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Igarashi M, 1997, J NEUROSCI, V17, P1460; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; LOCKERBIE RO, 1991, J CELL BIOL, V112, P1215, DOI 10.1083/jcb.112.6.1215; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140	49	124	124	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					58	66		10.1038/nn1814	http://dx.doi.org/10.1038/nn1814			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159991				2022-12-24	WOS:000243096100016
J	Deneen, B; Ho, R; Lukaszewicz, A; Hochstim, CJ; Gronostajski, RM; Anderson, DJ				Deneen, Benjamin; Ho, Ritchie; Lukaszewicz, Agnes; Hochstim, Christian J.; Gronostajski, Richard M.; Anderson, David J.			The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord	NEURON			English	Article							RADIAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; OLIGODENDROCYTE LINEAGE; MOTOR-NEURON; ASTROCYTE LINEAGE; DNA METHYLATION; SONIC HEDGEHOG; NOTCH ACTIVITY	The mechanisms controlling the transition from neurogenesis to gliogenesis in the vertebrate CNS are incompletely understood. We identified a family of transcription factors, called NFI genes, which are induced throughout the spinal cord ventricular zone (VZ) concomitantly with the induction of GLAST, an early marker of gliogenesis. NFIA is both necessary and sufficient for GLAST induction in the VZ. Unexpectedly, NFIA is also essential for the continued inhibition of neurogenesis in VZ progenitors. This function is mediated by the requirement of NFIA for the expression of HES5, a Notch effector. However, Notch effectors are unable to promote glial-fate specification in the absence of NFIA. Thus, NFIA links the abrogation of neurogenesis to a generic program of gliogenesis, in both astrocyte and oligodendrocyte VZ progenitors. At later stages, NFIA promotes migration and differentiation of astrocyte precursors, a function that is antagonized in oligodendrocyte precursors by Olig2.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; SUNY Buffalo, Neurosci Program, Buffalo, NY 14214 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Anderson, DJ (corresponding author), CALTECH, Div Biol, 216-76,1201 E Calif Blvd, Pasadena, CA 91125 USA.	wuwei@caltech.edu		Deneen, Benjmain/0000-0002-6335-1081; Ho, Ritchie/0000-0003-1496-4436; Gronostajski, Richard/0000-0003-4264-208X	NINDS NIH HHS [R01-NS23476, 1F32NS048666] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS048666, R01NS023476] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agius E, 2004, DEV BIOL, V270, P308, DOI 10.1016/j.ydbio.2004.02.015; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Araki T, 2000, CELL DEATH DIFFER, V7, P485, DOI 10.1038/sj.cdd.4400674; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BANDYOPADHYAY S, 1994, J BIOL CHEM, V269, P29949; Bisgrove DA, 1999, DEV DYNAM, V214, P195, DOI 10.1002/(SICI)1097-0177(199903)214:3<195::AID-AJA3>3.0.CO;2-8; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cebolla B, 2006, J NEUROCHEM, V97, P1057, DOI 10.1111/j.1471-4159.2006.03804.x; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fukuda S, 2004, CELL DEATH DIFFER, V11, P196, DOI 10.1038/sj.cdd.4401332; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mason HA, 2006, DEV NEUROSCI-BASEL, V28, P49, DOI 10.1159/000090752; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; Miller LK, 1997, J CELL PHYSIOL, V173, P178, DOI 10.1002/(SICI)1097-4652(199711)173:2<178::AID-JCP17>3.3.CO;2-Z; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Mukouyama Y, 2006, P NATL ACAD SCI USA, V103, P1551, DOI 10.1073/pnas.0510658103; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ogawa Y, 2005, DEV NEUROSCI-BASEL, V27, P364, DOI 10.1159/000088452; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Satow T, 2001, J NEUROSCI, V21, P1265; Shibata T, 1997, J NEUROSCI, V17, P9212; Shu TZ, 2003, J NEUROSCI, V23, P203; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Vincent S, 1996, DEVELOPMENT, V122, P131; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Yan Y, 2004, DEV DYNAM, V231, P248, DOI 10.1002/dvdy.20126; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	76	316	326	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					953	968		10.1016/j.neuron.2006.11.019	http://dx.doi.org/10.1016/j.neuron.2006.11.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178400	Bronze			2022-12-24	WOS:000243115100005
J	Kim, WY; Zhou, FQ; Zhou, J; Yokota, Y; Wang, YM; Yoshimura, T; Kaibuchi, K; Woodgett, JR; Anton, ES; Snider, WD				Kim, Woo-Yang; Zhou, Feng-Quan; Zhou, Jiang; Yokota, Yukako; Wang, Yan-Min; Yoshimura, Takeshi; Kaibuchi, Kozo; Woodgett, James R.; Anton, E. S.; Snider, William D.			Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NEURONAL POLARITY; PHARMACOLOGICAL INHIBITORS; SENSORY NEURONS; GSK-3-BETA; PROTEIN; PHOSPHORYLATION; GSK3-BETA; BINDING; CONES	Glycogen synthase kinase-3 beta (GSK-3 beta) is thought to mediate morphological responses to a variety of extracellular signals. Surprisingly, we found no gross morphological deficits in nervous system development in GSK-3 beta null mice. We therefore designed an shRNA that targeted both GSK-3 isoforms. Strong knockdown of both GSK-3 alpha and beta markedly reduced axon growth in dissociated cultures and slice preparations. We then assessed the role of different GSK-3 substrates in regulating axon morphology. Elimination of activity toward primed substrates only using the GSK-3 R96A mutant was associated with a defect in axon polarity (axon branching) compared to an overall reduction in axon growth induced by a kinase-dead mutant. Consistent with this finding, moderate reduction of GSK-3 activity by pharmacological inhibitors induced axon branching and was associated primarily with effects on primed substrates. Our results suggest that GSK-3 is a downstream convergent point for many axon growth regulatory pathways and that differential regulation of primed versus all GSK-3 substrates is associated with a specific morphological outcome.	Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Nagoya Univ, Dept Cell Pharmacol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Nagoya University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Johns Hopkins University; Johns Hopkins University	Snider, WD (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	wsnider@med.unc.edu	Woodgett, Jim/F-1087-2010; Zhou, Fengquan/X-5782-2019; Yoshimura, Takeshi/F-3817-2012	Woodgett, Jim/0000-0003-3731-5797; Zhou, Fengquan/0000-0002-1525-9969; Yoshimura, Takeshi/0000-0002-0316-8082	NINDS NIH HHS [R01NS050968, R01 NS050968] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050968] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Fischer PM, 2003, CHEM BIOL, V10, P1144, DOI 10.1016/j.chembiol.2003.12.009; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Goold RG, 2004, BIOCHEM SOC T, V32, P809, DOI 10.1042/BST0320809; Goold RG, 1999, J CELL SCI, V112, P3373; Goslin K., 1998, CULTURING NERVE CELL, P339; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lucas FR, 1998, J CELL SCI, V111, P1351; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Smith DS, 1997, J NEUROSCI, V17, P646; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; TWORNEY C, 2006, FEBS LETT, V580, P4015; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yu JY, 2003, MOL THER, V7, P228, DOI 10.1016/S1525-0016(02)00037-0; Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	44	190	196	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					981	996		10.1016/j.neuron.2006.10.031	http://dx.doi.org/10.1016/j.neuron.2006.10.031			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178402	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000243115100007
J	Alais, D; Parker, A				Alais, David; Parker, Amanda			Independent binocular rivalry processes for motion and form	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; VISUAL-CORTEX; SUPPRESSION; PERCEPTION; DEPTH; STIMULI; PSYCHOPHYSICS; NEURONS	During binocular rivalry, conflicting monocular images undergo alternating suppression. This study explores rivalry suppression by probing visual sensitivity during rivalry with various probe stimuli. When two faces engage in rivalry, sensitivity to face probes is reduced 4-fold during suppression. Rivaling global motions also rivaled very deeply when probed with a global motion. However, in a surprising finding, sensitivity to face probes is completely unimpaired during global motion rivalry, and motion sensitivity is unimpaired during face rivalry. This suggests that rivalry suppression is localized to the neurons representing the image conflict, which means that probes of a different kind suffer no suppression. Sensibly, this would leave visual processes not involved in rivalry free to function normally.	Univ Sydney, Dept Physiol, Sch Med Sci, Sydney, NSW 2006, Australia; Univ Sydney, Inst Biomed Res, Sch Med Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Alais, D (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	davida@psych.usyd.edu.au						Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; Alais D, 2000, PERCEPTION, V29, P1437, DOI 10.1068/p3017; Alais D, 1998, VISION RES, V38, P637, DOI 10.1016/S0042-6989(97)00190-9; ALAIS D, 2006, IN PRESS VISION RES; Andrews TJ, 1999, NAT NEUROSCI, V2, P405, DOI 10.1038/8068; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1979, J EXP PSYCHOL HUMAN, V5, P315, DOI 10.1037/0096-1523.5.2.315; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BLAKE R, 1974, VISION RES, V14, P687, DOI 10.1016/0042-6989(74)90065-0; BLAKE R, 1985, PERCEPT PSYCHOPHYS, V37, P114, DOI 10.3758/BF03202845; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carlson TA, 2000, CURR BIOL, V10, P1055, DOI 10.1016/S0960-9822(00)00672-2; Carlson TA, 2004, NEURON, V43, P907, DOI 10.1016/j.neuron.2004.08.039; CARNEY T, 1987, NATURE, V328, P647, DOI 10.1038/328647a0; Creed RS, 1935, J PHYSIOL-LONDON, V84, P381, DOI 10.1113/jphysiol.1935.sp003288; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; FOX R, 1972, J EXP PSYCHOL, V93, P283, DOI 10.1037/h0032455; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; He S., 2005, BINOCULAR RIVALRY, P81; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; MAKOUS W, 1978, VISUAL PSYCHOPHYSICS; Nguyen VA, 2001, PERCEPT PSYCHOPHYS, V63, P348, DOI 10.3758/BF03194475; Nguyen VA, 2003, VISION RES, V43, P2003, DOI 10.1016/S0042-6989(03)00314-6; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TREISMAN A, 1962, Q J EXP PSYCHOL, V14, P23, DOI 10.1080/17470216208416507; WALES R, 1970, PERCEPT PSYCHOPHYS, V8, P90, DOI 10.3758/BF03210180; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Watson TL, 2004, CURR BIOL, V14, P1670, DOI 10.1016/j.cub.2004.08.064; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554	45	51	51	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					911	920		10.1016/j.neuron.2006.10.027	http://dx.doi.org/10.1016/j.neuron.2006.10.027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145510	Bronze			2022-12-24	WOS:000242856400017
J	Fisher, PM; Meltzer, CC; Ziolko, SK; Price, JC; Hariri, AR				Fisher, P. M.; Meltzer, C. C.; Ziolko, S. K.; Price, J. C.; Hariri, A. R.			Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity	NATURE NEUROSCIENCE			English	Article							GENETIC-VARIATION; MAJOR DEPRESSION; MICE LACKING; POLYMORPHISM; BINDING	We examined the contribution of 5-HT1A autoreceptors ( with [ C-11] WAY100635 positron emission tomography) to amygdala reactivity ( with blood oxygenation level - dependent functional magnetic resonance imaging) in 20 healthy adult volunteers. We found a significant inverse relationship wherein 5-HT1A autoreceptor density predicted a notable 30 - 44% of the variability in amygdala reactivity. Our data suggest a potential molecular mechanism by which a reduced capacity for negative feedback regulation of 5-HT release is associated with increased amygdala reactivity.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hariri, AR (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA.	haririar@upmc.edu	Fisher, Patrick MacDonald/V-8158-2017; Hariri, Ahmad/D-5761-2011	Fisher, Patrick MacDonald/0000-0002-8115-0611; 	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH072837, K24MH064625, R01MH079164, R01MH067602] Funding Source: NIH RePORTER; NIMH NIH HHS [MH64625, R01 MH067602, K24 MH064625, MH072837, R01 MH079164, MH067602] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arborelius L, 1999, IDrugs, V2, P121; Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lemonde S, 2004, INT J NEUROPSYCHOPH, V7, P501, DOI 10.1017/S1461145704004699; Lemonde S, 2003, J NEUROSCI, V23, P8788; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Parsey RV, 2006, BIOL PSYCHIAT, V59, P106, DOI 10.1016/j.biopsych.2005.06.016	12	129	130	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1362	1363		10.1038/nn1780	http://dx.doi.org/10.1038/nn1780			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17013380				2022-12-24	WOS:000242403800010
J	Kobayashi, S; Nomoto, K; Watanabe, M; Hikosaka, O; Schultz, W; Sakagami, M				Kobayashi, Shunsuke; Nomoto, Kensaku; Watanabe, Masataka; Hikosaka, Okihide; Schultz, Wolfram; Sakagami, Masamichi			Influences of rewarding and aversive outcomes on activity in macaque lateral prefrontal cortex	NEURON			English	Article							SINGLE NEURON RESPONSES; ORBITOFRONTAL CORTEX; EXPECTED REWARD; MONKEY; ATTENTION; STIMULI; AMYGDALA; ENCODE; MECHANISMS; AVOIDANCE	Both appetitive and aversive outcomes can reinforce animal behavior. It is not clear, however, whether the opposing kinds of reinforcers are processed by specific or common neural mechanisms. To investigate this issue, we studied macaque monkeys that performed a memory-guided saccade task for three different outcomes, namely delivery of liquid reward, avoidance of air puff, and feedback sound only. Animals performed the task best in rewarded trials, intermediately in aversive trials, and worst in sound-only trials. Most task-related activity in lateral prefrontal cortex was differentially influenced by the reinforcers. Aversive avoidance had clear effects on some prefrontal neurons, although the effects of rewards were more common. We also observed neurons modulated by both positive and negative reinforcers, reflecting reinforcement or attentional processes. Our results demonstrate that information about positive and negative reinforcers is processed differentially in prefrontal cortex, which could contribute to the role of this structure in goal-directed behavior.	Tamagawa Univ, Res Inst, Brain Sci Res Ctr, Tokyo 1940041, Japan; Tokyo Metropolitan Inst Neurosci, Dept Psychol, Tokyo 1838526, Japan; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; Univ Tokyo, Sch Med, Dept Psychiat, Tokyo 1138655, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Cambridge; University of Tokyo	Kobayashi, S (corresponding author), Tamagawa Univ, Res Inst, Brain Sci Res Ctr, Tokyo 1940041, Japan.	skoba-tky@umin.ac.jp	Kobayashi, Shunsuke/C-2551-2008; schultz, wolfram/H-8958-2016	Kobayashi, Shunsuke/0000-0002-6868-9313; Nomoto, Kensaku/0000-0003-2953-4594; schultz, wolfram/0000-0002-8530-4518	Medical Research Council [G0001354] Funding Source: Medline; Wellcome Trust [095495] Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000415, Z01EY000415] Funding Source: NIH RePORTER; Medical Research Council [G0001354B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Bendiksby MS, 2006, NEUROPSYCHOLOGIA, V44, P2411, DOI 10.1016/j.neuropsychologia.2006.04.011; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; CAHILL L, 1990, BEHAV NEUROSCI, V104, P532, DOI 10.1037/0735-7044.104.4.532; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fanselow M.S., 1997, LEARNING MOTIVATION, P321; Gottfried JA, 2002, J NEUROSCI, V22, P10829; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Koyama T, 2001, NEUROSCI RES, V39, P421, DOI 10.1016/S0168-0102(01)00197-3; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; LEWIS DA, 1987, J NEUROSCI, V7, P279; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Luck SJ, 1995, BEHAV BRAIN RES, V71, P113, DOI 10.1016/0166-4328(95)00041-0; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MUIR JL, 1994, J NEUROSCI, V14, P2313; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Nishijo H, 1997, NEUROSCI LETT, V227, P79, DOI 10.1016/S0304-3940(97)00310-8; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Ravel S, 2003, J NEUROSCI, V23, P8489; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Solomon RL, 1953, PSYCHOL MONOGR-GEN A, V67, P1, DOI 10.1037/h0093649; SOLOMON RL, 1954, PSYCHOL REV, V61, P353, DOI 10.1037/h0054540; STERIADE H, 1990, BRAIN CHOLINERGIC SY, P3; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Yamada H, 2004, J NEUROSCI, V24, P3500, DOI 10.1523/JNEUROSCI.0068-04.2004; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001	41	79	84	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					861	870		10.1016/j.neuron.2006.08.031	http://dx.doi.org/10.1016/j.neuron.2006.08.031			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982429	Bronze			2022-12-24	WOS:000240997900022
J	Li, Y; Wu, YY; Zhou, Y				Li, Yong; Wu, Yuying; Zhou, Yi			Modulation of inactivation properties of Ca(v)2.2 channels by 14-3-3 proteins	NEURON			English	Article							GATED CA2+ CHANNELS; VOLTAGE-DEPENDENT INACTIVATION; PRESYNAPTIC CALCIUM CURRENT; N-TYPE; MOLECULAR DETERMINANTS; HIPPOCAMPAL-NEURONS; POTASSIUM CHANNEL; STRUCTURAL BASIS; BETA-SUBUNITS; IN-VIVO	Inactivation of presynaptic Ca(v)2.2 channels may play a role in regulating short-term synaptic plasticity. Here, we report a direct modulation of Ca(v)2.2 channel inactivation properties by 14-3-3, a family of signaling proteins involved in a wide range of biological processes. The structural elements critical for 14-3-3 binding and channel modulation lie in the carboxyl tail of the pore-forming alpha(1B) subunit, where we have identified two putative 14-3-3 interaction sites, including a phosphoserine-containing motif that directly binds to 14-3-3 and a second region near the EF hand and 10 domain. In transfected tsA 201 cells, 14-3-3 coexpression dramatically slows open-state inactivation and reduces cumulative inactivation of Ca(v)2.2 channels. In hippocampal neurons, interference with 14-3-3 binding accelerates Ca(v)2.2 channel inactivation and enhances short-term synaptic depression. These results demonstrate that 14-3-3 proteins are important regulators of Ca(v)2.2 channel activities and through this mechanism may contribute to their regulation of synaptic transmission and plasticity.	Univ Alabama, Dept Neurobiol, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Civitan Int Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zhou, Y (corresponding author), Univ Alabama, Dept Neurobiol, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA.	yizhou@uab.edu	Li, Yong/ABB-5588-2021					Baxter J, 2002, GENDER EDUC, V14, P5, DOI 10.1080/09540250120098843; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Degtiar VE, 2000, J NEUROSCI, V20, P4355, DOI 10.1523/JNEUROSCI.20-12-04355.2000; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Jarvis SE, 2001, J NEUROSCI, V21, P2939, DOI 10.1523/JNEUROSCI.21-09-02939.2001; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jones SW, 2003, J BIOENERG BIOMEMBR, V35, P461, DOI 10.1023/B:JOBB.0000008020.86004.28; Kaplan MP, 2003, SYNAPSE, V50, P41, DOI 10.1002/syn.10244; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Luk SCW, 1999, J CELL BIOCHEM, V73, P31, DOI 10.1002/(SICI)1097-4644(19990401)73:1<31::AID-JCB4>3.0.CO;2-X; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Mao H, 2005, J NEUROSCI, V25, P7934, DOI 10.1523/JNEUROSCI.0635-05.2005; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Moore BE, 1967, PHYSL BIOCH ASPECTS, P343; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nooney JM, 1997, TRENDS PHARMACOL SCI, V18, P363, DOI 10.1016/S0165-6147(97)01110-3; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; Park D, 1998, J NEUROSCI, V18, P6757; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; PLUMMER MR, 1991, NATURE, V351, P657, DOI 10.1038/351657a0; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; Thaler C, 2004, P NATL ACAD SCI USA, V101, P5675, DOI 10.1073/pnas.0303402101; Toyooka K, 2002, MOL BRAIN RES, V100, P13, DOI 10.1016/S0169-328X(02)00129-8; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhong HJ, 2001, P NATL ACAD SCI USA, V98, P4705, DOI 10.1073/pnas.051629098; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	52	39	41	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					755	771		10.1016/j.neuron.2006.08.014	http://dx.doi.org/10.1016/j.neuron.2006.08.014			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982421	Bronze			2022-12-24	WOS:000240997900014
J	Heurteaux, C; Lucas, G; Guy, N; El Yacoubi, M; Thummler, S; Peng, XD; Noble, F; Blondeau, N; Widmann, C; Borsotto, M; Gobbi, G; Vaugeois, JM; Debonnel, G; Lazdunski, M				Heurteaux, Catherine; Lucas, Guillaume; Guy, Nicolas; El Yacoubi, Malika; Thummler, Susanne; Peng, Xiao-Dong; Noble, Florence; Blondeau, Nicolas; Widmann, Catherine; Borsotto, Marc; Gobbi, Gabriella; Vaugeois, Jean-Marie; Debonnel, Guy; Lazdunski, Michel			Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype	NATURE NEUROSCIENCE			English	Article							DOMAIN K+ CHANNELS; TAIL SUSPENSION TEST; FORCED SWIM TEST; IN-VIVO; ANTIDEPRESSANT TREATMENTS; METABOLITE NORFLUOXETINE; HIPPOCAMPAL NEUROGENESIS; LEARNED HELPLESSNESS; ARACHIDONIC-ACID; NERVOUS-SYSTEM	Depression is a devastating illness with a lifetime prevalence of up to 20%. The neurotransmitter serotonin or 5-hydroxytryptamine (5-HT) is involved in the pathophysiology of depression and in the effects of antidepressant treatments. However, molecular alterations that underlie the pathology or treatment of depression are still poorly understood. The TREK-1 protein is a background K+ channel regulated by various neurotransmitters including 5-HT. In mice, the deletion of its gene (Kcnk2, also called TREK-1) led to animals with an increased efficacy of 5-HT neurotransmission and a resistance to depression in five different models and a substantially reduced elevation of corticosterone levels under stress. TREK-1-deficient (Kcnk2(-/-)) mice showed behavior similar to that of naive animals treated with classical antidepressants such as fluoxetine. Our results indicate that alterations in the functioning, regulation or both of the TREK-1 channel may alter mood, and that this particular K+ channel may be a potential target for new antidepressants.	Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, Inst Paul Hamel, F-06560 Valbonne, France; McGill Univ, Dept Psychiat, Montreal, PQ, Canada; CNRS, Fac Med & Pharm, Unite Neuropsychopharmacol Expt, FRE 2735,IFRMP 23, F-76183 Rouen, France; CNRS, Dept Pharmacochim Mol & Struct, INSERM U266, FRE 2463,Unite Format & Rech Sci Pharmaceut & Bio, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; McGill University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lazdunski, M (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, Inst Paul Hamel, 660 Route Lucioles, F-06560 Valbonne, France.	ipmc@ipmc.cnrs.fr	Blondeau, Nicolas P/M-5002-2016; BORSOTTO, Marc/M-5096-2016; Lucas, Guillaume/N-6993-2017; Blondeau, Nicolas/T-1136-2019; Yan, Shuo/B-8381-2009; HEURTEAUX, Catherine/M-4947-2016; Gobbi, Gabriella/I-2786-2013	Blondeau, Nicolas P/0000-0001-5954-4094; BORSOTTO, Marc/0000-0002-1302-7419; Lucas, Guillaume/0000-0003-0647-9756; HEURTEAUX, Catherine/0000-0002-9741-9777; Gobbi, Gabriella/0000-0003-4124-9825; THUMMLER, Susanne/0000-0001-9993-6981; Vaugeois, Jean-Marie/0000-0001-8296-672X; Noble, Florence/0000-0003-4497-0212; EL YACOUBI, Malika/0000-0002-1010-9179				Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; CACCIA S, 1990, PSYCHOPHARMACOLOGY, V100, P509, DOI 10.1007/BF02244004; Caldarone BJ, 2000, PHARMACOL BIOCHEM BE, V66, P811, DOI 10.1016/S0091-3057(00)00271-9; Caldarone BJ, 2003, PSYCHOPHARMACOLOGY, V170, P94, DOI 10.1007/s00213-003-1518-7; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; COPPEN A, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2002, EUR J PHARMACOL, V436, P197, DOI 10.1016/S0014-2999(01)01628-4; Delgado PL, 1999, BIOL PSYCHIAT, V46, P212, DOI 10.1016/S0006-3223(99)00014-1; DESCARRIES L, 1982, J COMP NEUROL, V207, P239, DOI 10.1002/cne.902070305; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gobbi G, 2001, J PHARMACOL EXP THER, V296, P987; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Haddjeri N, 1998, J NEUROSCI, V18, P10150; HERMANN G, 1994, J NEUROIMMUNOL, V53, P173, DOI 10.1016/0165-5728(94)90027-2; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heuser IJE, 1996, AM J PSYCHIAT, V153, P93; KAMEYAMA T, 1985, NEUROPHARMACOLOGY, V24, P285, DOI 10.1016/0028-3908(85)90133-9; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; KOMOROSKI RA, 1994, MAGNET RESON MED, V31, P204, DOI 10.1002/mrm.1910310214; LAPIN IP, 1969, LANCET, V1, P132; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Maes Michael, 1995, P933; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Owens M J, 1996, Depress Anxiety, V4, P153, DOI 10.1002/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Redrobe JP, 2005, PEPTIDES, V26, P1394, DOI 10.1016/j.peptides.2005.03.029; Reyes R, 2000, NEUROSCIENCE, V95, P893; Ripoll N, 2003, BEHAV BRAIN RES, V143, P193, DOI 10.1016/S0166-4328(03)00034-2; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Xu XG, 2002, J NEUROGENET, V16, P263, DOI 10.1080/01677060216294	49	290	314	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1134	1141		10.1038/nn1749	http://dx.doi.org/10.1038/nn1749			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16906152				2022-12-24	WOS:000240080800014
J	Moriceau, S; Sullivan, RM				Moriceau, Stephanie; Sullivan, Regina M.			Maternal presence serves as a switch between learning fear and attraction in infancy	NATURE NEUROSCIENCE			English	Article							MALTREATMENT; NEUROBIOLOGY; BEHAVIOR; AMYGDALA; EVENTS; STRESS	Odor-shock conditioning produces either olfactory preference or aversion in preweanling (12-15 days old) rats, depending on the context. In the mother's absence, odor-shock conditioning produces amygdala activation and learned odor avoidance. With maternal presence, this same conditioning yields an odor preference without amygdala activation. Maternal presence acts through modulation of pup corticosterone and corticosterone's regulation of amygdala activity. Over-riding maternal suppression of corticosterone through intra-amygdala corticosterone infusions permits fear conditioning and amygdala activation.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Sullivan, RM (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	rsullivan@ou.edu		Moriceau, Stephanie/0000-0002-1413-9359; Sullivan, Regina Marie/0000-0002-2406-8857	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033402] Funding Source: NIH RePORTER; NICHD NIH HHS [HD33402, R01 HD033402] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barr G A, 1995, NIDA Res Monogr, V158, P172; CAMP LL, 1988, DEV PSYCHOBIOL, V21, P25, DOI 10.1002/dev.420210103; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; HAROUTUNIAN V, 1979, SCIENCE, V205, P927, DOI 10.1126/science.472715; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Levine S, 2000, EUR J PHARMACOL, V405, P149, DOI 10.1016/S0014-2999(00)00548-3; Maestripieri D, 2005, NEUROSCI BIOBEHAV R, V29, P51, DOI 10.1016/j.neubiorev.2004.05.004; Moriceau S, 2004, BEHAV NEUROSCI, V118, P274, DOI 10.1037/0735-7044.118.2.274; MORICEAU S, J NEUROSCI, V26, P6737; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Roth TL, 2005, BIOL PSYCHIAT, V57, P823, DOI 10.1016/j.biopsych.2005.01.032; STANTON ME, 1990, DEV PSYCHOBIOL, V23, P411, DOI 10.1002/dev.420230504; Sullivan RM, 2000, NATURE, V407, P38, DOI 10.1038/35024156; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1	15	259	263	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1004	1006		10.1038/nn1733	http://dx.doi.org/10.1038/nn1733			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16829957	Green Accepted			2022-12-24	WOS:000240080300011
J	Pesaran, B; Nelson, MJ; Andersen, RA				Pesaran, Bijan; Nelson, Matthew J.; Andersen, Richard A.			Dorsal premotor neurons encode the relative position of the hand, eye, and goal during reach planning	NEURON			English	Article							ARM MOVEMENTS; VISUAL SPACE; PARIETAL; CORTEX; AREA; REPRESENTATION; TRANSFORMATIONS; MODULATION; DISCHARGE; DIRECTION	When reaching to grasp an object, we often move our arm and orient our gaze together. How are these movements coordinated? To investigate this question, we studied neuronal activity in the dorsal premotor area (PMd) and the medial intraparietal area (area MIP) of two monkeys while systematically varying the starting position of the hand and eye during reaching. PMd neurons encoded the relative position of the target, hand, and eye. MIP neurons encoded target location with respect to the eye only. These results indicate that whereas MIP encodes target locations in an eye-centered reference frame, PMd uses a relative position code that specifies the differences in locations between all three variables. Such a relative position code may play an important role in coordinating hand and eye movements by computing their relative position.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Pesaran, B (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	bijan@vis.caltech.edu	Nelson, Matthew/K-6635-2018	Nelson, Matthew/0000-0002-2325-4578; Pesaran, Bijan/0000-0003-4116-0038	NEI NIH HHS [R01 EY005522-21, R01 EY005522, EY05522-21] Funding Source: Medline; NIMH NIH HHS [R01 MH062528, MH62528-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062528] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Boussaoud D, 1998, J NEUROPHYSIOL, V80, P1132, DOI 10.1152/jn.1998.80.3.1132; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; CAMINITI R, 1990, EXP BRAIN RES, V83, P228; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Cisek P, 2002, J NEUROPHYSIOL, V88, P1064, DOI 10.1152/jn.00995.2001; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; CSORBA M, 1997, SPIE; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Khan AZ, 2005, CEREB CORTEX, V15, P1547, DOI 10.1093/cercor/bhi033; Matelli M, 1998, J COMP NEUROL, V402, P327; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Newman P., 1999, THESIS U SYDNEY SYDN; OLFATI R, 2002, P 15 IFAC C; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; SHADMEHR, 2005, COMPUTATIONAL NEUROB; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SOECHTING JF, 1995, J NEUROSCI, V15, P6271; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; TWEED D, 1987, J NEUROPHYSIOL, V58, P832, DOI 10.1152/jn.1987.58.4.832; van Donkelaar P, 2002, HUM MOVEMENT SCI, V21, P377, DOI 10.1016/S0167-9457(02)00121-5	45	252	261	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					125	134		10.1016/j.neuron.2006.05.025	http://dx.doi.org/10.1016/j.neuron.2006.05.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815337	Bronze, Green Accepted			2022-12-24	WOS:000239037700015
J	Hung, CP; Ramsden, BM; Roe, AW				Hung, Chou P.; Ramsden, Benjamin M.; Roe, Anna Wang			A functional circuitry for edge-induced brightness perception	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; FILLING-IN; MACAQUE V1; SPATIAL SUMMATION; STRIATE CORTEX; SIMPLE CELLS; SURFACE; REPRESENTATION; SYNCHRONIZATION; LUMINANCE	The identification of visual contours and surfaces is central to visual scene segmentation. One view of image construction argues that object contours are first identified and then surfaces are filled in. Although there are psychophysical and single-unit data to suggest that the filling-in view is correct, the underlying circuitry is unknown. Here we examine specific spike-timing relationships between border and surface responses in cat visual cortical areas 17 and 18. With both real and illusory ( Cornsweet) brightness contrast stimuli, we found a border-to- surface shift in the relative timing of spike activity. This shift was absent when borders were absent and could be reversed with relocation of the stimulus border, indicating that the direction of information flow is highly dependent on stimulus conditions. Furthermore, this effect was seen predominantly in 17-18,and not 17-17, interactions. These results demonstrate a border-to- surface mechanism at early stages of visual processing and emphasize the importance of interareal circuitry in vision.	Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA; Natl Yang Ming Univ, Inst Neurosci & Brain Res Ctr, Taipei 112, Taiwan; W Virginia Sch Med, Sensory Neurosci Res Ctr, Dept Neurobiol & Anat, Morgantown, WV 26506 USA	Vanderbilt University; National Yang Ming Chiao Tung University	Roe, AW (corresponding author), Vanderbilt Univ, Dept Psychol, 301 Wilson Hall, Nashville, TN 37203 USA.	anna.roe@vanderbilt.edu		Roe, Anna Wang/0000-0003-4146-9705	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015574] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011744, T32EY007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007290] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-15574] Funding Source: Medline; NEI NIH HHS [EY-11744, 5T32 EY-07115] Funding Source: Medline; NIDA NIH HHS [5T32 DA-07290] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; Blakeslee B, 2005, VISION RES, V45, P607, DOI 10.1016/j.visres.2004.09.027; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; BRAVO M, 1988, VISION RES, V28, P861, DOI 10.1016/0042-6989(88)90095-8; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1264, DOI 10.1152/jn.1979.42.5.1264; BURR DC, 1987, VISION RES, V27, P1903, DOI 10.1016/0042-6989(87)90056-3; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Cornsweet T., 1970, VISUAL PERCEPTION; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Davey MP, 1998, VISION RES, V38, P2037, DOI 10.1016/S0042-6989(97)00329-5; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; DEWEERD P, 1993, EUR J NEUROSCI, V5, P1695; Elder JH, 1998, VISION RES, V38, P143, DOI 10.1016/S0042-6989(97)00138-7; FERSTER D, 1991, J NEUROPHYSIOL, V66, P1667, DOI 10.1152/jn.1991.66.5.1667; GIVRE SJ, 1994, VISION RES, V34, P415, DOI 10.1016/0042-6989(94)90156-2; Grossberg S, 2006, SPATIAL VISION, V19, P263, DOI 10.1163/156856806776923399; Hung CP, 2001, VISION RES, V41, P1389, DOI 10.1016/S0042-6989(01)00075-X; Hung CP, 2002, J NEUROPHYSIOL, V87, P2542, DOI 10.1152/jn.00420.2001; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Komatsu H, 1998, BEHAV BRAIN SCI, V21, P761, DOI 10.1017/S0140525X98371757; Komatsu H, 2000, J NEUROSCI, V20, P9310; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; MacEvoy SP, 1998, NAT NEUROSCI, V1, P616, DOI 10.1038/2849; MUMFORD D, 1987, P NATL ACAD SCI USA, V84, P7354, DOI 10.1073/pnas.84.20.7354; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; Paradiso MA, 1996, VISION RES, V36, P2657, DOI 10.1016/0042-6989(96)00033-8; Paradiso MA, 2000, CURR BIOL, V10, pR15, DOI 10.1016/S0960-9822(99)00249-3; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Purves D, 1999, J NEUROSCI, V19, P8542; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Roe AW, 2005, P NATL ACAD SCI USA, V102, P3869, DOI 10.1073/pnas.0500097102; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; Siegel M, 2003, J NEUROSCI, V23, P4251; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; TSO DY, 1986, J NEUROSCI, V6, P1160; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; [No title captured]	48	46	46	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1185	1190		10.1038/nn1948	http://dx.doi.org/10.1038/nn1948			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17704775				2022-12-24	WOS:000249144000021
J	Day, JJ; Roitman, MF; Wightman, RM; Carelli, RM				Day, Jeremy J.; Roitman, Mitchell F.; Wightman, R. Mark; Carelli, Regina M.			Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; VENTRAL TEGMENTAL AREA; NEURONS ENCODE; REWARD; RECEPTORS; RESPONSES; RELEASE; CORE; PERFORMANCE; STIMULI	The ability to predict favorable outcomes using environmental cues is an essential part of learned behavior. Dopamine neurons in the midbrain encode such stimulus-reward relationships in a manner consistent with contemporary learning models, but it is unclear how encoding this translates into actual dopamine release in target regions. Here, we sampled dopamine levels in the rat nucleus accumbens on a rapid (100 ms) timescale using electrochemical technology during a classical conditioning procedure. Early in conditioning, transient dopamine-release events signaled a primary reward, but not predictive cues. After repeated cue-reward pairings, dopamine signals shifted in time to predictive cue onset and were no longer observed at reward delivery. In the absence of stimulus-reward conditioning, there was no shift in the dopamine signal. Consistent with proposed roles in reward prediction and incentive salience, these results indicate that rapid dopamine release provides a reward signal that is dynamically modified by associative learning.	Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carelli, RM (corresponding author), Univ N Carolina, Dept Psychol, CB 3270, Chapel Hill, NC 27599 USA.	rcarelli@unc.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399	NIDA NIH HHS [F31 DA021979-01, DA 018298, DA 10900, DA 021979, F31 DA021979, DA 017318] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA021979, R01DA017318, R01DA010900, K01DA018298] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bassareo V, 1997, J NEUROSCI, V17, P851; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Cardinal RN, 2002, BEHAV NEUROSCI, V116, P553, DOI 10.1037/0735-7044.116.4.553; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Cragg SJ, 2003, J NEUROSCI, V23, P4378; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Day JJ, 2006, EUR J NEUROSCI, V23, P1341, DOI 10.1111/j.1460-9568.2006.04654.x; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Eyny YS, 2003, J NEUROSCI, V23, P1584; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; MARGOLIS EB, 2006, J PHYSL, V15, P907; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Pan WX, 2005, J NEUROSCI, V25, P4725, DOI 10.1523/JNEUROSCI.0277-05.2005; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Phillips PEM, 2003, METH MOLEC MED, V79, P443; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Uslaner JM, 2006, BEHAV BRAIN RES, V169, P320, DOI 10.1016/j.bbr.2006.02.001; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243	50	443	446	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1020	1028		10.1038/nn1923	http://dx.doi.org/10.1038/nn1923			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603481				2022-12-24	WOS:000248357500016
J	Liu, Q; Vrontou, S; Rice, FL; Zylka, MJ; Dong, XZ; Anderson, DJ				Liu, Qin; Vrontou, Sophia; Rice, Frank L.; Zylka, Mark J.; Dong, Xinzhong; Anderson, David J.			Molecular genetic visualization of a rare subset of unmyelinated sensory neurons that may detect gentle touch	NATURE NEUROSCIENCE			English	Article							TACTILE AFFERENTS; HUMAN SKIN; FAMILY; RECEPTORS; FIBERS; HAIRY; GPCRS	C-fiber tactile afferents are a subpopulation of unmyelinated cutaneous sensory neurons activated by gentle stroking. Using a genetically encoded tracer, we found that Mas-related G protein-coupled receptor B4 marks a rare subpopulation of unmyelinated, nonpeptidergic sensory fibers that exclusively innervate hairy skin. These fibers terminate in large arborizations similar in size and distribution to C-fiber tactile afferent receptive fields, suggesting that MrgprB4 may provide genetic access to these elusive neurons in mice.	Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Howard Hughes Med Inst, Pasadena, CA 91125 USA; Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Univ N Carolina, Ctr Neurosci, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Johns Hopkins University; California Institute of Technology; Howard Hughes Medical Institute; Albany Medical College; University of North Carolina; University of North Carolina Chapel Hill	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	xdong2@jhmi.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS048499] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Habler HJ, 1999, NEUROSCIENCE, V89, P1259, DOI 10.1016/S0306-4522(98)00322-4; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; KUMAZAWA T, 1977, J PHYSIOLOGY PARIS, V73, P287; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Schmidt R, 2002, J NEUROPHYSIOL, V88, P1859, DOI 10.1152/jn.2002.88.4.1859; SENO N, 1993, NEUROSCIENCE, V55, P563, DOI 10.1016/0306-4522(93)90524-J; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	15	140	141	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					946	948		10.1038/nn1937	http://dx.doi.org/10.1038/nn1937			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618277				2022-12-24	WOS:000248357500007
J	Tsai, JW; Bremner, KH; Vallee, RB				Tsai, Jin-Wu; Bremner, K. Helen; Vallee, Richard B.			Dual subcellular roles for LIS1 and dynein in radial neuronal migration in live brain tissue	NATURE NEUROSCIENCE			English	Article							CYTOPLASMIC DYNEIN; BINDING PROTEIN; CENTROSOME; MYOSIN; ORGANIZATION; CDC42; MOVEMENT; DYNACTIN; DIVISION; MOTILITY	During brain development, neural precursor cells migrate along radial glial fibers to populate the neocortex. RNA interference (RNAi) of the lissencephaly gene LIS1 (also known as PAFAH1b1) inhibits somal movement but not process extension of neural precursors in live brain slices. Here we report imaging of the subcellular events accompanying neural precursor migration and the effects of LIS1, cytoplasmic dynein and myosin II inhibition. Centrosomes move continuously and often far in advance of nuclei, which show extreme saltatory behavior. LIS1 and dynein RNAi inhibit centrosomal and nuclear movement independently, whereas myosin II inhibition blocks only nuclear translocation. Imaging of the microtubule end-binding protein 3 (EB3) reveals a centrosome-centered array of microtubules in live neural precursors under all conditions examined. Dynein is concentrated both at a swelling in the leading process reported to initiate each migratory cycle and in the soma. Thus, dynein pulls on the microtubule network from the swelling. The nucleus is transported along the trailing microtubules by dynein assisted by myosin II.	Columbia Univ, Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Vallee, RB (corresponding author), Columbia Univ, Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, 630 W 168th St, New York, NY 10032 USA.	rv2025@columbia.edu	Tsai, Jin W/A-6428-2009	Tsai, Jin-Wu/0000-0003-0135-759X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047434, R37GM047434] Funding Source: NIH RePORTER; NICHD NIH HHS [HD40182] Funding Source: Medline; NIGMS NIH HHS [GM47434] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; JACOBS JR, 1986, J CELL BIOL, V103, P895, DOI 10.1083/jcb.103.3.895; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Morris R, 2000, NAT CELL BIOL, V2, pE201, DOI 10.1038/35041123; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Stepanova T, 2003, J NEUROSCI, V23, P2655; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Xie ZG, 2004, CELL CYCLE, V3, P108	38	326	329	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					970	979		10.1038/nn1934	http://dx.doi.org/10.1038/nn1934			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618279				2022-12-24	WOS:000248357500011
J	Lessard, J; Wu, JI; Ranish, JA; Wan, M; Winslow, MM; Staahl, BT; Wu, H; Aebersold, R; Graef, IA; Crabtree, GR				Lessard, Julie; Wu, Jiang I.; Ranish, Jeffrey A.; Wan, Mimi; Winslow, Monte M.; Staahl, Brett T.; Wu, Hai; Aebersold, Ruedi; Graef, Isabella A.; Crabtree, Gerald R.			An essential switch in subunit composition of a chromatin remodeling complex during neural development	NEURON			English	Article							MAMMALIAN SWI/SNF COMPLEXES; ASYMMETRIC CELL-DIVISION; STEM-CELLS; RETINOBLASTOMA PROTEIN; MASS-SPECTROMETRY; CNS PRECURSOR; CYCLE ARREST; BRG1; MAINTENANCE; GENES	Mammalian neural stem cells (NSCs) have the capacity to both self-renew and to generate all the neuronal and glial cell-types of the adult nervous system. Global chromatin changes accompany the transition from proliferating NSCs to committed neuronal lineages, but the mechanisms involved have been unclear. Using a proteomics approach, we show that a switch in subunit composition of neural, ATP-dependent SWI/SNF-like chromatin remodeling complexes accompanies this developmental transition. Proliferating neural stem and progenitor cells express complexes in which BAF45a, a Kruppel/PHD domain protein and the actin-related protein IBAF53a are quantitatively associated with the SW12/SNF2-like ATPases, Brg and Brm. As neural progenitors exit the cell cycle, these subunits are replaced by the homologous BAF45b, BAF45c, and BAF53b. BAF45a/53a subunits are necessary and sufficient for neural progenitor proliferation. Preventing the subunit switch impairs neuronal differentiation, indicating that this molecular event is essential for the transition from neural stem/progenitors to postmitotic neurons. More broadly, these studies suggest that SWI/SNF-like complexes in vertebrates achieve biological specificity by combinatorial assembly of their subunits.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Inst Syst Biol, Seattle, WA 98103 USA	Howard Hughes Medical Institute; Stanford University; Institute for Systems Biology (ISB)	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, 279 Campus Dr, Stanford, CA 94305 USA.	crabtree@stanford.edu			NHLBI NIH HHS [N01-HV-28179, N01HV28179] Funding Source: Medline; NICHD NIH HHS [R01 HD055391] Funding Source: Medline; NINDS NIH HHS [R37 NS046789, R01 NS046789-01, R01 NS046789-05, R01 NS046789, NS046789, R01 NS046789-04, R01 NS046789-03, R01 NS046789-02] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS046789, R01NS046789] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GILBERT SF, 2006, DEV BIOL, P373; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kondo T, 2006, CURR OPIN GENET DEV, V16, P502, DOI 10.1016/j.gde.2006.07.001; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamamichi-Nishina M, 2003, J BIOL CHEM, V278, P7422, DOI 10.1074/jbc.M208458200; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	54	525	554	2	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2007	55	2					201	215		10.1016/j.neuron.2007.06.019	http://dx.doi.org/10.1016/j.neuron.2007.06.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NW	17640523	Green Accepted, Bronze			2022-12-24	WOS:000248635800006
J	Alder, J; Zheng, JQ				Alder, Janet; Zheng, James Q.			Surfing on calcium waves	NEURON			English	Editorial Material							NEURONAL MIGRATION; CELL-MIGRATION; COMPLEXES; PATTERNS; CORTEX	A key question in brain development is how migration of neuronal precursors is guided to establish the ordered laminar layers. In the April 20,2007 issue of Cell, Guan et al. show that the leading process of migrating cerebellar granule neurons senses repulsive Slit molecules by generating a Ca2+ wave that propagates to the soma to cause reversal of cell polarity and migration.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Alder, J (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	alderja@umdnj.edu; zhengjq@umdnj.edu		Alder, Janet/0000-0002-5694-4946				Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; BRONNERFRASER M, 1994, FASEB J, V8, P699, DOI 10.1096/fasebj.8.10.8050668; Grunwald IC, 2002, CURR OPIN NEUROBIOL, V12, P250, DOI 10.1016/S0959-4388(02)00323-9; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HIGGINBOTHAM HR, 2007, IN PRESS TRENDS NEUR; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Komuro H, 2005, CELL CALCIUM, V37, P387, DOI 10.1016/j.ceca.2005.01.006; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Solecki DJ, 2006, J NEUROSCI, V26, P10624, DOI 10.1523/JNEUROSCI.4060-06.2006; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332	15	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 24	2007	54	4					502	505		10.1016/j.neuron.2007.04.024	http://dx.doi.org/10.1016/j.neuron.2007.04.024			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521563	Bronze			2022-12-24	WOS:000246970800005
J	Woo, RS; Li, XM; Tao, YM; Carpenter-Hyland, E; Huang, YZ; Weber, J; Neiswender, H; Dong, XP; Wu, J; Gassmann, M; Lai, C; Xiong, WC; Gao, TM; Mei, L				Woo, Ran-Sook; Li, Xiao-Ming; Tao, Yanmei; Carpenter-Hyland, Ezekiel; Huang, Yang Z.; Weber, Janet; Neiswender, Hannah; Dong, Xian-Ping; Wu, Jiong; Gassmann, Martin; Lai, Cary; Xiong, Wen-Cheng; Gao, Tian-Ming; Mei, Lin			Neuregulin-1 enhances depolarization-induced GABA release	NEURON			English	Article							GABAERGIC INTERNEURONS; PREFRONTAL CORTEX; GENE-EXPRESSION; TRANSGENIC MICE; CEREBRAL-CORTEX; RECEPTOR ERBB4; MESSENGER-RNA; SCHIZOPHRENIA; PROTEIN; ASSOCIATION	Neuregulin-1 (NRG1), a regulator of neural development, has been shown to regulate neurotransmission at excitatory synapses. Although ErbB4, a key NRG1 receptor, is expressed in glutamic acid decarboxylase (GAD)-positive neurons, little is known about its role in GABAergic transmission. We show that ErbB4 is localized at GABAergic terminals of the prefrontal cortex. Our data indicate a role of NRG1, both endogenous and exogenous, in regulation of GABAergic transmission. This effect was blocked by inhibition or mutation of ErbB4, suggesting the involvement of ErbB4. Together, these results indicate that NRG1 regulates GABAergic transmission via presynaptic ErbB4 receptors, identifying a novel function of NRG1. Because both NRG1 and ErbB4 have emerged as susceptibility genes of schizophrenia, these observations may suggest a mechanism for abnormal GABAergic neurotransmission in this disorder.	Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA; So Med Univ, Dept Anat & Neurobiol, Guangzhou 510515, Peoples R China; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; Cell Signalling Technol Inc, Danvers, MA 01923 USA; Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland	University System of Georgia; Augusta University; Southern Medical University - China; Duke University; Scripps Research Institute; University of Basel	Gao, TM (corresponding author), Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA.	tgao@fimmu.com; lmei@mcg.edu	Tao, Yanmei/AAH-1601-2022; Tao, Yanmei/AFL-9494-2022; Mei, Lin/G-8755-2012	Gassmann, Martin/0000-0001-6201-3032; Tao, Yanmei/0000-0002-4456-5447; Dong, Xianping/0000-0002-4496-7104				Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Belan PV, 2002, PFLUG ARCH EUR J PHY, V444, P26, DOI 10.1007/s00424-002-0783-3; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Canas N, 2004, BRAIN RES, V1016, P72, DOI 10.1016/j.brainres.2004.04.070; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Coyle JT, 2004, BIOCHEM PHARMACOL, V68, P1507, DOI 10.1016/j.bcp.2004.07.034; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Fukui N, 2006, NEUROSCI LETT, V396, P117, DOI 10.1016/j.neulet.2005.11.015; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gerlai R, 2000, BEHAV BRAIN RES, V109, P219, DOI 10.1016/S0166-4328(99)00175-8; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Hosak L, 2002, EUR PSYCHIAT, V17, P371, DOI 10.1016/S0924-9338(02)00696-X; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Kim JW, 2006, AM J MED GENET B, V141B, P281, DOI 10.1002/ajmg.b.30209; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; LAMBERT NA, 1994, J NEUROPHYSIOL, V72, P121, DOI 10.1152/jn.1994.72.1.121; Law AJ, 2004, NEUROSCIENCE, V127, P125, DOI 10.1016/j.neuroscience.2004.04.026; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Ma L, 2003, J NEUROSCI, V23, P3164; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Nicodemus KK, 2006, MOL PSYCHIATR, V11, P1062, DOI 10.1038/sj.mp.4001878; Ohnuma T, 1999, NEUROSCIENCE, V93, P441, DOI 10.1016/S0306-4522(99)00189-X; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tafoya LCR, 2006, J NEUROSCI, V26, P7826, DOI 10.1523/JNEUROSCI.1866-06.2006; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; TURNER TJ, 1989, BIOCHEMISTRY-US, V28, P586, DOI 10.1021/bi00428a026; Woo RS, 2002, BRIT J PHARMACOL, V137, P1063, DOI 10.1038/sj.bjp.0704975; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	49	235	240	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 24	2007	54	4					599	610		10.1016/j.neuron.2007.04.009	http://dx.doi.org/10.1016/j.neuron.2007.04.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521572	Bronze			2022-12-24	WOS:000246970800014
J	Xu, J; Mashimo, T; Sudhof, TC				Xu, Jun; Mashimo, Tomoyuki; Sudhof, Thomas C.			Synaptotagmin-1,-2, and-9: Ca2+ sensors for fast release that specify distinct presynaptic properties in subsets of neurons	NEURON			English	Article							SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; PC12 CELLS; NEUROTRANSMITTER RELEASE; CALCIUM SENSOR; CA2+-DEPENDENT EXOCYTOSIS; VESICLE EXOCYTOSIS; ACROSOME REACTION; I FUNCTIONS; VII	Synaptotagmin-1 and -2 are known Ca2+ sensors for fast synchronous neurotransmitter release, but the potential Ca2+-sensor functions of other synaptotagmins in release remain uncharacterized. We now show that besides synaptotagmin-1 and -2, only synaptotagmin-9 (also called synaptotagmin-5) mediates fast Ca2+ triggering of release. Release induced by the three different synaptotagmin Ca2+ sensors exhibits distinct kinetics and apparent Ca2+ sensitivities, suggesting that the synaptotagmin isoform expressed by a neuron determines the release properties of its synapses. Conditional knockout mice producing GFP-tagged synaptotagmin-9 revealed that synaptotagmin-9 is primarily expressed in the limbic system and striatum. Acute deletion of synaptotagmin-9 in striatal neurons severely impaired fast synchronous release without changing the size of the readily-releasable vesicle pool. These data show that in mammalian brain, only synaptotagmin-1, -2, and -9 function as Ca2+ sensors for fast release, and that these synaptotagmins are differentially expressed to confer distinct release properties onto synapses formed by defined subsets of neurons.	Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@UTSouthwestern.edu						Atluri PP, 1998, J NEUROSCI, V18, P8214; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; CRAXTON M, 1995, FEBS LETT, V361, P196, DOI 10.1016/0014-5793(95)00176-A; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2006, NEUROREPORT, V17, P179, DOI 10.1097/01.wnr.0000198435.14142.be; Fukuda M, 2004, J BIOL CHEM, V279, P52677, DOI 10.1074/jbc.M409241200; Fukuda M, 2004, BIOCHEM J, V380, P875, DOI 10.1042/BJ20040096; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; Hutt DM, 2005, J BIOL CHEM, V280, P20197, DOI 10.1074/jbc.M412920200; Iezzi M, 2005, FEBS LETT, V579, P5241, DOI 10.1016/j.febslet.2005.08.047; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Millar AG, 2005, J NEUROSCI, V25, P3113, DOI 10.1523/JNEUROSCI.4717-04.2005; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Shin OH, 2004, P NATL ACAD SCI USA, V101, P2554, DOI 10.1073/pnas.0308477100; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang P, 2005, MOL CELL BIOL, V25, P8693, DOI 10.1128/MCB.25.19.8693-8702.2005; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	49	232	238	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 24	2007	54	4					567	581		10.1016/j.neuron.2007.05.004	http://dx.doi.org/10.1016/j.neuron.2007.05.004			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521570	Bronze			2022-12-24	WOS:000246970800012
J	O'Shea, J; Johansen-Berg, H; Trief, D; Gobel, S; Rushworth, MFS				O'Shea, Jacinta; Johansen-Berg, Heidi; Trief, Danielle; Gobel, Silke; Rushworth, Matthew F. S.			Functionally specific in human premotor reorganization cortex	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN DORSAL PREMOTOR; ARBITRARY VISUOMOTOR ASSOCIATIONS; POSITRON-EMISSION-TOMOGRAPHY; CONTRALATERAL MOTOR CORTEX; HUMAN BRAIN; CALLOSAL CONNECTIONS; OBJECT MANIPULATION; MOVEMENT; SELECTION	After unilateral stroke, the dorsal premotor cortex (PMd) in the intact hemisphere is often more active during movement of an affected limb. Whether this contributes to motor recovery is unclear. Functional magnetic resonance imaging (fMRI) was used to investigate short-term reorganization in right PMd after transcranial magnetic stimulation (TMS) disrupted the dominant left PMd, which is specialized for action selection. Even when 1 Hz left PMd TMS had no effect on behavior, there was a compensatory increase in activity in right PMd and connected medial premotor areas. This activity was specific to task periods of action selection as opposed to action execution. Compensatory activation changes were both functionally specific and anatomically specific: the same pattern was not seen after TMS of left sensorimotor cortex. Subsequent TMS of the reorganized right PMd did disrupt performance. Thus, this pattern of functional reorganization has a causal role in preserving behavior after neuronal challenge.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Oxford, John Radcliffe Hosp, Ctr Funct MRI Brain, Oxford OX1 3UD, England	University of Oxford; University of Oxford	O'Shea, J (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	jacinta.oshea@psy.ox.ac.uk	O'Shea, Jacinta/R-7986-2017; Goebel, Silke/A-8046-2011	O'Shea, Jacinta/0000-0002-6007-0698; Goebel, Silke/0000-0001-8845-6026; Johansen-Berg, Heidi/0000-0002-4134-9730; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0600994] Funding Source: UKRI; Medical Research Council [G0600994] Funding Source: Medline; Wellcome Trust [078204] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Amiez C, 2006, J NEUROSCI, V26, P2724, DOI 10.1523/JNEUROSCI.4739-05.2006; Baeumer T, 2006, J PHYSIOL-LONDON, V572, P857, DOI 10.1113/jphysiol.2006.104901; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bestmann S, 2005, NEUROIMAGE, V28, P22, DOI 10.1016/j.neuroimage.2005.05.027; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Binkofski F, 1999, EXP BRAIN RES, V128, P210, DOI 10.1007/s002210050838; Boussaoud D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-67; Cavina-Pratesi C, 2006, J NEUROSCI, V26, P2704, DOI 10.1523/JNEUROSCI.3176-05.2006; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; Chouinard PA, 2005, J NEUROSCI, V25, P2277, DOI 10.1523/JNEUROSCI.4649-04.2005; DEIBER MP, 1993, BRAIN, V116, P267, DOI 10.1093/brain/116.1.267; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Gerschlager W, 2001, NEUROLOGY, V57, P449, DOI 10.1212/WNL.57.3.449; Grol MJ, 2006, J NEUROSCI, V26, P117, DOI 10.1523/JNEUROSCI.2786-05.2006; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; KUYPERS HGJ, 1970, BRAIN RES, V24, P29, DOI 10.1016/0006-8993(70)90272-6; Lee JH, 2006, J NEUROSCI, V26, P3330, DOI 10.1523/JNEUROSCI.3898-05.2006; Lee L, 2003, J NEUROSCI, V23, P5308; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Marconi B, 2003, EUR J NEUROSCI, V18, P775, DOI 10.1046/j.1460-9568.2003.02807.x; Mochizuki H, 2005, EXP BRAIN RES, V167, P414, DOI 10.1007/s00221-005-0047-5; Mochizuki H, 2004, J PHYSIOL-LONDON, V561, P331, DOI 10.1113/jphysiol.2004.072843; Nowak DA, 2005, EUR J NEUROSCI, V22, P2392, DOI 10.1111/j.1460-9568.2005.04425.x; Passingham RE, 1998, NOVART FDN SYMP, V218, P129; Paus T, 1997, J NEUROSCI, V17, P3178; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; Pleger B, 2006, J NEUROSCI, V26, P1945, DOI 10.1523/JNEUROSCI.4097-05.2006; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rizzo V, 2004, J PHYSIOL-LONDON, V554, P483, DOI 10.1113/jphysiol.2003.048777; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rounis E, 2006, J NEUROSCI, V26, P9629, DOI 10.1523/JNEUROSCI.2657-06.2006; Rushworth MFS, 1998, NEUROPSYCHOLOGIA, V36, P11, DOI 10.1016/S0028-3932(97)00101-2; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Schluter ND, 1999, NEUROPSYCHOLOGIA, V37, P233; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Scott SK, 2000, NEUROREPORT, V11, P1523, DOI 10.1097/00001756-200005150-00031; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Staudt M, 2002, BRAIN, V125, P2222, DOI 10.1093/brain/awf227; Strens LHA, 2003, CURR BIOL, V13, P1201, DOI 10.1016/S0960-9822(03)00453-6; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Toni I, 2002, J COGNITIVE NEUROSCI, V14, P769, DOI 10.1162/08989290260138663; Toni I, 2001, NEUROIMAGE, V14, P1048, DOI 10.1006/nimg.2001.0894; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	53	228	229	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 3	2007	54	3					479	490		10.1016/j.neuron.2007.04.021	http://dx.doi.org/10.1016/j.neuron.2007.04.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481399	Bronze			2022-12-24	WOS:000246855700016
J	Wierda, KDB; Toonen, RFG; de Wit, H; Brussaard, AB; Verhage, M				Wierda, Keimpe D. B.; Toonen, Ruud F. G.; de Wit, Heidi; Brussaard, Arjen B.; Verhage, Matthijs			Interdependence of PKC-dependent and PKC-independent pathways for presynaptic plasticity	NEURON			English	Article							PROTEIN-KINASE-C; READILY RELEASABLE POOL; EVOKED TRANSMITTER RELEASE; PHORBOL ESTER ENHANCEMENT; TERM SYNAPTIC PLASTICITY; BOVINE CHROMAFFIN CELLS; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; VESICLE FUSION; ASYNCHRONOUS RELEASE	Diacylglycerol (DAG) is a prominent endogenous modulator of synaptic transmission. Recent studies proposed two apparently incompatible pathways, via protein kinase C (PKC) and via Munc13. Here we show how these two pathways converge. First, we confirm that DAG analogs indeed continue to potentiate transmission after PKC inhibition (the Munc13 pathway), but only in neurons that previously experienced DAG analogs, before PKC inhibition started. Second, we identify an essential PKC pathway by expressing a PKC-insensitive Munc18-1 mutant in munc18-1 null mutant neurons. This mutant supported basic transmission, but not DAG-induced potentiation and vesicle redistribution. Moreover, synaptic depression was increased, but not Ca2+ independent release evoked by hypertonic solutions. These data show that activation of both PKC-dependent and -independent pathways (via Munc13) are required for DAG-induced potentiation. Munc18-1 is an essential downstream target in the PKC pathway. This pathway is of general importance for presynaptic plasticity.	Vrije Univ Amsterdam, CNCR, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, CNCR, Dept Expt Neurophysiol, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Verhage, M (corresponding author), Vrije Univ Amsterdam, CNCR, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands.	matthijs@cncr.vu.nl		Toonen, Ruud/0000-0002-9900-4233; verhage, matthijs/0000-0002-6085-7503; Wierda, Keimpe/0000-0002-8784-9490				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Basu J, 2007, J NEUROSCI, V27, P1200, DOI 10.1523/JNEUROSCI.4908-06.2007; Betz A, 1997, J BIOL CHEM, V272, P2520; Craig TJ, 2003, J NEUROCHEM, V86, P1450, DOI 10.1046/j.1471-4159.2003.01955.x; de Vries KJ, 2000, EUR J NEUROSCI, V12, P385, DOI 10.1046/j.1460-9568.2000.00931.x; DEKKER LV, 1991, PROG BRAIN RES, V89, P209; Dittman JS, 2000, J NEUROSCI, V20, P1374; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Finley MFA, 2003, NEUROPHARMACOLOGY, V45, P857, DOI 10.1016/S0028-3908(03)00283-1; Francis HW, 2002, BRAIN RES, V951, P9, DOI 10.1016/S0006-8993(02)03095-0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Goda Y, 1996, LEARN MEMORY, V3, P182, DOI 10.1101/lm.3.2-3.182; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Hulo S, 2002, EUR J NEUROSCI, V15, P1976, DOI 10.1046/j.1460-9568.2002.02026.x; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Majewski H, 1998, PROG NEUROBIOL, V55, P463, DOI 10.1016/S0301-0082(98)00017-3; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Moulder KL, 2006, NEUROSCIENTIST, V12, P11, DOI 10.1177/1073858405282431; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NICHOLS RA, 1987, J NEUROCHEM, V48, P615, DOI 10.1111/j.1471-4159.1987.tb04137.x; Nili U, 2006, NEUROSCIENCE, V143, P487, DOI 10.1016/j.neuroscience.2006.08.014; Oleskevich S, 2000, J PHYSIOL-LONDON, V526, P349, DOI 10.1111/j.1469-7793.2000.t01-1-00349.x; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sassa T, 1999, J NEUROSCI, V19, P4772; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Shoji-Kasai Y, 2002, EUR J NEUROSCI, V15, P1390, DOI 10.1046/j.1460-9568.2002.01972.x; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Virmani T, 2005, J NEUROSCI, V25, P10922, DOI 10.1523/JNEUROSCI.3766-05.2005; VITALE ML, 1992, NEUROSCIENCE, V51, P463, DOI 10.1016/0306-4522(92)90330-5; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x; Zhu HL, 2002, P NATL ACAD SCI USA, V99, P17055, DOI 10.1073/pnas.232588899; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	69	156	162	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					275	290		10.1016/j.neuron.2007.04.001	http://dx.doi.org/10.1016/j.neuron.2007.04.001			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442248	Bronze			2022-12-24	WOS:000246190600012
J	Tobler, PN; Fletcher, PC; Bullmore, ET; Schultz, W				Tobler, Philippe N.; Fletcher, Paul C.; Bullmore, Edward T.; Schultz, Wolfram			Learning-related human brain activations reflecting individual finances	NEURON			English	Article							ORBITOFRONTAL CORTEX; TEMPORAL PREDICTION; NEURONAL-ACTIVITY; REWARD; STRIATUM; IQ; REINFORCEMENT; MAGNITUDE; WEALTH; ERROR	A basic tenet of microeconomics suggests that the subjective value of financial gains decreases with increasing assets of individuals ("marginal utility"). Using concepts from learning theory and microeconomics, we assessed the capacity of financial rewards to elicit behavioral and neuronal changes during reward-predictive learning in participants with different financial backgrounds. Behavioral learning speed during both acquisition and extinction correlated negatively with the assets of the participants, irrespective of education and age. Correspondingly, response changes in midbrain and striatum measured with functional magnetic resonance imaging were slower during both acquisition and extinction with increasing assets and income of the participants. By contrast, asymptotic magnitudes of behavioral and neuronal responses after learning were unrelated to personal finances. The inverse relationship of behavioral and neuronal learning speed with personal finances is compatible with the general concept of decreasing marginal utility with increasing wealth.	Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Tobler, PN (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	pnt21@cam.ac.uk	Bullmore, Ed/C-1706-2012; Fletcher, Paul/F-5380-2011	Bullmore, Ed/0000-0002-8955-8283; Fletcher, Paul/0000-0001-8257-1517; Tobler, Philippe/0000-0002-4915-9448	Medical Research Council [G0001354B] Funding Source: researchfish; Medical Research Council [G0001354] Funding Source: Medline; Wellcome Trust [095495, 064351] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ANNAU Z, 1961, J COMP PHYSIOL PSYCH, V54, P428, DOI 10.1037/h0042199; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; CAMPBELL PE, 1972, J COMP PHYSIOL PSYCH, V81, P360, DOI 10.1037/h0033530; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Dickerson RE, 2006, INTELLIGENCE, V34, P291, DOI 10.1016/j.intell.2005.09.006; Fitzgerald F. Scott, 1926, ALL SAD YOUNG MEN; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FURNHAM A, 1985, J SOC PSYCHOL, V125, P571, DOI 10.1080/00224545.1985.9712030; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kanazawa S, 2006, INTELLIGENCE, V34, P593, DOI 10.1016/j.intell.2006.04.003; KINTSCH W, 1962, J COMP PHYSIOL PSYCH, V55, P882, DOI 10.1037/h0043377; Kreps D. M, 1990, COURSE MICROECONOMIC; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pavlov IP, 1927, CONDITIONAL REFLEXES; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rescorla RA, 2002, J EXP PSYCHOL ANIM B, V28, P369, DOI 10.1037//0097-7403.28.4.369; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; TAMBS K, 1989, BEHAV GENET, V19, P209, DOI 10.1007/BF01065905; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; WAGNER AR, 1964, J COMP PHYSIOL PSYCH, V58, P354, DOI 10.1037/h0048721	31	56	56	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					167	175		10.1016/j.neuron.2007.03.004	http://dx.doi.org/10.1016/j.neuron.2007.03.004			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	159EO	17408585	Bronze			2022-12-24	WOS:000245848400017
J	Leiser, SC; Moxon, KA				Leiser, Steven C.; Moxon, Karen A.			Responses of trigeminal ganglion neurons during natural whisking behaviors in the awake rat	NEURON			English	Article							SIMULTANEOUSLY RECORDED NEURONS; 1ST-ORDER VIBRISSA AFFERENTS; CORTICAL REPRESENTATION; SOMATOSENSORY SYSTEM; ENSEMBLE ACTIVITY; RODENT WHISKING; RECEPTIVE-FIELD; SENSORY INPUT; MOTOR CORTEX; ACTIVE TOUCH	Rats use their whiskers to locate and discriminate tactile features of their environment. Mechanoreceptors surrounding each whisker encode and transmit sensory information from the environment to the brain via afferents whose cell bodies lie in the trigerninal ganglion (Vg). These afferents are classified as rapidly (RA) or slowly (SA) adapting by their response to stimulation. The activity of these cells in the awake behaving rat is yet unknown. Therefore, we developed a method to chronically record Vg neurons during natural whisking behaviors and found that all cells exhibited (1) no neuronal activity when the whiskers were not in motion, (2) increased activity when the rat whisked, with activity correlated to whisk frequency, and (3) robust increases in activity when the whiskers contacted an object. Moreover, we observed distinct differences in the firing rates between RA and SA cells, suggesting that they encode distinct aspects of stimuli in the awake rat.	Drexel Univ, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Moxon, KA (corresponding author), Drexel Univ, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA.	km57@drexel.edu	Moxon, Karen/K-7407-2012	Moxon, Karen/0000-0002-5790-097X; Leiser, Steven/0000-0002-4680-2012				Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Albarracin AL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-42; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bermejo R, 2005, SOMATOSENS MOT RES, V22, P213, DOI 10.1080/08990220500262505; Bermejo R, 2002, SOMATOSENS MOT RES, V19, P341, DOI 10.1080/0899022021000037809; Berryman LJ, 2006, J NEUROPHYSIOL, V96, P27, DOI 10.1152/jn.01190.2005; Blake DT, 1997, J NEUROPHYSIOL, V78, P2503, DOI 10.1152/jn.1997.78.5.2503; Blake DT, 1997, J NEUROSCI, V17, P7480; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Cahusac PMB, 2006, SYNAPSE, V59, P235, DOI 10.1002/syn.20236; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Derdikman Dori, 2006, Novartis Found Symp, V270, P4; Devilbiss DM, 2002, J NEUROSCI METH, V121, P181, DOI 10.1016/S0165-0270(02)00263-7; Diamond J, 1988, Prog Brain Res, V74, P51; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Foffani G, 2004, J NEUROSCI, V24, P7266, DOI 10.1523/JNEUROSCI.2523-04.2004; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; Friedman RM, 2002, J NEUROSCI, V22, P9556; Gamzu E, 2001, J NEUROSCI, V21, P7416, DOI 10.1523/JNEUROSCI.21-18-07416.2001; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Garabedian CE, 2003, J NEUROPHYSIOL, V90, P1379, DOI 10.1152/jn.01158.2002; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; GIBSON JM, 1983, SOMATOSENS RES, V1, P95, DOI 10.3109/07367228309144543; GIBSON JM, 1983, SOMATOSENS RES, V1, P51, DOI 10.3109/07367228309144540; Goodwin AW, 2004, ANNU REV NEUROSCI, V27, P53, DOI 10.1146/annurev.neuro.26.041002.131032; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; Hipp J, 2006, J NEUROPHYSIOL, V95, P1792, DOI 10.1152/jn.01104.2005; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Johnson KO, 2000, NEURON, V26, P563, DOI 10.1016/S0896-6273(00)81193-9; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Jones LM, 2004, J NEUROPHYSIOL, V92, P665, DOI 10.1152/jn.00031.2004; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Kao T, 2006, BRAIN RES, V1112, P159, DOI 10.1016/j.brainres.2006.07.020; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; KYRIAZI HT, 1994, J NEUROPHYSIOL, V72, P392, DOI 10.1152/jn.1994.72.1.392; Leiser SC, 2006, J NEUROPHYSIOL, V95, P3129, DOI 10.1152/jn.00157.2005; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Minnery BS, 2003, J NEUROPHYSIOL, V89, P40, DOI 10.1152/jn.00272.2002; MOSCONI TM, 1993, J COMP NEUROL, V328, P222; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P647, DOI 10.1109/TBME.2003.821037; MOXON KA, 2000, NEURAL PROSTHESES RE; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; RICE FL, 1986, J COMP NEUROL, V252, P157; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Sachdev RNS, 2001, SOMATOSENS MOT RES, V18, P91; SEMBA K, 1986, J COMP NEUROL, V247, P144, DOI 10.1002/cne.902470203; Shetty P, 2003, SOMATOSENS MOT RES, V20, P233, DOI 10.1080/08990220310001622951; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Tachibana T, 2005, ARCH HISTOL CYTOL, V68, P383, DOI 10.1679/aohc.68.383; WAITE PME, 1992, J COMP NEUROL, V322, P233, DOI 10.1002/cne.903220209; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	73	92	92	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					117	133		10.1016/j.neuron.2006.10.036	http://dx.doi.org/10.1016/j.neuron.2006.10.036			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196535	Bronze			2022-12-24	WOS:000245126500013
J	Hsieh, H; Boehm, J; Sato, C; Iwatsubo, T; Tomita, T; Sisodia, S; Malinow, R				Hsieh, Helen; Boehm, Jannic; Sato, Chihiro; Iwatsubo, Takeshi; Tomita, Taisuke; Sisodia, Sangram; Malinow, Roberto			AMPAR removal underlies A beta-induced synaptic depression and dendritic spine loss	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM DEPRESSION; ALZHEIMERS-DISEASE; RECEPTOR TRAFFICKING; TRANSGENIC MICE; GLUTAMATE RECEPTORS; IN-VIVO; RAPID REDISTRIBUTION; MOLECULAR-MECHANISMS; HIPPOCAMPAL SLICES	Beta amyloid (A beta), a peptide generated from the amyloid precursor protein (APP) by neurons, is widely believed to underlie the pathophysiology of Alzheimer's disease. Recent studies indicate that this peptide can drive loss of surface AMPA and NMDA type glutamate receptors. We now show that A beta employs signaling pathways of long-term depression (LTD) to drive endocytosis of synaptic AMPA receptors. Synaptic removal of AMPA receptors is necessary and sufficient to produce loss of dendritic spines and synaptic NIVIDA responses. Our studies indicate the central role played by AMPA receptor trafficking in A beta-induced modification of synaptic structure and function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Behav Grad Program, Stony Brook, NY 11794 USA; Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Tokyo, Japan; Univ Chicago, Ctr Mol Neurobiol, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo; University of Chicago	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Boehm, Jannic/AAK-8882-2020; Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Sato, Chihiro/0000-0002-7639-8727	NIA NIH HHS [R01 AG032132-15, AG021494, R01 AG021494, R01 AG032132, R01 AG032132-14] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NIMH NIH HHS [R01 MH049159-09, R01 MH049159, R37 MH049159] Funding Source: Medline; NINDS NIH HHS [R01 NS032827] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132, R01AG021494] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cullen WK, 1997, NEUROREPORT, V8, P3213, DOI 10.1097/00001756-199710200-00006; EINSTEIN G, 1994, J NEUROSCI, V14, P5077; Freir DB, 2001, J NEUROPHYSIOL, V85, P708, DOI 10.1152/jn.2001.85.2.708; Giacchino J, 2000, BRAIN RES, V876, P185, DOI 10.1016/S0006-8993(00)02615-9; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim JH, 2001, J NEUROSCI, V21, P1327; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Rush AM, 2002, J NEUROSCI, V22, P6121; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thorns V, 1997, ACTA NEUROPATHOL, V94, P539, DOI 10.1007/s004010050748; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tyszkiewicz JP, 2005, J NEUROPHYSIOL, V93, P3102, DOI 10.1152/jn.00939.2004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	83	794	835	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					831	843		10.1016/j.neuron.2006.10.035	http://dx.doi.org/10.1016/j.neuron.2006.10.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145504	Green Accepted, Bronze			2022-12-24	WOS:000242856400011
J	Blumenfeld, B; Preminger, S; Sagi, D; Tsodyks, M				Blumenfeld, Barak; Preminger, Son; Sagi, Dov; Tsodyks, Misha			Dynamics of memory representations in networks with novelty-facilitated synaptic plasticity	NEURON			English	Article							NEURAL-NETWORKS; HIPPOCAMPAL-FORMATION; NEURONAL CORRELATE; TERM-MEMORY; INFORMATION; SYSTEMS; CORTEX; MODEL; TRANSMISSION; MODULATION	The ability to associate some stimuli while differentiating between others is an essential characteristic of biological memory. Theoretical models identify memories as attractors of neural network activity, with learning based on Hebb-like synaptic modifications. Our analysis shows that when network inputs are correlated, this mechanism results in overassociations, even up to several memories "merging" into one. To counteract this tendency, we introduce a learning mechanism that involves novelty-facilitated modifications, accentuating synaptic changes proportionally to the difference between network input and stored memories. This mechanism introduces a dependency of synaptic modifications on previously acquired memories, enabling a wide spectrum of memory associations, ranging from absolute discrimination to complete merging. The model predicts that memory representations should be sensitive to learning order, consistent with recent psychophysical studies of face recognition and electrophysiological experiments on hippocampal place cells. The proposed mechanism is compatible with a recent biological model of novelty-facilitated learning in hippocampal circuitry.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tsodyks, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	misha@weizmann.ac.il	tsodyks, misha/J-4430-2013; Sagi, Dov/A-5454-2008	Sagi, Dov/0000-0002-8446-9230; Tsodyks, Misha/0000-0002-5661-4349				Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1985, PHYS REV A, V32, P1007, DOI 10.1103/PhysRevA.32.1007; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Blumenfeld B, 2006, J COMPUT NEUROSCI, V20, P219, DOI 10.1007/s10827-006-6307-y; Brunel N., 2005, METHODS MODELS NEURO, VLXXX, P407; Carpenter G.A., 2003, HDB BRAIN THEORY NEU, P87, DOI DOI 10.1016/J.NEUNET.2012.09.017]; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Erickson CA, 1999, J NEUROSCI, V19, P10404; Ermentrout B, 1998, REP PROG PHYS, V61, P353, DOI 10.1088/0034-4885/61/4/002; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; FUSTER JM, 1971, NEURON, V14, P477; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Meltzer JA, 2005, NEUROIMAGE, V24, P384, DOI 10.1016/j.neuroimage.2004.09.001; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Movellan J. R, 1991, P 1990 CONN MOD SUMM, P10; Nyberg L, 2005, CURR OPIN NEUROL, V18, P424, DOI 10.1097/01.wco.0000168080.99730.1c; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Preminger S, 2005, PERCEPTION, V34, P14; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; TREVES A, 1990, PHYS REV A, V42, P2418, DOI 10.1103/PhysRevA.42.2418; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; TSODYKS MV, 1988, EUROPHYS LETT, V6, P101, DOI 10.1209/0295-5075/6/2/002; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	46	63	63	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					383	394		10.1016/j.neuron.2006.08.016	http://dx.doi.org/10.1016/j.neuron.2006.08.016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046699	Green Submitted, Bronze			2022-12-24	WOS:000241799900017
J	Riven, I; Iwanir, S; Reuveny, E				Riven, Inbal; Iwanir, Shachar; Reuveny, Eitan			GIRK channel activation involves a local rearrangement of a preformed G protein channel complex	NEURON			English	Article							BETA-GAMMA-SUBUNITS; RECTIFYING K+ CHANNELS; HETEROTRIMERIC G-PROTEINS; RECTIFIER POTASSIUM CHANNELS; C-TERMINAL DOMAIN; LIVING CELLS; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; PLASMA-MEMBRANE; ENERGY-TRANSFER	G protein-coupled signaling is one of the major mechanisms for controlling cellular excitability. One of the main targets for this control at postsynaptic membranes is the G protein-coupled potassium channels (GIRK/Kir3), which generate slow inhibitory postsynaptic potentials following the activation of Pertussis toxin-sensitive G protein-coupled receptors. Using total internal reflection fluorescence (TIRF) microscopy combined with fluorescence resonance energy transfer (FRET), in intact cells, we provide evidence for the existence of a trimeric G protein-channel complex at rest. We show that activation of the channel via the receptor induces a local conformational switch of the G protein to induce channel opening. The presence of such a complex thus provides the means for a precise temporal and highly selective activation of the channel, which is required for fine tuning of neuronal excitability.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il						AXELROD D, 1989, METHOD CELL BIOL, V30, P245; Bauer PH, 1998, J BIOL CHEM, V273, P9465, DOI 10.1074/jbc.273.16.9465; BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; Dowal L, 2001, BIOCHEMISTRY-US, V40, P414, DOI 10.1021/bi001923+; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Lei QB, 2003, MOL CELLS, V15, P1; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; Leifert WR, 2006, ANAL BIOCHEM, V355, P201, DOI 10.1016/j.ab.2006.04.042; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mirshahi T, 2002, J BIOL CHEM, V277, P36345, DOI 10.1074/jbc.M205359200; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Mullner C, 2000, J GEN PHYSIOL, V115, P547, DOI 10.1085/jgp.115.5.547; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151; Zhang Y, 1999, TUMOR TARGET, V4, P158; Zhao Q, 2003, MOL PHARMACOL, V64, P1085, DOI 10.1124/mol.64.5.1085	68	87	90	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					561	573		10.1016/j.neuron.2006.08.017	http://dx.doi.org/10.1016/j.neuron.2006.08.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950155	Bronze			2022-12-24	WOS:000240623400006
J	Knott, GW; Holtmaat, A; Wilbrecht, L; Welker, E; Svoboda, K				Knott, Graham W.; Holtmaat, Anthony; Wilbrecht, Linda; Welker, Egbert; Svoboda, Karel			Spine growth precedes synapse formation in the adult neocortex in vivo	NATURE NEUROSCIENCE			English	Article							RAT VISUAL-CORTEX; DENDRITIC SPINES; CELL-TYPE; 3-DIMENSIONAL STRUCTURE; STRUCTURAL PLASTICITY; NMDA RECEPTORS; AMPA; CA1; SYNAPTOGENESIS; EXPERIENCE	Dendritic spines appear and disappear in an experience-dependent manner. Although some new spines have been shown to contain synapses, little is known about the relationship between spine addition and synapse formation, the relative time course of these events, or whether they are coupled to de novo growth of axonal boutons. We imaged dendrites in barrel cortex of adult mice over 1 month, tracking gains and losses of spines. Using serial section electron microscopy, we analyzed the ultrastructure of spines and associated boutons. Spines reconstructed shortly after they appeared often lacked synapses, whereas spines that persisted for 4 d or more always had synapses. New spines had a large surface-to-volume ratio and preferentially contacted boutons with other synapses. In some instances, two new spines contacted the same axon. Our data show that spine growth precedes synapse formation and that new synapses form preferentially onto existing boutons.	Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	University of Lausanne; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Knott, GW (corresponding author), Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland.	Graham.Knott@unil.ch	Wilbrecht, Linda/J-7988-2013	Holtmaat, Anthony/0000-0002-7577-0769; Knott, Graham W/0000-0002-2956-9052				ADAMS I, 1982, BRAIN RES, V239, P349, DOI 10.1016/0006-8993(82)90514-5; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; Braitenberg V, 1991, ANATOMY CORTEX; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; COLONNIER MARC, 1968, BRAIN RES, V9, P268, DOI 10.1016/0006-8993(68)90234-5; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS MI, 1997, INT TXB DIABETES MEL, V1, P9; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Peters A., 1991, FINE STRUCTURE NERVO; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; VAUGHAN DW, 1973, J COMP NEUROL, V149, P355, DOI 10.1002/cne.901490305; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	48	417	423	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1117	1124		10.1038/nn1747	http://dx.doi.org/10.1038/nn1747			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892056				2022-12-24	WOS:000240080800012
J	Inbal, A; Kim, SH; Shin, J; Solnica-Krezel, L				Inbal, Adi; Kim, Seok-Hyung; Shin, Jimann; Solnica-Krezel, Lilianna			Six3 represses nodal activity to establish early brain asymmetry in zebrafish	NEURON			English	Article							MIDBRAIN TARGET; FOREBRAIN; GENE; EXPRESSION; MIDLINE; LATERALITY; EPITHALAMUS; INDUCTION; HEART; EYE	The vertebrate brain is anatomically and functionally asymmetric; however, the molecular mechanisms that establish left-right brain patterning are largely unknown. In zebrafish, asymmetric left-sided Nodal signaling within the developing dorsal diencephalon is required for determining the direction of epithalamic asymmetries. Here, we show that Six3, a transcription factor essential for forebrain formation and associated with holoprosencephaly in humans, regulates diencephalic Nodal activity during initial establishment of brain asymmetry. Reduction of Six3 function causes brainspecific deregulation of Nodal pathway activity, resulting in epithalamic laterality defects. Based on misexpression and genetic epistasis experiments, we propose that Six3 acts in the neuroectoderm to establish a prepattern of bilateral repression of Nodal activity. Subsequently, Nodal signaling from the left lateral plate mesoderm alleviates this repression ipsilaterally. Our data reveal a Six3-dependent mechanism for establishment of correct brain laterality and provide an entry point to understanding the genetic regulation of Nodal signaling in the brain.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Solnica-Krezel, L (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B 351634, Nashville, TN 37235 USA.	lilianna.solnica-krezel@vanderbilt.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052386] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS052386, R01 NS052386-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Campione M, 1999, DEVELOPMENT, V126, P1225; Carl M, 2002, DEVELOPMENT, V129, P4057; Carl M, 2007, NEURON, V55, P393, DOI 10.1016/j.neuron.2007.07.007; Cohen MM, 2006, BIRTH DEFECTS RES A, V76, P658, DOI 10.1002/bdra.20295; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Dufourcq P, 2004, GENE EXPR PATTERNS, V4, P53, DOI 10.1016/S1567-133X(03)00148-0; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Halpern ME, 2003, TRENDS NEUROSCI, V26, P308, DOI 10.1016/S0166-2236(03)00129-2; Harris JA, 1996, NEUROSCI BIOBEHAV R, V20, P637, DOI 10.1016/0149-7634(95)00077-1; Inbal A, 2006, GENESIS, V44, P584, DOI 10.1002/dvg.20253; Kobayashi M, 1998, DEVELOPMENT, V125, P2973; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Liang JO, 2000, DEVELOPMENT, V127, P5101; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Roessler E, 2001, BIOESSAYS, V23, P888, DOI 10.1002/bies.1130; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8; Seo HC, 1998, GENE, V216, P39, DOI 10.1016/S0378-1119(98)00328-X; Staudt N, 2007, PLOS BIOL, V5, P878, DOI 10.1371/journal.pbio.0050069; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Thisse C, 1999, DEVELOPMENT, V126, P229; Wienholds E, 2004, METHOD CELL BIOL, V77, P69; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9	37	46	47	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 2	2007	55	3					407	415		10.1016/j.neuron.2007.06.037	http://dx.doi.org/10.1016/j.neuron.2007.06.037			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678854	Green Accepted, Bronze			2022-12-24	WOS:000248711000009
J	Mahon, BZ; Milleville, SC; Negri, GAL; Rumiati, RI; Caramazza, A; Martin, A				Mahon, Bradford Z.; Milleville, Shawn C.; Negri, Gioia A. L.; Rumiati, Raffaella I.; Caramazza, Alfonso; Martin, Alex			Action-related properties shape object representations in the ventral stream	NEURON			English	Article							ANTERIOR INFEROTEMPORAL CORTEX; CORTICAL REGIONS; NEURAL BASIS; TOOL USE; DORSAL; BRAIN; FMRI; AREA; DISSOCIATION; ACTIVATION	The principles driving the organization of the ventral object-processing stream remain unknown. Here, we show that stimulus-specific repetition suppression (RS) in one region of the ventral stream is biased according to motor-relevant properties of objects. Quantitative analysis confirmed that this result was not confounded with similarity in visual shape. A similar pattern of biases in RS according to motor-relevant properties of objects was observed in dorsal stream regions in the left hemisphere. These findings suggest that neural specificity for "tools" in the ventral stream is driven by similarity metrics computed over motor-relevant information represented in dorsal structures. Support for this view is provided by converging results from functional connectivity analyses of the fMRl data and a separate neuropsychological study. More generally, these data suggest that a basic organizing principle giving rise to "category specificity" in the ventral stream may involve similarity metrics computed over information represented elsewhere in the brain.	Univ Trento, Ctr Mind Brain Sci, I-38068 Rovereto, TN, Italy; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA; Scuola Int Super Avanzati Trieste, Cognit Neurosci Sector, Trieste, Italy	University of Trento; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); International School for Advanced Studies (SISSA)	Mahon, BZ (corresponding author), Univ Trento, Ctr Mind Brain Sci, I-38068 Rovereto, TN, Italy.	mahon@fas.harvard.edu	martin, alex/B-6176-2009		Intramural NIH HHS [Z01 MH002588-17] Funding Source: Medline; NIDCD NIH HHS [R01 DC004542, R01 DC004542-05, DC0542] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004542] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Beauchamp MS, 2003, J COGNITIVE NEUROSCI, V15, P991, DOI 10.1162/089892903770007380; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Caramazza A, 2006, COGN NEUROPSYCHOL, V23, P13, DOI 10.1080/02643290542000021; Chao LL, 2002, CEREB CORTEX, V12, P545, DOI 10.1093/cercor/12.5.545; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crawford JR, 2006, COGN NEUROPSYCHOL, V23, P877, DOI 10.1080/02643290500538372; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HEILMAN KM, 1982, NEUROLOGY, V32, P342, DOI 10.1212/WNL.32.4.342; James M., 1991, VISUAL OBJECTS SPACE; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; KABLE JW, 2002, J COGNITIVE NEUROSCI, V17, P1855; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; LEVY I, 2006, NAT NEUROSCI, V12, P211; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Martin A, 2006, NEURON, V50, P173, DOI 10.1016/j.neuron.2006.04.004; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mechelli A, 2006, NEUROIMAGE, V30, P992, DOI 10.1016/j.neuroimage.2005.10.017; Miceli G, 2001, NAT NEUROSCI, V4, P662, DOI 10.1038/88497; Middleton FA, 1996, P NATL ACAD SCI USA, V93, P8683, DOI 10.1073/pnas.93.16.8683; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; Noppeney U, 2006, CEREB CORTEX, V16, P437, DOI 10.1093/cercor/bhi123; Okada T, 2000, NEUROSCI LETT, V296, P33, DOI 10.1016/S0304-3940(00)01612-8; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Pisella L, 2006, NEUROPSYCHOLOGIA, V44, P2734, DOI 10.1016/j.neuropsychologia.2006.03.027; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rumiati RI, 2004, NEUROIMAGE, V21, P1224, DOI 10.1016/j.neuroimage.2003.11.017; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Saleem KS, 2000, J NEUROSCI, V20, P5083; Shmuelof L, 2005, NEURON, V47, P457, DOI 10.1016/j.neuron.2005.06.034; Talairach J., 1988, COPLANAR STEREOTAXIC; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Tyler LK, 2003, COGN NEUROPSYCHOL, V20, P541, DOI 10.1080/02643290244000211; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Zhong YM, 2003, CEREB CORTEX, V13, P527, DOI 10.1093/cercor/13.5.527	59	229	230	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					507	520		10.1016/j.neuron.2007.07.011	http://dx.doi.org/10.1016/j.neuron.2007.07.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678861	Green Accepted, Bronze			2022-12-24	WOS:000248711000016
J	Young, JM; Waleszczyk, WJ; Wang, C; Calford, MB; Dreher, B; Obermayer, K				Young, Joshua M.; Waleszczyk, Wioletta J.; Wang, Chun; Calford, Michael B.; Dreher, Bogdan; Obermayer, Klaus			Cortical reorganization consistent with spike timing but not correlation-dependent plasticity	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; ADULT CAT; RETINAL LESIONS; STRIATE CORTEX; SYNAPTIC PLASTICITY; TOPOGRAPHIC REORGANIZATION; HORIZONTAL CONNECTIONS; QUANTAL AMPLITUDE; MONOCULAR LESIONS; SPECIFICITY	The receptive fields of neurons in primary visual cortex that are inactivated by retinal damage are known to 'shift' to nondamaged retinal locations, seemingly due to the plasticity of intracortical connections. We have observed in cats that these shifts occur in a pattern that is highly convergent, even among receptive fields that are separated by large distances before inactivation. Here we show, using a computational model of primary visual cortex, that the observed convergent shifts are inconsistent with the common assumption that the underlying intracortical connection plasticity is dependent on the temporal correlation of pre- and postsynaptic action potentials. The shifts are, however, consistent with the hypothesis that this plasticity is dependent on the temporal order of pre- and postsynaptic action potentials. This convergent reorganization seems to require increased neuronal gain, revealing a mechanism that networks may use to selectively facilitate the didactic transfer of neuronal response properties.	Berlin Univ Technol, Dept Elect & Comp Sci, Neural Informat Proc Grp, D-10587 Berlin, Germany; Humboldt Univ, Bernstein Ctr Comp Neurosci, D-10115 Berlin, Germany; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; Univ Newcastle, Sch Biomed Sci, Hunter Med Res Inst, Newcastle, NSW 2308, Australia	Technical University of Berlin; Humboldt University of Berlin; University of Sydney; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Hunter Medical Research Institute; University of Newcastle	Young, JM (corresponding author), Berlin Univ Technol, Dept Elect & Comp Sci, Neural Informat Proc Grp, Franklinstr 28-29, D-10587 Berlin, Germany.	joshua.young@bccn-berlin.de; oby@cs.tu-berlin.de	Waleszczyk, Wioletta/F-6027-2010; Calford, Mike/B-4637-2009	Calford, Mike/0000-0002-5727-0234; Waleszczyk, Wioletta/0000-0002-7300-6193				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Arckens L, 2000, EUR J NEUROSCI, V12, P4222, DOI 10.1046/j.0953-816X.2000.01328.x; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Calford MB, 1999, P ROY SOC B-BIOL SCI, V266, P499, DOI 10.1098/rspb.1999.0665; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; Calford MB, 2003, J NEUROSCI, V23, P6434; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chino Y, 2001, NAT NEUROSCI, V4, P689, DOI 10.1038/89469; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Eyding D, 2002, NEUROSCIENCE, V112, P195, DOI 10.1016/S0306-4522(02)00039-8; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FITZGIBBON T, 1991, VISUAL NEUROSCI, V6, P159, DOI 10.1017/S0952523800010543; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERTSMITH C, 1992, J NEUROSCI, V356, P150; Hebb Donald O., 1949, ORG BEHAV; HIRSCH JA, 1993, J PHYSIOL-LONDON, V461, P247, DOI 10.1113/jphysiol.1993.sp019512; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; MIIKULAINEN R, 1997, PSYCHOL LEARN MOTIV, P257; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; OLSON CR, 1980, EXP BRAIN RES, V39, P17; PEARSON JC, 1987, J NEUROSCI, V7, P4209; PETTIGREW JD, 1974, J PHYSIOL-LONDON, V237, P49, DOI 10.1113/jphysiol.1974.sp010469; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Waleszczyk WJ, 2003, EUR J NEUROSCI, V17, P2351, DOI 10.1046/j.1460-9568.2003.02674.x; Xing J, 1996, J NEUROPHYSIOL, V75, P217, DOI 10.1152/jn.1996.75.1.217; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Young JM, 2002, J PHYSIOL-LONDON, V541, P601, DOI 10.1113/jphysiol.2001.016212	50	65	67	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					887	895		10.1038/nn1913	http://dx.doi.org/10.1038/nn1913			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529985				2022-12-24	WOS:000247560200019
J	Plachta, N; Annaheim, C; Bissiere, S; Lin, S; Ruegg, M; Hoving, S; Muller, D; Poirier, F; Bibel, M; Barde, YA				Plachta, Nicolas; Annaheim, Christine; Bissiere, Stephanie; Lin, Shuo; Ruegg, Markus; Hoving, Sjouke; Muller, Dieter; Poirier, Francoise; Bibel, Miriam; Barde, Yves-Alain			Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; WALLERIAN DEGENERATION; BASAL FOREBRAIN; NERVE GROWTH; PERIPHERAL-NERVES; SCHWANN-CELLS; GALECTIN-1; MOUSE; AXOTOMY; MICE	Unlike the mechanisms involved in the death of neuronal cell bodies, those causing the elimination of processes are not well understood owing to the lack of suitable experimental systems. As the neurotrophin receptor p75(NTR) is known to restrict the growth of neuronal processes, we engineered mouse embryonic stem (ES) cells to express an Ngfr (p75(NTR)) cDNA under the control of the Mapt locus (the gene encoding tau), which begins to be active when ES cell - derived progenitors start elongating processes. This caused a progressive, synchronous degeneration of all processes, and a prospective proteomic analysis showed increased levels of the sugar-binding protein galectin-1 in the p75(NTR)-engineered cells. Function-blocking galectin-1 antibodies prevented the degeneration of processes, and recombinant galectin-1 caused the processes of wild-type neurons to degenerate first, followed by the cell bodies. In vivo, the application of a glutamate receptor agonist, a maneuver known to upregulate p75(NTR), led to an increase in the amount of galectin-1 and to the degeneration of neurons and their processes in a galectin-1-dependent fashion. Section of the sciatic nerve also rapidly upregulated levels of p75(NTR) and galectin-1 in terminal Schwann cells, and the elimination of nerve endings was delayed at the neuromuscular junction of mice lacking Lgals1 (the gene encoding galectin- 1). These results indicate that galectin-1 actively participates in the elimination of neuronal processes after lesion, and that engineered ES cells are a useful tool for studying relevant aspects of neuronal degeneration that have been hitherto difficult to analyze.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland; Novartis Inst Biomed Res, Genome & Proteome Sci Dept, CH-4002 Basel, Switzerland; Univ Paris 06, Inst Jacques Monod, CNRS, Unite Mixte Rech 7592, Paris, France; Univ Paris 07, Inst Jacques Monod, CNRS, Unite Mixte Rech 7592, Paris, France	University of Basel; Novartis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Barde, YA (corresponding author), Univ Basel, Bioctr, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	yves.barde@unibas.ch	Barde, Yves/F-6019-2011; Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Barde, Yves/0000-0002-7627-461X; Lin, Shuo/0000-0003-2317-0339				Aggarwal P, 2000, BRAIN RES, V882, P75, DOI 10.1016/S0006-8993(00)02832-8; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; BITTNER GD, 1991, TRENDS NEUROSCI, V14, P188, DOI 10.1016/0166-2236(91)90104-3; BROWN MC, 1991, NEUROSCIENCE, V43, P279, DOI 10.1016/0306-4522(91)90435-Q; CHEN S, 1993, J COMP NEUROL, V333, P449, DOI 10.1002/cne.903330310; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Finn JT, 2000, J NEUROSCI, V20, P1333; Hahn HP, 2004, CELL DEATH DIFFER, V11, P1277, DOI 10.1038/sj.cdd.4401485; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Horie H, 1999, J NEUROSCI, V19, P9964; Horie H, 2004, J NEUROSCI, V24, P1873, DOI 10.1523/JNEUROSCI.4483-03.2004; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kato T, 2001, BIOCHEM BIOPH RES CO, V282, P166, DOI 10.1006/bbrc.2001.4556; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Majdan M, 1997, J NEUROSCI, V17, P6988; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; McGraw J, 2005, EXP NEUROL, V195, P103, DOI 10.1016/j.expneurol.2005.04.004; McGraw J, 2004, EUR J NEUROSCI, V20, P2872, DOI 10.1111/j.1460-9568.2004.03802.x; Oh JD, 2000, BRAIN RES, V853, P174, DOI 10.1016/S0006-8993(99)02054-5; Parson SH, 1997, EUR J NEUROSCI, V9, P1586, DOI 10.1111/j.1460-9568.1997.tb01516.x; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; REICHERT F, 1994, J NEUROSCI, V14, P3231; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saporito MS, 1998, NEUROSCIENCE, V86, P461, DOI 10.1016/S0306-4522(98)00059-1; SPRINGER JE, 1987, J NEUROSCI RES, V17, P111, DOI 10.1002/jnr.490170204; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; YAN Q, 1988, J NEUROSCI, V8, P3481; Yeo TT, 1997, J NEUROSCI, V17, P7594; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	45	50	52	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					712	719		10.1038/nn1897	http://dx.doi.org/10.1038/nn1897			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486104				2022-12-24	WOS:000246799800013
J	Yoshii, A; Constantine-Paton, M				Yoshii, Akira; Constantine-Paton, Martha			BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; ENDOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; CALCIUM CHANNELS; LIPID RAFTS; SYNAPSES; PROTEINS; NEUROTROPHINS; TRANSMISSION	The N-methyl-D-aspartate receptor (NMDAR), brain-derived neurotrophic factor (BDNF), postsynaptic density protein 95 (PSD-95) and phosphatidylinositol 3-kinase (PI3K) have all been implicated in long-term potentiation. Here we show that these molecules are involved in a single pathway for synaptic potentiation. In visual cortical neurons in young rodents, the neurotrophin receptor TrkB is associated with PSD-95. When BDNF is applied to cultured visual cortical neurons, PSD-95-labeled synaptic puncta enlarge, and fluorescent recovery after photobleaching (FRAP) reveals increased delivery of green fluorescent protein-tagged PSD-95 to the dendrites. The recovery of fluorescence requires TrkB, signaling through PI3K and the serine-threonine kinase Akt, and an intact Golgi apparatus. Stimulation of NMDARs mimics the PSD-95 trafficking that is induced by BDNF but requires active BDNF and PI3K. Furthermore, local dendritic contact with a BDNF-coated microsphere induces PSD-95 FRAP throughout the dendrites of the stimulated neuron, suggesting that this mechanism induces rapid neuron-wide synaptic increases in PSD-95 and refinement whenever a few robust inputs activate the NMDAR-BDNF-PI3K pathway.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Yoshii, A (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ayoshii@mit.edu			NATIONAL EYE INSTITUTE [R01EY014074, R01EY006039] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY006039, R01EY014074] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AELD EH, 2002, CELL, V108, P849; Alarcon JM, 2006, J NEUROSCI, V26, P256, DOI 10.1523/JNEUROSCI.3196-05.2006; BANKERG, 1991, CULTURING NERVE CELL; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hering H, 2003, J NEUROSCI, V23, P3262; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Itami C, 2003, P NATL ACAD SCI USA, V100, P13069, DOI 10.1073/pnas.2131948100; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Stein V, 2003, J NEUROSCI, V23, P5503; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Washbourne P, 2004, NEURON, V44, P901, DOI 10.1016/S0896-6273(04)00799-8; Wu K, 1996, MOL BRAIN RES, V43, P286, DOI 10.1016/S0169-328X(96)00211-2; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100	50	222	229	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					702	711		10.1038/nn1903	http://dx.doi.org/10.1038/nn1903			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17515902				2022-12-24	WOS:000246799800012
J	Schwartz, G; Harris, R; Shrom, D; Berry, MJ				Schwartz, Greg; Harris, Rob; Shrom, David; Berry, Michael J., II			Detection and prediction of periodic patterns by the retina	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; RESPONSES; NOVELTY	A fundamental task of the brain is detecting patterns in the environment that enable predictions about the future. Here, we show that the salamander and mouse retinas can recognize a wide class of periodic temporal patterns, such that a subset of ganglion cells fire strongly and specifically in response to a violation of the periodicity. This sophisticated retinal processing may provide a substrate for hierarchical pattern detection in subsequent circuits.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Sussex, Sch Life Sci, Sussex Ctr Neurosci, Brighton BN1 9Q6, E Sussex, England	Princeton University; University of Sussex	Berry, MJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	berry@princeton.edu		Schwartz, Greg/0000-0001-8909-4397	NATIONAL EYE INSTITUTE [R01EY014196] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY14196, R01 EY014196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BULLOCK TH, 1994, ELECTROEN CLIN NEURO, V91, P42, DOI 10.1016/0013-4694(94)90017-5; BULLOCK TH, 1990, J NEUROPHYSIOL, V64, P903, DOI 10.1152/jn.1990.64.3.903; Busse L, 2003, NEUROIMAGE, V18, P856, DOI 10.1016/S1053-8119(03)00012-0; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; KARAMURSEL S, 1994, ELECTROEN CLIN NEURO, V90, P461, DOI 10.1016/0013-4694(94)90138-4; Karamursel S, 2000, INT J NEUROSCI, V100, P1, DOI 10.3109/00207450008999674; KLINKE R, 1968, ELECTROEN CLIN NEURO, V25, P119, DOI 10.1016/0013-4694(68)90135-1; Mecklinger A, 1997, NEUROSCI LETT, V235, P65, DOI 10.1016/S0304-3940(97)00712-X; ROGERS RL, 1992, ELECTROEN CLIN NEURO, V83, P146, DOI 10.1016/0013-4694(92)90028-G; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SUTTON S, 1967, SCIENCE, V155, P1436, DOI 10.1126/science.155.3768.1436; TIITINEN H, 1994, NEUROREPORT, V6, P190, DOI 10.1097/00001756-199412300-00048	13	54	54	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					552	554		10.1038/nn1887	http://dx.doi.org/10.1038/nn1887			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17450138	Green Accepted			2022-12-24	WOS:000245948000010
J	Mejia-Gervacio, S; Collin, T; Pouzat, C; Tan, YP; Llano, I; Marty, A				Mejia-Gervacio, Sheyla; Collin, Thibault; Pouzat, Christophe; Tan, Yusuf P.; Llano, Isabel; Marty, Alain			Axonal speeding: Shaping synaptic potentials in small neurons by the axonal membrane compartment	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; PYRAMIDAL CELLS; CURRENTS; STELLATE; INTEGRATION; INITIATION; SYNAPSES; AMPLIFICATION; PROBABILITY; MODULATION	The role of the axonal membrane compartment in synaptic integration is usually neglected. We show here that in interneurons of the cerebellar molecular layer, where dendrites are so short that the somatodendritic domain can be considered isopotential, the axonal membrane contributes a significant part of the cell input capacitance. We examine the impact of axonal membrane on synaptic integration by cutting the axon with two-photon illumination. We find that the axonal compartment acts as a sink for signals generated at fast conductance synapses, thus increasing the initial decay rate of corresponding synaptic potentials over the value predicted from the resistance-capacitance (RC) product of the cell membrane; signals generated at slower synapses are much less affected. This mechanism sharpens the spike firing precision of fast glutamatergic inputs without resorting to multisynaptic pathways.	Univ Paris 05, Lab Physiol Cerebrale, UFR Biomed, F-75006 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Marty, A (corresponding author), Univ Paris 05, Lab Physiol Cerebrale, UFR Biomed, 45 Rue St Peres, F-75006 Paris, France.	alain.marty@univ-paris5.fr	Pouzat, Christophe/HHM-2545-2022	Pouzat, Christophe/0000-0002-2844-8099				Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Auger C, 1998, J NEUROSCI, V18, P4532; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chavas J, 2003, J NEUROSCI, V23, P2019; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DURAND D, 1984, BIOPHYS J, V46, P645, DOI 10.1016/S0006-3495(84)84063-1; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Glitsch M, 1999, J NEUROSCI, V19, P511; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; JACKSON MB, 1993, J NEUROPHYSIOL, V69, P692, DOI 10.1152/jn.1993.69.3.692; JACKSON MB, 1992, BIOPHYS J, V61, P756, DOI 10.1016/S0006-3495(92)81880-5; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; JOHNSTON D, 2000, J PHYSL, V524, P75; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; KIRKWOOD PA, 1982, J PHYSIOL-LONDON, V322, P315, DOI 10.1113/jphysiol.1982.sp014039; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MAJOR G, 1994, J NEUROSCI, V14, P4613; Mann-Metzer P, 2002, J NEUROPHYSIOL, V87, P149, DOI 10.1152/jn.00310.2001; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Mejia-Gervacio S, 2006, J PHYSIOL-LONDON, V571, P43, DOI 10.1113/jphysiol.2005.101675; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouzat C, 1999, J NEUROSCI, V19, P1675; Pouzat C, 1997, J NEUROSCI, V17, P9104; Protti DA, 1998, J NEUROSCI, V18, P3715; R Development Core Team, 2005, R LANG ENV STAT COMP; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; RALL W, 1985, VOLTAGE PATCH CLAMPI, P191; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Sultan F, 1998, J COMP NEUROL, V393, P353; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; Tan YP, 1999, J NEUROSCI METH, V92, P123, DOI 10.1016/S0165-0270(99)00103-X; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	55	25	25	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					843	855		10.1016/j.neuron.2007.02.023	http://dx.doi.org/10.1016/j.neuron.2007.02.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359919	Bronze			2022-12-24	WOS:000245292800009
J	Peineau, S; Taghibiglou, C; Bradley, C; Wong, TP; Liu, LD; Lu, J; Lo, E; Wu, DC; Saule, E; Bouschet, T; Matthews, P; Isaac, JTR; Bortolotto, ZA; Wang, YT; Collingridge, GL				Peineau, Stephane; Taghibiglou, Changiz; Bradley, Clarrisa; Wong, Tak Pan; Liu, Lidong; Lu, Jie; Lo, Edmond; Wu, Dongchuan; Saule, Emilia; Bouschet, Tristan; Matthews, Paul; Isaac, John T. R.; Bortolotto, Zuner A.; Wang, Yu Tian; Collingridge, Graham L.			UP inhibits LTD in the hippocampus via regulation of GSK3 beta	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3; LONG-TERM DEPRESSION; PROTEIN-KINASE; TAU-PROTEIN; RECEPTOR TRAFFICKING; NMDA RECEPTORS; AREA CA1; EXPRESSION; INDUCTION; PHOSPHORYLATION	Glycogen synthase kinase-3 (GSK3) has been implicated in major neurological disorders, but its role in normal neuronal function is largely unknown. Here we show that GSK3 beta mediates an interaction between two major forms of synaptic plasticity in the brain, N-methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) and NMDA receptor-dependent long-term depression (LTD). In rat hippocampal slices, GSK3 beta inhibitors block the induction of LTD. Furthermore, the activity of GSK3 beta is enhanced during LTD via activation of PP1. Conversely, following the induction of LTP, there is inhibition of GSK3 beta activity. This regulation of GSK3 beta during LTP involves activation of NMDA receptors and the PI3K-Akt pathway and disrupts the ability of synapses to undergo LTD for up to 1 hr. We conclude that the regulation of GSK3 beta activity provides a powerful mechanism to preserve information encoded during LTP from erasure by subsequent LTD, perhaps thereby permitting the initial consolidation of learnt information.	MRC, Ctr Synapt Plast, Dept Anat, Sch Med Sci, Bristol BS8 1TD, Avon, England; Univ British Columbia, Brain Res Ctr, UBC Hosp, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, UBC Hosp, Vancouver, BC V6T 1Z3, Canada; NINDS, NIH, Bethesda, MD 20892 USA	University of Bristol; University of British Columbia; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Collingridge, GL (corresponding author), MRC, Ctr Synapt Plast, Dept Anat, Sch Med Sci, Univ Walk, Bristol BS8 1TD, Avon, England.	g.l.collingridge@bristol.ac.uk	collingridge, graham/AAI-8362-2020; Wang, Yu Tian/A-4729-2008; Collingridge, Graham L/C-4605-2015; Wu, Dong Chuan/O-3909-2015; Wang, Yu Tian/J-8255-2015; Bouschet, Tristan/C-8265-2019; Taghibiglou, Changiz/H-4590-2019	Collingridge, Graham L/0000-0002-9572-5359; Bouschet, Tristan/0000-0002-7858-6115; Matthews, Paul M/0000-0002-1619-8328; WU, DONG CHUAN/0000-0002-9539-5935; Liu, Lidong/0000-0002-7026-690X; Peineau, Stephane/0000-0002-4721-6795; Wong, Tak Pan/0000-0001-8611-4911	Medical Research Council [G9532377] Funding Source: Medline; MRC [G9532377] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Anderton BH, 1999, CURR BIOL, V9, pR106, DOI 10.1016/S0960-9822(99)80062-1; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beasley C, 2001, NEUROSCI LETT, V302, P117, DOI 10.1016/S0304-3940(01)01688-3; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kirschenbaum F, 2001, J BIOL CHEM, V276, P30701, DOI 10.1074/jbc.M102849200; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kozlovsky N, 2002, EUR NEUROPSYCHOPHARM, V12, P13, DOI 10.1016/S0924-977X(01)00131-6; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li BL, 2003, J CELL BIOCHEM, V90, P1224, DOI 10.1002/jcb.10674; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Takahashi M, 2000, BRAIN RES, V857, P193, DOI 10.1016/S0006-8993(99)02424-5; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	65	542	559	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					703	717		10.1016/j.neuron.2007.01.029	http://dx.doi.org/10.1016/j.neuron.2007.01.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329210	Green Submitted, Bronze			2022-12-24	WOS:000245127100011
J	Raingo, J; Castiglioni, AJ; Lipscombe, D				Raingo, Jesica; Castiglioni, Andrew J.; Lipscombe, Diane			Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors	NATURE NEUROSCIENCE			English	Article							GAMMA-BINDING DOMAIN; G-BETA-GAMMA; CA2+ CHANNELS; SENSORY NEURONS; CA(V)2.2 CHANNELS; KINASE-C; MODULATION; CURRENTS; PATHWAYS; SUBUNITS	Neurotransmitter release from mammalian sensory neurons is controlled by Ca(V)2.2 N-type calcium channels. N-type channels are a major target of neurotransmitters and drugs that inhibit calcium entry, transmitter release and nociception through their specific G protein-coupled receptors. G protein-coupled receptor inhibition of these channels is typically voltage-dependent and mediated by G beta gamma, whereas N-type channels in sensory neurons are sensitive to a second G protein - coupled receptor pathway that inhibits the channel independent of voltage. Here we show that preferential inclusion in nociceptors of exon 37a in rat Cacna1b ( encoding CaV2.2) creates, de novo, a C-terminal module that mediates voltage-independent inhibition. This inhibitory pathway requires tyrosine kinase activation but not G beta gamma. A tyrosine encoded within exon 37a constitutes a critical part of a molecular switch controlling N-type current density and G protein-mediated voltage-independent inhibition. Our data define the molecular origins of voltage-independent inhibition of N-type channels in the pain pathway.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Lipscombe, D (corresponding author), Brown Univ, Dept Neurosci, Sidney E Frank Hall Life Sci,185 Meeting St, Providence, RI 02912 USA.	Diane_Lipscombe@brown.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055251, R29NS029967, R01NS029967] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007601] Funding Source: Medline; NINDS NIH HHS [NS55251, R01 NS055251, NS29967, R01 NS055251-04, R01 NS029967] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bourinet E, 2005, CURR TOP MED CHEM, V5, P539, DOI 10.2174/1568026054367610; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; Castiglioni AJ, 2006, J PHYSIOL-LONDON, V576, P119, DOI 10.1113/jphysiol.2006.115030; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DiversePierluissi M, 1997, P NATL ACAD SCI USA, V94, P5417, DOI 10.1073/pnas.94.10.5417; DIVERSEPIERLUISSI M, 1993, NEURON, V10, P753, DOI 10.1016/0896-6273(93)90175-Q; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Elmslie KS, 2003, J BIOENERG BIOMEMBR, V35, P477, DOI 10.1023/B:JOBB.0000008021.55853.18; Fujikawa S, 1997, PFLUG ARCH EUR J PHY, V434, P84, DOI 10.1007/s004240050366; Hamid J, 1999, J BIOL CHEM, V274, P6195, DOI 10.1074/jbc.274.10.6195; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HILLE B, 1995, LIFE SCI, V56, P989, DOI 10.1016/0024-3205(95)00038-8; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; IKEDA SR, 1996, NATURE, V380, P258; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; Li B, 2004, MOL PHARMACOL, V66, P761; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lipscombe D, 2006, NAT NEUROSCI, V9, P8, DOI 10.1038/nn0106-8; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; Onofri F, 1997, P NATL ACAD SCI USA, V94, P12168, DOI 10.1073/pnas.94.22.12168; Ossipov MH, 2000, ANN NY ACAD SCI, V909, P12; Park D, 1998, J NEUROSCI, V18, P6757; Polo-Parada L, 1999, J NEUROSCI, V19, P5213; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; Richman RW, 2004, J BIOL CHEM, V279, P24649, DOI 10.1074/jbc.M312182200; Richman RW, 2004, METHOD ENZYMOL, V390, P224; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROUSSEL RR, 1991, P NATL ACAD SCI USA, V88, P10696, DOI 10.1073/pnas.88.23.10696; Strock J, 2004, MOL PHARMACOL, V66, P1071, DOI 10.1124/mol.104.002261; TADDESE A, 1995, SCIENCE, V270, P1366, DOI 10.1126/science.270.5240.1366; Thaler C, 2004, P NATL ACAD SCI USA, V101, P5675, DOI 10.1073/pnas.0303402101; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200	43	124	132	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					285	292		10.1038/nn1848	http://dx.doi.org/10.1038/nn1848			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293861	Green Accepted			2022-12-24	WOS:000244480300010
J	Wickersham, IR; Lyon, DC; Barnard, RJO; Mori, T; Finke, S; Conzelmann, KK; Young, JAT; Callaway, EM				Wickersham, Ian R.; Lyon, David C.; Barnard, Richard J. O.; Mori, Takuma; Finke, Stefan; Conzelmann, Karl-Klaus; Young, John A. T.; Callaway, Edward M.			Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; HERPES-SIMPLEX-VIRUS; A AVIAN-LEUKOSIS; RABIES VIRUS; VISUAL-CORTEX; IN-VIVO; TRANSNEURONAL TRACER; TRANSGENIC MICE; RETROVIRAL VECTORS; NEURAL ACTIVITY	There has never been a wholesale way of identifying neurons that are monosynaptically connected either to some other cell group or, especially, to a single cell. The best available tools, transsynaptic tracers, are unable to distinguish weak direct connections from strong indirect ones. Furthermore, no tracer has proven potent enough to label any connected neurons whatsoever when starting from a single cell. Here we present a transsynaptic tracer that crosses only one synaptic step, unambiguously identifying cells directly presynaptic to the starting population. Based on rabies virus, it is genetically targetable, allows high-level expression of any gene of interest in the synaptically coupled neurons, and robustly labels connections made to single cells. This technology should enable afar more detailed understanding of neural connectivity than has previously been possible.	Salk Inst Biol Studies, Infect Dis Labs, La Jolla, CA 92037 USA; Univ Munich, Max Von Pettenkofer Inst, D-81377 Munich, Germany; Univ Munich, Gene Ctr, D-81377 Munich, Germany	Salk Institute; University of Munich; University of Munich	Wickersham, IR (corresponding author), Salk Inst Biol Studies, Infect Dis Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	iwickersham@salk.edu	Mori, Takuma/AFS-0267-2022; Callaway, Edward/D-4336-2011; Conzelmann, Karl-Klaus/L-7239-2013; Mori, Takuma/GMX-3581-2022	Mori, Takuma/0000-0002-4195-2804; Callaway, Edward/0000-0002-6366-5267; Mori, Takuma/0000-0002-4195-2804; Conzelmann, Karl-Klaus/0000-0002-8614-3656; Lyon, David C./0000-0002-4367-5636; Finke, Stefan/0000-0001-8716-2341; Young, John/0000-0003-1824-2561	NCI NIH HHS [R01 CA070810, CA70810] Funding Source: Medline; NEI NIH HHS [R01 EY010742-16, R01 EY010742, EY10742] Funding Source: Medline; NIMH NIH HHS [MH63912, R01 MH063912, R01 MH063912-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070810] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barnard RJO, 2006, VIROLOGY, V344, P25, DOI 10.1016/j.virol.2005.09.021; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Boerger AL, 1999, P NATL ACAD SCI USA, V96, P9867, DOI 10.1073/pnas.96.17.9867; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Dantzker JL, 1998, J NEUROSCI, V18, P4145; Davis JRE, 2001, ENDOCRINOLOGY, V142, P795, DOI 10.1210/en.142.2.795; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; FEDERSPIEL MJ, 1994, P NATL ACAD SCI USA, V91, P11241, DOI 10.1073/pnas.91.23.11241; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gou D, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh129; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ito N, 2001, J VIROL, V75, P9121, DOI 10.1128/JVI.75.19.9121-9128.2001; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McGettigan JP, 2003, J VIROL, V77, P10889, DOI 10.1128/JVI.77.20.10889-10899.2003; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Melikyan GB, 2004, J VIROL, V78, P3753, DOI 10.1128/JVI.78.7.3753-3762.2004; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; Nassi JJ, 2006, NEURON, V50, P319, DOI 10.1016/j.neuron.2006.03.019; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Norgren RB, 1998, NEUROSCI BIOBEHAV R, V22, P695, DOI 10.1016/S0149-7634(98)00008-6; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Rinaman L, 2004, J NEUROSCI, V24, P2782, DOI 10.1523/JNEUROSCI.5329-03.2004; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thomson AM, 2002, PHILOS T R SOC B, V357, P1781, DOI 10.1098/rstb.2002.1163; Timofeeva E, 2005, J NEUROSCI, V25, P9135, DOI 10.1523/JNEUROSCI.3073-05.2005; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; UGOLINI G, 1987, BRAIN RES, V422, P242, DOI 10.1016/0006-8993(87)90931-0; UGOLINI G, 1989, SCIENCE, V243, P89, DOI 10.1126/science.2536188; UGOLINI G, 1995, VIRAL VECTORS TOOLS; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; YOUNG JAT, 1993, J VIROL, V67, P1811, DOI 10.1128/JVI.67.4.1811-1816.1993; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005; ZEMANICK MC, 1991, P NATL ACAD SCI USA, V88, P8048, DOI 10.1073/pnas.88.18.8048; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	59	766	785	6	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					639	647		10.1016/j.neuron.2007.01.033	http://dx.doi.org/10.1016/j.neuron.2007.01.033			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329205	Bronze, Green Accepted			2022-12-24	WOS:000245127100006
J	Lavenex, P; Lavenex, PB; Amaral, DG				Lavenex, Pierre; Lavenex, Pamela Banta; Amaral, David G.			Spatial relational learning persists following neonatal hippocampal lesions in macaque monkeys	NATURE NEUROSCIENCE			English	Article							ENDURING MEMORY IMPAIRMENT; MEDIAL TEMPORAL-LOBE; ENTORHINAL CORTEX; COGNITIVE NEUROSCIENCE; DEVELOPMENTAL AMNESIA; PRENATAL REMOVAL; EPISODIC MEMORY; SEMANTIC MEMORY; FIMBRIA-FORNIX; DAMAGE	The hippocampus is important for the acquisition of spatial representations of the environment and consequently in contextual memory. This suggests that the neural substrates underlying spatial cognition might be essential for remembering specific life episodes. Indeed, hippocampal lesions prevent spatial relational learning in adult rodents and monkeys, and result in profound amnesia in adult humans. In contrast, we show here that monkeys with neonatal hippocampal lesions learned new spatial relational information. Our experiments suggest that early hippocampal damage leads to functional brain reorganization that enables spatial information to be acquired through the use of brain regions that normally do not subserve this function.	Univ Calif Davis, Dept Psychiat & Behav Sci, Calif Natl Primate Res Ctr, MIND Inst,Ctr Neurosci, Sacramento, CA 95817 USA; Univ Fribourg, Dept Med, Unit Physiol, CH-1700 Fribourg, Switzerland	University of California System; University of California Davis; University of Fribourg	Lavenex, P (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Calif Natl Primate Res Ctr, MIND Inst,Ctr Neurosci, 2805 50th St, Sacramento, CA 95817 USA.	pierre.lavenex@unifr.ch		Lavenex, Pierre/0000-0002-9278-1312; Banta Lavenex, Pamela/0000-0001-8868-2912	NCRR NIH HHS [RR00169] Funding Source: Medline; NIMH NIH HHS [R01-MH57502] Funding Source: Medline; NINDS NIH HHS [R01-NS16980] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016980] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amaral D., 2006, HIPPOCAMPUS BOOK, VVolume 1, P37, DOI DOI 10.1093/ACPROF:OSO/9780195100273.001.0001; Astur RS, 2002, BEHAV BRAIN RES, V132, P77, DOI 10.1016/S0166-4328(01)00399-0; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Bauman MD, 2004, J NEUROSCI, V24, P711, DOI 10.1523/JNEUROSCI.3263-03.2004; Bohbot VD, 2004, NEUROPSYCHOLOGY, V18, P418, DOI 10.1037/0894-4105.18.3.418; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Coutureau E, 2000, EXP BRAIN RES, V131, P381, DOI 10.1007/s002219900301; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; GOLDMAN PS, 1978, BRAIN RES, V152, P451, DOI 10.1016/0006-8993(78)91103-4; GOLDMAN PS, 1978, SCIENCE, V202, P768, DOI 10.1126/science.102031; King JA, 2004, NEUROPSYCHOLOGY, V18, P405, DOI 10.1037/0894-4105.18.3.405; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Lavenex P, 2006, LEARN MEMORY, V13, P84, DOI 10.1101/lm.97606; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Lavenex PB, 2006, J NEUROSCI, V26, P4546, DOI 10.1523/JNEUROSCI.5412-05.2006; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nadel L, 2004, NEUROPSYCHOLOGY, V18, P473, DOI 10.1037/0894-4105.18.3.473; Nadel L., 1991, Hippocampus, V1, P221, DOI 10.1002/hipo.450010302; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Parslow DM, 2004, NEUROPSYCHOLOGY, V18, P450, DOI 10.1037/0894-4105.18.3.450; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schenk F., 1995, V82, P277; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Shelton AL, 2004, NEUROPSYCHOLOGY, V18, P442, DOI 10.1037/0894-4105.18.3.442; Spiers HJ, 2001, HIPPOCAMPUS, V11, P715, DOI 10.1002/hipo.1087; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; STEWARD O, 1992, HIPPOCAMPUS, V2, P247, DOI 10.1002/hipo.450020305; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Villablanca JR, 2000, NEUROSCIENCE, V95, P625; Whishaw IQ, 1995, HIPPOCAMPUS, V5, P595, DOI 10.1002/hipo.450050610; Winocur G, 2005, NEUROPSYCHOLOGIA, V43, P1580, DOI 10.1016/j.neuropsychologia.2005.01.013; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	44	39	39	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					234	239		10.1038/nn1820	http://dx.doi.org/10.1038/nn1820			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17195843	Green Submitted			2022-12-24	WOS:000244175200018
J	Krashes, MJ; Keene, AC; Leung, B; Armstrong, JD; Waddell, S				Krashes, Michael J.; Keene, Alex C.; Leung, Benjamin; Armstrong, J. Douglas; Waddell, Scott			Sequential use of mushroom body neuron subsets during Drosophila odor memory processing	NEURON			English	Article							SHORT-TERM-MEMORY; CONSOLIDATED MEMORY; COURTSHIP BEHAVIOR; MUTANT DROSOPHILA; OLFACTORY MEMORY; BODIES; MELANOGASTER; GENE; BRAIN; REPRESENTATIONS	Drosophila mushroom bodies (MB) are bilaterally symmetric multilobed brain structures required for olfactory memory. Previous studies suggested that neurotransmission from MB neurons is only required for memory retrieval. Our unexpected observation that Dorsal Paired Medial (DPM) neurons, which project only to MB neurons, are required during memory storage but not during acquisition or retrieval, led us to revisit the role of MB neurons in memory processing. We show that neurotransmission from the alpha'beta' subset of MB neurons is required to acquire and stabilize aversive and appetitive odor memory, but is dispensable during memory retrieval. In contrast, neurotransmission from MB alpha beta neurons is only required for memory retrieval. These data suggest a dynamic requirement for the different subsets of MB, neurons in memory and are consistent with the notion that recurrent activity in an MB alpha'beta' neuron-DPM neuron loop is required to stabilize memories formed in the MB alpha beta neurons.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh EH1 2QL, Midlothian, Scotland	University of Massachusetts System; University of Massachusetts Worcester; University of Edinburgh	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@umassmed.edu	Krashes, Michael/P-7677-2019	Armstrong, Douglas/0000-0002-5397-3864; Waddell, Scott/0000-0003-4503-6229	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH073311, F31MH009883, R01MH069883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007366] Funding Source: NIH RePORTER; NIMH NIH HHS [MH073311, R01 MH069883, F31 MH073311, F31 MH073311-02, MH09883] Funding Source: Medline; NINDS NIH HHS [NS007366, T32 NS007366] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Glanzman DL, 2006, BIOL BULL-US, V210, P271, DOI 10.2307/4134563; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Hammer M, 1998, LEARN MEMORY, V5, P146; Hawkins RD, 2006, BIOL BULL-US, V210, P174, DOI 10.2307/4134556; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Lukowiak K, 2003, J EXP BIOL, V206, P2097, DOI 10.1242/jeb.00374; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Martin JR, 1998, LEARN MEMORY, V5, P179; Martini SR, 2005, J NEUROBIOL, V64, P133, DOI 10.1002/neu.20130; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672	51	289	289	0	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					103	115		10.1016/j.neuron.2006.11.021	http://dx.doi.org/10.1016/j.neuron.2006.11.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196534	Green Accepted, Bronze			2022-12-24	WOS:000245126500012
J	Wehrman, T; He, XL; Raab, B; Dukipatti, A; Blau, H; Garcia, KC				Wehrman, Tom; He, Xiaolin; Raab, Bill; Dukipatti, Abhiram; Blau, Helen; Garcia, K. Christopher			Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors	NEURON			English	Article							AFFINITY NGF RECEPTOR; NF-KAPPA-B; LEUCINE-RICH MOTIF; NEUROTROPHIN RECEPTOR; FUNCTIONAL INTERACTIONS; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; LIGAND-BINDING; TYROSINE KINASE; SCATCHARD PLOTS	Nerve growth factor engages two structurally distinct transmembrane receptors, TrkA and p75, which have been proposed to create a "high-affinity" NGF binding site through formation of a ternary TrkA/NGF/p75 complex. To define a structural basis for the high-affinity site, we have determined the three-dimensional structure of a complete extracellular domain of TrkA complexed with NGF. The complex reveals a crab-shaped homodimeric TrkA structure, but a mechanism for p75 coordination is not obvious. We investigated the heterodimerization of membrane-bound TrkA and p75, on intact mammalian cells, using a beta-gal proteinprotein interaction system. We find that NGF dimerizes TrkA and that p75 exists on the cell surface as a preformed oligomer that is not dissociated by NGF. We find no evidence for a direct TrkA/p75 interaction. We propose that TrkA and p75 likely communicate through convergence of downstream signaling pathways and/or shared adaptor molecules, rather than through direct extracellular interactions.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol,Stem Cell Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Dukkipati, Abhiram/0000-0001-7267-7131	NIA NIH HHS [AG009521, AG024987, AG020961] Funding Source: Medline; NIBIB NIH HHS [EB005011] Funding Source: Medline; NICHD NIH HHS [HD018179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG020961, R01AG009521, R01AG024987] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BATTLEMAN DS, 1993, J NEUROSCI, V13, P941; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bilderback TR, 2001, J NEUROCHEM, V76, P1540, DOI 10.1046/j.1471-4159.2001.00171.x; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke MA, 2003, J NEUROBIOL, V55, P191, DOI 10.1002/neu.10174; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; COHEN S, 1959, J BIOL CHEM, V234, P1129; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Frade JM, 1996, NATURE, V383, P166; GROB PM, 1983, P NATL ACAD SCI-BIOL, V80, P6819, DOI 10.1073/pnas.80.22.6819; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Karchewski LA, 1999, J COMP NEUROL, V413, P327, DOI 10.1002/(SICI)1096-9861(19991018)413:2<327::AID-CNE11>3.0.CO;2-3; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLOTZ IM, 1984, J BIOL CHEM, V259, P60; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Lachyankar MB, 2003, J NEUROSCI RES, V71, P157, DOI 10.1002/jnr.10480; Lad SP, 2003, J BIOL CHEM, V278, P24808, DOI 10.1074/jbc.M212270200; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MacDonald JIS, 1996, MOL CELL NEUROSCI, V7, P371, DOI 10.1006/mcne.1996.0027; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Majdan M, 1997, J NEUROSCI, V17, P6988; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Nekhai SA, 1997, BIOCHEM J, V325, P401, DOI 10.1042/bj3250401; NICOSIA S, 1988, PHARMACOL RES, V20, P733, DOI 10.1016/S0031-6989(88)80713-6; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEREZ P, 1995, MOL CELL NEUROSCI, V6, P97, DOI 10.1006/mcne.1995.1010; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Urfer R, 1998, J BIOL CHEM, V273, P5829, DOI 10.1074/jbc.273.10.5829; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wang JJL, 2000, J NEUROSCI RES, V60, P587, DOI 10.1002/(SICI)1097-4547(20000601)60:5<587::AID-JNR3>3.0.CO;2-1; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wehrman TS, 2005, NAT METHODS, V2, P521, DOI 10.1038/NMETH771; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WINDISCH JM, 1995, FEBS LETT, V374, P125, DOI 10.1016/0014-5793(95)01047-I; WINDISCH JM, 1995, BIOCHEMISTRY-US, V34, P11256, DOI 10.1021/bi00035a035; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Yano H, 2000, Pharm Acta Helv, V74, P253, DOI 10.1016/S0031-6865(99)00036-9; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; ZIERLER K, 1989, TRENDS BIOCHEM SCI, V14, P314, DOI 10.1016/0968-0004(89)90157-6	75	220	236	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					25	38		10.1016/j.neuron.2006.09.034	http://dx.doi.org/10.1016/j.neuron.2006.09.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196528	Bronze			2022-12-24	WOS:000245126500006
J	Kozlov, AS; Risler, T; Hudspeth, AJ				Kozlov, Andrei S.; Risler, Thomas; Hudspeth, A. J.			Coherent motion of stereocilia assures the concerted gating of hair-cell transduction channels	NATURE NEUROSCIENCE			English	Article							MECHANOELECTRICAL TRANSDUCTION; MECHANICAL-PROPERTIES; BUNDLE STIFFNESS; AMPLIFICATION; SENSITIVITY; ADAPTATION; INTEGRITY	The hair cell's mechanoreceptive organelle, the hair bundle, is highly sensitive because its transduction channels open over a very narrow range of displacements. The synchronous gating of transduction channels also underlies the active hair-bundle motility that amplifies and tunes responsiveness. The extent to which the gating of independent transduction channels is coordinated depends on how tightly individual stereocilia are constrained to move as a unit. Using dual-beam interferometry in the bullfrog's sacculus, we found that thermal movements of stereocilia located as far apart as a hair bundle's opposite edges showed high coherence and negligible phase lag. Because the mechanical degrees of freedom of stereocilia are strongly constrained, a force applied anywhere in the hair bundle deflects the structure as a unit. This feature assures the concerted gating of transduction channels that maximizes the sensitivity of mechanoelectrical transduction and enhances the hair bundle's capacity to amplify its inputs.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Hudspeth, AJ (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	hudspaj@rockefeller.edu	Risler, Thomas/E-6943-2011	Risler, Thomas/0000-0003-1677-4636	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC000241-26, R01 DC000241] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000241] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bashtanov ME, 2004, J PHYSIOL-LONDON, V559, P287, DOI 10.1113/jphysiol.2004.065565; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DENK W, 1992, J NEUROPHYSIOL, V68, P927, DOI 10.1152/jn.1992.68.3.927; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; DENK W, 1990, APPL OPTICS, V29, P2382, DOI 10.1364/AO.29.002382; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; Henderson S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.088302; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1983, ANNU REV NEUROSCI, V6, P187, DOI 10.1146/annurev.ne.06.030183.001155; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; Iwasa KH, 2002, J ACOUST SOC AM, V111, P2208, DOI 10.1121/1.1466864; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Karavitaki KD, 2006, Auditory Mechanisms: Processes and Models, P286, DOI 10.1142/9789812773456_0048; Marquis RE, 1997, P NATL ACAD SCI USA, V94, P11923, DOI 10.1073/pnas.94.22.11923; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; Martin P, 2003, J NEUROSCI, V23, P4533; Nam JH, 2006, BIOPHYS J, V90, P2786, DOI 10.1529/biophysj.105.066027; Nowak MA, 1999, ASTROPHYS J, V510, P874, DOI 10.1086/306610; Silber J, 2004, HEARING RES, V197, P112, DOI 10.1016/j.heares.2004.06.006	22	75	78	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					87	92		10.1038/nn1818	http://dx.doi.org/10.1038/nn1818			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173047	Green Accepted, Green Submitted			2022-12-24	WOS:000243096100019
J	Wang, HY; Yan, Y; Liu, Q; Huang, YH; Shen, Y; Chen, LJ; Chen, Y; Yang, QY; Hao, Q; Wang, KW; Chai, JJ				Wang, Huayi; Yan, Yan; Liu, Qun; Huang, Yanhua; Shen, Yue; Chen, Linjie; Chen, Yi; Yang, Qiuyue; Hao, Quan; Wang, KeWei; Chai, Jijie			Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP subunits	NATURE NEUROSCIENCE			English	Article							POTASSIUM CHANNELS; I-TO; INACTIVATION; EXPRESSION; TRANSIENT; BINDING; ELIMINATION; COMPONENT; FAMILY; DOMAIN	KChIPs coassemble with pore-forming Kv4 alpha subunits to form a native complex in the brain and heart and regulate the expression and gating properties of Kv4 K+ channels, but the mechanisms underlying these processes are unknown. Here we report a co-crystal structure of the complex of human Kv4.3 N-terminus and KChIP1 at a 3.2-angstrom resolution. The structure reveals a unique clamping action of the complex, in which a single KChIP1 molecule, as a monomer, laterally clamps two neighboring Kv4.3 N-termini in a 4: 4 manner, forming an octamer. The proximal N-terminal peptide of Kv4.3 is sequestered by its binding to an elongated groove on the surface of KChIP1, which is indispensable for the modulation of Kv4.3 by KChIP1, and the same KChIP1 molecule binds to an adjacent T1 domain to stabilize the tetrameric Kv4.3 channels. Taken together with biochemical and functional data, our findings provide a structural basis for the modulation of Kv4 by KChIPs.	Peking Univ, Hlth Sci Ctr, Ctr Prot Sci, Minist Educ,Key Lab Neurosci,Dept Neurobiol,Neuro, Beijing 100083, Peoples R China; Natl Inst Biol Sci, Beijing 102206, Peoples R China; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA	Peking University; National Institute of Biological Sciences, Beijing; Cornell University	Wang, KW (corresponding author), Peking Univ, Hlth Sci Ctr, Ctr Prot Sci, Minist Educ,Key Lab Neurosci,Dept Neurobiol,Neuro, Beijing 100083, Peoples R China.	wangkw@bjmu.edu.cn; chaijijie@nibs.ac.cn	Hao, Quan/C-4304-2009; huang, yao/GWR-5388-2022; Huang, Yunhui/C-3752-2014; Liu, Qun/A-8757-2011	Liu, Qun/0000-0002-1179-290X; Hao, Quan/0000-0002-9642-0514; Chai, Jijie/0000-0001-7591-3873	NCRR NIH HHS [RR01646] Funding Source: Medline; PHS HHS [DMR-0225180] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Jahng AW, 2002, J BIOL CHEM, V277, P47885, DOI 10.1074/jbc.M208416200; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Kim LA, 2004, NEURON, V41, P513, DOI 10.1016/S0896-6273(04)00050-9; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Orlova EV, 2003, J MOL BIOL, V326, P1005, DOI 10.1016/S0022-2836(02)00708-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shibata R, 2000, J NEUROSCI, V20, P4145; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Trimmer JS, 1998, CURR OPIN NEUROBIOL, V8, P370, DOI 10.1016/S0959-4388(98)80063-9; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	36	107	113	5	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					32	39		10.1038/nn1822	http://dx.doi.org/10.1038/nn1822			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17187064				2022-12-24	WOS:000243096100013
J	Narayanan, NS; Laubach, M				Narayanan, Nandakumar S.; Laubach, Mark			Top-down control of motor cortex ensembles by dorsomedial prefrontal cortex	NEURON			English	Article							CINGULATE UNIT-ACTIVITY; MEDIAL FRONTAL-CORTEX; SUBTHALAMIC NUCLEUS; EFFECTIVE CONNECTIVITY; DISCRIMINANT-ANALYSIS; RESPONSE-INHIBITION; NEURONAL-ACTIVITY; LOCUS-COERULEUS; SPIKE TRAINS; ELAPSED TIME	Dorsomedial prefrontal cortex is critical for the temporal control of behavior. Dorsomedial prefrontal cortex might alter neuronal activity in areas such as motor cortex to inhibit temporally inappropriate responses. We tested this hypothesis by recording from neuronal ensembles in rodent dorsomedial prefrontal cortex during a delayed-response task. One-third of dorsomedial prefrontal neurons were significantly modulated during the delay period. The activity of many of these neurons was predictive of premature responding. We then reversibly inactivated dorsomedial prefrontal cortex while recording ensemble activity in motor cortex. Inactivation of dorsomedial prefrontal cortex reduced delay-related firing, but not response-related firing, in motor cortex. Finally, we made simultaneous recordings in dorsomedial prefrontal cortex and motor cortex and found strong delay-related temporal correlations between neurons in the two cortical areas. These data suggest that functional interactions between dorsomedial prefrontal cortex and motor cortex might serve as a top-down control signal that inhibits inappropriate responding.	John B Pierce Fdn Lab, New Haven, CT 06519 USA; Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University	Laubach, M (corresponding author), John B Pierce Fdn Lab, New Haven, CT 06519 USA.	mark.laubach@yale.edu		Narayanan, Nandakumar/0000-0002-0427-0003; Laubach, Mark/0000-0002-2403-4497	NIGMS NIH HHS [T32 GM007205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Barkley R.A, 1997, ADHD NATURE SELF CON; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Broersen LM, 1999, NEUROSCIENCE, V94, P47, DOI 10.1016/S0306-4522(99)00312-7; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; CONDE F, 1995, J COMP NEUROL, V352, P567, DOI 10.1002/cne.903520407; Divac I, 1993, Acta Neurobiol Exp (Wars), V53, P425; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Fuster JM, 2000, BRAIN RES BULL, V52, P331, DOI 10.1016/S0361-9230(99)00258-0; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Jacobsen C, 1936, COMP PSYCHOL MONOGR, V13, P1, DOI DOI 10.1001/ARCHNEURPSYC.1935.02250150108009; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Kyuhou S, 2002, BRAIN RES, V929, P101, DOI 10.1016/S0006-8993(01)03383-2; Laubach M, 2004, J NEUROSCI METH, V134, P159, DOI 10.1016/j.jneumeth.2003.11.007; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Lee HS, 2005, J COMP NEUROL, V481, P179, DOI 10.1002/cne.20365; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Los SA, 2001, ACTA PSYCHOL, V106, P121, DOI 10.1016/S0001-6918(00)00029-9; LOUGHLIN SE, 1982, BRAIN RES BULL, V9, P287, DOI 10.1016/0361-9230(82)90142-3; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Mulder AB, 2003, BEHAV BRAIN RES, V146, P77, DOI 10.1016/j.bbr.2003.09.016; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NEAFSEY EJ, 1982, BRAIN RES, V232, P151, DOI 10.1016/0006-8993(82)90617-5; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; NIKI H, 1976, BRAIN RES, V110, P381, DOI 10.1016/0006-8993(76)90412-1; OLLMAN RT, 1972, COGNITIVE PSYCHOL, V3, P311, DOI 10.1016/0010-0285(72)90010-2; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Risterucci C, 2003, EUR J NEUROSCI, V17, P1498, DOI 10.1046/j.1460-9568.2003.02541.x; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Rowe JB, 2005, CEREB CORTEX, V15, P85, DOI 10.1093/cercor/bhh111; RYAN LJ, 1991, EXP BRAIN RES, V86, P641; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Swanson LW, 1999, BRAIN MAPS STRUCTURE; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; VAADIA E, 1995, P ROY SOC B-BIOL SCI, V261, P407, DOI 10.1098/rspb.1995.0167; VANEDEN CG, 1992, EUR J NEUROSCI, V4, P77; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; WATERHOUSE BD, 1986, J COMP NEUROL, V249, P460, DOI 10.1002/cne.902490403; WHISHAW IQ, 1992, BEHAV BRAIN RES, V50, P93, DOI 10.1016/S0166-4328(05)80291-8; WICHMANN T, 1994, J NEUROPHYSIOL, V72, P521, DOI 10.1152/jn.1994.72.2.521; Winkowski DE, 2006, NATURE, V439, P336, DOI 10.1038/nature04411	67	228	229	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					921	931		10.1016/j.neuron.2006.10.021	http://dx.doi.org/10.1016/j.neuron.2006.10.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145511	Green Accepted, Bronze			2022-12-24	WOS:000242856400018
J	Patel, MR; Lehrman, EK; Poon, VY; Crump, JG; Zhen, M; Bargmann, CI; Shen, K				Patel, Maulik R.; Lehrman, Emily K.; Poon, Vivian Y.; Crump, Justin G.; Zhen, Mei; Bargmann, Cornelia I.; Shen, Kang			Hierarchical assembly of presynaptic components in defined C. elegans synapses	NATURE NEUROSCIENCE			English	Article							ACTIVE ZONE; LIPRIN-ALPHA; NEUROTRANSMITTER RELEASE; CAENORHABDITIS-ELEGANS; SYNAPTIC VESICLES; TYROSINE-PHOSPHATASE; NERVOUS-SYSTEM; PROTEIN; RECEPTOR; COMPLEX	The presynaptic regions of axons accumulate synaptic vesicles, active zone proteins and periactive zone proteins. However, the rules for orderly recruitment of presynaptic components are not well understood. We systematically examined molecular mechanisms of presynaptic development in egg-laying synapses of Caenorhabditis elegans, demonstrating that two scaffolding molecules, SYD-1 and SYD-2, have key roles in presynaptic assembly. SYD-2 (liprin-alpha) was previously shown to regulate the size and the shape of active zones. We now show that in syd-1 and syd-2 mutants, synaptic vesicles and numerous other presynaptic proteins fail to accumulate at presynaptic sites. SYD-1 and SYD-2 function cell-autonomously at presynaptic terminals, downstream of synaptic specificity molecule SYG-1. SYD-1 is likely to act upstream of SYD-2 to positively regulate its synaptic assembly activity. These data imply a hierarchical organization of presynaptic assembly, in which transmembrane specificity molecules initiate synaptogenesis by recruiting a few key scaffolding proteins, which in turn assemble other presynaptic components.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ So Calif, Zilkha Neurogent Inst, Los Angeles, CA 90089 USA; Univ Toronto, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Stanford University; Stanford University; University of Southern California; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Howard Hughes Medical Institute; Rockefeller University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu	Zhen, Mei/A-4967-2012	Zhen, Mei/0000-0003-0086-9622; Bargmann, Cornelia/0000-0002-8484-0618	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01NS048392, R01 NS048392] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Ackley BD, 2004, TRENDS NEUROSCI, V27, P540, DOI 10.1016/j.tins.2004.07.003; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRENNER S, 1974, GENETICS, V77, P71; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; FISCHER V, 1990, P NATL ACAD SCI USA, V87, P1988; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hata Y, 1996, J NEUROSCI, V16, P2488; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko J, 2003, J NEUROSCI, V23, P1667; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	50	133	164	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1488	1498		10.1038/nn1806	http://dx.doi.org/10.1038/nn1806			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115039	Green Accepted			2022-12-24	WOS:000242404000012
J	Hansel, C; de Jeu, M; Belmeguenai, A; Houtman, SH; Buitendijk, GHS; Andreev, D; De Zeeuw, CI; Elgersma, Y				Hansel, Christian; de Jeu, Marcel; Belmeguenai, Amor; Houtman, Simone H.; Buitendijk, Gabrielle H. S.; Andreev, Dmitri; De Zeeuw, Chris I.; Elgersma, Ype			alpha CaMKII is essential for cerebellar LTD and motor learning	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; CALMODULIN KINASE-II; RAT PURKINJE-CELLS; PROTEIN-KINASE; MUTANT MICE; VESTIBULOOCULAR REFLEX; C INHIBITOR; PLASTICITY; POTENTIATION	Activation of postsynaptic alpha-calclum/calmodulin-dependent protein kinase II (alpha CaMKII) by calcium influx is a prerequisite for the induction of long-term potentiation (LTP) at most excitatory synapses in the hippocampus and cortex. Here we show that postsynaptic UP is unaffected at parallel fiber-Purkinje cell synapses in the cerebellum of alpha CaMKII-/- mice. In contrast, a long-term depression (LTD) protocol resulted in only transient depression in juvenile alpha CaMKII-/- mutants and in robust potentiation in adult mutants. This suggests that the function of alpha CaMKII in parallel fiber-Purkinje cell plasticity is opposite to its function at excitatory hippocampal and cortical synapses. Furthermore, alpha CaMKII-/- mice showed impaired gain-increase adaptation of both the vestibular ocular reflex and optokinetic reflex. Since Purkinje cells are the only cells in the cerebellum that express alpha CaMKII, our data suggest that an impairment of parallel fiber LTD, while leaving UP intact, is sufficient to disrupt this form of cerebellar learning.	Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.dezeeuw@erasmusmo.nl; y.elgersma@erasmusmc.nl	Elgersma, Ype/F-5164-2013	Elgersma, Ype/0000-0002-3758-1297				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Kakegawa W, 2005, P NATL ACAD SCI USA, V102, P17846, DOI 10.1073/pnas.0508910102; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KARACHOT L, 1994, NEUROSCI RES, V21, P161, DOI 10.1016/0168-0102(94)90158-9; Kasahara J, 1998, NEUROSCI LETT, V247, P139, DOI 10.1016/S0304-3940(98)00299-7; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; SURNI M, 1991, BIOCHEM BIOPH RES CO, V181, P968; van Alphen AM, 2002, EUR J NEUROSCI, V16, P486, DOI 10.1046/j.1460-9568.2002.02094.x; WALAAS SI, 1988, MOL BRAIN RES, V4, P233, DOI 10.1016/0169-328X(88)90029-0; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	49	165	167	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					835	843		10.1016/j.neuron.2006.08.013	http://dx.doi.org/10.1016/j.neuron.2006.08.013			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982427	Bronze			2022-12-24	WOS:000240997900020
J	Nader, MA; Morgan, D; Gage, HD; Nader, SH; Calhoun, TL; Buchheimer, N; Ehrenkaufer, R; Mach, RH				Nader, Michael A.; Morgan, Drake; Gage, H. Donald; Nader, Susan H.; Calhoun, Tonya L.; Buchheimer, Nancy; Ehrenkaufer, Richard; Mach, Robert H.			PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ENDOGENOUS DOPAMINE; NONHUMAN-PRIMATES; VERTICAL SHIFTS; BINDING-SITES; IN-VIVO; DRUG; ADDICTION; MODEL; STRESS	Dopamine neurotransmission is associated with high susceptibility to cocaine abuse. Positron emission tomography was used in 12 rhesus macaques to determine if dopamine D2 receptor availability was associated with the rate of cocaine reinforcement, and to study changes in brain dopaminergic function during maintenance of and abstinence from cocaine. Baseline D2 receptor availability was negatively correlated with rates of cocaine self-administration. D2 receptor availability decreased by 15-20% within 1 week of initiating self-administration and remained reduced by similar to 20% during 1 year of exposure. Long-term reductions in D2 receptor availability were observed, with decreases persisting for up to 1 year of abstinence in some monkeys. These data provide evidence for a predisposition to self-administer cocaine based on D2 receptor availability, and demonstrate that the brain dopamine system responds rapidly following cocaine exposure. Individual differences in the rate of recovery of D2 receptor function during abstinence were noted.	Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University	Nader, MA (corresponding author), Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	mnader@wfubmc.edu	Morgan, Drake/A-6373-2008; Morgan, Drake/F-6664-2012		NIDA NIH HHS [DA 14637, DA 08468] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008468, R01DA014637] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Blum K, 1996, AM SCI, V84, P132; Bradberry CW, 2000, J NEUROSCI, V20, P7109, DOI 10.1523/JNEUROSCI.20-18-07109.2000; Calabresi P, 1997, NEUROSCIENCE, V78, P39; Czoty PW, 2005, SYNAPSE, V58, P215, DOI 10.1002/syn.20200; Dackis C, 2005, NAT NEUROSCI, V8, P1431, DOI 10.1038/nn1105-1431; DEWEY SL, 1995, J NEUROSCI, V15, P821; DEWEY SL, 1992, J NEUROSCI, V12, P3773; Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785; Griffiths R.R., 1980, ADV SUBSTANC ABUSE, P1; Grigson PS, 2002, BEHAV NEUROSCI, V116, P321, DOI 10.1037/0735-7044.116.2.321; Hietala J, 1997, PSYCHOPHARMACOLOGY, V132, P361, DOI 10.1007/s002130050356; KALIVAS PW, 1989, BIOL PSYCHIAT, V25, P913, DOI 10.1016/0006-3223(89)90271-0; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; Leshner AI, 2000, AM J MED GENET, V96, P590, DOI 10.1002/1096-8628(20001009)96:5<590::AID-AJMG2>3.0.CO;2-2; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Mach RH, 1996, SYNAPSE, V24, P322, DOI 10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; MACH RH, 1993, NUCL MED BIOL, V20, P777, DOI 10.1016/0969-8051(93)90165-Q; MACH RH, 1993, J MED CHEM, V36, P3707, DOI 10.1021/jm00075a028; MADRAS BK, 1989, J PHARMACOL EXP THER, V251, P131; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; Mello NK, 1996, NEUROPSYCHOPHARMACOL, V14, P375, DOI 10.1016/0893-133X(95)00274-H; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Moore RJ, 1998, SYNAPSE, V30, P88, DOI 10.1002/(SICI)1098-2396(199809)30:1<88::AID-SYN11>3.0.CO;2-L; Morgan Myfanwy., 2002, QUAL RES, V2, P5, DOI [10.1177/1468794102002001636, DOI 10.1177/1468794102002001636]; Nader MA, 2005, AM J PSYCHIAT, V162, P1473, DOI 10.1176/appi.ajp.162.8.1473; Nader MA, 1999, NEUROPSYCHOPHARMACOL, V21, P589, DOI 10.1016/S0893-133X(98)00101-8; Nader MA, 2002, NEUROPSYCHOPHARMACOL, V27, P35, DOI 10.1016/S0893-133X(01)00427-4; O'Brien MS, 2005, NEUROPSYCHOPHARMACOL, V30, P1006, DOI 10.1038/sj.npp.1300681; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; REITH MEA, 1980, LIFE SCI, V27, P1055, DOI 10.1016/0024-3205(80)90029-6; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SPEALMAN RD, 1978, ANNU REV PHARMACOL, V18, P313, DOI 10.1146/annurev.pa.18.040178.001525; *US DEP HHS, 2004, 2003 NAT SURV DRUG U; *US DEP HHS, 2002, EM DEP TRENDS DRUG A; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; WOOLVERTON WL, 1990, MODERN METHODS PHARM, V6, P165; World Health Organization, 2004, NEUR PSYCH SUBST US; Zernig G, 2004, PSYCHOPHARMACOLOGY, V171, P349, DOI 10.1007/s00213-003-1601-0	47	331	336	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1050	1056		10.1038/nn1737	http://dx.doi.org/10.1038/nn1737			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16829955				2022-12-24	WOS:000240080300018
J	Kindt, KS; Quast, KB; Giles, AC; De, S; Hendrey, D; Nicastro, I; Rankin, CH; Schafer, WR				Kindt, Katie S.; Quast, Kathleen B.; Giles, Andrew C.; De, Subhajyoti; Hendrey, Dan; Nicastro, Ian; Rankin, Catharine H.; Schafer, William R.			Dopamine mediates context-dependent modulation of sensory plasticity in C-elegans	NEURON			English	Article							PROTEIN-KINASE-C; NEMATODE CAENORHABDITIS-ELEGANS; RECEPTOR-INTERACTING PROTEIN; PREFRONTAL CORTICAL-NEURONS; EGG-LAYING BEHAVIOR; LONG-TERM-MEMORY; PYRAMIDAL NEURONS; SYNAPTIC-TRANSMISSION; CHANNEL HOMOLOG; NERVOUS-SYSTEM	Dopamine has been implicated in the modulation of diverse forms of behavioral plasticity, including appetitive learning and addiction. An important challenge is to understand how dopamine's effects at the cellular level alter the properties of neural circuits to modify behavior. In the nematode C. elegans, dopamine modulates habituation of an escape reflex triggered by body touch. In the absence of food, animals habituate more rapidly than in the presence of food; this contextual information about food availability is provided by dopaminergic mechanosensory neurons that sense the presence of bacteria. We find that dopamine alters habituation kinetics by selectively modulating the touch responses of the anterior-body mechanoreceptors; this modulation involves a D1-like dopamine receptor, a Gq/PLC-beta signaling pathway, and calcium release within the touch neurons. Interestingly, the body touch mechanoreceptors can themselves excite the dopamine neurons, forming a positive feedback loop capable of integrating context and experience to modulate mechanosensory attention.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; MRC, Mol Biol Lab, Cambridge CB2 0QH, England; Univ British Columbia, Grad Program Neurosci, Vancouver, BC V6R 2B5, Canada; Univ British Columbia, Dept Psychol, Vancouver, BC V6R 2B5, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6R 2B5, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; MRC Laboratory Molecular Biology; University of British Columbia; University of British Columbia; University of British Columbia	Schafer, WR (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	wschafer@mrc-lmb.cam.ac.uk	Kindt, Katie/AAS-3275-2020	Rankin, Catharine/0000-0002-1781-0654; Nicastro, Ian/0000-0002-4058-4720; Schafer, William/0000-0002-6676-8034	Medical Research Council [MC_U105185857] Funding Source: Medline; MRC [MC_U105185857] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bastiani CA, 2003, GENETICS, V165, P1805; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Carr DB, 2002, J NEUROSCI, V22, P6846; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Crisp KM, 2006, J NEUROSCI, V26, P3524, DOI 10.1523/JNEUROSCI.3056-05.2006; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Demongeot L, 2000, CR ACAD SCI III-VIE, V323, P69, DOI 10.1016/S0764-4469(00)00112-8; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Doupe AJ, 2004, ANN NY ACAD SCI, V1016, P495, DOI 10.1196/annals.1298.035; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; ELLICOTT A, 1990, AM J PSYCHIAT, V147, P1194; FELDER CC, 1989, J BIOL CHEM, V264, P8739; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gulledge AT, 1998, J NEUROSCI, V18, P9139; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Koh PO, 2003, ARCH GEN PSYCHIAT, V60, P311, DOI 10.1001/archpsyc.60.3.311; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lavin A, 2001, NEUROSCIENCE, V104, P335, DOI 10.1016/S0306-4522(01)00096-3; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Manji HK, 1999, AUST NZ J PSYCHIAT, V33, pS65, DOI 10.1111/j.1440-1614.1999.00670.x; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Mirnics K, 2001, TRENDS MOL MED, V7, P281, DOI 10.1016/S1471-4914(01)02067-6; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Pacheco MA, 1997, J NEUROCHEM, V69, P639; RANKIN CH, 1992, BEHAV NEUROSCI, V106, P239, DOI 10.1037/0735-7044.106.2.239; RANKIN CH, 1990, BEHAV BRAIN RES, V37, P89, DOI 10.1016/0166-4328(90)90074-O; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Rose JK, 2003, J NEUROSCI, V23, P9595; Rose JK, 2002, LEARN MEMORY, V9, P130, DOI 10.1101/lm.46802; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Seamans JK, 1997, J NEUROSCI, V17, P5936; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shyn SI, 2003, CURR BIOL, V13, P1910, DOI 10.1016/j.cub.2003.10.025; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2002, NEUROSCI LETT, V319, P13, DOI 10.1016/S0304-3940(01)02477-6; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Toselli M, 2005, EUR BIOPHYS J BIOPHY, V34, P217, DOI 10.1007/s00249-004-0444-x; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wicks SR, 1996, J COMP PHYSIOL A, V179, P675, DOI 10.1007/BF00216131; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yang CR, 1996, J NEUROSCI, V16, P1922; Yang CR, 1999, NEUROPSYCHOPHARMACOL, V21, P161, DOI 10.1016/S0893-133X(98)00112-2; Young CE, 2004, J NEUROSCI, V24, P8, DOI 10.1523/JNEUROSCI.1650-03.2004; Zhang ZJ, 2005, NEUROSCI LETT, V382, P134, DOI 10.1016/j.neulet.2005.03.001	84	108	125	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2007	55	4					662	676		10.1016/j.neuron.2007.07.023	http://dx.doi.org/10.1016/j.neuron.2007.07.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698017	Bronze			2022-12-24	WOS:000249159200013
J	Liu, T; Larsson, J; Carrasco, M				Liu, Taosheng; Larsson, Jonas; Carrasco, Marisa			Feature-based attention modulates orientation-selective responses in human visual cortex	NEURON			English	Article							CONTRAST ADAPTATION; MOTION; AREAS; PERFORMANCE; MECHANISMS; PLASTICITY; INCREASES; STRIATE; NEURONS; OBJECT	How does feature-based attention modulate neural responses? We used adaptation to quantify the effect of feature-based attention on orientation-selective responses in human visual cortex. Observers were adapted to two superimposed oblique gratings while attending to one grating only. We measured the magnitude of attention-induced orientation-selective adaptation both psycho physically, by the behavioral tilt aftereffect, and physiologically, using fMRI response adaptation. We found evidence for orientation-selective attentional modulation of neuronal responses-a lower fMRI response for the attended than the unattended orientation-in multiple visual areas, and a significant correlation between the magnitude of the tilt aftereffect and that of fMRI response adaptation in V1, the earliest site of orientation coding. These results show that feature-based attention can selectively increase the response of neuronal subpopulations that prefer the attended feature, even when the attended and unattended features are coded in the same visual areas and share the same retinotopic location.	NYU, Dept Psychol, New York, NY 10027 USA; NYU, Ctr Neural Sci, New York, NY 10027 USA; Univ London Royal Holloway & Bedford New Coll, Dept Psychol, Egham TW20 0EX, Surrey, England	New York University; New York University; University of London; Royal Holloway University London	Liu, T (corresponding author), NYU, Dept Psychol, New York, NY 10027 USA.	taosheng.liu@nyu.edu	Liu, Taosheng/K-9148-2013	Liu, Taosheng/0000-0002-9768-0393	NEI NIH HHS [R01 EY016200-01A2, R01 EY016200, EY016200-01A2] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016200] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Baldassi S, 2005, J VISION, V5, P556, DOI 10.1167/5.6.7; BLAKEMOR.C, 1970, NATURE, V228, P37, DOI 10.1038/228037a0; Blaser E, 2000, NATURE, V408, P196, DOI 10.1038/35041567; Boynton GM, 2004, NAT NEUROSCI, V7, P8, DOI 10.1038/nn0104-8; Boynton GM, 2003, J NEUROSCI, V23, P8781; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARPENTER RH, 1973, EXP BRAIN RES, V18, P287; Carrasco M, 2006, PROG BRAIN RES, V154, P33; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Fang F, 2005, J NEUROPHYSIOL, V94, P4188, DOI 10.1152/jn.00378.2005; Gardner JL, 2005, NEURON, V47, P607, DOI 10.1016/j.neuron.2005.07.016; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hopf JM, 2005, CURR OPIN NEUROBIOL, V15, P183, DOI 10.1016/j.conb.2005.03.008; Huk AC, 2002, NAT NEUROSCI, V5, P72, DOI 10.1038/nn774; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Larsson J, 2006, J NEUROPHYSIOL, V95, P862, DOI 10.1152/jn.00668.2005; Larsson J, 2001, THESIS KAROLINSKA I; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Ling S, 2006, NAT NEUROSCI, V9, P1243, DOI 10.1038/nn1761; Liu TS, 2007, VISION RES, V47, P108, DOI 10.1016/j.visres.2006.09.017; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Liu TS, 2003, CEREB CORTEX, V13, P1334, DOI 10.1093/cercor/bhg080; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Montaser-Kouhsari L, 2004, J VISION, V4, P434, DOI 10.1167/4.6.3; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rezec A, 2004, VISION RES, V44, P3035, DOI 10.1016/j.visres.2004.07.020; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; Schroeder CE, 2001, FRONT BIOSCI-LANDMRK, V6, pD672, DOI 10.2741/Schroed; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Spivey MJ, 2000, PERCEPT PSYCHOPHYS, V62, P1525, DOI 10.3758/BF03212153; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; WENDEROTH P, 1988, VISION RES, V28, P301, DOI 10.1016/0042-6989(88)90158-7; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73	59	123	125	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2007	55	2					313	323		10.1016/j.neuron.2007.06.030	http://dx.doi.org/10.1016/j.neuron.2007.06.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NW	17640531	Green Accepted, Bronze			2022-12-24	WOS:000248635800014
J	Schuske, K; Palfreyman, MT; Watanabe, S; Jorgensen, EM				Schuske, Kim; Palfreyman, Mark T.; Watanabe, Shigeki; Jorgensen, Erik M.			UNC-46 is required for trafficking of the vesicular GABA transporter	NATURE NEUROSCIENCE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; C-ELEGANS; ACETYLCHOLINE TRANSPORTER; LYSOSOME BIOGENESIS; SYNAPTIC VESICLES; PROTEIN; IDENTIFICATION; LOCALIZATION; ENDOPHILIN; LAMP-2	Mutations in unc-46 in Caenorhabditis elegans cause defects in all behaviors that are mediated by GABA. Here we show that UNC-46 is a sorting factor that localizes the vesicular GABA transporter to synaptic vesicles. The UNC-46 protein is related to the LAMP ( lysosomal associated membrane protein) family of proteins and is localized at synapses. In unc-46 mutants, the vesicular transporter is not found specifically in synaptic vesicles but rather is diffusely spread along the axon. Mislocalization of the transporter severely reduces the frequency of miniature currents, but the remaining currents are normal in amplitude. Because the number of synaptic vesicles is not depleted, it is likely that only a fraction of vesicles harbor the transporter in unc-46 mutants. Our data indicate that the transporter and UNC-46 have mutual roles in sorting. The vesicular GABA transporter recruits UNC-46 to synaptic vesicle precursors in the cell body, and UNC-46 sorts the transporter at the cell body and during endocytosis at the synapse.	Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Howard Hughes Med Inst, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu		Watanabe, Shigeki/0000-0001-7580-8141				Bamber BA, 1999, J NEUROSCI, V19, P5348; Barbosa J, 2002, J NEUROCHEM, V82, P1221, DOI 10.1046/j.1471-4159.2002.01068.x; CLARK SG, 1994, GENETICS, V137, P987; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; David A, 2007, J CELL SCI, V120, P353, DOI 10.1242/jcs.03316; De Gois S, 2006, CELL MOL NEUROBIOL, V26, P679, DOI 10.1007/s10571-006-9054-8; Eastman C, 1999, J NEUROSCI, V19, P6225; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Jin YS, 1999, J NEUROSCI, V19, P539; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kostich M, 2000, J CELL SCI, V113, P2595; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shan G, 2005, DEV BIOL, V280, P494, DOI 10.1016/j.ydbio.2005.01.032; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006	36	33	41	1	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					846	853		10.1038/nn1920	http://dx.doi.org/10.1038/nn1920			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558401				2022-12-24	WOS:000247560200014
J	Szobota, S; Gorostiza, P; Del Bene, F; Wyart, C; Fortin, DL; Kolstad, KD; Tulyathan, O; Volgraf, M; Numano, R; Aaron, HL; Scott, EK; Kramer, RH; Flannery, J; Baier, H; Trauner, D; Isacoff, EY				Szobota, Stephanie; Gorostiza, Pau; Del Bene, Filippo; Wyart, Claire; Fortin, Doris L.; Kolstad, Kathleen D.; Tulyathan, Orapim; Volgraf, Matthew; Numano, Rika; Aaron, Holly L.; Scott, Ethan K.; Kramer, Richard H.; Flannery, John; Baier, Herwig; Trauner, Dirk; Isacoff, Ehud Y.			Remote control of neuronal activity with a light-gated glutamate receptor	NEURON			English	Article							NEURAL CIRCUITRY; INDUCED ACTIVATION; VISUAL RESPONSES; TRANSGENIC MICE; EXCITABLE CELLS; OPTICAL CONTROL; BOUND AGONISTS; ION CHANNELS; IN-VIVO; ZEBRAFISH	The ability to stimulate select neurons in isolated tissue and in living animals is important for investigating their role in circuits and behavior. We show that the engineered light-gated ionotropic glutamate receptor (LiGluR), when introduced into neurons, enables remote control of their activity. Trains of action potentials are optimally evoked and extinguished by 380 nm and 500 nm light, respectively, while intermediate wavelengths provide graded control over the amplitude of depolarization. Light pulses of 1-5 ms in duration at similar to 380 nm trigger precisely timed action potentials and EPSP-like responses or can evoke sustained depolarizations that persist for minutes in the dark until extinguished by a short pulse of similar to 500 nm light. When introduced into sensory neurons in zebrafish larvae, activation of LiGluR reversibly blocks the escape response to touch. Our studies show that LiGluR provides robust control over neuronal activity, enabling the dissection and manipulation of neural circuitry in vivo.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020; Wyart, Claire/H-3783-2016; del bene, filippo/D-1245-2010; Wyart, Claire/AAB-4603-2020; Gorostiza, Pau/Q-2544-2015	Wyart, Claire/0000-0002-1668-4975; del bene, filippo/0000-0001-8551-2846; Wyart, Claire/0000-0002-1668-4975; Gorostiza, Pau/0000-0002-7268-5577; Isacoff, Ehud Y./0000-0003-4775-9359; Scott, Ethan/0000-0003-3150-9216; Flannery, John/0000-0002-0720-8897; Fortin, Doris/0000-0002-2729-7890	NATIONAL EYE INSTITUTE [P30EY003176] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY003176] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Argenton F, 1996, MOL CELL BIOL, V16, P1714; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; CHABALA LD, 1986, J PHYSIOL-LONDON, V379, P83, DOI 10.1113/jphysiol.1986.sp016242; Cox KJA, 1996, J NEUROSCI METH, V68, P185; Gillespie DC, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P232; GOROSTIZA P, 2007, IN PRESS P NATL ACAD; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; KIMMEL CB, 1990, NEUROSCI IN, P561; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kotani T, 2006, METHODS, V39, P199, DOI 10.1016/j.ymeth.2005.12.006; LESTER HA, 1980, J GEN PHYSIOL, V75, P207, DOI 10.1085/jgp.75.2.207; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Masai I, 2005, DEVELOPMENT, V132, P1539, DOI 10.1242/dev.01714; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Pedregal C, 2000, J MED CHEM, V43, P1958, DOI 10.1021/jm9911682; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pozhidaeva N, 2004, BIOCONJUGATE CHEM, V15, P1297, DOI 10.1021/bc049855h; Ren JQ, 2002, VISION RES, V42, P293, DOI 10.1016/S0042-6989(01)00284-X; Risner ML, 2006, VISION RES, V46, P2625, DOI 10.1016/j.visres.2005.12.014; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	42	244	253	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 24	2007	54	4					535	545		10.1016/j.neuron.2007.05.010	http://dx.doi.org/10.1016/j.neuron.2007.05.010			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521567	Bronze			2022-12-24	WOS:000246970800009
J	Silberberg, SD; Li, MF; Swartz, KJ				Silberberg, Shai D.; Li, Mufeng; Swartz, Kenton J.			Ivermectin interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels	NEURON			English	Article							GATED CHLORIDE CHANNEL; CAENORHABDITIS-ELEGANS; ION CHANNELS; DOMAIN; SUBUNIT; MECHANISM; MEMBRANES; RESIDUES; AVERMECTIN-B1A; IDENTIFICATION	P2X receptors are trimeric cation channels that open in response to binding of extracellular ATP. Each subunit contains a large extracellular ligand binding domain and two flanking transmembrane (TM) helices that form the pore, but the extent of gating motions of the TM helices is unclear. We probed these motions using ivermectin (IM), a macrocyclic lactone that stabilizes the open state of P2X(4) receptor channels. We find that IVM partitions into lipid membranes and that transfer of the TM regions of P2X(4) receptors is sufficient to convey sensitivity to the lactone, suggesting that IVM interacts most favorably with the open conformation of the two TM helices at the protein-lipid interface. Scanning mutagenesis of the two TMs identifies residues that change environment between closed and open states, and substitutions at a subset of these positions weaken IVM binding. The emerging patterns point to widespread rearrangements of the TM helices during opening of P2X receptor channels.	NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Silberberg, SD (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	silberbs@ninds.nih.gov; swartzk@ninds.nih.gov	Silberberg, Shai/ABA-2778-2020; Li, Mufeng/A-7859-2010		Intramural NIH HHS [ZIA NS003018-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003018] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; ALBERSSCHONBERG G, 1981, J AM CHEM SOC, V103, P4216, DOI 10.1021/ja00404a040; ARENA JP, 1995, J PARASITOL, V81, P286, DOI 10.2307/3283936; Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Calderon RO, 1997, J NEUROSCI RES, V49, P372; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; Egan TM, 1998, J NEUROSCI, V18, P2350; Geary TG, 2005, TRENDS PARASITOL, V21, P530, DOI 10.1016/j.pt.2005.08.014; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Hill WG, 2005, AM J PHYSIOL-RENAL, V289, pF217, DOI 10.1152/ajprenal.00022.2005; Hu Xiurong, 1998, Yaoxue Xuebao, V33, P449; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MARTIN RJ, 1992, PARASITOLOGY, V104, P549, DOI 10.1017/S0031182000063812; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Omura S, 2004, NAT REV MICROBIOL, V2, P984, DOI 10.1038/nrmicro1048; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; SIGEL E, 1987, MOL PHARMACOL, V32, P749; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SPRINGER JP, 1981, J AM CHEM SOC, V103, P4221, DOI 10.1021/ja00404a041; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Toulme E, 2006, MOL PHARMACOL, V69, P576, DOI 10.1124/mol.105.018812; Vassilatis DK, 1997, J BIOL CHEM, V272, P33167, DOI 10.1074/jbc.272.52.33167; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; White SH, 1998, METHOD ENZYMOL, V295, P62; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	42	107	107	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					263	274		10.1016/j.neuron.2007.03.020	http://dx.doi.org/10.1016/j.neuron.2007.03.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442247	Bronze			2022-12-24	WOS:000246190600011
J	Ledda, F; Paratcha, G; Sandoval-Guzman, T; Ibanez, CF				Ledda, Fernanda; Paratcha, Gustavo; Sandoval-Guzman, Tatiana; Ibanez, Carlos F.			GDNF and GFR alpha 1 promote formation of neuronal synapses by ligand-induced cell adhesion	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; RECEPTOR TYROSINE KINASE; NEUROTROPHIC FACTOR; C-RET; MOLECULE NCAM; IN-VIVO; BINDING; ACTIVATION; FAMILY; BRAIN	The establishment of synaptic connections requires precise alignment of pre- and postsynaptic terminals. The glial cell line derived neurotrophic factor (GDNF) receptor GFR alpha 1 is enriched at pre- and postsynaptic compartments in hippocampal neurons, suggesting that it has a function in synapse formation. GDNF triggered trans-homophilic binding between GFR alpha 1 molecules and cell adhesion between GFR alpha 1-expressing cells. This represents the first example of a cell-cell interaction being mediated by a ligand-induced cell adhesion molecule (LICAM). In the presence of GDNF, ectopic GFR alpha 1 induced localized presynaptic differentiation in hippocampal neurons, as visualized by clustering of vesicular proteins and neurotransmitter transporters, and by activity-dependent vesicle recycling. Presynaptic differentiation induced by GDNF was markedly reduced in neurons lacking GFR alpha 1. Gdnf mutant mice showed reduced synaptic localization of presynaptic proteins and a marked decrease in the density of presynaptic puncta, indicating a role for GDNF signaling in hippocampal synaptogenesis in vivo. We propose that GFR alpha 1 functions as a LICAM to establish precise synaptic contacts and induce presynaptic differentiation.	Karolinska Inst, Div Mol Neurobiol, S-17177 Stockholm, Sweden; Karolinska Inst, Mol & Cellular Neurosci Lab, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ledda, F (corresponding author), Karolinska Inst, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	fernanda.ledda@ki.se; carlos.ibanez@ki.se	Sandoval-Guzman, Tatiana/P-3795-2018; Sandoval-Guzmán, Tatiana/P-2473-2019; Sandoval-Guzmán, Tatiana/B-8172-2017	Sandoval-Guzmán, Tatiana/0000-0003-1802-5145; Sandoval-Guzmán, Tatiana/0000-0003-1802-5145				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Maximov A, 2002, J NEUROSCI, V22, P6939; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Serra MP, 2002, BRAIN RES, V928, P138, DOI 10.1016/S0006-8993(01)03377-7; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; TRUPP M, 1996, NATURE, V381, P789; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Voikar V, 2004, EUR J NEUROSCI, V20, P308, DOI 10.1111/j.1460-9568.2004.03475.x; Wang CY, 2002, J BIOL CHEM, V277, P10614, DOI 10.1074/jbc.M106116200; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Yamada MK, 2002, J NEUROSCI, V22, P7580; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	45	123	130	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					293	300		10.1038/nn1855	http://dx.doi.org/10.1038/nn1855			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310246				2022-12-24	WOS:000244480300011
J	van Woerden, GM; Harris, KD; Hojjati, MR; Gustin, RM; Qiu, SF; Freire, RDA; Jiang, YH; Elgersma, Y; Weeber, EJ				van Woerden, Geeske M.; Harris, Karen D.; Hojjati, Mohammad Reza; Gustin, Richard M.; Qiu, Shenfeng; Freire, Rogerio de Avila; Jiang, Yong-hui; Elgersma, Ype; Weeber, Edwin J.			Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alpha CaMKII inhibitory phosphorylation	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; UBE3A; HIPPOCAMPAL; MUTATIONS; LIGASE; GENE; AUTOPHOSPHORYLATION; PLASTICITY; DELETION	Angelman syndrome ( AS) is a severe neurological disorder characterized by mental retardation, motor dysfunction and epilepsy. We show that the molecular and cellular deficits of an AS mouse model can be rescued by introducing an additional mutation at the inhibitory phosphorylation site of alpha CaMKII. Moreover, these double mutants no longer show the behavioral deficits seen in AS mice, suggesting that these deficits are the direct result of increased inhibitory phosphorylation of aCaMKII.	Univ Med Ctr, Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Erasmus University Rotterdam; Erasmus MC; Vanderbilt University; Vanderbilt University; Baylor College of Medicine	Elgersma, Y (corresponding author), Univ Med Ctr, Erasmus MC, Dept Neurosci, Dr Molewaterplein 50,POB 2040, NL-3000 CA Rotterdam, Netherlands.	y.elgersma@erasmusmc.nl	Elgersma, Ype/F-5164-2013; Hojjati, Mohammad reza/B-9941-2013; Weeber, Edwin J/A-5396-2012	Elgersma, Ype/0000-0002-3758-1297; Hojjati, Mohammad reza/0000-0001-7889-2545; 				Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; CLAYTONSMITH J, 1993, AM J MED GENET, V46, P12, DOI 10.1002/ajmg.1320460105; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Moncla A, 1999, J MED GENET, V36, P554; Smith A, 1996, J MED GENET, V33, P107, DOI 10.1136/jmg.33.2.107; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Zhang L, 2005, J NEUROSCI, V25, P7697, DOI 10.1523/JNEUROSCI.2086-05.2005	15	208	215	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					280	282		10.1038/nn1845	http://dx.doi.org/10.1038/nn1845			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17259980	Green Submitted			2022-12-24	WOS:000244480300008
J	Fuchs, EC; Zivkovic, AR; Cunningham, MO; Middleton, S; LeBeau, FEN; Bannerman, DM; Rozov, A; Whittington, MA; Traub, RD; Rawlins, JNP; Monyer, H				Fuchs, Elke C.; Zivkovic, Aleksandar R.; Cunningham, Mark O.; Middleton, Steven; LeBeau, Fiona E. N.; Bannerman, David M.; Rozov, Andrei; Whittington, Miles A.; Traub, Roger D.; Rawlins, J. Nicholas P.; Monyer, Hannah			Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; BINDING PROTEIN PARVALBUMIN; AMPA RECEPTOR SUBUNITS; RAT HIPPOCAMPUS; NETWORK OSCILLATIONS; GAMMA OSCILLATIONS; GABAERGIC NEURONS; CA2+ PERMEABILITY; WORKING-MEMORY; GRANULE CELLS	Perisomatic inhibition provided by a subgroup of GABAergic interneurons plays a critical role in timing the output of pyramidal cells. To test their contribution at the network and the behavioral level, we generated genetically modified mice in which the excitatory drive was selectively reduced either by the knockout of the GluR-D or by conditional ablation of the GluR-A subunit in parvalbumin-positive cells. Comparable cell type-specific reductions of AMPA-mediated currents were obtained. Kainate-induced gamma oscillations exhibited reduced power in hippocampal slices from GluR-D-/- and GluR-A(PVCre-/-) mice. Experimental and modeling data indicated that this alteration could be accounted for by imprecise spike timing of fast-spiking cells (FS) caused by smaller interneuronal EPSPs. GWR-D-/- and GluR-A(PVCre-/-) mice exhibited similar impairments in hippocampus-dependent tasks. These findings directly show the effects of insufficient recruitment of fast-spiking cells at the network and behavioral level and demonstrate the role of this subpopulation for working and episodic-like memory.	Univ Hosp Neurol, Dept Clin Neurobiol, IZN, D-69120 Heidelberg, Germany; Newcastle Univ, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA	Ruprecht Karls University Heidelberg; Newcastle University - UK; University of Oxford; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Monyer, H (corresponding author), Univ Hosp Neurol, Dept Clin Neurobiol, IZN, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	monyer@urz.uni-hd.de	Rozov, Andrei/C-1997-2015	Cunningham, Mark/0000-0002-7389-9569; LeBeau, Fiona/0000-0003-1453-4022; Whittington, Miles Adrian/0000-0002-0247-1362; Middleton, Steven/0000-0001-8875-8956; Monyer, Hannah/0000-0002-9332-5749; Zivkovic, Aleksandar/0000-0003-0757-8895; Bannerman, David/0000-0002-3024-7595	Wellcome Trust [087736] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Angulo MC, 1997, J NEUROSCI, V17, P6685; BRAGIN A, 1995, J NEUROSCI, V15, P47; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CATANIA MV, 1995, J NEUROSCI, V15, P7046; Catania MV, 1998, EUR J NEUROSCI, V10, P3479, DOI 10.1046/j.1460-9568.1998.00356.x; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CELIO MR, 1988, CELL CALCIUM, V9, P81, DOI 10.1016/0143-4160(88)90027-9; Chrobak JJ, 1998, NEUROSCI BIOBEHAV R, V22, P303, DOI 10.1016/S0149-7634(97)00016-X; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; DeCoteau WE, 1998, BEHAV NEUROSCI, V112, P68, DOI 10.1037/0735-7044.112.1.68; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gilbert PE, 2004, NEUROBIOL LEARN MEM, V81, P39, DOI 10.1016/S1074-7427(03)00069-8; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Honey RC, 1998, J NEUROSCI, V18, P2226; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Joho RH, 1999, J NEUROPHYSIOL, V82, P1855, DOI 10.1152/jn.1999.82.4.1855; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Kondo M, 1997, J NEUROSCI, V17, P1570; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Meyer AH, 2002, J NEUROSCI, V22, P7055; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Racca C, 1996, EUR J NEUROSCI, V8, P1580, DOI 10.1111/j.1460-9568.1996.tb01303.x; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; RIBAK CE, 1990, J COMP NEUROL, V300, P449, DOI 10.1002/cne.903000402; SIK A, 1995, J NEUROSCI, V15, P6651; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SOLBACH S, 1991, ANAT EMBRYOL, V184, P103, DOI 10.1007/BF00942742; SORIANO E, 1992, NEUROSCI LETT, V142, P147, DOI 10.1016/0304-3940(92)90360-J; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tansey EP, 2002, HIPPOCAMPUS, V12, P137, DOI 10.1002/hipo.1104; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; VINOGRADOVA OS, 1977, ZH VYSSH NERV DEYAT+, V27, P1165; Vreugdenhil M, 2003, J NEUROPHYSIOL, V89, P1414, DOI 10.1152/jn.00576.2002; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YLINEN A, 1995, J NEUROSCI, V15, P30; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	75	373	378	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					591	604		10.1016/j.neuron.2007.01.031	http://dx.doi.org/10.1016/j.neuron.2007.01.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296559	Bronze			2022-12-24	WOS:000245126900016
J	Abe, K; Takeichi, M				Abe, Kentaro; Takeichi, Masatoshi			NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression	NEURON			English	Article							CELL-ADHESION MOLECULES; WNT SIGNALING PATHWAY; SYNAPTIC PLASTICITY; N-CADHERIN; DENDRITIC SPINES; MULTIPLE ROLES; HIPPOCAMPAL; TARGET; TRANSCRIPTION; BRAIN	The canonical Wnt-beta-catenin signaling pathway is important for a variety of developmental phenomena as well as for carcinogenesis. Here, we show that, in hippocampal neurons, NMDA-receptor-dependent activation of calpain induced the cleavage of beta-catenin at the N terminus, generating stable, truncated forms. These beta-catenin fragments accumulated in the nucleus and induced Tcf/Lef-dependent gene transcription. We identified Fosl1, one of the immediateearly genes, as a target of this signaling pathway. In addition, exploratory behavior by mice resulted in a similar cleavage of beta-catenin, as well as activation of the Tcf signaling pathway, in hippocampal neurons. Both beta-catenin cleavage and Tcf-dependent gene transcription were suppressed by calpain inhibitors. These findings reveal another pathway for beta-catenindependent signaling, in addition to the canonical Wnt-beta-catenin pathway, and suggest that this other pathway could play an important role in activity-dependent gene expression.	Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; RIKEN	Takeichi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012; Abe, Kentaro/A-6197-2008; Abe, Kentaro/T-2247-2019	Takeichi, Masatoshi/0000-0002-9931-3378; Abe, Kentaro/0000-0002-3923-6323				Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chong ZZ, 2005, BRAIN RES REV, V49, P1, DOI 10.1016/j.brainresrev.2004.11.005; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Faure A, 2006, BRAIN RES BULL, V68, P233, DOI 10.1016/j.brainresbull.2005.08.017; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Huntley GW, 2002, NEUROSCIENTIST, V8, P221, DOI 10.1177/1073858402008003008; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kerokoski P, 2004, NEUROSCI LETT, V368, P181, DOI 10.1016/j.neulet.2004.07.007; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Neumar RW, 1998, J CEREBR BLOOD F MET, V18, P876, DOI 10.1097/00004647-199808000-00007; NUSSE R, 2006, WNT HOMEPAGE; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Polakis P, 2000, GENE DEV, V14, P1837; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; Shibamoto S, 1998, GENES CELLS, V3, P659; STAUBLI U, 1988, BRAIN RES, V444, P153, DOI 10.1016/0006-8993(88)90922-5; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; VANDERKLISH P, 1995, MOL BRAIN RES, V32, P25, DOI 10.1016/0169-328X(95)00057-Y; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361	53	113	114	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					387	397		10.1016/j.neuron.2007.01.016	http://dx.doi.org/10.1016/j.neuron.2007.01.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270735	Bronze			2022-12-24	WOS:000245126800009
J	Atallah, HE; Lopez-Paniagua, D; Rudy, JW; O'Reilly, RC				Atallah, Hisham E.; Lopez-Paniagua, Dan; Rudy, Jerry W.; O'Reilly, Randall C.			Separate neural substrates for skill learning and performance in the ventral and dorsal striatum	NATURE NEUROSCIENCE			English	Article							CAUDATE-NUCLEUS LESIONS; BASAL GANGLIA; DORSOCENTRAL STRIATUM; DOUBLE DISSOCIATION; PREDICTION ERRORS; PREFRONTAL CORTEX; MAZE TASKS; REWARD; DOPAMINE; ORGANIZATION	It is widely accepted that the striatum of the basal ganglia is a primary substrate for the learning and performance of skills. We provide evidence that two regions of the rat striatum, ventral and dorsal, play distinct roles in instrumental conditioning ( skill learning), with the ventral striatum being critical for learning and the dorsal striatum being important for performance but, notably, not for learning. This implies an actor ( dorsal) versus director ( ventral) division of labor, which is a new variant of the widely discussed actor-critic architecture. Our results also imply that the successful performance of a skill can ultimately result in its establishment as a habit outside the basal ganglia.	Univ Colorado, Dept Psychiat, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Atallah, HE (corresponding author), Univ Colorado, Dept Psychiat, 345 UCB, Boulder, CO 80309 USA.	hisham.atallah@colorado.edu; randy.oreilly@colorado.edu	O'Reilly, Randall/A-5819-2008	O'Reilly, Randall/0000-0003-0322-4600	NIMH NIH HHS [MH069597-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069597] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Andrzejewski ME, 2004, BEHAV NEUROSCI, V118, P715, DOI 10.1037/0735-7044.118.4.715; Atallah HE, 2004, NEUROBIOL LEARN MEM, V82, P253, DOI 10.1016/j.nlm.2004.06.004; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Cheatwood JL, 2005, BRAIN RES, V1036, P90, DOI 10.1016/j.brainres.2004.12.049; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; DICKINSON A, 1995, ANIM LEARN BEHAV, V23, P197, DOI 10.3758/BF03199935; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Featherstone RE, 2004, BEHAV BRAIN RES, V150, P15, DOI 10.1016/S0166-4328(03)00218-3; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Han JS, 1997, J NEUROSCI, V17, P3913; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; JOEL D, 2000, CONC ADV BRAIN RES, V1, P209; Kantak KM, 2001, BEHAV NEUROSCI, V115, P589, DOI 10.1037//0735-7044.115.3.589; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Reep RL, 2003, J COMP NEUROL, V467, P271, DOI 10.1002/cne.10868; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	47	193	195	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					126	131		10.1038/nn1817	http://dx.doi.org/10.1038/nn1817			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17187065				2022-12-24	WOS:000243096100024
J	Lee, S; Zhou, ZJ				Lee, Seunghoon; Zhou, Z. Jimmy			The synaptic mechanism of direction selectivity in distal processes of starburst amacrine cells	NEURON			English	Article							RETINAL GANGLION-CELLS; TRANSMITTER RELEASE; CHOLINERGIC NEURONS; RABBIT RETINA; IMAGE MOTION; INHIBITION; COMPUTATION; RECEPTORS; DENDRITES; NETWORK	Patch-clamp recordings revealed that distal processes of starburst amacrine cells (SACs) received largely excitatory synaptic input from the receptive field center and nearly purely inhibitory inputs from the surround during both stationary and moving light stimulations. The direct surround inhibition was mediated mainly by reciprocal GABA(A) synapses between opposing SACs, which provided leading and prolonged inhibition during centripetal stimulus motion. Simultaneous Ca2+ imaging and current-clamp recording during apparent-motion stimulation further demonstrated the contributions of both centrifugal excitation and GABA(A/C)-receptor-mediated centripetal inhibition to the direction-selective Ca2+ responses in SAC distal processes. Thus, by placing GABA release sites in electrotonically semi-isolated distal processes and endowing these sites with reciprocal GABAA synapses, SACs use a radial-symmetric center-surround receptive field structure to build a polarasymmetric circuitry. This circuitry may integrate at least three levels of interactions-center excitation, surround inhibition, and reciprocal inhibitions that amplify the center-surround antagonism-to generate robust direction selectivity in the distal processes.	Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, ZJ (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	zhoujimmy@uams.edu			NEI NIH HHS [EY017353, R01 EY017353, R01 EY010894, EY10894] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010894, R01EY017353] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; HUGHES A, 1972, VISION RES, V12, P123, DOI 10.1016/0042-6989(72)90143-5; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; Munch TA, 2006, J NEUROPHYSIOL, V96, P471, DOI 10.1152/jn.00628.2005; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shields CR, 2000, J NEUROSCI, V20, P2673; TAUCHI M, 1985, J NEUROSCI, V5, P2494; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Vigh J, 2005, NEURON, V46, P469, DOI 10.1016/j.neuron.2005.03.027; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	38	133	133	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					787	799		10.1016/j.neuron.2006.08.007	http://dx.doi.org/10.1016/j.neuron.2006.08.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982423	Green Accepted, Bronze			2022-12-24	WOS:000240997900016
J	Nagel, KI; Doupe, AJ				Nagel, Katherine I.; Doupe, Allison J.			Temporal processing and adaptation in the songbird auditory forebrain	NEURON			English	Article							MALE ZEBRA FINCHES; SPECTROTEMPORAL RECEPTIVE-FIELDS; DORSAL COCHLEAR NUCLEUS; NATURAL SOUNDS; INFERIOR COLLICULUS; INFORMATION-TRANSMISSION; FUNCTIONAL-ORGANIZATION; CONTRAST ADAPTATION; DYNAMIC SPECTRA; UNIT RESPONSES	Songbird auditory neurons must encode the dynamics of natural sounds at many volumes. We investigated how neural coding depends on the distribution of stimulus intensities. Using reverse-correlation, we modeled responses to amplitude-modulated sounds as the output of a linear filter and a nonlinear gain function, then asked how filters and nonlinearities depend on the stimulus mean and variance. Filter shape depended strongly on mean amplitude (volume): at low mean, most neurons integrated sound over many milliseconds, while at high mean, neurons responded more to local changes in amplitude. Increasing the variance (contrast) of amplitude modulations had less effect on filter shape but decreased the gain of firing in most cells. Both filter and gain changes occurred rapidly after a change in statistics, suggesting that they represent nonlinearities in processing. These changes may permit neurons to signal effectively over a wider dynamic range and are reminiscent of findings in other sensory systems.	Univ Calif San Francisco, Dept Physiol, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Nagel, KI (corresponding author), Univ Calif San Francisco, Dept Physiol, Keck Ctr Integrat Neurosci, Box 0444, San Francisco, CA 94143 USA.	knagel@phy.ucsf.edu; ajd@phy.ucsf.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; NIMH NIH HHS [MH55987] Funding Source: Medline; NINDS NIH HHS [NS34835] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTIAS H, 1998, ADV NEURAL INFORM PR, V10; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Barbour DL, 2003, J NEUROSCI, V23, P7194, DOI 10.1523/JNEUROSCI.23-18-07194.2003; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Calhoun BM, 1998, EUR J NEUROSCI, V10, P926, DOI 10.1046/j.1460-9568.1998.00102.x; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Drew PJ, 2003, J NEUROPHYSIOL, V89, P2697, DOI 10.1152/jn.00801.2002; EGGERMONT JJ, 1993, HEARING RES, V66, P177, DOI 10.1016/0378-5955(93)90139-R; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; EPPING WJM, 1986, HEARING RES, V24, P55, DOI 10.1016/0378-5955(86)90005-5; Escabi MA, 2003, J NEUROSCI, V23, P11489; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FORTUNE ES, 1992, J COMP NEUROL, V325, P388, DOI 10.1002/cne.903250306; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; Gehr DD, 1999, NEUROREPORT, V10, P375, DOI 10.1097/00001756-199902050-00030; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hausberger M, 2000, BEHAV BRAIN RES, V114, P89, DOI 10.1016/S0166-4328(00)00191-1; HEIL P, 1985, EXP BRAIN RES, V58, P532; Hessler NA, 1999, J NEUROSCI, V19, P10461; HOSE B, 1987, BRAIN RES, V422, P367, DOI 10.1016/0006-8993(87)90946-2; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KIM PJ, 1994, J ACOUST SOC AM, V95, P410, DOI 10.1121/1.408335; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Lewicki MS, 1996, J NEUROSCI, V16, P6987; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Narayan R, 2005, J NEUROPHYSIOL, V94, P2970, DOI 10.1152/jn.00144.2005; Nelken I, 1997, J NEUROPHYSIOL, V78, P800, DOI 10.1152/jn.1997.78.2.800; NELKEN I, 1994, J NEUROPHYSIOL, V71, P2446, DOI 10.1152/jn.1994.71.6.2446; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; PHILLIPS DP, 1987, EXP BRAIN RES, V67, P479; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; REES A, 1987, HEARING RES, V27, P129, DOI 10.1016/0378-5955(87)90014-1; SACHS MB, 1980, J ACOUST SOC AM, V68, P858, DOI 10.1121/1.384825; SCHEICH H, 1979, CELL TISSUE RES, V204, P17; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WILD JM, 1993, J COMP NEUROL, V337, P32; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; YOUNG ED, 1982, HEARING RES, V6, P153, DOI 10.1016/0378-5955(82)90051-X; Yu JJ, 2000, P NATL ACAD SCI USA, V97, P11780, DOI 10.1073/pnas.97.22.11780	69	124	126	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					845	859		10.1016/j.neuron.2006.08.030	http://dx.doi.org/10.1016/j.neuron.2006.08.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982428	Bronze			2022-12-24	WOS:000240997900021
J	He, HY; Ray, B; Dennis, K; Quinlan, EM				He, Hai-Yan; Ray, Baisali; Dennis, Katie; Quinlan, Elizabeth M.			Experience-dependent recovery of vision following chronic deprivation amblyopia	NATURE NEUROSCIENCE			English	Review							OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; MONOCULAR DEPRIVATION; SELECTIVITY; RATS	The shift in ocular dominance induced by brief monocular deprivation is greatest during a postnatal critical period and is thought to decline irreversibly thereafter. However, here we demonstrate that complete visual deprivation through dark exposure restores rapid ocular dominance plasticity in adult rats. In addition, the loss of visual acuity resulting from chronic monocular deprivation is reversed if dark exposure precedes removal of the occlusion in adulthood, suggesting a potential use for dark exposure in the treatment of adult amblyopia.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Quinlan, EM (corresponding author), Univ Maryland, Dept Biol, 1210 Biol Psychol Bldg 144, College Pk, MD 20742 USA.	equinlan@umd.edu		He, Haiyan/0000-0002-6692-6012	NATIONAL EYE INSTITUTE [R03EY013818] Funding Source: NIH RePORTER; NEI NIH HHS [EY13818] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; Liao DS, 2004, J NEUROPHYSIOL, V92, P2113, DOI 10.1152/jn.00266.2004; MERABET LB, 1909, J NEUROPHYSIOL, V97, P1633; Mitchell Donald E, 2002, Clin Exp Optom, V85, P5; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005	16	166	172	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1134	1136		10.1038/nn1965	http://dx.doi.org/10.1038/nn1965			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17694050				2022-12-24	WOS:000249144000014
J	Green, EM; Barrett, CF; Bultynck, G; Shamah, SM; Dolmetsch, RE				Green, Eric M.; Barrett, Curtis F.; Bultynck, Geert; Shamah, Steven M.; Dolmetsch, Ricardo E.			The tumor suppressor eIF3e mediates calcium-dependent internalization of the L-type calcium channel Ca(v)1.2	NEURON			English	Article							TRANSLATION INITIATION; INDUCED ENDOCYTOSIS; CLASS-C; CA2+; HOMEOSTASIS; CALMODULIN; EXPRESSION; RECEPTORS; PROTEINS; SIGNALS	Voltage-gated calcium channels (VGCCs) convert electrical activity into calcium (Ca2+) Signals that regulate cellular excitability, differentiation, and connectivity. The magnitude and kinetics of Ca2+ signals depend on the number of VGCCs at the plasma membrane, but little is known about the regulation of VGCC surface expression. We report that electrical activity causes internalization of the L-type Ca2+ channel (LTC) Ca(v)1.2 and that this is mediated by binding to the tumor suppressor eIF3e/Int6 (eukaryotic initiation factor 3 subunit e). Using total internal reflection microscopy, we identify a population of Ca(v)1.2 containing endosomes whose rapid trafficking is strongly regulated by Ca2+. We define a domain in the II-III loop of Ca(v)1.2 that binds eIF3e and is essential for the activity dependence of both channel internalization and endosomal trafficking. These findings provide a mechanism for activity dependent internalization and trafficking of Ca(v)1.2 and provide a tantalizing link between Ca2+ homeostasis and a mammalian oncogene.	Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Archemix Corp, Cambridge, MA 02142 USA	Stanford University; Stanford University; Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Dept Neurobiol, 299 Campus Dr,Fairchild Res Bldg D227, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu		Green, Eric/0000-0001-7874-9482; Bultynck, Geert/0000-0002-5968-4828	NINDS NIH HHS [R01 NS048564, R01 NS048564-05, R01 NS048564-01, R01 NS048564-03, R01 NS048564-03S1, R01 NS048564-04, R01 NS048564-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Frey N, 2000, NAT MED, V6, P1221, DOI 10.1038/81321; Gabellini N, 2002, ANN NY ACAD SCI, V976, P282; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Guerini D, 1999, J BIOL CHEM, V274, P1667, DOI 10.1074/jbc.274.3.1667; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HESS P, 1988, CAN J PHYSIOL PHARM, V66, P1218, DOI 10.1139/y88-201; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Kapur A, 1998, J NEUROPHYSIOL, V79, P2181, DOI 10.1152/jn.1998.79.4.2181; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; KOCH C, 1993, J NEUROSCI, V13, P413; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; MARCZEWSKI P, 2001, COGNITIVE NEUROPSYCH, V6, P175, DOI DOI 10.1080/13546800042000115; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Porter NM, 1997, J NEUROSCI, V17, P5629; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Spitzer NC, 2002, CURR OPIN NEUROBIOL, V12, P315, DOI 10.1016/S0959-4388(02)00330-6; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; von Arnim AG, 2003, CURR BIOL, V13, pR323, DOI 10.1016/S0960-9822(03)00238-0; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; WICKENS JR, 1991, NEUROSCI LETT, V130, P128, DOI 10.1016/0304-3940(91)90244-N; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	43	71	72	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2007	55	4					615	632		10.1016/j.neuron.2007.07.024	http://dx.doi.org/10.1016/j.neuron.2007.07.024			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698014	Green Accepted, Bronze			2022-12-24	WOS:000249159200010
J	Leutgeb, JK; Moser, EI				Leutgeb, Jill K.; Moser, Edvard I.			Enigmas of the dentate gyrus	NEURON			English	Editorial Material							CA3 NMDA RECEPTORS; MEMORY; HIPPOCAMPUS; ENSEMBLES; CODES	We are rapidly approaching a better understanding of the mechanisms that allow our brains to form distinct representations for similar events or episodes. McHugh et al. have brought that goal one step closer by showing that NMDA receptor-dependent synaptic plasticity in the dentate gyrus is necessary for immediate differentiation between environments with similar features.	Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Leutgeb, Jill/0000-0002-2014-842X				[Anonymous], 1998, NEURAL NETWORKS BRAI; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Leutgeb S, 2006, HIPPOCAMPUS, V16, P765, DOI 10.1002/hipo.20201; MCHUGH TJ, 2007, IN PRESS SCIENCE; Muller R. U., 1991, BRAIN SPACE, P296; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J	16	16	16	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2007	55	2					176	178		10.1016/j.neuron.2007.07.002	http://dx.doi.org/10.1016/j.neuron.2007.07.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	198NW	17640520	Bronze			2022-12-24	WOS:000248635800003
J	Sulzer, D; Schmitz, Y				Sulzer, David; Schmitz, Yvonne			Parkinson's disease: Return of an old prime suspect	NEURON			English	Editorial Material							MIDBRAIN DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; I-H; MODELS; BRAIN; MOUSE	Pacemaking activity in adult substantia nigra (SN) dopamine neurons relies on L-type Ca2+, channels, but a surprising study in Nature by Chan et al. demonstrates that blockade of these channels by dihydropyridines re-establishes the pacemaking driven by sodium and HCN channels found in juvenile SN. This shift protects SN neurons in chemical models of Parkinson's disease (PD), suggesting that elevated intracellular Ca2+, participates in SN cell loss and that dihydropyridines may provide therapy in PD.	Columbia Univ, Sch Med, New York State Psychiat Inst, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Sch Med, New York State Psychiat Inst, Dept Pharmacol & Psychiat, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Sch Med, New York State Psychiat Inst, Dept Neurol, New York, NY 10032 USA.	ds43@columbia.edu	Schmitz, Yvonne/L-6183-2013					Beal MF, 1998, ANN NEUROL, V44, pS110; CHAN CS, 2007, IN PRESS NATURE; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; GRACE AA, 1989, J NEUROSCI, V9, P3463; Kuznetsov AS, 2006, J NEUROPHYSIOL, V95, P932, DOI 10.1152/jn.00691.2004; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; Striessnig J, 2006, BIOCHEM SOC T, V34, P903, DOI 10.1042/BST0340903; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009	15	21	21	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 5	2007	55	1					8	10		10.1016/j.neuron.2007.06.023	http://dx.doi.org/10.1016/j.neuron.2007.06.023			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610813	Bronze			2022-12-24	WOS:000248010700004
J	Klingauf, J				Klingauf, Jurgen			Synaptic vesicle dynamics sans dynamin	NEURON			English	Editorial Material							FROG NEUROMUSCULAR JUNCTION; ENDOCYTOSIS; TRANSMITTER; RELEASE	The neuron-specific guanosine triphosphatase dynamin 1 has been hypothesized to be critically required for pinching off synaptic vesicles during endocytosis. In a recent publication in Science, Ferguson et al. describe a series of experiments demonstrating an unexpectedly selective requirement of dynamin 1 in synaptic vesicle endocytosis only during high frequency (< 10 Hz) stimulation, but not after cessation of the stimulus train.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Klingauf, J (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Busgenweg 2, D-37077 Gottingen, Germany.	j.klingauf@mpi-bpc.mpg.de						Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Robinson PJ, 2007, SCIENCE, V316, P551, DOI 10.1126/science.1142705; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0	11	4	4	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 21	2007	54	6					857	858		10.1016/j.neuron.2007.06.010	http://dx.doi.org/10.1016/j.neuron.2007.06.010			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582327	Green Submitted, Bronze			2022-12-24	WOS:000247645600006
J	Rubinsztein, DC				Rubinsztein, David C.			Autophagy induction rescues toxicity mediated by proteasomem inhibition	NEURON			English	Editorial Material							AGGREGATE-PRONE PROTEINS; APOPTOSIS; POLYGLUTAMINE; EXPANSIONS; DROSOPHILA; DISEASE; HDAC6	The ubiquitin-proteasome and macroautophagy-lysosome pathways are major routes for intracytosolic protein degradation. In many systems, proteasome inhibition is toxic. A Nature article by Pandey et al. shows that this toxicity can be modulated by altering autophagic activity. Their tantalizing results suggest that overexpression of HDAC6 may increase flux through the autophagy pathway, thereby attenuating the toxicity resulting from proteasome inhibition.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England.	dcr1000@cam.ac.uk	Rubinsztein, David C/C-3472-2011		MRC [G0600194] Funding Source: UKRI; Medical Research Council [G0600194(77639), G0600194] Funding Source: Medline; Wellcome Trust [064354] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Chen QH, 2005, FREE RADICAL BIO MED, V38, P226, DOI 10.1016/j.freeradbiomed.2004.10.019; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x	14	46	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2007	54	6					854	856		10.1016/j.neuron.2007.06.005	http://dx.doi.org/10.1016/j.neuron.2007.06.005			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582326	Bronze			2022-12-24	WOS:000247645600005
J	Yakusheva, TA; Shaikh, AG; Green, AM; Blazquez, PM; Dickman, JD; Angelaki, DE				Yakusheva, Tatyana A.; Shaikh, Aasef G.; Green, Andrea M.; Blazquez, Pablo M.; Dickman, J. David; Angelaki, Dora E.			Purkinje cells in posterior cerebellar vermis encode motion in an inertial reference frame	NEURON			English	Article							QUALITATIVELY DIFFERENT MECHANISMS; INNERVATING OTOLITH ORGANS; CLIMBING FIBER AFFERENTS; VESTIBULOOCULAR REFLEX; SQUIRREL-MONKEY; VESTIBULAR SYSTEM; VESTIBULOCEREBELLAR NEURONS; OPTOKINETIC STIMULATION; PERCEPTUAL RESPONSES; SPATIAL ORIENTATION	The ability to orient and navigate through the terrestrial environment represents a computational challenge common to all vertebrates. It arises because motion sensors in the inner ear, the otolith organs, and the semicircular canals transduce self-motion in an egocentric reference frame. As a result, vestibular afferent information reaching the brain is inappropriate for coding our own motion and orientation relative to the outside world. Here we show that cerebellar cortical neuron activity in vermal lobules 9 and 10 reflects the critical computations of transforming head-centered vestibular afferent information into earth- referenced self-motion and spatial orientation signals. Unlike vestibular and deep cerebellar nuclei neurons, where a mixture of responses was observed, Purkinje cells represent a homogeneous population that encodes inertial motion. They carry the earth-horizontal component of a spatially transformed and temporally integrated rotation signal from the semicircular canals, which is critical for computing head attitude, thus isolating inertial linear accelerations during navigation.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu			NATIONAL EYE INSTITUTE [R01EY012814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC006540] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012814, R01 EY12814] Funding Source: Medline; NIDCD NIH HHS [F32 DC006540] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANGAUT P., 1967, ARCH ITAL BIOL, V105, P441; ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1729; ANGELAKI DE, 1994, J NEUROPHYSIOL, V71, P1222, DOI 10.1152/jn.1994.71.3.1222; Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; ANGELAKI DE, 1991, IEEE T BIO-MED ENG, V38, P1053, DOI 10.1109/10.99068; ANGELAKI DE, 1995, J NEUROPHYSIOL, V73, P1716, DOI 10.1152/jn.1995.73.4.1716; Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; ANGELAKI DE, 1995, J NEUROSCI, V15, P7201; Barmack NH, 2002, J NEUROPHYSIOL, V87, P962, DOI 10.1152/jn.00528.2001; Barmack NH, 1995, J NEUROPHYSIOL, V74, P2573, DOI 10.1152/jn.1995.74.6.2573; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; BERNARD JF, 1987, J COMP NEUROL, V263, P241, DOI 10.1002/cne.902630207; Chen-Huang C, 2006, EXP BRAIN RES, V168, P410, DOI 10.1007/s00221-005-0098-7; CLARK B, 1963, AM J PSYCHOL, V76, P18, DOI 10.2307/1419995; CLARK B, 1966, AM J PSYCHOL, V79, P377, DOI 10.2307/1420878; COHEN H, 1992, EXP BRAIN RES, V90, P526; Day BL, 2005, J PHYSIOL-LONDON, V567, P591, DOI 10.1113/jphysiol.2005.092544; Dean HL, 2006, J NEUROSCI, V26, P1117, DOI 10.1523/JNEUROSCI.2497-05.2006; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dickman JD, 2002, J NEUROPHYSIOL, V88, P3518, DOI 10.1152/jn.00518.2002; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P996, DOI 10.1152/jn.1976.39.5.996; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fitzpatrick RC, 2006, CURR BIOL, V16, P1509, DOI 10.1016/j.cub.2006.05.063; Fushiki H, 1997, J NEUROPHYSIOL, V78, P3083, DOI 10.1152/jn.1997.78.6.3083; GLASAUER S, 1995, ACTA OTO-LARYNGOL, P37; GOLDBERG JM, 1975, ANNU REV PHYSIOL, V37, P129, DOI 10.1146/annurev.ph.37.030175.001021; GRAYBIEL A, 1952, AMA ARCH OPHTHALMOL, V48, P605; GRAYBIEL A, 1979, AVIAT SPACE ENVIR MD, V50, P382; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2003, J NEUROSCI, V23, P9265; Green AM, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S02; GUEDRY FE, 1974, HDB SENSORY PHYSL, P1; Heinen S J, 1992, J Vestib Res, V2, P235; Howard IP, 2001, PERCEPTION, V30, P583, DOI 10.1068/p3106; Howard IP., 1986, HDB HUMAN PERCEPTION, P1; KANO M, 1991, NEUROSCI LETT, V128, P101, DOI 10.1016/0304-3940(91)90769-P; KANO M, 1990, EXP BRAIN RES, V80, P238; KANO MS, 1990, EXP BRAIN RES, V82, P499; Kaptein RG, 2006, J NEUROPHYSIOL, V95, P1936, DOI 10.1152/jn.00856.2005; MARINI G, 1975, BRAIN RES, V99, P367, DOI 10.1016/0006-8993(75)90038-4; MAYNE RA, 1974, HDB SENSORY PHYSL VE, P493; MCNEILAGE PR, 2007, IN PRESS EXP BRAIN R; Merfeld D.M., 1997, 3 DIMENSIONAL KINEMA, P387; MERFELD DM, 1995, EXP BRAIN RES, V106, P123; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P199, DOI 10.1152/jn.00905.2004; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; Mergner T, 1999, ANN NY ACAD SCI, V871, P430, DOI 10.1111/j.1749-6632.1999.tb09211.x; Musallam S, 2002, J NEUROPHYSIOL, V88, P2104, DOI 10.1152/jn.2002.88.4.2104; NAITO Y, 1995, HEARING RES, V87, P141, DOI 10.1016/0378-5955(95)00085-I; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; Ono S, 2000, EXP BRAIN RES, V134, P1, DOI 10.1007/s002210000424; PRECHT W, 1976, NEUROSCIENCE, V1, P301, DOI 10.1016/0306-4522(76)90057-9; Seidman SH, 1998, EXP BRAIN RES, V119, P307, DOI 10.1007/s002210050346; Shaikh AG, 2005, CURR BIOL, V15, P1657, DOI 10.1016/j.cub.2005.08.009; Shaikh AG, 2005, J NEUROPHYSIOL, V93, P853, DOI 10.1152/jn.00879.2004; Smith MA, 2005, NAT NEUROSCI, V8, P220, DOI 10.1038/nn1382; SOLOMON D, 1994, EXP BRAIN RES, V102, P57; STOCKWELL CW, 1970, ACTA OTO-LARYNGOL, V70, P170, DOI 10.3109/00016487009181874; TORMES FR, 1975, AVIAT SPACE ENVIR MD, V46, P387; Van Pelt S, 2005, J NEUROPHYSIOL, V94, P1432, DOI 10.1152/jn.00018.2005; WALBERG F, 1962, J COMP NEUROL, V118, P49, DOI 10.1002/cne.901180105; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; Wiest G, 1999, NEUROLOGY, V52, P417, DOI 10.1212/WNL.52.2.417; WYLIE DR, 1994, J COMP NEUROL, V349, P448, DOI 10.1002/cne.903490309; Xiong GX, 2000, EXP BRAIN RES, V133, P219, DOI 10.1007/s002210000372; Young L, 1984, HDB PHYSL NERVOUS SY, P1023; Zupan LH, 2003, J NEUROPHYSIOL, V89, P390, DOI 10.1152/jn.00513.2001; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	72	139	140	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2007	54	6					973	985		10.1016/j.neuron.2007.06.003	http://dx.doi.org/10.1016/j.neuron.2007.06.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582336	Bronze			2022-12-24	WOS:000247645600015
J	Fiacco, TA; Agulhon, C; Taves, SR; Petravicz, J; Casper, KB; Dong, XZ; Chen, J; McCarthy, KD				Fiacco, Todd A.; Agulhon, Cendra; Taves, Sarah R.; Petravicz, Jeremy; Casper, Kristen B.; Dong, Xinzhong; Chen, Ju; McCarthy, Ken D.			Selective stimulation of astrocyte calcium in situ does not affect neuronal excitatory synaptic activity	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; CULTURED HIPPOCAMPAL-NEURONS; INTRACELLULAR CALCIUM; GLUTAMATE RELEASE; ANION CHANNELS; RECEPTORS; CURRENTS; CELLS; OSCILLATIONS; BRAIN	Astrocytes are considered the third component of the synapse, responding to neurotransmitter release from synaptic terminals and releasing gliotransmitters-including glutamate-in a Ca(2+)-dependent manner to affect neuronal synaptic activity. Many studies reporting astrocyte-driven neuronal activity have evoked astrocyte Ca(2+) increases by application of endogenous ligands that directly activate neuronal receptors, making astrocyte contribution to neuronal effect(s) difficult to determine. We have made transgenic mice that express a Gq-coupled receptor only in astrocytes to evoke astrocyte Ca(2+) increases using an agonist that does not bind endogenous receptors in brain. By recording from CA1 pyramidal cells in acute hippocampal slices from these mice, we demonstrate that widespread Ca(2+) elevations in 80%-90% of stratum radiatum astrocytes do not increase neuronal Ca(2+), produce neuronal slow inward currents, or affect excitatory synaptic activity. Our findings call into question the developing consensus that Ca(2+)-dependent glutamate release by astrocytes directly affects neuronal synaptic activity in situ.	Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of California System; University of California San Diego	Fiacco, TA (corresponding author), Univ N Carolina, Dept Pharmacol, 1004 Mary Ellen Jones Bldg,CB 7365, Chapel Hill, NC 27599 USA.	tfiacco@med.unc.edu	Chen, Ju/E-5579-2011	Petravicz, Jeremy/0000-0001-5161-4641; Taves, Sarah/0000-0001-6759-9888; Agulhon, Cendra/0000-0001-7508-6978				Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Bianchi R, 1999, J NEUROPHYSIOL, V81, P2903, DOI 10.1152/jn.1999.81.6.2903; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Chen XK, 2005, J NEUROSCI, V25, P9236, DOI 10.1523/JNEUROSCI.1640-05.2005; Choe ES, 2006, NEUROSCI LETT, V394, P246, DOI 10.1016/j.neulet.2005.10.072; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Fellin T, 2006, J BIOL CHEM, V281, P4274, DOI 10.1074/jbc.M510679200; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Frick A, 2003, J NEUROSCI, V23, P3243; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Haak LL, 2001, J NEUROSCI, V21, P3860, DOI 10.1523/JNEUROSCI.21-11-03860.2001; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Heidinger V, 2002, J NEUROSCI, V22, P5452; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Kimelberg HK, 2004, NEUROCHEM INT, V45, P511, DOI 10.1016/j.neuint.2003.11.002; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Liu F, 2006, EUR J PHARMACOL, V536, P262, DOI 10.1016/j.ejphar.2006.02.003; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Martina M, 2003, J PHYSIOL-LONDON, V548, P411, DOI 10.1113/jphysiol.2002.037127; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Pisani A, 2001, NEUROSCIENCE, V106, P579, DOI 10.1016/S0306-4522(01)00297-4; Porter JT, 1996, J NEUROSCI, V16, P5073; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; ROTH BJ, 1995, CELL CALCIUM, V17, P53, DOI 10.1016/0143-4160(95)90102-7; Sharp AH, 1999, J COMP NEUROL, V406, P207; Shelton MK, 1999, GLIA, V26, P1, DOI 10.1002/(SICI)1098-1136(199903)26:1<1::AID-GLIA1>3.0.CO;2-Z; Shelton MK, 2000, J NEUROCHEM, V74, P555, DOI 10.1046/j.1471-4159.2000.740555.x; Shuai JW, 2003, P NATL ACAD SCI USA, V100, P506, DOI 10.1073/pnas.0236032100; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; YAGODIN S, 1995, MOL CELL BIOCHEM, V149, P137, DOI 10.1007/BF01076572	44	241	246	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 24	2007	54	4					611	626		10.1016/j.neuron.2007.04.032	http://dx.doi.org/10.1016/j.neuron.2007.04.032			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521573	Bronze			2022-12-24	WOS:000246970800015
J	Ge, SY; Yang, CH; Hsu, KS; Ming, GL; Song, HJ				Ge, Shaoyu; Yang, Chih-hao; Hsu, Kuei-sen; Ming, Guo-li; Song, Hongjun			A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain	NEURON			English	Article							LONG-TERM-POTENTIATION; RAT DENTATE GYRUS; GRANULE CELLS; NEUROGENESIS; RECEPTOR; HIPPOCAMPUS; MEMORY; INTEGRATION; EXPRESSION; MICE	Active adult neurogenesis occurs in discrete brain regions of all mammals and is widely regarded as a neuronal replacement mechanism. Whether adult-born neurons make unique contributions to brain functions is largely unknown. Here we systematically characterized synaptic plasticity of retrovirally labeled adult-born dentate granule cells at different stages during their neuronal maturation. We identified a critical period between 1 and 1.5 months of the cell age when adult-born neurons exhibit enhanced long-term potentiation with increased potentiation amplitude and decreased induction threshold. Furthermore, such enhanced plasticity in adult-born neurons depends on developmentally regulated synaptic expression of NR2B-containing NMDA receptors. Our study demonstrates that adult-born neurons exhibit the same classic critical period plasticity as neurons in the developing nervous system. The transient nature of such enhanced plasticity may provide a fundamental mechanism allowing adult-born neurons within the critical period to serve as major mediators of experience-induced plasticity while maintaining stability of the mature circuitry.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Cheng Kung University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013; Hsu, Kuei-Sen/AAV-8386-2021	Ming, Guo-li/0000-0002-2517-6075	NIA NIH HHS [R01 AG024984, R01 AG024984-03, AG024984] Funding Source: Medline; NINDS NIH HHS [R37 NS047344, R01 NS047344-04, R56 NS047344, R01 NS047344, NS047344] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R37NS047344, R56NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Cull-Candy S.G., 2004, SCI STKE 2004, V2004; CULLCANDY SG, 2004, SCI STKE; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nacher J, 2007, NEUROSCIENCE, V144, P855, DOI 10.1016/j.neuroscience.2006.10.021; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	45	675	692	1	63	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 24	2007	54	4					559	566		10.1016/j.neuron.2007.05.002	http://dx.doi.org/10.1016/j.neuron.2007.05.002			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521569	Bronze, Green Accepted			2022-12-24	WOS:000246970800011
J	Meredith, RM; Holmgren, CD; Weidum, M; Burnashev, N; Mansvelder, HD				Meredith, Rhiannon M.; Holmgren, Carl D.; Weidum, Meredith; Burnashev, Nail; Mansvelder, Huibert D.			Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene Fmr1	NEURON			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; DENDRITIC SPINES; KNOCKOUT MICE; MOUSE MODEL; SYNAPTIC PLASTICITY; MESSENGER-RNAS; SINGLE SPINES; SYNAPSES; ACTIVATION	Fragile X syndrome, caused by a mutation in the Fmr1 gene, is characterized by mental retardation. Several studies reported the absence of long-term potentiation (LTP) at neocortical synapses in Fmr1 knockout (FMR1-KO) mice, but underlying cellular mechanisms are unknown. We find that in the prefrontal cortex (PFC) of FMR1-KO mice, spike-timing-dependent LTP (tLTP) is not so much absent, but rather, the threshold for tLTP induction is increased. Calcium signaling in dendrites and spines is compromised. First, dendrites and spines more often fail to show calcium transients. Second, the activity of L-type calcium channels is absent in spines. tLTP could be restored by improving reliability and amplitude of calcium signaling by increasing neuronal activity. In FMR1-KO mice that were raised in enriched environments, tLTP was restored to WT levels. Our results show that mechanisms for synaptic plasticity are in place in the FMR1-KO mouse PFC, but require stronger neuronal activity to be triggered.	Vrije Univ Amsterdam, Dept Expt Neurophysiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Dept Anat & Neurosci, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Burnashev, N (corresponding author), Vrije Univ Amsterdam, Dept Expt Neurophysiol, Ctr Neurogenom & Cognit Res, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	nail.burnashev@falw.vu.nl; huib@cncr.vu.nl	Meredith, Rhiannon/A-4657-2010; Burnashev, Nail/G-4056-2013; Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340; Meredith, Rhiannon/0000-0003-0228-4169				Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; GROSSMAN AW, 2006, IN PRESS BRAIN RES; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2006, TRENDS NEUROSCI, V29, P183, DOI 10.1016/j.tins.2006.02.001; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; KEJA JA, 1991, NEUROENDOCRINOLOGY, V53, P349, DOI 10.1159/000125741; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kooy RF, 2003, TRENDS GENET, V19, P148; Li JX, 2002, MOL CELL NEUROSCI, V19, P138, DOI 10.1006/mcne.2001.1085; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Meredith RM, 2003, J NEUROSCI, V23, P11142, DOI 10.1523/jneurosci.23-35-11142.2003; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Sejnowski TJ, 1999, NEURON, V24, P773, DOI 10.1016/S0896-6273(00)81025-9; Simon JA, 2001, COGNITIVE NEUROPSYCH, V18, P1, DOI 10.1080/02643290126042; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005	45	129	130	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 24	2007	54	4					627	638		10.1016/j.neuron.2007.04.028	http://dx.doi.org/10.1016/j.neuron.2007.04.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174VL	17521574	Bronze			2022-12-24	WOS:000246970800016
J	Zalfa, F; Eleuteri, B; Dickson, KS; Mercaldo, V; De Rubeis, S; di Penta, A; Tabolacci, E; Chiurazzi, P; Neri, G; Grant, SGN; Bagni, C				Zalfa, Francesca; Eleuteri, Boris; Dickson, Kirsten S.; Mercaldo, Valentina; De Rubeis, Silvia; di Penta, Alessandra; Tabolacci, Elisabetta; Chiurazzi, Pietro; Neri, Giovanni; Grant, Seth G. N.; Bagni, Claudia			A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; NMDA RECEPTOR; ALZHEIMERS-DISEASE; BINDING PROTEINS; FMRP; TRANSLATION; MECHANISMS; SYNAPSES; MICE; IDENTIFICATION	Fragile X syndrome ( FXS) results from the loss of the fragile X mental retardation protein ( FMRP), an RNA- binding protein that regulates a variety of cytoplasmic mRNAs. FMRP regulates mRNA translation and may be important in mRNA localization to dendrites. We report a third cytoplasmic regulatory function for FMRP: control of mRNA stability. In mice, we found that FMRP binds, in vivo, the mRNA encoding PSD- 95, a key molecule that regulates neuronal synaptic signaling and learning. This interaction occurs through the 3' untranslated region of the PSD- 95 ( also known as Dlg4) mRNA, increasing message stability. Moreover, stabilization is further increased by mGluR activation. Although we also found that the PSD- 95 mRNA is synaptically localized in vivo, localization occurs independently of FMRP. Through our functional analysis of this FMRP target we provide evidence that dysregulation of mRNA stability may contribute to the cognitive impairments in individuals with FXS.	Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Fdn Santa Lucia, Ist Neurosci Sperimentali, I-00143 Rome, Italy; Univ Edinburgh, Div Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Cattolica, Ist Genet Med, I-00168 Rome, Italy; Wellcome Trust Res Labs, Sanger Inst, Hinxton CB10 1SA, Cambs, England	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Edinburgh; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Wellcome Trust Sanger Institute	Bagni, C (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Via Ric Sci 1, I-00133 Rome, Italy.	dickson.kris@gmail.com; claudia.bagni@uniroma2.it	Mercaldo, Valentina/AAA-6000-2019; TABOLACCI, Elisabetta/AAR-6538-2020; De Rubeis, Silvia/E-9852-2013; Zalfa, Francesca/J-7759-2018; Chiurazzi, Pietro/J-3169-2012	TABOLACCI, Elisabetta/0000-0002-4707-2242; De Rubeis, Silvia/0000-0001-9383-6883; Zalfa, Francesca/0000-0002-1922-9468; Grant, Seth/0000-0001-8732-8735; Bagni, Claudia/0000-0002-4419-210X	Telethon [GGP05269] Funding Source: Medline; Wellcome Trust [077155, 056523] Funding Source: Medline	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bencini G, 2005, BRAIN LANG, V95, P133, DOI 10.1016/j.bandl.2005.07.075; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Loesch DZ, 2004, MENT RETARD DEV D R, V10, P31, DOI 10.1002/mrdd.20006; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; REISS AL, 1994, NEUROLOGY, V44, P1317, DOI 10.1212/WNL.44.7.1317; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Smith CL, 2004, J NEUROBIOL, V61, P222, DOI 10.1002/neu.20038; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tonegawa S, 1996, COLD SPRING HARB SYM, V61, P225; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; VICKERS CA, 2006, BRAIN RES; Wang HP, 2004, HUM MOL GENET, V13, P79, DOI 10.1093/hmg/ddh009; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	50	275	284	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					578	587		10.1038/nn1893	http://dx.doi.org/10.1038/nn1893			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417632	Green Accepted, Green Published			2022-12-24	WOS:000245948000014
J	Smith, SL; Trachtenberg, JT				Smith, Spencer L.; Trachtenberg, Joshua T.			Experience-dependent binocular competition in the visual cortex begins at eye opening	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; CRITICAL-PERIOD; ORIENTATION SELECTIVITY; FERRET; MOUSE; COLUMNS; KITTEN; DEPRIVATION; MATURATION; AMBLYOPIA	Visual experience begins at eye opening, but current models consider cortical circuitry to be resistant to experience-dependent competitive modification until the activation of a later critical period. Here we examine this idea using optical imaging to map the time course of receptive field refinement in normal mice, mice in which the contralateral eye never opens and mice in which the contralateral eye is silenced. We found that the refinement of ipsilateral eye retinotopy is retarded by contralateral deprivation, but accelerated by silencing of the contralateral eye. Patterned visual experience through the ipsilateral eye is required for this acceleration. These differences are most obvious at postnatal day 15, long before the start of the critical period, indicating that experience-dependent binocular plasticity occurs much earlier than was previously thought. Furthermore, these results suggest that the quality of activity, in terms of signal to noise, and not the quantity, determines robust receptive field development.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Trachtenberg, JT (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.	jtrachtenberg@mednet.ucla.edu						Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Isenberg SJ, 2006, OPHTHALMOLOGY, V113, P893, DOI 10.1016/j.ophtha.2006.04.010; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; OLSON CR, 1980, EXP BRAIN RES, V39, P17; PETTIGREW JD, 1974, J PHYSIOL-LONDON, V237, P49, DOI 10.1113/jphysiol.1974.sp010469; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; SHERK H, 1976, J NEUROPHYSIOL, V39, P63, DOI 10.1152/jn.1976.39.1.63; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; VEREECKEN EP, 1984, ARCH OPHTHALMOL-CHIC, V102, P220; Wallace W, 2004, J NEUROSCI, V24, P6928, DOI 10.1523/JNEUROSCI.1110-04.2004; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	34	103	105	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					370	375		10.1038/nn1844	http://dx.doi.org/10.1038/nn1844			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17293862				2022-12-24	WOS:000244480300020
J	Kim, JH; Sizov, I; Dobretsov, M; von Gersdorff, H				Kim, Jun Hee; Sizov, Igor; Dobretsov, Maxim; von Gersdorff, Henrique			Presynaptic Ca2+ buffers control the strength of a fast post-tetanic hyperpolarization mediated by the alpha 3 Na+/K+-ATPase	NATURE NEUROSCIENCE			English	Article							AUDITORY BRAIN-STEM; TRAPEZOID BODY; NA+/CA2+ EXCHANGE; COCHLEAR NUCLEUS; NERVE-FIBERS; I-H; RAT; CALYX; PUMP; CHANNELS	The excitability of CNS presynaptic terminals after a tetanic burst of action potentials is important for synaptic plasticity. The mechanisms that regulate excitability, however, are not well understood. Using direct recordings from the rat calyx of Held terminal, we found that a fast Na+/K+-ATPase (NKA)-mediated post-tetanic hyperpolarization ( PTH) controls the probability and precision of subsequent firing. Notably, increasing the concentration of internal Ca2+ buffers or decreasing Ca2+ influx led to larger PTH amplitudes, indicating that an increase in [Ca2+](i) regulates PTH via inhibition of NKAs. The characterization for the first time of a presynaptic NKA pump current, combined with immunofluorescence staining, identified the alpha 3-NKA isoform on calyx terminals. Accordingly, the increased ability of the calyx to faithfully fire during a high-frequency train as it matures is paralleled by a larger expression of alpha 3-NKA during development. We propose that this newly discovered Ca2+ dependence of PTH is important in the post-burst excitability of nerve terminals.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Univ Arkansas Med Sci, Dept Anesthesiol, Little Rock, AR 72205 USA	Oregon Health & Science University; University of Arkansas System; University of Arkansas Medical Sciences	von Gersdorff, H (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	vongersd@ohsu.edu	Dobretsov, Maxim/U-9770-2018; Sizov, Igor/A-1814-2014	Sizov, Igor/0000-0003-0726-2006; Dobretsov, Maxim/0000-0001-6007-9775	NIDCD NIH HHS [DC04274] Funding Source: Medline; NIDDK NIH HHS [DK067248] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004274] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Carr CE, 2001, CURR OPIN NEUROBIOL, V11, P727, DOI 10.1016/S0959-4388(01)00276-8; Clapham DE, 1998, NEURON, V21, P5, DOI 10.1016/S0896-6273(00)80508-5; Clarke Donald D., 1994, P645; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Dobretsov M, 1999, NEUROSCIENCE, V93, P723, DOI 10.1016/S0306-4522(99)00122-0; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; GOLDING NL, 1995, J NEUROSCI, V15, P3138; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Hamada L, 2003, BRIT J PHARMACOL, V138, P1517, DOI 10.1038/sj.bjp.0705170; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; ISHII T, 1995, EMBO J, V14, P58, DOI 10.1002/j.1460-2075.1995.tb06975.x; Ishikawa T, 2003, J NEUROSCI, V23, P10445; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; Kadner A, 2006, J NEUROPHYSIOL, V95, P1499, DOI 10.1152/jn.00902.2005; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Leao RM, 2005, J NEUROSCI, V25, P3724, DOI 10.1523/JNEUROSCI.3983-04.2005; Leao RN, 2005, EUR J NEUROSCI, V22, P147, DOI 10.1111/j.1460-9568.2005.04185.x; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; MORITA K, 1993, J NEUROPHYSIOL, V70, P1874, DOI 10.1152/jn.1993.70.5.1874; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Parker D, 1996, J NEUROPHYSIOL, V76, P540, DOI 10.1152/jn.1996.76.1.540; RANG HP, 1968, J PHYSIOL-LONDON, V196, P183, DOI 10.1113/jphysiol.1968.sp008502; SCHNEIDER JW, 1988, P NATL ACAD SCI USA, V85, P284, DOI 10.1073/pnas.85.1.284; Senatorov VV, 1997, J PHYSIOL-LONDON, V502, P387, DOI 10.1111/j.1469-7793.1997.387bk.x; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; Soleng AF, 2003, J PHYSIOL-LONDON, V552, P459, DOI 10.1113/jphysiol.2003.048058; SOMMER I, 1993, EXP BRAIN RES, V95, P223; SPIROU GA, 1990, J NEUROPHYSIOL, V63, P1169, DOI 10.1152/jn.1990.63.5.1169; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Verdru P, 1997, J NEUROPHYSIOL, V77, P484, DOI 10.1152/jn.1997.77.1.484; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wetzel RK, 1999, J NEUROSCI, V19, P9878; WOJTOWICZ JM, 1985, J NEUROPHYSIOL, V54, P220, DOI 10.1152/jn.1985.54.2.220; WU SH, 1993, HEARING RES, V68, P189, DOI 10.1016/0378-5955(93)90123-I; Zhong N, 2001, J NEUROSCI, V21, P9598, DOI 10.1523/JNEUROSCI.21-24-09598.2001	50	86	89	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					196	205		10.1038/nn1839	http://dx.doi.org/10.1038/nn1839			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220883				2022-12-24	WOS:000244175200014
J	Tankersley, D; Stowe, CJ; Huettel, SA				Tankersley, Dharol; Stowe, C. Jill; Huettel, Scott A.			Altruism is associated with an increased neural response to agency	NATURE NEUROSCIENCE			English	Article							EMPATHY; MIND; PSYCHOLOGY; OTHERS; PEOPLE	Although the neural mechanisms underlying altruism remain unknown, empathy and its component abilities, such as the perception of the actions and intentions of others, have been proposed as key contributors. Tasks requiring the perception of agency activate the posterior superior temporal cortex ( pSTC), particularly in the right hemisphere. Here, we demonstrate that differential activation of the human pSTC during action perception versus action performance predicts self-reported altruism.	Duke Univ, Fuqua Sch Business, Durham, NC 27708 USA; Duke Univ, Med Ctr, Ctr Neuroecon Studies, Durham, NC 27710 USA; Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Huettel, SA (corresponding author), Duke Univ, Fuqua Sch Business, 1 Towerview Dr, Durham, NC 27708 USA.	scott.huettel@duke.edu			PHS HHS [70685, 41328] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Post SG, 2005, INT J BEHAV MED, V12, P66, DOI 10.1207/s15327558ijbm1202_4; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022	14	132	139	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					150	151		10.1038/nn1833	http://dx.doi.org/10.1038/nn1833			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237779				2022-12-24	WOS:000244175200008
J	Kuramoto, N; Wilkins, ME; Fairfax, BP; Revilla-Sanchez, R; Terunuma, M; Tamaki, K; Iemata, M; Warren, N; Couve, A; Calver, A; Horvath, Z; Freeman, K; Carling, D; Huang, L; Gonzales, C; Cooper, E; Smart, TG; Pangalos, MN; Moss, SJ				Kuramoto, Nobuyuki; Wilkins, Megan E.; Fairfax, Benjamin P.; Revilla-Sanchez, Raquel; Terunuma, Miho; Tamaki, Keisuke; Iemata, Mika; Warren, Noel; Couve, Andres; Calver, Andrew; Horvath, Zsolt; Freeman, Katie; Carling, David; Huang, Lan; Gonzales, Cathleen; Cooper, Edward; Smart, Trevor G.; Pangalos, Menelas N.; Moss, Stephen J.			Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase	NEURON			English	Article							CEREBRAL-ARTERY OCCLUSION; INTRALUMINAL SUTURE; UPSTREAM KINASE; PHOSPHORYLATION; TRAFFICKING; ISCHEMIA; CASCADE; RAT; EXCITOTOXICITY; ASSOCIATION	GABA(B) receptors are heterodimeric G protein-coupled receptors composed of R1 and R2 subunits that mediate slow synaptic inhibition in the brain by activating inwardly rectifying K+ channels (GIRKs) and inhibiting Ca2+, channels. We demonstrate here that GABAB receptors are intimately associated with 5'AMP-dependent protein kinase (AMPK). AMPK acts as a metabolic sensor that is potently activated by increases in 5'AMP concentration that are caused by enhanced metabolic activity, anoxia, or ischemia. AMPK binds the R1 subunit and directly phosphorylates S783 in the R2 subunit to enhance GABAB receptor activation of GIRKs. Phosphorylation of S783 is evident in many brain regions, and is increased dramatically after ischemic injury. Finally, we also reveal that S783 plays a critical role in enhancing neuronal survival after ischemia. Together our results provide evidence of a neuroprotective mechanism, which, under conditions of metabolic stress or after ischemia, increases GABAB receptor function to reduce excitotoxicity and thereby promotes neuronal survival.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; UCL, Dept Pharmacol, London WC1E 6BT, England; GlaxoSmithKline Inc, Neurol & GI CEDD, Harlow CM19 5AW, Essex, England; Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; GlaxoSmithKline Inc, Dept Comparat Genom Genet Res, Collegeville, PA 19426 USA; Hammersmith Hosp, MRC, Ctr Clin Sci, London W12 0NN, England; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Cellular & Dev Biol, Irvine, CA 92697 USA; Wyeth Res, Princeton, NJ 08543 USA	University of Pennsylvania; University of London; University College London; GlaxoSmithKline; University of Pennsylvania; GlaxoSmithKline; Imperial College London; University of California System; University of California Irvine; University of California System; University of California Irvine; Pfizer	Moss, SJ (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	sjmoss@mail.med.upenn.edu	Carling, David/F-1943-2014; couve, andres/I-2249-2013; Huang, Lan/C-3618-2011	Carling, David/0000-0002-2316-1830; couve, andres/0000-0003-4216-8672; Takarada-Iemata, Mika/0000-0002-2113-0707; Wilkins, Megan/0000-0003-0150-4457; Fairfax, Benjamin/0000-0001-7413-5002; Terunuma, Miho/0000-0003-1876-9726	MRC [G0601529] Funding Source: UKRI; Medical Research Council [MC_U120027537, G0601529] Funding Source: Medline; NINDS NIH HHS [R01 NS051195, R01 NS047478-01A2, NS 048045, R01 NS046478, NS051195, R01 NS081986, R21 NS080064, R21NS42100, R01 NS048045, R01 NS047478, NS 046478, R01 NS047478-02, R01 NS048045-01A2, R01 NS051195-01A1, R01 NS048045-02] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047478, R01NS051195, R21NS042100, R01NS048045, R01NS046478, R21NS080064, R01NS081986] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bowery NG, 2006, CURR OPIN PHARMACOL, V6, P37, DOI 10.1016/j.coph.2005.10.002; Brandon NJ, 1999, J NEUROSCI, V19, P9228; Brandon NJ, 1999, BIOCHEM SOC T, V27, P527, DOI 10.1042/bst0270527; Calver AR, 2001, J NEUROSCI, V21, P1203; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Choi D, 1998, MT SINAI J MED, V65, P133; Couve A, 2004, J BIOL CHEM, V279, P13934, DOI 10.1074/jbc.M311737200; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Huang L, 2001, J BIOL CHEM, V276, P28327, DOI 10.1074/jbc.M008342200; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Imura T, 1999, J NEUROSCI, V19, P9768; JacksonFriedman C, 1997, EXP NEUROL, V147, P346, DOI 10.1006/exnr.1997.6637; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kulinskii VI, 2000, B EXP BIOL MED+, V130, P772, DOI 10.1007/BF02766091; Kume T, 2002, EUR J PHARMACOL, V455, P91, DOI 10.1016/S0014-2999(02)02582-7; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674	40	150	155	2	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					233	247		10.1016/j.neuron.2006.12.015	http://dx.doi.org/10.1016/j.neuron.2006.12.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224405	Bronze, Green Accepted			2022-12-24	WOS:000245126600009
J	Lakatos, P; Chen, CM; O'Connell, MN; Mills, A; Schroeder, CE				Lakatos, Peter; Chen, Chi-Ming; O'Connell, Monica N.; Mills, Aimee; Schroeder, Charles E.			Neuronal oscillations and multisensory interaction in primary auditory cortex	NEURON			English	Article							SOURCE-DENSITY ANALYSIS; MACAQUE MONKEYS; ASSOCIATION CORTEX; EVOKED-POTENTIALS; LAMINAR PROFILE; LOW-LEVEL; CONNECTIONS; RESPONSES; INTEGRATION; DYNAMICS	Recent anatomical, physiological, and neuroimaging findings indicate multisensory convergence at early, putatively unisensory stages of cortical processing. The objective of this study was to confirm somatosensory-auditory interaction in Al and to define both its physiological mechanisms and its consequences for auditory information processing. Laminar current source density and multiunit activity sampled during multielectrode penetrations of primary auditory area Al in awake macaques revealed clear somatosensory-auditory interactions, with a novel mechanism: somatosensory inputs appear to reset the phase of ongoing neuronal oscillations, so that accompanying auditory inputs arrive during an ideal, high-excitability phase, and produce amplified neuronal responses. In contrast, responses to auditory inputs arriving during the opposing low-excitability phase tend to be suppressed. Our findings underscore the instrumental role of neuronal oscillations in cortical operations. The timing and laminar profile of the multisensory interactions in Al indicate that nonspecific thalamic systems may play a key role in the effect.	Nathan S Kline Inst Psychiat Res, Cognit Neurosci Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; Hungarian Acad Sci, Inst Psychol, H-1394 Budapest, Hungary; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Nathan Kline Institute for Psychiatric Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Columbia University	Schroeder, CE (corresponding author), Nathan S Kline Inst Psychiat Res, Cognit Neurosci Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA.	schrod@nki.rfmh.org	Chen, Chi-Ming/G-1321-2010	Chen, Chi-Ming/0000-0003-4419-1593; Lakatos, Peter/0000-0003-0221-4021	NIMH NIH HHS [MH61989, R01 MH061989] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061989] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; ATTEVELDT N, 2004, NEURON, V43, P271; BLUM PS, 1979, EXP BRAIN RES, V34, P1; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Callan DE, 2001, COGNITIVE BRAIN RES, V10, P349, DOI 10.1016/S0926-6410(00)00054-9; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; de la Mothe LA, 2006, J COMP NEUROL, V496, P72, DOI 10.1002/cne.20924; Falchier A, 2002, J NEUROSCI, V22, P5749; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fisher NI, 1995, STAT ANAL CIRCULAR D; Foxe JJ, 2000, COGNITIVE BRAIN RES, V10, P77, DOI 10.1016/S0926-6410(00)00024-0; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fu KMG, 2004, J NEUROPHYSIOL, V92, P3522, DOI 10.1152/jn.01228.2003; Fu KMG, 2003, J NEUROSCI, V23, P7510; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Kaiser J, 2005, CEREB CORTEX, V15, P646, DOI 10.1093/cercor/bhh166; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Kruglikov SY, 2003, J NEUROSCI, V23, P10122; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Lipton ML, 2006, J NEUROSCI, V26, P180, DOI 10.1523/JNEUROSCI.1073-05.2006; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; MOLINARI M, 1995, J COMP NEUROL, V362, P171, DOI 10.1002/cne.903620203; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; PETERSON NN, 1995, EVOKED POTENTIAL, V96, P248, DOI 10.1016/0168-5597(95)00006-E; POGGIO GF, 1960, B JOHNS HOPKINS HOSP, V106, P266; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sakowitz OW, 2005, COGNITIVE BRAIN RES, V23, P316, DOI 10.1016/j.cogbrainres.2004.10.012; Sakowitz OW, 2001, COGNITIVE BRAIN RES, V11, P267, DOI 10.1016/S0926-6410(00)00081-1; Sanabria D, 2005, EXP BRAIN RES, V165, P505, DOI 10.1007/s00221-005-2327-5; Schroeder CE, 1995, EEG CL N SU, P55; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Schurmann M, 2004, J ACOUST SOC AM, V115, P830, DOI 10.1121/1.1639909; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Senkowski D, 2006, CEREB CORTEX, V16, P1556, DOI 10.1093/cercor/bhj091; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Stein BE., 1993, MERGING SENSES; STEINSCHNEIDER M, 1995, BRAIN RES, V674, P147, DOI 10.1016/0006-8993(95)00008-E; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Werner-Reiss U, 2003, CURR BIOL, V13, P554, DOI 10.1016/S0960-9822(03)00168-4	59	675	683	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					279	292		10.1016/j.neuron.2006.12.011	http://dx.doi.org/10.1016/j.neuron.2006.12.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224408	Green Accepted, Bronze			2022-12-24	WOS:000245126600012
J	Oka, Y; Katada, S; Omura, M; Suwa, M; Yoshihara, Y; Touhara, K				Oka, Yuki; Katada, Sayako; Omura, Masayo; Suwa, Makiko; Yoshihara, Yoshihiro; Touhara, Kazushige			Odorant receptor map in the mouse olfactory bulb: In vivo sensitivity and specificity of receptor-defined glomeruli	NEURON			English	Article							NEURON INPUT; MICE DEFICIENT; FUNCTIONAL MRI; EXPRESSION; REPRESENTATIONS; DISCRIMINATION; LIGANDS; SYSTEM; IDENTIFICATION; RECONSTITUTION	Odorant identity is represented in the olfactory bulb (OB) by the glomerular activity pattern, which reflects a combination of activated odorant receptors (ORs) in the olfactory epithelium. To elucidate this neuronal circuit at the molecular level, we established a functional OR identification strategy based on glomerular activity by combining in vivo Ca2+, imaging, retrograde dye labeling, and single-cell RT-PCR. Spatial and functional mapping of OR-defined glomeruli revealed that the glomerular positional relationship varied considerably between individual animals, resulting in different OR maps in the OB. Notably, OR-defined glomeruli exhibited different ligand spectra and far higher sensitivity compared to the in vitro pharmacological properties of corresponding ORs. Moreover, we found that the olfactory mucus was an important factor in the regulation of in vivo odorant responsiveness. Our results provide a methodology to examine in vivo glomerular responses at the receptor level and further help address the long-standing issues of olfactory sensitivity and specificity under physiological conditions.	Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan; Natl Inst Adv Ind Sci & Technol AIST, CBRC, Tokyo 1350064, Japan; RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Osaka 5600082, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); RIKEN; Japan Science & Technology Agency (JST)	Touhara, K (corresponding author), Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan.	touhara@k.u-tokyo.ac.jp	Oka, Yoshitaka/G-4952-2014; Yoshihara, Yoshihiro/N-6481-2015; Suwa, Makiko/M-5056-2018	Oka, Yoshitaka/0000-0002-3482-3051; Yoshihara, Yoshihiro/0000-0002-0319-7166; Oka, Yuki/0000-0003-2686-0677; Suwa, Makiko/0000-0001-8812-1023; Katada, Sayako/0000-0002-0466-0466				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Bozza TC, 1998, J NEUROSCI, V18, P4560; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Firestein Stuart, 2004, Sci STKE, V2004, ppe15; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Kurtz DB, 2004, CHEM SENSES, V29, P763, DOI 10.1093/chemse/bjh079; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Luu P, 2004, J NEUROSCI, V24, P10128, DOI 10.1523/JNEUROSCI.3117-04.2004; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mizrahi A, 2004, NEUROPHARMACOLOGY, V47, P661, DOI 10.1016/j.neuropharm.2004.07.020; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Oka Y, 2004, CHEM SENSES, V29, P815, DOI 10.1093/chemse/bjh247; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Touhara K, 2002, MICROSC RES TECHNIQ, V58, P135, DOI 10.1002/jemt.10131; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Weiler E, 2006, CHEM SENSES, V31, P641, DOI 10.1093/chemse/bjl004; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	48	132	133	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					857	869		10.1016/j.neuron.2006.10.019	http://dx.doi.org/10.1016/j.neuron.2006.10.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145506	Bronze			2022-12-24	WOS:000242856400013
J	Shin, RM; Tsvetkov, E; Bolshakov, VY				Shin, Ryong-Moon; Tsvetkov, Evgeny; Bolshakov, Vadim Y.			Spatiotemporal asymmetry of associative synaptic plasticity in fear conditioning pathways	NEURON			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; POSTSYNAPTIC INDUCTION; SUBUNIT COMPOSITION; NMDA RECEPTORS; LTP; INPUTS; INTERNEURONS; TRANSMISSION; EXPRESSION	Input-specific long-term potentiation (LTP) in afferent inputs to the amygdala serves an essential function in the acquisition of fear memory. Factors underlying input specificity of synaptic modifications implicated in information transfer in fear conditioning pathways remain unclear. Here we show that the strength of naive synapses in two auditory inputs converging on a single neuron in the lateral nucleus of the amygdala (LA) is only modified when a postsynaptic action potential closely follows a synaptic response. The stronger inhibitory drive in thalamic pathway, as compared with cortical input, hampers the induction of LTP at thalamo-amygdala synapses, contributing to the spatial specificity of LTP in convergent inputs. These results indicate that spike timing-dependent synaptic plasticity in afferent projections to the LA is both temporarily and spatially asymmetric, thus providing a mechanism for the conditioned stimulus discrimination during fear behavior.	Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA	Harvard University	Bolshakov, VY (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu	Tsvetkov, Evgeny/C-1085-2016; Tsvetkov, Evgeny A/B-6573-2016	Tsvetkov, Evgeny/0000-0001-9339-1677; Tsvetkov, Evgeny A/0000-0002-6784-0907	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045625, R01NS044185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA015098] Funding Source: NIH RePORTER; NIDA NIH HHS [DA15098, R03 DA015098] Funding Source: Medline; NINDS NIH HHS [NS44185, R01 NS044185, R01 NS045625, NS045625] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bauer EP, 2001, NAT NEUROSCI, V4, P687, DOI 10.1038/89465; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; de Armentia ML, 2003, J NEUROSCI, V23, P6876; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Karmarkar UR, 2002, BIOL CYBERN, V87, P373, DOI 10.1007/s00422-002-0351-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000	42	65	66	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					883	896		10.1016/j.neuron.2006.10.010	http://dx.doi.org/10.1016/j.neuron.2006.10.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145508	Green Accepted, Bronze			2022-12-24	WOS:000242856400015
J	Filosa, JA; Bonev, AD; Straub, SV; Meredith, AL; Wilkerson, MK; Aldrich, RW; Nelson, MT				Filosa, Jessica A.; Bonev, Adrian D.; Straub, Stephen V.; Meredith, Andrea L.; Wilkerson, M. Keith; Aldrich, Richard W.; Nelson, Mark T.			Local potassium signaling couples neuronal activity to vasodilation in the brain	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; ARTERIAL SMOOTH-MUSCLE; K+ CHANNELS; ASTROCYTE ENDFEET; NEURAL ACTIVITY; GLIAL-CELLS; RAT; STIMULATION; MEMBRANE; OPENER	The mechanisms by which active neurons, via astrocytes, rapidly signal intracerebral arterioles to dilate remain obscure. Here we show that modest elevation of extracellular potassium ( K+) activated inward rectifier K+ ( Kir) channels and caused membrane potential hyperpolarization in smooth muscle cells ( SMCs) of intracerebral arterioles and, in cortical brain slices, induced Kir-dependent vasodilation and suppression of SMC intracellular calcium ( Ca2+) oscillations. Neuronal activation induced a rapid ( < 2 s latency) vasodilation that was greatly reduced by Kir channel blockade and completely abrogated by concurrent cyclooxygenase inhibition. Astrocytic endfeet exhibited large-conductance, Ca2+-sensitive K+ ( BK) channel currents that could be activated by neuronal stimulation. Blocking BK channels or ablating the gene encoding these channels prevented neuronally induced vasodilation and suppression of arteriolar SMC Ca2+, without affecting the astrocytic Ca2+ elevation. These results support the concept of intercellular K+ channel-to-K+ channel signaling, through which neuronal activity in the form of an astrocytic Ca2+ signal is decoded by astrocytic BK channels, which locally release K+ into the perivascular space to activate SMC Kir channels and cause vasodilation.	Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of Vermont; University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute; Stanford University; Stanford University	Nelson, MT (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, 89 Beaumont Ave, Burlington, VT 05405 USA.	Mark.Nelson@uvm.edu	Filosa, Jessica Andrea/ABG-4524-2020	Filosa, Jessica Andrea/0000-0001-7536-2039; Meredith, Andrea/0000-0003-1061-2302; Nelson, Mark/0000-0002-6608-8784	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044455, R01HL063722] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07944, HL63722, HL44455] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bradley KK, 1999, J PHYSIOL-LONDON, V515, P639, DOI 10.1111/j.1469-7793.1999.639ab.x; Brown LA, 2002, AUTON NEUROSCI-BASIC, V95, P137, DOI 10.1016/S1566-0702(01)00395-2; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Cheney JA, 2001, J CEREBR BLOOD F MET, V21, P396, DOI 10.1097/00004647-200104000-00008; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Gebremedhin D, 2003, J NEUROSCI, V23, P1678; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; Horiuchi T, 2002, STROKE, V33, P2692, DOI 10.1161/01.STR.0000034791.52151.6B; Horiuchi T, 2001, STROKE, V32, P218, DOI 10.1161/01.STR.32.1.218; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jensen BS, 2002, CNS DRUG REV, V8, P353; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; KUFFLER SW, 1966, J NEUROPHYSIOL, V29, P768; KUSCHINSKY W, 1972, CIRC RES, V31, P240, DOI 10.1161/01.RES.31.2.240; LANGTON PD, 1991, AM J PHYSIOL, V260, P927; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; MCCARRON JG, 1990, AM J PHYSIOL, V259, pH902, DOI 10.1152/ajpheart.1990.259.3.H902; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; NELSON MT, 1995, AM J PHYSIOL, V268, P799; NEWMAN EA, 1984, NATURE, V309, P155, DOI 10.1038/309155a0; NEWMAN EA, 1986, SCIENCE, V233, P453, DOI 10.1126/science.3726539; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; Park L, 2004, J CEREBR BLOOD F MET, V24, P334, DOI 10.1097/01.WCB.0000105800.49957.1E; Price DL, 2002, BRAIN RES, V956, P183, DOI 10.1016/S0006-8993(02)03266-3; QUAYLE JM, 1993, AM J PHYSIOL, V265, pC1363, DOI 10.1152/ajpcell.1993.265.5.C1363; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Rossi DJ, 2006, NAT NEUROSCI, V9, P159, DOI 10.1038/nn0206-159; Roy C S, 1890, J Physiol, V11, P85; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Silva AC, 1999, J CEREBR BLOOD F MET, V19, P871, DOI 10.1097/00004647-199908000-00006; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Simard M, 2003, J NEUROSCI, V23, P9254; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	44	383	391	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1397	1403		10.1038/nn1779	http://dx.doi.org/10.1038/nn1779			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17013381				2022-12-24	WOS:000242403800017
J	Goel, A; Jiang, B; Xu, LW; Song, LH; Kirkwood, A; Lee, HK				Goel, Anubhuthi; Jiang, Bin; Xu, Linda W.; Song, Lihua; Kirkwood, Alfredo; Lee, Hey-Kyoung			Cross-modal regulation of synaptic AMPA receptors in primary sensory cortices by visual experience	NATURE NEUROSCIENCE			English	Article							TRAFFICKING; PLASTICITY; EXPRESSION; NEURONS	Lack of a sensory input not only alters the cortical circuitry subserving the deprived sense, but also produces compensatory changes in the functionality of other sensory modalities. Here we report that visual deprivation produces opposite changes in synaptic function in primary visual and somatosensory cortices in rats, which are rapidly reversed by visual experience. This type of bidirectional cross-modal plasticity is associated with changes in synaptic AMPA receptor subunit composition.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, NACS Program, College Pk, MD 20742 USA; Johns Hopkins Univ, Mind Brain Inst, Dept Neurosci, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University	Lee, HK (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	hlee21@umd.edu		Lee, Hey-Kyoung/0000-0002-5554-983X	NATIONAL EYE INSTITUTE [R01EY014882, R01EY012124] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014882-02, R01 EY014882, R01-EY012124, R01 EY014882-03, R01 EY012124, R01-EY014882, R01 EY014882-01A1] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Goldreich D, 2003, J NEUROSCI, V23, P3439; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Washburn MS, 1997, J NEUROSCI, V17, P9393	13	150	153	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1001	1003		10.1038/nn1725	http://dx.doi.org/10.1038/nn1725			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819524	Green Accepted			2022-12-24	WOS:000240080300010
J	Wegmeyer, H; Egea, J; Rabe, N; Gezelius, H; Filosa, A; Enjin, A; Varoqueaux, F; Deininger, K; Schnuetgen, F; Brose, N; Klein, R; Kullander, K; Betz, A				Wegmeyer, Heike; Egea, Joaquirn; Rabe, Nadine; Gezelius, Henrik; Filosa, Alessandro; Enjin, Anders; Varoqueaux, Frederique; Deininger, Katrin; Schnuetgen, Frank; Brose, Nils; Klein, Ruediger; Kullander, Klas; Betz, Andrea			EphA4-Dependent axon guidance is mediated by the RacGAP alpha 2-chirnaerin	NEURON			English	Article							GROWTH-CONE COLLAPSE; MOUSE SPINAL-CORD; TYROSINE PHOSPHORYLATION; CORTICOSPINAL TRACT; KINASE-ACTIVITY; EPH RECEPTORS; NEONATAL RAT; ACTIVATION; ENDOCYTOSIS; PROTEINS	Neuronal network formation in the developing nervous system is dependent on the accurate navigation of nerve cell axons and dendrites, which is controlled by attractive and repulsive guidance cues. Ephrins and their cognate Eph receptors mediate many repulsive axonal guidance decisions by intercellular interactions resulting in growth cone collapse and axon retraction of the Eph-presenting neuron. We show that the Rac-specific GTPase-activating protein alpha 2-chimaerin binds activated EphA4 and mediates EphA4-triggered axonal growth cone collapse. alpha-Chimaerin mutant mice display a phenotype similar to that of EphA4 mutant mice, including aberrant midline axon guidance and defective spinal cord central pattern generator activity. Our results reveal an alpha-chimaerin-dependent signaling pathway downstream of EphA4, which is essential for axon guidance decisions and neuronal circuit formation in vivo.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, DFG Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Martinsried, Germany; Max Planck Inst Neurobiol, Int Max Planck Res Sch Mol Cellular Life Sci, D-82152 Martinsried, Germany; Uppsala Univ, Dept Neurosci, Unit Dev Genet, S-75123 Uppsala, Sweden; Univ Frankfurt, Sch Med, Dept Mol Hematol, D-60590 Frankfurt, Germany	Max Planck Society; German Research Foundation (DFG); Max Planck Society; Max Planck Society; Max Planck Society; Uppsala University; Goethe University Frankfurt	Betz, A (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	betz@em.mpg.de	Filosa, Alessandro/A-9448-2008; Egea, Joaquim/A-7501-2010; Schnütgen, Frank/ABD-8637-2020; Egea, Joaquim/AAT-1984-2021; Klein, Ruediger/C-6147-2008; Enjin, Anders/J-9706-2014; Bernhardt, Nadine/C-1779-2017; Varoqueaux, Frederique/AAC-1834-2021	Schnütgen, Frank/0000-0002-2426-6685; Klein, Ruediger/0000-0002-3109-0163; Bernhardt, Nadine/0000-0002-3188-8431; Varoqueaux, Frederique/0000-0002-3614-3121; Gezelius, Henrik/0000-0002-6242-6344; Egea Navarro, Joaquim/0000-0002-1164-8377; Enjin, Anders/0000-0001-7167-9434; Kullander, Klas/0000-0001-6418-5460				Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Betz A, 1997, J BIOL CHEM, V272, P2520; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bisson N, 2007, MOL BIOL CELL, V18, P1030, DOI 10.1091/mbc.E06-04-0294; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; BURRERY P, 2006, P NATL ACAD SCI USA, V103, P1924; Butt SJB, 2005, P NATL ACAD SCI USA, V102, P14098, DOI 10.1073/pnas.0503317102; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Glover JC., 1995, NEUROSCI PROTOCOLS, V95, P1; GREGERATH U, 2002, MECH DEV S1, V119, pS231; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Imondi R, 2000, DEVELOPMENT, V127, P1397; Jurney WM, 2002, J NEUROSCI, V22, P6019; Kadison SR, 2006, J NEUROSCI, V26, P8909, DOI 10.1523/JNEUROSCI.1569-06.2006; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Leskow FC, 2006, P NATL ACAD SCI USA, V103, P5373, DOI 10.1073/pnas.0508585103; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Murai KK, 2005, NEURON, V46, P161, DOI 10.1016/j.neuron.2005.04.004; Park D, 2001, MOL CELLS, V12, P244; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; VABDEVEN TJ, 2005, J NEUROSCI, V25, P9488; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	48	120	124	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 6	2007	55	5					756	767		10.1016/j.neuron.2007.07.038	http://dx.doi.org/10.1016/j.neuron.2007.07.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785182	Bronze			2022-12-24	WOS:000249857000011
J	Jin, P; Duan, RH; Qurashi, A; Qin, YL; Tian, DH; Rosser, TC; Liu, HJ; Feng, Y; Warren, ST				Jin, Peng; Duan, Ranhui; Qurashi, Abrar; Qin, Yunlong; Tian, Donghua; Rosser, Tracie C.; Liu, Huijie; Feng, Yue; Warren, Stephen T.			Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome	NEURON			English	Article							MYOTONIC-DYSTROPHY TYPE-1; INTRANUCLEAR INCLUSIONS; MUSCLEBLIND PROTEINS; SYNDROME FXTAS; NUCLEAR FOCI; RNA; PREMUTATION; CGG; TRANSPORT; IDENTIFICATION	Fragile X-associated tremor/ataxia syndrome (FXTAS) is a recently recognized neurodegenerative disorder in fragile X premutation carriers with FMR1 alleles containing 55-200 CGG repeats. Previously, we developed a Drosophila model of FXTAS and demonstrated that transcribed premutation repeats alone are sufficient to cause neurodegeneration, suggesting that rCGG-repeat-binding proteins (RBPs) may be sequestered from their normal function by rCGG binding. Here, we identify Pur a and hnRNP A2/B1 as RBPs. We show that Pur alpha and rCGG repeats interact in a sequence-specific fashion that is conserved between mammals and Drosophila. Overexpression of Pur alpha in Drosophila could suppress rCGG-mediated neurodegeneration in a dose-dependent manner. Furthermore, Pur a is also present in the inclusions of FXTAS patient brains. These findings support the disease mechanism of FXTAS of rCGG repeat sequestration of specific RBPs, leading to neuronal cell death, and implicate that Pur alpha plays an important role in the pathogenesis of FXTAS.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	pjin@genetics.emory.edu; swarren@genetics.emory.edu	qin, YUNlong/AAP-6907-2020; Warren, Stephen T/A-2498-2012; Qurashi, Abrar/AFP-7475-2022	Qurashi, Abrar/0000-0001-9173-6598; Feng, Yue/0000-0002-7905-2182	NICHD NIH HHS [P30 HD024064, R37 HD020521, R37 HD20521, P30 HD24064] Funding Source: Medline; NIMH NIH HHS [R01 MH076090] Funding Source: Medline; NINDS NIH HHS [R01 NS051630-01A1, R01 NS051630-02, R01 NS051630] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051630] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arocena DG, 2005, HUM MOL GENET, V14, P3661, DOI 10.1093/hmg/ddi394; Deissler H, 1996, J BIOL CHEM, V271, P4327; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hagerman RJ, 2005, CURR OPIN PSYCHIATR, V18, P490, DOI 10.1097/01.yco.0000179485.39520.b0; Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Johnson EM, 2003, ANTICANCER RES, V23, P2093; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; SHERMAN S, 2002, DIAGNOSIS TREATMENT, P136; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko LT, 2002, ADV EXP MED BIOL, V516, P27; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WARREN ST, 2001, METABOLIC MOL BASES, P1257; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200	36	246	252	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2007	55	4					556	564		10.1016/j.neuron.2007.07.020	http://dx.doi.org/10.1016/j.neuron.2007.07.020			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698009	Bronze, Green Accepted			2022-12-24	WOS:000249159200005
J	Dellisanti, CD; Yao, Y; Stroud, JC; Wang, ZZ; Chen, L				Dellisanti, Cosma D.; Yao, Yun; Stroud, James C.; Wang, Zuo-Zhong; Chen, Lin			Crystal structure of the extracellular domain of nAChR alpha 1 bound to alpha-bungarotoxin at 1.94 A resolution	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; CYS-LOOP RECEPTORS; ESCHERICHIA-COLI; GATING MECHANISM; AGONIST BINDING; PICHIA-PASTORIS; PROTEIN; SUBUNIT; CHANNEL	We determined the crystal structure of the extracellular domain of the mouse nicotinic acetylcholine receptor (nAChR) alpha 1 subunit bound to alpha-bungarotoxin at 1.94 angstrom resolution. This structure is the first atomic-resolution view of a nAChR subunit extracellular domain, revealing receptor-specific features such as the main immunogenic region (MIR), the signature Cys-loop and the N-linked carbohydrate chain. The toxin binds to the receptor through extensive protein-protein and protein-sugar interactions. To our surprise, the structure showed a well-ordered water molecule and two hydrophilic residues deep in the core of the a1 subunit. The two hydrophilic core residues are highly conserved in nAChRs, but correspond to hydrophobic residues in the nonchannel homolog acetylcholine-binding proteins. We carried out site-directed mutagenesis and electrophysiology analyses to assess the functional role of the glycosylation and the hydrophilic core residues. Our structural and functional studies show essential features of the nAChR and provide new insights into the gating mechanism.	Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Univ So Calif, Norris Canc Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ Calif Los Angeles, Inst Genom & Proteom, Dept Energy, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Los Angeles	Chen, L (corresponding author), Univ So Calif, 1050 Childs Way,RIH201, Los Angeles, CA 90089 USA.	zzwang@usc.edu; linchen@usc.edu	chen, Lin/A-3392-2008; Stroud, James C/B-3230-2012	chen, Lin/0000-0003-4798-6199; Stroud, James C/0000-0003-0850-4812	NHLBI NIH HHS [R01 HL076334] Funding Source: Medline; NIGMS NIH HHS [R01 GM077320, R01 GM064642] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077320, R01GM064642] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexeev T, 1999, EUR J BIOCHEM, V259, P310, DOI 10.1046/j.1432-1327.1999.00041.x; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Chen DN, 1998, J NEUROCHEM, V70, P349; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; daCosta CJB, 2005, BIOPHYS J, V88, P1755, DOI 10.1529/biophysj.104.052944; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gehle VM, 1997, MOL BRAIN RES, V45, P219, DOI 10.1016/S0169-328X(96)00256-2; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Karlin A, 2004, NEURON, V41, P841, DOI 10.1016/S0896-6273(04)00151-5; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Konstantakaki M, 2007, BIOCHEM BIOPH RES CO, V359, P413, DOI 10.1016/j.bbrc.2007.05.126; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P9250, DOI 10.1073/pnas.83.23.9250; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Psaridi-Linardaki L, 2002, J BIOL CHEM, V277, P26980, DOI 10.1074/jbc.M110731200; Qasba PK, 2000, CARBOHYD POLYM, V41, P293, DOI 10.1016/S0144-8617(99)00148-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Sullivan DA, 2000, J BIOL CHEM, V275, P12651, DOI 10.1074/jbc.275.17.12651; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tsouloufis T, 2000, INT IMMUNOL, V12, P1255, DOI 10.1093/intimm/12.9.1255; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Wang T, 2003, PROTEIN EXPRES PURIF, V30, P140, DOI 10.1016/S1046-5928(03)00098-6; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YAO J, 1994, J MOL BIOL, V243, P736, DOI 10.1016/0022-2836(94)90044-2; Yao Y, 2002, J BIOL CHEM, V277, P12613, DOI 10.1074/jbc.M108845200	50	347	354	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					953	962		10.1038/nn1942	http://dx.doi.org/10.1038/nn1942			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17643119				2022-12-24	WOS:000248357500009
J	Lishko, PV; Procko, E; Jin, X; Phelps, CB; Gaudet, R				Lishko, Polina V.; Procko, Erik; Jin, Xiangshu; Phelps, Christopher B.; Gaudet, Rachelle			The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity	NEURON			English	Article							VANILLOID RECEPTOR TRPV1; CAPSAICIN-RECEPTOR; ION-CHANNEL; X-RAY; DESENSITIZATION; CALMODULIN; KINASE; ARCHITECTURE; DETERMINANT; ACTIVATION	TRPV1 plays a key role in nociception, as it is activated by heat, low pH, and ligands such as capsaicin, leading to a burning pain sensation. We describe the structure of the cytosolic ankyrin repeat domain (ARD) of TRPV1 and identify a multiligand-binding site important in regulating channel sensitivity within the TRPV1 ARD. The structure reveals a binding site that accommodates triphosphate nucleotides such as ATP, and biochemical studies demonstrate that calmodulin binds the same site. Electrophysiology experiments show that either ATP or PIP2 prevent desensitization to repeated applications of capsaicin, i.e., tachyphylaxis, while calmodulin plays an opposing role and is necessary for tachyphylaxis. Mutations in the TRPV1-ARD binding site eliminate tachyphylaxis. We present a model for the calcium-dependent regulation of TRPV1 via competitive interactions of ATP and calmodulin at the TRPV1 ARD-binding site and discuss its relationship to the C-terminal region previously implicated in interactions with PIP2 and calmodulin..	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Gaudet, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	gaudet@mcb.harvard.edu	Lishko, Polina/L-1191-2017; Gaudet, Rachelle/Y-3985-2019; Gaudet, Rachelle/I-4133-2014; Lishko, Polina/GQH-9569-2022	Gaudet, Rachelle/0000-0002-9177-054X; Gaudet, Rachelle/0000-0002-9177-054X; Procko, Erik/0000-0002-0028-490X; Jin, Xiangshu/0000-0002-6551-8850				Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Deng YP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-264; Drum CL, 2001, ACTA CRYSTALLOGR D, V57, P1881, DOI 10.1107/S0907444901014937; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Koplas PA, 1997, J NEUROSCI, V17, P3525; Kwak J, 2000, J NEUROSCI, V20, P8298, DOI 10.1523/JNEUROSCI.20-22-08298.2000; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Niemeyer BA, 2005, N-S ARCH PHARMACOL, V371, P285, DOI 10.1007/s00210-005-1053-7; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Rosenbaum T, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-4; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; TAYLOR JS, 1991, P NATL ACAD SCI USA, V88, P6810, DOI 10.1073/pnas.88.15.6810; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	43	296	310	4	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 21	2007	54	6					905	918		10.1016/j.neuron.2007.05.027	http://dx.doi.org/10.1016/j.neuron.2007.05.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582331	Bronze			2022-12-24	WOS:000247645600010
J	Qiu, FTT; von der Heydt, D				Qiu, Fangtu T.; von der Heydt, Diger			Neural representation of transparent overlay	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; PERCEPTION; DEPTH	Perceptual transparency is a surprising phenomenon in which a number of regions of different shades organize into overlaying transparent objects. We recorded single neuron responses from Macaca mulatta area V2 to a display of two bright and two dark squares that appeared as two overlaying bars. We found that neurons assign border ownership according to the transparent interpretation, representing the shapes of the bars rather than the squares.	Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	von der Heydt, D (corresponding author), Johns Hopkins Univ, Krieger Mind Brain Inst, 3400 N Charles St, Baltimore, MD 21218 USA.	von.der.heydt@jhu.edu		von der Heydt, Rudiger/0000-0002-8741-813X	NATIONAL EYE INSTITUTE [R01EY002966, R01EY016281] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016281, R01 EY02966, R01 EY016281-03, R01 EY002966] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adelson E. H., 2000, NEW COGNITIVE NEUROS, V339, P339, DOI DOI 10.1068/P230869; ADELSON EH, P AM ASS ART INT WOR, P77; BECK J, 1984, PERCEPT PSYCHOPHYS, V35, P407, DOI 10.3758/BF03203917; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; NAKAYAMA K, 1990, PERCEPTION, V19, P497, DOI 10.1068/p190497; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	9	37	38	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					283	284		10.1038/nn1853	http://dx.doi.org/10.1038/nn1853			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310247	Green Accepted			2022-12-24	WOS:000244480300009
J	Ulanovsky, N; Moss, CF				Ulanovsky, Nachum; Moss, Cynthia F.			Hippocampal cellular and network activity in freely moving echolocating bats	NATURE NEUROSCIENCE			English	Article							THETA-RHYTHM; EPTESICUS-FUSCUS; PHASE PRECESSION; PYRAMIDAL CELLS; OSCILLATIONS; PLACE; SLEEP; DYNAMICS; MEMORY; RAT	The hippocampus is crucial for episodic and spatial memory. In freely moving rodents, hippocampal pyramidal neurons show spatially selective firing when the animal passes through a neuron's 'place- field', and theta-band oscillation is continuously present during locomotion. Here we report the first hippocampal recordings from echolocating bats, mammals phylogenetically distant from rodents, which showed place cells very similar to those of rodents. High- frequency 'ripple' oscillations were also rodent- like. Theta oscillation, however, differed from rodents in two important ways: ( i) theta occurred when bats explored the environment without locomoting, using distal sensing through echolocation, and ( ii) theta was not continuous, but occurred in short intermittent bouts. The intermittence of theta suggests that models of hippocampal function that rely on continuous theta may not apply to bats. Our data support the hypothesis that theta oscillation in the mammalian hippocampus is involved in sequence learning and hence, theta power should increase with sensory- input rate-which explains why theta power correlates with running speed in rodents and with echolocation call rate in bats.	Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ulanovsky, N (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	nulanovsky@psyc.umd.edu	; Moss, Cynthia/J-5208-2017	Ulanovsky, Nachum/0000-0001-8598-4667; Moss, Cynthia/0000-0001-6916-0000	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056366] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH56366] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bodizs R, 2001, HIPPOCAMPUS, V11, P747, DOI 10.1002/hipo.1090; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cantero JL, 2003, J NEUROSCI, V23, P10897; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; ELLINS SR, 1974, BRAIN BEHAV EVOLUT, V9, P248, DOI 10.1159/000123669; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Georges-Francois P, 1999, CEREB CORTEX, V9, P197, DOI 10.1093/cercor/9.3.197; Griffin D. R., 1970, P233; Griffin DR, 1958, LISTENING DARK; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lengyel M, 2005, BIOL CYBERN, V92, P393, DOI 10.1007/s00422-005-0567-x; Ludvig N, 2004, BRAIN RES, V1014, P97, DOI 10.1016/j.brainres.2004.03.071; MACRIDES F, 1982, J NEUROSCI, V2, P1705; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; MCCRACKEN GF, 1993, ANIM BEHAV, V45, P811, DOI 10.1006/anbe.1993.1094; MULLER HC, 1979, J MAMMAL, V60, P198; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OKEEFE J, 1978, HIPPOCAMPU COGNITIVE; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; RINGO JL, 1994, J NEUROPHYSIOL, V71, P1285, DOI 10.1152/jn.1994.71.3.1285; ROBINSON TE, 1980, BRAIN RES REV, V2, P69, DOI 10.1016/0165-0173(80)90004-1; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siegel JJ, 2000, HIPPOCAMPUS, V10, P627, DOI 10.1002/1098-1063(2000)10:6<627::AID-HIPO1000>3.0.CO;2-W; SIMMONS JA, 1990, J COMP PHYSIOL A, V166, P449; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Suzuki WA, 2000, CURR OPIN NEUROBIOL, V10, P768, DOI 10.1016/S0959-4388(00)00148-3; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WILLIAMS TC, 1970, ANIM BEHAV, V18, P302, DOI 10.1016/S0003-3472(70)80042-2; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINSON J, 1972, BEHAV BIOL, V7, P479, DOI 10.1016/S0091-6773(72)80210-4	50	161	163	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					224	233		10.1038/nn1829	http://dx.doi.org/10.1038/nn1829			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17220886				2022-12-24	WOS:000244175200017
J	Zhang, YL; Guo, HF; Kwan, H; Wang, JW; Kosek, J; Lu, BW				Zhang, Yali; Guo, Huifu; Kwan, Helen; Wang, Ji-Wu; Kosek, Jon; Lu, Bingwei			PAR-1 kinase phosphorylates Dlg and regulates its postsynaptic targeting at the Drosophila neuromuscular junction	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; C-ELEGANS EMBRYOS; DISCS-LARGE; ALZHEIMERS-DISEASE; SYNAPTIC GROWTH; FASCICLIN-II; INTRAMOLECULAR INTERACTION; CELL POLARITY; PROTEIN; LOCALIZATION	Targeting of synaptic molecules to their proper location is essential for synaptic differentiation and plasticity. PSD-95/Dig proteins have been established as key components of the post-synapse. However, the molecular mechanisms regulating the synaptic targeting, assembly, and disassembly of PSD-95/Dlg are not well understood. Here we show that PAR-1 kinase, a conserved cell polarity regulator, is critically involved in controlling the postsynaptic localization of Dig. PAR-1 is prominently localized at the Drosophila neuromuscular junction (NMJ). Loss of PAR-1 function leads to increased synapse formation and synaptic transmission, whereas overexpression of PAR-1 has the opposite effects. PAR-1 directly phosphorylates Dig at a conserved site and negatively regulates its mobility and targeting to the postsynapse. The ability of a nonphosphorylatable Dig to largely rescue PAR-1-induced synaptic defects supports the idea that Dig is a major synaptic substrate of PAR-1. Control of Dig synaptic targeting by PAR-1-mediated phosphorylation thus constitutes a critical event in synaptogenesis.	Stanford Univ, Sch Med, Dept Pathol, GRECC,VAPAHCS, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Pathol, Pathol Serv,VAPAHCS, Palo Alto, CA 94304 USA; Blanchette Rockefeller Neurosci Inst, Rockville, MD 20852 USA	Geriatric Research Education & Clinical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Lu, BW (corresponding author), Stanford Univ, Sch Med, Dept Pathol, GRECC,VAPAHCS, Palo Alto, CA 94304 USA.	bingwei@stanford.edu		Wang, Jiwu/0000-0002-9516-3384; Lu, Bingwei/0000-0002-5807-7014	NIMH NIH HHS [R01 MH080378] Funding Source: Medline; NINDS NIH HHS [NS043167, R01 NS043167] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043167] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Brenman JE, 1998, J NEUROSCI, V18, P8805; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Doerflinger H, 2006, CURR BIOL, V16, P1090, DOI 10.1016/j.cub.2006.04.001; Drewes G, 2004, TRENDS BIOCHEM SCI, V29, P548, DOI 10.1016/j.tibs.2004.08.001; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Guo HF, 2006, J NEUROSCI, V26, P4004, DOI 10.1523/JNEUROSCI.3616-05.2006; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Mendoza C, 2003, J NEUROSCI, V23, P2093; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	52	66	66	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					201	215		10.1016/j.neuron.2006.12.016	http://dx.doi.org/10.1016/j.neuron.2006.12.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224403	Green Accepted, Bronze			2022-12-24	WOS:000245126600007
J	Fu, WY; Chen, Y; Sahin, M; Zhao, XS; Shi, L; Bikoff, JB; Lai, KO; Yung, WH; Fu, AKY; Greenberg, ME; Ip, NY				Fu, Wing-Yu; Chen, Yu; Sahin, Mustafa; Zhao, Xiao-Su; Shi, Lei; Bikoff, Jay B.; Lai, Kwok-On; Yung, Wing-Ho; Fu, Amy K. Y.; Greenberg, Michael E.; Ip, Nancy Y.			Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GROWTH CONE DYNAMICS; LONG-TERM DEPRESSION; EPH RECEPTORS; NEURAL DEVELOPMENT; AXON GUIDANCE; TYROSINE PHOSPHORYLATION; NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH	The development of dendritic spines is thought to be crucial for synaptic plasticity. Dendritic spines are retracted upon Eph receptor A4 ( EphA4) activation, but the mechanisms that control this process are not well understood. Here we report an important function of cyclin-dependent kinase 5 (Cdk5) in EphA4-dependent spine retraction in mice. We found that blocking Cdk5 activity inhibits ephrin-A1- triggered spine retraction and reduction of mEPSC frequency at hippocampal synapses. The activation of EphA4 resulted in the recruitment of Cdk5 to EphA4, leading to the tyrosine phosphorylation and activation of Cdk5. EphA4 and Cdk5 then enhanced the activation of ephexin1, a guanine-nucleotide exchange factor that regulates activation of the small Rho GTPase RhoA. The association between EphA4 and ephexin1 was significantly reduced in Cdk5(-/-) brains and Cdk5-dependent phosphorylation of ephexin1 was required for the ephrin-A1- mediated regulation of spine density. These findings suggest that ephrin-A1 promotes EphA4-dependent spine retraction through the activation of Cdk5 and ephexin1, which in turn modulates actin cytoskeletal dynamics.	Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China; Childrens Hosp, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Chinese Univ Hong Kong, Dept Physiol, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Chinese University of Hong Kong	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Clear Water Bay, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	SAHIN, MUSTAFA/I-8653-2019; Yung, Ho/R-6161-2018; Lai, Kwok-On/E-5182-2011; Bikoff, Jay/N-8107-2018; Lai, Kwok-On/L-7468-2019; Lai, Kwok On/ABC-8046-2021	SAHIN, MUSTAFA/0000-0001-7044-2953; Yung, Ho/0000-0002-5542-8173; Lai, Kwok-On/0000-0002-4069-054X; Fu, Kit Yu/0000-0003-4085-6201; Shi, Lei/0000-0001-8695-3432; Ip, Nancy Yuk-Yu/0000-0002-2763-8907	NICHD NIH HHS [K08 HD01384, HD18655] Funding Source: Medline; NINDS NIH HHS [NS045500, R01 NS045500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Chen JX, 2003, COMPUT SCI ENG, V5, P12, DOI 10.1109/MCISE.2003.1182957; Cheng Q, 2003, MOL CELL NEUROSCI, V24, P632, DOI 10.1016/S1044-7431(03)00220-3; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Fu WY, 2002, NEUROREPORT, V13, P243, DOI 10.1097/00001756-200202110-00014; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; IP NY, 1993, J NEUROSCI, V13, P3394; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Lai KO, 2001, MOL CELL NEUROSCI, V17, P1034, DOI 10.1006/mcne.2001.0997; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Murai KK, 2005, NEURON, V46, P161, DOI 10.1016/j.neuron.2005.04.004; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	50	243	262	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					67	76		10.1038/nn1811	http://dx.doi.org/10.1038/nn1811			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17143272	Green Submitted			2022-12-24	WOS:000243096100017
J	Gurden, H; Uchida, N; Mainen, ZF				Gurden, Hirac; Uchida, Naoshige; Mainen, Zachary F.			Sensory-evoked intrinsic optical signals in the olfactory bulb are coupled to glutamate release and uptake	NEURON			English	Article							CEREBRAL-BLOOD-FLOW; ACTIVITY-DEPENDENT INCREASES; RECEPTOR NEURON INPUT; CAT VISUAL-CORTEX; MITRAL CELLS; PRESYNAPTIC INHIBITION; ODORANT REPRESENTATIONS; FUNCTIONAL-ORGANIZATION; DOPAMINERGIC MODULATION; OXIDATIVE-METABOLISM	Functional imaging signals arise from metabolic and hemodynamic activity, but how these processes are related to the synaptic and electrical activity of neurons is not well understood. To provide insight into this issue, we used in vivo imaging and simultaneous local pharmacology to study how sensory-evoked neural activity leads to intrinsic optical signals (IOS) in the well-defined circuitry of the olfactory glomerulus. Odorevoked IOS were tightly coupled to release of glutamate and were strongly modulated by activation of presynaptic dopamine and GABA-B receptors. Surprisingly, IOS were independent of postsynaptic transmission through ionotropic or metabotropic glutamate receptors, but instead were inhibited when uptake by astrocytic glutamate transporters was blocked. These data suggest that presynaptic glutamate release and uptake by astrocytes form a critical pathway through which neural activity is linked to metabolic processing and hence to functional imaging signals.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Mainen, ZF (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	mainen@cshi.edu		Uchida, Naoshige/0000-0002-5755-9409; Mainen, Zachary/0000-0001-7913-9109	NIDCD NIH HHS [5 RO1 DC006104-03] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006104] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BAILEY MS, 1993, J COMP NEUROL, V328, P501, DOI 10.1002/cne.903280405; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Berkowicz DA, 2000, BRAIN RES, V855, P90, DOI 10.1016/S0006-8993(99)02342-2; BERKOWICZ DA, 1994, J NEUROPHYSIOL, V71, P2557, DOI 10.1152/jn.1994.71.6.2557; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Bonino M, 1999, NEUROSCI LETT, V274, P195, DOI 10.1016/S0304-3940(99)00697-7; Bonvento G, 2002, TRENDS NEUROSCI, V25, P359, DOI 10.1016/S0166-2236(02)02168-9; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Buchheim K, 2005, EUR J NEUROSCI, V22, P125, DOI 10.1111/j.1460-9568.2005.04203.x; Caesar K, 2003, P NATL ACAD SCI USA, V100, P4239, DOI 10.1073/pnas.0635075100; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chao TI, 1997, J COMP NEUROL, V388, P191; Cholet N, 2001, J CEREBR BLOOD F MET, V21, P404, DOI 10.1097/00004647-200104000-00009; COOPERSMITH R, 1995, BRAIN RES, V674, P230, DOI 10.1016/0006-8993(94)01445-N; Coronas V, 1997, J CHEM NEUROANAT, V12, P243, DOI 10.1016/S0891-0618(97)00215-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Duchamp-Viret P, 2000, NEUROSCIENCE, V97, P771, DOI 10.1016/S0306-4522(00)00055-5; DuchampViret P, 1997, NEUROSCIENCE, V79, P203, DOI 10.1016/S0306-4522(96)00646-X; Ennis M, 2006, J NEUROPHYSIOL, V95, P2233, DOI 10.1152/jn.01150.2005; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Ennis M, 1996, NEUROREPORT, V7, P989, DOI 10.1097/00001756-199604100-00007; Fayuk D, 2002, J NEUROPHYSIOL, V87, P1924, DOI 10.1152/jn.00231.2001; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; GALL CM, 1987, J COMP NEUROL, V266, P307, DOI 10.1002/cne.902660302; Gutierrez-Mecinas M, 2005, EUR J NEUROSCI, V22, P1357, DOI 10.1111/j.1460-9568.2005.04328.x; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Heinbockel T, 2004, J NEUROPHYSIOL, V92, P3085, DOI 10.1152/jn.00349.2004; Higashi K, 2001, AM J PHYSIOL-CELL PH, V281, pC922, DOI 10.1152/ajpcell.2001.281.3.C922; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Iserhot C, 2004, BRAIN RES, V1027, P151, DOI 10.1016/j.brainres.2004.08.052; JAN DD, 2005, J NEUROSCI, V25, P2917, DOI DOI 10.1523/JNEUR0SCI.5042-04.2005; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kayser C, 2004, CEREB CORTEX, V14, P881, DOI 10.1093/cercor/bhh047; Keller A, 1998, J NEUROSCI, V18, P2602; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Koster NL, 1999, J COMP NEUROL, V411, P666, DOI 10.1002/(SICI)1096-9861(19990906)411:4<666::AID-CNE10>3.0.CO;2-S; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; MCLEAN JH, 1988, J NEUROSCI, V8, P3658; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; NICKELL WT, 1994, BRAIN RES BULL, V35, P119, DOI 10.1016/0361-9230(94)90091-4; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Palouzier-Paulignan B, 2002, NEUROSCIENCE, V111, P241, DOI 10.1016/S0306-4522(02)00003-9; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2003, J NEUROSCI, V23, P3959; RAICHLE ME, 1999, ANNU REV NEUROSCI, V23, P499; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SALLAZ M, 1992, NEUROREPORT, V3, P833, DOI 10.1097/00001756-199210000-00003; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; Schoppa NE, 1997, J NEUROPHYSIOL, V78, P1468, DOI 10.1152/jn.1997.78.3.1468; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Shulman RG, 1998, P NATL ACAD SCI USA, V95, P11993, DOI 10.1073/pnas.95.20.11993; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Simard M, 2003, J NEUROSCI, V23, P9254; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thomsen K, 2004, J PHYSIOL-LONDON, V560, P181, DOI 10.1113/jphysiol.2004.068072; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Utsumi M, 2001, MOL BRAIN RES, V92, P1, DOI 10.1016/S0169-328X(01)00098-5; VANDENPOL AN, 1995, J COMP NEUROL, V359, P253, DOI 10.1002/cne.903590206; Voutsinos-Porche B, 2003, CEREB CORTEX, V13, P1110, DOI 10.1093/cercor/13.10.1110; Vucinic D, 2006, J NEUROPHYSIOL, V95, P1881, DOI 10.1152/jn.00918.2005; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Yuan Q, 2006, J NEUROPHYSIOL, V95, P3097, DOI 10.1152/jn.00001.2006; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	92	93	96	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					335	345		10.1016/j.neuron.2006.07.022	http://dx.doi.org/10.1016/j.neuron.2006.07.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046695	Bronze			2022-12-24	WOS:000241799900013
J	Watabe-Uchida, M; John, KA; Janas, JA; Newey, SE; Van Aelst, L				Watabe-Uchida, Mitsuko; John, Keisha A.; Janas, Justyna A.; Newey, Sarah E.; Van Aelst, Linda			The Rac activator DOCK7 regulates neuronal polarity through local phosphorylation of stathmin/Op18	NEURON			English	Article							HIPPOCAMPAL-NEURONS; PHOSPHOPROTEIN FAMILY; AXON SPECIFICATION; CELL-CYCLE; MICROTUBULE; PROTEIN; GROWTH; RHO; GSK-3-BETA; TUBULIN	The polarization of a neuron generally results in the formation of one axon and multiple dendrites, allowing for the establishment of neuronal circuitry. The molecular mechanisms involved in priming one neurite to become the axon, particularly those regulating the microtubule network, remain elusive. Here we report the identification of DOCK7, a member of the DOCK180-related protein superfamily, as a Rac GTPase activator that is asymmetrically distributed in unpolarized hippocampal neurons and selectively expressed in the axon. Knockdown of DOCK7 expression prevents axon formation, whereas overexpression induces formation of multiple axons. We further demonstrate that DOCK7 and Rac activation lead to phosphorylation and inactivation of the microtubule destabilizing protein stathmIn/Op18 in the nascent axon and that this event is important for axon development. Our findings unveil a pathway linking the Rac activator DOCK7 to a microtubule regulatory protein and highlight the contribution of microtubule network regulation to axon development.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Van Aelst, L (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	vanaelst@cshl.edu		Janas, Justyna A/0000-0001-9840-9928	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082808] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH082808] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Baas PW, 2002, NAT CELL BIOL, V4, pE194, DOI 10.1038/ncb0802-e194; BANKER G, 1998, CULTURING NERVE CELL; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Esch T, 1999, J NEUROSCI, V19, P6417; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gavet O, 1998, J CELL SCI, V111, P3333; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Janas J, 2006, METHOD ENZYMOL, V406, P593, DOI 10.1016/S0076-6879(06)06046-0; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kim MD, 2003, DEV BIOL, V262, P282, DOI 10.1016/S0012-1606(03)00393-2; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Schubart UK, 1996, J BIOL CHEM, V271, P14062, DOI 10.1074/jbc.271.24.14062; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Van Aelst L, 1998, METH MOL B, V84, P201; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; YU WQ, 1994, J NEUROSCI, V14, P2818; Yu WQ, 2001, J NEUROCYTOL, V30, P861, DOI 10.1023/A:1020622530831; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	56	157	168	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					727	739		10.1016/j.neuron.2006.07.020	http://dx.doi.org/10.1016/j.neuron.2006.07.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982419	Bronze			2022-12-24	WOS:000240997900012
J	Komai, S; Licznerski, P; Cetin, A; Waters, J; Denk, W; Brecht, M; Osten, P				Komai, Shoji; Licznerski, Pawel; Cetin, Ali; Waters, Jack; Denk, Winfried; Brecht, Michael; Osten, Pavel			Postsynaptic excitability is necessary for strengthening of cortical sensory responses during experience-dependent development	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; NEOCORTICAL PYRAMIDAL NEURONS; PRIMARY SOMATOSENSORY CORTEX; IN-VIVO; ACTION-POTENTIALS; RECEPTIVE-FIELDS; DENDRITIC SPINES; STRIATE CORTEX; MAP PLASTICITY; CEREBRAL-CORTEX	Sensory experience is necessary for normal cortical development. This has been shown by sensory deprivation and pharmacological perturbation of the cortex. Because these manipulations affect the cortical network as a whole, the role of postsynaptic cellular properties during experience-dependent development is unclear. Here we addressed the developmental role of somatodendritic excitability, which enables postsynaptic spike timing-dependent forms of plasticity, in rat somatosensory cortex. We used short interfering RNA (siRNA)-based knockdown of Na+ channels to suppress the somatodendritic excitability of small numbers of layer 2/3 pyramidal neurons in the barrel cortex, without altering the ascending sensory pathway. In vivo recordings from siRNA-expressing cells revealed that this manipulation interfered with the normal developmental strengthening of sensory responses. The sensory responsiveness of neighboring cortical neurons was unchanged, indicating that the cortical network was unchanged. We conclude that somatodendritic excitability of the postsynaptic neuron is needed for the regulation of synaptic strength in the developing sensory cortex.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Univ Rotterdam, Med Ctr, Erasmus MC, Dept Neurosci, Rotterdam, Netherlands	Max Planck Society; Northwestern University; Feinberg School of Medicine; Erasmus University Rotterdam; Erasmus MC	Osten, P (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	p-osten@northwestern.edu	denk, winfried/I-6627-2012; Komai, Shoji/L-9273-2018	Komai, Shoji/0000-0002-8474-7800; Brecht, Michael/0000-0002-5387-0953; Licznerski, Pawel/0000-0003-2761-8428				Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; [Anonymous], [No title captured]; BEAR MF, 1990, J NEUROSCI, V10, P909; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; FOX K, 1992, J NEUROSCI, V12, P1826; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Ruthazer ES, 2005, NEURON, V45, P825, DOI 10.1016/j.neuron.2005.03.008; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Waters J, 2003, J NEUROSCI, V23, P8558; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	50	24	29	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1125	1133		10.1038/nn1752	http://dx.doi.org/10.1038/nn1752			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921372				2022-12-24	WOS:000240080800013
J	Ferris, J; Ge, H; Liu, LZ; Roman, G				Ferris, Jacob; Ge, Hong; Liu, Lingzhi; Roman, Gregg			G(o) signaling is required for Drosophila associative learning	NATURE NEUROSCIENCE			English	Article							PERTUSSIS TOXIN; MUSHROOM BODIES; PROTEIN; MEMORY; EXPRESSION; GENE; MELANOGASTER; DEFICIENT; SUBUNIT; RESCUE	Heterotrimeric G(o) is one of the most abundant proteins in the brain, yet relatively little is known of its neural functions in vivo. Here we demonstrate that G(o) signaling is required for the formation of associative memory. In Drosophila melanogaster, pertussis toxin (PTX) is a selective inhibitor of G(o) signaling. The postdevelopmental expression of PTX within mushroom body neurons robustly and reversibly inhibits associative learning. The effect of G(o) inhibition is distributed in both gamma- and alpha/beta-lobe mushroom body neurons. However, the expression of PTX in neurons adjacent to the mushroom bodies does not affect memory. PTX expression also does not interact genetically with a rutabaga adenylyl cyclase loss-of-function mutation. Thus, G(o) defines a new signaling pathway required in mushroom body neurons for the formation of associative memory.	Baylor Univ, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor University	Roman, G (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	gwroman@UH.edu	Roman, Gregg/W-1586-2019	Roman, Gregg/0000-0003-1519-4699	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042185] Funding Source: NIH RePORTER; NINDS NIH HHS [NS042185-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; FITCH CL, 1993, CELL SIGNAL, V5, P187, DOI 10.1016/0898-6568(93)90070-3; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Goodwin SF, 1997, J NEUROSCI, V17, P8817; GUILLEN A, 1990, EMBO J, V9, P1449, DOI 10.1002/j.1460-2075.1990.tb08261.x; HOPKINS RS, 1988, BIOCHIM BIOPHYS ACTA, V970, P355, DOI 10.1016/0167-4889(88)90135-8; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; KATADA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P290, DOI 10.1016/0003-9861(83)90212-6; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Roman G, 1999, BIOTECHNIQUES, V27, P54, DOI 10.2144/99271bm09; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; THAMBI NC, 1989, J BIOL CHEM, V264, P18552; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	30	49	52	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1036	1040		10.1038/nn1738	http://dx.doi.org/10.1038/nn1738			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16845387				2022-12-24	WOS:000240080300016
J	Sofola, OA; Jin, P; Qin, YL; Duan, RH; Liu, HJ; de Haro, M; Nelson, DL; Botas, J				Sofola, Oyinkan A.; Jin, Peng; Qin, Yunlong; Duan, Ranhui; Liu, Huijie; de Haro, Maria; Nelson, David L.; Botas, Juan			RNA-Binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS	NEURON			English	Article							CEREBELLAR-TREMOR/ATAXIA-SYNDROME; MYOTONIC-DYSTROPHY; INTRANUCLEAR INCLUSIONS; CARRIERS	Fragile X-associated tremor/ataxia syndrome (FXTAS) is a recently described neurodegenerative disorder of older adult carriers of premutation alleles (60-200 CGG repeats) in the fragile X mental retardation gene (FMR1). It has been proposed that FXTAS is an RNA-mediated neuroclegenerative disease caused by the titration of RNA-binding proteins by the CGG repeats. To test this hypothesis, we utilize a transgenic Drosophila model of FXTAS that expresses a premutation-length repeat (90 CGG repeats) from the 5' UTR of the human FMR1 gene and displays neuronal degeneration. Here, we show that overexpression of RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppresses the phenotype of the CGG transgenic fly. Furthermore, we show that hnRNP A2/B1 directly interacts with riboCGG repeats and that the CUGBP1 protein interacts with the riboCGG repeats via hnRNP A2/B1.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Baylor College of Medicine; Emory University	Nelson, DL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Pl, Houston, TX 77030 USA.	nelson@bcm.tmc.edu; jbotas@bcm.tmc.edu	qin, YUNlong/AAP-6907-2020	de Haro, Maria/0000-0002-8654-2526	NICHD NIH HHS [P50 HD024064, P30 HD024064, R01 HD038038] Funding Source: Medline; NIMH NIH HHS [R01 MH076090] Funding Source: Medline; NINDS NIH HHS [R01 NS042179-05, R56 NS042179, NS42179, R01 NS051630, R01 NS042179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042179, R56NS042179, R01NS051630] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arocena DG, 2005, HUM MOL GENET, V14, P3661, DOI 10.1093/hmg/ddi394; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Pancetti F, 1999, BIOCHEM BIOPH RES CO, V260, P17, DOI 10.1006/bbrc.1999.0849; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Sengupta Sonali, 2006, RNA Biol, V3, P28; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; WARREN ST, 2001, METABOLIC MOL BASES, P1257; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Zu K, 1996, MOL BIOL CELL, V7, P1059, DOI 10.1091/mbc.7.7.1059	23	255	264	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2007	55	4					565	571		10.1016/j.neuron.2007.07.021	http://dx.doi.org/10.1016/j.neuron.2007.07.021			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698010	Green Accepted, Bronze			2022-12-24	WOS:000249159200006
J	Sutton, MA; Taylor, AM; Ito, HT; Pham, A; Schuman, EM				Sutton, Michael A.; Taylor, Anne M.; Ito, Hiroshi T.; Pham, Anh; Schuman, Erin M.			Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis	NEURON			English	Article							LONG-TERM POTENTIATION; ELONGATION FACTOR-II; TRANSLATIONAL CONTROL; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; KINASE-II; PLASTICITY; PHOSPHORYLATION; INHIBITION; ACTIVATION	Activity-dependent regulation of dendritic protein synthesis is critical for enduring changes in synaptic function, but how the unique features of distinct activity patterns are decoded by the dendritic translation machinery remains poorly understood. Here, we identify eukaryotic elongation factor-2 (eEF2), which catalyzes ribosomal translocation during protein synthesis, as a biochemical sensor in dendrites that is specifically and locally tuned to the quality of neurotransmission. We show that intrinsic action potential (AP)-mediated network activity in cultured hippocampal neurons maintains eEF2 in a relatively dephosphorylated (active) state, whereas spontaneous neurotransmitter release (i.e., miniature neurotransmission) strongly promotes the phosphorylation (and inactivation) of eEF2. The regulation of eEF2 phosphorylation is responsive to bidirectional changes in miniature neurotransmission and is controlled locally in dendrites. Finally, direct spatially controlled inhibition of eEF2 phosphorylation induces local translational activation, suggesting that eEF2 is a biochemical sensor that couples miniature synaptic events to local translational suppression in neuronal dendrites.	CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Sutton, Michael/C-6264-2011; Taylor, Anne Marion/F-4454-2012; Schuman, Erin M/D-6204-2011	Taylor, Anne Marion/0000-0003-0998-087X; Sutton, Michael/0000-0002-0692-6459				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; ABRAHAM AK, 1983, BIOCHIM BIOPHYS ACTA, V741, P197, DOI 10.1016/0167-4781(83)90059-3; Arora S, 2003, CANCER RES, V63, P6894; Ashton AC, 2001, J BIOL CHEM, V276, P44695, DOI 10.1074/jbc.M108088200; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bradshaw KD, 2003, EUR J NEUROSCI, V18, P3150, DOI 10.1111/j.1460-9568.2003.03054.x; Carroll M, 2004, J NEUROCHEM, V90, P1464, DOI 10.1111/j.1471-4159.2004.02634.x; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; GSCHWENDT M, 1994, FEBS LETT, V338, P85, DOI 10.1016/0014-5793(94)80121-5; Holland EC, 2004, CELL CYCLE, V3, P452; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; HUGHES SJ, 1993, BIOCHEM J, V289, P795, DOI 10.1042/bj2890795; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Marin P, 1997, J NEUROSCI, V17, P3445; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MITSUI K, 1993, J BIOL CHEM, V268, P13422; NAIM AC, 1987, J BIOL CHEM, V262, P17299; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STEWARD O, 1988, J NEUROSCI, V8, P176; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; THOMPSON RC, 1982, P NATL ACAD SCI-BIOL, V79, P4922, DOI 10.1073/pnas.79.16.4922; WALDEN WE, 1986, BIOCHEMISTRY-US, V25, P2033, DOI 10.1021/bi00356a030; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976	43	193	196	2	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2007	55	4					648	661		10.1016/j.neuron.2007.07.030	http://dx.doi.org/10.1016/j.neuron.2007.07.030			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	206BP	17698016	Bronze			2022-12-24	WOS:000249159200012
J	Zhou, PC; Porcionatto, M; Pilapil, M; Chen, YC; Choi, Y; Tolias, KF; Bikoff, JB; Hong, EJ; Greenberg, ME; Segal, RA				Zhou, Pengcheng; Porcionatto, Marimelia; Pilapil, Mariecel; Chen, Yicheng; Choi, Yoojin; Tolias, Kimberley F.; Bikoff, Jay B.; Hong, Elizabeth J.; Greenberg, Michael E.; Segal, Rosalind A.			Polarized signaling endosomes coordinate BDNF-induced chemotaxis of cerebellar precursors	NEURON			English	Review							SCHWANN-CELL MIGRATION; NEURONAL MIGRATION; DIFFERENTIAL EXPRESSION; NEUROTROPHIN RELEASE; NERVOUS-SYSTEM; PROTEIN-KINASE; MESSENGER-RNA; ALPHA-ADAPTIN; TRK RECEPTORS; ENDOCYTOSIS	During development, neural precursors migrate in response to positional cues such as growth factor gradients. However, the mechanisms that enable precursors to sense and respond to such gradients are poorly understood. Here we show that cerebellar granule cell precursors (GCPs) migrate along a gradient of brain-derived neurotrophic factor (BDNF), and we demonstrate that vesicle trafficking is critical for this chemotactic process. Activation of TrkB, the BDNF receptor, stimulates GCPs to secrete BDNF, thereby amplifying the ambient gradient. The BDNF gradient stimulates endocytosis of TrkB and associated signaling molecules, causing asymmetric accumulation of signaling endosomes at the subcellular location where BDNF concentration is maximal. Thus, regulated BDNF exocytosis; and TrkB endocytosis enable precursors to polarize and migrate in a directed fashion along a shallow BDNF gradient.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Universidade Federal de Sao Paulo (UNIFESP); Baylor College of Medicine	Segal, RA (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	rosalind_segal@dfci.harvard.edu	Bikoff, Jay/N-8107-2018; Porcionatto, Marimelia/C-3322-2012	Porcionatto, Marimelia/0000-0001-6287-916X; Choi, Yoojin/0000-0002-0272-5959; Tolias, Kimberley/0000-0002-2092-920X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037757, R01NS045500] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD18655, P30 HD018655] Funding Source: Medline; NINDS NIH HHS [R01 NS037757-09, R01 NS037757-08, NS045500, NS377057, R01 NS037757, R01 NS045500] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Bentley CA, 2000, J NEUROSCI, V20, P7706; Bielas SL, 2004, J NEUROBIOL, V58, P149, DOI 10.1002/neu.10280; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279; Carter AR, 2003, MOL CELL NEUROSCI, V22, P1, DOI 10.1016/S1044-7431(02)00015-5; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; DARNKE H, 1984, J CELL BIOL, V127, P915; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Ehler E, 1997, MOL CELL NEUROSCI, V9, P1, DOI 10.1006/mcne.1997.0602; FISHELL G, 1991, DEVELOPMENT, V113, P755; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gammill LS, 2006, DEVELOPMENT, V133, P99, DOI 10.1242/dev.02187; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hamasaki T, 2001, J NEUROSCI, V21, P4272, DOI 10.1523/JNEUROSCI.21-12-04272.2001; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; KLEIN R, 1990, DEVELOPMENT, V109, P845; Klein RS, 2001, DEVELOPMENT, V128, P1971; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; KRAMER H, 2000, SCI STKE; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Medina DL, 2004, EMBO J, V23, P3803, DOI 10.1038/sj.emboj.7600399; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Myers SA, 2005, MOL BIOL CELL, V16, P2191, DOI 10.1091/mbc.E04-09-0844; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Piper M, 2003, BIOESSAYS, V25, P32, DOI 10.1002/bies.10199; Polleux F, 2002, DEVELOPMENT, V129, P3147; Qin J, 2000, ACTA NEUROPATHOL, V100, P168, DOI 10.1007/s004019900154; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; RIVAS RJ, 1995, J NEUROSCI, V15, P981; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Saarelainen T, 2001, CELL MOL NEUROBIOL, V21, P429, DOI 10.1023/A:1012775808253; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Santiago A, 2002, DEVELOPMENT, V129, P3621; Sawada J, 2000, BLOOD, V95, P2052, DOI 10.1182/blood.V95.6.2052; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; SEGAL RA, 1995, J NEUROSCI, V15, P4970; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; TAPLEY P, 1992, ONCOGENE, V7, P371; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Webb Donna J., 2004, V294, P3; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yang ZF, 2006, BIOCHEM BIOPH RES CO, V346, P981, DOI 10.1016/j.bbrc.2006.06.007; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Yuen EC, 1999, EXP NEUROL, V159, P297, DOI 10.1006/exnr.1999.7148; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	101	115	119	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 5	2007	55	1					53	68		10.1016/j.neuron.2007.05.030	http://dx.doi.org/10.1016/j.neuron.2007.05.030			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610817	Green Accepted, Bronze			2022-12-24	WOS:000248010700008
J	Jakubcakova, V; Oster, H; Tamanini, F; Cadenas, C; Leitges, M; van der Horst, GTJ; Eichele, G				Jakubcakova, Vladimira; Oster, Henrik; Tamanini, Filippo; Cadenas, Cristina; Leitges, Michael; van der Horst, Gijsbertus T. J.; Eichele, Gregor			Light entrainment of the mammalian circadian clock by a PRKCA-dependent posttranslational mechanism	NEURON			English	Article							PROTEIN-KINASE-C; RAT SUPRACHIASMATIC NUCLEUS; EARLY GENE-EXPRESSION; INDUCED PHASE-SHIFTS; CREB PHOSPHORYLATION; PERIOD HOMOLOGS; CKI-EPSILON; I EPSILON; MPER2; MOUSE	Light is the most potent stimulus for synchronizing endogenous circadian rhythms with external time. Photic clock resetting in mammals involves cAMP-responsive element binding protein (CREB)-mediated transcriptional activation of Period clock genes in the suprachiasmatic nuclei (SCN). Here we provide evidence for an additional photic input pathway to the mammalian circadian clock based on Protein Kinase C alpha (PRKCA). We found that Prkca-deficient mice show an impairment of light-mediated clock resetting. In the SCN of wildtype mice, light exposure evokes a transient interaction between PRKCA and PERIOD 2 (PER2) proteins that affects PER2 stability and nucleocytoplasmic distribution. These posttranslational events, together with CREB-mediated transcriptional regulation, are key factors in the molecular mechanism of photic clock resetting.	Max Planck Inst Biophys Chem, Dept Genes & Behav, D-37077 Gottingen, Germany; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Erasmus Univ, Med Ctr, Dept Genet, MGC, NL-3000 CA Rotterdam, Netherlands; Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany	Max Planck Society; University of Oxford; Wellcome Centre for Human Genetics; Erasmus University Rotterdam; Erasmus MC; Hannover Medical School	Eichele, G (corresponding author), Max Planck Inst Biophys Chem, Dept Genes & Behav, D-37077 Gottingen, Germany.	geichel@gwdg.de	van der Horst, Gijsbertus TJ/E-3661-2015; Oster, Henrik/O-4426-2019; Leitges, Michael/AAN-1953-2021; Oster, Henrik/D-2335-2013	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Oster, Henrik/0000-0002-1414-7068; Oster, Henrik/0000-0002-1414-7068; Leitges, Michael/0000-0003-4203-6995				Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Bae K, 2003, J BIOL RHYTHM, V18, P123, DOI 10.1177/0748730403252248; Beaule C, 2003, J MOL NEUROSCI, V21, P133, DOI 10.1385/JMN:21:2:133; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Cagampang FRA, 1998, MOL BRAIN RES, V53, P277, DOI 10.1016/S0169-328X(97)00309-4; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Ding JM, 1997, J NEUROSCI, V17, P667; Dkhissi-Benyahya O, 2000, J NEUROSCI, V20, P7790; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Franchi L, 2005, MOL MICROBIOL, V56, P334, DOI 10.1111/j.1365-2958.2005.04545.x; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Obrietan K, 1998, J NEUROPHYSIOL, V79, P1360, DOI 10.1152/jn.1998.79.3.1360; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Paul KN, 2003, NEUROSCIENCE, V119, P137, DOI 10.1016/S0306-4522(03)00098-8; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rivera-Bermudez MA, 2003, NEUROSCI LETT, V346, P37, DOI 10.1016/S0304-3940(03)00590-1; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schak KM, 1999, BRAIN RES, V840, P158, DOI 10.1016/S0006-8993(99)01787-4; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; Takano A, 2000, FEBS LETT, V477, P106, DOI 10.1016/S0014-5793(00)01755-5; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tamanini F, 2005, METHOD ENZYMOL, V393, P418, DOI 10.1016/S0076-6879(05)93020-6; Tischkau SA, 2000, J NEUROSCI, V20, P7830; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; VANDERZEE EA, 1995, BRAIN RES, V701, P99, DOI 10.1016/0006-8993(95)00968-1; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Yokota S, 2001, J NEUROCHEM, V77, P618, DOI 10.1046/j.1471-4159.2001.00270.x; Yoshimura T, 1998, BRAIN RES, V779, P188, DOI 10.1016/S0006-8993(97)01122-0; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	73	54	56	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 7	2007	54	5					831	843		10.1016/j.neuron.2007.04.031	http://dx.doi.org/10.1016/j.neuron.2007.04.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553429	Bronze, Green Submitted			2022-12-24	WOS:000247329900014
J	Sale, A; Maya-Vetencourt, JF; Medinin, P; Cenni, MC; Baroncelli, L; De Pasquale, R; Maffei, L				Sale, Alessandro; Maya-Vetencourt, Jose Fernando; Medinin, Paolo; Cenni, Maria Cristina; Baroncelli, Laura; De Pasquale, Roberto; Maffei, Lamberto			Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; VISUAL-CORTEX; CRITICAL-PERIOD; DEPRIVATION	Loss of visual acuity caused by abnormal visual experience during development (amblyopia) is an untreatable pathology in adults. We report that environmental enrichment in adult amblyopic rats restored normal visual acuity and ocular dominance. These effects were due to reduced GABAergic inhibition in the visual cortex, accompanied by increased expression of BDNF and reduced density of extra-cellular-matrix perineuronal nets, and were prevented by enhancement of inhibition through benzodiazepine cortical infusion.	Scuola Normale Super Pisa, I-56100 Pisa, Italy; CNR, Inst Neurosci, I-56100 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Sale, A (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56100 Pisa, Italy.	a.sale@sns.it	Maya-Vetencourt, Jose Fernando/F-3566-2011; Medini, Paolo/GWC-1936-2022; Maya-Vetencourt, Jose Fernando/Q-6539-2019; Baroncelli, Laura/K-5823-2016; DE PASQUALE, ROBERTO/AAE-2941-2019; Sale, Alessandro/K-7760-2016	Maya-Vetencourt, Jose Fernando/0000-0003-3808-8944; Baroncelli, Laura/0000-0001-6739-2860; Sale, Alessandro/0000-0001-7608-4456; De Pasquale, Roberto/0000-0003-3383-7715				ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Erisir A, 2003, J NEUROSCI, V23, P5208; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Levi DM, 1997, INVEST OPHTH VIS SCI, V38, P1493; Mitchell Donald E, 2002, Clin Exp Optom, V85, P5; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	15	352	362	0	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					679	681		10.1038/nn1899	http://dx.doi.org/10.1038/nn1899			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17468749				2022-12-24	WOS:000246799800007
J	Xu, HT; Pan, F; Yang, G; Gan, WB				Xu, Hua-Tai; Pan, Feng; Yang, Guang; Gan, Wen-Biao			Choice of cranial window type for in vivo imaging affects dendritic spine turnover in the cortex	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; ADULT CORTEX; BRAIN; STABILITY; NEOCORTEX		NYU, Sch Med, Dept Physiol & Neurosci, Mol Neurobiol Program,Skirball Inst, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Mol Neurobiol Program,Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu		Yang, Guang/0000-0002-5739-9126				Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Meyer MP, 2003, CURR BIOL, V13, pR180, DOI 10.1016/S0960-9822(03)00118-0; NAVARI RM, 1978, MICROVASC RES, V16, P304, DOI 10.1016/0026-2862(78)90064-X; Ottersen OP, 2002, NATURE, V420, P751, DOI 10.1038/420751a; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Super H, 2005, PROG BRAIN RES, V147, P263, DOI 10.1016/S0079-6123(04)47020-4; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	15	293	301	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					549	551		10.1038/nn1883	http://dx.doi.org/10.1038/nn1883			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17417634				2022-12-24	WOS:000245948000009
J	Couey, JJ; Meredith, RM; Spijker, S; Poorthuis, RB; Smit, AB; Brussaard, AB; Mansvelder, HD				Couey, Jonathan J.; Meredith, Rhiannon M.; Spijker, Sabine; Poorthuis, Rogier B.; Smit, August B.; Brussaard, Arjen B.; Mansvelder, Huibert D.			Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC-TRANSMISSION; ACETYLCHOLINE-RECEPTORS; PYRAMIDAL CELLS; GLUTAMATE RELEASE; HIPPOCAMPAL CA1; WORKING-MEMORY; RAT; NEURONS; CALCIUM	Nicotine enhances attention and working memory by activating nicotinic acetylcholine receptors (nAChRs). The prefrontal cortex (PFC) is critical for these cognitive functions and is also rich in nAChR expression. Specific cellular and synaptic mechanisms underlying nicotine's effects on cognition remain elusive. Here we show that nicotine exposure increases the threshold for synaptic spike-timing-dependent potentiation (STDP) in layer V pyramidal neurons of the mouse PFC. During coincident presynaptic and postsynaptic activity, nicotine reduces dendritic calcium signals associated with action potential propagation by enhancing GABAergic transmission. This results from a series of presynaptic actions involving different PFC interneurons and multiple nAChR subtypes. Pharmacological block of nAChRs or GABA(A) receptors prevented nicotine's actions and restored STDP, as did increasing dendritic calcium signals with stronger postsynaptic activity. Thus, by activating nAChRs distributed throughout the PFC neuronal network, nicotine affects PFC information processing and storage by increasing the amount of postsynaptic activity necessary to induce STDP.	Vrije Univ Amsterdam, Dept Expt & Neurophysiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Mansvelder, HD (corresponding author), Vrije Univ Amsterdam, Dept Expt & Neurophysiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands.	huib@cncr.vu.nl	Smit, August B/E-8410-2011; Couey, Jonathan/GXG-6340-2022; Meredith, Rhiannon/A-4657-2010; Spijker, Sabine/F-2300-2011; Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340; Spijker, Sabine/0000-0002-6814-2019; Meredith, Rhiannon/0000-0003-0228-4169; Couey, Jonathan/0000-0003-2658-692X				Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Alkondon M, 2004, PROG BRAIN RES, V145, P109, DOI 10.1016/S0079-6123(03)45007-3; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; DAY M, 2006, IN PRESS BIOCH PHARM; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Gabbott PLA, 1997, J COMP NEUROL, V377, P465, DOI 10.1002/(SICI)1096-9861(19970127)377:4<465::AID-CNE1>3.0.CO;2-0; Ge SY, 2005, J NEUROSCI, V25, P6084, DOI 10.1523/JNEUROSCI.0542-05.2005; Gioanni Y, 1999, EUR J NEUROSCI, V11, P18, DOI 10.1046/j.1460-9568.1999.00403.x; GRANON S, 1995, PSYCHOPHARMACOLOGY, V119, P139, DOI 10.1007/BF02246154; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Gulledge AT, 2003, J NEUROSCI, V23, P11363; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Helmchen F, 2002, TRENDS NEUROSCI, V25, P438, DOI 10.1016/S0166-2236(02)02232-4; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L; Laroche S, 2000, HIPPOCAMPUS, V10, P438; LEVIN ED, 1992, PSYCHOPHARMACOLOGY, V108, P417, DOI 10.1007/BF02247415; Levin ED, 2005, PSYCHOPHARMACOLOGY B, V184, P523, DOI DOI 10.1007/S00213-005-0164-7; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2006, PSYCHOPHARMACOLOGY, V184, P292, DOI 10.1007/s00213-005-0070-z; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; McGehee DS, 1996, CURR OPIN NEUROBIOL, V6, P342, DOI 10.1016/S0959-4388(96)80118-8; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Meredith RM, 2003, J NEUROSCI, V23, P11142, DOI 10.1523/jneurosci.23-35-11142.2003; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Mirza NR, 1998, PSYCHOPHARMACOLOGY, V138, P266, DOI 10.1007/s002130050671; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Newhouse P, 2004, CURR TOP MED CHEM, V4, P267, DOI 10.2174/1568026043451401; Newhouse PA, 2004, CURR OPIN PHARMACOL, V4, P36, DOI 10.1016/j.coph.2003.11.001; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Picciotto MR, 2002, J NEUROBIOL, V53, P641, DOI 10.1002/neu.10102; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; VIDAL C, 1993, NEUROSCIENCE, V56, P23, DOI 10.1016/0306-4522(93)90558-W; VIDAL C, 1989, NEUROSCIENCE, V29, P261, DOI 10.1016/0306-4522(89)90056-0; Wonnacott S, 2000, EUR J PHARMACOL, V393, P51, DOI 10.1016/S0014-2999(00)00005-4; Wonnacott S, 2005, CURR OPIN PHARMACOL, V5, P53, DOI 10.1016/j.coph.2004.12.002; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Yang CR, 1996, J NEUROSCI, V16, P1904; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	66	181	183	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					73	87		10.1016/j.neuron.2007.03.006	http://dx.doi.org/10.1016/j.neuron.2007.03.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408579	Bronze			2022-12-24	WOS:000245848400011
J	Jourdain, P; Bergersen, LH; Bhaukaurally, K; Bezzi, P; Santello, M; Domercq, M; Matute, C; Tonello, F; Gundersen, V; Volterra, A				Jourdain, Pascal; Bergersen, Linda H.; Bhaukaurally, Khaleel; Bezzi, Paola; Santello, Mirko; Domercq, Maria; Matute, Carlos; Tonello, Fiorella; Gundersen, Vidar; Volterra, Andrea			Glutamate exocytosis from astrocytes controls synaptic strength	NATURE NEUROSCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; GYRUS GRANULE CELLS; RAT HIPPOCAMPUS; NMDA RECEPTORS; DENTATE GYRUS; CALCIUM OSCILLATIONS; ENTORHINAL CORTEX; GLIAL-CELLS; IN-SITU; RELEASE	The release of transmitters from glia influences synaptic functions. The modalities and physiological functions of glial release are poorly understood. Here we show that glutamate exocytosis from astrocytes of the rat hippocampal dentate molecular layer enhances synaptic strength at excitatory synapses between perforant path afferents and granule cells. The effect is mediated by ifenprodil-sensitive NMDA ionotropic glutamate receptors and involves an increase of transmitter release at the synapse. Correspondingly, we identify NMDA receptor 2B subunits on the extrasynaptic portion of excitatory nerve terminals. The receptor distribution is spatially related to glutamate-containing synaptic-like microvesicles in the apposed astrocytic processes. This glial regulatory pathway is endogenously activated by neuronal activity-dependent stimulation of purinergic P2Y1 receptors on the astrocytes. Thus, we provide the first combined functional and ultrastructural evidence for a physiological control of synaptic activity via exocytosis of glutamate from astrocytes.	Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland; Univ Oslo, Dept Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; Univ Basque Country, Dept Neurosci, Vizcaya 48640, Spain; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; Univ Hosp, Dept Neurol, Rikshosp, N-0023 Oslo, Norway	University of Lausanne; University of Oslo; University of Oslo; University of Basque Country; University of Padua; University of Oslo; National Hospital Norway	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	andrea.volterra@unil.ch	Domercq, Maria/Z-2274-2019; Tonello, Fiorella/G-8957-2013; Matute, Carlos/N-5559-2014; Tonello, Fiorella/AAM-6737-2021; Bezzi, Paola/AAP-2440-2020; Santello, Mirko/F-9007-2014	Domercq, Maria/0000-0002-4918-9276; Tonello, Fiorella/0000-0001-8935-8938; Matute, Carlos/0000-0001-8672-711X; Tonello, Fiorella/0000-0001-8935-8938; Santello, Mirko/0000-0002-7709-4127; Volterra, Andrea/0000-0003-1069-1602; Bergersen, Linda Hildegard/0000-0002-9964-9744				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Boyer JL, 1996, MOL PHARMACOL, V50, P1323; Bushong EA, 2003, J COMP NEUROL, V462, P241, DOI 10.1002/cne.10728; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Crippa D, 2006, J PHYSIOL-LONDON, V570, P567, DOI 10.1113/jphysiol.2005.094052; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dalby NO, 2003, J NEUROPHYSIOL, V90, P786, DOI 10.1152/jn.00118.2003; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2006, J NEUROSCI, V26, P9312, DOI 10.1523/JNEUROSCI.2836-06.2006; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gundersen V, 1998, J NEUROSCI, V18, P6059; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Rossetto O, 2001, TOXICON, V39, P1151, DOI 10.1016/S0041-0101(00)00252-X; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Rusakov DA, 2002, TRENDS NEUROSCI, V25, P492, DOI 10.1016/S0166-2236(02)02230-0; RUTECKI PA, 1989, J NEUROSURG, V70, P667, DOI 10.3171/jns.1989.70.5.0667; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STALEY KJ, 1991, SYNAPSE, V9, P219, DOI 10.1002/syn.890090308; STEINHAUSER C, 1992, EUR J NEUROSCI, V4, P472, DOI 10.1111/j.1460-9568.1992.tb00897.x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; VONKUGELGEN I, 2000, N-S ARCH PHARMACOL, V352, P310; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101	50	574	593	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					331	339		10.1038/nn1849	http://dx.doi.org/10.1038/nn1849			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310248				2022-12-24	WOS:000244480300015
J	Mokeichev, A; Okun, M; Barak, O; Katz, Y; Ben-Shahar, O; Lampl, I				Mokeichev, Alik; Okun, Michael; Barak, Omri; Katz, Yonatan; Ben-Shahar, Ohad; Lampl, Ilan			Stochastic emergence of repeating cortical motifs in spontaneous membrane potential fluctuations in vivo	NEURON			English	Article							PRECISELY REPLICATING PATTERNS; NEURONAL AVALANCHES; STIMULUS DEPENDENCE; FAVORED PATTERNS; FRONTAL-CORTEX; VISUAL-CORTEX; SPIKE TRAINS; DYNAMICS; MODULATION; NETWORK	It was recently discovered that subthreshold membrane potential fluctuations of cortical neurons can precisely repeat during spontaneous activity, seconds to minutes apart, both in brain slices and in anesthetized animals. These repeats, also called cortical motifs, were suggested to reflect a replay of sequential neuronal firing patterns. We searched for motifs in spontaneous activity, recorded from the rat barrel cortex and from the cat striate cortex of anesthetized animals, and found numerous repeating patterns of high similarity and repetition rates. To test their significance, various statistics were compared between physiological data and three different types of stochastic surrogate data that preserve dynamical characteristics of the recorded data. We found no evidence for the existence of deterministically generated cortical motifs. Rather, the stochastic properties of cortical motifs suggest that they appear by chance, as a result of the constraints imposed by the coarse dynamics of subthreshold ongoing activity.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Dept Comp Sci, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem	Lampl, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ilan.lampl@weizmann.ac.il	Ben-Shahar, Ohad/F-8918-2015	Katz, Yonatan/0000-0003-1674-0508; Barak, Omri/0000-0002-7894-6344; Katz, Yonatan/0000-0002-1256-9515; Okun, Michael/0000-0002-7795-5513; Okun, Michael/0000-0002-6247-9358; Ben-Shahar, Ohad/0000-0001-5346-152X; Lampl, Ilan/0000-0002-9380-0730				ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cowan AI, 2004, J NEUROPHYSIOL, V92, P2137, DOI 10.1152/jn.01262.2003; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DAYHOFF JE, 1983, J NEUROPHYSIOL, V49, P1334, DOI 10.1152/jn.1983.49.6.1334; DAYHOFF JE, 1983, J NEUROPHYSIOL, V49, P1349, DOI 10.1152/jn.1983.49.6.1349; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; GRAY CM, 1992, VISUAL NEUROSCI, V8, P337, DOI 10.1017/S0952523800005071; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Katz Y, 2006, J NEUROSCI, V26, P13363, DOI 10.1523/JNEUROSCI.4056-06.2006; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Lestienne R, 1998, NEUROSCIENCE, V82, P315; LESTIENNE R, 1987, BRAIN RES, V437, P214, DOI 10.1016/0006-8993(87)91638-6; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Richard V, 1990, Rev Med Brux, V11, P64; Richmond BJ, 1999, NEURAL PLAST, V6, P133, DOI 10.1155/NP.1999.133; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Victor JD, 1998, J NEUROPHYSIOL, V80, P554, DOI 10.1152/jn.1998.80.2.554; Wilson CJ, 1996, J NEUROSCI, V16, P2397	47	71	74	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					413	425		10.1016/j.neuron.2007.01.017	http://dx.doi.org/10.1016/j.neuron.2007.01.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270737	Bronze			2022-12-24	WOS:000245126800011
J	Ray, A; van Naters, WVG; Shiraiwa, T; Carlson, JR				Ray, Anandasankar; van Naters, Wynand van der Goes; Shiraiwa, Takashi; Carlson, John R.			Mechanisms of odor receptor gene choice in Drosophila	NEURON			English	Article							OLFACTORY SENSORY NEURONS; TASTE RECEPTORS; MAXILLARY PALP; PRONEURAL GENE; AXON GUIDANCE; CELL FATES; ANTENNA; SYSTEM; EXPRESSION; LOZENGE	A remarkable problem in neurobiology is how olfactory receptor neurons (ORNs) select, from among a large odor receptor repertoire, which receptors to express. We use computational algorithms and mutational analysis to define positive and negative regulatory elements that are required for selection of odor receptor (Or) genes in the proper olfactory organ of Drosophila, and we identify an element that is essential for selection in one ORN class. Two odor receptors are coexpressed by virtue of the alternative splicing of a single gene, and we identify dicistronic m1RNAs that each encode two receptors. Systematic analysis reveals no evidence for negative feedback regulation, but provides evidence that the choices made by neighboring ORNs of a sensillum are coordinated via the asymmetric segregation of regulatory factors from a common progenitor. We show that receptor gene choice in Drosophila also depends on a combinatorial code of transcription factors to generate the receptor-to-neuron map.	Yale Univ, Dept Mol Cellular & Anim Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Anim Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	Ray, Anandasankar/0000-0003-4133-2581; van der Goes van Naters, Wynand/0000-0002-6808-0161	NIDCD NIH HHS [R01 DC004729-03, R01 DC004729, R01 DC002174, R01 DC002174-20, R01 DC002174-21, R01 DC004729-07, DC04729, R01 DC004729-04, R01 DC002174-19, R01 DC002174-22, R01 DC002174-18A1, R01 DC004729-05, R01 DC004729-06, DC02174] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174, R01DC004729] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERGMAN C, 2002, GENOME BIOL, V3; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1998, DEV BIOL, V203, P400, DOI 10.1006/dbio.1998.9064; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Maier D, 2002, P NATL ACAD SCI USA, V99, P15480, DOI 10.1073/pnas.242596699; Melkman T, 2004, DEV BIOL, V265, P302, DOI 10.1016/j.ydbio.2003.07.005; MISRA S, 2002, GENOME BIOL, V3; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; RiesgoEscovar JR, 1997, J COMP PHYSIOL A, V180, P143, DOI 10.1007/s003590050035; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Schuldt AJ, 1999, DEV BIOL, V205, P287, DOI 10.1006/dbio.1998.9014; Sen A, 2003, DEV BIOL, V254, P79, DOI 10.1016/S0012-1606(02)00021-0; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; STOCKER RF, 1993, J NEUROGENET, V9, P29, DOI 10.3109/01677069309167274; van Heiden J, 2000, NUCLEIC ACIDS RES, V28, P1808, DOI 10.1093/nar/28.8.1808; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yedvobnick B, 2004, GENETICS, V166, P1281, DOI 10.1534/genetics.166.3.1281	53	83	86	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					353	369		10.1016/j.neuron.2006.12.010	http://dx.doi.org/10.1016/j.neuron.2006.12.010			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270733	Green Accepted, Bronze			2022-12-24	WOS:000245126800007
J	Williams, ME; Lu, XW; McKenna, WL; Washington, R; Boyette, A; Strickland, P; Dillon, A; Kaprielian, Z; Tessier-Lavigne, M; Hinck, L				Williams, Megan E.; Lu, Xiaowei; McKenna, William L.; Washington, Raesha; Boyette, Adam; Strickland, Phyllis; Dillon, Allison; Kaprielian, Zaven; Tessier-Lavigne, Marc; Hinck, Lindsay			UNC5A promotes neuronal apoptosis during spinal cord development independent of netrin-1	NATURE NEUROSCIENCE			English	Article							CELL-DEATH; INTERACTING PROTEIN; RECEPTORS; EXPRESSION; MECHANISM; HOMOLOG; NRAGE; DCC	In addition to their role as chemorepellent netrin-1 receptors, UNC5 proteins may mediate cell death because they induce apoptosis in cultured cells. To test this in vivo, we generated Unc5a (formerly Unc5h1) knockout mice and found that this deletion decreased apoptosis and increased the number of neurons in the spinal cord. In contrast, loss of netrin-1 (Ntn1) did not affect the amount of apoptosis, suggesting that NTN1 is not required for neuronal apoptosis in vivo.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Roche Holding; Genentech	Hinck, L (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	hinck@biology.ucsc.edu		Hinck, Lindsay/0000-0002-4009-3913; Kaprielian, Zaven/0000-0003-3364-3806; Williams, Megan/0000-0002-5461-4126	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039572] Funding Source: NIH RePORTER; NIMH NIH HHS [MH12813] Funding Source: Medline; NINDS NIH HHS [NS39572, R01 NS039572] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dillon AK, 2005, J NEUROSCI, V25, P10119, DOI 10.1523/JNEUROSCI.3455-05.2005; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang H, 1999, J NEUROSCI, V19, P4938; Williams ME, 2003, J NEUROSCI, V23, P11279; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200	14	45	47	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					996	998		10.1038/nn1736	http://dx.doi.org/10.1038/nn1736			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16829956				2022-12-24	WOS:000240080300008
J	Yano, H; Ninan, I; Zhang, H; Milner, TA; Arancio, O; Chao, MV				Yano, Hiroko; Ninan, Ipe; Zhang, Hong; Milner, Teresa A.; Arancio, Ottavio; Chao, Moses V.			BDNF-mediated neurotransmission relies upon a myosin VI motor complex	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; TRKB RECEPTORS; KNOCKOUT MICE; PROTEIN; TRANSPORT; RELEASE; ROLES	Brain-derived neurotrophic factor (BDNF) has been implicated in higher-order cognitive functions and in psychiatric disorders such as depression and schizophrenia. BDNF modulates synaptic transmission and plasticity primarily through the TrkB receptor, but the molecules involved in BDNF-mediated synaptic modulation are largely unknown. Myosin VI (Myo6) is a minus end directed actin-based motor found in neurons that express Trk receptors. Here we report that Myo6 and a Myo6-binding protein, GIPC1, form a complex that can engage TrkB. Myo6 and GIPC1 were necessary for BDNF-TrkB-mediated facilitation of long-term potentiation in postnatal day 12-13 (P12-13) hippocampus. Moreover, BDNF-mediated enhancement of glutamate release from presynaptic terminals depended not only upon TrkB but also upon Myo6 and GIPC1. Similar defects in basal synaptic transmission as well as presynaptic properties were observed in Myo6 and GIPC1 mutant mice. Together, these results define an important role for the Myo6-GIPC1 motor complex in presynaptic function and in BDNF-TrkB-mediated synaptic plasticity.	NYU, Sch Med, Skirball Inst Biomol Med,Mol Neurobiol Program, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med,Mol Neurobiol Program, Dept Physiol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med,Mol Neurobiol Program, Dept Neurosci, New York, NY 10016 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	New York University; New York University; New York University; Columbia University; Columbia University; Cornell University	Chao, MV (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med,Mol Neurobiol Program, Dept Cell Biol, 540 1St Ave, New York, NY 10016 USA.	chao@saturn.med.nyu.edu	arancio, ottavio/AAB-7959-2019	Ninan, Ipe/0000-0001-9774-6455; Chao, Moses/0000-0002-6969-3744; arancio, ottavio/0000-0001-6335-164X	NHLBI NIH HHS [HL-18974] Funding Source: Medline; NICHD NIH HHS [HD23315] Funding Source: Medline; NIDA NIH HHS [DA08259] Funding Source: Medline; NINDS NIH HHS [NS21072, NS40045] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040045, R01NS021072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bridgman PC, 2004, J NEUROBIOL, V58, P164, DOI 10.1002/neu.10320; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; DePina AS, 1999, MICROSC RES TECHNIQ, V47, P93, DOI 10.1002/(SICI)1097-0029(19991015)47:2<93::AID-JEMT2>3.0.CO;2-P; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Drake CT, 1999, J NEUROSCI, V19, P8009; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Evans LL, 1998, J CELL SCI, V111, P2055; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Purcell AL, 2003, TRENDS NEUROSCI, V26, P625, DOI 10.1016/j.tins.2003.09.005; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Roberts R, 2004, PHILOS T R SOC B, V359, P1931, DOI 10.1098/rstb.2004.1563; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tyler WJ, 2002, NEUROSCIENTIST, V8, P524, DOI 10.1177/1073858402238511; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Wu HJ, 2002, J BIOL CHEM, V277, P30928, DOI 10.1074/jbc.M203735200; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	48	106	109	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2006	9	8					1009	1018		10.1038/nn1730	http://dx.doi.org/10.1038/nn1730			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078CZ	16819522				2022-12-24	WOS:000240080300013
J	Goldfarb, M; Schoorlemmer, J; Williams, A; Diwakar, S; Wang, C; Huan, X; Giza, J; Tchetchik, D; Kelley, K; Vega, A; Matthews, G; Rossi, P; Ornitz, DM; D'Angelo, E				Goldfarb, Mitchell; Schoorlemmer, Jon; Williams, Anthony; Diwakar, Shyam; Wang, Cling; Huan, Xiao; Giza, Joanna; Tchetchik, Dafna; Kelley, Kevin; Vega, Ana; Matthews, Gary; Rossi, Paola; Ornitz, David M.; D'Angelo, Egidio			Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels	NEURON			English	Article							CEREBELLAR GRANULE CELLS; INACTIVATION GATE; PURKINJE NEURONS; NERVOUS-SYSTEM; NA(V)1.6; MUTATION; SEGMENT; FIBROBLAST-GROWTH-FACTOR-14; EXPRESSION; PERSISTENT	Neurons integrate and encode complex synaptic inputs into action potential outputs through a process termed "intrinsic excitability." Here, we report the essential contribution of fibroblast growth factor homologous factors (FHFs), a family of voltage-gated sodium channel binding proteins, to this process. Fhf1(-/-)Fhf4(-/-) mice suffer from severe ataxia and other neurological deficits. In mouse cerebellar slice recordings, WT granule neurons can be induced to fire action potentials repetitively (similar to 60 Hz), whereas Fhf1(-/-)Fhf4(-/-) neurons often fire only once and at an elevated voltage spike threshold. Sodium channels in Fhf1(-/-)Fhf4(-/-) granule neurons inactivate at more negative membrane potential, inactivate more rapidly, and are slower to recover from the inactivated state. Altered sodium channel physiology is sufficient to explain excitation deficits, as tested in a granule cell computer model. These findings offer a physiological mechanism underlying human spinocerebellar ataxia induced by Fhf4 mutation and suggest a broad role for FHFs in the control of excitability throughout the CNS.	CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; Mt Sinai Sch Med, Dept Mol Cell & Dev Biol, New York, NY 10029 USA; Univ Pavia, Dept Pharmacol & Physiol Sci, I-27100 Pavia, Italy; Univ Milan, Dept Math, Milan, Italy; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	City University of New York (CUNY) System; Hunter College (CUNY); Icahn School of Medicine at Mount Sinai; University of Pavia; University of Milan; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goldfarb, M (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	goldfarb@genectr.hunter.cuny.edu	Vega, Ana/M-1769-2019; Schoorlemmer, Jon/R-6814-2019; D'Angelo, Egidio/AAC-3846-2022; Diwakar, Shyam/C-2455-2015; Vega, Ana V/B-3226-2015	Vega, Ana/0000-0002-2178-2780; Schoorlemmer, Jon/0000-0001-6933-0567; D'Angelo, Egidio/0000-0002-6007-7187; Diwakar, Shyam/0000-0003-1546-0184; Vega, Ana V/0000-0002-2178-2780; Ornitz, David/0000-0003-1592-7629; ROSSI, Paola/0000-0002-1134-4111	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039906] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS039906-07, R01-NS39906, R01 NS039906] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern CA, 2005, CIRC RES, V96, P991, DOI 10.1161/01.RES.0000166324.00524.dd; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; ECCLES JC, 1967, EXP BRAIN RES, V3, P58; Gall D, 2003, J NEUROSCI, V23, P9320; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Magistretti J, 2006, J PHYSIOL-LONDON, V573, P83, DOI 10.1113/jphysiol.2006.106682; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ornitz DM, 2001, GENOME BIOL, V2; Osorio N, 2005, J PHYSIOL-LONDON, V569, P801, DOI 10.1113/jphysiol.2005.097022; PATTON DE, 1993, NEURON, V11, P967; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; PATTON DE, 1994, J BIOL CHEM, V269, P17649; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wittmack EK, 2005, J NEUROSCI, V25, P6621, DOI 10.1523/JNEUROSCI.0541-05.2005; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014	47	176	184	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2007	55	3					449	463		10.1016/j.neuron.2007.07.006	http://dx.doi.org/10.1016/j.neuron.2007.07.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	199QT	17678857	Bronze, Green Accepted			2022-12-24	WOS:000248711000012
J	Mazzuca, M; Heurteaux, C; Alloui, A; Diochot, S; Baron, A; Voilley, N; Blondeau, N; Escoubas, P; Gelot, A; Cupo, A; Zimmer, A; Zimmer, AM; Eschalier, A; Lazdunski, M				Mazzuca, Michel; Heurteaux, Catherine; Alloui, Abdelkrim; Diochot, Sylvie; Baron, Anne; Voilley, Nicolas; Blondeau, Nicolas; Escoubas, Pierre; Gelot, Agnes; Cupo, Anny; Zimmer, Andreas; Zimmer, Anne M.; Eschalier, Alain; Lazdunski, Michel			A tarantula peptide against pain via ASIC1a channels and opioid mechanisms	NATURE NEUROSCIENCE			English	Article								Psalmotoxin 1, a peptide extracted from the South American tarantula Psalmopoeus cambridgei, has very potent analgesic properties against thermal, mechanical, chemical, inflammatory and neuropathic pain in rodents. It exerts its action by blocking acid-sensing ion channel 1a, and this blockade results in an activation of the endogenous enkephalin pathway. The analgesic properties of the peptide are suppressed by antagonists of the mu and delta-opioid receptors and are lost in Penk1(-/-) mice.	Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, Inst Paul Hamel, F-06560 Valbonne, France; CHU, Fac Med, INSERM, Unite Mixte Rech 766, Clermont Ferrand, France; Univ Bonn, Dept Mol Psychiat, D-53105 Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bonn	Lazdunski, M (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, Inst Paul Hamel, 660 Route Lucioles, F-06560 Valbonne, France.	ipmc@ipmc.cnrs.fr	Blondeau, Nicolas/T-1136-2019; Blondeau, Nicolas P/M-5002-2016; ESCHALIER, Alain/L-9957-2015; Zimmer, Andreas/B-8357-2009; BARON, Anne/N-5691-2016; HEURTEAUX, Catherine/M-4947-2016; Diochot, Sylvie/ABG-5495-2020	Blondeau, Nicolas P/0000-0001-5954-4094; BARON, Anne/0000-0002-8026-6380; HEURTEAUX, Catherine/0000-0002-9741-9777; 				Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Ettaiche M, 2006, J NEUROSCI, V26, P5800, DOI 10.1523/JNEUROSCI.0344-06.2006; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mamet J, 2002, J NEUROSCI, V22, P10662; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Sluka KA, 2007, PAIN, V129, P102, DOI 10.1016/j.pain.2006.09.038; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wood J N, 2007, Handb Exp Pharmacol, P329	15	195	204	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					943	945		10.1038/nn1940	http://dx.doi.org/10.1038/nn1940			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17632507				2022-12-24	WOS:000248357500006
J	Chihara, T; Luginbuhl, D; Luo, L				Chihara, Takahiro; Luginbuhl, David; Luo, Liqun			Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization	NATURE NEUROSCIENCE			English	Article							TRANSFER-RNA SYNTHETASE; MARIE-TOOTH-DISEASE; SACCHAROMYCES-CEREVISIAE; OLFACTORY MAP; GENE MUTATION; DROSOPHILA; MORPHOGENESIS; NEURONS; REPRESENTATION; NEUROPATHY	We identified a mutation in Aats-gly (also known as gars or glycyl-tRNA synthetase), the Drosophila melanogaster ortholog of the human GARS gene that is associated with Charcot-Marie-Tooth neuropathy type 2D (CMT2D), from a mosaic genetic screen. Loss of gars in Drosophila neurons preferentially affects the elaboration and stability of terminal arborization of axons and dendrites. The human and Drosophila genes each encode both a cytoplasmic and a mitochondrial isoform. Using additional mutants that selectively disrupt cytoplasmic or mitochondrial protein translation, we found that cytoplasmic protein translation is required for terminal arborization of both dendrites and axons during development. In contrast, disruption of mitochondrial protein translation preferentially affects the maintenance of dendritic arborization in adults. We also provide evidence that human GARS shows equivalent functions in Drosophila, and that CMT2D causal mutations show loss-of-function properties. Our study highlights different demands of protein translation for the development and maintenance of axons and dendrites.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo 1130033, Japan	Howard Hughes Medical Institute; Stanford University; University of Tokyo	Luo, L (corresponding author), Stanford Univ, Howard Hughes Med Inst, 385 Serra Mall, Stanford, CA 94305 USA.	lluo@stanford.edu	Chihara, Takahiro/G-7639-2019	Chihara, Takahiro/0000-0001-9989-3619; Luo, Liqun/0000-0001-5467-9264	NIDCD NIH HHS [R01-DC005982, R01 DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Mudge SJ, 1998, GENE, V209, P45, DOI 10.1016/S0378-1119(98)00007-9; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Overly CC, 1996, J CELL SCI, V109, P971; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Seshaiah P, 1999, MOL BIOL CELL, V10, P1595, DOI 10.1091/mbc.10.5.1595; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Shy ME, 2004, CURR OPIN NEUROL, V17, P579, DOI 10.1097/00019052-200410000-00008; Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Toivonen JM, 2001, GENETICS, V159, P241; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100	48	83	85	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					828	837		10.1038/nn1910	http://dx.doi.org/10.1038/nn1910			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17529987				2022-12-24	WOS:000247560200012
J	Chubykin, AA; Atasoy, D; Etherton, MR; Brose, N; Kavalali, ET; Gibson, JR; Sudhof, TC				Chubykin, Alexander A.; Atasoy, Deniz; Etherton, Mark R.; Brose, Nils; Kavalali, Ege T.; Gibson, Jay R.; Suedhof, Thomas C.			Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2	NEURON			English	Article							NMDA RECEPTOR SUBUNITS; CELL-ADHESION MOLECULE; ALPHA-NEUREXINS; SILENT SYNAPSES; BETA-NEUREXINS; PSD-95; AUTISM; TRANSMISSION; MUTATION; BINDING	Neuroligins enhance synapse formation in vitro, but surprisingly are not required for the generation of synapses in vivo. We now show that in cultured neurons, neuroligin-1 overexpression increases excitatory, but not inhibitory, synaptic responses, and potentiates synaptic NMDAR/AMPAR ratios. In contrast, neuroligin-2 overexpression increases inhibitory, but not excitatory, synaptic responses. Accordingly, deletion of neuroligin-1 in knockout mice selectively decreases the NMDAR/AMPAR ratio, whereas deletion of neuroligin-2 selectively decreases inhibitory synaptic responses. Strikingly, chronic inhibition of NMDARs or CaM-Kinase 11, which signals downstream of NMDARs, suppresses the synapse-boosting activity of neuroligin-1, whereas chronic inhibition of general synaptic activity suppresses the synapse-boosting activity of neuroligin-2. Taken together, these data indicate that neuroligins do not establish, but specify and validate, synapses via an activity-dependent mechanism, with different neuroligins acting on distinct types of synapses. This hypothesis reconciles the overexpression and knockout phenotypes and suggests that neuroligins contribute to the use-dependent formation of neural circuits.	Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Atasoy, Deniz/AAR-7917-2020; Atasoy, Deniz/B-3414-2018	Atasoy, Deniz/0000-0002-3325-8820; Chubykin, Alexander/0000-0001-8224-9296	NIMH NIH HHS [R01 MH069585, R01 MH069585-04, R37 MH052804, R37 MH52804-08] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804, R01MH069585] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Cantallops I, 2000, CURR BIOL, V10, pR620, DOI 10.1016/S0960-9822(00)00663-1; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gomperts SN, 2000, J NEUROSCI, V20, P2229; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hussain NK, 2005, SCIENCE, V307, P1207, DOI 10.1126/science.1110011; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Levinson JN, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-12; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Niethammer M, 1996, J NEUROSCI, V16, P2157; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	422	438	0	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 21	2007	54	6					919	931		10.1016/j.neuron.2007.05.029	http://dx.doi.org/10.1016/j.neuron.2007.05.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184MK	17582332	Green Accepted, Bronze			2022-12-24	WOS:000247645600011
J	Tanaka, K; Khiroug, L; Santamaria, F; Doi, T; Ogasawara, H; Ellis-Davies, GCR; Kawato, M; Augustine, GJ				Tanaka, Keiko; Khiroug, Leonard; Santamaria, Fidel; Doi, Tomokazu; Ogasawara, Hideaki; Ellis-Davies, Graham C. R.; Kawato, Mitsuo; Augustine, George J.			Ca2+ requirements for cerebellar long-term synaptic depression: Role for a postsynaptic leaky integrator	NEURON			English	Article							PROTEIN-KINASE-C; CALCIUM TRANSIENTS; CLIMBING FIBER; PURKINJE-CELLS; NITRIC-OXIDE; SIGNAL-TRANSDUCTION; PARALLEL FIBERS; POTENTIATION; INDUCTION; LTD	Photolysis of a caged Ca2+ compound was used to characterize the dependence of cerebellar long-term synaptic depression (LTD) on postsynaptic Ca2+ concentration ([Ca2+](i)). Elevating [Ca2+](i) was sufficient to induce LTD without requiring any of the other signals produced by synaptic activity. A sigmoidal relationship between [Ca2+](i) and LTD indicated a highly cooperative triggering of LTD by Ca2+. The duration of the rise in [Ca2+](i) influenced the apparent Ca2+ affinity of LTD, and this time-dependent behavior could be described by a leaky integrator process with a time constant of 0.6 s. A computational model, based on a positive-feedback cycle that includes protein kinase C and MAP kinase, was capable of simulating these properties of Ca2+-triggered LTD. Disrupting this cycle experimentally also produced the predicted changes in the Ca2+ dependence of LTD. We conclude that LTD arises from a mechanism that integrates postsynaptic Ca2+ signals and that this integration may be produced by the positive-feed back cycle.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA 19102 USA; ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto 6190288, Japan; Natl Inst Informat & Commun Technol, Kyoto 6190288, Japan	Duke University; University of Helsinki; Drexel University; National Institute of Information & Communications Technology (NICT) - Japan	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	georgea@neuro.duke.edu	Augustine, George James/J-9228-2013; Ogasawara, Hideaki/B-9526-2008; Santamaria, Fidel/H-4721-2019; Santamaria, Fidel/I-2544-2012	Ogasawara, Hideaki/0000-0003-4593-2891; Santamaria, Fidel/0000-0001-8750-2932; Santamaria, Fidel/0000-0001-8750-2932; Tanaka-Yamamoto, Keiko/0000-0002-1246-9784	NIGMS NIH HHS [GM-65473, R01 GM053395, GM-53395, R01 GM053395-12] Funding Source: Medline; NINDS NIH HHS [NS-34045] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395, R24GM065473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034045] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bastianetto S, 2000, J NEUROCHEM, V74, P2268, DOI 10.1046/j.1471-4159.2000.0742268.x; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; Eilers J, 1997, LEARN MEMORY, V4, P159, DOI 10.1101/lm.4.1.159; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; Eilers J, 1996, CELL CALCIUM, V20, P215, DOI 10.1016/S0143-4160(96)90108-6; Ellis-Davies GCR, 1998, TETRAHEDRON LETT, V39, P953, DOI 10.1016/S0040-4039(97)10668-2; Ellis-Davies GCR, 2006, CELL CALCIUM, V39, P75, DOI 10.1016/j.ceca.2005.10.003; Ellis-Davies GCR, 2003, METHOD ENZYMOL, V360, P226; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FOHLMEISTER JF, 1977, J GEN PHYSIOL, V69, P815, DOI 10.1085/jgp.69.6.815; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Hartell Nicholas A, 2002, Cerebellum, V1, P3, DOI 10.1080/147342202753203041; Hernjak N, 2005, BIOPHYS J, V89, P3790, DOI 10.1529/biophysj.105.065771; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; KARACHOT L, 1994, NEUROSCI RES, V21, P161, DOI 10.1016/0168-0102(94)90158-9; KASONO K, 1994, NEUROREPORT, V6, P17, DOI 10.1097/00001756-199412300-00006; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; KOHLER T, 1992, BIOCHEM PHARMACOL, V44, P805, DOI 10.1016/0006-2952(92)90419-J; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Kuroda S, 2001, J NEUROSCI, V21, P5693, DOI 10.1523/JNEUROSCI.21-15-05693.2001; Launey T, 2004, P NATL ACAD SCI USA, V101, P676, DOI 10.1073/pnas.0302914101; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; Matsumoto M, 2000, INORG REACT MECH, V2, P19; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Morgan JR, 2000, J NEUROSCI, V20, P8667; Namiki S, 2005, J PHYSIOL-LONDON, V566, P849, DOI 10.1113/jphysiol.2005.088799; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ogasawara H, 2007, PLOS COMPUT BIOL, V3, P49, DOI 10.1371/journal.pcbi.0020179; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Reynolds T, 2001, NEUROREPORT, V12, P133, DOI 10.1097/00001756-200101220-00034; Reynolds T, 2000, J PHYSIOL-LONDON, V527, P563, DOI 10.1111/j.1469-7793.2000.00563.x; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Santamaria F, 2006, NEURON, V52, P635, DOI 10.1016/j.neuron.2006.10.025; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Sepulveda MR, 2004, EUR J NEUROSCI, V19, P542, DOI 10.1111/j.0953-816X.2003.03156.x; SHENOLIKAR S, 1986, J CYCLIC NUCL PROT, V11, P531; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	74	82	82	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 7	2007	54	5					787	800		10.1016/j.neuron.2007.05.014	http://dx.doi.org/10.1016/j.neuron.2007.05.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553426	Bronze			2022-12-24	WOS:000247329900011
J	Davis, RL				Davis, Ronald L.			The scent of Drosophila sex	NEURON			English	Editorial Material							PHEROMONE; ORGANIZATION; RESPONSES; NEURONS; BRAIN	Three recent studies report on the olfactory mechanisms used for gender identification in Drosophila and on the olfactory receptors stimulated by the pheromone 11-cis-vaccenyl acetate. This pheromone activates specific olfactory receptors that suppress the courtship of males with other males, promote the sexual receptivity of females, and participate in the formation of memories about prior courtship experiences.	Baylor Coll Med, Dept Mol & Cellular Biol, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608				Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	11	5	5	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					14	16		10.1016/j.neuron.2007.03.012	http://dx.doi.org/10.1016/j.neuron.2007.03.012			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408574	Bronze			2022-12-24	WOS:000245848400006
J	Olsen, SR; Bhandawat, V; Wilson, RI				Olsen, Shawn R.; Bhandawat, Vikas; Wilson, Rachel I.			Excitatory interactions between olfactory processing channels in the Drosophila antennal lobe	NEURON			English	Article							PRESYNAPTIC INHIBITION; PERIPLANETA-AMERICANA; BULB GLOMERULI; NEURONS; SYSTEM; MELANOGASTER; MECHANISMS; GABA; FLY; REPRESENTATIONS	Each odorant receptor gene defines a unique type of olfactory receptor neuron (ORN) and a corresponding type of second-order neuron. Because each odor can activate multiple ORN types, information must ultimately be integrated across these processing channels to form a unified percept. Here, we show that, in Drosophila, integration begins at the level of second-order projection neurons (PNs). We genetically silence all the ORNs that normally express a particular odorant receptor and find that PNs postsynaptic to the silent glomerulus receive substantial lateral excitatory input from other glomeruli. Genetically confining odor-evoked ORN input to just one glomerulus reveals that most PNs postsynaptic to other glomeruli receive indirect excitatory input from the single ORN type that is active. Lateral connections between identified glomeruli vary in strength, and this pattern of connections is stereotyped across flies. Thus, a dense network of lateral connections distributes odor-evoked excitation between channels in the first brain region of the olfactory processing stream.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266; Olsen, Shawn/0000-0002-9568-7057	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER; NIDCD NIH HHS [1R01DC008174-01, R01 DC008174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; BUCK LB, 1996, NEUROSCIENCE, V19, P517; Christensen TA, 1998, J NEUROSCI, V18, P5999; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; ERNST KD, 1983, CELL TISSUE RES, V229, P1, DOI 10.1007/BF00217877; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; HOSKINS SG, 1986, CELL TISSUE RES, V244, P243; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leitch B, 1996, J COMP NEUROL, V372, P487; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MALUN D, 1991, HISTOCHEMISTRY, V96, P197, DOI 10.1007/BF00271538; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Python F, 2002, J COMP NEUROL, V453, P157, DOI 10.1002/cne.10383; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2002, MICROSC RES TECHNIQ, V58, P365, DOI 10.1002/jemt.10144; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	42	198	202	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					89	103		10.1016/j.neuron.2007.03.010	http://dx.doi.org/10.1016/j.neuron.2007.03.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408580	Green Accepted, Bronze			2022-12-24	WOS:000245848400012
J	Steuber, V; Mittmann, W; Hoebeek, FE; Silver, RA; De Zeeuw, CI; Hausser, M; De Schutter, E				Steuber, Volker; Mittmann, Wolfgang; Hoebeek, Freek E.; Silver, R. Angus; De Zeeuw, Chris I.; Hausser, Michael; De Schutter, Erik			Cerebellar LTD and pattern recognition by Purkinje cells	NEURON			English	Article							LONG-TERM DEPRESSION; ACTIVE MEMBRANE MODEL; KINASE-C INHIBITOR; PARALLEL FIBER LTD; BIDIRECTIONAL PLASTICITY; SYNAPTIC CURRENTS; GRANULE CELL; SIMPLE SPIKE; RAT; NEURONS	Many theories of cerebellar function assume that long-term depression (LTD) of parallel fiber (PF) synapses enables Purkinje cells to learn to recognize PF activity patterns. We have studied the LTD-based recognition of PF patterns in a biophysically realistic Purkinje-cell model. With simple-spike firing as observed in vivo, the presentation of a pattern resulted in a burst of spikes followed by a pause. Surprisingly, the best criterion to distinguish learned patterns was the duration of this pause. Moreover, our simulations predicted that learned patterns elicited shorter pauses, thus increasing Purkinje-cell output. We tested this prediction in Purkinje-cell recordings both in vitro and in vivo. In vitro, we found a shortening of pauses when decreasing the number of active PFs or after inducing LTD. In vivo, we observed longer pauses in LTD-deficient mice. Our results suggest a novel form of neural coding in the cerebellar cortex.	Univ Antwerp, Lab Theoret Neurobiol, B-2610 Antwerp, Belgium; UCL, Dept Physiol, London WC1E 6BT, England; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Royal Acad Sci, KNAW, NIN, NL-1105 BA Amsterdam, Netherlands; Okinawa Inst Sci & Technol, Computat Neurosci Unit, Okinawa 9040411, Japan	University of Antwerp; University of London; University College London; University of London; University College London; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Okinawa Institute of Science & Technology Graduate University	Steuber, V (corresponding author), Univ Antwerp, Lab Theoret Neurobiol, B-2610 Antwerp, Belgium.	v.steuber@herts.ca.uk	Hausser, Michael/AAW-6827-2020; De Schutter, Erik/G-8460-2011	Hausser, Michael/0000-0002-2673-8957; De Schutter, Erik/0000-0001-8618-5138; Silver, Robin/0000-0002-5480-6638; Steuber, Volker/0000-0003-0186-3580	Medical Research Council [G0400598] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0400598] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Bower JM, 1998, BOOK GENESIS EXPLORI; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Cingolani LA, 2002, J NEUROSCI, V22, P4456, DOI 10.1523/JNEUROSCI.22-11-04456.2002; Cohen D, 2000, J NEUROPHYSIOL, V83, P1932, DOI 10.1152/jn.2000.83.4.1932; Czubayko U, 2001, J NEUROPHYSIOL, V85, P2017, DOI 10.1152/jn.2001.85.5.2017; DAYAN P, 1991, BIOL CYBERN, V65, P253, DOI 10.1007/BF00206223; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DESCHUTTER E, 1994, P NATL ACAD SCI USA, V91, P4736, DOI 10.1073/pnas.91.11.4736; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; Eccles JC, 1967, CEREBELLUM NEURONAL; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Etzion Y, 1998, EXP BRAIN RES, V122, P283, DOI 10.1007/s002210050516; FOX EA, 1993, NEUROSCI LETT, V149, P103, DOI 10.1016/0304-3940(93)90358-R; GARDETTE R, 1985, DEV BRAIN RES, V19, P47, DOI 10.1016/0165-3806(85)90230-5; GILBERT PFC, 1974, BRAIN RES, V70, P1, DOI 10.1016/0006-8993(74)90208-X; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Graham BP, 2001, NETWORK-COMP NEURAL, V12, P473, DOI 10.1088/0954-898X/12/4/304; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; ITO M, 1982, J PHYSL, V324, P133; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Kreitzer AC, 2000, J NEUROSCI, V20, P1348; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Monsivais P, 2005, J NEUROSCI, V25, P464, DOI 10.1523/JNEUROSCI.3871-04.2005; MOUGINOT D, 1995, NEUROSCIENCE, V64, P699, DOI 10.1016/0306-4522(94)00456-F; MURI R, 1994, J NEUROPHYSIOL, V71, P420, DOI 10.1152/jn.1994.71.1.420; MURPHY JT, 1970, BRAIN RES, V17, P515, DOI 10.1016/0006-8993(70)90259-3; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Schweighofer N, 2000, P NATL ACAD SCI USA, V97, P10661, DOI 10.1073/pnas.97.19.10661; Shin SL, 2007, EUR J NEUROSCI, V25, P785, DOI 10.1111/j.1460-9568.2007.05308.x; Shin SL, 2006, J NEUROPHYSIOL, V96, P3485, DOI 10.1152/jn.00570.2006; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Solinas SMG, 2006, EUR J NEUROSCI, V23, P1207, DOI 10.1111/j.1460-9568.2005.04564.x; Steuber V, 2001, NEUROCOMPUTING, V38, P383, DOI 10.1016/S0925-2312(01)00458-1; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sultan F, 1998, J COMP NEUROL, V393, P353; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677; Walter JT, 2006, J NEUROSCI, V26, P12861, DOI 10.1523/JNEUROSCI.4507-05.2006; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Womack MD, 2003, J NEUROSCI, V23, P2600; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	81	115	118	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					121	136		10.1016/j.neuron.2007.03.015	http://dx.doi.org/10.1016/j.neuron.2007.03.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408582	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000245848400014
J	Wong, PCM; Skoe, E; Russo, NM; Dees, T; Kraus, N				Wong, Patrick C. M.; Skoe, Erika; Russo, Nicole M.; Dees, Tasha; Kraus, Nina			Musical experience shapes human brainstem encoding of linguistic pitch patterns	NATURE NEUROSCIENCE			English	Article							LANGUAGE; SPEECH; CORTEX	Music and speech are very cognitively demanding auditory phenomena generally attributed to cortical rather than subcortical circuitry. We examined brainstem encoding of linguistic pitch and found that musicians show more robust and faithful encoding compared with nonmusicians. These results not only implicate a common subcortical manifestation for two presumed cortical functions, but also a possible reciprocity of corticofugal speech and music tuning, providing neurophysiological explanations for musicians' higher language-learning ability.	Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; Northwestern Univ, Interdepartmental Neurosci Program, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Dept Otolaryngol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Wong, PCM (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, 2240 Campus Dr, Evanston, IL 60208 USA.	pwong@northwestern.edu	Wong, Patrick/A-8102-2012	Wong, Patrick/0000-0002-6105-5027; Russo-Ponsaran, Nicole/0000-0002-9430-152X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD051827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC007468, R01DC001510] Funding Source: NIH RePORTER; NICHD NIH HHS [R03HD051827, R03 HD051827] Funding Source: Medline; NIDCD NIH HHS [R01 DC001510, R01DC001510, R21DC007468, R21 DC007468] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Gordon M, 2000, J COMP NEUROL, V426, P165, DOI 10.1002/1096-9861(20001016)426:2<165::AID-CNE1>3.0.CO;2-I; GREENBERG S, 1987, HEARING RES, V25, P91, DOI 10.1016/0378-5955(87)90083-9; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; WONG PCM, IN PRESS HUM BRAIN M	15	607	625	1	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					420	422		10.1038/nn1872	http://dx.doi.org/10.1038/nn1872			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	150PL	17351633	Green Accepted			2022-12-24	WOS:000245228600011
J	Fry, EJ; Ho, C; David, S				Fry, Elizabeth J.; Ho, Carole; David, Samuel			A role for Nogo receptor in macrophage clearance from injured peripheral nerve	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NECROSIS-FACTOR-ALPHA; WALLERIAN DEGENERATION; AXONAL REGENERATION; NEURITE OUTGROWTH; SCIATIC-NERVE; FAMILY-MEMBER; SPINAL-CORD; IN-VIVO; RHO	We report a role for Nogo receptors (NgRs) in macrophage efflux from sites of inflammation in peripheral nerve. Increasing numbers of macrophages in crushed rat sciatic nerves express NgR1 and NgR2 on the cell surface in the first week after injury. These macrophages show reduced binding to myelin and MAG in vitro, which is reversed by NgR siRNA knockdown and by inhibiting Rho-associated kinase. Fourteen days after sciatic nerve crush, regenerating nerves with newly synthesized myelin have fewer macrophages than cut/ligated nerves that lack axons and myelin. Almost all macrophages in the cut/ligated nerves lie within the Schwann cell basal lamina, while in the crushed regenerating nerves the majority migrate out. Furthermore, crush-injured nerves of NgR1 and MAG-deficient mice and Y-27632-treated rats show impaired macrophage efflux from Schwann cell basal lamina containing myelinated axons. These data have implications for the resolution of inflammation in peripheral nerve and CNS pathologies.	McGill Univ, Ctr Hlth, Neurosci Res Ctr, Montreal, PQ, Canada; Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Genentech Inc, Div Res, San Francisco, CA 94080 USA	McGill University; Stanford University; Roche Holding; Genentech	David, S (corresponding author), McGill Univ, Ctr Hlth, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ, Canada.	sam.david@mcgill.ca			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048058] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 048058] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aepfelbacher M, 1996, J IMMUNOL, V157, P5070; Bendszus M, 2003, J NEUROSCI, V23, P10892; BRAY GM, 1972, BRAIN RES, V42, P297, DOI 10.1016/0006-8993(72)90532-X; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Feroze-Merzoug F, 2002, BIOTECHNIQUES, V32, P776, DOI 10.2144/02324st03; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; George A, 2004, EXP NEUROL, V188, P187, DOI 10.1016/j.expneurol.2004.02.011; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kuhlmann T, 1999, NEUROSCI LETT, V275, P191, DOI 10.1016/S0304-3940(99)00782-X; Kuhlmann T, 2001, J NEUROSCI, V21, P3401, DOI 10.1523/JNEUROSCI.21-10-03401.2001; LEBLANC AC, 1990, J NEUROSCI RES, V26, P317, DOI 10.1002/jnr.490260308; Leskovar A, 2000, J EXP BIOL, V203, P1783; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Liao H, 2004, J NEUROCHEM, V90, P1156, DOI 10.1111/j.1471-4159.2004.02573.x; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; McKerracher L, 2004, NAT MED, V10, P1052, DOI 10.1038/nm1004-1052; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Pomorski P, 2004, CELL MOTIL CYTOSKEL, V57, P143, DOI 10.1002/cm.10159; PRINEAS JW, 1976, J NEUROL SCI, V27, P427, DOI 10.1016/0022-510X(76)90213-6; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; ROTSHENKER S, 1992, J NEUROIMMUNOL, V39, P75, DOI 10.1016/0165-5728(92)90176-L; ROTSHENKER S, 2001, GLIAL INTERFACES NER, P3; Saada A, 1996, J CELL BIOL, V133, P159, DOI 10.1083/jcb.133.1.159; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Siebert H, 2003, BRAIN RES, V960, P152, DOI 10.1016/S0006-8993(02)03806-4; Siebert H, 2001, J NEUROPATH EXP NEUR, V60, P85, DOI 10.1093/jnen/60.1.85; Stoll G, 2004, BRAIN PATHOL, V14, P51, DOI 10.1111/j.1750-3639.2004.tb00497.x; STOLL G, 1993, J NEUROIMMUNOL, V45, P175, DOI 10.1016/0165-5728(93)90178-2; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Trigueros SDA, 2003, MOL CELL NEUROSCI, V24, P753, DOI 10.1016/S1044-7431(03)00241-0; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	55	86	89	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					649	662		10.1016/j.neuron.2007.02.009	http://dx.doi.org/10.1016/j.neuron.2007.02.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329206	Bronze			2022-12-24	WOS:000245127100007
J	Wadel, K; Neher, E; Sakaba, T				Wadel, Kristian; Neher, Erwin; Sakaba, Takeshi			The coupling between synaptic vesicles and Ca2+ channels determines fast neurotransmitter release	NEURON			English	Article							SHORT-TERM PLASTICITY; TRANSMITTER RELEASE; CLIMBING FIBER; CALCIUM-DEPENDENCE; PRINCIPAL NEURON; CALYX; POOL; MODULATION; DEPRESSION; TRANSMISSION	In order to release neurotransmitter synchronously in response to a presynaptic action potential, synaptic vesicles must be both release competent and located close to presynaptic Ca2+ channels. It has not been shown, however, which of the two is the more decisive factor. We tested this issue at the calyx of Held synapse by combining Ca2+ uncaging and electrophysiological measurements of postsynaptic responses. After depletion of the synaptic vesicles that are responsible for synchronous release during action potentials, uniform elevation of intracellular Ca2+ by Ca2+ uncaging could still elicit rapid release. The Ca2+ sensitivity of remaining vesicles was reduced no more than 2-fold, which is insufficient to explain the slow-down of the kinetics of release (10-fold) observed during a depolarizing pulse. We conclude that recruitment of synaptic vesicles to sites where Ca2+ channels cluster, rather than fusion competence, is a limiting step for rapid neurotransmitter release in response to presynaptic action potentials.	Max Planck Inst Biophys Chem, Res Grp Biophys Synapt Transmiss, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Sakaba, T (corresponding author), Max Planck Inst Biophys Chem, Res Grp Biophys Synapt Transmiss, D-37077 Gottingen, Germany.	tsakaba@gwdg.de	Neher, Erwin/A-2109-2013; Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Sakaba, Takeshi/0000-0003-0688-7717				ADLER EM, 1991, J NEUROSCI, V11, P1496; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Katz B., 1969, RELEASE NEURAL TRANS; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koike-Tani M, 2005, J NEUROSCI, V25, P199, DOI 10.1523/JNEUROSCI.3861-04.2005; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Neher E, 2001, J NEUROSCI, V21, P9638, DOI 10.1523/JNEUROSCI.21-24-09638.2001; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Rettig J, 1997, J NEUROSCI, V17, P6647; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Satzler K, 2002, J NEUROSCI, V22, P10567; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneggenburger R., 2005, IMAGING NEUROSCIENCE, P415; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	63	176	179	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					563	575		10.1016/j.neuron.2007.01.021	http://dx.doi.org/10.1016/j.neuron.2007.01.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296557	Bronze, Green Submitted			2022-12-24	WOS:000245126900014
J	Bhatt, DH; McLean, DL; Hale, ME; Fetcho, JR				Bhatt, Dimple H.; McLean, David L.; Hale, Melina E.; Fetcho, Joseph R.			Grading movement strength by changes in firing intensity versus recruitment of spinal interneurons	NEURON			English	Article							LARVAL ZEBRAFISH; MOTOR PATTERNS; RETICULOSPINAL NEURONS; LOCOMOTOR NETWORK; XENOPUS-EMBRYOS; LAMPREY; ESCAPE; MOTONEURONS; CORD; CELL	Animals can produce movements of widely varying speed and strength by changing the recruitment of motoneurons according to the well-known size principle. Much less is known about patterns of recruitment in the spinal interneurons that control motoneurons because of the difficulties of monitoring activity simultaneously in multiple interneurons of an identified class. Here we use electrophysiology in combination with in vivo calcium imaging of groups of identified excitatory spinal interneurons in larval zebrafish to explore how they are recruited during different forms of the escape response that fish use to avoid predators. Our evidence indicates that escape movements are graded largely by differences in the level of activity within an active pool of interneurons rather than by the recruitment of an inactive subset.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Chicago	Fetcho, JR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jrf49@cornell.edu	; McLean, Dianne/H-2449-2012	Bhatt, D/0000-0002-7646-0981; McLean, Dianne/0000-0002-0306-8348	NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NINDS NIH HHS [NS 26539, R01 NS026539, NS043977,, R01 NS026539-25] Funding Source: Medline; PHS HHS [NRSA 44728] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026539, R01NS026539, R29NS026539, R01NS043977] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berkowitz A, 2006, J NEUROPHYSIOL, V95, P2821, DOI 10.1152/jn.01246.2005; BERKOWITZ A, 1994, J NEUROSCI, V14, P5089; Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P948, DOI 10.1152/jn.1982.47.5.948; Cangiano L, 2005, J NEUROSCI, V25, P923, DOI 10.1523/JNEUROSCI.2301-04.2005; Cope TC, 1999, J PHYSIOL-PARIS, V93, P81, DOI 10.1016/S0928-4257(99)80138-7; Deliagina TG, 2000, J NEUROPHYSIOL, V83, P853, DOI 10.1152/jn.2000.83.2.853; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; EATON RC, 1991, J EXP BIOL, V161, P469; FETCHO JR, 1988, J NEUROSCI, V8, P4192; FETCHO JR, 1992, J NEUROPHYSIOL, V67, P1574, DOI 10.1152/jn.1992.67.6.1574; FETCHO JR, 1995, J NEUROPHYSIOL, V73, P399, DOI 10.1152/jn.1995.73.1.399; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Green CS, 1996, J COMP PHYSIOL A, V178, P279; Hale ME, 2004, J NEUROSCI, V24, P3070, DOI 10.1523/JNEUROSCI.5624-03.2004; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Higashijima S, 2004, J COMP NEUROL, V480, P19, DOI 10.1002/cne.20279; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; KOCH M, 1992, NEUROSCIENCE, V49, P617, DOI 10.1016/0306-4522(92)90231-P; Li WC, 2004, J NEUROSCI, V24, P5840, DOI 10.1523/JNEUROSCI.1633-04.2004; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Saint-Amant L, 2001, NEURON, V31, P1035, DOI 10.1016/S0896-6273(01)00416-0; SILLAR KT, 1993, J PHYSIOL-LONDON, V472, P557, DOI 10.1113/jphysiol.1993.sp019962; SOFFE SR, 1993, J NEUROSCI, V13, P4456; Zelenin PV, 2003, J NEUROPHYSIOL, V90, P3161, DOI 10.1152/jn.00555.2003	32	68	68	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					91	102		10.1016/j.neuron.2006.11.011	http://dx.doi.org/10.1016/j.neuron.2006.11.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196533	Bronze			2022-12-24	WOS:000245126500011
J	Sieburth, D; Madison, JM; Kaplan, JM				Sieburth, Derek; Madison, Jon M.; Kaplan, Joshua M.			PKC-1 regulates secretion of neuropeptides	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; READILY RELEASABLE POOL; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; PHORBOL ESTERS; DEPENDENT PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; FLUORESCENT PROTEIN; CYTOSOLIC PROTEIN	The secretion of neurotransmitters and neuropeptides is mediated by distinct organelles-synaptic vesicles (SVs) and dense-core vesicles (DCVs), respectively. Relatively little is known about the factors that differentially regulate SV and DCV secretion. Here we show that protein kinase C-1 (PKC-1), which is most similar to the vertebrate PKC eta and epsilon isoforms, regulates exocytosis of DCVs in Caenorhabditis elegans motor neurons. Mutants lacking PCK-1 activity had delayed paralysis induced by the acetylcholinesterase inhibitor aldicarb, whereas mutants with increased PKC-1 activity had more rapid aldicarb-induced paralysis. Imaging and electrophysiological assays indicated that SV release occurred normally in pkc-1 mutants. By contrast, genetic analysis of aldicarb responses and imaging of fluorescently tagged neuropeptides indicated that mutants lacking PKC-1 had reduced neuropeptide secretion. Similar neuropeptide secretion defects were found in mutants lacking unc-31 ( encoding the protein CAPS) or unc-13 (encoding Munc13). These results suggest that PKC-1 selectively regulates DCV release from neurons.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Simches 7,185 Cambridge St, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu			NINDS NIH HHS [1F32NS10310] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010310] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BRENNER S, 1974, GENETICS, V77, P71; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Craig TJ, 2003, J NEUROCHEM, V86, P1450, DOI 10.1046/j.1471-4159.2003.01955.x; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Fares H, 2001, GENETICS, V159, P133; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gonelle-Gispert C, 2002, BIOCHEM J, V368, P223, DOI 10.1042/BJ20020896; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; KUPFERMANN I, 1991, PHYSIOL REV, V71, P683, DOI 10.1152/physrev.1991.71.3.683; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LAND M, 1994, J BIOL CHEM, V269, P9234; LAND M, 1994, J BIOL CHEM, V269, P14820; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lonart G, 2000, J BIOL CHEM, V275, P27703; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Martin TFJ, 2003, BBA-MOL CELL RES, V1641, P157, DOI 10.1016/S0167-4889(03)00093-4; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; Misonou H, 1998, CELL MOL NEUROBIOL, V18, P379, DOI 10.1023/A:1022593330685; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy G, 2002, J NEUROSCI, V22, P9278; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; NGUYEN M, 1995, GENETICS, V140, P527; NISHIZAKI T, 1992, J BIOL CHEM, V267, P23972; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Searl TJ, 2003, J PHYSIOL-LONDON, V553, P445, DOI 10.1113/jphysiol.2003.051300; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Smith C, 1999, J NEUROSCI, V19, P589; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Waters J, 2000, J NEUROSCI, V20, P7863; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	65	169	187	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					49	57		10.1038/nn1810	http://dx.doi.org/10.1038/nn1810			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17128266				2022-12-24	WOS:000243096100015
J	Zhang, JS; Pho, V; Bonasera, SJ; Holtzman, J; Tang, AT; Hellmuth, J; Tang, SW; Janak, PH; Tecott, LH; Huang, EJ				Zhang, Jiasheng; Pho, Vanee; Bonasera, Stephen J.; Holtzman, Jed; Tang, Amy T.; Hellmuth, Joanna; Tang, Siuwah; Janak, Patricia H.; Tecott, Laurence H.; Huang, Eric J.			Essential function of HIPK2 in TGF beta-dependent survival of midbrain dopamine neurons	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-BETA; INTERACTING PROTEIN KINASE-2; NERVOUS-SYSTEM; SUBSTANTIA-NIGRA; CELL-DEATH; NEUROTROPHIC FACTOR; IN-VIVO; TRANSCRIPTION FACTORS; PARKINSONS-DISEASE; SYNAPTIC GROWTH	Transforming growth factor beta (TGF beta) is a potent trophic factor for midbrain dopamine (DA) neurons, but its in vivo function and signaling mechanisms are not entirely understood. We show that the transcriptional cofactor homeodomain interacting protein kinase 2 (HIPK2) is required for the TGF beta-mediated survival of mouse DA neurons. The targeted deletion of Hipk2 has no deleterious effect on the neurogenesis of DA neurons, but leads to a selective loss of these neurons that is due to increased apoptosis during programmed cell death. As a consequence, Hipk2(-/-) mutants show an array of psychomotor abnormalities. The function of HIPK2 depends on its interaction with receptor-regulated Smads to activate TGFb target genes. In support of this notion, DA neurons from Hipk2(-/-) mutants fail to survive in the presence of TGF beta 3 and Tgf beta 3(-/-) mutants show DA neuron abnormalities similar to those seen in Hipk2(-/-) mutants. These data underscore the importance of the TGF beta-smad-HIPK2 pathway in the survival of DA neurons and its potential as a therapeutic target for promoting DA neuron survival during neurodegeneration.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; VA Med Ctr, Pathol Serv 113B, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, EJ (corresponding author), Univ Calif San Francisco, Dept Pathol, 505 Parnassus Ave, San Francisco, CA 94143 USA.	eric.huang2@ucsf.edu	Huang, Eric J./AAH-7997-2019	Huang, Eric J./0000-0002-5381-3801; Bonasera, Stephen/0000-0001-6808-2821; Janak, Patricia/0000-0002-3333-9049	NIA NIH HHS [AG23501, P50 AG023501] Funding Source: Medline; NINDS NIH HHS [NS48393, K02 NS044223, NS44223, R01 NS048393] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048393, K02NS044223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chin J, 2002, J NEUROSCI, V22; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Enomoto H, 2000, DEVELOPMENT, V127, P4877; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Farkas LM, 2003, J NEUROSCI, V23, P5178; Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HYMAN C, 1994, J NEUROSCI, V14, P335; HYNES MA, 1994, J NEUROSCI RES, V37, P144, DOI 10.1002/jnr.490370118; Jackson-Lewis V, 2000, J COMP NEUROL, V424, P476, DOI 10.1002/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kholodilov N, 2004, J NEUROSCI, V24, P3136, DOI 10.1523/JNEUROSCI.4506-03.2004; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; Lie DC, 2002, J NEUROSCI, V22, P6639; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Oo TF, 2003, J NEUROSCI, V23, P5141; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	49	100	100	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					77	86		10.1038/nn1816	http://dx.doi.org/10.1038/nn1816			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17159989	Green Accepted			2022-12-24	WOS:000243096100018
J	Wintermantel, TM; Campbell, RE; Porteous, R; Bock, D; Grone, HJ; Todman, MG; Korach, KS; Greiner, E; Perez, CA; Schutz, G; Herbison, AE				Wintermantel, Tim M.; Campbell, Rebecca E.; Porteous, Robert; Bock, Dagmar; Groene, Hermann-Josef; Todman, Martin G.; Korach, Kenneth S.; Greiner, Erich; Perez, Cristian A.; Schuetz, Guenther; Herbison, Allan E.			Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LUTEINIZING-HORMONE; PREOPTIC AREA; RAT-BRAIN; PSEUDORABIES VIRUS; NERVOUS-SYSTEM; LHRH NEURONS; FEMALE RAT; SURGE; ALPHA	The mechanisms through which estrogen regulates gonadotropin-releasing hormone (GnRH) neurons to control mammalian ovulation are unknown. We found that estrogen positive feedback to generate the preovulatory gonadotropin surge was normal in estrogen receptor beta knockout (ER beta) mutant mice, but absent in ER alpha mutant mice. An ER alpha-selective compound was sufficient to generate positive feedback in wild-type mice. As GnRH neurons do not express ER alpha, estrogen positive feedback upon GnRH neurons must be indirect in nature. To establish the cell type responsible, we generated a neuron-specific ERa mutant mouse line. These mice failed to exhibit estrogen positive feedback, demonstrating that neurons expressing ER alpha are critical. We then used a GnRH neuron-specific Pseudorabies virus (PRV) tracing approach to show that the ER alpha-expressing neurons innervating GnRH neurons are located within rostral periventricular regions of the hypothalamus. These studies demonstrate that ovulation is driven by estrogen actions upon ER alpha-expressing neuronal afferents to GnRH neurons.	German Canc Res Ctr, D-69120 Heidelberg, Germany; Univ Otago, Sch Med Sci, Ctr Neuroendocrinol, Dunedin 9001, New Zealand; Univ Otago, Sch Med Sci, Dept Physiol, Dunedin 9001, New Zealand; NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA; Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Otago; University of Otago; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rockefeller University	Schutz, G (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.schuetz@dkfz.de; allan.herbison@stonebow.otago.ac.nz	Perez, Cristian A./A-2341-2008; Oka, Yoshitaka/C-9670-2010; Campbell, Rebecca E/F-6430-2010	Oka, Yoshitaka/0000-0002-3482-3051; Campbell, Rebecca E/0000-0002-0309-532X; Korach, Kenneth/0000-0002-7765-418X; Herbison, Allan/0000-0002-9615-3022	Wellcome Trust [063216] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065, ZIAES070065] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abraham IM, 2003, J NEUROSCI, V23, P5771; BRONSON FH, 1981, ENDOCRINOLOGY, V108, P506, DOI 10.1210/endo-108-2-506; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CARD JP, 1995, CRIT REV NEUROBIOL, V9, P137; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Couse JF, 1999, ENDOCRINOLOGY, V140, P5855, DOI 10.1210/en.140.12.5855; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; DELFALCO J, 2001, SCIENCE, V291, P2608; Dupont S, 2000, DEVELOPMENT, V127, P4277; Evans NP, 1997, ENDOCRINOLOGY, V138, P5408, DOI 10.1210/en.138.12.5408; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gu GB, 1997, J COMP NEUROL, V384, P142; Hegele-Hartung C, 2004, P NATL ACAD SCI USA, V101, P5129, DOI 10.1073/pnas.0306720101; Herbison AE, 1998, ENDOCR REV, V19, P302, DOI 10.1210/edrv.19.3.0332; Herbison AE, 2001, FRONT NEUROENDOCRIN, V22, P292, DOI 10.1006/frne.2001.0219; HERBISON AE, 1995, J NEUROENDOCRINOL, V7, P377, DOI 10.1111/j.1365-2826.1995.tb00772.x; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Horvath S, 2002, EUR J NEUROSCI, V15, P937, DOI 10.1046/j.1460-9568.2002.01923.x; HORVATH TL, 1993, J NEUROENDOCRINOL, V5, P71, DOI 10.1111/j.1365-2826.1993.tb00365.x; Hrabovszky E, 2001, ENDOCRINOLOGY, V142, P3261, DOI 10.1210/en.142.7.3261; Karsch FJ, 1997, BIOL REPROD, V56, P303, DOI 10.1095/biolreprod56.2.303; Le WW, 1999, ENDOCRINOLOGY, V140, P510, DOI 10.1210/en.140.1.510; LEE WS, 1990, P NATL ACAD SCI USA, V87, P5163, DOI 10.1073/pnas.87.13.5163; LEGAN SJ, 1975, ENDOCRINOLOGY, V96, P50, DOI 10.1210/endo-96-1-50; Levine JE, 1997, BIOL REPROD, V56, P293, DOI 10.1095/biolreprod56.2.293; Li C, 1999, BRAIN RES, V824, P267, DOI 10.1016/S0006-8993(99)01217-2; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; PETERSEN SL, 1989, BRAIN RES, V484, P279, DOI 10.1016/0006-8993(89)90371-5; Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745; Prevot V, 2002, J NEUROENDOCRINOL, V14, P247, DOI 10.1046/j.0007-1331.2001.00772.x; Rage F, 1997, J NEUROSCI, V17, P9145; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Shughrue PJ, 1997, ENDOCRINOLOGY, V138, P5476, DOI 10.1210/en.138.12.5476; Shupnik MA, 1996, TRENDS ENDOCRIN MET, V7, P272, DOI 10.1016/S1043-2760(96)00124-5; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Simonian SX, 1999, J COMP NEUROL, V411, P346, DOI 10.1002/(SICI)1096-9861(19990823)411:2<346::AID-CNE13>3.0.CO;2-S; Skinner DC, 2005, J NEUROENDOCRINOL, V17, P29, DOI 10.1111/j.1365-2826.2005.01271.x; Skynner MJ, 1999, ENDOCRINOLOGY, V140, P5195, DOI 10.1210/en.140.11.5195; Skynner MJ, 1999, J NEUROSCI, V19, P5955, DOI 10.1523/JNEUROSCI.19-14-05955.1999; Smith MJ, 2001, REPRODUCTION, V122, P1, DOI 10.1530/rep.0.1220001; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vente A, 1999, NAT GENET, V22, P22, DOI 10.1038/8734; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335; XIA L, 1992, ENDOCRINOLOGY, V131, P2812, DOI 10.1210/en.131.6.2812; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	50	430	438	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					271	280		10.1016/j.neuron.2006.07.023	http://dx.doi.org/10.1016/j.neuron.2006.07.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046690	Bronze, Green Accepted			2022-12-24	WOS:000241799900008
J	Thompson, SK; von Kriegstein, K; Deane-Pratt, A; Marquardt, T; Deichmann, R; Griffiths, TD; McAlpine, D				Thompson, Sarah K.; von Kriegstein, Katharina; Deane-Pratt, Adenike; Marquardt, Torsten; Deichmann, Ralf; Griffiths, Timothy D.; McAlpine, David			Representation of interaural time delay in the human auditory midbrain	NATURE NEUROSCIENCE			English	Article							INFERIOR COLLICULUS; LATERALIZATION; SENSITIVITY; NOISE; BANDS; DISCRIMINATION; DIFFERENCE; BANDWIDTH; STIMULI; TONES	Interaural time difference (ITD) is a critical cue to sound-source localization. Traditional models assume that sounds leading at one ear, and perceived on that side, are processed in the opposite midbrain. Using functional magnetic resonance imaging we demonstrate that as the ITDs of sounds increase, midbrain activity can switch sides, even though perceived location remains on the same side. The data require a new model for human ITD processing.	UCL, Dept Physiol, London WC1X 8EE, England; UCL, Ear Inst, London WC1X 8EE, England; UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ Newcastle Upon Tyne, Auditory Grp, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of London; University College London; University of London; University College London; University of London; University College London; Newcastle University - UK	McAlpine, D (corresponding author), UCL, Dept Physiol, 332 Grays Inn Rd, London WC1X 8EE, England.	d.mcalpine@ucl.ac.uk	von Kriegstein, Katharina/C-3135-2008	von Kriegstein, Katharina/0000-0001-7989-5860; Deane-Pratt, Ade/0000-0001-9940-9233; McAlpine, David/0000-0001-5467-6725; Griffiths, Timothy/0000-0001-8066-4381	MRC [G0300417] Funding Source: UKRI; Medical Research Council [G0300417] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bernstein LR, 2003, J ACOUST SOC AM, V113, P3335, DOI 10.1121/1.1570431; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; McAlpine D, 1996, HEARING RES, V97, P136, DOI 10.1016/0378-5955(96)00068-8; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; SCHIANO JL, 1986, J ACOUST SOC AM, V79, P1563, DOI 10.1121/1.393683; STERN RM, 1985, J ACOUST SOC AM, V77, P753, DOI 10.1121/1.392345; STERN RM, 1997, P 11 INT S HEAR; TRAHIOTIS C, 1986, J ACOUST SOC AM, V79, P1950, DOI 10.1121/1.393202; Trahiotis C, 2001, J ACOUST SOC AM, V109, P321, DOI 10.1121/1.1327579; TRAHIOTIS C, 1994, J ACOUST SOC AM, V96, P3804, DOI 10.1121/1.410570; TRAHIOTIS C, 1989, J ACOUST SOC AM, V86, P1285, DOI 10.1121/1.398743; WAGNER H, 1987, J NEUROSCI, V7, P3105; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	15	53	54	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1096	1098		10.1038/nn1755	http://dx.doi.org/10.1038/nn1755			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921369				2022-12-24	WOS:000240080800009
J	Assisi, C; Stopfer, M; Laurent, G; Bazhenov, M				Assisi, Collins; Stopfer, Mark; Laurent, Gilles; Bazhenov, Maxim			Adaptive regulation of sparseness by feedforward inhibition	NATURE NEUROSCIENCE			English	Article							LOCUST ANTENNAL LOBE; OSCILLATING NEURAL ASSEMBLIES; OLFACTORY NETWORK DYNAMICS; ODOR REPRESENTATIONS; SYSTEM; CELLS; MODEL; SYNCHRONIZATION; INFORMATION; MECHANISMS	In the mushroom body of insects, odors are represented by very few spikes in a small number of neurons, a highly efficient strategy known as sparse coding. Physiological studies of these neurons have shown that sparseness is maintained across thousand-fold changes in odor concentration. Using a realistic computational model, we propose that sparseness in the olfactory system is regulated by adaptive feedforward inhibition. When odor concentration changes, feedforward inhibition modulates the duration of the temporal window over which the mushroom body neurons may integrate excitatory presynaptic input. This simple adaptive mechanism could maintain the sparseness of sensory representations across wide ranges of stimulus conditions.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; NICHHD, US NIH, Bethesda, MD 20892 USA; CALTECH, Pasadena, CA 91125 USA	Salk Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); California Institute of Technology	Bazhenov, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bazhenov@salk.edu	Laurent, Gilles/A-4583-2012; Assisi, Collins/R-7467-2016	Laurent, Gilles/0000-0002-2296-114X; Assisi, Collins/0000-0003-0108-582X; Stopfer, Mark/0000-0001-9200-1884	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006306] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDCD NIH HHS [R01 DC006306-01A1, R01 DC006306] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSON P, 1995, PHYSIOL ENTOMOL, V20, P189, DOI 10.1111/j.1365-3032.1995.tb00001.x; Anton S., 1999, INSECT OLFACTION; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; ERNST KD, 1977, CELL TISSUE RES, V176, P285, DOI 10.1007/BF00221789; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kanerva P., 1988, SPARSE DISTRIBUTED M; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005	43	80	80	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1176	1184		10.1038/nn1947	http://dx.doi.org/10.1038/nn1947			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17660812	Green Accepted			2022-12-24	WOS:000249144000020
J	Shima, Y; Kawaguchi, S; Kosaka, K; Nakayama, M; Hoshino, M; Nabeshima, Y; Hirano, T; Uemura, T				Shima, Yasuyuki; Kawaguchi, Shin-ya; Kosaka, Kazuyoshi; Nakayama, Manabu; Hoshino, Mikio; Nabeshima, Yoichi; Hirano, Tomoo; Uemura, Tadashi			Opposing roles in neurite growth control by two seven-pass transmembrane cadherins	NATURE NEUROSCIENCE			English	Article							CELL POLARIZATION; IN-VIVO; DROSOPHILA; FLAMINGO; GENES; AXON; SUPERFAMILY; RECEPTOR; POLARITY; CALCIUM	The growth of neurites (axon and dendrite) should be appropriately regulated by their interactions in the development of nervous systems where a myriad of neurons and their neurites are tightly packed. We show here that mammalian seven-pass transmembrane cadherins Celsr2 and Celsr3 are activated by their homophilic interactions and regulate neurite growth in an opposing manner. Both gene-silencing and coculture assay with rat neuron cultures showed that Celsr2 enhanced neurite growth, whereas Celsr3 suppressed it, and that their opposite functions were most likely the result of a difference of a single amino acid residue in the transmembrane domain. Together with calcium imaging and pharmacological analyses, our results suggest that Celsr2 and Celsr3 fulfill their functions through second messengers, and that differences in the activities of the homologs results in opposite effects in neurite growth regulation.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068501, Japan; Kazusa DNA Res Inst, Chiba 2920818, Japan; Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Brandeis University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kazusa DNA Research Institute; Kyoto University	Uemura, T (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 S St, Waltham, MA 02454 USA.	tauemura@lif.kyoto-u.ac.jp	Kawaguchi, Shin-ya/X-4166-2018	Kawaguchi, Shin-ya/0000-0002-8386-1185; UEMURA, Tadashi/0000-0001-7204-3606				Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Harmar AJ, 2001, GENOME BIOL, V2; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kimura H, 2006, J CELL SCI, V119, P1118, DOI 10.1242/jcs.02832; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; MILLER M, 1981, J NEUROCYTOL, V10, P859, DOI 10.1007/BF01262658; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shima Y, 2002, DEV DYNAM, V223, P321, DOI 10.1002/dvdy.10054; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tanabe K, 2004, DEV DYNAM, V229, P899, DOI 10.1002/dvdy.10493; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang YS, 2002, J NEUROSCI, V22, P8563; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yagi T, 2000, GENE DEV, V14, P1169; Ye B, 2005, TRENDS CELL BIOL, V15, P64, DOI 10.1016/j.tcb.2004.12.003	46	114	115	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					963	969		10.1038/nn1933	http://dx.doi.org/10.1038/nn1933			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17618280				2022-12-24	WOS:000248357500010
J	Qu, D; Rashidian, J; Mount, MP; Aleyasin, H; Parsanejad, M; Lira, A; Haque, E; Zhang, Y; Callaghan, S; Daigle, M; Rousseaux, MWC; Slack, RS; Albert, PR; Vincent, I; Woulfe, JM; Park, DS				Qu, Dianbo; Rashidian, Juliet; Mount, Matthew P.; Aleyasin, Hossein; Parsanejad, Mohammad; Lira, Arman; Haque, Emdadul; Zhang, Yi; Callaghan, Steve; Daigle, Mireille; Rousseaux, Maxime W. C.; Slack, Ruth S.; Albert, Paul R.; Vincent, Inez; Woulfe, John M.; Park, David S.			Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; CYSTEINE-SULFINIC ACID; NIGRAL CELL-DEATH; NEURONAL DEATH; DOPAMINERGIC-NEURONS; POLYACRYLAMIDE-GELS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; MOUSE MODEL; DNA-DAMAGE	We reported previously that calpain-mediated Cdk5 activation is critical for mitochondrial toxin-induced dopaminergic death. Here, we report a target that mediates this loss. Prx2, an antioxidant enzyme, binds Cdk5/p35. Prx2 is phosphorylated at T89 in neurons treated with MPP+ and/or MPTP in animals in a calpain/Cdk5/p35-dependent manner. This phosphorylation reduces Prx2 peroxidase activity. Consistent with this, p35(-/-) neurons show reduced oxidative stress upon MPP+ treatment. Expression of Prx2 and Prx2T89A, but not the phosphorylation mimic Prx2T89E, protects cultured and adult neurons following mitochondrial insult. Finally, downregulation of Prx2 increases oxidative stress and sensitivity to MPP+. We propose a mechanistic model by which mitochondrial toxin leads to calpain-mediated Cdk5 activation, reduced Prx2 activity, and decreased capacity to eliminate ROS. Importantly, increased Prx2 phosphorylation also occurs in nigral neurons from postmortem tissue from Parkinson's disease patients when compared to control, suggesting the relevance of this pathway in the human condition.	Univ Ottawa, Ottawa Hlth Res Inst, Neurosci Grp, Ottawa, ON K1H 8M5, Canada; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5A 4H4, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia	Park, DS (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, Neurosci Grp, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca	, Dianbo/AAU-8480-2021; Albert, Paul/E-4804-2010; Qu, Dianbo/C-5121-2011	, Dianbo/0000-0002-0435-9585; Albert, Paul/0000-0002-1809-3554; Slack, Ruth/0000-0002-1552-2835; Aleyasin, Hossein/0000-0002-0021-2586; Park, David/0000-0002-4490-3784; Rousseaux, Maxime/0000-0002-2737-6193				Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Aleyasin H, 2004, J NEUROSCI, V24, P2963, DOI 10.1523/JNEUROSCI.0155-04.2004; Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bu BT, 2002, J NEUROSCI, V22, P6515; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; BURNS RS, 1985, NEW ENGL J MED, V312, P1418, DOI 10.1056/NEJM198505303122203; Busser J, 1998, J NEUROSCI, V18, P2801; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fortin A, 2001, J CELL BIOL, V155, P207, DOI 10.1083/jcb.200105137; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; ITO M, 1993, FEBS LETT, V320, P125, DOI 10.1016/0014-5793(93)80076-7; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; JONSSON G, 1986, ACTA PHYSIOL SCAND, V128, P187, DOI 10.1111/j.1748-1716.1986.tb07965.x; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee DS, 1996, J SEISM EXPLOR, V5, P5; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Martins AR, 1999, J NEUROSCI METH, V92, P25, DOI 10.1016/S0165-0270(99)00090-4; McShea A, 1997, AM J PATHOL, V150, P1933; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; MouattPrigent A, 1996, NEUROSCIENCE, V73, P979, DOI 10.1016/0306-4522(96)00100-5; Nakamura S, 1997, ACTA NEUROPATHOL, V94, P153, DOI 10.1007/s004010050687; Nguyen MD, 2003, J NEUROSCI, V23, P2131; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Rideout HJ, 2003, J NEUROSCI, V23, P1237, DOI 10.1523/JNEUROSCI.23-04-01237.2003; Sarafian TA, 1998, MOL CHEM NEUROPATHOL, V34, P39, DOI 10.1007/BF02815135; Schapira AHV, 2001, ADV NEUROL, V86, P155; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Smythies J, 1998, BBA-GEN SUBJECTS, V1380, P159, DOI 10.1016/S0304-4165(97)00131-1; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; WATABE S, 1994, J BIOCHEM, V115, P648, DOI 10.1093/oxfordjournals.jbchem.a124390; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xiang H, 1996, J NEUROSCI, V16, P6753; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006	68	193	199	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 5	2007	55	1					37	52		10.1016/j.neuron.2007.05.033	http://dx.doi.org/10.1016/j.neuron.2007.05.033			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189TF	17610816	Bronze			2022-12-24	WOS:000248010700007
J	Chevaleyre, V; Heifets, BD; Kaeser, PS; Sudhof, TC; Purpura, DP; Castillo, PE				Chevaleyre, Vivien; Heifets, Boris D.; Kaeser, Pascal S.; Sudhof, Thomas C.; Purpura, Dominick P.; Castillo, Pablo E.			Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1 alpha	NEURON			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; PROTEIN-KINASE-A; INHIBITORY SYNAPTIC-TRANSMISSION; METABOTROPIC GLUTAMATE RECEPTORS; RAT CEREBELLAR STELLATE; ENDOGENOUS CANNABINOIDS; PRESYNAPTIC INHIBITION; CALCIUM-CHANNELS; CA2+ CHANNELS; CYCLIC-AMP	Endocannabinoids (eCBs) have emerged as key activity-dependent signals that, by activating presynaptic cannabinoid receptors (i.e., CB1) coupled to G(i/o) protein, can mediate shortterm and long-term synaptic depression (LTD). While the presynaptic mechanisms underlying eCB-dependent short-term depression have been identified, the molecular events linking CB1 receptors to LTD are unknown. Here we show in the hippocampus that long-term, but not short-term, eCB-dependent depression of inhibitory transmission requires presynaptic cAMP/PKA signaling. We further identify the active zone protein RIM1 alpha as a key mediator of both CB1 receptor effects on the release machinery and eCB-dependent LTD in the hippocampus. Moreover, we show that eCB-dependent LTD in the amygdala and hippocampus shares major mechanistic features. These findings reveal the signaling pathway by which CB1 receptors mediate long-term effects of eCBs in two crucial brain structures. Furthermore, our results highlight a conserved mechanism of presynaptic plasticity in the brain.	Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Neurosci, Dallas, TX 75390 USA	Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA.	pcastill@aecom.yu.edu		Heifets, Boris/0000-0003-1474-0379; Castillo, Pablo/0000-0002-9834-1801; Chevaleyre, Vivien/0000-0002-3679-4856	NIDA NIH HHS [R01 DA017392, R01 DA017392-04, R01 DA017392-05] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; Arai A, 1995, BRAIN RES, V704, P298, DOI 10.1016/0006-8993(95)01137-4; Azad SC, 2004, J NEUROSCI, V24, P9953, DOI 10.1523/JNEUROSCI.2134-04.2004; Azad SC, 2003, LEARN MEMORY, V10, P116, DOI 10.1101/lm.53303; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Chhatwal JP, 2005, NEUROPSYCHOPHARMACOL, V30, P516, DOI 10.1038/sj.npp.1300655; Childers SR, 1996, BIOCHEM PHARMACOL, V52, P819, DOI 10.1016/0006-2952(96)00419-4; Collin T, 2005, CURR OPIN NEUROBIOL, V15, P275, DOI 10.1016/j.conb.2005.05.003; Daniel H, 2004, J PHYSIOL-LONDON, V557, P159, DOI 10.1113/jphysiol.2004.063263; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; Diana MA, 2003, J NEUROSCI, V23, P5906; Dittman JS, 1996, J NEUROSCI, V16, P1623; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2003, BRIT J PHARMACOL, V140, P781, DOI 10.1038/sj.bjp.0705466; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GEREAU RW, 1995, J NEUROSCI, V15, P6879; GOHEN GA, 1992, NEURON, V9, P325; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Heinbockel T, 2005, J NEUROSCI, V25, P9449, DOI 10.1523/JNEUROSCI.2078-05.2005; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hescheler J, 1993, Curr Opin Neurobiol, V3, P360, DOI 10.1016/0959-4388(93)90129-M; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; HOWLETT AC, 1986, MOL PHARMACOL, V29, P307; Huang CC, 2002, MOL PHARMACOL, V61, P578, DOI 10.1124/mol.61.3.578; Huang YY, 2005, P NATL ACAD SCI USA, V102, P9365, DOI 10.1073/pnas.0503777102; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarolimek W, 1997, J NEUROSCI, V17, P1025; Kaeser PS, 2005, BIOCHEM SOC T, V33, P1345, DOI 10.1042/BST0331345; Kamprath K, 2006, J NEUROSCI, V26, P6677, DOI 10.1523/JNEUROSCI.0153-06.2006; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Kondo S, 1997, J PHYSIOL-LONDON, V498, P165, DOI 10.1113/jphysiol.1997.sp021849; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; LAMBERT NA, 1991, J NEUROPHYSIOL, V66, P1538, DOI 10.1152/jn.1991.66.5.1538; Lenz RA, 1998, J PHYSIOL-LONDON, V512, P61, DOI 10.1111/j.1469-7793.1998.061bf.x; Linden DJ, 1999, J NEUROSCI, V19, P10221; LLANO I, 1993, J PHYSIOL-LONDON, V468, P201, DOI 10.1113/jphysiol.1993.sp019767; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mikics E, 2006, BEHAV PHARMACOL, V17, P223; Morishita W, 1998, J NEUROSCI, V18, P4870; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; PITLER TA, 1994, NEURON, V13, P1447; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2001, J NEUROSCI, V21, P109, DOI 10.1523/JNEUROSCI.21-01-00109.2001; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SALTOW F, 2005, J PHYSL, V565, P487; SCANZIANI M, 1995, NEUROPHARMACOLOGY, V34, P1549, DOI 10.1016/0028-3908(95)00119-Q; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; SCIANCALEPORE M, 1995, NEUROSCI LETT, V187, P91, DOI 10.1016/0304-3940(95)11348-7; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Szabo B, 2005, HANDB EXP PHARMACOL, V168, P327; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; UMEMIYA M, 1995, J NEUROPHYSIOL, V73, P1192, DOI 10.1152/jn.1995.73.3.1192; Varma N, 2002, NEUROPHARMACOLOGY, V43, P550, DOI 10.1016/S0028-3908(02)00168-5; Varvel SA, 2005, PSYCHOPHARMACOLOGY, V179, P863, DOI 10.1007/s00213-004-2121-2; Varvel SA, 2002, J PHARMACOL EXP THER, V301, P915, DOI 10.1124/jpet.301.3.915; Varvel SA, 2007, NEUROPSYCHOPHARMACOL, V32, P1032, DOI 10.1038/sj.npp.1301224; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Yamasaki M, 2006, J NEUROSCI, V26, P86, DOI 10.1523/JNEUROSCI.2258-05.2006	97	192	196	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 7	2007	54	5					801	812		10.1016/j.neuron.2007.05.020	http://dx.doi.org/10.1016/j.neuron.2007.05.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179ZQ	17553427	Green Accepted, Bronze			2022-12-24	WOS:000247329900012
J	Dhaka, A; Murray, AN; Mathur, J; Earley, TJ; Petrus, MJ; Patapoutian, A				Dhaka, Ajay; Murray, Amber N.; Mathur, Jayanti; Earley, Taryn J.; Petrus, Matt J.; Patapoutian, Ardem			TRPM8 is required for cold sensation in mice	NEURON			English	Article							ION CHANNELS; RECEPTOR; TRPA1; NEURONS; CONTRIBUTES; PAIN; TRANSDUCTION; HYPERALGESIA; INHIBITION; STIMULI	ThermoTRPs, a subset of the Transient Receptor Potential (TRP) family of cation channels, have been implicated in sensing temperature. TRPM8 and TRPA1 are both activated by cooling; however, it is unclear whether either ion channel is required for thermosensation in vivo. We show that mice lacking TRPM8 have severe behavioral deficits in response to cold stimuli. In thermotaxis assays of temperature gradient and two-temperature choice assays, TRPM8-deficient mice exhibit strikingly reduced avoidance of cold temperatures. TRPM8-deficient mice also lack behavioral response to cold-inducing icilin application and display an attenuated response to acetone, an unpleasant cold stimulus. However, TRPM8-deficient mice have normal nociceptive-like responses to subzero centigrade temperatures, suggesting the presence of at least one additional noxious cold receptor. Finally, we show that TRPM8 mediates the analgesic effect of moderate cooling after administration of formalin, a painful stimulus. Therefore, depending on context, TRPM8 contributes to sensing unpleasant cold stimuli or mediating the effects of cold analgesia.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	apatapou@gnf.org			NINDS NIH HHS [NS049104, NS046303] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303, R01NS049104] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Galeotti N, 2002, NEUROSCI LETT, V322, P145, DOI 10.1016/S0304-3940(01)02527-7; Hensel H, 1981, Monogr Physiol Soc, V38, P1; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karim F, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-2; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Sauls J, 1999, ONLINE J KNOWL SYN N, V6; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; TSE SYH, 1986, PSYCHOPHARMACOLOGY, V90, P322; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Werkheiser JL, 2006, EUR J PHARMACOL, V547, P101, DOI 10.1016/j.ejphar.2006.07.026	34	606	618	5	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 3	2007	54	3					371	378		10.1016/j.neuron.2007.02.024	http://dx.doi.org/10.1016/j.neuron.2007.02.024			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481391	Bronze			2022-12-24	WOS:000246855700008
J	Saglietti, L; Dequidt, C; Kamieniarz, K; Rousset, MC; Valnegri, P; Thoumine, O; Beretta, F; Fagni, L; Choquet, D; Sala, C; Sheng, M; Passafaro, M				Saglietti, Laura; Dequidt, Caroline; Kamieniarz, Kinga; Rousset, Marie-Claude; Valnegri, Pamela; Thoumine, Olivier; Beretta, Francesca; Fagni, Laurent; Choquet, Daniel; Sala, Carlo; Sheng, Morgan; Passafaro, Maria			Extracellular interactions between GluR2 and N-cadherin in spine regulation	NEURON			English	Article							AMPA RECEPTOR TRAFFICKING; CELL-ADHESION MOLECULES; DENDRITIC SPINES; LIGAND-BINDING; PROTEIN INTERACTIONS; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; SYNAPTIC FUNCTION; COMPLEX-FORMATION	Via its extracellular N-terminal domain (NTD), the AMPA receptor subunit GluR2 promotes the formation and growth of dendritic spines in cultured hippocampal neurons. Here we show that the first N-terminal 92 amino acids of the extracellular domain are necessary and sufficient for GluR2's spine-promoting activity. Moreover, overexpression of this extracellular domain increases the frequency of miniature excitatory postsynaptic currents (mEPSCs). Biochemically, the NTD of GluR2 can interact directly with the cell adhesion molecule N-cadherin, in cis or in trans. N-cadherin-coated beads recruit GluR2 on the surface of hippocampal neurons, and IN-cadherin immobilization decreases GluR2 lateral diffusion on the neuronal surface. RNAi knockdown of N-cadherin prevents the enhancing effect of GluR2 on spine morphogenesis and mEPSC frequency. Our data indicate that in hippocampal neurons N-cadherin and GluR2 form a synaptic complex that stimulates presynaptic development and function as well as promoting dendritic spine formation.	Univ Milan, CNR, DTI Dulbecco Telethon Inst, Inst Neurosci Cellular & Mol Pharmacol,Dept Pharm, Milan, Italy; Univ Bordeaux, CNRS, UMR 5091, Inst Magendie Neurosci, Bordeaux, France; Inst Genom Fonct, UMR 5203, F-34000 Montpellier, France; Univ Milan, CNR, Dept Pharmacol, Inst Neurosci Cellular & Mol Pharmacol, Milan, Italy; MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA	Consiglio Nazionale delle Ricerche (CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Milan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN	Passafaro, M (corresponding author), Univ Milan, CNR, DTI Dulbecco Telethon Inst, Inst Neurosci Cellular & Mol Pharmacol,Dept Pharm, Milan, Italy.	m.passafaro@in.cnr.it	Choquet, Daniel/K-7893-2018; Sala, Carlo/A-2493-2009; Thoumine, Olivier/GZK-4998-2022; Choquet, Daniel/E-4203-2013; Choquet, Daniel/GOJ-8825-2022	Choquet, Daniel/0000-0003-4726-9763; Sala, Carlo/0000-0003-0662-9523; Thoumine, Olivier/0000-0002-8041-1349; Choquet, Daniel/0000-0003-4726-9763; Sheng, Morgan/0000-0002-8703-5366; Kamieniarz-Gdula, Kinga/0000-0003-3789-5381	Telethon [TCR07006] Funding Source: Medline	Telethon(Fondazione Telethon)		Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Bamji SX, 2005, NEURON, V47, P175, DOI 10.1016/j.neuron.2005.06.024; BEESLEY PW, 1995, J NEUROCHEM, V64, P2288; Benson DL, 1998, J NEUROSCI, V18, P6892; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chan YM, 1998, J CELL BIOL, V143, P2033, DOI 10.1083/jcb.143.7.2033; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Elste AM, 2006, J COMP NEUROL, V495, P324, DOI 10.1002/cne.20876; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hering H, 2003, J NEUROSCI, V23, P3262; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lambert M, 2000, J CELL SCI, V113, P2207; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Thoumine O, 2006, MOL BIOL CELL, V17, P862, DOI 10.1091/mbc.E05-04-0335; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132	58	265	274	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 3	2007	54	3					461	477		10.1016/j.neuron.2007.04.012	http://dx.doi.org/10.1016/j.neuron.2007.04.012			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	173EG	17481398	Bronze			2022-12-24	WOS:000246855700015
J	Di Giorgio, FP; Carrasco, MA; Siao, MC; Maniatis, T; Eggan, K				Di Giorgio, Francesco Paolo; Carrasco, Monica A.; Siao, Michelle C.; Maniatis, Tom; Eggan, Kevin			Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; EXTEND SURVIVAL; MOUSE EMBRYOS; DISEASE; DEGENERATION; MUTATIONS; GENE; DIFFERENTIATION	Here we report an in vitro model system for studying the molecular and cellular mechanisms that underlie the neurodegenerative disease amyotrophic lateral sclerosis ( ALS). Embryonic stem cells ( ESCs) derived from mice carrying normal or mutant transgenic alleles of the human SOD1 gene were used to generate motor neurons by in vitro differentiation. These motor neurons could be maintained in long-term coculture either with additional cells that arose during differentiation or with primary glial cells. Motor neurons carrying either the nonpathological human SOD1 transgene or the mutant SOD1G93A allele showed neurodegenerative properties when cocultured with SOD1G93A glial cells. Thus, our studies demonstrate that glial cells carrying a human SOD1G93A mutation have a direct, non - cell autonomous effect on motor neuron survival. More generally, our results show that ESC- based models of disease provide a powerful tool for studying the mechanisms of neural degeneration. These phenotypes displayed in culture could provide cell- based assays for the identification of new ALS drugs.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Stem Cell Inst, Stowers Med Inst, Cambridge, MA 02138 USA; Univ Perugia, I-06100 Perugia, Italy	Harvard University; Harvard University; Stowers Institute for Medical Research; University of Perugia	Maniatis, T (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	maniatis@mcb.harvard.edu; eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018	Siao, Michelle/0000-0002-3600-9483	NICHD NIH HHS [R01 HD046732, R01 HD046732-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS043915-27, R01 NS043915] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043915] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BANKER G, 1998, CULTURING NERVE CELL; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Ben-Nun IF, 2006, MOL CELL ENDOCRINOL, V252, P154, DOI 10.1016/j.mce.2006.03.034; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cole N, 1999, SEMIN NEUROL, V19, P407, DOI 10.1055/s-2008-1040855; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hogan B, 1994, MANIPULATING MOUSE E; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	32	613	647	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					608	614		10.1038/nn1885	http://dx.doi.org/10.1038/nn1885			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435754	Green Accepted			2022-12-24	WOS:000245948000017
J	Jiang, Y; Zhou, K; He, S				Jiang, Yi; Zhou, Ke; He, Sheng			Human visual cortex responds to invisible chromatic flicker	NATURE NEUROSCIENCE			English	Article							OCCIPITAL CORTEX; COLOR; AWARENESS; ADAPTATION; ACHROMATOPSIA; FEEDFORWARD; PERCEPTION; SIGNAL; AREA	When two isoluminant colors alternate at frequencies of 25 Hz or higher, observers perceive only one fused color. Chromatic flicker beyond the fusion frequency induces flicker adaptation in human observers and stimulates monkey V1 neurons. Here we use functional magnetic resonance imaging ( fMRI) to show that many human visual cortical areas, with the exception of VO, can distinguish between fused chromatic flicker and its matched nonflickering control. This result supports the existence of significant intracortical temporal filtering of high-frequency chromatic information. The result also suggests that a considerable difference in cortical activation in many visual cortical areas does not necessarily lead to different conscious experiences.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Chinese Acad Sci, Grad Sch, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.	sheng@umn.edu	Jiang, Yi/I-1688-2018; Zhou, Ke/B-6745-2014	Jiang, Yi/0000-0002-5746-7301; 	NATIONAL EYE INSTITUTE [R01EY015261] Funding Source: NIH RePORTER; NEI NIH HHS [EY-015261-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BLAKE R, 2005, FITTING MIND WORLD A; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; Brown JL, 1965, VISION VISUAL PERCEP; Carmel D, 2006, CURR BIOL, V16, P907, DOI 10.1016/j.cub.2006.03.055; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; DAMASIO A, 1980, NEUROLOGY, V30, P1064, DOI 10.1212/WNL.30.10.1064; Davison AC, 1997, BOOTSTRAP METHODS TH; DELANGEDZN H, 1958, J OPT SOC AM, V48, P784, DOI 10.1364/JOSA.48.000784; Efron B., 1994, INTRO BOOTSTRAP; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; Juan CH, 2003, PROG BRAIN RES, V144, P117, DOI 10.1016/S0079-6123(03)14400-8; KELLY DH, 1971, J OPT SOC AM, V61, P537, DOI 10.1364/JOSA.61.000537; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2001, ACTA PSYCHOL, V107, P209, DOI 10.1016/S0001-6918(01)00020-8; Liu JJ, 2005, J NEUROSCI, V25, P3459, DOI 10.1523/JNEUROSCI.4206-04.2005; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MATIN L, 1968, J OPT SOC AM, V58, P404, DOI 10.1364/JOSA.58.000404; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PEARLMAN AL, 1979, ANN NEUROL, V5, P253, DOI 10.1002/ana.410050307; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; Steven MS, 2006, CORTEX, V42, P304, DOI 10.1016/S0010-9452(08)70356-3; Vul E, 2006, NAT NEUROSCI, V9, P873, DOI 10.1038/nn1723; Williams PE, 2004, J NEUROSCI, V24, P8278, DOI 10.1523/JNEUROSCI.2716-04.2004; ZEKI S, 1990, BRAIN, V113, P1721, DOI 10.1093/brain/113.6.1721	32	78	78	5	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					657	662		10.1038/nn1879	http://dx.doi.org/10.1038/nn1879			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17396122				2022-12-24	WOS:000245948000023
J	Huang, X; Albright, TD; Stoner, GR				Huang, Xin; Albright, Thomas D.; Stoner, Gene R.			Adaptive surround modulation in cortical area MT	NEURON			English	Article							TEMPORAL VISUAL AREA; MACAQUE V1 NEURONS; CLASSICAL RECEPTIVE-FIELD; OWL MONKEY; DIRECTIONAL SELECTIVITY; FUNCTIONAL-PROPERTIES; SPATIAL-DISTRIBUTION; CONTRAST DEPENDENCE; RESPONSE PROPERTIES; MOTION COHERENCE	Visual motion perception relies on two opposing operations: integration and segmentation. Integration overcomes motion ambiguity in the visual image by spatial pooling of motion signals, whereas segmentation identifies differences between adjacent moving objects. For visual motion area MT, previous investigations have reported that stimuli in the receptive field surround, which do not elicit a response when presented alone, can nevertheless modulate responses to stimuli in the receptive field center. The directional tuning of this "surround modulation" has been found to be mainly antagonistic and hence consistent with segmentation. Here, we report that surround modulation in area MT can be either antagonistic or integrative depending upon the visual stimulus. Both types of modulation were delayed relative to response onset. Our results suggest that the dominance of antagonistic modulation in previous MT studies was due to stimulus choice and that segmentation and integration are achieved, in part, via adaptive surround modulation.	Salk Inst Biol Studies, Vis Ctr Lab, La Jolla, CA 92037 USA	Salk Institute	Huang, X (corresponding author), Salk Inst Biol Studies, Vis Ctr Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	huangx@phy.ucsf.edu; gene@salk.edu			NEI NIH HHS [R01 EY012872-07, R01 EY012872-06, R01 EY012872-05, R01 EY012872-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012872] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Bair W, 2003, J NEUROSCI, V23, P7690; BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; Berezovskii VK, 2000, J NEUROSCI, V20, P1157, DOI 10.1523/JNEUROSCI.20-03-01157.2000; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Bradley DC, 1998, J NEUROSCI, V18, P7552; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; GATTASS R, 1988, J NEUROSCI, V8, P1831; Hanada M, 2004, VISION RES, V44, P1757, DOI 10.1016/j.visres.2004.03.001; HEINEMANN EG, 1955, J EXP PSYCHOL, V50, P89, DOI 10.1037/h0040919; HELSON H, 1963, J OPT SOC AM, V53, P179, DOI 10.1364/JOSA.53.000179; Krekelberg B, 2005, J NEUROPHYSIOL, V93, P2908, DOI 10.1152/jn.00473.2004; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Morgan MJ, 1997, VISION RES, V37, P2737, DOI 10.1016/S0042-6989(97)00074-6; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; MURAKAMI I, 1993, VISION RES, V33, P2091, DOI 10.1016/0042-6989(93)90008-K; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Pack CC, 2005, J NEUROPHYSIOL, V93, P1809, DOI 10.1152/jn.00629.2004; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Perge JA, 2005, EUR J NEUROSCI, V22, P2049, DOI 10.1111/j.1460-9568.2005.04363.x; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; TANAKA K, 1986, J NEUROSCI, V6, P134; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WESTHEIMER G, 1986, J PHYSIOL-LONDON, V370, P619, DOI 10.1113/jphysiol.1986.sp015954; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; XIAO DK, 1995, P NATL ACAD SCI USA, V92, P11303, DOI 10.1073/pnas.92.24.11303; Xiao DK, 1997, CEREB CORTEX, V7, P662, DOI 10.1093/cercor/7.7.662; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	51	57	57	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					761	770		10.1016/j.neuron.2007.01.032	http://dx.doi.org/10.1016/j.neuron.2007.01.032			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329214	Green Accepted, Bronze			2022-12-24	WOS:000245127100015
J	Tzingounis, AV; Kobayashi, M; Takamatsu, K; Nicoll, RA				Tzingounis, Anastassios V.; Kobayashi, Masaaki; Takamatsu, Ken; Nicoll, Roger A.			Hippocalcin gates the calcium activation of the slow afterhyperpolarization in hippocampal pyramidal cells	NEURON			English	Article							POTASSIUM CHANNELS; K+ CURRENT; PHOTOLYTIC MANIPULATION; CA2+ TRANSIENTS; ION CHANNELS; CA1 NEURONS; TIME-COURSE; RAT-BRAIN; KINETICS; CALMODULIN	In the brain, calcium influx following a train of action potentials activates potassium channels that mediate a slow afterhyperpolarization current (I-sAHP). The key steps between calcium influx and potassium channel activation remain unknown. Here we report that the key intermediate between calcium and the sAHP channels is the diffusible calcium sensor hippocalcin. Brief depolarizations sufficient to activate the IsAHP in wild-type mice do not elicit the I-sAHP in hippocalcin knockout mice. Introduction of hippocalcin in cultured hippocampal neurons leads to a pronounced IsAHP, while neurons expressing a hippocalcin mutant lacking N-terminal myristoylation exhibit a small I-sAHP that is similar to that recorded in uninfected neurons. This implies that hippocalcin must bind to the plasma membrane to mediate its effects. These findings support a model in which the calcium sensor for the sAHP channels is not preassociated with the channel complex.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Toho Univ, Sch Med, Dept Physiol, Ohta Ku, Tokyo 1438540, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu			NIMH NIH HHS [R37 MH038256] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; ALGER BE, 1994, NEUROSCI LETT, V168, P23, DOI 10.1016/0304-3940(94)90407-3; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Elliott RC, 2003, J NEUROSCI, V23, P2218; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Gerlach AC, 2004, PFLUG ARCH EUR J PHY, V448, P187, DOI 10.1007/s00424-003-1237-2; Jahromi BS, 1999, NEUROSCIENCE, V88, P719, DOI 10.1016/S0306-4522(98)00203-6; KNOPFEL T, 1990, P NATL ACAD SCI USA, V87, P4083, DOI 10.1073/pnas.87.11.4083; Kobayashi M, 2005, NEUROSCIENCE, V133, P471, DOI 10.1016/j.neuroscience.2005.02.034; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; Korhonen L, 2005, MOL CELL NEUROSCI, V28, P85, DOI 10.1016/j.mcn.2004.08.015; LANCASTER B, 1994, J PHYSIOL-LONDON, V475, P229, DOI 10.1113/jphysiol.1994.sp020064; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; O'Callaghan DW, 2003, J CELL BIOL, V163, P715, DOI 10.1083/jcb.200306042; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Sah P, 1999, J NEUROSCI, V19, P3657; SAH P, 1992, J NEUROPHYSIOL, V68, P2237, DOI 10.1152/jn.1992.68.6.2237; Shah M, 2000, J NEUROPHYSIOL, V83, P2554, DOI 10.1152/jn.2000.83.5.2554; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zhang L, 1995, J NEUROPHYSIOL, V74, P2225, DOI 10.1152/jn.1995.74.6.2225	35	85	86	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					487	493		10.1016/j.neuron.2007.01.011	http://dx.doi.org/10.1016/j.neuron.2007.01.011			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296551	Bronze, Green Accepted			2022-12-24	WOS:000245126900008
J	Brown, RM; Robertson, EM				Brown, Rachel M.; Robertson, Edwin M.			Inducing motor skill improvements with a declarative task	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; MEMORY; SLEEP; CONSOLIDATION; SYSTEMS	During sequence learning, individuals show motor- skill acquisition and an ability to verbally describe items within the sequence. We disrupted this latter, declarative component by having participants learn a word list immediately after sequence learning. This induced off- line skill improvements. We conclude that off- line memory processing relies not only on the engagement of neuroplastic mechanisms but also on the disengagement of an interaction between declarative and procedural memory systems.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Robertson, EM (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Noninvas Brain Stimulat, 330 Brookline Ave,Kirstein Bldg KS 446, Boston, MA 02215 USA.	emrobert@bidmc.harvard.edu		Brown, Rachel M./0000-0002-4851-8429	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051446] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051446] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Fischer S, 2006, J COGNITIVE NEUROSCI, V18, P311, DOI 10.1162/089892906775990598; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Willingham DB, 1997, NEURON, V18, P5, DOI 10.1016/S0896-6273(01)80040-4; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047	12	93	93	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2007	10	2					148	149		10.1038/nn1836	http://dx.doi.org/10.1038/nn1836			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	135TB	17237776	Green Accepted			2022-12-24	WOS:000244175200007
J	Paradis, S; Harrar, DB; Lin, YX; Koon, AC; Hauser, JL; Griffith, EC; Zhu, L; Brass, LF; Chen, CF; Greenberg, ME				Paradis, Suzanne; Harrar, Dana B.; Lin, Yingxi; Koon, Alex C.; Hauser, Jessica L.; Griffith, Eric C.; Zhu, Li; Brass, Lawrence F.; Chen, Chinfei; Greenberg, Michael E.			An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development	NEURON			English	Article							DENDRITIC SPINE MORPHOGENESIS; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; NERVOUS-SYSTEM; PLASTICITY; NEUROLIGINS; RECEPTORS; REM2; DIFFERENTIATION; TRANSMISSION	We report the results of a genetic screen to identify molecules important for synapse formation and/or maintenance. siRNAs were used to decrease the expression of candidate genes in neurons, and synapse development was assessed. We surveyed 22 cadherin family members and demonstrated distinct roles for cadherin-11 and cadherin-13 in synapse development. Our screen also revealed roles for the class 4 Semaphorins Sema4B and Sema4D in the development of glutamatergic and/or GABAergic synapses. We found that Sema4D affects the formation of GABAergic, but not glutamatergic, synapses. Our screen also identified the activity-regulated small GTPase Rem2 as a regulator of synapse development. A known calcium channel modulator, Rem2 may function as part of a homeostatic mechanism that controls synapse number. These experiments establish the feasibility of RNAi screens to characterize the mechanisms that control mammalian neuronal development and to identify components of the genetic program that regulate synapse formation and/or maintenance.	Childrens Hosp, Dept Neurol, Program Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania	Greenberg, ME (corresponding author), Childrens Hosp, Dept Neurol, Program Neurobiol, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu		Harrar, Dana/0000-0001-6382-8479; Hauser Chatterjee, Jessica/0000-0002-9992-1736; /0000-0002-7002-1275; Griffith, Eric/0000-0003-0428-3215; Koon, Alex/0000-0002-4274-7052	NEI NIH HHS [R01 EY013613] Funding Source: Medline; NHLBI NIH HHS [HL81012, P50 HL081012] Funding Source: Medline; NICHD NIH HHS [P30 HD018655-25, P30 HD018655, HD18655] Funding Source: Medline; NINDS NIH HHS [NS45500, R01 NS045500, R01 NS045500-20] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013613] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Burkhardt C, 2005, FEBS LETT, V579, P3821, DOI 10.1016/j.febslet.2005.05.079; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HE Z, 2002, SCI STKE, V119, pRE1, DOI DOI 10.1126/STKE.2002.119.RE1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Nusser Z, 1998, J NEUROSCI, V18, P1693; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Sala C, 2003, J NEUROSCI, V23, P6327; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	45	178	183	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					217	232		10.1016/j.neuron.2006.12.012	http://dx.doi.org/10.1016/j.neuron.2006.12.012			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224404	Bronze, Green Accepted			2022-12-24	WOS:000245126600008
J	Kim, YJ; Grabowecky, M; Paller, KA; Muthu, K; Suzuki, S				Kim, Yee Joon; Grabowecky, Marcia; Paller, Ken A.; Muthu, Krishnakumar; Suzuki, Satoru			Attention induces synchronization-based response gain in steady-state visual evoked potentials	NATURE NEUROSCIENCE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; FREQUENCY SELECTIVITY; CORTICAL-NEURONS; MODULATION; CORTEX; DISCRIMINATION; SENSITIVITY; COMPETITION; MECHANISMS; DYNAMICS	When attention is voluntarily directed to a spatial location, visual sensitivity increases at that location. What causes this improved sensitivity? Studies of single neuron spike rates in monkeys have provided mixed results in regard to whether attending to a stimulus increases its effective contrast ( contrast gain) or multiplicatively boosts stimulus-driven neural responses ( response or activity gain). We monitored frequency-tagged steady-state visual evoked potentials (SSVEPs) in humans and found that voluntary sustained attention multiplicatively increased stimulus-driven population electrophysiological activity. Analyses of intertrial phase coherence showed that this attentional response gain was at least partially due to the increased synchronization of SSVEPs to stimulus flicker. These results suggest that attention operates in a complementary manner at different levels; attention seems to increase single-neuron spike rates in a variety of ways, including contrast, response and activity gains, while also inducing a multiplicative boost on neural population activity via enhanced response synchronization.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Suzuki, S (corresponding author), Northwestern Univ, Dept Psychol, 2029 Sheridan Rd, Evanston, IL 60208 USA.	satoru@northwestern.edu	Paller, Ken/M-2676-2019	Paller, Ken/0000-0003-4415-4143	NEI NIH HHS [EY14110] Funding Source: Medline; NINDS NIH HHS [NS34639] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034639, R29NS034639] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Buia C, 2006, J COMPUT NEUROSCI, V20, P247, DOI 10.1007/s10827-006-6358-0; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Di Russo F, 2001, VISION RES, V41, P2435, DOI 10.1016/S0042-6989(01)00134-1; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; EDWARDS DP, 1995, VISION RES, V35, P1501, DOI 10.1016/0042-6989(94)00253-I; Fell J, 2003, BRAIN RES REV, V42, P265, DOI 10.1016/S0165-0173(03)00178-4; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Hou C, 2003, J NEUROSCI, V23, P8630; Huang LQ, 2005, VISION RES, V45, P1201, DOI 10.1016/j.visres.2004.10.024; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Ling S, 2006, VISION RES, V46, P1210, DOI 10.1016/j.visres.2005.05.008; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Regan D., 1989, HUMAN BRAIN ELECTROP; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; SCHILLER PH, 1990, VISUAL NEUROSCI, V5, P321, DOI 10.1017/S0952523800000420; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005	50	168	170	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					117	125		10.1038/nn1821	http://dx.doi.org/10.1038/nn1821			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173045				2022-12-24	WOS:000243096100023
J	Koida, K; Komatsu, H				Koida, Kowa; Komatsu, Hidehiko			Effects of task demands on the responses of color-selective neurons in the inferior temporal cortex	NATURE NEUROSCIENCE			English	Article							PRIMATE PREFRONTAL CORTEX; MACAQUE VISUAL-CORTEX; AREA V4; INFEROTEMPORAL CORTEX; SINGLE NEURONS; RECOGNITION MEMORY; ATTENTION; DISCRIMINATION; MONKEYS; SEARCH	Categorization and fine discrimination are two different functions in visual perception, and we can switch between these two functions depending on the situation or task demands. To explore how visual cortical neurons behave in such situations, we recorded the activities of color-selective neurons in the inferior temporal ( IT) cortex of two monkeys trained to perform a color categorization task, a color discrimination task and a simple fixation task. Many IT neurons changed their activity depending upon the task, although color selectivity was well conserved. A majority of neurons showed stronger responses during the categorization task. Moreover, for the population of IT neurons as a whole, signals contributing to performing the categorization task were enhanced. These results imply that judgment of color category by color-selective IT neurons is facilitated during the categorization task and suppressed during the discrimination task as a consequence of task-dependent modulation of their activities.	Natl Inst Physiol Sci, Div Sensory & Cognit Informat, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Komatsu, H (corresponding author), Natl Inst Physiol Sci, Div Sensory & Cognit Informat, Okazaki, Aichi 4448585, Japan.	komatsu@nips.ac.jp	Koida, Kowa/F-5712-2010	Koida, Kowa/0000-0003-0156-3406				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Bornstein MH., 1987, CATEGORICAL PERCEPTI, P287; Buckley MJ, 1997, J NEUROPHYSIOL, V77, P587, DOI 10.1152/jn.1997.77.2.587; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Conner CE, 1997, J NEUROSCI, V17, P3201; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; ESKANDAR EN, 1992, J NEUROPHYSIOL, V68, P1277, DOI 10.1152/jn.1992.68.4.1277; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; HEYWOOD CA, 1995, EUR J NEUROSCI, V7, P1064, DOI 10.1111/j.1460-9568.1995.tb01093.x; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Huxlin KR, 2000, CEREB CORTEX, V10, P671, DOI 10.1093/cercor/10.7.671; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kaiser P.K, 1996, HUMAN COLOR VISION; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOMATSU H, 1992, J NEUROSCI, V12, P408; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MIKAMI A, 1980, BRAIN RES, V182, P65, DOI 10.1016/0006-8993(80)90830-6; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; RICHMOND BJ, 1987, J NEUROPHYSIOL, V58, P1292, DOI 10.1152/jn.1987.58.6.1292; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Suzuki W, 2006, J NEUROSCI, V26, P10524, DOI 10.1523/JNEUROSCI.1532-06.2006; Takechi H, 1997, NEUROSCI LETT, V230, P17, DOI 10.1016/S0304-3940(97)00461-8; Takeda M, 2005, NEURON, V48, P839, DOI 10.1016/j.neuron.2005.09.028; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	47	88	89	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					108	116		10.1038/nn1823	http://dx.doi.org/10.1038/nn1823			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173044				2022-12-24	WOS:000243096100022
J	Chung, HJ; Jan, LY				Chung, Hee Jung; Jan, Lily Y.			Channeling to the nucleus	NEURON			English	Editorial Material							CALCIUM-CHANNELS; CLASS-C; SUBUNITS	L-type voltage-gated calcium channels (LTCs) may control neuronal gene expression by increasing nuclear Ca2+ levels or regulating Ca2+/calmoclulin-dependent transcription factors. In the November 3 issue of Cell, Gomez-Ospina et al. demonstrate another signaling mechanism, in which a C-terminal fragment of LTC translocates to the nucleus in a calcium-dependent manner and directly regulates transcription.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Chung, HJ (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.			Chung, Hee Jung/0000-0002-5555-9907; Jan, Lily/0000-0003-3938-8498				Belliveau DJ, 2006, J BIOL CHEM, V281, P20920, DOI 10.1074/jbc.M600026200; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6	12	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					937	940		10.1016/j.neuron.2006.12.001	http://dx.doi.org/10.1016/j.neuron.2006.12.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178398	Bronze			2022-12-24	WOS:000243115100003
J	MacLeod, D; Dowman, J; Hammond, R; Leete, T; Inoue, K; Abeliovich, A				MacLeod, David; Dowman, Julia; Hammond, Rachel; Leete, Thomas; Inoue, Keiichi; Abeliovich, Asa			The familial parkinsonism gene LRRK2 regulates neurite process morphology	NEURON			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; MUTATIONS; TRANSCRIPTION; OUTGROWTH; SYNUCLEIN	Mutations in LRRK2 underlie an autosomal-dominant, inherited form of Parkinson's disease (PD) that mimics the clinical features of the common "sporadic" form of PD. The LRRK2 protein includes putative GTPase, protein kinase, WD40 repeat, and leucine-rich repeat (LRR) domains of unknown function. Here we show that PD-associated LRRK2 mutations display disinhibited kinase activity and induce a progressive reduction in neurite length and branching both in primary neuronal cultures and in the intact rodent CNS. In contrast, LRRK2 deficiency leads to increased neurite length and branching. Neurons that express PD-associated LRRK2 mutations additionally harbor prominent phospho-tau-positive inclusions with lysosomal characteristics and ultimately undergo apoptosis.	Columbia Univ Coll Phys & Surg, Dept Pathol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Taub Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Abeliovich, A (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Ctr Neurobiol & Behav, 15-403 630 W 168th St, New York, NY 10032 USA.	aa900@columbia.edu		Inoue, Keiichi/0000-0002-7101-486X; Leete, Thomas/0000-0001-8655-1476				Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; TROY CM, 1992, J CELL BIOL, V117, P1085, DOI 10.1083/jcb.117.5.1085; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	17	453	470	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					587	593		10.1016/j.neuron.2006.10.008	http://dx.doi.org/10.1016/j.neuron.2006.10.008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114044	Bronze			2022-12-24	WOS:000242413100007
J	Preuschoff, K; Bossaerts, P; Quartz, SR				Preuschoff, Kerstin; Bossaerts, Peter; Quartz, Steven R.			Neural differentiation of expected reward and risk in human subcortical structures	NEURON			English	Article							SOMATIC MARKER HYPOTHESIS; DOPAMINE NEURONS; DECISION-MAKING; ASSET PRICES; UNCERTAINTY; RESPONSES; BRAIN; ANTICIPATION; MIDBRAIN; CORTEX	In decision-making under uncertainty, economic studies emphasize the importance of risk in addition to expected reward. Studies in neuroscience focus on expected reward and learning rather than risk. We combined functional imaging with a simple gambling task to vary expected reward and risk simultaneously and in an uncorrelated manner. Drawing on financial decision theory, we modeled expected reward as mathematical expectation of reward, and risk as reward variance. Activations in dopaminoceptive structures correlated with both mathematical parameters. These activations differentiated spatially and temporally. Temporally, the activation related to expected reward was immediate, while the activation related to risk was delayed. Analyses confirmed that our paradigm minimized confounds from learning, motivation, and salience. These results suggest that the primary task of the dopaminergic system is to convey signals of upcoming stochastic rewards, such as expected reward and risk, beyond its role in learning, motivation, and salience.	CALTECH, Computat & Neural Syst Program, Social Cognit Neurosci Lab, Pasadena, CA 91125 USA; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Preuschoff, K (corresponding author), CALTECH, Computat & Neural Syst Program, Social Cognit Neurosci Lab, 1200 E California Blvd 228-77, Pasadena, CA 91125 USA.	kerstinp@caltech.edu	Preuschoff, Kerstin/AAG-4725-2019; Bossaerts, Peter/AAZ-9851-2020; Preuschoff, Kerstin/G-4710-2015; Zhang, Xiao/V-9027-2017; Bossaerts, Peter/O-9964-2015	Preuschoff, Kerstin/0000-0001-7254-833X; Bossaerts, Peter/0000-0003-2308-2603; Zhang, Xiao/0000-0002-2932-5875; 				ABEL AB, 1990, AM ECON REV, V80, P38; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; BIALEK W, 1992, TRENDS NEUROSCI, V15, P428, DOI 10.1016/0166-2236(92)90005-S; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Bossaerts P., 2004, Review of Finance, V8, P135, DOI 10.1023/B:EUFI.0000035190.24818.e5; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Clark L, 2001, AM J PSYCHIAT, V158, P1605, DOI 10.1176/appi.ajp.158.10.1605; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DAVIDSON R, 1981, ECONOMETRICA, V49, P781, DOI 10.2307/1911522; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-7; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; LINTNER J, 1965, REV ECON STAT, V47, P13, DOI 10.2307/1924119; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; Minassian A, 2004, J AFFECT DISORDERS, V82, P203, DOI 10.1016/j.jad.2003.11.010; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MOSSIN J, 1966, ECONOMETRICA, V34, P768, DOI 10.2307/1910098; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; REAL LA, 1991, SCIENCE, V253, P980, DOI 10.1126/science.1887231; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; Samuelson W., 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Shurman B, 2005, SCHIZOPHR RES, V72, P215, DOI 10.1016/j.schres.2004.03.020; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1007/BF00115009; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; TOBIN J, 1957, REV ECON STUD, V25, P65; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	54	457	462	0	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 3	2006	51	3					381	390		10.1016/j.neuron.2006.06.024	http://dx.doi.org/10.1016/j.neuron.2006.06.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	075TT	16880132	Bronze, Green Submitted			2022-12-24	WOS:000239908800013
